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Summary
From 1962 to 1971, the U.S. military sprayed herbicides over Vietnam to 
strip the thick jungle canopy that could conceal opposition forces, to destroy 
crops that those forces might depend on, and to clear tall grasses and bushes from 
the perimeters of U.S. base camps and outlying fire-support bases. Mixtures of 
2,4-dichlorophenoxyacetic acid (2,4-D), 2,4,5-trichlorophenoxyacetic acid (2,4, 
5-T), picloram, and cacodylic acid (collectively, the “chemicals of interest” or 
COIs) made up the bulk of the herbicides sprayed. The herbicide mixtures used 
were named according to the colors of identification bands painted on the storage 
drums. The most-used chemical mixture sprayed was Agent Orange,1 a 50:50 mix-
ture of 2,4-D and 2,4,5-T. At the time of the spraying, 2,3,7,8-tetrachlorodibenzo- 
p-dioxin (TCDD), the most toxic form of dioxin, was an unintended contaminant 
generated during the production of 2,4,5-T and so was present in Agent Orange 
as well as some of the other formulations sprayed in Vietnam.
Concerns from returning Vietnam veterans about their own health and that 
of their children combined with emerging toxicologic evidence of the adverse 
effects of phenoxy herbicides and TCDD exposure from animal studies and some 
positive findings from epidemiologic studies led Congress to pass Public Law 
(PL) 102-4, the Agent Orange Act of 1991. This legislation directed the Secretary 
of Veterans Affairs to ask the National Academies of Sciences, Engineering, and 
Medicine (the “National Academies”) to perform a comprehensive evaluation 
1 Despite loose usage of “Agent Orange” as a collective term for all of the herbicides sprayed by 
U.S. forces during the Vietnam War—including in the title of this publication—it was only one of 
the formulations used. The text of the report uses “herbicides” or “COIs” to refer to the full range of 
herbicide agents, while “Agent Orange” is reserved for that specific formulation.
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2 VETERANS AND AGENT ORANGE: UPDATE 2014
of scientific and medical information regarding the health effects of exposure to 
Agent Orange, other herbicides used in Vietnam, and the various components of 
those herbicides, including TCDD. The legislation also instructed the Secretary 
to ask the National Academies to conduct updates every 2 years for 10 years from 
the date of the first report in order to review newly available literature and draw 
conclusions from the overall evidence.
In response to the first request, the Institute of Medicine convened a committee 
whose conclusions were published in 1994 in Veterans and Agent Orange: Health 
Effects of Herbicides Used in Vietnam (VAO). The work of later committees re-
sulted in a series of biennial updates (Update 1996, Update 1998, Update 2000, 
Update 2002, and Update 2004) and focused reports on the scientific evidence 
regarding type 2 diabetes, acute myeloid leukemia in the children of veterans, 
and the latent period for respiratory cancers.
Enacted in 2002, PL 107-103, the Veterans Education and Benefits Expan-
sion Act of 2001, mandated a continuation of the VAO biennial updates. Update 
2006, Update 2008, Update 2010, Update 2012, and Update 2014 were published 
under that legislation and subsequent extensions to the Department of Veterans 
Affairs’ (VA’s) authority to request reports. The current update presents this 
committee’s review of peer-reviewed scientific reports concerning associations 
between various health outcomes and exposure to TCDD and other chemicals in 
the herbicides used in Vietnam that were published between September 30, 2014, 
and December 31, 2017, and the committee’s integration of this information with 
the previously established evidence database.
CHARGE TO THE COMMITTEE
The committee was asked to “determine (to the extent that available sci-
entific data permit meaningful determinations)” the following regarding asso-
ciations between specific health outcomes and exposure to TCDD and other 
chemicals present in the herbicides used by the military in Vietnam:
A. whether a statistical association with herbicide exposure exists, taking 
into account the strength of the scientific evidence and the appropriate-
ness of the statistical and epidemiological methods used to detect the 
association;
B. the increased risk of disease among those exposed to herbicides during 
service in the Republic of Vietnam during the Vietnam era; and
C. whether there exists a plausible biological mechanism or other evidence 
of a causal relationship between herbicide exposure and the disease. [PL 
102-4, § 3(d)]
In addition, the committee was asked to address the current research available on 
possible generational health effects that may be the result of exposures to these 
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chemicals, including the biologic plausibility or potential for exposures to lead 
to an increased risk of birth defects or other adverse conditions in the descen-
dants of male veterans; on myeloproliferative neoplasms (MPN) as part of its 
consideration of the literature concerning leukemias and related diseases; and on 
glioblastoma multiforme in its review of brain cancers.
In conducting its work, the committee operated independently of VA and 
other government agencies. It was not asked to make and did not make judgments 
regarding specific cases in which individual Vietnam veterans have claimed injury 
from herbicide exposure or such broader issues as the potential costs of compensa-
tion for veterans or policies regarding such compensation.
COMMITTEE’S APPROACH TO ITS CHARGE
Following the pattern established by previous VAO committees, the present 
committee concentrated its review on epidemiologic studies so as to fulfill its charge 
of assessing whether specific human health effects are associated with exposure to 
at least one of the herbicides sprayed in Vietnam or to TCDD. The committee also 
examined controlled laboratory investigations that provided information on whether 
a scientifically relevant association between the COIs and a given effect is biologi-
cally plausible. Information on dioxins other than TCDD and dioxin-like chemicals 
was considered because of the common mode of action underlying biologic effects.
The evidence evaluation process presumes neither the presence nor the ab-
sence of association for any particular health outcome. Over the sequence of re-
views, evidence has accrued of various degrees of association, lack of association, 
or persistent indeterminacy with respect to a wide array of disease states. For many 
conditions, however, particularly ones that are very uncommon, any association 
with the COIs has remained unaddressed in the medical research literature. The 
committee does not offer a conclusion for these conditions unless the condition 
is logically subsumed under a broader disease category that has been evaluated, 
abiding by the maxim that “absence of evidence is not evidence of absence.”
In accord with Congress’s mandated presumption of herbicide exposure of all 
Vietnam veterans, VAO committees have treated Vietnam-veteran status as a proxy 
for herbicide exposure when no more specific exposure information is available. 
To anticipate the health conditions associated with aging and to obtain additional 
information potentially relevant to the evaluation of health effects in Vietnam vet-
erans, the committees have reviewed studies of other groups potentially exposed 
to the constituents present in the herbicide mixtures used in Vietnam. 
The original legislation calling for the report series, PL 102-4, did not pro-
vide a list of specific diseases and conditions suspected of being associated with 
herbicide exposure. Instead, a list was developed on the basis of diseases and con-
ditions that had been mentioned in the scientific literature or in other documents 
identified through the original VAO’s extensive literature searches. The VAO list 
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has since been augmented in response to new scientific findings, requests by VA, 
and concerns of Vietnam veterans.
The information that the present committee reviewed was identified through 
a comprehensive search of relevant databases, including databases covering epi-
demiologic, biologic, medical, toxicologic, chemical, historical, and regulatory 
information. To determine whether there is a scientifically relevant association 
between exposure and a health outcome, epidemiologists estimate the magni-
tude of an appropriate measure (such as the relative risk or the odds ratio) that 
describes the relationship between exposure and disease in a defined population 
or group. In evaluating the strength of the evidence linking herbicide exposure 
with a particular outcome, the committee considered whether such estimates of 
risk might not be consistent with a causal association (because of confounding, 
chance, or bias related to errors in selection and measurement) or might be an 
indication of a true association. Although they are not required, data support-
ing biologic plausibility can increase the confidence that an association is not 
spurious, and such data are presented in each of the sections. In this regard, it 
is important to note that while the biologic plausibility for a particular effect 
has been considered sufficient evidence of association by other bodies that have 
reviewed the health effects of environmental exposures, PL 102-4 specifies that 
the scientific determinations concerning the association between exposures and 
outcomes be supported by epidemiologic evidence. It has been the practice of all 
VAO committees to evaluate all studies according to the same criteria and then 
to weight findings of similar strength and validity equivalently, whether or not 
the study subjects are Vietnam veterans, when drawing conclusions. The com-
mittee recognizes that an absolute conclusion about the absence of association 
might never be attained, because—as is generally the case in science—studies of 
health outcomes after an exposure cannot demonstrate that a purported outcome 
is impossible, only that it is statistically improbable.
Tables on individual health outcomes summarizing the salient results of 
epidemiologic studies that have been evaluated over the entire series of VAO 
reports have been compiled and are available in digital form from www.nap.edu/
catalog/25137. The results for a particular endpoint are grouped by study popu-
lation to emphasize and clarify the relationship among successive publications 
based on the repeated study of particular exposed populations.
EVIDENCE REVIEWED BY THE COMMITTEE
The sections below describe the epidemiologic information that was newly 
evaluated for this update and illustrate the broad scope and nature of that informa-
tion. The studies are divided, both here and in the report’s health-outcome chapters, 
into four categories—Vietnam-veteran, occupational, environmental, and case-
control—reflecting the committee’s judgement of their relative relevance to the 
exposures of interest. Details of these publications are presented in Chapters 5–11.
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Vietnam-Veterans Studies
There has been an upswing of research interest in studies of the health of 
veterans of the Vietnam War, with publications addressing both U.S. and other 
populations. The committee considered analyses of the data and biospecimens 
collected in the course of the Air Force Health Study—a 20-year study of per-
sonnel involved in wartime aerial herbicide spray missions and a matched com-
parison group—to be particularly valuable because of the large amount of health 
and other information collected over an extended time period and because of the 
availability of measured serum dioxin levels. Since Update 2014, investigators 
have published studies of monoclonal gammopathy of undetermined significance 
(MGUS) and testosterone levels (which influence type 2 diabetes risk) in the 
cohort. A new study of hypertension in Army Chemical Corps personnel, who 
managed ground spraying operations, was also reviewed. Researchers using data 
from VA’s Agent Orange Registry, a database containing health information on 
Vietnam veterans who voluntarily undergo examinations in a VA medical center, 
produced papers on various health outcomes that relied on surrogates of herbicide 
exposure such as self-reports. Studies of health outcomes for Australian, Korean, 
and New Zealand Vietnam veterans were also released.
Occupational Studies
In contrast with Update 2014, which found few studies of health outcomes in 
workers occupationally exposed to the COIs, there were several new publications 
available for the current committee to consider. The subjects of these included 
chemical manufacturing workers in the United States, New Zealand agrochemical 
production personnel, waste incineration workers in Japan, and employees of an 
electric arc furnace facility in Italy, a transformer and capacitor recycling plant in 
Germany, and five factories in the United Kingdom manufacturing or formulating 
phenoxy herbicides.
The Agricultural Health Study—a longstanding examination how agricul-
tural, lifestyle, and genetic factors affect the health of U.S. farming populations 
being conducted by the National Institutes of Health (NIH)—has yielded numer-
ous papers reviewed in the VAO series of reports. New studies of asthma, body 
mass index (a risk factor for type 2 diabetes), end-stage renal disease, lung cancer, 
prostate cancer, and rheumatoid arthritis were reviewed by this committee.
Environmental Studies
The committee reviewed a considerable number of studies of the effects 
of environmental exposures to the COIs. Most involved measurements of com-
pounds with dioxin-like activity in blood samples and their association with 
a diverse set of health outcomes. The U.S. efforts included analyses of data 
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from Centers for Disease Control and Prevention’s (CDC’s) National Health and 
Nutrition Examination Surveys and NIH’s Longitudinal Investigation of Fertility 
and the Environment study cohorts. The large body of international work exam-
ined included the Danish Fetal Origins 1988–1989 Cohort, Duisburg (Germany) 
Birth Cohort Study, Hokkaido Study on Environment and Children’s Health and 
its Sapporo companion study, the (Chapaevsk) Russian Children’s Study, the 
Seveso (Italy) Woman’s Health Study, and publications concerning populations 
in Belgium, Brazil, Canada, China, Finland, France, Greece, Hong Kong, Italy, 
Korea, Nicaragua, Norway, Spain, and Taiwan. Ten newly published studies of 
birth and other health outcomes in the Vietnamese population were also identi-
fied and reviewed.
Case-Control Studies
Several new publications using case-control methodology from the CDC’s 
National Birth Defects Prevention Study were identified for the current update. 
These included studies of parental exposure to the COIs and spina bifida, con-
genital heart defects, gastroschisis, and a series of defects including anotia/
microtia, anorectal atresia/stenosis, transverse limb deficiency, craniosynostosis, 
and diaphragmatic hernia in offspring. 
A number of case-control studies in various other populations that examined 
forms of cancer (including cutaneous melanoma, female breast cancer, hepatocel-
lular carcinoma, infiltrating ductal carcinomas, non-Hodgkin lymphoma, pancre-
atic cancer, prostate cancer, soft tissue sarcoma, and testicular cancer) and other 
health outcomes including Parkinson disease, amyotrophic lateral sclerosis, and 
kidney and urinary disorders were also reviewed.
THE COMMITTEE’S CONCLUSIONS
General Observations Regarding Findings
VAO committees classify the evidence regarding exposure to the COIs and 
health outcomes into four categories: sufficient, limited or suggestive, inadequate 
or insufficient, and no association. Table S-1 sets forth the criteria for assigning 
categorizations and summarizes the committee’s conclusions, with the changes in 
classification made since the previous volume (Update 2014) indicated in bold-
face. The classifications are based on the committee’s evaluation of the epide-
miologic literature and reflect the committee members’ judgement of the relative 
certainty of the association between the outcome and exposure to the herbicides 
that were used in Vietnam or to any of their components or contaminants (with 
no intention of specifying particular chemicals).
The changes and the decisions not to modify other findings from earlier VAO 
committees were made after the present committee weighed the strengths and 
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TABLE S-1 Summary of the Eleventh Biennial Update Findings on  
Vietnam-Veteran, Occupational, and Environmental Studies Regarding 
Scientifically Relevant Associations Between Exposure to Herbicides and 
Specific Health Outcomesа
Sufficient Evidence of an Association
Epidemiologic evidence is sufficient to conclude that there is a positive association. That is, 
a positive association has been observed between exposure to herbicides and the outcome in 
studies in which chance, bias, and confounding could be ruled out with reasonable confidence.b 
For example, if several small studies that are free of bias and confounding show an association 
that is consistent in magnitude and direction, there could be sufficient evidence of an association. 
There is sufficient evidence of an association between exposure to the chemicals of interest and the 
following health outcomes:
 Soft-tissue sarcoma (including heart)
* Non-Hodgkin lymphoma
*  Chronic lymphocytic leukemia (including hairy cell leukemia and other chronic B-cell 
  leukemias)
* Hodgkin lymphoma
 Chloracne
 Hypertension (category change from Limited or Suggestive in Update 2014)
  Monoclonal gammopathy of undetermined significance (MGUS) (newly considered 
  condition)
The committee did not reach consensus on whether the evidence regarding type 2 diabetes 
(mellitus) was more properly classified as Sufficient or Limited or Suggestive.
Limited or Suggestive Evidence of an Association
Epidemiologic evidence suggests an association between exposure to herbicides and the 
outcome, but a firm conclusion is limited because chance, bias, and confounding could not be 
ruled out with confidence.b For example, a well-conducted study with strong findings in accord 
with less compelling results from studies of populations with similar exposures could constitute 
such evidence. There is limited or suggestive evidence of an association between exposure to the 
chemicals of interest and the following health outcomes:
 Laryngeal cancer
 Cancer of the lung, bronchus, or trachea
 Prostate cancer
 Cancer of the urinary bladder
* Multiple myeloma
* AL amyloidosis
 Early-onset peripheral neuropathy
 Parkinson disease (including Parkinsonism and Parkinson-like syndromes)
 Porphyria cutanea tarda
 Ischemic heart disease
 Stroke
 Hypothyroidism
The committee did not reach consensus on whether the evidence regarding type 2 diabetes 
(mellitus) was more properly classified as Sufficient or Limited or Suggestive.
continued
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TABLE S-1 Continued
Inadequate or Insufficient Evidence to Determine an Association
The available epidemiologic studies are of insufficient quality, consistency, or statistical power to 
permit a conclusion regarding the presence or absence of an association. For example, studies fail 
to control for confounding, have inadequate exposure assessment, or fail to address latency. There 
is inadequate or insufficient evidence to determine association between exposure to the chemicals 
of interest and the following health outcomes that were explicitly reviewed:
Cancers of the oral cavity (including lips and tongue), pharynx (including tonsils), or nasal 
cavity (including ears and sinuses)
Cancers of the pleura, mediastinum, and other unspecified sites in the respiratory system 
and intrathoracic organs
Esophageal cancer
Stomach cancer
Colorectal cancer (including small intestine and anus)
Hepatobiliary cancers (liver, gallbladder, and bile ducts)
Pancreatic cancer
Bone and joint cancers
Melanoma
Non-melanoma skin cancer (basal-cell and squamous-cell)
Breast cancer
Cancers of reproductive organs (cervix, uterus, ovary, testes, and penis; excluding prostate)
Renal cancer (kidney and renal pelvis)
Cancers of brain and nervous system (including eye)
Endocrine cancers (thyroid, thymus, and other endocrine organs)
Leukemia (other than chronic lymphocytic leukemia, including hairy-cell leukemia and 
other chronic B-cell leukemias)
   Other myeloid diseases (including myeloproliferative neoplasms)
Cancers at other and unspecified sites
Infertility
Spontaneous abortion (other than after paternal exposure to TCDD, which appears not to be 
associated)
Neonatal or infant death and stillbirth in offspring of exposed people
Low birth weight in offspring of exposed people
Birth defects in offspring of exposed people, including spina bifida
Childhood cancer (including acute myeloid leukemia) or other adverse health outcomes in 
offspring of exposed people
Neurobehavioral disorders (cognitive and neuropsychiatric)
Neurodegenerative diseases, excluding Parkinson disease
Chronic peripheral nervous system disorders
Hearing loss
Respiratory disorders (wheeze or asthma, chronic obstructive pulmonary disease, and 
farmer’s lung)
Gastrointestinal, metabolic, and digestive disorders (changes in hepatic enzymes, liver 
disorders including cirrhosis, lipid abnormalities, and ulcers)
Immune system disorders (immune suppression, allergy, and autoimmunity)
Circulatory disorders (other than hypertension, ischemic heart disease, and stroke)
Endometriosis
continued
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limitations of the epidemiologic evidence reviewed in this report and in previous 
VAO reports. Although the studies published since Update 2014 are the subject 
of detailed evaluation in this report, the committee drew its conclusions in the 
context of the entire body of literature, and the committee did not weigh new 
findings more heavily than past research.
As mandated by PL 102-4, the distinctions among categories are based on 
statistical association and not on strict causality. The committee was directed to 
review the scientific data, not to recommend VA policy; therefore, the conclusions 
reported in Table S-1 are not intended to imply or suggest policy decisions. The 
conclusions are related to the associations between exposure and outcomes in 
TABLE S-1 Continued
Disruption of thyroid homeostasis (other than hypothyroidism)
Eye problems
Bone conditions
   Kidney and urinary disorders (including chronic kidney disorder, differences in kidney  
   function, nephropathy, and end stage renal disorder)
   Chronic skin disorders (including skin infections and changes in skin pigmentation)
The committee used a classification that spans the full array of cancers. However, reviews for 
non-malignant conditions were conducted only if they were found to have been the subjects of 
epidemiologic investigation or at the request of the Department of Veterans Affairs. By default, any 
health outcome on which no epidemiologic information has been found falls into this category.
Limited or Suggestive Evidence of No Association
Several adequate studies, which cover the full range of human exposure, are consistent in 
not showing a positive association between any magnitude of exposure to a component of the 
herbicides of interest and the outcome. A conclusion of “no association” is inevitably limited to the 
conditions, exposures, and length of observation covered by the available studies. In addition, the 
possibility of a very small increase in risk at the exposure studied can never be excluded. There is 
limited or suggestive evidence of no association between exposure to the herbicide components of 
interest and the following health outcome:
Spontaneous abortion after paternal exposure to TCDD
 aHerbicides indicates the following chemicals of interest: 2,4-dichlorophenoxyacetic acid (2,4-D), 
2,4,5-trichlorophenoxyacetic acid (2,4,5-T) and its contaminant 2,3,7,8-tetrachlorodibenzo-p-dioxin 
(TCDD or dioxin), cacodylic acid, and picloram. The evidence regarding association was drawn 
from veteran, occupational, and environmental cohort studies in which people were exposed to the 
herbicides used in Vietnam, to their components, or to their contaminants.
 bEvidence of an association is strengthened by experimental data supporting biologic plausibility, 
but its absence would not detract from the epidemiologic evidence.
 *The committee notes the consistency of these findings with the biologic understanding of the 
clonal derivation of lymphohematopoietic cancers that is the basis of the World Health Organiza-
tion classification system (Campo et al., 2011; see table here: www.ncbi.nlm.nih.gov/pmc/articles/
PMC3109529/table/T1, accessed May 17, 2018).
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human populations, not to the likelihood that any individual’s health problem is 
associated with or caused by the herbicides in question.
Hypertension
The committee concluded that the information now assembled constitutes 
sufficient evidence of an association between exposure to at least one of the 
COIs and hypertension. The decision to change the classification from limited or 
suggestive evidence of an association was motivated in large part by the work 
of Cypel and colleagues (2016). These investigators conducted a study on the 
population of interest, U.S. Vietnam veterans (specifically, the Army Chemi-
cal Corps), that was characterized by a large sample size, appropriate controls, 
and validated health endpoints. The statistical analyses conducted were robust, 
used state-of-the-art methods, and adjusted for relevant confounders. The study 
clearly showed that self-reported hypertension rates were the highest among 
those military personnel with the greatest opportunity for exposure to the COIs. 
Among Vietnam-deployed veterans, there was a statistically significantly elevated 
association between the odds of hypertension for sprayers versus nonsprayers that 
remained after an adjustment for potential confounders. Similarly, for those veter-
ans who did not deploy to Vietnam, self-reported hypertension was significantly 
elevated among sprayers compared with nonsprayers. Earlier studies reviewed 
in previous updates consistently reported increased hypertension with increasing 
levels of serum dioxin in Vietnam veterans as well as increased prevalence in 
veterans with higher presumed exposure to the COIs. When considered in light 
of other new research and earlier studies that demonstrated a consistency in the 
direction and magnitude of this effect, the committee found that this body of 
literature constitutes sufficient evidence of an association.
Monoclonal Gammopathy of Undetermined Significance (MGUS)
The committee also concluded that there was sufficient evidence of an as-
sociation between exposure to at least one of the COIs and MGUS. MGUS is a 
precursor to multiple myeloma, although only an estimated 1% of MGUS cases 
progress to multiple myeloma each year. It is a clinically silent condition defined 
by the presence of a monoclonal antibody, antibody heavy chain, or antibody 
light chain in the blood or urine of a person lacking symptoms or signs of a 
more serious plasma cell dyscrasia. The foundation of this finding was a well-
conducted study by Landgren and colleagues (2015) that examined data and bio-
specimens from a population of veterans that included participants with known 
exposure to herbicides in Vietnam: the Air Force Health Study cohort. The study 
used previously measured serum levels of TCDD and performed a new assay of 
serum samples to detect MGUS. Known confounders including age, race, body 
mass index, smoking and drinking history, and a history of radiation therapy or 
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chemotherapy were considered. The investigators found a statistically significant 
higher prevalence of MGUS in veterans involved in herbicide spray operations 
than in comparison veterans. Although no previous study directly addressed 
MGUS incidence, the direct relevance of the exposure and exposed population 
and the high quality of the study and underlying database were persuasive in 
finding sufficient evidence of an association.
Type 2 Diabetes
Finally, the committee—after extensive deliberations—could not come to 
a consensus on whether the available evidence regarding exposure to the COIs 
and type 2 diabetes continued to be limited or suggestive or merited elevation 
to sufficient. Both newly reviewed and previously reviewed studies quite con-
sistently show a relationship between well-characterized exposures to dioxin 
and dioxin-like chemicals and measures of diabetes health outcomes in diverse 
cohorts, including Vietnam veteran populations. However, the lack of exposure 
specificity and the potential for uncontrolled confounding that characterized 
many of these studies complicates any attribution of the outcome to the COIs. 
Thus, a case can be made that the body of literature regarding the exposure to 
the COIs and diabetes meets the criteria for sufficient evidence of an association, 
but it was not clear to the committee as a whole whether a category change was 
appropriate, given its limitations. 
Findings on Health Outcomes Identified for Special Focus by VA
As noted, VA asked the committee to specifically address three health out-
comes: possible generational health effects that may be the result of herbicide 
exposure among male Vietnam veterans, myeloproliferative neoplasms, and glio-
blastoma multiforme. 
Research on the effects of paternal chemical exposures on their descendants 
is burgeoning. Few studies address Vietnam veterans, however, and almost all of 
them that were conducted on other populations have weaknesses—prominently, 
different exposures than those experienced by veterans and poor exposure char-
acterization—that limit their usefulness when assessing the risks for veterans. 
Some find associations between exposures and various outcomes, but there are 
no circumstances where there is a consistent and compelling body of evidence 
that would lead the committee to conclude that there might be limited or sug-
gestive or sufficient evidence of an association between an exposure to a COI 
and a particular outcome. Transgenerational effects—those that might occur in 
descendants when gestational exposure did not take place—are of great interest 
to veterans, but no literature exists to evaluate whether the COIs might have an 
influence on outcomes. Given these gaps in the knowledge base, the committee 
strongly believes that more work in this area is warranted. It concurs with the 
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Update 2014 committee that there is a critical need for this research to include 
animal studies in order to elucidate whether and which mechanisms for intergen-
erational and transgenerational effects might exist. It is in principle possible to 
do studies on the health of children and grandchildren of veterans, but it must be 
understood up front that such complex studies will need to be carefully planned 
and conducted if they are to yield meaningful results. Voluntary participation 
surveys and registries relying on self-reported information will not be helpful. 
Myeloproliferative neoplasms (MPNs) and myelodysplastic syndromes are 
diseases of the blood cells and bone marrow. VA asked that MPNs be explicitly 
examined as part of the consideration of the literature concerning leukemias 
and related diseases. However, after conducting a targeted search of science and 
medical databases, the committee was able to identify only one relevant paper, 
which assessed cancer incidence among Korean veterans who had served in 
Vietnam during 1964–1973 and was evaluated by the Update 2014 committee. 
The paper’s authors reported non-significant and imprecise increased risks of 
myeloproliferative disease and of myelodysplastic syndromes in internal com-
parisons of high- and low-exposure groups. The committee observes that, in 
general, those studies that have looked at the correlation between exposure to the 
COIs and hematological outcomes have generated much more compelling re-
sults for abnormalities of lymphoid development and immune function, such as 
non-Hodgkin lymphoma, chronic lymphocytic leukemia, multiple myeloma, and 
MGUS, than have those that examined myeloid neoplasms of granulocytic lineage 
such as MPN. Given the absence of new studies, the paucity of epidemiologic 
studies in general, and the lack of information on the biologic plausibility of a 
connection between exposures to the COIs and abnormalities of hematopoietic 
cells, the committee concluded there was inadequate or insufficient evidence of 
an association between exposure to the COIs and MPN. Because the outcome 
has not been subject to previous research attention and is of interest to veterans, 
the committee recommends that investigators examine existing databases on 
myeloid diseases to determine whether there are data available that would 
allow for an evaluation of MPN in Vietnam veterans and others who have 
been exposed to dioxin and the other COIs.
The scientific literature regarding exposure to the COIs and brain and other 
nervous system cancers, including glioblastoma, has been examined since the 
first VAO report. The body of evidence that has been developed has not found 
statistically significant associations between exposure and any relevant outcome 
in studies performed on Vietnam-veteran, occupational, or environmental co-
horts. These studies have by and large been underpowered because of the rela-
tive rarity of these cancers. Given the limited epidemiologic data available on 
glioblastoma, the committee heard invited presentations from two experts on the 
disease. While their presentations to the committee were helpful and impressive, 
demonstrating that the biological understanding of glioblastoma in particular 
is rapidly advancing, they reinforced the absence of clear data suggesting that 
the COIs are associated with the occurrence of brain cancers. Information on 
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glioblastomas in Vietnam veterans submitted for the committee’s consideration 
by the Sierra Valley Cancer Registry Services, Inc., was, in part, anecdotal and 
without documented levels of exposure and was therefore of limited usefulness 
for the purpose of drawing conclusions. Furthermore, the committee did not 
identify any animal studies that have reported an association between exposure 
to the COIs and any brain cancer. While some studies have put forward mecha-
nisms that might explain why dioxin exposure would be associated with glioblas-
toma, the information reviewed by the committee along with the presentations 
it received from experts in the field were not sufficient to alter the conclusion 
of previous reports that the evidence is inadequate or insufficient to determine 
whether there is an association between exposure to the COIs and brain or other 
nervous system cancers. The committee believes it is appropriate for VA to be 
mindful of the concerns raised about the possible association between Vietnam 
service and glioblastoma, but it observes that the outcome is so rare and the 
information concerning herbicide exposures so imprecise that it is doubtful that 
any logistically and economically feasible epidemiologic study of veterans—no 
matter how well designed or executed—would produce meaningful results. The 
committee therefore recommends that epidemiologic studies of glioblastoma 
in Vietnam veterans should not be pursued and that VA should instead focus 
on fostering advancements in other areas that may be used to inform im-
proved treatment options. 
Risk in Vietnam Veterans
Part of the committee’s charge was to determine, to the extent permitted by 
available scientific data, the increased risk of disease among veterans exposed to 
herbicides or the contaminant TCDD during service in Vietnam. Estimating the 
magnitude of risk of each particular health outcome among herbicide-exposed 
Vietnam veterans requires quantitative information about the dose–time–response 
relationship for the health outcome, information on the extent of herbicide ex-
posure among Vietnam veterans, and estimates of individual exposure. Vietnam 
veterans were exposed to other agents and stresses—such as tobacco smoke, 
insecticides, therapeutics, drugs, diesel fumes, alcohol, hot and humid conditions, 
and combat—that may have independent effects or increase or decrease the abil-
ity of chemicals in herbicides to produce a particular adverse health outcome. 
Few, if any, studies either in humans or in experimental animals have examined 
those interactions. The committees that produced the first VAO report and the 
updates found that the body of evidence was sufficient for reaching conclusions 
about statistical associations between herbicide exposures and health outcomes 
but that the lack of adequate data on Vietnam veterans themselves complicated 
the consideration of this part of the charge. The committees responsible for the 
VAO report series have therefore concluded that, in general, it is impossible to 
quantify the risk posed to veterans by their exposure to herbicides in Vietnam.
Veterans and Agent Orange: Update 11 (2018)
Copyright National Academy of Sciences. All rights reserved.
14 VETERANS AND AGENT ORANGE: UPDATE 2014
COMMITTEE RECOMMENDATIONS
As part of their charge, all VAO committees have been asked to offer recom-
mendations concerning the need for additional scientific studies and research to 
resolve areas of continuing scientific uncertainty concerning the health effects 
of the COIs. The previous (tenth; Update 2014) update of the VAO series was 
originally understood to be the last of the reports mandated by Congress. The 
committee responsible for that update thus considered it appropriate to compile 
the recommendations made by prior VAO committees and, in light of the lessons 
learned in this process, to consider what would be the most important activi-
ties to undertake in the future. That committee produced a compendium of the 
recommendations of prior committees condensed and sorted into topic areas, 
with comments on what response these recommendations had received from VA, 
Department of Defense (DoD), and other parties along with a summary of the 
future activities that the committee considered most important for monitoring and 
evaluating the health issues of Vietnam veterans and other veterans who might 
experience service-related health problems long after discharge.
Generally speaking, the recommendations of previous VAO committees fell 
into four primary areas: better management of veterans’ health information; ad-
ditional epidemiologic studies; improvement of exposure estimation; and priority 
areas for toxicologic research. Suggested future activities included these areas 
plus initiatives related to the collection and analysis of additional information on 
Vietnam veterans’ service, exposures, and health. 
While there have been a few laudable exceptions—notably, the initiation 
of additional epidemiologic studies on Vietnam veterans, the development of a 
herbicide exposure assessment model for use in studies of Vietnam veterans, and 
the fostering of additional research on the data and biospecimens collected in the 
course of the Air Force Health Study2—there has been no known follow-up to 
the vast majority of recommendations that have been offered. The current com-
mittee did not choose to revisit this issue in general, concluding that the Update 
2014 committee had effectively covered it. It does observe, though, that the very 
first VAO (1994) indicated that “carefully conducted epidemiologic studies—with 
adequate sample size to detect elevated associations—of the reproductive history 
of individuals with occupational or environmental exposure to herbicides and 
dioxin are . . . needed” (p. 731). Several subsequent volumes have echoed and 
expanded on this. The current committee is in agreement with these sentiments 
and therefore recommends further specific study of the health of offspring of 
male Vietnam veterans.
The Update 2014 committee also offered suggestions for research activities 
that should follow the end of the VAO report series. Several of these addressed 
2 The Institute of Medicine publications Disposition of the Air Force Health Study (2006) and The 
Air Force Health Study Assets Research Program (2015) provide details of this work.
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reproductive outcomes. As that committee noted, although progress has been 
made in understanding the health effects of exposure to the COIs and the mecha-
nisms underlying these effects, significant gaps in our knowledge remain. Many 
additional opportunities for progress via continuing and new toxicologic, mecha-
nistic, and epidemiologic research exist. Such work should include efforts to gain 
new knowledge through the integration of existing DoD and VA databases. While 
they were mentioned in previous VAO updates, that committee restated them to 
emphasize their conviction that more progress should be made in the fields noted. 
This committee concurs in this assessment and endorses the recommendations 
offered in Table 12-3, noting that research in the rapidly advancing field of epi-
genetics appears to hold particular promise.
FINAL OBSERVATIONS
In the course of carrying out its Statement of Task, the committee has offered 
myriad criticisms of the conduct of studies of Vietnam veterans’ health, pointing 
out specific weaknesses and shortcomings in particular papers and widespread 
(although not universal) issues such as poor exposure characterization, failure 
to fully control for confounding influences on outcomes, and sample sizes that 
are inadequate to draw statistically meaningful results. It wishes to make clear, 
though, that the difficulty in conducting research on Vietnam veteran health issues 
should not act as a barrier to carrying out such work. There are many questions 
regarding veterans’ health that cannot be adequately answered by examining 
superficially analogous exposures and outcomes in other populations. It is only 
through research on veterans themselves that the totality of the military service 
experience can be properly accounted for.
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1
Introduction
The Agent Orange Act of 1991—Public Law (PL) 102-4, enacted February 6, 
1991, and codified as Section 1116 of Title 38 of the United States Code—
directed the Secretary of Veterans Affairs to ask the National Academies of 
Sciences, Engineering, and Medicine (“the National Academies”) to conduct 
an independent comprehensive review and evaluation of scientific and medical 
information regarding the health effects of exposure to herbicides used during 
military operations in Vietnam. The act specified that the herbicides picloram and 
cacodylic acid were to be addressed, as were chemicals in various formulations 
that contain the herbicides 2,4-dichlorophenoxyacetic acid (2,4-D) and 2,4,5- 
trichlorophenoxyacetic acid (2,4,5-T). 
Agent Orange refers specifically to a 50:50 formulation of 2,4-D and 2,4,5-T, 
which was stored in barrels identified by an orange band, but the term has 
come to often be used more generically to refer to all the herbicides sprayed 
by the U.S. military in Vietnam.1 2,4,5-T contained the contaminant 2,3,7,8- 
tetrachlorodibenzo-p-dioxin, commonly referred to as “dioxin,” which is referred 
to in this report as TCDD, to represent a single—and the most toxic—congener 
of the tetrachlorodibenzo-p-dioxins. It should be noted that TCDD and Agent 
Orange are not synonymous. The National Academies was also asked to recom-
mend, as appropriate, additional studies needed to resolve continuing scientific 
uncertainties related to health effects and herbicide exposures and to comment 
1 Despite loose usage of “Agent Orange” by many people, in numerous publications, and even in 
the title of this series, this committee uses “herbicides” to refer to the full range of herbicide expo-
sures experienced in Vietnam, while “Agent Orange” is reserved for a specific one of the mixtures 
sprayed in Vietnam.
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on particular programs mandated in the law. The original legislation called for 
biennial reviews of newly available information for a period of 10 years, which 
was subsequently extended to October 1, 2014, by the Veterans Education and 
Benefits Expansion Act of 2001 (PL 107-103). Subsequently, through the Depart-
ment of Veterans Affairs Expiring Authorities Act, the Agent Orange Act of 1991 
was extended annually for 4 years (PL 113-175, PL 114-58, PL 114-228, and PL 
115-62), with a final termination date of September 30, 2018. Although the previ-
ous Veterans and Agent Orange (VAO) update was thought to be the final update 
in the series mandated by PL 107-103, the Department of Veterans Affairs (VA) 
interpreted the extension act to require an additional study.
PREVIOUS VETERANS AND AGENT ORANGE REPORTS
In response to the request from VA, the Institute of Medicine (IOM)2 of the 
National Academies convened the Committee to Review the Health Effects in 
Vietnam Veterans of Exposure to Herbicides. The results of the original commit-
tee’s work were published in 1994 as Veterans and Agent Orange: Health Effects 
of Herbicides Used in Vietnam, hereafter referred to as VAO (IOM, 1994). Suc-
cessor committees formed to fulfil the requirement for updated reviews produced 
Veterans and Agent Orange: Update 1996 (IOM, 1996), Update 1998 (IOM, 
1999), Update 2000 (IOM, 2001), Update 2002 (IOM, 2003c), Update 2004 
(IOM, 2005), Update 2006 (IOM, 2007), Update 2008 (IOM, 2009), Update 2010 
(IOM, 2011a), Update 2012 (IOM, 2014), and Update 2014 (NASEM, 2016a).
Intermittently between biennial updates, VA has requested targeted reviews 
of specific health outcomes to determine whether they are associated with ex-
posure to any of the chemicals of interest (COIs). These separate and focused 
topics have included type 2 diabetes (IOM, 2000b), childhood acute myelogenous 
leukemia (now generally referred to as acute myeloid leukemia) associated with 
parental exposure to any of the COIs (IOM, 2002), and respiratory cancers (IOM, 
2004). The respiratory cancer review was included in PL 107-103, which was 
passed by Congress in 2001 and which directed the Secretary of Veterans Affairs 
to ask the National Academies to review “available scientific literature on the 
effects of exposure to an herbicide agent containing dioxin on the development of 
respiratory cancers in humans” and to address “whether it is possible to identify a 
period of time after exposure to herbicides after which a presumption of service-
connection” of the disease would not be warranted.
Each report in the VAO series contains detailed reviews of the scientific stud-
ies evaluated by the committees and their implications for cancers, reproductive 
and developmental effects, neurologic disorders, and other health effects. VA 
has specified particular areas of focus for each update, for example, the Update 
2 Since March 2016, the Health and Medicine Division of the National Academies has continued the 
consensus studies and convening activities previously undertaken by the Institute of Medicine (IOM).
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2014 committee was asked to specifically address whether all neurodegenerative 
diseases with Parkinson-like symptoms should be considered service-related un-
der the association identified between Parkinson disease and herbicide exposure 
by the committee for Update 2006. Each committee used the compilation of 
evidence presented in the previous reports as a starting point for updating the evi-
dence base concerning the associations of health outcomes with exposure to any 
of the COIs. As such, each committee operated independently of prior commit-
tees, chose how to present the new and existing information, and determined its 
own conclusions regarding the strength of the evidence and each health outcome. 
In conducting their work, the committees responsible for the updates and the 
targeted reviews operated independently of VA and other government agencies. 
They were not asked to and did not make judgments regarding specific cases 
in which individual Vietnam veterans claimed injury from herbicide exposure. 
The reports are intended to provide evidence-based assessments of the scientific 
information available for the Secretary of Veterans Affairs to consider as VA ex-
ercises its responsibilities to Vietnam veterans. This report and all previous VAO 
reports are freely accessible online at the National Academies Press’s website 
(http://www.nap.edu).
CHARGE TO THE COMMITTEE
Box 1-1 shows the committee’s Statement of Task. A VA representative 
delivered the charge to the committee during the open session of the commit-
tee’s first meeting. In addition to the standard language of assessing associations 
between health outcomes and exposures to chemicals present in the herbicides 
used by the military in Vietnam that all VAO update committees are charged 
with reviewing, the committee for this final update was asked to assess three 
health outcomes in particular: possible generational effects on the descendants 
of male Vietnam veterans that may be the result of exposure to any of the COIs, 
myeloproliferative neoplasms, and glioblastoma multiforme. In addition, the 
committee was asked to offer recommendations as appropriate, such as which 
areas to prioritize for future research, a request that has been made of each of the 
VAO committees. 
Both the committee’s congressional mandate and the Statement of Task in-
struct that the evaluation be focused on the “association” between exposure and 
health outcomes, although biologic mechanisms and causal relationships are also 
mentioned as part of the evaluation in Article C. The criteria for causation do 
not themselves constitute a set checklist, but they are more stringent than those 
for association. The unique mandate of VAO committees to evaluate association 
rather than causation means that the rigor of the evidence required to support a 
finding of statistical association is weaker than what is required to support cau-
sality. Positive findings on any of the indicators for causality would strengthen a 
conclusion that an observed statistical association is valid. In accordance with its 
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charge, the committee examined a variety of indicators appropriate for the task, 
including factors commonly used to evaluate statistical associations, such as the 
adequacy of control for bias and confounding and the likelihood that an observed 
association could be explained by chance, and it assessed evidence concerning 
biologic plausibility derived from laboratory findings in cell culture or animal 
model systems. As such, a full array of indicators was used to categorize the 
strength of the evidence. In particular, associations supported by multiple indica-
tors were interpreted as having stronger scientific support. 
INFORMATION GATHERING
The committee convened by the National Academies included experts in 
epidemiology, biostatistics, environmental health, exposure assessment, military 
and veteran’s health, genetics and epigenetics, toxicology, oncology, and repro-
ductive health. It comprised 12 members who met in person 7 times over 14 
months. Between in-person meetings, small groups of committee members would 
BOX 1-1  
Committee’s Statement of Task
In accordance with PL 102-4, the committee was asked to “determine (to 
the extent that available scientific data permit meaningful determinations)” the 
following regarding associations between specific health outcomes and exposure 
to TCDD and other chemicals present in the herbicides used by the military in 
Vietnam:
A)  whether a statistical association with herbicide exposure exists, taking into 
account the strength of the scientific evidence and the appropriateness of the 
statistical and epidemiological methods used to detect the association;
B)  the increased risk of the disease among those exposed to herbicides during 
service in the Republic of Vietnam during the Vietnam era; and
C)  whether there exists a plausible biological mechanism or other evidence of a 
causal relationship between herbicide exposure and the disease. [PL 102-4, 
Section 3(d)]
It will also assess the current research available on possible generational 
health effects that may be the result of exposures to these chemicals—including 
the biologic plausibility or potential for an exposure to lead to an increased risk of 
birth defects or other adverse conditions in the descendants of male veterans—
and will address myeloproliferative neoplasms (MPNs) as part of its consideration 
of the literature concerning leukemias and related diseases. The review of brain 
cancer will address, in particular, glioblastoma multiforme. The report will offer 
findings, conclusions, and recommendations as appropriate.
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hold conference calls related to reviewing the specific studies or to discuss the 
evidence base on a particular topic. 
Several activities were undertaken to develop the scientific foundation for 
the report’s findings, conclusions, and recommendations. As has been the prac-
tice of previous VAO committees, the committee held three open sessions not 
only to gather additional information from people who have particular expertise 
on topics and subjects that arise during deliberations (such as VA researchers, 
experts in glioblastoma multiforme, and specialists in environmental exposures 
and heritable health effects), but also especially to listen to individual Vietnam 
veterans and others, such as spouses and other family members and veterans 
service organization advocates, who are concerned about aspects of health that 
may be service-related. Open sessions were held during meetings 1, 3, and 4, 
the agendas and presentation topics of which are presented in Appendix A. The 
comments and information provided by the public at the open meetings and over 
the course of the study were used to identify information gaps in the literature 
regarding specific health outcomes of concern to Vietnam veterans.
In addition to information provided from invited speakers and public attend-
ees at open sessions, the committee made information requests to VA to follow up 
on issues raised during presentations and on sources of data on Vietnam veterans 
who use VA health care. All presentations, responses to information requests, and 
written comments are available in the public access file for the project. 
The principal source of information on health effects from potential exposure 
to the COIs for the committee to consider and deliberate on came from detailed 
searches of the peer-reviewed literature published since VAO: Update 2014 
(NASEM, 2016a). The literature search strategy and process for reviewing all 
results is discussed in detail in Chapter 3: Evaluating the Evidence Base. This 
was supplemented by examining other pertinent published literature, govern-
ment documents and reports, and testimony presented to Congress; attending 
professional meetings and educational events; and consulting relevant National 
Academies reports. The committee also received data from VA, veterans’ advo-
cacy organizations, and other sources including the Sierra Valley Cancer Registry. 
ORGANIZATION OF THE REPORT
The remainder of this report is organized into 11 chapters, 2 appendixes, 
and an online supplement of studies reviewed in the course of the VAO series 
for each health outcome that has an associated conclusion. Chapter 2 presents 
background information about the population of Vietnam veterans and the mili-
tary herbicides used in the conflict and addresses exposure-assessment issues. 
Chapter 3 briefly describes the considerations that guided the committee’s review 
and evaluation of the scientific evidence. Chapter 4 summarizes the toxicology 
data on the effects of 2,4-D, 2,4,5-T and its contaminant TCDD, cacodylic 
acid, and picloram; these data contribute to the committee’s consideration of the 
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biologic plausibility of health effects in human populations. Chapter 5 offers a 
selected overview of the study populations that have generated findings (in some 
instances presented in dozens of separate publications) reviewed in the VAO re-
port series as well as those studies that have presented multiple health outcomes, 
which are presented and discussed in several chapters. In addition to showing 
where the new literature fits into the compendium of previous publications on 
Vietnam veterans, occupational cohorts, environmentally exposed groups, and 
case-control study populations, that chapter includes a description and critical 
appraisal of the approaches used in the design, exposure assessment, and analysis 
in these studies. 
The committee’s evaluation of the epidemiologic literature and its conclu-
sions regarding the associations between exposures and the particular health 
outcomes that might be manifested long after exposure to the COIs are presented 
in Chapters 6–11. Because many individual outcomes are included in each chap-
ter, a summary of the findings for each health outcome reviewed in a particular 
chapter is presented at the beginning of the chapter.
Chapter 6, the first of the chapters evaluating epidemiologic evidence con-
cerning particular health outcomes, addresses immunologic effects and discusses 
the reasons for what might be perceived as a discrepancy between a clear dem-
onstration of immunotoxicity in animal studies and a paucity of human epide-
miologic studies with similar findings. Its placement in the report reflects the 
committee’s belief that immunologic changes may constitute an intermediate 
step in the generation of distinct clinical conditions, as discussed in subsequent 
chapters.
Chapter 7 discusses issues related to the possible overall carcinogenic poten-
tial of the COIs, particularly TCDD, and then assesses, in order of their codes 
in the International Classification of Diseases, the available epidemiologic 
evidence on specific types of cancer, which are regarded as individual disease 
states that might be found to be service-related. Two of the conditions speci-
fied in the committee’s charge—glioblastoma multiforme and myeloproliferative 
neoplasms—are covered in this chapter. 
Chapter 8 addresses reproductive outcomes that may have been manifested 
in the veterans themselves, such as reduced fertility and pregnancy loss. It then 
covers gestational issues, including low birth weight and preterm delivery. This 
is followed by problems that might be manifested in veterans’ children at birth 
(traditionally defined as birth defects) or later in their lives (childhood cancers, 
plus a broad spectrum of conditions for which impacts from parental exposures 
have been posited) or even in later generations.
Chapter 9 addresses neurologic disorders and diseases of the nervous system. 
Chapter 10 covers conditions related to cardiovascular and metabolic effects 
(including diabetes) on the basis of their apparent interrelationship in the emerg-
ing medical phenomenon known as “metabolic syndrome.” Chapter 11 contains 
information covering the residual “other chronic health outcomes” about which 
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epidemiologic results related to the COIs have been encountered in the course 
of this series of VAO reports and in the current literature search: respiratory dis-
orders, gastrointestinal problems and liver toxicity, kidney and urinary bladder 
disease, thyroid homeostasis and other endocrine disorders, chronic skin condi-
tions (new to this report), eye problems, and bone conditions.
A summary of the committee’s findings and its research recommendations are 
presented in Chapter 12. In the previous report, which was intended to be the final 
report of the series as mandated by PL 102-4 and PL 107-103 (and extended by 
PL 113-175, PL 114-58, PL 114-228, and PL 115-62), the committee reported on 
the status of recommendations made throughout the VAO series. 
In the interest of minimizing unnecessary repetition, the citations for all chap-
ters have been merged into a single reference list that follows all of the chapters. 
Appendix A provides a list of open meeting agendas and invited presentation top-
ics. Committee and staff biographies can be found in Appendix B. Compendium 
tables summarizing new results identified for this current update as well as those 
reviewed by prior committees are available in digital form only and can be ac-
cessed from www.nap.edu/catalog/25137. 
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2
Background
This chapter provides background information on the current population of 
Vietnam veterans, the military use of herbicides during the Vietnam War, how dif-
ferent groups of veterans were exposed to the herbicides and how that exposure 
can be characterized, and the determination of risks due to that exposure. It con-
denses and updates some of the information presented in chapters 2 (Evaluating 
the Evidence) and 3 (Exposure to the Herbicides Used in Vietnam) of Veterans 
and Agent Orange: Update 2014 (NASEM, 2016a), which contain more detailed 
descriptions of the topics under discussion.
THE CURRENT POPULATION OF VIETNAM VETERANS
Although the conflict ended more than 40 years ago, there are a substantial 
number of Vietnam veterans who are still living and who, because of herbicide 
exposure in Vietnam, may have a higher risk than the general public for various 
negative health effects. The exact number of U.S. military personnel who served 
in Vietnam is unknown because deployment to the theater was not specifically 
recorded in military records. Estimates range from 2.6 million to 4.3 million 
(see Table 2-1), depending on which dates are used to define the Vietnam era 
and which areas are included in the Vietnam theater of operations (that is, Laos, 
Cambodia, Vietnam, and the surrounding waters). Approximately 7,500 Ameri-
can women are thought to have served in Vietnam (VA, 2017a). The lack of a 
comprehensive or official roster of U.S. Vietnam veterans has made it much 
more difficult to conduct epidemiology studies of health trends in this group of 
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military personnel or to track their survival. However, Australian, New Zealand, 
and South Korean militaries did keep registries of personnel who were deployed 
to Vietnam.
Beginning in 1990, the Bureau of Labor Statistics used its Current Popula-
tion Surveys to generate several estimates of the number and age distributions 
of deployed and non-deployed male Vietnam-era veterans in the civilian popula-
tion. The 1990 Survey estimated that the number of surviving deployed Vietnam 
veterans was 29.0% of living male Vietnam-era veterans and 32.7% of surviving 
non-deployed veterans (Cohany, 1992; NASEM, 2016a).
In 2018, VA estimated that approximately 5,978,000 Vietnam-era veterans 
(deployed and non-deployed, defined as dates of service from August 1964 to 
April 1975) were living (VA, 2018c). The committee notes that current informa-
tion on overall mortality in U.S. Vietnam veterans themselves has been elusive. 
The most recent reliable information was obtained in the 30-year update of 
mortality (through 2000) based on the Vietnam Experience Study (Boehmer et 
al., 2004). The study reported that mortality among the deployed veterans was 
approximately 9% higher than among the non-deployed veterans. A follow-up 
study of a random sample of 1,000 Australian Vietnam veterans selected from 
Australia’s comprehensive roster of 57,643 service members deployed to Vietnam 
found that mortality among Vietnam veterans was 11.7% through 2004 (O’Toole 
et al., 2010). This estimate of mortality among Australian veterans is slightly 
higher than but comparable with what was reported among Americans in the 
Vietnam Experience Study. The most recent update on mortality among female 
U.S. Vietnam veterans stated that at the end of 2010, 20.2% of the deployed 
women in the cohort had died compared with 24.6% of those who remained in the 
United States (Kang et al., 2014a). However, there are considerable differences 
TABLE 2-1 Estimates (in millions) of the Vietnam Veteran Population 
(adapted from IOM, 1994)
Reference Definition of Service Time Period N (millions)
DoD (1976) Vietnam 1/1/65 – 3/31/73 2.6
Fischer et al. (1980) Vietnam 8/64 – 6/75 3.8
VA (1985) Vietnam theater 8/4/64 – 5/7/75 2.7
Kulka et al. (1988) Vietnam theater 8/64 – 5/75 3.1
DoD (1976) Vietnam theater 1/1/65 – 3/31/73 3.4
BLS (1990) Vietnam theater 8/64 – 5/75 (males) 3.7
Fischer et al. (1980) Vietnam theater 8/64 – 6/75 4.3
BLS (1990) Vietnam era 8/64 – 5/75 (males) 7.9
VA (1985) Vietnam era 8/4/64 – 5/7/75 8.3
DoD (1976) Vietnam era 8/4/64 – 1/27/73 8.7
NOTE: BLS, Bureau of Labor Statistics; DoD, Department of Defense; VA, Department of Veterans 
Affairs.
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in mortality profiles between men and women, and the information provided by 
Kang and colleagues may not necessarily apply to the majority of American Viet-
nam veterans who are male. VA informed the committee that an updated mortality 
study was underway as of 2017 (Davey, 2017), but no results were available at 
the time the committee completed its work.
MILITARY USE OF HERBICIDES IN VIETNAM
Military use of herbicides in Vietnam took place from 1962 through 1971. 
Specific herbicides were selected based on tests conducted in the United States 
and elsewhere that were designed to evaluate defoliation efficacy (IOM, 1994; 
Young and Newton, 2004). Four compounds were used in the herbicide formula-
tions in Vietnam: 2,4-dichlorophenoxyacetic acid (2,4-D); 2,4,5-trichlorophen-
oxyacetic acid (2,4,5-T); 4-amino-3,5,6-trichloropicolinic acid (picloram); and 
dimethylarsinic acid (DMA, or cacodylic acid). These herbicides were used to 
defoliate inland hardwood forests, coastal mangrove forests, cultivated lands, and 
zones around military bases. Whereas the chlorinated phenoxy acids 2,4-D and 
2,4,5-T persist in soil for only a few weeks, picloram is much more stable and can 
persist in soil for years, and cacodylic acid is nonvolatile and stable in sunlight 
(NRC, 1974). More details on the herbicides used are presented in Chapter 4.
However, other toxic compounds were also present in these herbicide formu-
lations. Specifically, polychlorinated dibenzo-p-dioxins (PCDDs), which includes 
75 different congeners that vary by the number and placement of the chlorine 
atoms, can be formed during the manufacture of 2,4,5-T and the half-lives of 
these in subsurface soil may exceed 100 years (Sinkkonen and Paasivirta, 2000). 
One contaminant of particular concern is 2,3,7,8-tetrachlorodibenzo-p-dioxin 
(TCDD). This compound is an unintentional byproduct of the production of 2,4,5- 
trichlorophenol (NRC,1974). The structures of the chemicals of interest (COIs) 
identified above are shown in Figure 2-1.
Herbicides were identified by the color of a band on 55-gallon shipping con-
tainers and were called Agent Pink, Agent Green, Agent Purple, Agent Orange, 
Agent White, and Agent Blue. Table 2-2 shows the herbicides used in Vietnam 
by color code name and summarizes the chemical constituents, concentration of 
active ingredients, years used, and estimated amount sprayed, based on original 
and revised estimates. Two different formulations of Agent Orange were used 
in the course of military operations in Vietnam. All agents were liquid except 
Agent Blue, which was used in powder form in 1962–1964 and as a liquid in 
1964–1971. Agent Pink, Agent Green, Agent Purple, Agent Orange, and Agent 
Orange II all contained 2,4,5-T and were contaminated to some extent with 
TCDD. Agent White contained 2,4-D and picloram. Agent Blue (powder and 
liquid) contained cacodylic acid.
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Phenoxy Herbicides
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FIGURE 2-1 Chemical structures and Chemical Abstracts Service (CAS) numbers for 
the specific chemicals of interest.
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TABLE 2-2 Military Use of Herbicides in Vietnam (1961–1971)
Code Name Chemical Constituentsa
Concentration 
of Active 
Ingredienta
Years 
Useda
Amount Sprayed
VAO  
Estimateb
Revised 
Estimatea
Pink 60% n-butyl ester,  
40% isobutyl ester of 2,4,5-T
961–1,081 g/L 
acid equivalent
1961, 
1965
464,817 L  
(122,792 gal)
50,312 L 
sprayed; 
413,852 L 
additional on 
procurement 
records
Green n-butyl ester of 2,4,5-T — 1961, 
1965
31,071 L  
(8,208 gal)
31,026 L on 
procurement 
records
Purple
50% n-butyl ester of 2,4-D, 
30% n-butyl ester of 2,4,5-T,  
20% isobutyl ester of 2,4,5-T
1,033 g/L acid 
equivalent
1962–
1965
548,883 L  
(145,000 gal)
1,892,733 L
Orange
50% n-butyl ester of 2,4-D, 
50% n-butyl ester of 2,4,5-T
1,033 g/L acid 
equivalent
1965–
1970
42,629,013 L 
(11,261,429 
gal)
45,677,937 
L (could 
include 
Agent 
Orange II)
Orange II 50% n-butyl ester of 2,4-D, 
50% isooctyl ester of 2,4,5-T
910 g/L acid 
equivalent
After 
1968
— Unknown; 
at least 
3,591,000 L 
shipped
White Acid weight basis: 21.2% 
triisopropanolamine  
salts of 2,4-D,  
5.7% picloram
By acid 
weight, 240 
g/L 2,4-D, 65 
g/L picloram
1966–
1971
19,860,108 L 
(5,246,502 gal)
20,556,525 L
Blue, 
powder
Cacodylic acid 
(dimethylarsinic acid)  
sodium cacodylate
Acid, 65% 
active 
ingredient; salt, 
70% active 
ingredient
1962–
1964
— 25,650 L
Blue, 
aqueous 
solution
21% sodium cacodylate 
+ cacodylic acid to yield 
at least 26% total acid 
equivalent by weight
Acid weight, 
360 g/L
1964–
1971
4,255,952 L  
(1,124,307 gal)
4,715,731 L
Total, all 
formulations
— — — 67,789,844 L 
(17,908,238 
gal)
76,954,766 
L (including 
procured)
aBased on Stellman et al., 2003a.
bIOM, 1994, based on data from MRI, 1967; NRC, 1974; Young and Reggiani, 1988.
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Estimates of TCDD Concentrations and Amounts of Herbicides Sprayed
TCDD concentrations in individual herbicide shipments were known to vary 
between batches and between manufacturers, but the concentrations were not re-
corded (FAO/UNEP, 2009; Young et al., 1976). In 1974, domestic manufacturing 
standards for 2,4,5-T required that TCDD not be present at more than 0.05 parts 
per million (ppm) (NRC, 1974). Tests of TCDD concentrations were conducted in 
stocks of Agent Orange that remained after the conflict that had been returned from 
South Vietnam or had been procured but not shipped. The concentration of TCDD 
in these samples ranged from less than 0.05 ppm to almost 50 ppm, and averaged 
2–3 ppm in two sets of samples (NRC, 1974; Young et al., 1978). Later work by 
Stellman et al. (2003a) resulted in substantial revisions of the earlier estimates of 
TCDD contamination in the herbicide formulations. The researchers concluded that 
the mean TCDD concentration in Agent Orange was closer to 13 ppm than to the 
earlier estimate of 3 ppm. Using their revised estimate, the researchers proposed that 
366 kilograms of TCDD was likely applied in Vietnam between 1961 and 1971.
Several studies have attempted to estimate the amount of herbicides sprayed 
in Vietnam. Through the National Academies of Sciences, Engineering, and 
Medicine (“the National Academies”), one committee used records gathered from 
August 1965 through February 1971 and calculated that about 18 million gallons 
(about 69 million liters) of herbicides were sprayed from helicopters and other 
aircraft over an area of about 3.6 million acres in Vietnam over that time period 
(NRC, 1974). This estimate does not include the amount of herbicides sprayed on 
the ground to defoliate the perimeters of base camps and fire bases or the amount 
sprayed by Navy boats along river banks.
A revised analysis of spray activities and of the exposure potential of troops 
emerged from a study overseen by a committee of the Institute of Medicine (IOM, 
1997, 2003a,b). That work yielded new estimates of the amounts of military her-
bicides used in Vietnam from 1961 through 1971 (J. M. Stellman et al., 2003a). 
The investigators reanalyzed the original data sources used to develop herbicide-
use estimates in the 1970s and identified errors that had inappropriately removed 
spraying missions from the dataset. They also added new data on spraying mis-
sions that took place from 1961 to 1965. Finally, a comparison of procurement 
records with spraying records found errors that suggested that additional spraying 
had taken place but had gone unrecorded at the time. The new analyses led to 
a revision of the estimates of the amounts of the agents applied, as indicated in 
Table 2-2, as well as of the concentration of TCDD-containing herbicides. The 
new research effort estimated that about 77 million liters were applied, which is 
about 9 million liters more than the previous estimate.
EXPOSURE OF DIFFERENT GROUPS OF VIETNAM VETERANS
The lack of accurate estimates of chemical exposures experienced by 
U.S. military personnel who served in Vietnam has significantly hindered 
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the epidemiological study of the health effects associated with herbicides 
and TCDD. For example, some military personnel stationed in cities or on 
large bases may have received little or no herbicide exposure, whereas troops 
who moved through defoliated areas soon after treatment may have been 
exposed through many pathways, including skin contact (directly or indi-
rectly through clothing), direct (through contaminated foodstuffs) or indirect 
(through hand-to-mouth contact) ingestion, or via contaminated water (drink-
ing, bathing, or immersion during operations). The lack of records regarding 
individual behaviors and locations combined with the lack of contempora-
neous chemical measurements and the lack of a full understanding of the 
movement and behavior of the defoliants in the environment greatly reduces 
the ability to conduct the exposure assessments that are necessary for ascer-
taining the association between the COIs and health effects among Vietnam 
veterans.
Consequently, most studies have focused on populations that had well-
defined tasks that brought them into contact with the agents. These populations 
primarily include Air Force personnel involved in fixed-wing aircraft spraying 
activities (often referred to as Operation Ranch Hand) and members of the U.S. 
Army Chemical Corps. The exposures of ground troops are difficult to define, 
so this group has not been studied as intensively. In accordance with Congress’s 
mandated presumption of herbicide exposure of all Vietnam veterans, Veterans 
and Agent Orange (VAO) committees have treated Vietnam-veteran status as a 
proxy for herbicide exposure when more specific exposure information is not 
available.
Herbicide Handlers
Military personnel who came into direct contact with the herbicidal chemi-
cals through mixing, loading, spraying, and clean-up activities had relatively high 
chemical exposures. The precise number of U.S. military personnel who handled 
herbicides directly is not known. However, two groups have been identified 
as high-risk subpopulations among veterans: Air Force personnel involved in 
Operation Ranch Hand and members of the Army Chemical Corps. Additional 
units and individuals handled or sprayed herbicides around bases or communica-
tion lines. For example, Navy river patrols were reported to have used herbicides 
to clear inland waterways, and engineering personnel used herbicides to remove 
underbrush and dense growth when constructing fire-support bases. At the time, 
the herbicides used in Vietnam were not thought to present an important human 
health hazard, so few precautions were taken to prevent the exposure of person-
nel (GAO, 1978, 1979). Thus, military personnel did not typically use chemical-
protective gloves, coveralls, or protective aprons, and dermal exposure almost 
certainly occurred in these populations in addition to exposure by inhalation and 
other routes.
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Operation Ranch Hand
Air Force personnel who participated in Operation Ranch Hand were the 
first Vietnam-veteran population to receive special attention with regard to 
herbicide exposure. The Air Force Health Study (AFHS) was a longitudinal, 
prospective epidemiologic study initiated by the Air Force in 1979. Its purpose 
was to determine whether Air Force personnel who had participated in Operation 
Ranch Hand had experienced adverse health outcomes as a result of their service. 
The study protocol had three components: a retrospective mortality study, a ret-
rospective morbidity study, and a 20-year prospective follow-up study.
The 20-year prospective follow-up study identified 1,242 Ranch Hands who 
were individually matched on age, race, and military occupation to comparison 
subjects who served in the Air Force between 1962 and 1971 and who were 
stationed in and flew cargo operations elsewhere in Southeast Asia during the 
Vietnam conflict but had not been exposed to tactical herbicides. The compari-
son group was assumed to be similar to the Ranch Hands regarding lifestyle, 
training profiles, and socioeconomic factors. The study itself consisted of six 
comprehensive exams that began with a baseline exam in 1982 and occurred 
thereafter in years 3, 5, 10, 15, and 20 of the study. A comprehensive set of 
clinical measurements and observations were made, and biological specimens 
(serum, whole blood, urine, semen, and adipose tissue) were obtained and pre-
served during the exams. In all, 2,758 individuals participated in at least one 
exam cycle. Data collection and analysis for the formal study was completed in 
2006 (IOM, 2015).
Exposure among Ranch Hands and the comparison group was evaluated by 
objective measurements of TCDD in serum samples drawn in 1987 or later, and 
serum TCDD concentrations were often used as the primary exposure metric 
for epidemiologic classification in the AFHS (AFHS, 1991a; Kern et al., 2004; 
Michalek et al., 2001a, 2003; Pavuk et al., 2003). Pavuk et al. (2014) examined 
the serum concentrations of several dioxins and dioxin-like chemicals in serum 
samples gathered in 2002 from 777 Ranch Hands and 1,173 AFHS comparison 
subjects. While the median serum TCDD levels were more than twice as high in 
the Ranch Hands as in the comparison veterans (5.0 and 2.2 pg/g, respectively), 
no substantial differences were found between these groups for the other COIs. 
Additionally, the authors compared serum dioxin levels in AFHS participants 
with data collected by the National Health and Nutrition Examination Survey 
(NHANES) during 2001–2002 in U.S. civilian men of the same age range. The 
Ranch Hands had serum concentrations of dioxins that were similar to those 
found in the civilians except for TCDD, where the Ranch Hand mean level of 
9.5 pg/g lipid was more than three times the NHANES mean level of 2.5 pg/g 
lipid. This demonstrates the specificity of the dioxin exposure experienced from 
contact in Vietnam with military herbicides.
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Additionally, several methods for estimating the herbicide exposure of mem-
bers of the cohort were developed based on questionnaires that focused on such 
factors as the number of days of skin exposure, the percentage of skin area ex-
posed, and the concentration of TCDD in the different herbicidal formulations 
(Michalek et al., 1995). Overall, serum TCDD was generally elevated among 
airmen whose jobs involved more frequent handling of herbicides, but there was 
no clear demarcation between the distributions of serum TCDD concentrations 
in the Ranch Hands and those in the comparison group (AFHS, 1991a). A more 
detailed discussion of the study design and exposure measurement methods used 
in the AFHS can be found in Chapter 5.
As illustrated by Figure 2-2, the median TCDD levels in veterans who had 
worked in Operation Ranch Hand were higher than those measured in their own 
comparison group or in ground troops. The TCDD concentrations found in the 
controls were of the magnitude of a few parts per trillion (ppt), which are in the 
range of contemporaneous background levels. Herbicide production workers, by 
contrast, have serum TCDD levels that are about an order of magnitude higher, 
and individuals who resided near the site of the industrial explosion in Seveso, 
Italy, had serum TCDD levels that are about two orders of magnitude higher 
(Pirkle et al., 1995).
Ground troop veterans in AOVS
Ranch hand veterans
Occupational exposures
Seveso, Italy population
Controls
Low
Medium
Controls
Officers, nonflying
Officers, flying (navigators)
Officers, flying (pilots)
NIOSH workers, quintile 1
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quintile 3
quintile 4
quintile 5
German plant workers
New Zealand sprayers
Serum dioxin, (ppt)
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4540
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355
Enlisted men, flying
Enlisted men, nonflying
High
FIGURE 2-2  Median serum TCDD levels in various study populations.
NOTE: AOVS = Centers for Disease Control and Prevention’s Agent Orange Validation 
Study (CDC, 1989a); NIOSH = National Institute for Occupational Safety and Health.
SOURCE: Pirkle et al., 1995.
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Army Chemical Corps
Members of the Army Chemical Corps used hand-operated equipment and 
helicopters to conduct smaller-scale operations, including defoliation around 
special-forces camps; clearing of the perimeters of airfields, depots, and other 
bases; and small-scale crop destruction (NRC, 1980; Thomas and Kang, 1990; 
Warren, 1968). Studies of health effects related to herbicide exposure in this 
population were first conducted in the late 1980s (Thomas and Kang, 1990). A 
small feasibility study of deployed and non-deployed Vietnam-era veterans from 
within the Army Chemical Corps found an association between veterans reporting 
having sprayed herbicides and higher serum TCDD concentrations (Kang et al., 
2001); this finding was confirmed in a follow-up study of a larger fraction of the 
cohort (Kang et al., 2006). Modeling efforts (Ross et al., 2015a,b) have also found 
that higher exposures were probably experienced by those involved with mixer, 
loader, and applicator activities than by bystanders because the former were gen-
erally in closer proximity to and had more frequent contact with the herbicides.
Other Groups of Herbicide Handlers
Other veteran populations also handled herbicides during their service in 
Vietnam, although probably to a small degree. For example, as part of Operation 
PACER IVY, Air Force personnel who were separate from, but who were also 
assisted by, the Ranch Hands and Army Chemical Corps were responsible for 
removing stocks of Agent Orange from Vietnam to Johnston Island in the central 
Pacific Ocean (Young, 2009). As part of the operation, procedures included the 
identification of unused herbicides, the transport of the identified herbicides to 
a central location in Vietnam for relabeling, and re-drumming for about half of 
the barrels before shipment. Most of the relabeling, repackaging, and handling 
of Agent Orange during PACER IVY was overseen and conducted by contrac-
tors from China, local residents, and the Vietnam military, so exposure to U.S. 
military personnel was likely low. However, there were spills of Agent Orange 
in the re-drumming and storage areas, which contaminated surrounding soils 
and asphalt (Young, 2009), and these have been suggested as possible sources 
of exposure.
Other possible points of contamination for Vietnam-era veterans include 
defoliation tests conducted in South Vietnam as part of Project AGILE; ports in 
the United States that served as embarkation points for shipping of Agent Orange 
to Vietnam; storage locations on Johnston Island, where contamination could 
have occurred from the re-drumming and maintenance of drums that contained 
Agent Orange; and at-sea incineration of Agent Orange as part of Operation 
PACER HO (Young, 2009). Because the Army of the Republic of Vietnam was 
responsible for the handling, transport, and storage of herbicides from the time 
it was delivered to Vietnam until it was loaded onto Ranch Hand aircraft, Young 
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asserts that the herbicide exposures of Allied troops during these procedures may 
have been negligible.
Ground Troops
Given the widespread, long-term use of herbicides in Vietnam, it is rea-
sonable to assume that many military personnel were inadvertently exposed to 
the COIs. In contrast with government reports and veterans’ testimony about 
exposure (CDC, 1989b; GAO, 1979), Young et al. (2004a,b) used data from un-
published military records and environmental-fate studies to argue that ground 
troops had little direct contact with herbicide sprays and that TCDD residues in 
Vietnam had low bioavailability. They also argued that direct exposures of ground 
troops were relatively low because herbicide-spraying missions were carefully 
planned and because spraying occurred only when friendly forces were not in 
the target area.
To resolve the issue, numerous attempts were made in the 1980s to character-
ize the herbicide exposures of ground troops in Vietnam (CDC, 1988a; Erickson 
et al., 1984a; NRC, 1982; S. D. Stellman and J. M. Stellman, 1986; S. D. Stellman 
et al., 1988a). Those efforts combined self-reports of contact with herbicides or 
military service records with aerial-spray data to produce a measure of the oppor-
tunity for exposure (discussed in greater detail later in this chapter). The search 
for a way to validate this method led to the development of exposure biomarkers 
in veterans. Initial studies measured concentrations of dioxin in the adipose tis-
sue of veterans (Gross et al., 1984; Schecter et al., 1987), and dioxin concentra-
tions in adipose tissue were then linked to dioxin concentrations in blood (Kahn 
et al., 1988). The Centers for Disease Control and Prevention’s (CDC’s) Agent 
Orange Validation Study measured TCDD concentrations in blood serum from 
a relatively large sample of Vietnam veterans and other Vietnam-era veterans 
(CDC, 1989a) but did not find a statistically significant difference in mean serum 
TCDD concentrations between the groups. The mean values in each group were 
about 4 ppt (CDC, 1988a). However, the long lag time between exposure and the 
serum measurements (about 20 years) leads to questions regarding the accuracy 
of exposure classification based on serum concentrations. The first VAO commit-
tee cautioned that serum TCDD measurements that are collected years after the 
potential exposure occurred should not be regarded as a “gold standard” or as a 
fully accurate measure of herbicide exposure because each COI has a different 
biological half-life. More details on the metabolism of the COIs are presented 
later in this chapter.
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Brown Water Navy
Navy riverine units (or the “Brown Water Navy”) are known to have used 
herbicides while patrolling inland waterways (IOM, 1994).1 It is generally ac-
knowledged that estuarine waters became contaminated with herbicides and 
dioxin as a result of shoreline spraying and runoff from spraying on land, particu-
larly in heavily sprayed areas that experienced frequent flooding. Thus, military 
personnel who did not serve on land could have been among those exposed to 
the chemicals during their service in Vietnam.
Blue Water Navy
Dioxin exposure among personnel who served offshore but within the ter-
ritorial limits of the Republic of Vietnam has also been of concern. It has been 
hypothesized that in addition to possibly experiencing drift from herbicide-spray 
missions, personnel on ships that converted seawater by distillation may have 
been exposed via drinking water. Those concerns were heightened by the findings 
of an Australian study that showed that TCDD could be enriched in a simulation 
of the potable-water distillation process that was used on U.S. Navy and Royal 
Australian Navy ships during the Vietnam War era (Muller et al., 2002). The 
National Academies convened the Blue Water Navy Vietnam Veterans and Agent 
Orange Exposure Committee to address that specific issue; its report found that 
there was inadequate information to determine the extent of exposure experienced 
by Blue Water Navy personnel, but that there were possible routes of exposure 
(IOM, 2011b).
Vietnam Military and Civilians
Although studies of the residents of Vietnam are not directly relevant to 
the committee’s task, a summary is provided because these studies may inform 
possible routes of exposure in U.S. military forces, future epidemiologic stud-
ies, and the development of risk-mitigation policies. Researchers have attempted 
to characterize the herbicide exposure of residents of Vietnam in the process of 
trying to assess adverse reproductive and other outcomes (Constable and Hatch, 
1985). Some researchers compared residents of South Vietnam with residents of 
unsprayed North Vietnam, others compared South Vietnam residents who lived in 
sprayed and unsprayed villages as determined by observed defoliation, and other 
researchers compared women from North Vietnam married to veterans who had 
served in South Vietnam with women whose husbands had not in order to evalu-
ate reproductive and pregnancy outcomes. Few studies have provided information 
1 E. R. Zumwalt, Jr. 1993. Letter to the Institute of Medicine Committee to Review the Health Effects 
in Vietnam Veterans of Exposure to Herbicides regarding draft version of the IOM chapter on the 
U.S. military and the herbicide program in Vietnam, May 20.
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on TCDD concentrations in Vietnamese civilians who were exposed to the COIs 
during the conflict (Schecter et al., 1986, 2002, 2006).
Armitage et al. (2015) indirectly estimated dermal exposure from direct over-
spray and long-term dietary exposures in South Vietnam using an aerial dispersion 
model coupled with a chemical fate and transport model and additional models. 
The investigators concluded that people in the upland forests of South Vietnam did 
not commonly experience highly elevated exposures. Dwernychuk et al. (2002) 
evaluated dioxin contamination around former air bases in Vietnam. The re-
searchers collected environmental and food samples, human blood, and breast 
milk from residents of the Aluoi Valley of central Vietnam and identified lo-
cations where relatively high dioxin concentrations existed in soil and water 
systems. Soil dioxin concentrations were particularly high in areas (termed “hot 
spots”) around former airfields and military bases where herbicides were handled. 
Other hot spots included depots of chemical defoliants, air bases used for defoli-
ant spray missions, and areas where chemical defoliants were used extensively. 
People have since inhabited the areas in and around many former air bases and 
depots, which have become the focus of studies of environmental contamination 
and bioaccumulation. For example, studies of poultry raised by Vietnam residents 
currently living in hot spots have found that dioxin total toxic equivalent (TEQ) 
levels in poultry eggs are more than twice the adult exposure guideline set by the 
World Health Organization (WHO) and more than five times the child guideline 
(Hoang et al., 2014) and that the dioxin content per unit of fat mass in the muscle 
and liver of the poultry also exceeded the WHO guidelines (Banout et al., 2014).
Publications reviewed in earlier updates have reported environmental con-
centrations and human body burdens of dioxins in various areas throughout 
Vietnam (Brodsky et al., 2009; Feshin et al., 2008; Hatfield Consultants, 2009a,b; 
Nhu et al., 2009; Saito et al., 2010; Tai et al., 2011) and have found pervasive 
exposure to dioxins more than 50 years after the Vietnam War. Dioxin concentra-
tions in breast milk reflect the residence location of the mothers, with levels and 
TEQs being elevated in areas where herbicides were sprayed or stored during 
the war.2 Another study compared men who had lived in and around the Phu Cat 
airbase for 50 years or more with men who lived in the unsprayed Kim Bang 
district of Ha Nam Province in North Vietnam (Manh et al., 2014). Men currently 
living in the vicinity of the Phu Cat air base have a greater body burden of dioxin 
than those who spent time in areas that had been the target of herbicide spraying 
(a geometric mean TEQ of 41.7 pg/g lipid in men who spent time closest to the 
air base, versus ~29 pg/g lipid for those in two nearby sprayed areas).
2 For example, Tai et al. (2011, pp. 6629–6630) reported that “[t]he total toxic equivalents of 
2,3,7,8-substituted PCDDs/PCDFs in breast milk of mothers living in the hot spots, and the sprayed 
and unsprayed areas were 14.10 pg/g lipid, 10.89 pg/g lipid, and 4.09 pg/g lipid for primiparae and 
11.48 pg/g lipid, 7.56 pg/g lipid, and 2.84 pg/g lipid for multiparae, respectively, with significant 
differences in the values among the three areas.”
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International Forces
Military personnel of the Republic of Korea served in Vietnam during 1964–
1973. The Korean Veterans Health Study is a large epidemiological study of more 
than 114,000 South Korean veterans who served in Vietnam. Several publications 
from it, including one on how exposure metrics were derived, have been reviewed 
by prior VAO committees. A more detailed discussion of exposure measurement 
methods used with this cohort is found in Chapter 5.
Other nations also sent military personnel to assist the South Vietnam mili-
tary. Reports on the morbidity and mortality of Australian Vietnam veterans have 
been published on different groups of service members who deployed to Vietnam. 
These groups include military and some nonmilitary personnel of both sexes who 
served on land or in the waters of Vietnam from May 23, 1962, to July 1, 1973. 
However, the comprehensive studies are limited to male members of the military, 
and most of the analyses focus on men who served in the defense forces—the 
Army (41,084), the Navy (13,538), and the Air Force (4,570). Objective measures 
of exposure were not collected, and deployment to Vietnam is generally consid-
ered a surrogate of exposure.
A total of 3,394 men and women from New Zealand served in Vietnam 
between 1962 and 1971, 36 of whom were killed in action or died of wounds 
or accidents. A cohort of 2,783 living male veterans has been followed prospec-
tively using the New Zealand Veterans Affairs and National Health Index. The 23 
women who served in Vietnam were excluded because analyses by sex would not 
have sufficient statistical power to rule out chance findings. As with the Austra-
lian cohort, objective measures of exposure were not collected, and deployment 
to Vietnam is considered a surrogate of exposure.
Previous volumes of the VAO series and later chapters of this report provide 
citations to research on these populations as appropriate.
CHARACTERIZING EXPOSURE
The development of a means of characterizing the exposure of individual Viet-
nam veterans has long been a prime objective of researchers who are interested in 
refining epidemiologic investigations of health outcomes in this population. Serum 
TCDD levels might have been a very useful proxy for harmful exposures to all 
the components of the herbicides used by the U.S. military in Vietnam had they 
been measured both before and after deployment; however, these data were not 
collected. Since over time metabolic processes would have reduced the initial 
chemical concentrations by many half-lives, collecting new samples would not 
provide valuable information about exposures that occurred during the Vietnam 
War even among individuals who were likely highly exposed, such as some of the 
Ranch Hands. For example, serum TCDD measurements taken in 2002 from the 
Ranch Hands were still sufficiently elevated to distinguish exposed and unexposed 
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veterans at the group level. However, TCDD has a half-life of about 7.6 years, and 
the half-lives of the other COIs are considerably less. With the passage of several 
decades, serum concentrations decrease exponentially, and newly drawn serum 
samples are thus unlikely to be useful metrics for assessing health outcomes in 
surviving Vietnam veterans, occupational cohorts, or Seveso residents. The factors 
influencing TCDD’s half-life are discussed in Chapter 4.
The consideration of records detailing the herbicide spray missions has 
provided another approach to deriving individual-specific exposure estimates. 
Two models—a proximity-based Exposure Opportunity Index (EOI) model and 
an aerial spray distribution model (explained and contrasted below)—have been 
proposed for estimating the exposure of Vietnam veterans. However, to date only 
a few studies (which are addressed in detail later in the chapter) have used these 
exposure assessment methodologies to study the health of Vietnam veterans.
Other National Academies reports have addressed the issue of exposure assess-
ment in military environments, pointing out both the challenges of gathering good 
contemporaneous information and the desirability of such data for assessing service 
members’ and veterans’ health and well-being (IOM, 2000a; NRC, 2000a,b).
Methodologic Issues and Considerations in Exposure Assessment
The focus of this section is on three key methodological issues that com-
plicate the development of accurate exposure estimates in the Vietnam-veteran 
population and the other study populations discussed in this report: the latent 
period between exposure and disease, exposure misclassification, and exposure 
specificity.
Latency
The temporal relationship between exposure and disease is complex and 
often difficult to define in studies of human populations. Many diseases do not 
appear immediately after exposure. Cancers, for example, might not appear for 
many years after exposure. The latency period refers to the amount of time be-
tween an initiative event, such as a toxic exposure, and the manifestation of the 
clinical disease. For many disease processes the latency period is not known. 
If the latency period is underestimated, the effect of the exposure of interest on 
health outcomes will not be captured by epidemiological methods. Exposures can 
be brief (acute) or occur over a longer period of time (chronic). At one extreme, 
an exposure can be the result of a single event, as in an accidental poisoning. At 
the other extreme, a person exposed to a chemical that is stored in the body may 
continue to experience “internal exposure” for years even if exposure from the 
environment has ceased.
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Exposure Misclassification
Exposure misclassification in epidemiologic studies can affect estimates of 
risk. In a case-control study, this would be a situation in which the reported mea-
surement of exposure in either the cases or the controls (or sometimes in both cases 
and controls) is incorrect (classifying a person who was not exposed as having been 
exposed, for example). Non-differential exposure misclassification occurs if the 
probability of exposure misclassification is the same in both cases and controls. If 
this happens, then the estimated association between disease and exposure is biased 
toward the null value. In other words, one would expect the true association, if it 
exists, to be stronger than the observed association. Differential exposure misclas-
sification occurs if the probability of misclassification is different between cases 
and controls. If this occurs, then the estimated association can be biased in either 
direction, either toward the null value or away from the null value. Then the true 
association, if it exists, might be stronger or weaker than the observed association.
When exposure is classified into more than two levels, the slope of a dose–
response trend is not necessarily attenuated toward the null value even if the 
probability of misclassification is the same in the two groups of subjects being 
compared. Therefore, the observed trend in disease risk among the several levels 
of exposure may be either an overestimate or an underestimate of the true trend 
(Dosemeci et al., 1990). Greenland and Gustafson (2006) discussed the effects 
of exposure misclassification on the statistical significance of the result and dem-
onstrated that if one adjusts for exposure misclassification when the exposure is 
represented as a binary variable, the resulting association is not necessarily more 
significant than in the unadjusted estimate. That result remains true even though 
the observed magnitude of the association might be increased.
The Update 2014 committee was concerned about the strong degree of mis-
classification associated with publications concerning various health outcomes au-
thored by researchers who categorized exposure based on a variable in a patient’s 
electronic medical record indicating whether the individual was “exposed to Agent 
Orange” (Ansbaugh et al., 2013; Q. Li et al., 2013). Likewise, several studies of 
VA health care–user populations have been identified that continue to define ex-
posure on the basis of that indicator in the medical record. That variable conveys 
a degree of authenticity that this and the prior committee strongly suspected is 
unmerited because there is little documentation about the source of information 
used to make this classification—deployment status, entry on the Agent Orange 
Registry, the veteran’s self-report, a physician’s observation that the patient has a 
condition presumed to be service-related, results of serum TCDD measurements 
performed on some patients, or perhaps some other criterion. Regardless, none of 
these approaches offers a reliable method of determining whether an individual 
was truly exposed to herbicides (above some unspecified level) or yields a method 
that can be applied uniformly to all veterans using the VA medical system, who 
themselves are a self-selected subset of veterans. The current committee concurs 
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with the Update 2014 committee’s concern that these publications do not ad-
equately discuss the reliability of their exposure metric.
Specificity
The evaluation of the findings of studies of persons exposed to components 
of the herbicides sprayed in Vietnam requires some decisions about their relative 
contributions to the VAO project’s evidentiary database. Only a few herbicidal 
chemicals were used as defoliants during the Vietnam conflict: esters and salts of 
2,4-D and 2,4,5-T, cacodylic acid, and picloram in various formulations. TCDD 
as a contaminant of 2,4,5-T is also of import. The committee recognizes that 
in real-world conditions, exposure to TCDD virtually never occurs in isolation 
and that there are hundreds of similar compounds to which humans might be 
exposed, including other PCDDS, polychlorinated dibenzofurans (PCDFs), and 
polychlorinated biphenyls (PCBs). Human exposure to TCDD is almost always 
accompanied by an exposure to one or more of the other compounds, but the 
exposure of Vietnam veterans to substantial amounts of the other chemicals rela-
tive to the exposure to TCDD has not been documented. Studies that analyzed 
for dioxin-like PCDF and PCB congeners and expressed the results in terms of 
TEQs have also been considered since Update 1998.
Among the various chemical classes of herbicides that have been identified 
in published studies reviewed by the committee, phenoxy herbicides, particu-
larly 2,4-D and 2,4,5-T, are directly relevant to the exposures experienced by 
U.S. military forces in Vietnam. On the basis of the assumption that compounds 
with similar chemical structure may have analogous biologic activity, informa-
tion on the effects of other chemicals in the phenoxy herbicide class—such 
as 2-(2,4,5-trichlorophenoxy) propionic acid (fenoprop or Silvex), 2-methyl-
4-chlorophenoxyacetic acid (MCPA), 2-(2-methyl-4-chlorophenoxy) propionic 
acid (mecoprop, MCPP), and 3,6-dichloro-2-methoxybenzoic acid (dicamba)—
has been factored into the committee’s deliberations with somewhat less weight 
(see Figure 2-1).
Many scientific studies reviewed by the current and prior committees re-
port exposures to broad categories of chemicals rather than to those specific 
chemicals. Many studies have examined the relationship between exposure to 
“pesticides” and adverse health outcomes, while others have used the category 
of “herbicides” without identifying specific chemicals. A careful reading of a 
publication often reveals that none of the COIs contributed to the exposures of the 
study population, so such studies could be excluded from consideration. Chapter 
3, Evaluation of the Evidence Base, contains a detailed discussion of inclusion 
and exclusion criteria for the studies reviewed in the current update.
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Modeling Herbicide Exposure in Vietnam
Two models have been used to estimate exposure to herbicides experienced 
by ground personnel in Vietnam: the EOI and AgDRIFT®. The models have dif-
ferent purposes; the EOI model was specifically developed to estimate herbicide 
exposure potential to persons on the ground on the basis of data on aerial spray 
history and troop locations, whereas AgDRIFT® is a modification of a model 
developed by the U.S. Forest Service that predicts agricultural pesticide ground 
concentrations based on variables related to dispersal, drift, and deposition. The 
AgDRIFT® model thus does not consider troop-location data, nor is it specific to 
exposures in Vietnam.
Exposure Opportunity Index Model
Following from recommendations contained in the first VAO report (IOM, 
1994), VA asked the National Academies to issue a request for proposals seek-
ing individuals and organizations to develop historical exposure-reconstruction 
approaches suitable for epidemiologic studies of the herbicide exposure of U.S. 
veterans during the Vietnam War (IOM, 1997). A team of researchers in Colum-
bia University’s Mailman School of Public Health was awarded the contract for 
the Characterizing Exposure of Veterans to Agent Orange and Other Herbicides 
in Vietnam project. Several sources of information concerning spraying activi-
ties and information on the locations of military units assigned to Vietnam were 
integrated into a database. The resulting EOI model (J. M. Stellman and S. D. 
Stellman, 2003) generates individualized estimates (EOI scores) of the exposure 
potential of troops who served in Vietnam.
Mobility factor analysis, a technique used for studying troop movement, 
was developed for use in reconstructing herbicide-exposure histories. The 
analysis is a three-part classification system for characterizing the location and 
movement of military units in Vietnam. It comprises a mobility designation 
(stable or mobile), a distance designation (usually in kilometers) to indicate 
how far a unit might travel in a day, and a notation of the modes of travel avail-
able to the unit (by air, by water, or on the ground by truck, tank, or armored 
personnel carrier). A mobility factor was assigned to every unit that served in 
Vietnam.
The data were combined into a geographic information system (GIS) for 
Vietnam. Herbicide-spraying records were integrated into the GIS and linked with 
data on military-unit locations to derive individual EOI scores. The results are the 
subject of reports by the contractor (J. M. Stellman and S. D. Stellman, 2003) and 
the Committee on the Assessment of Wartime Exposure to Herbicides in Vietnam 
(IOM, 2003a,b). A summary of the findings on the extent and pattern of herbicide 
spraying (Stellman et al., 2003a), a description of the GIS for characterizing 
exposure to Agent Orange and other herbicides in Vietnam (Stellman et al., 
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2003b), and an explanation of the EOI model based on that work (S. D. Stellman 
and J. M. Stellman, 2004) have been published in peer-reviewed journals. In 
those publications the researchers argued that it is feasible to conduct epidemio-
logic investigations of veterans who served as ground troops during the Vietnam 
War. The National Academies later issued a report that examined the feasibility of 
using the EOI model (IOM, 2008). The report concluded that “despite the short-
comings of the exposure assessment model in its current form and the inherent 
limitations in the approach, the committee agreed that the model holds prom-
ise for supporting informative epidemiologic studies of herbicides and health 
among Vietnam veterans and that it should be used to conduct studies” (p. 2). 
This model has since been used in analyses of the Korean Veterans Health Study 
(Yi and Ohrr, 2014; Yi et al., 2014b).
AgDRIFT®-Based Model
Ginevan et al. (2009a,b, 2014, 2015) proposed the use of the AgDRIFT® Tier 
III forestry model for estimating the deposition of herbicides via aerial spraying 
as alternative to the EOI model. They suggested that dermal exposure through 
both direct deposition and post-application transfer from foliage could be derived 
from application information such as aircraft speed and altitude, from nozzle 
characteristics, and from droplet evaporation and environmental parameters such 
as canopy density, canopy roughness, and crosswind speed. The authors did not 
consider exposures resulting from contact with soil and dust or through inhala-
tion because they considered these routes to be negligible (Ginevan et al., 2009a; 
citing Driver et al., 1989; Gunther et al., 1977; Nadal et al., 2004). However, 
subsequent reviews of the methodology underlying the authors’ analyses (S. D. 
Stellman and J. M. Stellman, 2014, 2015) found several weaknesses that call the 
results by Ginevan et al. into serious question.
DETERMINING INCREASED RISK IN VIETNAM VETERANS
Part of the committee’s charge—derived from the text of Public Law 102-4— 
was to determine, to the extent permitted by the available scientific data, the 
increased risk of disease among veterans exposed to herbicides or the con-
taminant TCDD during service in Vietnam. Estimating the magnitude of risk 
of each particular health outcome among herbicide-exposed Vietnam veterans 
requires quantitative information about the dose–time response relationship for 
the health outcome in humans, information on the extent of herbicide exposure 
among Vietnam veterans, and estimates of individual exposure. Vietnam veterans 
were exposed to other agents and stressors—such as tobacco smoke, insecti-
cides, therapeutics, drugs, diesel fumes, alcohol, hot and humid conditions, and 
combat—that may increase or decrease the ability of chemicals in herbicides to 
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produce a particular adverse health outcome. Few, if any, studies either in humans 
or in experimental animals have examined those interactions.
As mentioned earlier in this chapter, most health studies of Vietnam veterans 
were hampered by relatively poor measures of exposure to herbicides or TCDD 
and by other methodological problems. Most of the evidence on which the 
findings regarding associations are based, therefore, comes from studies of people 
exposed to TCDD or herbicides in occupational and environmental settings rather 
than from studies of Vietnam veterans. The committees that produced the first 
VAO report and the updates found that the body of evidence was sufficient for 
reaching conclusions about statistical associations between herbicide exposures 
and health outcomes but that the lack of adequate data on Vietnam veterans them-
selves complicated the consideration of this part of the charge.
Although some groups had well-documented high exposures of herbicides 
(such as participants in Operation Ranch Hand and Army Chemical Corps personnel), 
most Vietnam veterans had lower exposures to herbicides and TCDD than did the 
subjects of many occupational and environmental studies (see Figure 2-2 from 
Pirkle et al., 1995). The committees responsible for the first VAO report and the 
updates have concluded that in general it is impossible to quantify the risk posed 
to veterans by their exposure to herbicides in Vietnam.
After decades of research, the challenge of estimating the magnitude of 
potential risk posed by exposure to the COIs remains intractable. The requisite 
information is still not available despite concerted efforts to use modeling to re-
construct likely exposure from records of troop movements and spraying missions 
(J. M. Stellman and S. D. Stellman, 2003; S. D. Stellman and J. M. Stellman, 
2004; J. M. Stellman et al., 2003a,b), to extrapolate from agricultural models 
of drift associated with spraying (Ginevan et al., 2009a; Teske et al., 2002), to 
measure serum TCDD in individual veterans (Kang et al., 2006; Michalek et al., 
1995), and to model the pharmacokinetics of TCDD clearance (Aylward et al., 
2005a,b;  H. L. Chen et al., 2006; Emond et al., 2004, 2005, 2006). Addition-
ally, there is still uncertainty about the toxicity and health effects of the specific 
COIs. Prior committees have thought it unlikely that additional information or 
more sophisticated methods would permit any sort of quantitative assessment of 
Vietnam veterans’ increased risks of particular adverse health outcomes that are 
attributable to exposure to the chemicals associated with herbicide spraying in 
Vietnam. Even if one accepts an individual veteran’s serum TCDD concentration 
as the best available surrogate for overall exposure to Agent Orange and the other 
herbicide mixtures sprayed in Vietnam, not only is it nontrivial to make this mea-
surement, but the hurdle of accounting for biologic clearance and extrapolating 
to the proper timeframe remains. Accordingly, the lack of exposure estimations 
for Vietnam veterans will likely remain a hurdle to epidemiologic studies, and 
unless this issue is resolved, the potential for additional epidemiologic studies to 
yield improved information regarding the specific question of whether an associa-
tion exists between herbicide exposure and health outcomes will remain limited.
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Evaluation of the Evidence Base
This chapter describes the approach and methods that the committee used to 
identify and evaluate the scientific and medical literature on exposures to herbi-
cides that occurred in U.S. military personnel during the Vietnam War as well as 
the process that the committee used to reach conclusions on the association be-
tween exposures to the chemicals of interest (COIs)—2,4-dichlorophenoxyacetic 
acid (2,4-D); 2,4,5-trichlorophenoxyacetic acid (2,4,5-T); picloram; dimethyl-
arsinic acid (DMA or cacodylic acid); and 2,3,7,8-tetrachlorodibenzo-p-dioxin 
(TCDD)—and a given health outcome. The committee’s process entailed the 
following steps: a literature search, screening of abstracts, a full text review of 
studies flagged in the abstract screening, and the evaluation of a final set of stud-
ies identified as relevant after the full text review. The first part of this chapter 
details the methodology used to identify and screen the literature. The second part 
of the chapter details the evaluation criteria used to review the relevant studies, 
including the types of studies considered, the health outcomes considered, and the 
categories of association used to draw conclusions about the strength of the evi-
dence of possible health effects resulting from herbicide exposure. The committee 
also describes some of the issues it encountered when reviewing the literature on 
Vietnam War exposures and health outcomes, such as multiple exposures and in-
dividual variability. Because the current committee closely followed the approach 
used by prior Veterans and Agent Orange (VAO) and Update committees, much 
of the following information was previously described in those volumes as well, 
particularly Update 2014 (NASEM, 2016a).
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IDENTIFICATION AND SCREENING OF THE LITERATURE
Literature Identification
Much as was the case with previous VAO committees, this committee was 
tasked with comprehensively reviewing, evaluating, and summarizing the sci-
entific literature that has appeared since the previous biennial update regarding 
associations between TCDD and other chemicals present in the herbicides used 
by the U.S. military in Vietnam and health outcomes and then adding this new 
information to the existing compendium of evidence to draw conclusions on the 
strength of associations between exposure and health outcomes. To begin, the 
committee oversaw extensive searches of the scientific literature using a strategy 
adapted from prior committees’ literature search methodology (see Box 3-1). 
This committee’s search included additional terms to evaluate specific conditions 
called out in the Statement of Task: possible generational health effects, myelo-
proliferative neoplasms, and brain cancer, in particular, glioblastoma multiforme 
(see Chapter 1 for the full Statement of Task).
For this update, electronic searches of the medical and scientific literature 
were carried out on four databases: Web of Science, Scopus, Medline, and Em-
base. In the previous VAO updates, only Medline and Embase were used. The 
four searchable databases index biological, chemical, medical, and toxicological 
publications. The full texts of the articles were searched so that if any of the 
search terms was included in the title or abstract or indexed in the key words or 
text of the article (excluding the cited references section), the article would be 
included in the results of the search. Search terms included full and abbreviated 
chemical names, common and manufacturer trade names, the Chemical Abstracts 
Service numbers, and MeSH1 descriptors for each of the COIs and other similar 
chemicals on an assumption that compounds with similar chemical structure 
may have analogous biologic activity. The aryl hydrocarbon receptor (AHR) and 
related MeSH descriptors were also included as primary search terms since this 
protein appears to mediate essentially all of the toxicity of TCDD.
Using the search terms in Box 3-1, the databases were searched in two 
phases, with the searches spanning over timeframes that were extended from 
those used in prior updates. In the spring of 2017, the databases were searched 
for articles published between January 1, 2014, and March 31, 2017. Then in 
early February 2018 the databases were again searched for any articles with 
the relevant search terms published between March 1, 2017, and December 31, 
2017. The timeframes for those searches overlapped each other and also over-
lapped with the Update 2014 committee’s search (October 1, 2012–September 
30, 2014). The overlapping dates made possible the capture of articles that might 
1MeSH descriptors are sets of terms naming descriptors in a hierarchical structure that permits 
searching at various levels of specificity. For example, MeSH terms for 2,3,7,8-tetrachlorodibenzo-
p-dioxin include “TCDD” and “dioxin,” without those terms having to be specified individually.
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BOX 3-1
Search Terms
TERMS INCLUDED IN PREVIOUS VAO SEARCHES
Herbicide Formulations2,4-dichlorophenoxyacetic acid (2,4-D), 2,4,5-trichloro-
phenoxyacetic acid (2,4,5-T), 4-amino-3,5,6-trichloropicolinic acid (picloram), and 
dimethylarsinic acid (DMA or cacodylic acid) and the contaminant 2,3,7,8-tetra-
chlorodibenzo-p-dioxin (TCDD).
Other Similar Chemicals
2-(2,4,5-trichlorophenoxy) propionic acid (Silvex), 2-methyl-4-chlorophen-
oxyacetic acid, 2-(2-methyl-4-chlorophenoxy) propionic acid (Mecoprop), 3,6- 
dichloro-2-methoxybenzoic acid (dicamba), and polycholorinated biphenyls (PCBs). 
Full and abbreviated chemical names, common and manufacturer trade names, 
the Chemical Abstracts Service (CAS) numbers (that serve as a unique identifier 
for every chemical), and MeSH descriptors for each of the chemicals of interest.
TCDD Toxicity Mediator
Aryl hydrocarbon receptor (AHR) and related MeSH descriptors
Generic Terms
Vietnam, veteran, Vietnam veteran, Agent Orange, dioxin, herbicide, and 
phenoxy
SEARCH TERMS FOR CONDITIONS SPECIFIED IN THE 
STATEMENT OF TASK
Generational Health Effects
Reproductive OR Reproduction OR Gonads OR Fertility OR Infertility OR 
Fertilization OR Sperm* OR Testes OR Testicular OR Pregnancy OR Birth OR 
Embryo OR Fetus OR Fetal OR Spermatozoon (MeSH) OR Infertility, male 
(MeSH) OR Infertility, female (MeSH) OR Testis (MeSH) OR Testicle OR Sperm–
ovum interactions (MeSH) OR Semen OR Semen quality OR Ova OR Ovum OR 
Oocyte OR Egg OR Parturition (MeSH) OR Embryonic structures (MeSH) OR 
Fetal development OR Embryonic and fetal development (MeSH) OR Pregnancy 
complications (MeSH C13.703) OR Abortion, spontaneous (MeSH) OR Miscar-
riage OR Premature birth OR Fetal death OR Pregnancy loss OR Preconception 
injuries (MeSH C21.676) OR Germline OR Microbiome OR DNA methylation OR 
Histone modification OR Histone* OR SNP* OR Polymorphism* OR Non-coding 
RNAs OR ncRNA* OR Small RNA* OR MicroRNA* OR miRNA OR Imprinted 
gene* OR Gene–environment OR Gene OR Epigenetic processes OR Epigenetic 
OR Epigenomic OR Transgeneration* OR Trans-generation* OR Multigeneration* 
OR Multi-generation* OR Intergeneration* OR Inter-generation* OR Generation* 
OR Multigenerational effect* OR Multi-generational effect* OR Multigenerational 
inheritance OR Multi-generational inheritance OR Multigenerational epigenetic 
inheritance OR Multi-generational epigenetic inheritance OR F1 OR “F 1” OR 
continued
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have been published but not indexed at the time of the first search. Other than 
dates, no limitations (such as language, populations, or species) were put on the 
search. In addition, potentially relevant articles were also identified by searching 
the reference lists of relevant review and research articles, books, and reports. 
Exact duplicate articles and those that had been summarized and referenced in 
Update 2014 were deleted. The committee became aware of a few studies that 
reported updated findings on relevant exposed populations (such as the Seveso, 
Italy, cohort and New Zealand phenoxy herbicide producers) published following 
the December 31, 2017, search cutoff and reviewed these studies as well.
Literature Screening
The search strategy was devised to ensure that abstracts of all potentially 
relevant articles were subjected to closer screening, but it also resulted in the 
“F(1)” OR F2 OR “F 2” OR “F(2)” OR F3 OR “F 3” OR “F(3)” OR F4 OR “F 4” 
OR “F(4)” OR Offspring OR Progeny OR One generation OR Two generation* 
OR Second generation* OR Three generation* OR Third generation* OR Four 
generation* OR Fourth generation* OR Child* OR Parent* OR Father* OR Son* 
OR Daughter* OR Grandparent* OR Grand parent* OR Grandfather* OR Grand 
father OR Grandmother OR Grand mother OR Grandchild* OR Grandson* OR 
Grand son* OR Granddaughter* OR Grand daughter* OR Greatgrandparent* OR 
Great-grandparent* OR Greatgrandmother* OR Great-grandmother* OR Great-
grandchild* OR Great-grandchild* OR Greatgrandson* OR Great-grandson* OR 
Greatgranddaughter* OR Great-granddaughter*
Myeloproliferative Neoplasms
Myeloproliferative disorder* OR Myeloproliferative neoplasm* OR Aryl hy-
drocarbon receptor OR Myeloproliferative syndromes OR Myeloproliferative dis-
orders OR “P vera” OR Polycythemia vera OR “ET” essential thrombocytosis 
OR Essential thrombocythemia OR Myeloid metasplasia OR Agnogenic myeloid 
metaplasia OR Myelofibrosis OR Primary myelofibrosis OR Chronic idiopathic 
myelofibrosis OR “CML” OR Chronic myelogenous leukemia OR Jak2 mutation 
OR Janus kinase 2 OR bcr-abl OR Philadelphia chromosome OR “CALR” muta-
tion OR Calreticulin mutation OR MPL mutation OR Thombopoietin mutations OR 
“XPD polymorphism” OR LNK (Src homology 2B3) OR CBL (Casitas B lineage 
lymphoma)
Glioblastomas
“TET” OR ASXL2 OR IDH OR IKZF1 OR EZH2 OR DNMT3A OR Glioblas-
toma OR Glioblastoma cell line OR Brain neoplasm OR Glioblastoma multiforme 
OR Astrocytoma grade IV OR Multifocal glioblastoma OR Glioma OR Neuroepi-
thelial neoplasm OR Optic glioblastoma OR T98G glioblastoma multiforme cell 
line OR brain tumor (MeSH)
BOX 3-1 Continued
Veterans and Agent Orange: Update 11 (2018)
Copyright National Academy of Sciences. All rights reserved.
EVALUATION OF THE EVIDENCE BASE 49
identification of a large number of non-relevant studies. The first search produced 
in excess of 12,000 “hits,” and the second search identified more than 1,600 
articles of potential relevance. The articles were generally in English, but VAO 
committees have traditionally obtained translations for crucial ones that were not 
in English. Article titles and abstracts were screened for relevance by committee 
members and the Health and Medicine Division staff to determine which studies 
should be considered for full-text retrieval using the criteria in Box 3-2.
In the VAO series, neurologic deficits associated with Vietnam service are 
distinguished from psychiatric/psychologic conditions—such as posttraumatic 
stress disorder (PTSD), depression, and anxiety—and their sequelae. While, as 
past VAO committees have noted, the increased risks of these types of mental 
health conditions among veterans of all U.S. conflicts are of scientific and public 
health concern, military service alone, including deployment and service in Viet-
nam, is known to confer a range of exposures to potentially traumatic events that 
may be expected to increase the risk of developing PTSD and related psychologic 
conditions. For example, compelling evidence has established that the prevalence 
of PTSD is more than twice as high for operational infantry units exposed to 
direct combat than it is in the general population (Kok et al., 2012). Previous 
committees further drew the conclusion that it would be infeasible to disentangle 
potential adverse effects from exposure to the COIs on mental health outcomes 
that may occur independently of psychological effects accrued through military 
service. The current committee expands upon that perspective by placing it in a 
framework that underscores the relevance of the concepts of multifactorial causa-
tion, the literature on which has recently begun to mature and offer new insights. 
Both independent and interacting risk factors may play a role. An example of 
multiple independent effects can be seen in a recent study of Vietnam veterans in 
Australia, which found that both sons and daughters of veteran fathers diagnosed 
with PTSD had an increased risk for PTSD even after controlling for PTSD in the 
mother and for other diagnoses (O’Toole et al., 2017). The statistical interactions 
of risk factors, which can have synergist or antagonistic effects, can result in ef-
fects of combined exposures that would not have been predicted based on their 
independent impacts. An example of a synergistic interaction is the association 
with lung cancer from combined exposures to workplace arsenic and smoking: 
in this case, the risks from arsenic are much higher among smokers than among 
non-smokers (Hertz-Picciotto et al., 1992).
Disentangling the separate effects of combined exposures or risk factors in 
relation to a particular outcome does raise serious challenges, however, and it 
may indeed be infeasible when the correlations among those exposures are ex-
ceedingly high, to the point of inseparability, or when sufficiently large studies 
cannot be conducted. For example, service-related emotional trauma, such as 
occurs in combat, and exposures to the COIs in Vietnam are associated (J. M. 
Stellman et al., 1988), but whether they are separable depends on the extent to 
which those experiencing service-related trauma also had high exposures to the 
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COIs and, conversely, the extent to which those with high exposures to the COIs 
invariably had a high degree of service-related trauma.
Current epidemiologic thinking recognizes that multiple risk factors may 
operate not only independently, but also synergistically, and that sometimes the 
BOX 3-2
Criteria for Excluding Scientific Articles  
from Further Consideration
• Study does not include the chemicals used as tactical herbicides in military 
operations in Vietnam. Examples include exposure to herbicides containing 
organophosphates (not otherwise specified), atrazine, paraquat, glyphosate, 
metamifop, rotenone, clarityon, and diuron; and exposure to pesticides and 
insecticides (e.g., chlorpyrifos, imidacloprid, thiacloprid, DDT, DDE, etc.), fun-
gicides, rodenticides, and non-dioxin-like PCBs.
• Descriptions of ecosystem or environmental monitoring or exposure 
surveillance.
• Evaluations of chemical toxicities in environmental samples (e.g., plants, 
water, soils).
• Therapeutic or treatment studies following intentional or unintentional expo-
sure to one of the chemicals of interest (COIs).
• Descriptions of intentional acute chemical exposure or poisoning (including 
suicide).
• Case studies or case series (while such reports may be interesting and provide 
unusual information, it is not appropriate to extrapolate findings from a single 
case to an entire population).
• Conference abstracts or proceedings, commentaries, or letters to the editor.
• Stated narrative or historical accounts of the Vietnam era.
• Studies that did not relate exposure to a COI and a health outcome.
• Exposures experienced as children or adolescents (if the study subjects were 
exposed prenatally and followed, the article was further considered).
• Studies of lactation or ingestion of breast milk as the sole outcome of interest 
without associated outcomes.
• Studies about occupational exposure in greenhouse workers (consistent with 
previous updates).
• Described mental health or psychological conditions as a result of herbicide or 
pesticide exposure, because it would be impossible to disentangle the potential 
adverse effects on mental health outcomes caused by exposure to the COIs that 
may occur independently of psychological effects accrued through military service.
• Epidemiologic literature on the health effects of inorganic arsenic. Inorganic ar-
senic and benzene were not considered as relevant service-related exposures 
among Vietnam veterans and were not evaluated in relation to their potential risk 
of adverse health outcomes. VAO committees have considered and reviewed 
toxicologic studies in which animals were directly exposed to dimethylarsinic acid 
(DMA), but the extensive literature on the health effects of exposure to inorganic 
arsenic (including the epidemiologic research, animal experiments, and mecha-
nistic studies) has been regarded as not primarily pertinent to DMA exposure and 
has not been considered.
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combined impacts may have both an independent and synergistic or antagonistic 
component. Thus, a nuanced and comprehensive approach to combined exposures 
is critical to understanding causation. Underlying susceptibility is not always ge-
netic, but can instead be a prior or concomitant exposure, and thus the possibility 
of multifactorial causation requires paying attention to confounding as well as to 
interactions. Few studies have rigorously addressed the combination of combat 
duty and the COIs through an assessment of interactions. In addition, a review of 
the vast toxicology literature that relates to the COIs reveals that there is a dearth 
of reports that address the potential associations and mechanistic explanations 
relating to how exposure to the COIs may influence the risk of developing mental 
health conditions. This applies specifically to an overall absence of published evi-
dence as to how TCDD exposure could be etiologically implicated in the develop-
ment of PTSD and related psychological comorbidities. Animal models will not 
be informative for studying potential associations between exposure to the COIs 
and development of PTSD. Because the literature appears to be quite limited, it 
does not provide the opportunity to address effects on PTSD or other mental health 
conditions that may occur as a result of the combined effect of military service/
combat duty and the COIs. Thus, at this time the committee was not able to deter-
mine whether the COIs might magnify the impact of traumatic events.
Although exposure to 2,4-D, 2,4,5-T, TCDD, cacodylic acid, and piclo-
ram are most germane to the committee’s charge and given the most weight 
in the review of the evidence on a particular health outcome, chemicals that 
are structurally similar to the herbicides and contaminants found in the tacti-
cal herbicides used in Vietnam are assumed to have similar biologic activity 
and thus were also included in the committee’s review of the literature, consis-
tent with prior VAO Update committees. These related chemicals include other 
phenoxy herbicides—such as 2-(2,4,5-trichlorophenoxy) propionic acid (Silvex), 
2-methyl-4-chlorophenoxyacetic acid (MCPA), 2-(2-methyl-4-chlorophenoxy) 
propionic acid (Mecoprop or MCPP), and 3,6-dichloro-2-methoxybenzoic acid 
(dicamba)—as well as dioxin-like chemicals such as those found in mono-ortho 
and non-ortho-substituted polychlorinated biphenyls (PCBs) and also metabo-
lites of organic arsenic (DMAV). Very few epidemiologic studies on exposure to 
picloram or cacodylic acid have been published, which is another reason for the 
committee to consider metabolites of these compounds.
Examining the structural representation of the COIs shown in Figure 2-1, 
one can readily see the basis of an assertion heard repeatedly from individual 
Vietnam veterans that “benzene is contained in TCDD.” Indeed, the two rings 
at the ends of the three-ring structure constituting the basic structure of dioxin 
compounds, to which chlorine molecules or other chemical radicals can be at-
tached, do have the molecular structure of a single benzene molecule, and the 
“dibenzo-dioxin” in TCDD’s chemical name does mean that the molecule is a 
benzene-substituted dioxane. The benzene ring structure is a basic building block 
of a vast number of organic compounds, both industrial (such as polyaromatic 
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hydrocarbons, the phenoxy herbicides, picloram, and PCBs) and natural (such 
as estradiol, a hormone present in both men and women). However, the biologi-
cally active compound benzene does not emerge from dioxin, whose three-ring 
structure is extremely stable and resistant to metabolism.
An interaction or synergism among the COIs or in conjunction with other agents 
is another theoretical concern. The committee was not charged with attributing 
effects to specific COIs, and joint effects among them should be adequately identi-
fied by the committee’s approach. The combinations of the chemicals with other 
agents that might lead to problems are virtually infinite, and hence, not feasible 
for systematic and comprehensive evaluation. Real-life experience, as investigated 
with epidemiologic studies, effectively integrates any results of exposure to a target 
substance in combination with other substances that may be etiologically relevant.
Thus, in aggregate, the primary COIs evaluated by the committee with 
respect to potential associations with adverse health outcomes among Vietnam 
veterans are 2,4-D, 2,4,5-T, picloram, cacodylic acid, and TCDD. As explained, 
inorganic arsenic and benzene were not considered as relevant service-related 
exposures among Vietnam veterans and thus were not evaluated in terms of their 
risk for adverse health outcomes.
The committee recognizes that in real-world conditions, human exposure to 
TCDD virtually never occurs in isolation and that there are hundreds of similar 
compounds to which humans might be exposed, including other polychlorinated 
dibenzo-p-dioxins, polychlorinated dibenzofurans (PCDFs), and PCBs which 
have dioxin-like biologic activity. The literature on the other compounds, particu-
larly PCBs, has not been reviewed systematically by the committee except for 
those reports in which TCDD was identified as an important component of the 
exposure or when the risks of health effects were evaluated in relation to exposures 
to dioxin-like chemicals. In many cases, when dioxin-like chemicals are present 
the exposure is expressed in terms of toxic equivalencies (TEQs), which are the 
sums of toxicity equivalence factors (TEFs) for individual dioxin-like chemicals 
as measured by activity with AHR. Studies that report TEQs based only on mono-
ortho PCBs (which are PCBs 105, 114, 118, 123, 156, 157, 167, and 189) are con-
sidered even though their TEQs are several orders of magnitude lower than those 
of the non-ortho PCBs (77, 81, 126, and 169), based on the revised World Health 
Organization (WHO) 2005 TEF values (La Rocca et al., 2008; van den Berg et al., 
2006). This is because the lower TEQs of the mono-ortho PCBs may be counter-
balanced by their abundance, which is generally many orders of magnitude higher 
than the non-ortho PCBs (H.-Y. Park et al., 2010). For example, PCB congeners 
118 and 156 are present in numerous human populations (United States, Europe, 
and Japan), at levels that are 4 to 5 orders of magnitude greater than the levels of 
TCDD itself (Bake et al., 2007; Becher et al., 1995; Lorber et al., 2009, Tsuchiya 
et al., 2003), with the levels of mono-ortho TEQs closely approximating those of 
TCDD or in some cases exceeding them (H.-Y. Park et al., 2010).
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Exposure to non-dioxin-like PCBs only has not been considered by VAO 
committees for two reasons. First, Vietnam veterans may have been exposed to 
substantial amounts of the other chemicals, and the amount of exposure to those 
chemicals relative to TCDD has not been documented. Second, the most impor-
tant mechanism for TCDD toxicity involves its ability to bind to and activate the 
AHR. Many of the other chemicals act by different or multiple mechanisms, so 
it is difficult to attribute toxic effects after such exposures specifically to TCDD. 
Furthermore, an individual’s exposures to dioxin-like chemicals and their non-
dioxin-like counterparts tend to be correlated, which means that it is difficult 
for epidemiologic studies to attribute any observed association to a particular 
chemical configuration (Longnecker and Michalek, 2000); carrying out analyses 
in terms of TEQs somewhat circumvents this problem. The interaction or syner-
gism among the COIs or in combination with other agents is a concern, but the 
combinations of the COIs with other toxicants, or physical, biological stressors 
is outside of the committee’s charge.
In cases when the title or abstract mentioned only broad chemical categories 
or used non-specific terms such as “herbicide” or “pesticide,” the full text was re-
viewed for mention of the specific COIs. It was evident from most of the abstracts 
that the article did not address health effects in association with exposure to the 
specific COIs. The committee only deleted studies from further consideration if 
it verified that exposure information specifically did not include at least one of 
the COIs or if the study was not at all relevant, such as studies that evaluated the 
efficacy of the COIs in killing specific plants or that measured concentrations of 
the COIs in environmental samples, studies that merely provided a description 
of manufacturing processes, or studies that did not include a health outcome. All 
studies that discussed health effects or changes in pathophysiology or cell sig-
naling were considered if the text indicated that any of the herbicides of interest 
(or any of their components) may have been investigated. The committee only 
included literature that had undergone peer review or government reports and 
invited presentations that were provided to the committee, under the assumption 
that they have been carefully reviewed. The process of peer review by fellow 
professionals increases the likelihood that high-quality studies will appear in 
the literature, but it does not guarantee the validity of any particular study or the 
ability to generalize its findings.
Because the use of the general search terms “pesticides” or “pesticide,” 
“defoliants,” “defoliant agent,” and “herbicide” or “herbicides” resulted in more 
than 57,000 “hits,” the committee focused its search on the specific COIs as 
well as related chemical classes. Even using the more targeted terms for the COI 
identified many studies that examined the relationship between exposure to “pes-
ticides” or “herbicides” and adverse health outcomes without identifying specific 
chemicals. After carefully reading the full text of an identified article, if none of 
the COIs were specified as contributing to the exposures of the study population, 
the committee generally excluded such a study from further consideration and 
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did not summarize it. An exception to this practice was made for studies that 
indicated exposure to herbicides but did not characterize exposure with sufficient 
specificity for their results to meet the committee’s criteria for inclusion in the 
evidentiary database. For example, numerous case-control studies characterized 
exposure to pesticides or herbicides on the basis of job titles, farm residence, or 
longest-worked industry. Consistent with prior VAO reports, such studies were 
not given full evidentiary weight because their results are not regarded as fully 
relevant for the purpose of this review, but they are presented more briefly under 
the heading of “Other Identified Studies.” However, given that the exposure 
was not adequately described for these studies, their results are not included in 
supplementary summary tables.
Articles using the generic term “herbicide” were kept if a published report 
specified that the COIs were among the pesticides or herbicides used by the study 
population or the COIs are used commonly for the crops identified in the study 
or the COIs are used commonly for a specific purpose, such as the removal of 
weeds and shrubs along highways. For instance, this rubric would apply to any 
published articles from the Agricultural Health Study because 2,4-D was one of 
the most frequently used pesticides in this large prospective cohort, but some 
results have lumped all herbicide exposure together. In general, if the COIs were 
not presented separately in the results of a study, the study was considered to be 
of limited relevance and acknowledged as an “other identified study.” Exposures 
to dioxin-like chemicals, such as mono-ortho and non-ortho substituted PCBs, 
PCDFs, and dioxins other than 2,3,7,8-TCDD, were also considered relevant to 
the committee’s charge and were included as long as the results were expressed 
in terms of total or individual congener toxic equivalents. The most weight was 
given to studies that used quantitative measures (such as TEQs) and specified 
exposure.
Studies with original data collection and analyses were preferred over stud-
ies that were re-analyses of a population (without the incorporation of additional 
information), pooled analyses or meta-analyses, reviews, and so on, and the 
former are the type of evidence that the committee preferentially considered 
when assessing the strength of association between herbicide exposure and a 
health outcome when drawing its conclusions. While studies of the latter type 
may be informative and may be discussed in conjunction with primary results or 
in synthesis sections on a given health outcome, they are not themselves part of 
the evidence dataset and therefore were not considered in the final count of new 
literature considered in this volume.
EVALUATION PROCESS
This section details the methods used by the committee for evaluating and 
synthesizing the relevant studies identified by the literature search and screening 
and for making its conclusions on the relationships between the COIs and health 
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outcomes among Vietnam veterans. The quantitative and qualitative procedures 
underlying the committee’s literature evaluation have been made as explicit as 
possible, but ultimately the conclusions about associations expressed in this 
report are based on the committee’s collective judgment. The committee has 
endeavored to express its judgments as clearly and precisely as the data allow.
A total of 14,750 abstracts were retrieved from the two literature searches. 
Full text was then obtained for any articles that were considered potentially rel-
evant based on their titles and abstracts and after applying the inclusion and ex-
clusion criteria. Full-text articles were distributed among the committee members 
based on their areas of expertise, with at least two committee members reviewing 
each paper. As with all VAO committees, the committee began its assessment of 
the literature by assuming neither the presence nor the absence of an association 
between exposure and any particular health outcome. Because of the variability in 
the descriptions and diagnoses of the health conditions considered in this report, 
the committee made no a priori assumptions about the usefulness of any article or 
report for a health outcome. Each study was reviewed and objectively evaluated 
for each health outcome it presented. If a study examined more than one health 
outcome, it was considered separately for each of those outcomes. After reading, 
if the full text revealed that the study met one of the exclusion criteria (see Box 
3-2), it was excluded from further consideration.
After review of the full text of the identified articles, studies that were con-
sidered relevant (165 epidemiologic studies and nearly 100 toxicologic studies) 
were discussed and evaluated thoroughly, and are included in this report. New 
evidence on each health outcome was reviewed in detail, but the committee’s 
conclusions are based on the accumulated evidence of all VAO reports, not just 
on recently published studies.
The responsible committee members then presented the information from 
each new relevant study—including the methods used for selecting the study 
populations and conducting the research (i.e., design, measures of exposure and 
health outcomes, statistical analyses used, adjustment factors, etc.), the results, 
and an assessment of the strengths, limitations, and potential biases—to the full 
committee for discussion. Based on the details of exposure and the description of 
how exposure was measured, an epidemiologic study was classified either as a 
primary article, in which case it was given full evidentiary weight, or as a second-
ary article, in which case it was reviewed and more briefly described under the 
heading of “Other Identified Studies.” In a secondary study, the exposure was 
either not adequately described or considered not to be specific enough for its 
findings to contribute evidentiary weight. An epidemiologic study was also clas-
sified as secondary if the outcome was a biologic marker of effect as opposed to 
a recognized condition or disease. Studies that measured well-defined functional 
outcomes indicative of mild impairments and likely of worsening function that 
have not yet progressed to frank clinical diagnoses, such as cognitive function 
and loss of grip strength, as evaluated in Chapter 9: Neurologic Disorders, were 
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considered primary evidence. Mechanistic and toxicologic studies contributed to 
the evidence for biologic plausibility but were not considered primary studies, so 
that based on those studies alone, their weight would not be enough to change the 
level of evidence of an association.
Following the discussion of each individual study for a specific health out-
come, the lead committee member for an outcome then reviewed and summarized 
for the full committee the epidemiologic evidence reported in prior VAO updates 
and the most recent conclusion from Update 2014 on that health outcome. The 
toxicologists on the committee provided a summary of previous and new mecha-
nistic or toxicologic studies for that health outcome. Although both primary and 
secondary studies contributed to the committee’s conclusion regarding the evi-
dence of the COIs to be associated with a particular health condition or outcome, 
primary studies were given more weight. Using all of the available information, 
the full committee then came to a consensus regarding the conclusion and as-
signed a category of association (discussed later in this chapter) on the strength of 
the evidence of exposure to at least one of the COIs and the health outcome under 
scrutiny. When drafting language for a conclusion, the committee considered the 
nature of the exposures, the nature of the specific health outcome, the populations 
exposed, and the quality of the evidence examined.
The draft text was reviewed and discussed in further plenary sessions until 
all committee members reached a consensus on the description of the studies and 
the conclusion for each health outcome. The committee did not use a formulaic 
approach to determining the number of primary or supporting studies that would 
be necessary to assign a specific category of association. Rather the committee’s 
review required a thoughtful and nuanced consideration of all the studies as well 
as expert judgment, and this could not be accomplished by adherence to a nar-
rowly prescribed formula of what data would be required for each category of 
association or for a particular health outcome.
The supplementary tables to this report (available online at www.nap.edu/
catalog/25137) were revised to include only the new primary epidemiologic stud-
ies; secondary studies, including mechanistic and toxicologic studies, were not 
included in the compendium evidence tables for each outcome. If no new primary 
studies for a health outcome were identified, the evidence table from Update 
2014 was included. Effect estimates, data, and units of measure are presented as 
reported in the cited studies, except where otherwise noted. The committee did 
not collect original data, nor did it perform any secondary data analyses, such as 
meta-analyses.
Types of Studies Considered
The committee focused on epidemiologic studies because epidemiology 
deals with the determinants, frequency, and distribution of disease in human 
populations rather than in individuals and animal models, which have several 
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limitations as discussed below. Epidemiologic studies effectively integrate any 
results of exposure to a target substance in combination with other substances 
that may be etiologically relevant. Several types of epidemiologic studies were 
evaluated, including cohort, case-control, and cross-sectional designs. Other re-
ports of health outcomes among veteran populations have described these major 
types of epidemiologic studies and chronicled the limitations inherent in conduct-
ing them and in using them to make conclusions based on associations between 
deployment-related factors and health conditions (IOM, 1994; NASEM, 2016a).
The committee weighed the importance of the epidemiologic studies in the 
following order: Vietnam veterans, occupationally exposed workers, and people 
who were exposed environmentally. Exposures gleaned from case-control designs 
were considered separately. Vietnam veterans (U.S. veterans and those from al-
lied countries) are presumed to have been exposed to all the COIs; the limitations 
of such an assumption are discussed in Chapter 2. Although Vietnam veterans 
constitute the source population of interest, the committee has taken into account 
the potential for more precise quantification and evaluation of the risks of adverse 
health outcomes associated with the COIs in better characterized cohorts (for 
example, occupational and environmental cohorts). Including these more highly 
exposed populations had the additional advantage that epidemiologic studies of 
them were likely to have greater statistical power to detect any adverse effects 
that might occur with exposure. Within the occupational-study populations, due 
to the substantial differences in the nature and intensity of their exposures, work-
ers in the production of herbicides and other industrial products contaminated 
with TCDD were prioritized, followed by those involved in occupational use of 
the herbicides of interest (such as agricultural workers). The committee for VAO 
and the first several updates gave more weight to results that were based on job 
title (for example, “farmer” with no additional information) than have the com-
mittees since Update 2006 (where such studies are now considered secondary 
and given less weight). Those first committees also entirely excluded findings 
from the Yusho and Yucheng PCDF and PCB poisonings, whereas recent com-
mittees have considered these and other environmental studies that analyzed for 
dioxin-like PCDF and PCB congeners and expressed the results in terms of TEQs. 
Toxicologic studies, particularly in animal models, are included to inform the 
understanding of biologic plausibility through the toxicology of the chemicals 
and their exposure pathways.
Vietnam Veterans
Because Vietnam veterans are the target population of the charge to the 
VAO committees, studies of these veterans (whether American or otherwise) 
have always been accorded considerable weight in the committees’ deliberations 
and are presented first in the literature for each health outcome. The commit-
tee reviewed all identified studies of U.S. and international Vietnam veterans 
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published since Update 2014. In general, few studies include objective measures 
of TCDD or other chemical concentrations; those that are available were per-
formed in small subsets of Vietnam veterans, such as those from the Air Force 
Health Study and Army Chemical Corps. Instead, having served in Vietnam or 
participating in the Agent Orange Registry is often considered a proxy of her-
bicide exposure. Therefore, it is difficult to quantify the risk of specific health 
outcomes when the exposures of the total at-risk population have not been mea-
sured or estimated. In the absence of actual measures of exposure, comparisons 
between deployed and non-deployed Vietnam-era veterans are considered the 
next most relevant comparison. Moreover, in many studies of Vietnam veterans, 
not all health outcomes of interest were reported (in some cases there were too 
few cases to report, only specific health outcomes were of interest, or the veteran 
population was too young for a particular manifestation). Consequently, several 
other groups known or thought to have potentially higher and better-characterized 
exposure to TCDD or phenoxy herbicides than the Vietnam veterans themselves 
were considered.
Human Studies Among Non-Veterans
Whereas exposure estimation and characterization of the COIs has been 
lacking in many (especially early) studies of Vietnam veterans, studies of oc-
cupational exposure (for example, among chemical-production, paper and pulp, 
railroad, agricultural, and forestry workers) and of environmental exposure (for 
example, residents of dioxin-contaminated sites such as Seveso, Italy, and the ar-
eas around some former U.S. military installations in Vietnam) to TCDD and the 
other COIs provide evidence of exposure and health outcomes to supplement the 
studies of Vietnam veterans. Some occupational and environmental cohorts that 
received exceptionally high exposures have produced many informative results 
and provide stronger evidence about health outcomes than studies of Vietnam 
veterans because the exposures were better characterized and measured sooner 
relative to the exposure. Moreover, in several studies of chemical-production 
plant workers, the magnitude and duration of exposure to the chemicals were 
measured and generally greater than among Vietnam veterans, so the likelihood 
that any possible health consequences would be manifested was greater. Some 
of the populations used in these types of studies were large enough to examine 
dose–response relationships. Other populations, such as the Agricultural Health 
Study, a prospective cohort study of U.S. agricultural workers with specific in-
formation on the COIs, continue to contribute new evidence of association with 
health outcomes.
As the information on populations that had established exposure to the COIs 
has grown, VAO committees have become less dependent on data from studies 
that had non-specific exposure information (e.g., exposure to non-specified herbi-
cides) and have been able to focus more on the findings of studies that had refined 
Veterans and Agent Orange: Update 11 (2018)
Copyright National Academy of Sciences. All rights reserved.
EVALUATION OF THE EVIDENCE BASE 59
exposure specificity. For each health outcome, occupational and environmental 
studies are presented after the studies of Vietnam veterans.
Animal and Mechanistic Studies
The committee used studies of toxicology data to determine whether there 
is a plausible biologic mechanism or other evidence of a causal relationship 
between herbicide exposure and a health effect. A positive statistical association 
between an exposure and an outcome does not necessarily mean that the exposure 
is the cause of that outcome. Data from toxicology studies may support or conflict 
with a hypothesis that a specific chemical can contribute to the occurrence of a 
particular disease. Insights about biologic processes inform whether an observed 
pattern of statistical association might be interpreted as the product of more 
than error, bias, confounding, or chance. Discussions on biologic plausibility are 
presented after new epidemiologic evidence and before the synthesis of all the evi-
dence. The degree of biologic plausibility itself influences whether the committee 
perceives positive findings to be indicative of a pattern or the product of statistical 
fluctuations. Ultimately, the results of the toxicology studies should be consistent 
with what is known about the human disease process if they are to support a 
conclusion that the development of the disease was influenced by an exposure.
Aryl Hydrocarbon Receptor Many of the available toxicologic and mechanis-
tic studies involve the AHR because it has been found that essentially all of the 
toxic effects of TCDD involve interaction with this protein (receptor). The AHR 
can modulate transcription by binding TCDD and other aromatic hydrocarbons 
with high affinity. The formation of an active complex that involves the intracel-
lular receptor, the ligand (the TCDD molecule), and other proteins is followed 
by an interaction of the activated complex with specific sites on DNA, which 
can alter the expression of specific genes involved in the regulation of cellular 
processes. The affinity of TCDD for the AHR is species- and strain-specific, and 
responses to the binding of the receptor vary among cell types and developmental 
stages.
Although studying AHR biology in transformed human cell lines minimizes 
the inherent error associated with species extrapolations, it is still not clear to 
what extent toxicity is affected by the transformation itself or by the conditions 
under which cell lines are cultured in vitro. Genetically based differences in the 
properties of the AHR are known to exist in human populations (Zhou et al., 
2010), as they are in laboratory animals, so there are genetically based differ-
ences in people’s responses to TCDD, which leads to some people having an 
intrinsically greater risk of toxic effects from the same TCDD exposure, while 
others have less risk. Therefore, as humans have AHR with differing affinities 
for dioxin, a single transformed human cell line will not accurately reflect the 
spectrum of responses observed in the entire human population. As a result, the 
Veterans and Agent Orange: Update 11 (2018)
Copyright National Academy of Sciences. All rights reserved.
60 VETERANS AND AGENT ORANGE: UPDATE 11
TEQ approach should be seen as qualitatively generalizable, but cannot be de-
finitively quantitative when discussing differences between tissues or individual 
humans.
Limitations of Animal Models Animal models are the basis for many of the 
toxicologic and mechanistic studies, although cell lines and in vitro cell cultures 
(human or animal) are also used. Studies that use isolated cells in culture also can 
elucidate how a chemical alters cellular processes. The objectives of those toxi-
cology studies are to determine what toxic effects are observed at different ex-
posure levels and to identify the mechanisms by which the effects are produced.
To be considered an acceptable surrogate for the study of a human disease, 
an animal model must reproduce, with some degree of fidelity, the manifesta-
tions of the disease in humans. However, a given effect of an exposure in an 
animal species does not necessarily establish its occurrence in humans, nor does 
the apparent absence of a particular effect in animals mean that the effect could 
not occur in humans. In addition to possible species differences, many factors 
affect the ability to extrapolate results from animal studies to health effects 
in humans. For example, animals used in experimental studies are most often 
exposed to purified chemicals, not to mixtures. Even if herbicide formulations 
or mixtures are used, the conditions of exposure might not realistically repro-
duce the human exposures that occur in the field. Other variables, including 
the amount and duration of exposure, can be controlled precisely in laboratory 
settings.
TCDD is thought to be responsible for many of the toxic effects of the her-
bicides used in Vietnam. Attempts to establish correlations between the effects 
of TCDD on experimental systems and their effects on humans are particularly 
difficult because there are well-known species-, sex-, and outcome-specific dif-
ferences in susceptibility to TCDD toxicity. Even in humans, the data on TCDD’s 
toxic effects are not consistent (DeVito and Birnbaum, 1995; Ema et al., 1994; 
Moriguchi et al., 2003). Differences in vulnerability may also be affected by 
variations in metabolism and by the rate at which TCDD is eliminated from 
the body. Although the degree of susceptibility is generally thought to be an 
inherent biological response, it can be influenced by life stage, past history, and 
co-exposures.
Many factors may contribute to differences between the results of controlled 
animal studies and the effects observed in humans. The following, which are 
elaborated on in Chapter 4, are among the most important:
• Physiologic differences. Laboratory animals are not miniature humans. 
Depending on the biologic process under investigation, a particular test 
species may match the human system more closely and so be a better 
experimental model than others.
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• Magnitude of exposure. As is often the case for toxicologic studies of 
any chemical, the TCDD exposure used for animal studies has been many 
orders of magnitude higher than Vietnam veterans are likely to have re-
ceived during military service, although the ultimate body burdens may 
not be as different.
• Duration of exposure. Although TCDD is a persistent organic pollutant, 
animal studies seldom examine the chronic low-level exposure that occurs 
over a period of years or even many months.
• Timing of exposure. It is well known that many organ systems are highly 
susceptible to xenobiotic exposure during critical stages of development, 
such as gestation; the response of some systems (such as the immune sys-
tem) may also depend on the timing of the exposure to antigens relative 
to the timing of the exposure to xenobiotics such as TCDD.
• The route of exposure. The route of exposure by which an exogenous agent 
enters an organism may influence the nature of any toxic response elicited. 
The outcomes of animal studies may be perturbed by the delivery of treat-
ment doses by “unnatural” routes of exposure, such as a bolus by gavage 
or intraperitoneal injection, but the route of exposure does not seem to be 
a major reason that the results of epidemiology studies may not agree with 
the findings of controlled studies for the COIs considered in the VAO series.
• Genetic constitution and expression. The etiologies of most diseases 
in humans and in animals are likely to be influenced by numerous genes 
and to involve complex gene–environment interactions, and preliminary 
evidence suggests that TCDD can induce epigenetic modifications of an 
organism’s DNA and alter expression of its genes.
• Sex differences. There are well-known differences between male and 
female animals (including humans) in susceptibility to xenobiotic expo-
sures, some of which are modified by sex steroids.
• Prior and recurring exposures to multiple sources. Humans are 
exposed to xenobiotics from multiple sources throughout their lifetimes.
• Complex mixtures. Most xenobiotic exposures occur in complex mix-
tures; the makeup of these mixtures can heavily influence the ultimate 
toxic effects. In addition to the dietary modulation of responses to other 
exposures of both humans and animals, including dietary supplements 
in humans, prescription and over-the-counter pharmaceuticals, and other 
factors (such as cigarette smoking and ambient pollution) may have effects.
• Stress. Stress—of known or unknown origin—is a well-known modifier 
of human disease responses (such as immune responses); stress is an ever-
present variable that is difficult to assess or control for in epidemiologic 
studies because there is substantial individual variation in response to it.
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Selection of Health Outcomes
The committee was charged with summarizing the strength of the scientific 
evidence concerning associations between exposure to various herbicides and 
contaminants during service in the Vietnam War and individual diseases or other 
health outcomes. The list of outcomes was developed on the basis of diseases 
and conditions identified from searches of the scientific literature, as first done 
by the original VAO committee and amended and expanded as needed by VAO 
Update committees. For example, the current committee included chronic skin 
conditions, which had not specifically been addressed by prior committees. Some 
health outcomes in the series have been added in response to requests from the 
Department of Veterans Affairs (VA) and various Veterans Service Organizations 
and in response to concerns of Vietnam veterans and their families. Comments 
received at public hearings and in written submissions from veterans and other 
interested persons have been valuable in identifying issues to be pursued to 
greater depth in the scientific literature. The current committee defined a health 
outcome as any recognized diagnosis (based on ICD-9 or ICD-102). Studies of 
exposure to the COIs that examined changes in pathophysiology, cell signaling, 
or other biologic markers of effect, such as hormone levels and blood counts, 
are more briefly mentioned as “Other Identified Studies” in applicable chapters, 
but because of the uncertainty of their relevance on the actual health outcome of 
interest, they are not considered further.
In aggregate, the health outcomes that the committee has focused on include 
cancers of all types, cardiovascular and metabolic outcomes such as diabetes, 
immune system disorders, and neurologic disorders. Other chronic health out-
comes have also been considered, including respiratory disorders, gastrointestinal 
disorders, endocrine disorders, and bone conditions. Generational effects were 
specifically included in the committee’s charge and are addressed along with re-
productive outcomes in a combined chapter. Although for most health outcomes 
the primary focus of the evaluation was on adverse outcomes in the veterans 
themselves, to examine potential effects, the children of Vietnam veterans and also 
later generations were included in the evaluation of the literature.
After reviewing the updated literature, the committee agreed that some reor-
ganization of the health conditions was warranted for this volume. For example, 
it was more appropriate to group monoclonal gammopathy of undetermined 
significance, multiple myeloma, and amyloid lightchain amyloidosis under the 
heading “Plasma Cell Dyscrasias.” Whereas reproductive outcomes and effects 
on descendants were presented in a single chapter from VAO through Update 
2010, the committees for Update 2012 and Update 2014 divided these outcomes 
into two chapters. The current committee believed that it made more sense to 
2 ICD refers to the International Classification of Diseases, which is maintained by the World 
Health Organization. Its current version, ICD-10, is the 10th revision.
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present the reproductive outcomes and effects on descendants as a continuum in 
a single chapter.
Because any effect of the herbicides or contaminants in individuals or groups 
of veterans is evaluated in terms of disease or medical outcome, the committee 
paid particular attention to disease diagnosis and classification as it assembled 
pertinent data from various investigations related to a particular outcome in prepa-
ration for integrating the information. Pathologists, clinicians, and epidemiologists 
use several classification systems, including the International Classification of 
Diseases (ICD), which has been updated over time and with regard to topic. ICD 
codes are a hierarchic system for indicating the type of disease and site. For ex-
ample, whereas many medical insurance and research investigators preferentially 
use the ninth revision of ICD (ICD-9) or its clinical modification (ICD-9-CM) 
to classify diagnoses or clinical outcomes, the tenth revision (ICD-10) is used to 
classify mortality information. Although outcome misclassification is still a pos-
sibility when recording a diagnosis with a specific ICD code into a record, the 
ICD system has been refined over many decades and is virtually universally used 
and understood, in addition to being exhaustive and explicit. Therefore, this and 
previous VAO committees have opted to use the ICD system as an organizing tool.
Many of the epidemiologic studies reviewed by VAO committees have not 
used the ICD approach to classification of disease and have relied instead on 
clinical impression alone. Self-reported diagnoses obtained from survey ques-
tionnaires often have inaccuracies due to recall bias and misinterpretations of the 
questions being asked. For example, a patient may report having been treated for 
stomach cancer when the correct diagnosis was gastric adenocarcinoma, gastric 
lymphoma, or peritoneal cancer. Furthermore, many epidemiologic studies report 
disease outcome by organ system. Sometimes this is done because there are few 
cases of a specific outcome and the study is lacking the necessary statistical 
power to make valid statistical associations using such specific diagnoses. How-
ever, such grouping into broader outcome categories can be problematic (and 
the same is true when categorizing potential exposure). For instance, the term 
“digestive system” may be used for conditions that are benign or malignant and 
that affect the esophagus, stomach, liver, pancreas, small intestine, large intestine, 
or rectum. Therefore, if a report indicated that a cohort has an increased incidence 
of digestive system cancers, then it would be unclear whether the association 
was attributable to excess cases of any single organ or type or to some combina-
tion thereof. Additionally, such generalization is complicated by the fact that the 
cause of cancer may differ among anatomic sites. For instance, there are strong 
associations between smoking and squamous cell carcinoma of the esophagus and 
between chronic hepatitis B infection and hepatic cancer. Furthermore, a single 
site may experience a carcinogenic response to multiple agents, while the same 
agent may cause cancer at multiple sites.
Several of the identified studies examined the association of exposure to 
at least one of the COIs (or a mixture containing it) with an individual health 
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outcome. However, some of the primary studies (for example, Collins et al., 
2016; Cox et al., 2015) reported multiple health outcomes, and individuals might 
have been counted in more than one category. This can also be an issue in mortal-
ity studies when more than the primary cause of death is used. Designing studies 
to analyze concurrent health outcomes is much more difficult, and valid methods 
that can be applied with confidence to identify patterns among multiple health 
outcomes associated with a single exposure have not yet been developed. If such 
methods were developed, studies of multiple health outcomes could potentially 
provide more insight into whether the COIs cause multiple health effects, into 
competing risks among various health outcomes, and into the interactive effects 
of health outcomes.
Defining Statistical Association
Box 3-3 provides brief definitions of some of the most common terms used 
in the epidemiologic studies considered by this committee. The strength of an as-
sociation between exposure and a condition is generally estimated quantitatively 
by using relative risks, odds ratios, correlation coefficients, or hazard ratios, 
depending on the epidemiologic design used. A ratio greater than 1.0 indicates 
that the outcome variable has occurred more frequently in the exposed group, 
and a ratio less than 1.0 indicates that it has occurred less frequently. Ratios 
are typically reported with a confidence interval (CI) to quantify random error. 
Statistical significance may be represented by a CI or a p-value. If the 95% CI 
for a risk estimate (such as a risk ratio or odds ratio) includes 1.0, the associa-
tion is not considered to be statistically significant; however, if the interval does 
not include 1.0, the association is said to be statistically significant with a type I 
alpha error (likelihood that the association is due to chance) of less than 5% (that 
is, p < 0.05).
Determining whether an estimated association between an exposure and an 
outcome represents a real relationship requires careful scrutiny because there can 
be more than one explanation for an estimate. Bias is a general term for a distor-
tion of the measure of association. There are several types of biases, and each 
type may affect the estimate differently. For example, misclassification bias may 
result in exaggerated or underestimated estimates, whereas self-selection bias af-
fects the representativeness of the study population and can limit the applicability 
of the results to the larger population of interest. Another type of bias that may 
potentially affect studies of Vietnam veterans is detection bias, in which veterans 
who are encouraged to and who choose to participate in screening programs or 
registries, such as the Agent Orange Registry (discussed in Chapter 5) may have 
additional tests or follow-up exams that could potentially detect disease or a con-
dition earlier or because more thorough assessments were conducted. This type 
of bias may occur disproportionately for Vietnam veterans with known or who 
report herbicide-exposure compared with Vietnam-era veterans who were not 
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known to be exposed to herbicides or who were deployed elsewhere. Detection 
bias may lead to an overestimate or underestimate of the true effect size.
Confounding is a common type of bias in epidemiologic studies that occurs 
when a risk factor for the disease is also related to the exposure and creates a 
spurious exposure–disease association. Potentially, if a confounder is known, 
there are methods that can be used to adjust for its effects; however, not all con-
founders are always known or identified, and unknown confounders may affect 
the estimate of association. Effect modifiers differ from confounders in that the 
BOX 3-3
Statistical Terms Used in This Report
Confidence interval (CI) is a range of values for the estimate within which the 
true value is thought to lie, with a (usually specified) 95% level of confidence.
Hazard ratio (HR) is a ratio of the chance of an event occurring in one group 
compared with the chance in another group.
Incidence is the number of new cases of illness during a given period of time 
in a specified population divided by the total population.
Odds ratio (OR) represents the odds that an outcome will occur, given a partic-
ular exposure, compared with the odds of the outcome occurring in the absence 
of exposure. The measure approximates the relative risk when a disease is rare.
Prevalence is the number of existing cases of an illness or disease in a given 
population at a specific time or within a specified time period.
Relative risk (RR) denotes the risk of a disease or outcome in a population with a 
given exposure compared to a population without the exposure. Relative risk may 
be described by a risk ratio, rate ratio, or odds ratio.
Standardized hospitalization ratio (SHR) is the ratio of hospitalizations among 
a population for a specific condition by person-years of follow-up divided by the 
national age- and sex-specific hospitalization rates for a health outcome using the 
annual hospitalization numbers and annual mean resident population estimates.
Standardized incidence ratio (SIR) is the ratio of observed new cases of an out-
come in the exposed cohort to the expected number of new cases in the general 
population. The term “standardized” refers to adjustments made for age and sex 
differences between the study population and the general population.
Standardized mortality ratio (SMR) is the ratio of the number of deaths observed 
in a study population to the number of deaths expected if the study population had 
the same mortality rate as the general population. The term “standardized” refers 
to adjustments made for age and sex differences between the study population 
and the general population.
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former are associated with the outcome but not the exposure. Effect modifica-
tion occurs when an exposure has a different effect among different subgroups 
or strata. Chance is the degree to which an estimated association might vary 
randomly among different samples of the population studied.
Integrating New Information into the Evidence Base
Because relatively few studies of exposure to herbicides or TCDD (espe-
cially with objective measures) and health effects have been conducted among 
cohorts of Vietnam veterans, much of the evidence that VAO committees have 
considered has been from studies of well-documented populations that received 
occupational or environmental exposures to TCDD or specific herbicides. In 
many other studies, TCDD exposure was combined with exposures to an array of 
“dioxin-like” chemicals, and the herbicides were often analyzed as members of a 
functional class. Such studies are less informative for the committee’s purposes 
than individual results on a specific chemical but are still considered as part of the 
evidence base. In the case of epidemiologic studies, exposure to multiple, possi-
bly toxic, chemicals is common in some industries, such as agriculture, and those 
exposures cannot be controlled for in the same way that laboratory experiments 
can. In its examination of these epidemiologic studies, the committee looked for 
evidence of health effects that are associated with the specific compounds in the 
herbicides used in Vietnam and sought consideration of and adjustment for other 
possibly confounding exposures. When all the available epidemiologic evidence 
has been evaluated, Vietnam veterans are presumed to be at increased risk for a 
specific health outcome if there is evidence of a positive association between one 
or more of the COIs and the outcome.
The quality of exposure information in the scientific literature reviewed 
by this and previous VAO committees varies widely. Some studies relied on 
interviews or questionnaires to determine the extent and frequency of exposure. 
Such self-reported information, which has the potential for recall bias, generally 
carries less weight than do more objective measures of exposure, such as levels 
of a contaminant as measured in serum or other biospecimens. The strength of 
questionnaire-based information as evidence of exposure is enhanced to the 
extent that the information can be corroborated or validated by other sources. 
Similarly, greater weight is given for studies that use more objective measures of 
health outcome assessments (such as clinical diagnosis).
In drawing conclusions, the committee examined the most thoroughly ad-
justed quantitative estimates of association, judged whether an adjustment for any 
crucial confounders was lacking, and evaluated the potential influences of bias and 
chance. In integrating the findings of various studies, the committee considered the 
degree of statistical significance associated with every estimated risk (a reflection 
of the magnitude of the observed effect and the power of the study designs) and 
took note of whether dose–response relationships were evident with increasing 
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exposure rather than simply tallying the “significant” and “non-significant” out-
comes as dichotomous items of evidence. The committee also considered whether 
controlled laboratory investigations provide information consistent with the COIs 
being associated with a given effect and perhaps causally linked to it.
Categories of Association
As was done in previous volumes, the current committee used four categories 
of association to rate health outcomes based on the strength of the scientific evi-
dence. The criteria for each category express a degree of confidence based on the 
extent to which bias and other sources of error could be reduced. The coherence 
of the full body of epidemiologic information, including biologic plausibility, is 
considered when the committee reaches a judgment about association for a given 
outcome. As was the case with the past three update committees, this committee 
did not use the Bradford Hill criteria for causality (Hill, 1965) as a checklist for 
its strength-of-association assessments. The committee discussed the evidence 
and reached consensus on the categorization of the evidence for each health 
outcome, which appears in the Conclusion section for each health outcome. 
Those categories of association have gained wide acceptance by Congress, VA, 
researchers, and veterans groups.
Sufficient Evidence of an Association
For effects in this category, a positive association between herbicides and 
the outcome must be observed in studies in which chance, bias, and confounding 
can be ruled out with reasonable confidence. For example, the committee might 
regard evidence from several small studies that are free of bias and confound-
ing and that show an association that is consistent in magnitude and direction to 
be sufficient evidence of an association. Experimental data supporting biologic 
plausibility strengthen the evidence of an association but are not a prerequisite 
and are not enough to establish an association without corresponding epidemio-
logic findings.
Limited or Suggestive Evidence of an Association
In the category of “limited or suggestive evidence of an association,” the ev-
idence must suggest an association between exposure to herbicide compounds or 
COIs and the outcome in studies of humans, but the evidence can be limited by an 
inability to confidently rule out chance, bias, or confounding. Typically, at least 
one high-quality study indicates a positive association, but the results of other 
studies could be inconsistent. Because the VAO series has a number of agents 
of concern whose toxicity profiles are not expected to be uniform—specifically, 
four herbicides and TCDD—apparent inconsistencies can be expected among 
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study populations that have experienced different exposures. Even for a single 
exposure, a spectrum of results would be expected, depending on the power of 
the studies, inherent biological relationships, and other study design factors.
Inadequate or Insufficient Evidence to Determine an Association
By default, any health outcome is placed in the category of “inadequate 
or insufficient evidence to determine an association” before enough reliable 
scientific data have accumulated to promote it to the category of sufficient evi-
dence or limited or suggestive evidence of an association or to move it to the 
category of limited or suggestive evidence of no association. In this category, 
the available human studies may have inconsistent findings or be of insufficient 
quality, validity, consistency, or statistical power to support a conclusion regard-
ing the presence of an association. Such studies might have failed to control for 
confounding factors or might have had inadequate assessment of exposure. Sev-
eral health effects have been moved into or out of this category since the original 
VAO committee reviewed the evidence then available.
For nonmalignant conditions, the diversity of disease processes involved 
makes the use of broad ICD ranges less useful, but because VAO committees 
could not possibly address every rare nonmalignant disease, they do not draw 
explicit conclusions about diseases that are not discussed, and thus, this category 
is the default or starting point for any health outcome. If a condition or outcome 
is not addressed specifically, then it will be in this category.
Limited or Suggestive Evidence of No Association
The original VAO committee defined the category “limited or suggestive 
evidence of no association” for health outcomes for which several adequate 
studies covering the “full range of human exposure” were consistent in showing 
no association with exposure to herbicides at any concentration and had relatively 
narrow confidence intervals. A conclusion of “no association” is inevitably lim-
ited to the conditions, exposures, and observation periods covered by the avail-
able studies, and the possibility of a small increase in risk related to the magnitude 
of exposure studied can never be excluded. However, a change in classification 
from inadequate or insufficient evidence of an association to limited or sug-
gestive evidence of no association would require new studies that correct for the 
methodologic problems of previous studies and that have samples large enough 
to limit the possible study results attributable to chance.
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Biologic Mechanisms
The committee reviewed all the relevant experimental studies of 2,4- 
dichlorophenoxyacetic acid (2,4-D), 2,4,5-trichlorophenoxyacetic acid (2,4,5-T), 
4-amino-3,5,6-trichloropicolinic acid (picloram), dimethylarsinic acid (DMA, 
also called cacodylic acid), and 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 
that have been published since Update 2014 (NASEM, 2016a). The findings 
have been incorporated into this chapter when it is appropriate and into the 
biologic-plausibility sections of Chapters 6–11 when they are of consequence for 
particular health outcomes. For each substance, this chapter includes a review of 
its toxicokinetic properties, a brief summary of the toxic outcomes investigated 
in animal experiments, and a discussion of underlying mechanisms of action as 
illuminated by in vitro studies. The final section of this chapter discusses factors 
that complicate the extrapolation of findings from laboratory experimentation 
to humans. Additionally, information about three emerging subjects in molecu-
lar and biologic science—epigenetics, developmental immunotoxicology, and 
oxidative stress—are discussed because they provide insights into the potential 
mechanisms that could explain biologic responses associated with exposure to 
the herbicides sprayed in Vietnam.
The establishment of biologic plausibility through laboratory studies 
strengthens the case for a cause–effect relationship between herbicide exposure 
and health effects that has been reported in epidemiologic studies. Such informa-
tion supports the existence of the less stringent relationship of association, which 
is the target of this committee’s work. Experimental studies of laboratory animals 
or cultured cells make it possible to observe the effects of herbicide exposure 
under controlled conditions, which is difficult or impossible to do in epidemio-
logic studies. The conditions that can be controlled in a laboratory animal study 
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include genetic differences, the frequency and magnitude of exposure, exposure 
to other chemicals, dietary intake, preexisting and confounding health condi-
tions,  stressors, and the tissues or cells under examination. The limitations of 
extrapolating results of laboratory studies to human responses is discussed later 
in this chapter.
Once a chemical contacts the body, it becomes subject to the processes of 
absorption, distribution, metabolism, and excretion. The combination of those 
four biologic processes determines the concentration of the chemical in the vari-
ous tissues and organs in the body and how long each organ or tissue is exposed 
to the chemical and thus influences its pharmacologic and possibly toxic activity 
(Lehman-McKeeman, 2013). 
The absorption of a substance in an organism can occur through different 
routes. If ingested, it normally is taken up into the bloodstream from mucous sur-
faces, such as the intestinal walls of the digestive tract. If inhaled, the substance 
enters the bloodstream through the alveoli in the lungs. Some compounds can 
also be absorbed across the skin (dermal adsorption). Animal studies may involve 
additional routes of exposure that are not ordinarily encountered by humans, 
such as intravenous or intraperitoneal injection, when a chemical is injected into, 
respectively, the bloodstream or the abdominal cavity. The route of exposure and 
other factors influence how much of a chemical dose is absorbed by the organism. 
For example, the hydrophobicity of a chemical and its solubility in fat influence 
how much of that chemical is absorbed. Thus, absorption is a critical determinant 
of a chemical’s bioavailability—that is, the fraction of the chemical that reaches 
systemic circulation.
Once a chemical is absorbed, it is affected by distribution. This refers to the 
movement of a substance from the site of entry to the different tissues and organs 
in the organism. Distribution takes place most commonly via the bloodstream. 
As the chemical is moved through the body, it may enter a target tissue where 
it may have its ultimate toxic effect, or it may enter into tissues that sequester 
it. As a chemical is distributed in the organism, it will also begin to undergo 
metabolism. 
Biotransformation or metabolism is the process by which a foreign substance 
is chemically modified when it enters an organism. For many environmental 
toxicants, this process takes place largely in the liver via the action of enzymes, 
including cytochromes P450, which catalyze the oxidative metabolism of many 
chemicals. As metabolism occurs, the parent chemical is converted into new 
chemicals called metabolites, which are often more water-soluble (polar) and 
thus more readily excreted. When the resulting metabolites are pharmacologi-
cally or toxicologically inert, metabolism has deactivated the administered dose 
of the parent chemical and thus reduced its effects on the body. Metabolism may, 
however, generate a chemical that is more potent or more toxic than the parent 
compound. This process is often referred to as bioactivation. A chemical’s struc-
ture influences the organism’s ability to metabolize (structurally transform) the 
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chemical, and this ability ultimately determines whether it persists in the body 
or is excreted.
Excretion is the removal of substances or their metabolites from the body, 
most commonly in urine or feces. This is different from elimination, which refers 
to the disappearance of the parent molecule from the bloodstream. The rate of 
excretion of a chemical from the body is often limited by the rate of metabolism 
of the parent chemical into more water-soluble, readily excreted metabolites. 
Excretion is often incomplete, especially in the case of chemicals that resist 
biotransformation. Incomplete excretion results in the accumulation of foreign 
substances that can adversely affect biologic functions. 
Elimination is referred to as “first-order” when its rate is directly propor-
tional to the amount of chemical in the body, in which case the chemical’s 
half-life is independent of dose. A half-life is defined as the time required for 
the plasma concentration or the amount of a chemical in the body to be reduced 
by half. The half-life of TCDD in humans is estimated to vary from 0.4 to more 
than 10 years, based on measurements of TCDD in serum samples; the half-life 
depends on a number of factors, including a person’s body mass index (BMI), 
age, sex, and exposure (Aylward et al., 2005a; Emond et al., 2005; Flesch-Janys 
et al., 1996; Geusau et al., 2002; Kumagai and Koda, 2005; Leung et al., 2006; 
Michalek et al., 2002; Milbrath et al., 2009; Needham et al., 1994; Pirkle et al., 
1989; Sorg et al., 2009). Shorter half-lives were observed in humans during the 
first months after exposure or in severely contaminated persons, which is consis-
tent with the nonlinear elimination predicted by physiologically based pharmaco-
kinetic models. Several studies of the half-life of TCDD have been conducted in 
monkeys, mice, and rats, but the estimates are generally shorter than those found 
in humans, ranging from 8 to 74 days, and are generally proportional to body 
weight (DeVito and Birnbaum, 1995; Emond et al., 2006; Gasiewicz et al., 1983; 
Hurst et al., 1998; Koshakji et al., 1984; Minero et al., 2001; Neubert et al., 1990; 
Viluksela et al., 1996). 
Collectively, the routes and rates of absorption, distribution, biotransforma-
tion or metabolism, and excretion of a toxic substance make up the toxicokinetics 
(or the pharmacokinetics for chemicals used as pharmaceutical agents) of the 
substance. Those processes determine the amount of a particular substance or 
metabolite that will reach specific organs or cells and the amount of a particular 
substance that persists in the body. Understanding the toxicokinetics of a chemi-
cal is useful for assembling a valid reconstruction of a human exposure. It is also 
important in assessing the concentration of the active chemical in target tissues, 
which influences the risk of disease. The basic principles involved in toxico-
kinetics are similar from chemical to chemical, but the precise way in which 
principles are applied will depend on the structure and other inherent properties 
of the particular chemical under consideration. For example, the lipophilicity or 
hydrophobicity of a chemical influences how long that chemical will persist in the 
body because those factors influence how much of the chemical is absorbed into 
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fat cells, metabolized, and excreted. The degree to which different toxicokinetic 
processes influence the toxic potential of a chemical depends on the metabolic 
pathways, which often differ among species. Animal and cell culture studies are 
often conducted at higher exposures and for shorter durations than are typical 
in human exposures, which can influence biotransformation. For that reason, at-
tempts to extrapolate from experimental animal studies to human exposures must 
be done extremely carefully.
Many chemicals were used by the U.S. armed forces in Vietnam. The nature 
of the substances themselves was discussed in detail in Chapter 4 of the original 
Veterans and Agent Orange: Health Effects of Herbicides Used in Vietnam (VAO) 
report (IOM, 1994). Four herbicides documented in military records were of par-
ticular concern in that report and are examined here: 2,4-D; 2,4,5-T; picloram; 
and cacodylic acid. This chapter also examines TCDD, the most toxic congener 
of the tetrachlorodibenzo-p-dioxins, also commonly referred to as dioxin, which 
is a contaminant of 2,4,5-T. Considerably more information is available on 
TCDD than on the herbicides themselves. Other contaminants present in 2,4-D 
and 2,4,5-T are of less concern. Except as noted, the laboratory studies of the 
chemicals of concern used pure compounds or formulations; the epidemiologic 
studies discussed in later chapters often tracked exposures to mixtures.
PICLORAM
Chemistry
Picloram (Chemical Abstracts Service Number [CAS No.] 1918-02-1; see 
chemical structure in Figure 4-1) was used with 2,4-D in the herbicide formula-
tion Agent White, which was sprayed in Vietnam. It is also used commonly in 
Australia in a formulation that has the trade name Tordon 75D®. Tordon 75D 
contains several chemicals, including 2,4-D; picloram; a surfactant, diethylene-
glycolmonoethyl ether; and a silicone defoamer. A number of studies of picloram 
used such mixtures as Tordon formulations or other mixtures of 2,4-D and piclo-
ram that are similar to Agent White.
HO
CI
CI
CI
NH2
NO
4-amino-3,5,6-trichloropicolinic acid
FIGURE 4-1 Chemical structure of picloram.
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Toxicokinetics
The original VAO committee reviewed studies of the toxicokinetics of  picloram 
(IOM, 1994). Studies of animals showed a rapid absorption through the gastro-
intestinal tract and a rapid elimination of picloram in unaltered form in urine. In 
humans, Nolan et al. (1984) examined the toxicokinetics of picloram in six healthy 
male volunteers who were given a single oral dose of either 0.5 or 5.0 mg/kg or 
a dermal dose of 2.0 mg/kg. In the oral study picloram was rapidly absorbed and 
 rapidly excreted unchanged in urine. More than 75% of the dose was excreted 
within 6 hours, and the remainder with an average half-life of 27 hours. On the 
basis of the quantity of picloram excreted in urine in the dermal study, the authors 
concluded that only 0.2% of the picloram applied to the skin was absorbed. Because 
of its rapid excretion, picloram has low potential to accu mulate in humans.
In general, the literature on picloram toxicity continues to be sparse. Studies 
of humans and animals indicate that picloram is rapidly eliminated as the parent 
chemical. Studies of animals indicate that picloram has low toxicity even at high 
doses (IARC, 1991).
Toxicity Profile
The original VAO committee reviewed studies of the carcinogenicity, geno-
toxicity, acute toxicity, chronic systemic toxicity, reproductive and developmental 
toxicity, and immunotoxicity of picloram (IOM, 1994). In general, there is some 
evidence of benign liver carcinogenicity in female Osborne-Mendel rats but 
picloram was not found to be carcinogenic for either male or female Osborne-
Mendel rats or B6C3F1 mice (NCI, 1978). Because of some concern that con-
taminants in picloram (in particular, hexachlorobenzene) might be responsible 
for the carcinogenicity, picloram itself has not been established as a chemical 
carcinogen. Furthermore, studies conducted by the Environmental Protection 
Agency (EPA, 1988) yielded no evidence that picloram is a genotoxic agent. 
Acute Toxicity
Picloram is considered a mild irritant. At high doses, it has produced ery-
thema in rabbits. Some neurologic effects—including hyperactivity, ataxia, and 
tremors—were reported in pregnant rats exposed to picloram at 750 or 1,000 
mg/kg (Thompson et al., 1972). However, the available information on the acute 
toxicity of picloram is very limited.
Chronic Systemic Toxicity
There is some evidence from chronic experimental animal studies that ingest-
ing high doses of picloram affects the liver. Several studies have reported various 
effects of technical-grade picloram on the livers of rats. In the carcinogenicity 
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bioassay conducted by Stott et al. (1990), treatment-related hepatomegaly, he-
patocellular swelling, and altered tinctorial properties were noted in the central 
regions of the liver lobules in groups of rats exposed at 60 and 200 mg/kg per 
day. Gorzinski et al. (1987) reported a dose-related increase in hepatocellular 
hypertrophy and changes in centrilobular tinctorial properties in male and female 
F344 rats exposed for 13 weeks to picloram at 150 mg/kg per day and higher 
in the diet. In a 90-day study, cloudy swelling in the liver cells and bile duct 
epithelium occurred in male and female F344 rats given 0.3% or 1.0% technical 
picloram in the diet (EPA, 1988). No other toxic effects of chronic exposure to 
picloram have been reported.
Reproductive and Developmental Toxicity
The reproductive toxicity of picloram was evaluated in a two-generation study. 
No toxicity was detected at the highest dose tested, which was 150 mg/kg per day; 
however, only a few animals were evaluated (EPA, 1988). Some devel opmental 
toxicity was produced in the offspring of pregnant rabbits exposed to picloram 
by gavage at 400 mg/kg per day on gestation days 6–18. Fetal  abnormalities were 
forelimb flexure, fused ribs, hypoplastic tail, and  omphalocele, each occurring in 
a single litter (John-Greene et al., 1985). Some maternal toxicity was observed at 
that dose, however, and EPA concluded on the basis of the sporadic nature of the 
findings that the malformations were not treatment related (EPA, 1988). No terato-
genic effects were produced in the offspring of rats given picloram by gavage at 
up to 1,000 mg/kg per day on gestation days 6–15, but the occurrence of bilateral 
accessory ribs was significantly increased (Thompson et al., 1972).
Immunotoxicity
Studies of the potential immunotoxicity of picloram have included dermal 
sensitization in humans and rodent immunoassays. In one study, 53 volunteers 
received nine 24-hour applications of 0.5 mL of a 2% potassium picloram solu-
tion on the skin of both upper arms. Each volunteer received challenge doses 
17–24 days later. The particular formulation of picloram (its potassium salt) was 
not a skin sensitizer or an irritant (EPA, 1988). In a similar study, a 5% solution 
of picloram (M-2439, Tordon 101 formulation) produced a slight dermal irrita-
tion and a sensitization response in 6 of the 69 volunteers exposed. When the 
individual components of M-2439—picloram, triisopropanolamine (TIPA) salt, 
and 2,4-D TIPA salt—were tested separately, no sensitization reaction occurred 
(EPA, 1988). Tordon K+, but not technical-grade picloram, was also found to be 
a skin sensitizer in guinea pigs (EPA, 1988). CD1 mice exposed to Tordon 202C 
(94% 2,4-D and 6% picloram) had no consistent adverse effects on antibody re-
sponses (Blakley, 1997), but the lack of a consistent response may be due to the 
fact that CD1 mice are outbred. 
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Mechanisms
No well-characterized mechanisms of toxicity for picloram are known.
CACODYLIC ACID
Chemistry
Arsenic (As) is a naturally occurring element. It exists in inorganic forms 
that can be trivalent (As+3 or AsIII) or pentavalent (As+5 or AsV). It can also exist 
in organic forms that are often methylated. See Figure 4-2 for the chemical struc-
tures of selected arsenic-containing compounds. Sodium arsenite, which contains 
AsIII, is generally considered to be the most toxic of these arsenic compounds. 
Inorganic arsenic is commonly present in drinking-water sources that are associ-
ated with volcanic soils and can reach high concentrations (more than 50 parts 
per billion). Numerous human health effects have been attributed to drinking 
water contaminated with inorganic arsenic, particularly bladder, skin, kidney, 
and lung cancers; developmental effects on learning and memory; reproductive 
endpoints; skin lesions; and diabetes and vascular diseases (NRC, 2001; WHO, 
2018). Inorganic arsenic is readily metabolized in humans and other species into 
organic forms of arsenic. Although organic forms of arsenic can be converted into 
inorganic forms by microorganisms in the soil, there is no evidence that this can 
occur in humans or other vertebrate species (Cohen et al., 2006).
The arsenic in cacodylic acid (CAS No. 75-60-5) is an organic form of ar-
senic and has a valence of +5. Cacodylic acid (also known by its more standard 
chemical name, dimethylarsinic acid [DMAV]) was the form of arsenic used in 
Agent Blue, one of the mixtures used for defoliation in Vietnam. DMAV made 
up about 30% of Agent Blue. Agent Blue was chemically and toxicologically 
unrelated to Agent Orange, which consisted of phenoxy herbicides contami-
nated with dioxin-like compounds. Potential cacodylic acid exposure of Vietnam 
veterans would have involved direct exposure to exogenous DMAV, rather than 
exposure to inorganic arsenic, which would have led to the endogenous forma-
tion of MMAV and MMAIII and then DMAV. The old hypothesis that methylation 
of inorganic arsenic was a detoxifying mechanism has been dispelled by newer 
studies. The direct treatment of laboratory animals with these metabolic products 
has demonstrated the products to be linked to an increased incidence of cancers 
and non-cancer health outcomes. However, it is still the trivalent species (AsIII 
and MMAIII) that appear to be the most toxic. No studies of health effects in 
humans following direct exposure to DMA have been identified by the VAO 
committees. If there were, such studies could provide epidemiologic evidence 
of an association between DMA and health effects. However, most studies have 
focused on exposure to inorganic arsenic, which human metabolism turns into 
DMA. Consequently, VAO committees have excluded studies where the source 
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of exposure was inorganic arsenic and have only considered and reviewed toxi-
cologic studies in which the animals were directly exposed to DMA. Informa-
tion about effects of inorganic arsenic exposure may be found in reviews by the 
International Agency for Research on Cancer (IARC, 2012a) and the National 
Research Council (NRC, 2013).
Toxicokinetics
In humans, metabolism studies have generally found DMAV to be rapidly ex-
creted and mostly unchanged in the urine after an exposure has occurred (Cohen 
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FIGURE 4-2 Chemical structures of selected arsenic-containing compounds.
NOTES: Inorganic arsenic (AsV and AsIII) is commonly found in the environment and is 
metabolized by humans to form methylated organic arsenic species (MMA and DMA). 
The methylation process is incomplete in humans, and both inorganic and organic arsenic 
species are excreted in urine when approximately 10% is in inorganic forms (AsV and 
AsIII), 10–20% is MMA, and 70–80% is DMA. Cacodylic acid, which is the type of arse-
nic found in Agent Blue, is the same as DMAV and is excreted in urine as DMA.
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et al., 2006; S. Suzuki et al., 2010). However, rats differ from most other mam-
mals (including humans) in that a larger percentage of DMAV binds to hemoglo-
bin in their red blood cells, which leads to a considerably longer half-life in blood 
(Cui et al., 2004; K. T. Suzuki et al., 2004). The binding of DMAV to hemoglobin 
is 10 times higher in rats than in humans (M. Lu et al., 2004). Chronic exposure 
of normal rat hepatocytes to DMAV results in decreased uptake and increased 
excretion, so that over time the rats developed resistance to the cytotoxic effects 
of DMAV (Kojima et al., 2006). This tolerance is mediated by the induction of 
glutathioneS-transferase activity and of multiple-drug-resistant protein expression. 
Recent work by Banerjee et al. (2014, 2016) found that multiple-drug-resistant 
protein 4 on renal proximal tubules transports DMAV, which facilitates urinary 
excretion, and that polymorphic variants of this protein can alter the transport 
activity and change local cellular responses. Rats also appear to biotransform 
DMAV to DMAIII. Adair et al. (2007) examined the tissue distribution of DMA 
in F344 rats after they were exposed to DMA for 14 days through drinking water. 
They found that DMAV was extensively metabolized to trimethylated forms that 
may play a role in toxicity. In a study of DMA treatment of Wistar rats for 10 
weeks, the metabolism to trimethylated forms was far less apparent, and the tis-
sue distribution of DMAV and trimethylated metabolites was strikingly different 
(S. Liu et al., 2015). Thus, DMA distribution and metabolism may differ accord-
ing to exposure duration or the strain of rat, or both.
A physiologically based pharmacokinetic model of intravenous and ingested 
DMAV has been developed on the basis of mouse data (Evans et al., 2008). Simi-
lar models have been developed for humans on the basis of exposure to inorganic 
arsenic (El-Masri and Kenyon, 2008), but these models have limited relevance 
for assessing potential harm to Vietnam veterans, who are presumed to have been 
directly exposed to DMAV.
Although epidemiologic studies of direct exposure to DMAV are not avail-
able, investigations into the relationship between health outcomes and the meta-
bolic profiles of humans exposed to inorganic arsenic provide some insight 
into the roles of the individual metabolites in producing adverse outcomes. An 
increased incidence of urothelial cancer (cancer of the bladder, kidney, renal 
pelvis, ureter, and urethra) among people exposed to high levels of inorganic 
arsenic in drinking water was found in those who generate more MMA and less 
DMA endogenously (S. K. Huang et al., 2008). Also, a lower risk of arsenical 
skin lesions was associated with evidence of higher arsenic methylation capacity 
in people in areas of high arsenic exposure via the drinking water (Q. Zhang et 
al., 2014a,b) as well as in smelter workers (Wen et al., 2012). These results could 
suggest that elevated cumulative levels of urinary MMA may be causally associ-
ated with an increased risk of inorganic arsenic-induced adverse health outcomes, 
but they could also imply that complete methylation of inorganic arsenic to DMA 
and resulting enhanced excretion are relatively protective. 
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Toxicity Profile
This section discusses the toxicity associated with organic forms of arsenic, 
most notably DMAV because it is the active ingredient in Agent Blue. The toxicity 
of inorganic arsenic is not considered to be relevant to veteran exposures to 
Agent Blue.
Neurotoxicity
Kruger et al. (2006) found that both DMAIII and DMAV significantly attenu-
ated neuronal ion currents through N-methyl-D–aspartate receptor ion channels, 
whereas only DMAV inhibited ion currents through α-amino-3-hydroxy-5-
methylisoxazole-4-propionic acid receptors. The data suggest that DMA may 
have neurotoxic potential.
Immunotoxicity
Previous studies have shown that a low concentration of DMAV (10–7 M) 
could increase the proliferation of human peripheral blood monocytes after 
their stimulation with phytohemagglutinin, whereas it took a high concentration 
(10–4 M) to inhibit the release of interferon-γ. This suggested that different 
concentrations of DMAV may produce various immunomodulatory effects (Di 
Giampaolo et al., 2004).
Skin Toxicity
In an evaluation of the effects of topical exposure of pregnant mice to DMA 
(valence not stated) on the skin of the dams and offspring (E. Kim et al., 2012), no 
effects were observed in offspring, but the exposure did increase skin thickness 
in the area of application and alter the expression of multiple apoptosis-related 
genes (Bcl-2, Bad, Casp-12). The results suggested that transient DMA exposure 
can be a skin irritant and produce dermatitis.
Genotoxicity and Carcinogenicity
DMAIII and DMAV are genotoxic and increase oxidative stress and cause 
DNA damage, particularly aneuploidy, but they are poor mutagens (Rossman 
and Klein, 2011). Gómez et al. (2005) demonstrated that DMAIII induces a dose-
related increase in DNA damage and oxidative stress in Jurkat cells. DMAIII 
was considerably more potent than DMAV in inducing DNA damage in Chinese 
hamster ovary cells (Dopp et al., 2004), which was associated with a greater 
uptake of DMAIII into the cells. Similarly, an analysis of arsenical dimethylated 
metabolites in human bladder cancer cells found dimethylmonothioarsinic acid 
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(DMMTAV) and DMAIII to be more toxic and DMAV to be less toxic in terms of 
DNA damage (Naranmandura et al., 2011). DNA damage from DMMTAV was 
shown to be related to the accumulation of reactive oxygen species and to the 
down-regulation of p53 and p21 (DNA repair proteins); these processes were 
mediated in part through the intracellular conversion of DMMTAV to DMAV 
and DMAIII (Naranmandura et al., 2011). Thus, although extracellular DMAV 
has little toxic effect in cells because of its low uptake, intracellular DMAV can 
be highly toxic. Gene-expression profiling of bladder urothelium after chronic 
exposure to DMAV in drinking water showed significant increases in genes that 
regulate oxidative stress (Sen et al., 2005). Additionally, hepatic gene-expression 
profiling showed that DMAV exposure induced changes consistent with oxidative 
stress (Xie et al., 2004). In vivo, DMAV-induced proliferation of the urinary blad-
der epithelium could be attenuated with the antioxidant N-acetylcysteine (M. Wei 
et al., 2005). Arsenicals, including DMA, also interfere with certain DNA repair 
mechanisms (both base- and nucleotide-excision repair) and may thereby act as 
co-carcinogens enhancing the effect of other genotoxic carcinogens (Rossman 
and Klein, 2011). In fact, MMAIII is a stronger inhibitor of nucleotide-excision 
repair than inorganic arsenic (Shen et al., 2008).
Toxicological data suggest DMAIII and DMAV are carcinogenic. Cancers 
have been induced in the urinary bladder, kidneys, liver, thyroid glands, and 
lungs of laboratory animals exposed to high concentrations of DMA. In a 2-year 
bioassay of F344/Crl rats fed a diet containing 40 or 100 parts per million (ppm) 
DMAV, the females consuming the highest dose (100 ppm) developed urothelial 
carcinomas and papillomas in the bladder, and males and females at both dose 
levels (40 and 100 ppm) developed hyperplastic non-neoplastic changes in the 
bladder (Arnold et al., 2006). M. Wei et al. (2002) exposed male F344/DuCrj 
rats to DMA (valence not stated) via their drinking water and found statistically 
significant incidences of bladder hyperplasia and transitional cell papillomas and 
carcinomas at doses of 50 and 100 ppm. Similarly, A. Wang et al. (2009) found 
that exposure of F344 rats to DMAV in drinking water at 1, 4, 40, or 100 ppm 
resulted in a change in the urinary bladder epithelium, but there were no changes 
in DNA repair capacity. In another study, Cohen et al. (2007b) exposed F344 rats 
to DMAV in the diet for 2 years and found an increase in bladder tumors in those 
receiving 100 ppm. As noted above, at least some strains of rats can reduce DMAV 
to DMAIII, and thus these researchers proposed that that trimethylated forms of 
arsenic (MMAIII and DMAIII) may be responsible for bladder cancer in rats. 
 Direct intravesical administration of 90 mg/kg DMAV to female adult rats resulted 
in increased bromodeoxyuridine labeling in urothelial cells, indicating DNA dam-
age; weak neutrophil infiltration; and the proliferation of urothelial epithelium 
mediated through modest increases in oxidative-stress indexes (Takahashi et al., 
2011). Increased urothelial cell proliferation was also found following DMA 
(valence not stated) exposure via the drinking water (M. Wei et al., 2002). It is 
noteworthy that co-treatment with an antioxidant, N-acetylcysteine, worsened 
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the DMAV-induced bladder injury rather than ameliorating it as expected. This 
suggests that the carcinogenic mechanism of DMAV is more complicated than a 
simple production of oxidative stress. In the mouse lung, DMAV acts as a tumor 
initiator (Yamanaka et al., 2009) and as a tumor promoter (Mizoi et al., 2005). 
DMAV can also act as a complete carcinogen, inducing lung tumors in susceptible 
strains of mice, including those with deficient DNA-repair activity (Hayashi et 
al., 1998; Kinoshita et al., 2007). In F344/DuCrj rats treated with a mixture of 
carcinogens for 4 weeks, subsequent exposure to DMA (no indication of whether 
this was DMAIII or DMAV) via their drinking water for 24 weeks caused tumor 
promotion in the urinary bladder, kidney, liver, and thyroid gland but inhibited 
the induction of tumors of the nasal passages (S. Yamamoto et al., 1995). In a 
similarly designed experiment, DMA (valence not stated) was found to be a 
bladder tumor promotor after treatment with the bladder carcinogen N′-butyl-N′-
(4-hydroxybutyl) nitrosamine (Wanibuchi et al., 1996). Yamanaka et al. (2009) 
suggested that DMAIII can act as a tumor promoter through the formation of a 
DMAIII radical after the reduction of DMAV. Studies have also found that an oral 
exposure of adult mice to 200 ppm DMAV in addition to fetal inorganic arsenic 
exposure can act as a promoter of renal and hepatocellular carcinoma, markedly 
increasing tumor incidence beyond that produced by the fetal arsenic exposure 
alone (Tokar et al., 2012). These findings emphasize how multiple life events can 
contribute to an adverse health outcome in which adult DMAV exposure triggered 
an otherwise dormant disease.
Mechanisms
It is believed that arsenic exerts its toxicity through several different mecha-
nisms. Anwar-Mohamed et al. (2014) found that DMAV and other pentavalent 
arsenic metabolites induce the carcinogen-activating enzyme CYP1A1. There 
is also considerable evidence that arsenic induces oxidative stress, which can 
induce cancers in animals. Ebert et al. (2016) found that thio-DMAV exposure 
upregulated DNA repair and damage response proteins in human urothelial cells, 
and studies have shown that mice that are deficient in enzymes associated with 
the repair of oxidative DNA damage are highly susceptible to the induction of 
tumors, particularly lung tumors, by DMAV (Kinoshita et al., 2007). Some studies 
have also suggested that methylated arsenicals (MMAIII and DMAIII) can induce 
aneuploidy in mammalian cells at concentrations below those required to produce 
oxidative stress after in vitro exposure (Kligerman and Tennant, 2007; Rossman 
and Klein, 2011). The chemical reaction of arsenicals with thiol groups in sensi-
tive target tissues, such as red blood cells and kidneys, may also be a mechanism 
by which organic arsenicals act (Naranmandura and Suzuki, 2008).
Cohen et al. (2007b) postulated that regenerative cell proliferation in re-
sponse to cytotoxicity in the urothelium is a major factor in the carcinogenicity 
of DMA to the rat bladder, and, indeed, urothelial cell proliferation has been 
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shown to increase following DMA exposure (Takahashi et al., 2011; M. Wei et 
al., 2002). There may also be epigenetic effects involved in DMA carcinogenicity, 
as suggested by a study in humans in which there was a significant association 
between global DNA methylation and urinary DMA levels (Tellez-Plaza et al., 
2014). Unterberg et al. (2014) observed DNA hypomethylation in urothelial cells 
that had been incubated for 21-days with inorganic AsIII or thio-DMAV.
The variation in the susceptibility of various animal species to tumor for-
mation caused by inorganic and organic arsenic is thought to arise in large part 
from differences in metabolism and distribution. Thus, genetic differences may 
play an important role. Numerous investigators have examined potential human 
susceptibility factors and gene polymorphisms that may increase a person’s risk 
of cancer and other diseases induced by arsenicals (Aposhian and Aposhian, 
2006; Hernandez et al., 2008; S. K. Huang et al., 2008; Y. K. Huang et al., 2008; 
McCarty et al., 2007; Meza et al., 2007; Steinmaus et al., 2007, 2010), but no 
polymorphisms that may contribute to a person’s susceptibility to DMA-induced 
cancers or tissue injury have yet been identified.
Summary
DMA is genotoxic and carcinogenic in certain animal models and in vitro 
assays, including studies in human cells. It is believed to exert a direct toxic ef-
fect by generating oxidative stress, inducing epigenetic dysregulation, binding to 
thiols, and interfering with DNA repair mechanisms. These mechanisms of action 
may be involved in gene damage and carcinogenesis. However, it is not clear 
whether these effects would also occur in humans directly exposed to DMAV.
PHENOXY HERBICIDES: 2,4-DICHLOROPHENOXY ACID AND  
2,4,5,-TRICHLOROPHENOXYACETIC ACID
Chemistry
2,4-D (CAS No. 94-75-7) is an odorless crystalline powder that, when pure, 
is white in color (see Figure 4-3); it may appear yellow when phenolic impurities 
2,4-D [94-75-7]
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OHCI
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FIGURE 4-3 Chemical structures of 2,4-D and 2,4,5-T.
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are present. The melting point of 2,4-D is 138° C, and the free acid is corrosive to 
metals. It is soluble in water and in a variety of organic solvents (such as acetone, 
alcohols, ketones, ether, and toluene). 2,4,5-T (CAS No. 93-76-5) is an odorless, 
white to light-tan solid with a melting point of 158° C. 2,4,5-T is noncorrosive 
and is soluble in alcohol and water. It reacts with organic and inorganic bases to 
form salts and with alcohols to form esters.
Uses of 2,4-D and 2,4,5-T
2,4-D has been used commercially in the United States since World War II 
to control the growth of broadleaf plants and weeds on range lands, lawns, golf 
courses, forests, roadways, parks, and agricultural land; it remains a widely used 
herbicide that is approved for use by both the European Union and EPA. Formu-
lations include 2,4-D amine and alkali salts and esters, which are mobile in soil 
and readily absorbed through the leaves and roots of many plants. Like 2,4-D, 
2,4,5-T was developed and marketed as a herbicide during World War II. How-
ever, the registration for 2,4,5-T was canceled by EPA in 1978 when it became 
clear that it was contaminated with TCDD during the manufacturing process. It 
is recognized that the production of 2,4-D also involves the generation of some 
contaminants with dioxin-like activity, but the fraction of TCDD represented in 
the toxic equivalent (TEQ) is comparatively very small.
The herbicidal properties of 2,4-D and 2,4,5-T are related to the chemical’s 
ability to mimic the plant growth hormone indole acetic acid. They are selective 
herbicides in that they affect the growth of only broadleaf dicots (which include 
most weeds) and do not affect monocots, such as wheat, corn, and rice.
Toxicokinetics
Several studies have examined the absorption, distribution, metabolism, 
and excretion of 2,4-D and 2,4,5-T in animals and humans. Data on both com-
pounds are consistent among species and support the conclusion that the absorp-
tion of oral or inhaled doses is rapid and complete. One study indicates that 
2,4-D can bind to innate intestinal, intracellular lipid-binding proteins, which 
may be how these compounds move through columnar absorptive epithelial 
cells from the intestines to systemic distribution (Carbone and Velkov, 2013). 
Absorption through the skin is much lower but may be increased with the use 
of sunscreens or alcohol (Brand et al., 2002; Pont et al., 2004). After absorp-
tion, 2,4-D and 2,4,5-T are distributed widely in the body but are eliminated 
quickly, predominantly in an unmetabolized form in urine (Sauerhoff et al., 
1977), but 2,4,5-trichlorophenol and 2,4-dichlorophenol have been identified 
as trace metabolites in urine. The half-life of single doses of 2,4-D or 2,4,5-T 
in humans has been estimated to be about 18–23 hours and is highly dependent 
on urinary pH (Gehring et al., 1973; Kohli et al., 1974; Sauerhoff et al., 1977; 
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WHO, 1984). Hines et al. (2003) found that concentrations of 2,4-D and its 
metabolites in the urine of herbicide applicators—that is, those who apply the 
herbicides—were consistent with 2,4-D urinary half-life estimates of 13–40 hours 
in humans.
Toxicity Profile
The toxicity database on 2,4-D is extensive, whereas the available data on 
the toxicity of purified 2,4,5-T, independent of its contamination by TCDD, are 
sparse. TCDD is much more toxic than 2,4,5-T, and much of the toxicity that had 
been attributed to 2,4,5-T in early studies was later shown to be caused by the 
TCDD contaminant. The following summary therefore focuses on 2,4-D toxicity, 
and information on pure 2,4,5-T is added when it is available.
A 2018 monograph from the IARC classified 2,4-D as possibly carcinogenic 
to humans. This statement originated from limited evidence available on the 
carcino genic effects in animals and inadequate evidence in humans (IARC, 2018). 
When reviewing animal literature, studies show that after a single oral dose, 2,4-D 
is considered to produce moderate acute toxicity with a dose lethal to 50% of 
exposed animals (LD50) of 375 mg/kg in rats, 370 mg/kg in mice, and from less 
than 320 to 1,000 mg/kg in guinea pigs. Rats and rabbits have dermal LD50s of 
1,500 mg/kg and 1,400 mg/kg, respectively. 2,4,5-T itself also produces moder-
ate acute toxicity, with oral LD50s of 389 mg/kg in mice and 500 mg/kg in rats. 
Death from acute poisoning with 2,4-D or 2,4,5-T has been attributed to the ability 
of the chemicals to uncouple oxidative phosphorylation, a vital process used by 
almost all cells in the body as the primary means of generating energy. After an 
animal is exposed to a high dose, death due to multiple organ failure can occur 
rapidly. Studies in rats, cats, and dogs indicate that the central nervous system is 
the principal target organ for acute 2,4-D toxicity in mammals and suggest that the 
primary site of action is the cerebral cortex or the reticular formation (Arnold et 
al., 1991; Dési et al., 1962a,b). Based on case reports, in humans the predominant 
effect of acute inhalation and oral exposure to 2,4-D is neurotoxicity; symptoms 
include stiffness of the arms and legs, lack of coordination, lethargy, anorexia, 
stupor, and coma. 2,4-D is also an irritant of the gastrointestinal tract that causes 
nausea, vomiting, and diarrhea.
Chronic exposure to 2,4-D at relatively high concentrations has been shown to 
produce a variety of toxic effects, including hepatic and renal toxicity, neurotoxicity, 
and hematologic changes. A no-observed-effect level of 2,4-D of 1 mg/kg was iden-
tified for renal toxicity in rats (Hazleton Laboratories America, 1986). Exposure to 
2,4-D was associated with reduced survival and decreased growth rates in offspring 
of mothers fed high doses during pregnancy; these doses were also associated with 
maternal toxicity (Munro et al., 1992). Charles et al. (2001) found that 2,4-D did 
not affect fertility or produce teratogenic effects in the offspring of rats or rabbits 
given doses lower than 90 mg/kg/day by gavage, which did, however, cause overt 
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maternal toxicity. A one-generation study in which rats were fed diets containing 
2,4-D (females: up to 40 mg/kg/day; males: up to 45 mg/kg/day) from 4 weeks be-
fore breeding through 3 weeks of lactation confirmed these results and furthermore 
found that even at the highest exposure there is no evidence of interaction with the 
androgen, estrogen, or steroidogenesis pathways in the pups (Marty et al., 2013). 
Other studies, however, suggest that exposure to 2,4-D does have an impact on the 
male reproductive system (Alves et al., 2013; Joshi et al., 2012). Alves et al. (2013) 
found that the exposure of rat Serotoli cells in culture at 10 μM 2,4-D resulted in 
alterations in cellular metabolism linked to effective spermatogenesis, which could 
be a mechanism that would reduce sperm density. Mazhar et al. (2014) treated preg-
nant rats by gavage on gestation days 1–19 with 100 mg/kg/day of 2,4-D alone or 
administered with 100 mg/kg/day of the antioxidant vitamin E. Morphological and 
skeletal defects and low birth weight were observed in the fetuses of dams treated 
with only 2,4-D, but not in those whose mothers were also treated with vitamin E, 
thereby suggesting that 2,4-D exposure elicits fetotoxicity through inducing oxi-
dative stress. In vitro exposure of human erythrocytes to 2,4-D caused changes 
in antioxidant enzyme activity as well as increased protein carbonyls, indicating 
induction of oxidative stress (Bukowska, 2003). Similar changes were observed in 
the liver of exposed rats (Tayeb et al., 2010, 2013). The immunotoxicity of 2,4-D 
has been reported in a small number of studies, including a few studies of 2,4-D 
applicators showing both immunosuppression (Faustini et al., 1996) and immuno-
stimulation (Figgs et al., 2000; Holland et al., 2002). At high doses that produced 
clinical toxicity in experimental animals, a suppression of the antibody response 
was observed, whereas other measures of immune function were normal. The im-
munotoxicity of 2,4,5-T has not been evaluated in laboratory animals. 
The carcinogenicity of 2,4-D and 2,4,5-T has been studied in rats, mice, and 
dogs after exposure in their food, direct placement in their stomachs, or exposure 
on their skin. Early studies in mice (NTIS, 1968) and rats (W. H. Hansen et al., 
1971) found little to suggest tumor induction when animals were treated with 
2,4-D by gavage or subcutaneously. Hazelton Laboratories of America (1986, 
1987) conducted a series of studies in rats and mice, which all had negative 
results except one that found an increased incidence of brain tumors in male 
rats—but not female rats—that received the highest dose of 45 mg/kg/day 2,4-D 
in their feed. The occurrence of malignant lymphomas in dogs kept as pets was 
reported to be higher when owners reported that they used 2,4-D on their lawns 
than when they did not (Hayes et al., 1991, 1995), but a detailed reanalysis did 
not confirm this finding (Kaneene and Miller, 1999). A controlled study that used 
dogs exposed to 2,4-D in the laboratory had negative results. Timchalk (2004) 
suggested that dogs are not relevant for comparative evaluation of human health 
risk attributable to 2,4-D exposure because they excrete 2,4-D less efficiently than 
rats or humans. Given the degree of variability observed in humans (Hines et al., 
2003), however, the canine information might be applicable for some people. 
2,4-D is not metabolized to reactive intermediates capable of interacting with 
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DNA, and the evidence supports the conclusion that 2,4-D is not a genotoxic 
carcinogen. However, Sandal and Yilmaz (2011) found that lymphocytes from 
smokers show genotoxic damage after exposure to 2,4-D, whereas lymphocytes 
from non-smokers do not. In the Agricultural Health Study (AHS), Andreotti et 
al. (2015) found that a cumulative metric of 2,4-D exposure in pesticide applica-
tors was associated with shorter relative telomere length in leukocytes. Although 
2,4-D may not be a carcinogen, it may have some role influencing the activity of 
known carcinogens or potentially carcinogenic changes within a cell.
Genetic Studies
In recent years, a number of investigators have used telomere length as a sensi-
tive marker of exposure to a variety of chemical pollutants. Telomere length gener-
ally decreases with age and the assumption is that the activation of many different 
biochemical pathways affects telomere maintenance and repair. The alterations in 
these pathways can in turn either reduce or increase telomere length, depending on 
which factors they affect. Since Update 2014, two large studies of telomere length 
have examined the effects of exposure to the chemicals of interest (COIs). 
Andreotti et al. (2015) studied 568 cancer-free male subjects from the AHS 
who were between 31 and 94 years, taking blood samples from them between 
2006 and 2008. Relative telomere length in DNA from blood was examined for 
associations with self-reported cumulative pesticide use of 57 types, with expo-
sure data collected at enrollment (1993–1997) and in two follow-up telephone 
questionnaires (1998–2003, 2005–2008). The researchers used three metrics of 
pesticide use (ever use, lifetime days, and intensity-weighted lifetime days), 
 divided into tertiles and applied multivariable linear regression analysis to ex-
amine associations, adjusting for age at blood-draw and the use of other pesti-
cides. Further adjustments were made for potential confounding from the use of 
other pesticides. The analysis showed an association between blood telomere 
shortening, independent of age, and the cumulative use of 2,4-D in lifetime days 
(p < 0.01) for ever versus never used, but is borderline significant when using 
lifetime intensity-weighted days (p < 0.05). Similar effects had previously been 
observed for buccal relative telomere length in a subset of 40 AHS subjects, but 
their sample buccal and blood relative telomere length values were uncorrelated. 
A significant trend (p < 0.001) was shown for categorical 2,4-D lifetime use (low, 
medium, high) (Andreotti et al., 2015); however, the 2,4-D never used category 
had substantially longer telomeres than any other group in the study and some 
of the other chemicals were shown to lead to longer telomeres and this could 
confound analysis. Thus, relative telomere length might show an effect with 
 cumulative 2,4-D exposure in blood leukocytes, but the mechanisms of action 
and consequences for disease are unknown.
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2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN
Chemistry
TCDDs are polychlorinated dibenzo-p-dioxins that have a triple-ring struc-
ture consisting of two benzene rings connected by an oxygenated ring with four 
attached chlorine atoms; in the case of the dioxin congener of greatest concern, 
2,3,7,8-TCDD (commonly called simply TCDD), the chlorine atoms are attached 
at the 2, 3, 7, and 8 positions of the benzene rings (see Figure 4-4). The chemi-
cal properties of TCDD include a molecular weight of 322, a melting point of 
305–306°C, a boiling point of 445.5°C, and a log octanol–water partition coeffi-
cient of 6.8 (National Toxicology Program substance profile). It is very lipophilic, 
or fat soluble; is virtually insoluble in water (19.3 ng/L); and is soluble in organic 
solvents, such as benzene and acetone. It has been suggested that the volatiliza-
tion of dioxin from water may be an important mechanism of transfer from the 
aqueous to the atmospheric phase (EPA, 2004); however, because of its very low 
water solubility, most TCDD is bound to sediments and particulate matter. 
Toxicokinetics
The disposition of TCDD (which includes its absorption, distribution, bio-
transformation, and excretion) has been extensively studied in humans and a 
number of other animal models over the past 30 years. Given the plethora of data, 
this section highlights and summarizes only key findings. TCDD is absorbed into 
the body rapidly but is eliminated slowly. Because it is very lipophilic, resistant 
to biotransformation, and slowly eliminated, the concentration of TCDD in the 
lipid fraction of blood serum is thought to be in dynamic equilibrium with that 
in the lipid fraction in other tissue compartments. Thus, the lipid-adjusted blood 
serum concentration of TCDD is used to estimate total body burdens; however, 
at high TCDD concentrations, the liver sequesters some of the dioxin, so a lipid 
adjustment that ignores the hepatic fraction would underestimate the total body 
burden. The exposure of humans to TCDD is thought to occur primarily via the 
mouth, skin, and lungs. In laboratory animals, oral administration of TCDD has 
been shown to result in absorption of 50–93% of the administered dose (Nolan 
et al., 1979; Rose et al., 1976). Similarly, a study performed in a 42-year-old 
man found that 87% of the oral dose was absorbed (Poiger and Schlatter, 1986). 
 Dermal absorption appears to be dose-dependent: lower absorption occurs at 
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FIGURE 4-4 Chemical structure of 2,3,7,8-tetrachlorodibenzo-p-dioxin.
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higher doses (Banks and Birnbaum, 1991). In vitro studies of tissues isolated 
from humans indicate that intact human skin may not be readily penetrable 
(Weber et al., 1991). The varied and complex environmental matrices make envi-
ronmental exposures difficult to quantify. Animal studies have demonstrated that 
the presence of soil or lipophilic agents dramatically reduces dermal absorption 
of TCDD: application in an activated carbon–water paste essentially eliminates 
absorption in contrast with the absorption of the pure compound dissolved in 
solvents. The oral bioavailability of TCDD and related compounds also depends 
on the matrix: contaminated breast milk and food products have much higher 
bioavailability than soil-bound or sediment-bound TCDD, and activated carbon 
essentially blocks oral bioavailability (Olson, 2012).
After ingestion and gastrointestinal absorption, TCDD associates primarily 
with the lipoprotein fraction of the blood and later partitions into the cellular 
membranes and tissues (Henderson and Patterson, 1988). TCDD is distributed to 
all compartments of the body; the amounts differ from organ to organ, but most 
studies indicate that the primary distribution of TCDD is in the liver and adipose 
tissues. For example, in a human volunteer it was found that 135 days after inges-
tion, 90% of TCDD was in fat (Poiger and Schlatter, 1986), and TCDD persists in 
adipose tissue in the rhesus monkey (Bowman et al., 1989). The specific details of 
the distribution and elimination of TCDD depend on the tissue examined, the time 
that has elapsed since exposure, total exposure, and other factors. For example, 
the concentration of cytochrome P450 1A2 (CYP1A2) in the liver is increased by 
TCDD (Poland et al., 1989). Direct binding of TCDD to CYP1A2 is thought to 
result in the sequestration of TCDD in the liver and to inhibit its distribution to 
other tissues. The importance of CYP1A2 concentrations for the toxic actions of 
TCDD has also been demonstrated in several laboratory situations; for instance, 
CYP1A2-knockout mice were more susceptible than wild-type mice to TCDD 
immunotoxicity (Smialowicz et al., 2008), and maternal hepatic CYP1A2 was 
found to sequester TCDD and protect mouse fetuses against TCDD-induced 
teratogenesis (Dragin et al., 2006). In addition, the distribution of TCDD is age 
dependent, as shown by studies in which young animals displayed the highest 
concentration of TCDD in the liver and aged animals the highest concentrations 
in kidneys, skin, and muscle (Pegram et al., 1995). Finally, the rate of elimination 
of TCDD, particularly after low exposures, depends heavily on the amount of 
adipose tissue mass (Aylward et al., 2005a; Emond et al., 2005, 2006).
In laboratory animals, TCDD is metabolized slowly. It is eliminated primar-
ily in feces as both the parent chemical and its more polar metabolites. However, 
elimination appears to be dose dependent; at low doses, about 35% of the ad-
ministered dose of TCDD was detected in the feces, while at higher doses, about 
46% was observed (Diliberto et al., 2001). The dose-dependent occurrence of 
TCDD metabolites in the feces is thought to be due to the increased expression 
of metabolizing enzymes at higher doses and to hepatic sequestration, which 
makes dioxins more available for metabolism. Milbrath et al. (2009) conducted 
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a comprehensive review of studies that reported the congener-specific elimination 
rates of TCDD and related compounds and analyzed the relationships between 
the apparent half-lives of the compounds as a function of age, body fat, smok-
ing status, and breastfeeding. In infants (less than 2 years old), the compounds 
have a reported half-life of 0.4 year (Leung et al., 2006), and in adults a half-life 
of 7.2 years, based on the regression method used by Flesch-Janys et al. (1996) 
(Milbrath et al., 2009). Aging results in an increase in and redistribution of body 
fat and lipophilic chemicals that alters their rate of elimination (Van der Molen 
et al., 1996). Human studies of the Ranch Hand cohort have consistently found a 
similar relationship between an increasing half-life of TCDD and an increasing 
BMI (Michalek and Tripathi, 1999; Michalek et al., 1992, 1996). Smoking and 
breastfeeding are associated with promoting the elimination of TCDD and, in the 
case of breastfeeding, exposing infants through breast milk. Polycyclic aromatic 
hydrocarbons (PAHs) in cigarette smoke are capable of inducing CYP1A1, 1A2, 
and 1B1, which in turn may increase the rate of metabolism and subsequent 
elimination of TCDD. Smoking has been associated with a 30% decrease in 
TCDD plasma half-life (Flesch-Janys et al., 1996). Update 2014 (NASEM, 
2016a) includes a table (4-1; pp. 95–96) summarizing the results of studies of 
TCDD half-life in humans and animals.
Special Case of the Poisoning of Victor Yushchenko
In 2004 Victor Yushchenko, a candidate for the presidency of the Ukraine, 
was poisoned with TCDD. It led to severe chloracne and a blood serum TCDD 
concentration of 108,000 ppt (pg/g lipid), which was about 50,000 times as great 
as that in the general population. The incident provided an unfortunate opportu-
nity to assess the toxicokinetics of TCDD after a single large exposure. Serum 
and fat analysis of TCDD supports the first-order elimination half-life of 15.4 
months in Yushchenko, and the similarity in the decay curves of serum lipids 
and subcutaneous fat confirmed that TCDD was in equilibrium between the two 
(Sorg et al., 2009). The elimination half-life of 15.4 months is much shorter than 
the 7.2-year reference half-life reported by Milbrath et al. (2009) and supports a 
dose-dependent elimination of TCDD, which is associated with the induction of 
potential TCDD-metabolizing enzymes (CYP1A1, 1A2, and 1B1) in very high 
TCDD exposures. Two metabolites of TCDD (2,3,7-trichloro-8-hydroxydibenzo-
p-dioxin and 1,3,7,8-tetrachloro-2-hydroxydibenzo-p-dioxin) were detected in 
Yushchenko’s feces, serum, and urine but not in his fat or skin. Over a 12-month 
period, about 38% of the TCDD-derived material was eliminated as metabolites 
(95% in feces, 5% in urine) and 62% as parent chemical. The metabolite-to-
TCDD ratio in the blood serum was about one-fiftieth of that in the feces; this 
supports the conclusion that the metabolites were not originally ingested with 
TCDD (Sorg et al., 2009). The very slow metabolism of TCDD has been previ-
ously reported in laboratory animal models (Gasiewicz et al., 1983; Olson, 1986; 
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Olson et al., 1980; Poiger and Schlatter, 1979) and in humans (Wendling et al., 
1990). It is also noteworthy that the structures of the human metabolites are the 
same as previously reported in the rat and dog (Poiger et al., 1982; Sawahata et 
al., 1982). A continued analysis of Yushchenko’s condition has revealed putative 
metabolomic and transcriptomic biomarkers that may prove useful for predicting 
health effects in populations with significant TCDD exposures (Jeanneret et al., 
2014; Saurat et al., 2012).
In light of the variables discussed above and the effect of differences in 
physiologic states and metabolic processes, which can affect the mobilization of 
lipids and possibly of the compounds stored in them, complex physiologically 
based pharmacokinetic models have been developed to integrate exposure dose 
with organ mass, blood flow, metabolism, and lipid content in order to predict 
the movement of toxicants into and out of each organ. A number of modeling 
studies have been performed in an effort to understand the relevance of animal 
experimental studies to the exposures that occur in human populations (Aylward 
et al., 2005a,b; Beaudouin et al., 2010; Emond et al., 2005).
Toxicity Profile
Effects on Tissues and Organs of Laboratory Animals
The effects of TCDD in laboratory animals have been observed in several 
species (rats, mice, guinea pigs, hamsters, monkeys, cows, and rabbits) after the 
administration of a variety of doses and after periods that represent acute expo-
sures (less than 24 hours), sub-chronic exposures (1 day–3 months), and chronic 
exposure (more than 3 months). Some differences have been observed between 
species, particularly with respect to the degree of sensitivity, but in general the 
effects observed are qualitatively similar. Some differences in sensitivity have 
been observed within rodent species, and has been found to be related to species-
specific aryl hydrocarbon receptor (Ahr)1 AHR polymorphisms (Ema et al., 1994; 
Pohjanvirta et al., 1998). Relatively high exposures of TCDD affect a variety of 
organs and result in organ dysfunction and death. The lethal toxicity of TCDD 
varies widely among animal species; the oral LD50 of the chemical varies from 
1 μg/kg in guinea pigs to 5,000 μg/kg in hamsters. The developing fetus, however, 
is especially vulnerable to TCDD exposure, and there is only about a 10-fold vari-
ability in fetal lethal potency among these species (Kransler et al., 2007; Peterson 
et al., 1993; Poland and Knutson, 1982). One characteristic of TCDD exposure 
is a wasting syndrome that includes the loss of adipose and muscle tissue and 
severe weight loss, but the specific mechanisms of lethality remain unknown. 
Hwang et al. (2016) suggested that mitochondrial dysfunction caused by Ahr-
mediated, TCDD-induced toxicity contributes to wasting syndrome and metabolic 
1 The aryl hydrocarbon receptor is denoted as AHR when in human cells and Ahr in rodent models.
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dysfunction. In most rodents, exposure to TCDD leads to hepatic enlargement, 
the presence of hepatic lesions, and impaired hepatic function (Harrill et al., 
2016); work by X. Cheng et al. (2014) suggest a role for TCDD-AHR acting on 
fibroblast growth factor 21 as a contributor to liver effects. The thymus is also 
sensitive. Recent work by Diani-Moore et al. (2017) in a chick-embryo model 
found poly(ADP-ribose) polymerase activation and resulting NAD+ loss offers a 
possible unifying mechanism for the effects of TCDD exposure such as wasting, 
hepatosteatosis, and thymus atrophy. Finally, in both humans and nonhuman pri-
mates, TCDD exposure results in chloracne and associated dermatologic changes. 
As will be discussed in more detail in Chapters 6–11, studies performed in ani-
mal models have indicated that exposure to TCDD adversely affects the heart, 
the skin, and the immune, endocrine, and reproductive systems and increases 
the incidence of cancers of the liver, skin, thyroid, adrenal cortex, hard palate, 
nasal turbinates, tongue, and respiratory and lymphatic systems (ATSDR, 1998; 
 Barouki et al., 2012; Birnbaum, 1994; Huff et al., 1994; Knerr and Schrenk, 2006; 
Tian et al., 2015). When TCDD has been administered to pregnant animals, birth 
defects—such as cleft palate, malformations of the reproductive organs of male 
and female progeny, and abnormalities in the cardiovascular, pulmonary, endo-
crine, skeletal, and nervous systems—have been observed. Of course, effects aris-
ing from perinatal exposure are not in question for Vietnam veterans themselves, 
but this activity is of concern with respect to their offspring. The developmental 
origins of health and disease are discussed in more detail in Chapter 8.
Effects on Enzymes, Hormones, and Receptors in 
Laboratory Animals and Cultured Cells
In addition to adversely affecting the ability of specific organs to fulfill 
their normal physiologic roles, TCDD has been found to alter the function and 
expression of essential proteins, particularly a number of enzymes. The enzymes 
that are most affected by TCDD are ones that act on or metabolize xenobiotics 
and hormones, often by changing the chemicals’ polarity (water solubility) and 
thus promoting the elimination of the metabolites. Among the enzymes affected 
by TCDD, the best studied is CYP1A1, which metabolizes some xenobiotics. 
In laboratory animals, exposure to TCDD commonly results in an increase in 
CYP1A1 in most tissues; CYP1A1 therefore is often used as a marker of TCDD 
exposure. Related enzymes whose levels are also increased with TCDD exposure 
include CYP1B1 and CYP1A2, which together with CYP1A1 are capable of 
biotransforming some procarcinogens to potentially mutagenic and carcinogenic 
metabolites. 
In addition to CYP1A1 and CYP1A2, TCDD can affect other enzymes that 
metabolize hormones, such as thyroid hormones, retinoic acid, testosterone, 
estrogens, and adrenal steroids (reviewed in Kung et al., 2009, and Safe et al., 
2000). Those hormones transmit their signals by interacting with specific proteins 
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called receptors and in this manner initiate a chain of events in many tissues of the 
body. For example, the binding of the primary female sex hormone, estrogen, to 
the estrogen receptor promotes the formation of breasts and the thickening of the 
endometrium, regulates the menstrual cycle, and influences brain development. 
Exposure to TCDD can increase the metabolism of estrogen and thus lead to a 
decrease in the amount of estrogen available for binding and activating the estro-
gen receptor. The ultimate effect of TCDD is an interference with all the bodily 
functions that are regulated by estrogens. Similarly, the actions of TCDD on the 
adrenal steroids can adversely affect their ability to regulate glucose tolerance, 
insulin sensitivity, lipid metabolism, body weight, vascular function, and cardiac 
remodeling. In addition to changing the amount of hormone present, TCDD has 
been found to interfere with the ability of receptors to fulfill their role in transmit-
ting hormone signals. Those actions of TCDD on enzymes and hormone receptors 
are thought to underlie, in part, the observed developmental and reproductive 
effects and cancers that are hormone responsive.
Effects on Paths of Cellular Differentiation
The broad spectrum of TCDD effects on hormone and growth factor sys-
tems, cytokines, and other signal-transducer pathways indicates that TCDD is an 
extremely powerful growth dysregulator (Birnbaum, 1994). Research performed 
primarily in cultured cells has shown that TCDD can affect the ability of cells to 
undergo such processes as proliferation, differentiation, and apoptosis (Duan et 
al., 2014; Marlowe and Puga, 2005). During the proliferation process, cells grow 
and divide. When cells are differentiating, they are undergoing a change from less 
specialized to more specialized. Cellular differentiation is essential for an organ-
ism to mature from a fetal to an adult state. In the adult, proper differentiation 
is required for the normal functioning of the body—for example, in maintaining 
a normally responsive immune system. The processes of controlled cell death, 
such as apoptosis, are similarly important during the development of the fetus 
and are necessary for normal physiologic functions in the adult. Apoptosis is a 
way for the body to eliminate damaged or unnecessary cells. The ability of a cell 
to undergo proliferation, differentiation, and apoptosis is tightly controlled by 
an intricate network of signaling molecules that allows the body to maintain the 
appropriate size and number of all the specialized cells that form the fabric of 
complex tissues and organs. Any disruption of the network that alters the delicate 
balance of cell fate can have severe consequences, including impairment of the 
function of the organ because of the absence of specialized cells. Alternatively, 
the presence of an excess of some kinds of cells can result in the formation and 
development of tumors. Thus, the ability of TCDD to disrupt the normal course 
of a specific cell to proliferate, differentiate, or undergo apoptosis is thought 
to underlie (at least in part) its adverse effects on the immune system and the 
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developing fetus and its ability to promote the formation of some cancers (Kolluri 
et al., 2017). 
Mechanisms
TCDD binds and activates AHR in the cells of virtually every tissue in the 
body. The ability of TCDD to bind to AHR with high affinity is necessary—but 
not sufficient—to produce most of the adverse effects associated with TCDD 
exposure, including those from direct TCDD binding to and activation of the 
AHR and later alterations in the expression of TCDD-regulated genes as well 
as changes to those signaling pathways altered through interactions with the 
canonical AHR pathway (Poland and Knutson, 1982; Safe, 1990; Schmidt and 
Bradfield, 1996; Whitlock, 1990).
In the canonical pathway, AHR functions as a ligand-activated nuclear 
 transcription factor. Upon binding of agonists (ligands), such as TCDD, AHR 
forms a heterodimer with a structurally related protein called AHR nuclear trans-
locator (ARNT). The dimeric complex (structural model proposed by Corrada et 
al., 2017) binds to core DNA sequences called xenobiotic-responsive elements or 
dioxin-responsive elements in the promoter region of responsive genes and en-
hances the transcription of those genes. Many of the AHR-regulated genes encode 
drug-metabolizing enzymes, such as CYP1A1, CYP1A2, CYP1B1, and a variety 
of Phase II conjugating enzymes. Although the up-regulation of these enzymes is 
a sensitive biomarker of exposure to TCDD and may contribute mechanistically 
to some of the adverse effects of TCDD, the tissue-, species-, time-, and dose-
specific modulation (increase or decrease) of many genes is thought to contrib-
ute to the wide array of toxic responses to TCDD exposure (Black et al., 2012; 
Boverhof et al., 2006; Y. Chen et al., 2017; Ovando et al., 2006, 2010; Perdew, 
2008; Puga et al., 2009; Schneider et al., 2014). Many of these effects may be 
the result of activation of non-canonical cytoplasmic AHR pathways that lead to 
SRC activation, calcium release, and binding to other transcription factors, and 
their downstream effects as reviewed in Larigot et al. (2018).
AHR Signaling Pathways
The primary and most intensely studied pathway by which TCDD elicits 
biologic responses is depicted in Figure 4-5. In the absence of a bound ligand, 
the inactive AHR is retained in the cytoplasm of the cell in a complex consist-
ing of two molecules of the heat-shock protein HSP90, one molecule of prosta-
glandin E synthase 3 (p23) (Kazlauskas et al., 1999), and one molecule of 
the  immunophilin-like protein hepatitis B virus X-associated protein 2 (XAP2) 
( Petrulis et al., 2003), previously identified as either AHR-interacting protein (Ma 
and Whitlock, 1997) or AHR-associated protein 9 (Carver and Bradfield, 1997). 
The HSP90 dimer–p23 complex plays multiple roles in the protection of the AHR 
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from proteolysis, maintaining it in a conformation that makes it accessible to 
ligand binding at the same time that it prevents the premature binding of ARNT 
(Carver et al., 1994; Pongratz et al., 1992; Whitelaw et al., 1993). XAP2 interacts 
with the carboxyl terminus of HSP90 and with the AHR nuclear- localization 
signal, a short amino acid domain that targets the receptor for interaction with 
nuclear-transport proteins. The binding of XAP2 blocks such an interaction, 
preventing the inappropriate trafficking of the receptor into the nucleus (Petrulis 
et al., 2003).
The binding of ligands (such as TCDD) induces the release of XAP2 and the 
exposure of the nuclear localization signal and leads to the binding of nuclear-
import proteins and the translocation of the cytosolic complex into the nucleus 
(Davarinos and Pollenz, 1999; Song and Pollenz, 2002). Once the cytosolic 
complex is in the nucleus, HSP90, p23, and XAP2 dissociate from the AHR, 
which allows the binding of ARNT (Hoffman et al., 1991; Probst et al., 1993). 
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FIGURE 4-5 Mechanisms of gene regulation by the AHR following activation by TCDD. 
NOTES: In the canonical pathway, activation of the AHR though binding TCDD or other 
ligands, the AHR undergoes conformational changes that result in the dissociation of the 
AHR/HSP90 complex and its translocation to the nucleus. Once in the nucleus, the AHR 
establishes protein–protein interactions with the AHR nuclear translocator (ARNT) and 
additional coactivators and transcription factors. These complexes bind to AHRE (aryl 
hydrocarbon response elements) to control the transcriptional activity of target genes (e.g., 
CYP1A1, AHR repressor [AHRR]). In the non-canonical pathway, activation of the AHR 
through binding TCDD, or other ligands, results in cytoplasmic interactions leading to 
rapid changes in intracellular calcium, activation of signaling pathways, and direct binding 
to other transcription factors.
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The activated AHR–ARNT heterodimeric complex is then capable of directly 
or indirectly interacting with DNA by binding to recognition sequences in the 
regulatory region of responsive genes (Dolwick et al., 1993; Probst et al., 1993). 
DeGroot and Denison (2014) found that the nucleotide specificity of DNA bind-
ing by the activated AHR-ARNT is not affected by structurally different ligands.
The canonical DNA recognition motif of the AHR–ARNT complex is re-
ferred to as the AHR-responsive element (AHRE, also referred to as the  dioxin- or 
xenobiotic-response element, respectively). This element is found in the promoter 
region of AHR-responsive genes and contains the core sequence 5′-GCGTG-3′ 
(Shen and Whitlock, 1992), which is part of a more extensive consensus-binding 
sequence, 5′-T/GNGCGTGA/CG/CA-3′ (Lusska et al., 1993; Yao and Denison, 
1992). The AHR–ARNT complex binds to the AHRE core sequence in such a 
manner that ARNT binds to 5′-GTG-3′ and AHR binds to 5′-TC/TGC-3′ (Bacsi 
et al., 1995; Swanson et al., 1995). A second type of element, termed AHRE-II, 
5′-CATG(N6)C[T/A]TG-3′, has been shown to be capable of acting indirectly with 
the AHR–ARNT complex (Boutros et al., 2004; Sogawa et al., 2004). The end 
result of the process is the recruitment of the transcriptional machinery asso ciated 
with RNA polymerase II and the initiation of differential changes in the expres-
sion of the genes bearing the AHR–ARNT recognition motif. Many of the genes 
code for proteins responsible for detoxification reactions directed at the elimina-
tion of the ligand. Research suggests that posttranslational modifications in histone 
proteins may modify the response (Hestermann and Brown, 2003; J. B. Kim et 
al., 2017; Schnekenburger et al., 2007).
In the canonical pathway, the actions of TCDD are mediated by the binding 
of the activated AHR–ARNT dimer to AHREs on DNA, which results in altered 
gene expression (see Figure 4-5). More recently, studies suggest that a non-
canonical pathway within the cytoplasm also contributes to the toxic effects of 
TCDD, as first reviewed by Matsumura (2009). The TCDD-mediated activation 
of AHR within the cytoplasm does not involve binding to ARNT or DNA and 
appears to contribute to the rapid inflammatory responses associated with TCDD 
(Sciullo et al., 2008). In several cell lines, the activation of protein kinase C and 
the later activation of the serine phosphorylated form of cytosolic phospholi-
pase A2 (cPLA2) takes place within 15 minutes of TCDD exposure (Dong and 
Matsumura, 2008; S. Park et al., 2007). It is proposed that within the cytoplasm, 
the TCDD-mediated activation of AHR leads to a rapid increase in intracellular 
Ca2+, plus activation of cPLA2, protein kinases, and pro-inflammatory proteins, 
such as cyclooxygenase (COX-2) (Matsumura, 2009). This pathway and other 
alternative mechanisms of TCDD-mediated AHR activation have also been re-
viewed by Denison et al. (2011), Larigot et al. (2018), Perdew (2008), and Wright 
et al. (2017).
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AHR Physiology
The vertebrate AHR is presumed to have evolved from its counterpart in 
invertebrates, in which it serves a ligand-independent role in normal develop-
ment processes. The ancestral function of the AHR appears to be the regulation 
of specific aspects of embryonic development, it having acquired the ability to 
bind xenobiotic compounds only during vertebrate evolution (Hahn, 2001; Hahn 
et al., 2017). The invertebrate AHR also functions as a transcription factor and 
binds to the same dimerization partner (ARNT) and DNA-response elements as 
the vertebrate protein, but it does not respond to any of the environmental ligands 
recognized by the vertebrate receptor. Instead, it regulates diverse developmental 
processes that are independent of exogenous ligand exposure, such as neuronal 
differentiation during worm development in Caenorhabditis elegans (X. Huang 
et al., 2004; Qin and Powell-Coffman, 2004) or the normal morphogenesis of 
legs, antennae, and bristles in Drosophila melanogaster (Adachi-Yamada et al., 
2005; Céspedes et al., 2010). In developing vertebrates, AHR seems to play a 
role in cellular proliferation and differentiation and, in keeping with this role in 
invertebrates, also has a developmental role in craniofacial, muscle, pulmonary, 
renal, cardiovascular, and reproductive tract morphogenesis and blood cell dif-
ferentiation (Birnbaum et al., 1989; C. Chiu et al., 2014; Fernandez-Salguero et 
al., 1997; Lahvis et al., 2005). Other potential functional roles of AHR include 
reproduction, innate immunity, tumor suppression, and blood-pressure regula-
tion (Fujii-Kuriyama and Kawajiri, 2010). Dietrich (2016) reviewed antioxidant 
functions of the AHR.
The clearest adaptive physiologic response to AHR activation is the in-
duction of xenobiotic-metabolizing enzymes involved in the detoxification of 
toxic ligands. Evidence of that response, which was described above, was first 
observed in conjunction with the induction of CYP1A1, which resulted from 
exposure to PAHs or TCDD and was directly related to the activation of the 
AHR signaling pathway (Israel and Whitlock, 1983, 1984). Because of the pres-
ence of the AHRE motif in their gene promoters, other metabolizing genes were 
tested and found to be induced by AHR ligands, which led to the identification 
of a so-called AHR gene battery of phase I and phase II detoxification genes that 
code for the drug-metabolizing enzymes CYP1A1, CYP1A2, CYP1B1, NQO1, 
ALHD3A1, UGT1A2, and GSTA1 (Nebert et al., 2000). Presumably, vertebrates 
have evolved those enzymes to detect a wide array of foreign, potentially toxic 
chemicals, represented in the wide variety of substrates that the AHR is able to 
bind to and whose biotransformation and elimination it is able to facilitate.
A potential complication of the adaptive responses elicited by AHR activa-
tion is the induction of a toxic response. Toxicity may result from the adaptive 
response itself if the induction of metabolizing enzymes results in the production 
of toxic metabolites. For example, the PAH benzo[a]pyrene, an AHR ligand, 
induces its own metabolism and detoxification by the AHR-dependent signaling 
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mechanism described earlier, but paradoxically it becomes bioactivated to a toxic 
metabolite in several tissues by a metabolism that depends on CYP1A1 and 
CYP1B1 activity (Harrigan et al., 2004). A second potential source of AHR-me-
diated toxicity may be aberrant changes in global gene expression beyond those 
observed in the AHR gene battery. The global changes in gene expression may 
lead to deleterious changes in cellular processes and physiology. Microarray and 
other transcriptomic analyses have proved invaluable in understanding and char-
acterizing that response (Boverhof et al., 2006; Martinez et al., 2002; Ovando et 
al., 2006, 2010; Puga et al., 2000, 2004; Takeda et al., 2012; Vezina et al., 2004).
Endogenous AHR functions likely involve interaction with endogenous 
ligands that activate specific physiological processes. Several chemicals and 
chemical classes have been identified as putative endogenous ligands, includ-
ing equilenin, indigoids, 2-(1′H-indole-3′-carbonyl)-thiazole-4-carboxylic 
acid methyl ester, leukotrienes, heme metabolites, arachidonic acid metabo-
lites,  tryptophan metabolites, and ultraviolet (UV) photoproducts of tryptophan 
(Guyot et al., 2013; Nguyen and Bradfield, 2008). The tryptophan catabolite and 
AHR ligand kynurenine has been identified as a tumor promoter that suppresses 
anti-tumor immune responses and promotes tumor-cell survival and motility 
(Opitz et al., 2011). The tryptophan UV photoproduct 6-formylindolo[3,2-b]
carbazole (FICZ) is a high-affinity AHR ligand, an inducer of CYP1A1 (Y.-D. 
Wei et al., 1998), and a substrate for CYP1A1 (Wincent et al., 2012). This 
auto regulatory loop maintains endogenous low levels of FICZ, which influence 
circadian rhythms, responses to UV light, homeostasis associated with pro- and 
anti-inflammatory processes, and genomic stability (Wincent et al., 2012). FICZ 
has been shown to reduce the inflammatory response in skin inflammation models 
(Di Meglio et al., 2014) and to enhance natural killer cell control of tumors (Shin 
et al., 2013).
It is clear that AHR is an essential component of the toxicity of dioxin and 
of dioxin-like chemicals. Studies of certain genetic polymorphisms in AHR in 
human cells suggest an association with differential susceptibility to dioxins 
(Kovalova et al., 2016; G. Liu et al., 2015), and experimental alteration of  human 
AHR can suppress ARNT function (J. H. Xie et al., 2014). The homozygous 
 deletion of Ahr in mice leads to a phenotype that is resistant to the toxic effects 
of TCDD and to the carcinogenic effects of benzo[a]pyrene (Fernandez-Salguero 
et al., 1996; Lahvis and Bradfield, 1998; Schmidt and Bradfield, 1996). The Ahr 
knockout mice, however, have other phenotypic effects, including reduced liver 
size, hepatic fibrosis, and cardiovascular abnormalities. Ahr knockout rats also 
demonstrate resistance to the toxic effects of TCDD and, in contrast to mice, 
display pathological alterations to the urinary tract in the absence of TCDD 
(Harrill et al., 2013). Hence, it is likely that dioxin has effects that are due to the 
disruption of endogenous AHR functions and that are unrelated to the intrinsic 
toxicity of some of its ligands.
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Definition of Dioxin-Like Compounds, Toxic 
Equivalence Factor, and Toxic Equivalents
TCDD has the highest affinity for the AHR, but many other chemicals 
have dioxin-like properties: they have similar chemical structures, have similar 
physiochemical properties, and cause a common battery of toxic responses be-
cause of their relatively high affinity for the AHR. Because of their hydrophobic 
nature and resistance to metabolism, these chemicals persist and bioaccumulate 
in the fatty tissues of animals and humans. Although there are several hundred 
polychlorinated, polybrominated, and mixed polychlorinated–polybrominated 
dibenzo-p-dioxins, dibenzofurans, and biphenyls, only a relatively small num-
ber of congeners of these chemical classes display dioxin-like activity. Only 17 
polychlorinated dibenzo-p-dioxins (PCDDs) and polychlorinated dibenzofurans 
(PCDFs) with chlorine at the 2, 3, 7, and 8 positions and a few of the coplanar 
polychlorinated biphenyls (PCBs) that are often measured in environmental 
samples are recognized as being dioxin-like chemicals.
In the context of risk assessment, these polychlorinated–polybrominated 
dibenzo-p-dioxin, polychlorinated dibenzofuran, and biphenyl dioxin-like chemi-
cals are commonly found as complex mixtures when detected in environmental me-
dia and biologic tissues or when measured as environmental releases from specific 
sources. That complicates the human health risk assessment that may be associated 
with exposures to varied mixtures of dioxin-like chemicals. To address the prob-
lem, the concept of toxic equivalence has been elaborated by the scientific com-
munity, and the toxic equivalence factor (TEF) has been developed and introduced 
to facilitate the risk assessment of exposures to those chemical mixtures (reviewed 
in Tavakoly Sany et al., 2015; van den Berg et al., 2006). On the most basic level, 
TEFs compare the potential toxicity of each dioxin-like chemical found in a mix-
ture with the toxicity of TCDD, the most toxic member of the group. The procedure 
involves assigning individual TEFs to the dioxin-like chemicals on the basis of in 
vivo and in vitro potency relative to TCDD, which is assigned a TEF of 1.0. The 
dioxin-like chemicals have been assigned TEFs ranging from 0.00001 to 1.0 by 
the World Health Organization (WHO) (van den Berg et al., 2006, as summarized 
in Table 4-1). This approach has significant limitations due to the lack of in vivo 
human data and the difficulty of extrapolating cell line and rodent data to humans.
Larsson et al. (2015) used 17 in vitro assays from multiple species and in 
silico models to develop consensus toxicity factors that were then compared to 
internationally recognized WHO TEF values. The vast majority of the consensus 
toxicity factors for PCDDs and PCDFs were generally lower than the WHO TEFs 
but within an order of magnitude. The greatest differences between the human 
(but not rodent) consensus toxicity factor and TEQ values were in the effects of 
PCBs, which were inactive in the human cell line assays. The computational tools 
used by Larsson et al. (2015) could be quite useful in future discussion of TEF 
values, however, in vivo data must have more weight. 
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Interim TEF values have been established for brominated congeners by the 
2011 joint WHO–UN Environment Programme meeting to evaluate the WHO 
TEF scheme. The recommendation is to use the TEF of the corresponding chlo-
rinated congener as an interim TEF value for brominated congeners for human 
risk assessment (van den Berg et al., 2013).
When several chemicals are present in a mixture, the toxicity of the mixture 
is estimated by multiplying the TEF of each dioxin-like chemical in the mixture 
TABLE 4-1 World Health Organization Toxicity Equivalence Factors (TEFs) 
for Dioxin-Like Chemicals (values revised in 2005)
Chemical TEF
Chlorinated dibenzo-p-dioxins
2,3,7,8-TCDD 1.0
1,2,3,7,8-PeCDD 1.0
1,2,3,4,7,8-HxCDD 0.1
1,2,3,6,7,8-HxCDD 0.1
1,2,3,7,8,9-HxCDD 0.1
1,2,3,4,6,7,8-HpCDD 0.01
OctoCDD 0.0003
Chlorinated dibenzofurans
2,3,7,8-TCDF 0.1
1,2,3,7,8-PeCDF 0.03
2,3,4,7,8-PeCDF 0.3
1,2,3,4,7,8-HxCDF 0.1
1,2,3,6,7,8-HxCDF 0.1
1,2,3,7,8,9-HxCDF 0.1
2,3,4,7,8,9-HxCDF 0.1
1,2,3,4,6,7,8-HpCDF 0.01
1,2,3,4,7,8,9-HpCDF 0.01
OctoCDF 0.0003
Non-ortho-substituted PCBs
PCB 77—3,3′,4,4′-tetraCB 0.0001
PCB 81—3,4,4′,5-tetraCB 0.0003
PCB 126—3,3′,4,4′,5-pentaCB 0.1
PCB 169—3,3′,4,4′,5,5′-hexaCB 0.03
Mono-ortho-substituted PCBs
PCB 105—2,3,3′,4,4′-pentaCB 0.00003
PCB 114—2,3,4,4′,5-pentaCB 0.00003
PCB 118—2,3′,4,4′,5-pentaCB 0.00003
PCB 123—2′,3,4,4′,5-pentaCB 0.00003
PCB 156—2,3,3′,4,4′,5-hexaCB 0.00003
PCB 157—2,3,3′,4,4′,5′-hexaCB 0.00003
PCB 167—2,3′,4,4′,5,5′-hexaCB 0.00003
PCB 189—2,3,3′,4,4′,5,5′-heptaCB 0.00003
NOTE: CB, chlorinated biphenyl; CDD, chlorinated dibenzo-p-dioxin; CDF, chlorinated dibenzofu-
ran; PCB, polychlorinated biphenyl; TEF, toxicity equivalence factor.
SOURCE: Adapted from van den Berg et al., 2006.
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by its mass concentration and summing the products to yield the TCDD TEQs 
of the mixture. In that approach to assessing the dioxin-like activity of a com-
plex real-world mixture of dioxin-like chemicals, an environmental or biologic 
specimen with a 100-ppt (100-pg/g) TEQ is toxicologically equivalent to 100-ppt 
TCDD. There are two accepted specialized methods for assessing the dioxin-like 
chemicals in a complex biologic or environmental specimen: one involves ana-
lytic chemistry that quantifies specific dioxin-like chemicals (high-resolution gas 
chromatography–mass spectroscopy), and the other is a reporter-gene biologic 
screen that assesses dioxin-like activity due to binding to AHR in a transformed 
cell line (CALUX, EPA method 4435). Epidemiologic studies discussed in this 
and other updates assess exposure by reporting the specific concentration of 
TCDD in a specimen or by expressing dioxin-like activity in a complex mixture 
in units of TEQs.
Carcinogenic Classification
EPA and IARC have developed criteria to classify the potential carcinogenic-
ity of chemicals on the basis of the weight of scientific evidence from animal, 
human, epidemiologic, mechanistic, and mode-of-action studies. EPA classi-
fied TCDD as a “probable human carcinogen” in 1985 and as “carcinogenic to 
humans” in a 2003 reassessment. In 1998 an IARC panel of experts concluded 
that the weight of scientific evidence supported the classification of dioxin as a 
class I carcinogen, that is, as “carcinogenic to humans.” Four years later the U.S. 
National Toxicology Program upgraded its classification to “known to be a hu-
man carcinogen.” In 2006 a panel of experts convened by the National Research 
Council to evaluate the EPA reassessment concluded that TCDD was “likely to 
be carcinogenic to humans”; this designation reflected the revised EPA Guidelines 
for Carcinogen Risk Assessment made public in 2005.
Genotoxicity
Genotoxicity refers to a deleterious action that affects the integrity of a cell’s 
DNA. Genotoxic substances are known to be potentially mutagenic or carcino-
genic. Although TCDD is carcinogenic in humans and laboratory animals, it is 
generally classified as nongenotoxic and nonmutagenic (Wassom et al., 1977). 
There is no evidence of covalent binding of TCDD or its  metabolites to DNA 
(Poland and Glover, 1979). TCDD does interact with DNA through a receptor-
mediated pathway that involves the initial binding of TCDD to AHR, binding of 
the activated receptor complex to dioxin responsive elements on DNA and later 
alterations in the expression of TCDD-regulated genes, and altered signaling of 
the biologic pathways that interact with the AHR signal-transduction mechanism 
(Poland and Knutson, 1982; Safe, 1990; Schmidt and Bradfield, 1996; Whitlock, 
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1990). TCDD, 2,4,5-T, and 2,4-D were not mutagenic in Salmonella typhimurium 
with or without the addition of liver metabolic-activation enzymes (Blevins, 
1991; Mortelmans et al., 1984). TCDD-induced cytogenetic damage in laboratory 
mice showed no increase in the frequencies of sister-chromatid exchanges, chro-
mosomal aberrations, or micronuclei in the bone marrow cells of either C57Bl/6J 
or DBA/2J mice after the administration of a single high dose of TCDD—up to 
150 μg/kg (Meyne et al., 1985). TCDD did not alter the frequency or the spectrum 
of mutations in male and female Big Blue transgenic rats (Thornton et al., 2001). 
There is one report of a positive result with TCDD in a test that measured the 
induction of chromosomal deletions resulting from intra chromosomal recombina-
tion in mouse embryos in vivo (Schiestl et al., 1997). More recently, Scinicariello 
and Buser (2015) found associations of dioxin-like PCBs and dioxins (other than 
TCDD) with longer leukocyte telomere length. In that study, leukocyte telomere 
length asays were used to assess the effects of exposure to dioxin-like PCBs (126, 
169), PCDDs, and 1,2,3,4,6,7,8-heptachlorodibenzofuran. The study sample con-
sisted of 2,413 adults from the 1999–2002 cycle of National Health and Nutrition 
Examination Survey (NHANES). Lipid-adjusted PCBs, PCDDs, and PCDFs 
were measured for a randomly selected one-third of all NHANES subjects. Both 
individual values and TEQs were estimated. Multivariate linear regression was 
used to study associations between natural log-transformed leukocyte telomere 
length and persistent organic pollutant quartiles. Individuals in the 3rd and 4th 
quartiles of the sum of PCBs were associated with, respectively, 8.33% (95% 
confidence interval [CI] 4.08–13.88) and 11.63% (95% CI 6.18–17.35) longer 
leukocyte telomere length, compared with the lowest quartile, with an evidence of 
a dose–response relationship (p-trend < 0.01). Most of these effects were stronger 
in the non-dioxin-like congeners than in the dioxin-like congeners, which brings 
into question the direct relevance to the committee’s charge. No significant asso-
ciations were observed between leukocyte telomere length and the sum of PCDD; 
however, the congener 1,2,3,6,7,8-hexachlorodibenzo-p-dioxin was associated 
with a longer leukocyte telomere length. By TEQs, the highest quartiles of dioxin-
like and the TEQ PCBs were associated with 11.63% (95% CI 4.08–18.53) and 
6.18 (95% CI 1.01–11.63) longer leukocyte telomere length; both demonstrated a 
dose–response relationship (p < 0.01). This study suggests that telomere length 
may be influenced by exposure to dioxin and dioxin-like chemicals, however, the 
association between telomere length and disease is not well understood. 
In summary, although TCDD does have some genotoxic activity, the vast 
majority of studies did not detect mutagenic activity of TCDD in a variety of in 
vitro and in vivo short-term tests.
Epigenetic Activity
Chromosomes contain the genetic material of an organism and are com-
posed of both DNA and proteins called histones. Interactions between DNA 
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and histones regulate the accessibility of DNA to binding factors that activate or 
suppress gene transcription. This interaction is controlled by chemical modifica-
tions of the DNA (generally methylation of cytosine bases in cytosine–guanine 
dinucleotides or CpG sites) and histones (such as methylation, acetylation, sulfa-
tion, and ubiquitination), which are maintained by enzymatic processes. These 
modifications are considered “epigenetic” because they control the function of 
genes without changing the coding sequence. TCDD has been associated with 
epigenetic marks on the chromosomes, indicating that it could potentially be 
altering the function of numerous genes. Below is a brief summary of the epigen-
etic effects of TCDD. More detailed information about epigenetic mechanisms 
in general can be found later in this chapter, particularly concerning somatic 
modifications in an individual, and again in Chapter 8 with respect to effects that 
may affect offspring of an exposed organism.
The exposure of rodents to TCDD has been shown to result in the methyla-
tion of DNA in the adult rodents’ tissues—sperm, mammary tissue, liver, and a 
number of other solid tissues (Amenya et al., 2016; Papoutsis et al., 2013; Somm 
et al., 2013). The effects on DNA methylation were found to persist in rats for 
three generations following maternal exposure to 100 ng/kg TCDD and so could 
essentially be considered permanent and heritable (Manikkam et al., 2012a). As 
Ahr activation is generally considered necessary, but not sufficient, to induce ad-
verse biological responses, and the dose–response relationship for Ahr activation 
is generally quite steep, the relevance of high-dose rodent studies such as these to 
human “low-dose exposures” is not always clear. When Olsvik et al. (2014) fed 
female zebrafish TCDD in their diet prior to breeding, they found no change in 
the level of DNA methylation throughout the genomes of fish or their embryos, 
but altered methylation was identified by probes for the promoter regions of a 
number of specific genes, with corresponding marked elevations in the expression 
of CYP1A1 and CYP1B1 in the mothers and embryos (Olsvik et al., 2014). To 
date, however, there have not been publications reporting on the persistence of 
methylation or other epigenetic modifications in the offspring of males exposed 
to TCDD as adults. In vitro studies in cell lines have identified altered DNA 
methylation and expression in genes related to adipocyte differentiation following 
TCDD exposure (van den Dungen et al., 2017) and in CYP1A1 following PCB 
126 exposure (Vorrink et al., 2014).
Other Toxic Outcomes
Chloracne is a signature effect of high exposure to TCDD and dioxin-like 
chemicals in some species and in humans who are sensitive. There is an ex-
tensive body of evidence from experimental studies in animal model systems 
that TCDD, other dioxins, and several dioxin-like chemicals are immunotoxic 
(Kerkvliet, 2009, 2012;  Kreitinger et al., 2016). Although the available evidence 
on dioxin immuno toxicity in humans is scant, mechanistic considerations support 
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the suggestion that chemical alterations of immune function would cause adverse 
health outcomes because of the critical role that the immune system plays in gen-
eral  protection—fighting off infection and eliminating cancer cells at early stages. 
Because of those considerations, the chemicals are potential immunotoxicants.
Similarly, reproduction and embryonic development clearly are targets of 
TCDD (Chen and Chan, 2016), other dioxins, and dioxin-like chemicals; it 
is a consistent finding that the adverse effects are more prevalent during fetal 
development than in the adult. Data on the developmental effects of dioxin-like 
chemicals in humans have begun to emerge over the past 10 years (Mocarelli et 
al., 2008). Human and animal studies have revealed other potential health out-
comes, including cardiovascular disease, hepatic disease, thyroid dysfunction, 
lipid disorders, neurotoxicity, and metabolic disorders such as diabetes.
A number of effects of TCDD exposure in vitro appear to be independent 
of AHR-mediated transcription and, in at least one instance, perhaps indepen-
dent of AHR itself. Guo et al. (2004) showed that TCDD induced expression of 
transforming growth factor α and other genes involved in extracellular matrix 
deposition in cells from mice that had homozygous ablation of the Ahr gene. 
Studies have shown that TCDD can mobilize calcium from intracellular sources 
and increase calcium imported from the culture medium (Puga et al., 1995). 
Mitochondrial oxidative stress has been shown to be induced when calcium is mo-
bilized (Senft et al., 2002). Calcium mobilization by TCDD may have an important 
effect on signal-transduction mechanisms that control gene expression, inasmuch 
as several proto-oncogenes, such as c-fos, are activated by calcium changes.
Earlier VAO Update reports address the other toxic effects of TCDD in 
greater detail, including the relationship between human and animal-model sen-
sitivity to exposure.
Summary of Biologic Plausibility That TCDD 
Induces Adverse Effects in Humans
Mechanistic studies in vitro and in laboratory animals have characterized 
the biochemical pathways and types of biologic events that contribute to the 
adverse effects of exposure to TCDD. For example, much evidence indicates 
that TCDD, acting via AHR in partnership with ARNT, alters gene expression. 
Receptor binding may result in the release of other cytoplasmic proteins that 
alter the expression or activity of other cell-regulatory proteins. Mechanistic 
studies also indicate that many other cellular-component proteins contribute to 
the gene-regulatory effect and that the response to TCDD exposure involves a 
complex interplay between genetic and environmental factors. Comparative data 
from animal and  human cells in vitro and from tissues suggest a strong qualitative 
similarity among species in their response to TCDD, and this further supports the 
applicability to humans of the generalized model of initial events in response to 
dioxin exposure. 
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Biochemical and biologic responses to TCDD exposure are considered adap-
tive or simply reflective of exposure and not adverse in themselves if they take 
place within the normal homeostatic ranges of an organism; the exception to this 
is during development. However, they may exceed normal physiologic bound-
aries or constitute early events in a pathway that leads to damage in sensitive 
members of the population. In the latter case, the response is toxic and would 
be expected to cause an adverse health effect. Those qualitative generalizations 
about dose–response and individual variability are central to establishing biologic 
plausibility, which in the case of TCDD largely relies on extrapolation from ani-
mal studies to human risks. However, there are significant quantitative differences 
between responses in humans and rodents. Evidence from highly exposed human 
populations is an important means for corroborating biological plausibility. 
OVERARCHING TOXICOLOGIC ISSUES  
RELATED TO THE CHEMICALS OF INTEREST
Limitations of Extrapolating Results of Laboratory 
Studies to Human Responses
In some instances, the toxic responses identified in laboratory-animal and 
cell-culture studies are not detected in epidemiologic studies with human ex-
posure to the same chemicals. Although animal and cell-culture studies provide 
important links to understanding the biochemical and molecular mechanisms as-
sociated with toxicity induced by xenobiotics, many factors must be considered 
in extrapolating their results to human disease and disease progression. The fol-
lowing are key factors that might limit the ability of laboratory studies to predict 
human responses completely and accurately. 
• Magnitude and duration of exposure In many instances, animal and cell-
culture studies are conducted at higher exposures and for shorter durations 
than are typical in human exposures. For example, the concentrations of 
TCDD used in animal studies can be many times higher than was typical in 
the TCDD exposures of Vietnam veterans during their military service. In 
addition, TCDD is a persistent organic pollutant, and this results in  human 
exposure that occurs over a lifetime, whereas animal studies seldom exam-
ine chronic low-level exposures that occur over a  period of many months 
or years, except those that evaluate chronic toxicity or carcinogenicity. 
Animal studies that establish a measurement of body burden over a specific 
period provide the best potential for extrapolation to humans. 
• Toxicokinetics The toxicokinetics—absorption, distribution, metabolism, 
and excretion—of xenobiotics can differ sharply between laboratory ani-
mals and humans. As described previously, the biologic half-life of TCDD 
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varies from 8 to 29 days in rats and mice, while it is about 7 years in humans 
even though the drug-metabolizing enzymes—including cytochrome P450 
1A1, 1A2, and 1B1—are up-regulated or induced via TCDD-mediated 
activation of the AHR in both rat and human liver (Black et al., 2012).
• Timing of exposure Many organ systems are more susceptible to xe-
nobiotic exposure during critical stages of development, differentiation, 
or function—such as during gestation or in the face of another external 
challenge (for example, antigens, smoking, dietary salt, and fat)—than at 
other times. Therefore, the response of some systems (such as the immune 
or cardiovascular systems) may depend on the timing of exposure relative 
to the other challenges.
• Exposure composition Most animal and cell-culture studies involve ex-
posure to single chemicals or to a well-defined mixture, but most human 
exposures are to complex mixtures from multiple sources, so it is difficult 
to definitively attribute any observed effects to a particular component of 
the environment.
• Difference in AHR affinity The binding affinity of AHR for TCDD 
differs between species (discussed in Okey et al., 2005). Many of the 
strains of mice used for toxicologic studies harbor a high-affinity Ahr 
 allele (Ahrb), and these mice exhibit greater sensitivity to hepatic CYP1A 
induction, immunosuppression, birth defects, and other responses than 
do strains that carry the low-affinity allele (Ahrd). Such a simple allelic 
difference in AHR affinity has not been observed in humans, and the 
TCDD-binding affinity of the AHR found in most humans more closely 
resembles the low-affinity mouse Ahrd allele. Nonetheless, Nebert et al. 
(2004) reported that some people have TCDD-binding affinity that is 12 
times higher than that found in others. Thus, although humans are gener-
ally considered to be less sensitive on the basis of an AHR that has low 
TCDD-binding affinity, this assumption may not apply to everyone.
• Complex disease etiology and environment The etiology of human dis-
eases is highly influenced by genetics, environmental factors, and gene– 
environment interactions; these factors can be protective as well as deleterious. 
In addition to the COIs, the environmental factors that commonly influence 
human responses include diet, prescription and over-the-counter pharmaceu-
ticals, cigarette smoking, alcohol consumption, physical activity, the micro-
biome, and stress. Stress (not to be confused with oxidative stress) produced 
via known or unknown sources is a well-known modifier of human disease 
responses (for example, immune and cardiovascular responses). Further more, 
stress is an ever-present factor that is difficult to assess or control for in epide-
miologic studies because there is substantial individual variation in response 
to it (Cohen et al., 2007a). In contrast, laboratory studies are often conducted 
with inbred strains of animals and under tightly controlled experimental 
conditions, thus possibly underestimating or overestimating the potential 
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contribution of a single chemical exposure to disease development. On the 
other hand, direct cause-and-effect relationships are more easily established 
in animal studies because of their standardization.
• Sex differences There are well-known differences in susceptibility to xe-
nobiotic exposures between male and female animals, some of which are 
modified by sex steroids. For example, female Sprague Dawley rats are sig-
nificantly more responsive to the hepatotoxic (neoplastic and non-neoplastic) 
effects of TCDD than are males of the same strain (Kociba et al., 1978).
Epigenetics
Epigenetics, as previously noted, is the term used to describe the mechanisms 
that regulate gene expression and genomic stability but that involve no changes 
in DNA sequence. The epigenetic marks on DNA and bound histones are mitoti-
cally stable because they are maintained every time a cell divides. The totality of 
epigenetics marks in each cell, termed the epigenome, creates and maintains the 
identity and function of the cell type (Christensen and Marsit, 2011; Cortessis et 
al., 2012; Skinner et al., 2010).
Conrad Waddington used the term “epigenetics” in the 1940s to describe 
environment–gene interactions that alter biologic traits (Waddington, 1940, 1953, 
1956). It was not until the 1970s, however, that the first molecular epigenetic 
factor was described: DNA methylation, the chemical addition of a methyl group 
to DNA (Holliday and Pugh, 1975). In the 1980s, the role of DNA methyla-
tion in modifying gene expression—turning genes on and off—was established 
(Chen and Riggs, 2005). In the 1990s, the chemical modification of histone 
proteins associated with DNA was shown to also modify gene expression, thus 
establishing a second molecular epigenetic mechanism (Turner, 1998). In the 
early 2000s, various small noncoding RNA molecules were shown to regulate 
DNA activity (Sato et al., 2011). Around 2005, the first mapping of the yeast 
epigenome was conducted (Pokholok et al., 2005). Since that time, the mapping 
of cell-specific human epigenomes has accelerated under the National Institutes 
of Health’s  Epigenomics Roadmap and ENCODE Project, and more than 100 
human cell lines and tissues have been epigenetically characterized (Kundaje et 
al., 2015). The studies show that epigenetic marks act together in an exquisitely 
choreographed fashion to control cellular differentiation and the cellular ability 
to interact with, process, and initiate events and to respond to the signals and 
needs of the individual and local tissue environment. New National Institutes of 
Health efforts are under way within the Toxicant Exposures and Responses by 
Genomic and Epigenomic Regulators of Transcription Program to use mouse 
models of human relevant exposures to address the role of the environment in 
disease susceptibility as a function of changes to the epigenome, including TCDD 
and arsenic (T. Wang et al., 2018).
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Today, the processes recognized as epigenetic mechanisms are DNA meth-
ylation (Chen and Riggs, 2005; Holliday and Pugh, 1975), histone modification 
(Turner, 1998), alterations in chromatin structure (Murr, 2010), and modulation 
of expression by some small and long non-coding RNA molecules (Valeri et al., 
2009). DNA methylation is the addition of a methyl group onto specific nucleo-
tides. In mammals it occurs mostly at cytosine nucleotides that are adjacent to 
guanine nucleotides (CpG sites), but it can also occur at cytosine nucleotides 
followed by other bases in embryonic cells and brain cells (Lister et al., 2013). 
Methylation of DNA in the promoter region of the gene can reduce the expression 
of the adjacent gene. Other modulations of DNA include hydroxymethylation 
(which is prominent in stem cells and brain cells), formylcytosine, and carbox-
ylcytosine (X. Cheng et al., 2014; Song et al., 2013). Histones are the proteins 
that bind and form complex structures with DNA called nucleosomes in which 
DNA is wrapped around the histone core. The combination of DNA and histones 
is called chromatin. Chemical modifications of histones, such as methylation 
and acetylation, can alter the histone structure and modify gene expression by 
attracting protein complexes that can stimulate or repress transcription, in part by 
changing nucleosome spacing (Reid et al., 2009; Zhang and Pradhan, 2014). The 
influence of regulatory non-coding RNA including small interfering RNA and 
piwi-interacting RNA, as well as long non-coding RNA, on gene transcription is 
another field of epigenetic gene regulation that is now emerging. For example, 
recent findings suggest that micro-RNAs may be important regulators of cyto-
kines involved in T-cell polarization and the allergic response (Tay et al., 2014).
Small RNAs can elicit both epigenetic and non-epigenetic responses depend-
ing on whether they are inhibiting transcription via the RNA-induced initiation 
of transcriptional silencing (RITS) pathway (epigenetic) or degrading mRNA 
through RNA-induced silencing complex (RISC) complex (not epigenetic). For 
example, short antisense RNA transcripts are produced within the nucleus by the 
action of the enzyme Dicer, which cleaves double-stranded RNA precursors into 
21–26 nucleotide long RNA species (Matzke and Birchler, 2005; Verdel et al., 
2005). These then associate with silencing–effector complexes, such as RISC, 
which directs cleavage of cognate mRNA or causes translational repression and 
RITS, which mediates heterochromatin formation at target loci and abrogates 
gene expression (Verdel et al., 2005). Thus, regulation mediated by small non-
coding RNAs occurs both at the posttranscriptional and transcriptional levels. 
The latter transcriptional regulation is referred to as “epigenetic silencing,” and is 
mediated either by covalent modifications of chromatin (such as H3 methylation 
at Lys9) or by DNA methylation (Verdel and Moazed, 2005). 
The interaction of all those epigenetic processes creates the epigenome, 
which has a critical role in regulating gene expression (Christensen and Marsit, 
2011; Cortessis et al., 2012; Skinner et al., 2010). The variation that is possible 
in the epigenome is remarkable: The histone proteins that control chromatin 
configurations have dozens of possible modifications, and there are upwards of 
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50 million nucleotides in the DNA where methylation can occur and participate 
in regulating the cellular state. That implies that trillions of configurations of the 
epigenome are possible, although typically only about half of all genes are ex-
pressed in any given cell. Epigenetic marks are erased and re-established at two 
times during the life cycle—shortly after fertilization and during  gametogenesis—
to allow gamete-specific epigenomes to be converted to cell-specific epigenomes 
and vice versa (Dean, 2014).
Environmental epigenetics is the study of how environmental factors such 
as nutrition, toxicants, and stress alter epigenetic programming. In particular, 
epigenetics provides a molecular mechanism—other than mutations in the DNA 
itself—by which environmental factors can influence disease etiology (Jirtle 
and Skinner, 2007; Szyf, 2007). Epigenetics has been shown to have a role in 
the disease etiology of cancers and a number of other diseases (Christensen and 
Marsit, 2011; Cortessis et al., 2012; Skinner et al., 2010). In addition, exposure 
to environmental factors at critical times of development when epigenomes are 
shifting has the ability to alter epigenetic programming and cause changes in 
gene expression because these are times when epigenomes are evolving rapidly 
as stems cells differentiate into more mature cell types (Skinner et al., 2010). 
Hence, immune responses, fetal development, and gamete formation are impor-
tant examples of physiological processes whose functioning can be affected by 
environmentally induced epigenetic changes.
New investigative tools and a more refined understanding of the epigenetic 
process have given rise to active research on the nature of the relationship be-
tween environmental exposure to epigenetically active agents and the occurrence 
of diverse disease states, including cancers, reproductive-developmental prob-
lems, immune dysregulation, diabetes, obesity, and psychiatric illnesses (Brookes 
and Shi, 2014). The committee sought to review data on the potential relationship 
of the exposures of interest with adverse epigenetic effects in directly exposed 
veterans in an attempt to find evidence linking the exposures to disease processes 
that might have been mediated epigenetically. The committee also sought to re-
view relevant data on female veterans and male veterans separately inasmuch as 
the epigenetic consequences of exposures could be different, particularly in the 
case of adverse reproductive outcomes. Of note, possibly the greatest limitation 
to environmental epigenetic studies in human cohorts is access to the target tis-
sue of interest. Researchers rely on more accessible proxy tissues such as blood 
leukocytes, saliva, buccal cells, or placenta. A second consideration is that DNA 
methylation levels change as a function of age in both humans and animal models 
and that these age-related changes in methylation are gene- and tissue-specific, 
can be either random or predictable, and are thought to play a role in chronic 
disease development.
A relevant example within the COIs is that the in vitro exposure of preim-
plantation embryos to TCDD alters the DNA methylation of imprinted genes (Q. 
Wu et al., 2004). Imprinted genes are a unique category of genes in which only 
Veterans and Agent Orange: Update 11 (2018)
Copyright National Academy of Sciences. All rights reserved.
108 VETERANS AND AGENT ORANGE: UPDATE 11
one copy is expressed in a parent-of-origin specific manner, and imprinted genes 
are important for growth and development. Similar results to those of Q. Wu et 
al. were obtained more recently when several solid tissues and sperm DNA were 
analyzed in adult male mice exposed to TCDD in utero (Somm et al., 2013). In 
utero exposure to TCDD was also associated with altered DNA methylation and 
reduced expression of the BRCA1 (breast cancer) gene in mammary tissue in 
adult female offspring (Papoutsis et al., 2013). More generally, studies of the de-
velopmental origins of health and disease have shown that early-life exposures or 
environmental influences can be associated with the onset of disease much later in 
life (Barker et al., 2010). These early developmental alterations in the epigenome 
provide a molecular mechanism by which environmental exposures of female 
veterans can have effects on their children into adulthood. In humans, using data 
from the AHS, Rusiecki et al. (2017) evaluated high pesticide exposure events 
and altered DNA methylation in the blood of male pesticide applicators (n = 695). 
A candidate gene approach was used to investigate three gene promoters as well 
as the repetitive element LINE-1. Ever having had a high pesticide exposure 
event was associated with increased DNA methylation at the GSTp1 promoter, 
an effect that was more pronounced among applicators older than 59 years. High 
pesticide exposure events were also associated with decreased DNA methylation 
at the MGMT promoter among applicators older than 59 and in applicators with 
less than 16.6 ng/mL plasma folate.
Of note, there are almost no toxicological studies with animal models that 
have evaluated more than a single, and at times very high dose, of the COIs. The 
potential for epigenetic changes induced via TCDD in Vietnam veterans and their 
descendants remains uncertain until more dose–response studies are completed to 
determine if epigenetic effects are secondary to AHR activation or separate from 
AHR activation. If epigenetic responses are the result of downstream events fol-
lowing extensive and prolonged AHR activation, they may be irrelevant to expo-
sure scenarios that are inadequate to extensively induce AHR. On the other hand, 
if evidence demonstrates that TCDD can induce epigenetic changes at doses 
that cause no or minimal induction of AHR, it could well be the most important 
toxicological outcome to potentially occur in humans. There is precedent within 
the endocrine disrupting chemical literature for epigenetic alterations to have 
low-dose and non-monotonic effects, which are not necessarily linked to blocking 
or mimicking hormones, but may occur through other mechanisms such as oxida-
tive stress or direct interactions with any of the many epigenetic enzymes and 
co-factors necessary for epigenetic gene regulation (Tapia-Orozco et al., 2017).
Most epigenetic modifications occur in somatic cells and are heritable only 
within the altered cell line, thereby having the potential to generate effects in 
the exposed individual but not in that individual’s offspring. Other studies have 
found direct effects of exposures on the germline (e.g., sperm or oocytes), which 
can be multi-generationally transmitted to the next generation. The possibility 
exists, however, of epigenetic transgenerational inheritance, which involves the 
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environment promoting a stable alteration in the germline that is transmitted to 
later unexposed generations (Schmidt, 2013; Skinner, 2014; Skinner et al., 2010; 
Y. Wei et al., 2015). Manikkam et al. (2012b) showed that the exposure of preg-
nant female rats to TCDD at critical times of development of the germline (when 
epigenetic programming is being established) can lead to abnormalities in the 
third-generation offspring, including kidney disease and changes in the ovaries 
and sperm of the offspring. There are few data on possible male-mediated herita-
ble effects of TCDD or other environmental compounds. The sparse data include 
the results of studies of lead, a known developmental and neurologic toxicant. 
Lead exposure can alter semen quality in males (Alexander et al., 1996) and has 
been shown to induce paternally mediated developmental toxicity in rats (Anjum 
et al., 2011); this demonstrates that male-mediated effects on reproduction can 
be induced by reproductive toxicants. It has been suggested that environmental 
exposures can result in reduced fertility (Guerrero-Bosagna and Skinner, 2014; 
Paoloni-Giacobino, 2014). However, a serious need exists for additional study of 
the question, particularly of the effects of the COIs to this committee.
In summary, the ability of epigenetic mechanisms to regulate gene expres-
sion coupled with the interaction of the epigenome and the environment, includ-
ing multi- and trans-generational effects, might underlie the ability of xenobiotic 
exposure to contribute to disease development and the potential for offspring to 
inherit the effects of the disrupted epigenetic processes.
Developmental Immunotoxicity
A second emerging field in the biologic sciences that may provide insight 
into the mechanism of xenobiotic-induced disease is developmental immunotox-
icity, the study of the disruption of the developing immune system by xenobiotic 
exposure. The developing immune system is among the most sensitive physi-
ologic targets of prenatal and childhood environmental insult. The sensitivity is 
due, in part, to the novel processes of gene rearrangement, somatic-cell selection, 
and immune-cell distribution that are required to produce a security system that 
can effectively protect not only the child but also the aging adult from disease. 
To produce that security system, the immune system, as it matures, must coor-
dinate steps that result in highly specialized immune cells that are capable of 
self-versus-non-self recognition and that are tailored to the specialized functional 
environments of different tissues and organs (such as brain, lungs, skin, liver, gas-
trointestinal tract, and reproductive tract). A disruption of immune development 
can place the integrity of the organism at risk.
Among the known risk factors for developmental immunotoxicity are 
various chemicals including heavy metals, some pesticides, TCDD, industrial 
solvents such as trichloroethylene, and PCBs. The adverse outcomes of develop-
mental immunotoxicity may become apparent soon after exposure or can emerge 
much later in life (Gascon et al., 2013). Often, childhood or adult infections can 
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trigger the appearance of developmental immunotoxicity-associated immune 
problems that were established earlier in life (Dietert, 2009). Developmental 
 immunotoxicity-induced alterations can also contribute to myriad health prob-
lems related to dysfunction or pathologic conditions in virtually any tissue or 
organ. Chemicals, drugs, infectious agents, and physical and emotional stressors 
can act synergistically and increase the risk of developmental immunotoxicity. 
Not everyone is at identical risk for developmental immunotoxicity. People 
who have particular genotypes may be at increased risk for specific chemical-
induced developmental immunotoxicity on the basis of heritable factors that 
affect  metabolism or immune vulnerability.
The heightened sensitivity of the developing immune system is due to the 
existence of critical developmental windows of vulnerability during which en-
vironmental interference with key steps of immune maturation can change the 
entire course of immune development and result in later-life immune dysfunc-
tion and an increased risk of disease. The events programmed for these critical 
developmental windows have several basic features:
• They are necessary, usually one-time events of early development, with 
no equivalents in adults.
• They lock in building blocks on which additional maturational events rely.
• If they do not occur both on time and efficiently, the ramifications are 
usually profound, prolonged, and irreversible.
Examples of critical windows of immune vulnerability and the chemicals 
that can cause disruptions have been described in several reviews (R. Dietert and 
J. Dietert, 2008; R. Dietert and Piepenbrink, 2006; R. Dietert et al., 2000; Hessel 
et al., 2015; Holsapple et al., 2003; Landreth, 2002) and include
• The process of the seeding of immune cells in tissues where they grow 
into resident populations.
• The selection process of thymocytes in the thymus to distinguish nonself 
from self during the development of acquired immunity.
• The maturation of macrophage populations in the lung, in the brain, and 
elsewhere.
• The maturation of dendritic cells to provide balanced immune responses.
• The initial development, expansion, and seeding to the periphery of regu-
latory cell populations.
• Comparison with current tolerable daily intakes and their underlying 
overall no observed adverse effect levels showed that for some of the 
compounds, the tolerable daily intakes may need reconsideration based 
on developmental immune parameters.
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The increased sensitivity of the fetal, neonatal, and juvenile immune systems 
compared with the immune system of an adult can manifest itself as a sensitivity 
to lower doses of chemical exposure than the doses that affect the adult, a greater 
persistence of the immune problems that follow exposure than are seen in adults, 
a broader array of immune problems than are experienced by adults, and a greater 
likelihood that a second later-life chemical exposure or environmental stressor 
will trigger an unexpected immune problem (Rooney et al., 2008). It is also im-
portant to note, similar to epigenetic mechanisms discussed above, the relevance 
of single or high-dose animal model studies remains uncertain until more dose–
response studies are completed to determine if developmental immunotoxicity 
effects are secondary to AHR activation or separate from AHR activation.
Disruption of immune maturation is not the only route for developmental 
immunotoxicity. Early-life chemical exposure may affect the status of genes (the 
epigenome) in such a way that their pattern of expression in later life is affected 
and thereby alters immune functional capacity (J. Xu et al., 2016a). Such changes 
in gene status that affect immune status could occur in the exposed generation 
(for people exposed in utero or during childhood), or they could carry through 
one or more additional generations as a result of epigenetic alterations. 
MEDIATORS OF HEALTH OUTCOMES
Identifying and assessing the mediators of health outcomes, which are ef-
fectors in the pathway of exposure to disease and may contribute to disease 
progression, is essential for characterizing the impact of toxicant exposures on 
health outcomes. Such mediators include oxidative stress, the cytogenetic sta-
tus of cells, and factors that affect normal function and the development of the 
blood–brain barrier. 
Recently, the study of oxidative stress has emerged as a mechanism for 
investigating toxicity. Oxidative stress is classically defined as an imbalance in 
oxidant and antioxidant species within a system in which oxidant species are pre-
dominant (Lushchak et al., 2014). Although oxidative stress and exposure to toxi-
cants have been associated with many of the same health effects, they are rarely 
studied in parallel. For example, both oxidative stress and toxicant exposures 
have been associated with metabolic syndrome, insulin resistance, diabetes, obe-
sity, and cardiovascular complications (Bonomini et al., 2015; Lang et al., 2008). 
Using a longitudinal study of non-smoking Iowa corn farmers (n = 30) and 
non-farming controls (n = 10), Lerro et al. (2017) evaluated the effects of atrazine 
and 2,4-D exposures on three markers of oxidative stress in 225 samples col-
lected during five agricultural periods (pre-planting, planting, growing, harvest, 
and off-season). Farmers exhibited higher urinary levels of atrazine and 2,4-D 
than controls. 2,4-D exposure (but not atrazine exposure) was associated with 
elevated levels of 8-OHdG (a marker of oxidative damage) and 8-isoPGF (a 
marker of lipoprotein peroxidation). No effects on the oxidative stress biomarker 
Veterans and Agent Orange: Update 11 (2018)
Copyright National Academy of Sciences. All rights reserved.
112 VETERANS AND AGENT ORANGE: UPDATE 11
malondialdehyde were observed in either atrazine or 2,4-D. Thus, 2,4-D may 
induce oxidative stress and contribute to the pathogenesis of cancer and other 
chronic diseases.
Using the Prospective Investigation of the Vasculature in Uppsala Seniors 
(PIVUS) cohort, Kumar et al. (2014a) evaluated serum persistent organic pol-
lutants levels and several biomarkers of oxidative stress in 992 male and female 
subjects 70 years and older. Measurements included PCBs, organochlorine pes-
ticides, octachlorinated dibenzo-p-dioxin, and polybrominated diphenyl ethers, 
and TEQ values were calculated for dioxin and dioxin-like mono-ortho PCBs via 
the van den Berg method. Oxidative stress markers consisted of protein stress 
markers (e.g., homocysteine, GSH, GSSG), lipid stress (e.g., conjugated dienes), 
and total antioxidant capacity. Several PCBs showed a significant positive as-
sociation with oxidized low density lipoproteins (PCB 99, 138, 153, 156, 170, 
180, 194, 206, and 209). In multivariable-adjusted analyses, the sum of PCBs 
was positively associated with oxidized low density lipoproteins and negatively 
associated with glutathione-related markers. Other summary measures did not 
show any significant associations with oxidative stress markers.
Sycheva et al. (2016) studied the cytogenetic status of cells isolated from 
the buccal and nasal epithelium from a sample of cases (n = 26) and controls 
(n = 35) from a rural population in Vietnam. The cases were individuals living in 
dioxin-contaminated areas (TCDD in soil 2.6 ng/kg), and the controls were vil-
lagers living in an area with negligible contamination (TCDD in soil 0.18 ng/kg). 
A variety of cellular damage parameters were examined, and a small increase in 
cell death was found for both types of epithelial cells in males from the contami-
nated area, indicating that dioxins had a more pronounced effect and that years of 
residence and aging affected the results inversely. Thus, the increase in apoptosis 
could suggest a dioxin effect and serve as a marker for cellular damage generally. 
However, the small sample size and the lack of a dioxin association with oral 
or nasopharyngeal cancers limits the confidence with which conclusions can be 
drawn from this study.
There is increasing investigation into the mechanics of the interactions be-
tween TCDD (and dioxin-like chemicals) and the normal function and develop-
ment of the blood–brain barrier. Filbrandt et al. (2004) first demonstrated that 
TCDD was active in regulating gene expression in isolated murine cerebral 
vascular endothelial cells and astrocytes. X. Wang et al. (2011) demonstrated that 
TCDD exposure results in an increased expression and activity of several xenobi-
otic efflux transporters at the blood–brain barrier in rats and isolated capillaries in 
vitro. This has the potential to alter the delivery of drugs or endogenous chemi-
cals to the brain. Miyazaki et al. (2016) reported that exposure to TCDD during 
blood–brain barrier formation disrupts and impairs blood–brain barrier function 
in part by the suppression of glial cell derived neurotrophic factor action, which 
may contribute to the adverse effects of TCDD on the fetal central nervous sys-
tem. In a human cerebral microvascular endothelial cell line, Jacob et al. (2015) 
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did not observe a change in the expression or activity of two of the major efflux 
transporters in the human cerebral endothelium (ABCB1 and ABCG2) after ex-
posure to TCDD. In a second study using the same cell line, Jacob et al. (2017) 
demonstrated that TCDD exposure increased the levels of the pro-inflammatory 
cytokines IL-1β and IL-6, which could induce blood–brain barrier breakdown and 
contribute to the pathogenesis of a variety of neurologic disorders.
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5
Background on Selected Epidemiologic 
Studies and Populations
The process of updating the evidence base of possible health effects of the 
chemicals of interest (COIs)—2,4-dichlorophenoxyacetic acid (2,4-D); 2,4,5- 
trichlorophenoxyacetic acid (2,4,5-T) and its contaminant 2,3,7,8-tetrachlorodibenzo-
p-dioxin (TCDD); 4-amino-3,5,6-trichloropicolinic acid (picloram); and dimethyl 
arsenic acid (DMA or cacodylic acid)—has involved the evaluation and integration 
of thousands of epidemiologic publications over successive reports. The search 
strategy used to identify these publications, along with refinements that have been 
made since the initial volume of the series was prepared, are described in Chapter 3.
In addition to reviewing studies involving exposures to the specific COIs, 
the current and previous Veterans and Agent Orange (VAO) committees have 
considered studies that examined compounds chemically related to the herbi-
cides used in Vietnam, such as 2-(2-methyl-4-chlorophenoxy) propionic acid, 
hexachlorophene, and chlorophenols, particularly 2,4,5-trichlorophenol. If a pub-
lication did not specify the herbicides or polychlorinated biphenyls (PCBs) with 
dioxin-like actions to which study participants were exposed or the magnitude 
of exposure, those limitations were considered when weighing the evidence of 
each publication. The committee considers studies of exposure to PCBs and other 
dioxin-like chemicals informative if their results were reported in terms of TCDD 
toxic equivalents (TEQs) or concentrations of specific congeners of dioxin-like 
chemicals. The details of the exposure assessments conducted within individual 
studies are presented in this chapter, whereas generic issues of exposure assess-
ment are discussed in Chapter 3 along with the special challenges involved in 
characterizing and reconstructing the herbicide exposures of Vietnam veterans.
This chapter presents study design and other important methodologic in-
formation on populations of Vietnam veterans, occupational cohorts, and 
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environmentally exposed groups that have been reported on repeatedly, often 
for many health outcomes, as well as on case-control studies that have generated 
multiple epidemiologic publications relevant to the VAO series. This integrative 
approach has been taken to avoid repeating design information in multiple health-
outcomes chapters and to make evident to the reader the extensive degree of 
interrelationship among many of the published analyses that have been reviewed 
in the course of the VAO series. If new results are based on updating information 
from or adding subjects to previously studied populations or use a subset of the 
original study population, then this synthesis considers the redundancy among 
studies while recognizing that separately reported information can impart new 
relevance to other data on a study population. Such clusters of studies are useful 
in describing the course of a population’s response to an exposure, and joint con-
sideration of an entire body of research on a population may yield insights into 
relationships with potential confounding factors. The various study designs have 
strengths and weaknesses that influence the evidentiary weight that they contrib-
ute, and these factors are addressed in the health-outcomes chapters. One-time 
reports on a study population that addressed only a single health outcome are not 
described in this chapter, but instead are described and critiqued in the sections 
of the report that discuss the results related to that particular health outcome.
Many of the cohorts that have contributed to the cumulative findings of the 
VAO committees, occupational cohorts in particular, are no longer being followed. 
For completeness, these cohorts are mentioned briefly in this chapter and, where 
relevant, in the body of this report. Additional detailed background information on 
them is available in the earlier volumes of the series. This chapter is intended to 
give a brief overview of those major cohorts and studies that have contributed to 
the evidence base of potential health outcomes that stem from exposure to the COIs 
and for which new information has become available on the incidence or preva-
lence of disease and other health outcomes since Update 2014. It is not intended 
to be a compendium of every study or population ever reviewed in the VAO series.
Many groups potentially exposed to the COIs have been monitored periodi-
cally, including the cohorts of the International Agency for Research on Cancer 
(IARC) and the National Institute for Occupational Safety and Health (NIOSH); 
residents of Seveso, Italy; and Ranch Hand and Army Chemical Corps (ACC) 
personnel who served in Vietnam. Discussions of the specific cohorts in this 
chapter include references both to publications discussed in previous VAO reports 
and to new publications. In drawing its conclusions, the committee combined the 
evidence in new publications and the evidence synthesized from Update 2014, 
taking into account the interdependence of related publications.
Individual researchers who belong to the research consortia that are evaluat-
ing cohorts in large multicenter studies (such as the IARC and NIOSH cohort 
studies) sometimes publish reports based on subsets of study participants who 
they themselves are monitoring. VAO committees consider all published re-
ports, including those based on entire cohorts and those based on subcohorts. 
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In drawing its conclusions, the committee factored in both types of studies, taking 
into consideration the interdependence among related studies. In particular, some 
subcohort studies have access to information not available for the entire cohort, 
such as data on individual serum TCDD concentrations and personal information 
that can be used to adjust for additional confounders. Furthermore, in the case 
of analyses based on an entire cohort that include data from a subcohort as a 
subset, using the reports on the subcohort as part of the evaluation might provide 
additional information on the consistency of the relationships among subcohorts, 
such as whether there are important subcohort-by-exposure interaction effects 
that were not considered in the full-cohort analysis. As long as the design and 
analysis methods of the study populations are recognized, VAO committees have 
been less concerned about over-weighting unstable positive findings based on 
small subgroups or giving “repeated consideration” to duplicative results than 
they would have been if a quantitative meta-analysis were being undertaken.
The chapter is organized to present the study populations in the order that 
roughly reflects the importance attributed to the data generated (Vietnam  veterans, 
occupationally exposed workers, and people who have been environmentally ex-
posed). It begins with Vietnam veterans and first covers studies conducted in the 
United States by the Air Force, the Centers for Disease Control and Prevention 
(CDC), the Department of Veterans Affairs (VA), and other groups, before describ-
ing studies of veterans from other countries (particularly Australia, New Zealand, 
and South Korea) who served in Vietnam. The section “Occupational Studies” 
covers studies of workers who, through employment or other work (other than 
military service), were exposed to the COIs and dioxin-like chemicals, including 
production workers, agriculture and forestry workers (including herbicide and pes-
ticide applicators), and other groups (e.g., sawmill and paper and pulp  workers). 
Again, studies of U.S. workers are presented before those of international cohorts. 
The section “Environmental Studies” covers studies of populations exposed to 
the COIs and dioxin-like chemicals from non-occupational sources and includes 
assessments of the general population, such as the National Health and Nutrition 
Examination Survey (NHANES), and also assessments of people who had unusu-
ally high exposures because of war-related or industrial sources in their residential 
neighborhoods (such as the residents of southern Vietnam; suburban Taichung, 
Taiwan; and Chapaevsk, Russia) or accidents (such as Seveso, Italy, and the Yusho 
poisoning in Western Japan). The chapter ends with a section that addresses the 
publications that are based on repeatedly mentioned case-control study popula-
tions; the case-control studies that assessed Vietnam-veteran status, however, are 
included in the section on veteran studies, and nested case-control studies are 
presented along with the cohorts from which they were derived.
Because of the breadth of literature reviewed in this chapter, Figure 5-1 pro-
vides the reader with a comprehensive overview of the individual study popula-
tions that have been reviewed in the course of the VAO series, although not all of 
these populations are discussed in this chapter or even in this volume.
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Vietnam Veterans
U.S. Department of Veterans Affairs
U.S. Air Force Health Study
Other U.S. Vietnam-Veteran Studies
Australian Vietnam-Veteran Studies
New Zealand Vietnam-
Veteran Studies
Korean Vietnam-Veteran Studies
IARC Cancer Phenoxy
Herbicide Cohort
IARC Subcohort of Workers
Other International (non-IARC)
Subcohorts of Workers
Studies of Other Industrial Cohorts
Studies of Herbicide-Using Workers
U.S. National Health and
Examination Nutrition Survey
Other U.S. Environmental
Studies
Seveso, Italy, Industrial Accident
International Environmental
Studies
Birth Cohort Studies
Canadian Studies
U.S. Studies
U.S. National Institute for
Occupational Safety and Health
Studies (NIOSH)
Occupational Studies
Herbicide
Production
Workers
Herbicide-Using
Workers
Environmental Studies
Case-Control Studies
U.S. Centers for Disease Control and
Prevention
FIGURE 5-1 Overview of the individual study populations reviewed in the VAO series. 
 continued
Veterans and Agent Orange: Update 11 (2018)
Copyright National Academy of Sciences. All rights reserved.
BACKGROUND ON SELECTED EPIDEMIOLOGIC STUDIES AND POPULATIONS 119
*Army Chemical Corps
*National Vietnam Veterans Readjustment Study
*Birth Defects Study
*American Legion Study
*Australian Vietnam Veterans
*Australian Conscripted Army National Service
*TCDD Concentrations in Korean Vietnam Veterans
*Other Studies of Korean Vietnam Veterans
*Austria  *Denmark  *Germany  *Great Britain  *Netherlands  *New Zealand
*NIOSH PCP Cohort
*NIOSH TCDD Mortality Cohort:
*BASF Ludwigshafen Plant (Germany)
*Waste Incineration (Japan, Korea)
*Sawmill Workers (Canada, New Zealand)
*Other Chemical Plants (Croatia, Germany, Italy, Russia, United Kingdom, United States)
*US: Agricultural Health Study, California United Farm Workers of America Study
*International Herbicide Users: *Argentina  *Australia  *Canada  *Denmark  *Finland  *Germany  *Iceland
*India  *Italy  *Mexico  *Netherlands  *New Zealand  *Norway  *Sweden
*Anniston, AL Community Health Survey
*Salinas Mothers and Children Cohort *Longitudinal Investigation of Fertility and the Environment Study
*Seveso Full Cohort *Seveso Women’s Health Study
Country-specific Environmental Studies: *Belgium  *Brazil  *Canada  *China  *Denmark  *Finland  *France
*Germany  *Greece  *Hong Kong  *Italy (other than Seveso)  *Japan  *Korea  *Netherlands  *Nicaragua
*Norway  *Russia  *Spain  *Sweden  *Taiwan  *Vietnam
*Danish Fetal Origins 1988–1989 Cohort  *Norwegian Mother and Child Cohort Study
*Duisburg (Germany) Birth Cohort  *Hokkaido (Japan) Study on Environment and Children’s Health
*Other birth cohorts and mother-child pair studies in Belgium, Denmark, Netherlands, Taiwan, and Vietnam
*Cross-Canada Study of Pesticides and Health
*National Birth Defects Prevention Study  *Upper Midwest Health Study
*Times Beach and Quail Run Cohort *Iowa Women’s Health Study
*Automobile Foundry Workers (China)
*Paper and Pulp Cohorts (United States, Finland, Denmark, IARC)
*Czechoslovakia
*Monsanto Mortality Study *Dow Herbicide Production Workers
*NIOSH Cross-Sectional Medical Study
*Korean Vietnam Veterans Health Study
*Birth Defects in Australian Infants
*Australian Vietnam Veterans Family Study *Sample of 1,000 Veterans
*State-specific studies
*Agent Orange Validation Study *Vietnam Experience Study *Selected Cancers Study
*Female Vietnam Veterans *Proportionate Mortality *VE-HEROeS *Other VA Studies
FIGURE 5-1 Continued
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VIETNAM-VETERAN STUDIES
Studies of Vietnam veterans who might have been exposed to herbicides, 
including Agent Orange, have been conducted in the United States at the national 
and state levels and in Australia, South Korea, and New Zealand. Exposures have 
been defined in various ways, and health outcomes have been evaluated with 
reference to various comparison or control groups. This section is organized 
primarily by research organization or sponsor because it is more conducive to a 
methodical presentation of the studies. The means by which herbicide or dioxin 
exposures were characterized varies from the individually specified exposures of 
Ranch Hand and ACC personnel, as reflected in serum TCDD measurements, to 
the use of service in Vietnam as a surrogate for TCDD exposure in some studies.
Several comparison groups have been used for veteran cohort studies: Vietnam 
veterans who were stationed in areas where herbicide-spraying missions were 
unlikely to have taken place; Vietnam-era veterans who were in the military at 
the time of the conflict but did not serve in Vietnam; veterans who served in other 
wars or conflicts, such as the Korean War and World War II; and various state and 
national populations. In all of the studies of Vietnam veterans, whether or not the 
study participants were American, the study participants were the target popu-
lation of the committee’s charge, and they were assumed to have had a higher 
probability of exposure to the COIs than people who did not serve in Vietnam, 
regardless of whether there was any information on individual exposures beyond 
the mere fact that they were deployed to Vietnam.
The studies in the publication period considered in the present update ex-
amined a range of health outcomes among Vietnam veterans with service history 
from the United States as well as those from New Zealand. These included new 
analyses of the Air Force Health Study cohort (AFHS) (Landgren et al., 2015; 
Mazur et al., 2013, 2014), ACC personnel (Cypel et al., 2016), several publica-
tions from VA Medical Centers (Krishnamurthy et al., 2016; Nosrati et al., 2014; 
Ovadia et al., 2015), and a 20-year hospitalization study of New Zealand Vietnam 
veterans (Cox et al., 2015).
Air Force Health Study
Reports and findings from the AFHS have provided important information 
that has been incorporated throughout the VAO series, including the current vol-
ume, and it continues to be considered an important cohort in the committee’s 
assessment of the overall evidence of exposure to the COIs and health outcomes. 
Active data collection from this cohort was completed in 2002, but VAO commit-
tees have remained interested in reviewing additional publications that provide 
longitudinal analysis of the vast amount of information assembled or that make 
use of the collection of preserved biologic samples. As yet, the few new published 
findings have been disease specific and not always focused on the effects of 
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exposure to the herbicides, but have grouped all participants to examine outcomes 
related to aging (IOM, 2015).
Major defoliation activities in Vietnam were conducted by Air Force person-
nel as part of Operation Ranch Hand. Veterans who took part in the defoliation 
activities became the first subpopulation of Vietnam veterans to receive special 
attention with regard to herbicide exposure and have become known as the Ranch 
Hand cohort within the AFHS. To determine whether exposure to herbicides, 
including Agent Orange, had adverse health effects on these veterans, the Air 
Force made a commitment to Congress and the White House in 1979 to conduct 
an epidemiologic study of Ranch Hand personnel (AFHS, 1982). The study 
protocol had three components: a retrospective mortality study, a retrospective 
morbidity study, and a 20-year prospective follow-up study with longitudinal data 
and biospecimens collection. Details on the mortality and retrospective morbidity 
arms can be found in prior reports (IOM, 2006b, 2015). The prospective study 
arm has been the focus of multiple reports on a variety of health outcomes in the 
cohort as well as new research using these assets.
Prospective Study Design and Data Collection
Records from the National Personnel Records Center and the Air Force 
 Human Resources Laboratory were searched and cross-referenced to identify all 
Ranch Hand personnel (AFHS, 1982; Michalek et al., 1990). The exact number 
of Ranch Hands varies among published reports, depending on the time frame 
of identification, but the most widely used estimate is 1,242, which reflects the 
number who served in Vietnam and who were not killed in action. Ultimately, 
however, not all of those who have been identified actually participated in the 
AFHS (some were deceased before the study began, others were unlocatable, and 
a small number refused to participate) (IOM, 2015). A comparison population of 
24,971 C-130 crew members and support personnel who served in the U.S. Air 
Force between 1962 and 1971 and were assigned to duty in Southeast Asia but 
who were not occupationally exposed to tactical herbicides (AFHS, 1983, 1984a) 
was selected from the same data sources. Each Ranch Hand was matched to a pool 
of 8 to 10 comparisons, who were selected based on the first living and compliant 
person randomly selected from the individual-level pool. Individual comparison 
participants remained associated with their matched Ranch Hand for the duration 
of the study, but those who died, dropped out, or were lost to follow-up were 
replaced with the next best comparable control who was living and agreed to 
participate (AFHS, 1982). Comparison participants were individually matched for 
age, type of job (differentiated into five categories: officer/pilot, officer/navigator, 
officer/other, enlisted/flight engineer, and enlisted/other), and race (white or not 
white) to control for possible differences in the development of chronic disease 
that may relate to age, race, or educational and socioeconomic status (AFHS, 
1984a). To control for the many potential confounders related to the physical and 
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psycho-physiologic effects of combat stress and the Southeast Asia environment, 
Ranch Hands were matched to control participants who performed similar combat 
or combat-related jobs (AFHS, 1982). Comparisons were assumed to be similar to 
the Ranch Hands regarding lifestyle, training profiles, and socioeconomic factors. 
Although not representative of the U.S. population, the sample was diverse in 
terms of socioeconomic status and educational background (IOM, 2015).
The prospective follow-up consisted of six comprehensive exams that began 
with the baseline exam in 1982 and occurred thereafter in years 3, 5, 10, 15, and 
20 of the study (the final physical exam was conducted in 2002 and final analysis 
for the formal AFHS study was completed in 2006). Morbidity was ascertained 
through comprehensive questionnaires and accompanying physical examination, 
which included more than 200 laboratory and clinical tests (although the number 
and type of laboratory tests performed at each physical examination changed 
over time, reflecting changes in science and technology). Questionnaire data 
included information relating to demographics; employment; child and family 
health; health habits; recreation, leisure, and physical activities; toxic exposures; 
military experience; and wartime herbicide exposure. Data collected during the 
physical examinations included indices of health status that encompassed general 
health and endpoints by major organ system. Additional sources of data col-
lected in the course of the AFHS included medical records from the participants’ 
physicians, dentists, and other health providers; vital status records, such as 
birth and death certificates; information on the participants’ families, including 
spouses and children who were under 18 years old at the time of the exam; and 
military administrative records that contained duty station orders, flight records, 
performance reports, awards and decorations, and discharge documents (IOM, 
2015). The number of Ranch Hand and comparison participants who completed 
the questionnaire and physical exam differed at each follow-up. In all, 2,758 
individuals participated in at least one exam cycle.
Over the course of the AFHS, more than 91,000 unaliquoted biospecimens 
were collected as part of the physical exam component. The number of samples 
varied by type of specimen, participant, and cycle. Although some samples were 
collected as part of the laboratory testing and work-ups, additional biospecimens 
samples were collected from study participants at each exam cycle and preserved 
to be used for future analyses. Serum and urine were collected longitudinally 
across multiple cycles, while semen and whole blood were collected at a single 
exam cycle. Adipose tissue was collected from a subset of individuals at one 
exam cycle. To obtain samples for a TCDD assay carried out by the CDC on 777 
Ranch Hand and 1,174 matched comparisons, a separate blood draw was per-
formed during cycles 3–6 (see discussion on estimating exposure in the cohort, 
below). Multiple blood samples were drawn for a subset of the population for use 
in dioxin biological half-life and other studies.
Results have been published for baseline morbidity (AFHS, 1984a) and 
baseline mortality (AFHS, 1983) and for reproductive outcomes (AFHS, 1992; 
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Michalek et al., 1998a,c; Wolfe et al., 1995). Mortality updates have been pub-
lished for 1984–1986, 1989, and 1991 (AFHS, 1984b, 1985, 1986, 1989, 1991b). 
An interim technical report updated cause-specific mortality in Ranch Hands 
through 1993 (AFHS, 1996). Michalek et al. (1998b) and Ketchum and Michalek 
(2005), respectively, reported on 15-year and 20-year follow-ups of post-service 
mortality in the Ranch Hand veterans, updating an earlier cause-specific mortality 
study by Michalek et al. (1990). Many analyses presented in the voluminous re-
ports on the follow-up examinations of 1984, 1987, 1992, 1997, and 2002, which 
are cited as AFHS (1987, 1990, 1995, 2000, 2005), have been deemed not useful 
for the purposes of the VAO reviews because they were limited to comparisons 
of data on those in the cohort who were still alive and participated in a particular 
examination.
Exposure Estimation
As described in Chapter 2, the results of biologic-marker studies of Ranch 
Hand personnel have been consistent with their being exposed, as a group, to 
TCDD. When the Ranch Hand cohort was classified by military occupation, a 
higher level of serum TCDD was detected in people whose jobs involved more 
frequent handling of herbicides (AFHS, 1991a). The exposure index initially 
proposed in the AFHS relied on military records that documented spraying mis-
sions of TCDD-containing herbicides (Agent Orange, Agent Purple, Agent Pink, 
and Agent Green) as reported in the Herbicide Reporting System tapes for the 
period starting in July 1965. For exposure before July 1965, exposure information 
would be based on military procurement records and dissemination information. 
In 1991 the record-based exposure index was compared with the results of the 
Ranch Hand serum-TCDD sampling conducted on personnel at least 10 years 
after their service in Vietnam. The exposure index and the TCDD serum levels, 
which the authors referred to as body burden, correlated weakly.
Blood samples for use in determining serum TCDD concentrations were 
drawn at the periodic examinations conducted in 1982 (cycle 1) from 36 Ranch 
Hands (Pirkle et al., 1989), in 1987 (cycle 3) from 866 Ranch Hands (AFHS, 
1991a), in 1992 (cycle 4) from 455 Ranch Hands (AFHS, 1995), and in 1997 
(cycle 5) from 443 Ranch Hands (AFHS, 2000). For veterans whose TCDD 
was not measured in 1987 but was measured later, the later measurement was 
extrapolated to 1987 by using a first-order kinetics model with a constant half-
life of 7.6 years.
Michalek et al. (1995) developed several indexes of herbicide exposure of 
members of the Ranch Hand cohort and tried to relate them to the measurements 
of serum TCDD from 1987 to 1992. Self-administered questionnaires completed 
by the Ranch Hand veterans were used to develop several indexes of herbicide or 
TCDD exposure: the number of days of skin exposure, the percentage of skin area 
exposed, and the product of the number of days of skin exposure, the percentage 
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of skin exposed, and a factor for the concentration of TCDD in the herbicide. A 
fourth index, which used no information gathered from individual study partici-
pants, was calculated by multiplying the volume of herbicide sprayed during a 
person’s tour of duty by the concentration of TCDD in herbicides sprayed in that 
period and then dividing the product by the number of crew members in each 
job specialty at the time.
Each of the four indexes tested was significantly related to serum TCDD con-
centrations, although the models explained only 19% to 27% of the variability in 
serum TCDD concentrations. Days of skin exposure had the highest correlation. 
Military job classification (for example, Ranch Hand combat troops, Ranch Hand 
administrators, Ranch Hand flight engineers, and Ranch Hand ground crew), 
which is not included in any of the four indexes, explained 60% of the variability 
in serum TCDD. When the questionnaire-derived indexes were applied within 
each job classification, days of skin exposure added statistical significance, but 
not substantially, to the variability explained by job alone.
Ranch Hands were divided into three categories on the basis of their potential 
exposure:
• Low potential. Pilots, copilots, and navigators. Exposure was primarily 
through preflight checks and spraying missions.
• Moderate potential. Crew chiefs, aircraft mechanics, and support person-
nel. Exposure could occur by contact during de-drumming and aircraft 
loading operations, onsite repair of aircraft, and repair of spray equipment.
• High potential. Spray-console operators and flight engineers. Exposure 
could occur during operation of spray equipment and through contact with 
herbicides in the aircraft.
At times, other metrics of exposure were also applied. For example, rank was 
used as a surrogate of exposure because officers (pilots, copilots, and navigators) 
were unlikely to handle the herbicides.
Pavuk et al. (2014) analyzed serum concentrations of TCDD and dioxin-like 
chemicals (i.e., polychlorinated dibenzo-p-dioxins [PCDDs], poly chlorinated 
dibenzofurans [PCDFs], and PCBs) from samples collected in 2002 from 777 
Ranch Hand and 1,173 comparison subjects. In addition, the results were com-
pared with serum samples from 436 age- and gender-matched adults from the 
NHANES research initiative. The main findings showed that median serum 
TCDD levels were more than two times higher in the Ranch Hand veterans than 
in either the AFHS comparison veterans or the NHANES comparison group. 
However, the absolute values of serum TCDD levels, as well as the group differ-
ences in median serum TCDD levels, were substantially lower than results from 
prior serum samples collected in 1987. For the other dioxin-like chemicals, the 
concentrations in 2002 were similar in all three groups. These data demonstrate 
the unique TCDD signature experienced from herbicide exposure in Vietnam and 
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indicate that, over time, the elimination rate is higher than the ongoing intake rate 
from background exposure to TCDD in both groups of AFHS veterans.
Analyses of the serum TCDD readings were included in the 1987 examina-
tion report (AFHS, 1991a). Other Ranch Hand publications have addressed the 
relationship between serum TCDD and reproductive hormones (Henriksen et al., 
1996); diabetes mellitus, glucose, and insulin (Henriksen et al., 1997); skin disor-
ders (Burton et al., 1998); preterm birth and infant death (Michalek et al., 1998a); 
sex ratios (Michalek et al., 1998c); skin cancers (Ketchum et al., 1999); insulin, 
fasting glucose, and sex-hormone-binding globulin (Michalek et al., 1999a); im-
munologic responses (Michalek et al., 1999b); diabetes mellitus (Longnecker and 
Michalek, 2000; Steenland et al., 2001); cognitive function (Barrett et al., 2001); 
hepatic abnormalities (Michalek et al., 2001b); peripheral neuropathy (Michalek 
et al., 2001c); hematologic results (Michalek et al., 2001a); psychologic function-
ing (Barrett et al., 2003); correlations between diabetes and TCDD elimination 
(Michalek et al., 2003); thyroid function (Pavuk et al., 2003); cancer incidence 
(Akhtar et al., 2004; Pavuk et al., 2005); insulin sensitivity (Kern et al., 2004); 
prostate cancer (Pavuk et al., 2006); serum testosterone and the risk of benign pros-
tate hyperplasia (Gupta et al., 2006); and diabetes and cancer incidence (Michalek 
and Pavuk, 2008).
The tendency of the AFHS researchers to use different cutpoints and popu-
lation definitions for analogous analyses suggests that they used an a posteriori 
selection that may have influenced the results. For example, Michalek and Pavuk 
(2008) allude to the commonly held assumption that Agent Orange was more 
heavily contaminated earlier in the war as the motivation for making various 
temporal partitions in their analyses, but the choices were not consistent among 
studies. With respect to the development of cancer, service in 1968 or earlier was 
considered to have been in the critical exposure period, whereas for diabetes, 
the critical exposure period was considered to be 1969 or earlier. Additionally, 
the construction of low- and high-exposure variables based on “days of spray-
ing” was done differently for cancer than it was diabetes. Days of spraying were 
grouped into 30-day blocks for cancer, and into blocks of 90 or more days for 
diabetes.
Impact of the AFHS on VAO Reviews
Ostensibly, the AFHS was designed to answer exactly the question that the 
VAO series is asking: Is exposure to the herbicides used during the Vietnam 
War associated with long-term health outcomes or outcomes in the offspring of 
exposed veterans? The AFHS is perceived by many to be the central piece of re-
search for decision making by the VAO committees because it used longitudinally 
collected data and objective, quantifiable measures of TCDD exposure through 
serum samples, on a population that was directly exposed to the COIs in the 
Vietnam theater. Unlike many other studies of Vietnam veterans, data on alcohol 
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use and smoking status were collected and included in the analysis when they 
were known risk factors for the outcome of interest. However, the AFHS also has 
important limitations that all VAO committees have had to consider.
Although the study was carefully designed to match Ranch Hand and com-
parison subjects to minimize bias to the extent possible, the AFHS population 
is likely not representative of the entire population of Vietnam veterans, so its 
findings might not be generalizable to all Vietnam veterans. The 1987 TCDD 
serum assay found the comparison subjects to also have elevated levels of TCDD, 
although the exposure was significantly higher in the Ranch Hand group than 
in the comparison group. Therefore, the comparison is not an ideal exposed-
versus-unexposed comparison but rather a high-exposure-versus-low-exposure 
comparison (IOM, 2006b, 2015). The exposure in the comparison group might 
also make the study findings vulnerable to bias toward the null if the difference 
in exposures between the AFHS group and the comparison group was not large 
enough to allow an association between exposure and outcome to be detected. 
That problem does not affect the validity of positive findings, however. Similarly, 
for AFHS analyses that used non-AFHS Vietnam veterans as the comparison 
group, those individuals might also have been exposed to the COIs, which would 
likewise influence results toward the null.
The AFHS might be underpowered for detecting small effects, especially 
rare outcomes, because of its relatively small sample size. Therefore, its findings 
are vulnerable to false negatives (failure to detect an important association). This 
also raises questions about the stability of positive findings; this is somewhat less 
of a problem if the findings are repeated over examination cycles, although the 
results of the examination cycles themselves are not fully independent repetitions.
Three new studies have been published using AFHS data since Update 
2014. In the first study, Landgren et al. (2015) used data and serum samples 
from 479 Ranch Hands and 479 comparison veterans to examine the associa-
tion between  serum TCDD levels and the presence of monoclonal gammopathy 
of  undetermined significance (MGUS). After the model had been adjusted for 
several demographic and clinical factors, Ranch Hands were found to have a 
2.4-fold increased risk for MGUS. This study is the first to correlate an objec-
tive measurement of levels of TCDD exposure with MGUS and additional detail 
of it is found in Chapter 7. The second study used AFHS data from 991 AFHS 
participants to examine the relationship between testosterone levels and the 
levels of fasting glucose and, therefore, a diagnosis of type 2 diabetes (Mazur et 
al., 2014). The authors found that low testosterone levels in men were an inde-
pendent risk factor (comparable to aging and obesity) for high fasting glucose 
and, therefore, that testosterone was a weak predictor of a diagnosis of type 2 
diabetes. In a second publication based on AFHS data, Mazur et al. (2013) used 
data from the same 991 AFHS subjects to examine the relationship of obesity to 
individual and population-level declines in testosterone. Over 20 years of follow-
up, mean testosterone levels declined at least twice as much as would have been 
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expected from cross-sectional estimates of the decline usually associated with 
aging. However, because neither of the Mazur studies considered exposure status 
or TCDD levels in the analysis, these studies were not considered to be relevant 
to the committee’s charge even though they were conducted using AFHS data.
Department of Veterans Affairs
Army Chemical Corps Cohort
Analyses of members of the ACC were conducted by VA, whose other re-
search efforts on Vietnam veterans are discussed together below. Like the Ranch 
Hand personnel, ACC personnel performed chemical operations involving the 
direct handling and distribution of herbicides, but instead of using planes, they 
performed these tasks on the ground and by helicopter in Vietnam. Nearly 1,000 
men serving in ACC units were deployed to Vietnam between 1966 and 1971. 
ACC members were responsible for the storage, preparation (handling and mix-
ing), and application of herbicides, tear gas, and napalm among other chemicals. 
ACC units were also tasked with cleaning and maintenance of the equipment used 
to prepare and apply the chemicals (Thomas and Kang, 1990). Because the ACC 
personnel were expected to have been highly exposed to herbicides, VAO com-
mittees recommended studying this important group of Vietnam veterans (IOM, 
1994) and later encouraged the publication of the study’s findings (IOM, 2005). 
The availability of serum TCDD concentrations in a subset of this cohort of 
Vietnam veterans has made its findings particularly useful in appraising possible 
associations with various health outcomes. The primary strengths and limitations 
of the ACC studies are similar to those of the AFHS.
ACC service members were belatedly identified using morning reports for 
all ACC units known to have been assigned to Vietnam between 1966 and 1971 
for a study of health effects and mortality related to herbicide exposure (Thomas 
and Kang, 1990). However, the findings of increased risk of certain outcomes, 
such as digestive diseases, were based on small numbers of cases and cannot 
be associated with particular exposures since serum samples or other objective 
measures of exposure were not collected. In an extension of that study, Dalager 
and Kang (1997) compared the mortality of ACC veterans who deployed to 
Vietnam with the mortality of those who did not. For that study, ACC veterans 
were identified using a combination of the same morning reports for ACC units 
stationed in Vietnam as used by Thomas and Kang (1990), Defense Manpower 
Data Center tapes of Vietnam-era Army personnel with a military occupational 
specialty code indicating a chemical operations position between 1971 and 1974, 
and class rosters for chemical courses conducted at the Army Chemical School at 
Fort McClellan, Alabama, from 1965 to 1972. Analyses compared cause-specific 
mortality among Vietnam-deployed ACC men (n = 2,872) and those who never 
deployed to Southeast Asia (n = 2,737), and also compared each group to the 
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standardized U.S. population. Because all men who served in ACC units were 
stationed at Fort McClellan for at least some time, and Fort McClellan is in close 
proximity to Anniston, Alabama, where Monsanto operated a plant that produced 
PCBs, all ACC veterans were likely exposed to at least low levels of these and 
other chemicals. Therefore, comparisons using deployed and non-deployed ACC 
men are likely to be biased toward the null due to this baseline of increased ex-
posure, but this bias is not the case for analyses that used the standardized U.S. 
population as the comparison group. 
The results of an initial feasibility study that measured serum dioxin levels 
in a subset of Vietnam-deployed and nondeployed ACC veterans were reported 
by Kang et al. (2001). The researchers recruited 565 veterans: 284 Vietnam vet-
erans and 281 non-Vietnam veterans as controls. Blood samples were collected 
in 1996 from 50 Vietnam veterans and 50 control veterans, and 95 of the samples 
met CDC standards of quality assurance. A comparison of both groups showed 
that the geometric mean TCDD concentrations did not differ between groups 
(p = 0.6). The 50 Vietnam-deployed veterans were then stratified into those who 
sprayed herbicides and those who did not, based on self-reported information. 
The sprayers had higher TCDD concentrations than those who reported no spray-
ing activities. The authors concluded that Agent Orange exposure was a likely 
contributor to TCDD concentrations in Vietnam veterans who had a history of 
spraying herbicides.
Following the 2001 feasibility study Kang et al. (2006) reported the findings 
from the larger study of this population of ACC veterans. A health survey was 
administered by telephone to 1,499 Vietnam-deployed veterans and 1,428 non-
Vietnam-deployed veterans. Exposure to herbicides was assessed by analyzing 
serum specimens from a sample of 897 veterans for dioxin. Consistent with the 
findings from the feasibility study, veterans who reported spraying herbicides 
had significantly higher TCDD serum concentrations than veterans who did not 
report herbicide spraying.
Having determined the vital status—that is, whether an individual was alive 
or had died—of the ACC personnel through 2005, Cypel and Kang (2010) pre-
sented results on mortality from the following causes: cancers (oral and pharyn-
geal, digestive, respiratory, prostate, testicular, skin, brain, and lymphopoietic 
[leukemia]), diabetes, circulatory conditions (hypertension and cerebrovascular), 
respiratory conditions (pneumonia, influenza, and chronic obstructive pulmonary 
disease), and cirrhosis of the liver. The study compared 2,872 ACC personnel 
who served in Vietnam with 2,737 ACC personnel who did not serve in Vietnam, 
using survival analysis that controlled for race, age at entry into follow-up, 
rank, and duration of military service. It also compared 662 ACC personnel who 
served in Vietnam and reported spraying herbicides with 811 who did not serve in 
Vietnam and did not report spraying herbicides, controlling for additional covari-
ates of body mass index (BMI) and smoking status obtained in the telephone 
survey. Mortality in both cohorts was also compared with the expected mortality 
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in U.S. males. Concerns were raised over the lack of adjustment for smoking 
status in the analysis of respiratory diseases in Vietnam-deployed veterans and 
non-Vietnam-deployed veterans. (The subcohort analyses that compared sprayers 
with nonsprayers were adjusted for smoking status.)
In a new study of ACC veterans, Cypel et al. (2016) analyzed the results of 
a 2013 survey of 3,086 ACC veterans that compared prevalence of self-reported, 
physician-diagnosed hypertension in both Vietnam-deployed and non-Vietnam-
deployed herbicide sprayers and non-sprayers. This study, which is reviewed in 
Chapter 10, reports that the mean serum TCDD level in ACC Vietnam-service 
sprayers was 4.3 parts per trillion (ppt) (lipid based) as compared with a mean 
level of 9.5 ppt in AFHS participants.
U.S. Female Vietnam Veterans Cohort
Although estimates have varied, the most recent estimates from VA are 
that 7,500 U.S. women served in Vietnam between August 1964 and May 1975 
(VA, 2017a). The vast majority of them served as combat nurses—mostly in the 
Army Nurse Corps—but some also served in the Women’s Army Corps and the 
Air Force, Navy, and Marine Corps (Spoonster-Schwartz, 1987; Thomas et al., 
1991; VA, 2017a).
In 1986, Public Law (PL) 99-972 was enacted. It required that an epide-
miologic study be conducted to examine the long-term adverse health effects 
on female Vietnam veterans who had exposure to traumatic events, exposure 
to herbicides such as Agent Orange or other chemicals or medications, or any 
other related experience or exposure during such service. The first study that VA 
conducted to assess mortality in female Vietnam veterans was by Thomas et al. 
(1991). No comprehensive record of female personnel who served in Vietnam 
in 1964–1972 existed, so the researchers gathered military service data from 
each branch of the armed forces through December 31, 1987. Female Army and 
Navy personnel were identified from morning reports and muster rolls of hospi-
tals and administrative support units where women were likely to have served. 
Military personnel were identified as female by their names, leaving open the 
possibility that some women may have been inadvertently excluded from the 
analysis. Women who served in the Air Force and Marine Corps were identified 
through military records. The combined roster of all female personnel from the 
military branches was considered by the researchers to be generally complete. 
A comparison group of female veterans was identified through the same process 
as the women who served in Vietnam but the comparison group had not served 
in Vietnam during their military service. Demographic information and infor-
mation on overseas tours of duty, unit assignments, jobs, and principal duties 
were abstracted from military records. Mortality information was obtained from 
VA’s Beneficiary Identification Records Locator Subsystem, the Social Security 
 Administration, the Internal Revenue Service, the National Death Index (NDI), 
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and military personnel records. Women whose service in the military fell outside 
the period of interest, whose records were missing data, or who served in South-
east Asia but not in Vietnam were excluded. The analysis included 132 deaths 
among 4,582 female Vietnam veterans and 232 deaths among 5,324 comparison 
veterans who served in the military from July 4, 1965, to March 28, 1973, which 
was when combat operations occurred. Cause-specific mortality was derived for 
both groups of veterans and compared with mortality in U.S. women with adjust-
ments for race, age, and calendar period. Dalager et al. (1995a) updated mortality 
in the original cohort through December 31, 1991, using the same study protocol 
as Thomas et al. (1991). After updating the mortality figures and adjusting the 
existing cohort on the basis of new information about the study groups based on 
the inclusion criteria, an additional 4 Vietnam-deployed veterans and 1 compari-
son veteran were included in the final study population (Dalager et al., 1995a).
Updates of mortality among women Vietnam veterans have been published 
periodically. Cypel and Kang (2008) conducted a mortality study of female vet-
erans who deployed to Vietnam, comparing them with a control group of women 
veterans matched on rank and military occupation who were in the military at 
the same time period but who were not deployed to Vietnam. Kang and col-
leagues (2014a) updated total and cause-specific mortality analyses of female 
U.S. Vietnam-era veterans through December 31, 2010, using the same sources 
to determine vital status as were used by Thomas et al. (1991) and Dalager et 
al. (1995a). For deaths that occurred before 1992, the cause of death was ascer-
tained from official death certificates. For deaths occurring on or after January 
1, 1992, cause-of-death information was obtained from NDI Plus, which codes 
the cause of death by the International Classification of Diseases (ICD) system. 
The underlying causes of death were formally assigned by a qualified nosologist. 
This mortality update was structured as a retrospective cohort study consisting 
of three study groups of female veterans who served during the Vietnam era us-
ing the same dates as Thomas et al. (1991) and Dalager et al. (1995a). The first 
group included 4,734 female veterans who served in Vietnam, the second group 
consisted of 2,062 female veterans who served near Vietnam, and the third group 
included 5,313 female veterans who did not deploy outside of the United States. 
Mortality comparisons were made using either the non-deployed U.S. cohort or 
women of the U.S. general population, adjusted for age, race, and calendar year, 
as the reference group. Of the total sample of 12,109 female veterans, 2,743 
(23%) were deceased by the study end date of December 31, 2010, and the cause 
of death was available for 96.2% of the deaths. The adjusted total mortality and 
heart-disease-specific rates were lower in the female Vietnam veterans than in the 
U.S. Vietnam-era female veterans or in the U.S. general population. The cancer 
mortality rate was approximately equal between the female Vietnam veterans 
group and both the U.S. cohort of female veterans and the U.S. general popula-
tion. When the analysis was constrained to nurses only (approximately two-thirds 
of the study cohort), higher adjusted mortality rates for pancreatic, brain, and 
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other nervous system cancers were reported for the female Vietnam veterans. 
Whereas all reports from the female U.S. Vietnam-veteran cohort provide direct 
information on the health and mortality status of female military personnel who 
served in Vietnam, the limitations of the results must be kept in mind. Specifi-
cally, female veterans likely experienced low herbicide exposure because they 
were not involved in applying herbicides or engaged in direct combat, and their 
in-country tours of duty were generally limited to 1 year and at fixed locations 
that were not in proximity to known defoliated areas. In summary, this analysis 
does not provide evidence of a higher risk of total or cause-specific mortality in 
female Vietnam-deployed veterans compared with non-deployed female Vietnam 
veterans and the U.S. general population. The suggestion of higher rates of mor-
tality from pancreatic, brain, and other nervous system cancers among Vietnam 
nurse veterans should be cautiously interpreted, given the study’s limitations and 
the large number of causes of mortality examined.
VA also published studies of pregnancy outcomes and gynecologic cancers—
namely, neoplasms of the cervix, uterus, and ovary—in U.S. female Vietnam vet-
erans (Kang et al., 2000a,b). Army veterans were identified from a list obtained 
by the Army and Joint Services Environmental Support Group; computerized 
lists were also provided by the Air Force, Navy, and Marine Corps. Military-
service data were abstracted from personnel records. Of 5,230 eligible veterans, 
4,390 with a documented tour of duty in Vietnam were alive on January 1, 1992. 
From a pool of 6,657 women whose military units did not serve in Vietnam, 
4,390 veterans who were alive on January 1, 1992, were randomly selected as 
controls. After the research group excluded 250 veterans and 250 nonveterans 
who participated in a pilot study as well as those who could not be located 
(n = 370), who were deceased (n = 339), or who declined to participate (n = 775, 
13% of Vietnam veterans and 17% of non-Vietnam veterans), 6,430 women 
completed a full telephone interview, and another 366 women completed only 
a short, written questionnaire. The information collected included demographic 
background, general health, lifestyle, menstrual history, pregnancy history, preg-
nancy outcomes, and military experience, including nursing occupation and 
combat exposure. Informa tion on pregnancy risks and complications—including 
smoking,  infections, medications, exposure to X-rays, occupational history, and 
exposure to anesthetic gases, ethylene oxide, herbicides, and pesticides—was 
collected for each pregnancy. In Kang et al. (2000a), for each woman veteran, 
the first pregnancy following the beginning of Vietnam service was designated as 
the index pregnancy. For the comparison group, the first pregnancy after July 4, 
1965, was designated as the index pregnancy. The study analyzed data on 3,392 
Vietnam and 3,038 non-Vietnam veterans and on 1,665 Vietnam and 1,912 non-
Vietnam veteran index pregnancies. In Kang et al. (2000b), a self-reported history 
of  gynecologic cancers (defined by the authors as cancers of the breast, ovary, 
uterus, and cervix) was collected. The authors attempted to “retrieve hospital 
records on all reported cancers as far back as 30 years.” Of records successfully 
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found, 99% of the breast cancer and 90% of all cancer diagnoses were confirmed. 
The authors did not provide specific data on diagnosis confirmation for the three 
sites other than the breast, but they stated that Vietnam status was not associated 
with a greater likelihood of finding confirmatory medical records.
After the publications by Kang et al. (2000a,b), Congress passed PL 106-419, 
which provides compensation for the children of female Vietnam veterans who 
are born with birth defects unrelated to an existing familial disorder, to a birth-
related injury, or to a fetal or neonatal infirmity with a well-established cause. The 
legislation covers 18 birth defects, including cleft lip or palate, congenital heart 
disease, hypospadias, neural-tube defects, and Williams syndrome. A complete 
list of covered birth defects can be found in 38 CFR 3.815.
Proportionate-Mortality Cohort
Among the earliest reports on health outcomes in Vietnam veterans was 
a proportionate-mortality study by Breslin et al. (1988). The participants were 
Army and Marine Corps ground troops (all men) who served at any time from 
July 4, 1965, through March 1, 1973. A list of 186,000 Vietnam-era Army and 
Marine Corps veterans who were reported deceased as of July 1, 1982, was as-
sembled from VA’s Beneficiary Identification Records Locator Subsystem. From 
this list, 75,617 individuals were randomly selected for inclusion in the study. The 
information extracted from the selected military records included duty stations, 
dates of tours, branch of military service, date of birth, sex, race, military oc-
cupation specialty codes, education level, type of discharge, and confirmation of 
service in Vietnam. Additional information was extracted on veterans who served 
in Southeast Asia, including the first and last dates of service in Southeast Asia, 
the military unit, and the country where the veteran served. For the final sample 
of Army and Marine Corps veterans, the cause of death was ascertained from 
death certificates or Department of Defense (DoD) Report of Casualty forms for 
24,235 men who served in Vietnam and 26,685 men who did not serve in South-
east Asia. Each veteran’s cause of death was coded by a nosologist who used 
ICD-8. Exposue to herbicides or other environmental factors was not considered 
in the analysis. Deaths from external causes (accidents, poisonings, and violence) 
were slightly eleveated among Vietnam veterans who served in the Army but 
not among marines who served in Vietnam. Death from any cancer was elevated 
among marines who served in Vietnam but not Army veterans. When examined 
by type of cancer, proportionate mortality ratios were not elevated for Army 
veterans, but proportionate mortality ratios for lung and non-Hodgkin lymphoma 
(NHL) were elevated among the Marine Corps veterans.  
Using the proportionate-mortality cohort assembled by Breslin et al. (1988), 
Burt et al. (1987) conducted a nested case-control study of NHL with controls 
selected from among the cardiovascular-disease deaths. Although unrecognized 
at the time of that publication, using cardiovascular deaths as the control group 
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biased estimates of NHL toward the null because some cardiovascular diseases, 
such as hypertension, are associated with exposure to herbicides, see Chapter 10. 
When all Army and Marine Corps veterans who were deployed to Vietnam were 
compared with veterans who did not serve in Vietnam, no excess of mortality 
from NHL was found. When stratified by service branch and age, only marines 
with combat roles or who served in Vietnam from 1967 to 1969 (when herbicide 
spraying was greatest) had statistically significant increased odds of death from 
NHL. In a follow-up of the Breslin et al. (1988) study, Bullman et al. (1990) 
compared cause-specific proportionate mortality of 6,668 Army I Corps Vietnam 
veterans, who served in the northernmost part of South Vietnam in a combat zone 
designated as Military Region I by the U.S. military, with 27,917 Army Vietnam-
era veterans who had not served in Vietnam. The subjects studied by Bullman 
et al. included the study population identified by Breslin et al. and an additional 
9,555 Army Vietnam-era veterans whose deaths were identified after VA’s Ben-
eficiary Identification Records Locator Subsystem database was searched for 
mortality data through December 31, 1984. Deaths from external causes (ac-
cidents, poisonings, and violence) were found to be slightly eleveated among 
Army I Corps Vietnam veterans, particularly deaths attributed to motor vehicle 
accidents and accidental poisonings. Similarly, Watanabe et al. (1991) updated 
the Vietnam-veteran mortality experience reported by Breslin et al. (1988) by ex-
tending the follow-up from January 1, 1982, to December 31, 1984. An additional 
11,325 deceased Army and Marine Corps Vietnam-era veterans were identified 
from the period and included in the study. The study population for Watanabe 
et al. consisted of 62,068 military veterans, of whom 29,646 served in Vietnam 
and 32,422 never served in Southeast Asia. Proportionate-mortality ratios were 
calculated for three referent groups: branch-specific (Army and Marine Corps) 
non-Vietnam veterans, all non-Vietnam veterans combined, and the U.S. male 
population. Deaths from external causes were again statistically significantly 
elevated among Vietnam-deployed marines compared with non-Vietnam veterans 
and Army veterans who served in Vietnam compared with Army veterans who 
did not serve in Vietnam and all non-Vietnam veterans. Cancer of the larynx was 
statistically significantly higher among Vietnam-deployed Army veterans than 
either non-Vietnam Army veterans or all non-Vietnam veterans but lung cancer 
was only significantly different for Army Vietnam veterans compared with all 
non-Vietanm veterans. Deaths from lung cancer, NHL, and Hodgkin disease were 
all statistically significantly elevated for Marine Corps veterans who had served 
in Vietnam compared with marines who had not served in Vietnam only. A third 
follow-up proportionate-mortality study (Watanabe and Kang, 1996) used the vet-
erans from Breslin et al. (1988) and Watanabe et al. (1991) and included an addi-
tional 9,040 randomly selected Vietnam-era veterans who died from July 1, 1984, 
through June 30, 1988. The final study included 70,630 veterans—33,833 who 
had served in Vietnam and 36,797 who had never served in Southeast Asia. The 
analyses were performed using the same referent groups described in Watanabe 
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et al. (1991). Just as in the previous analyses of mortality, Army and Marine 
Corps Vietnam veterans had statistically significant excesses of deaths from 
external causes. Army Vietnam veterans had statistically significant excesses 
of deaths for laryngeal cancer and lung cancer when compared to both Army 
non-Vietnam veterans and all non-Vietnam veterans. Results showing statistical 
significance for Marine Corps Vietnam veterans varied according to the referent 
population used (non-Vietnam marine veterans or all non-Vietnam veterans). 
When compared with non-Vietnam marine veterans, marine Vietnam veterans 
had significantly elevated proportionate mortality ratios for deaths from NHL, 
Hodgkin disease, and cancers of the pancreas, lung, and skin. Deaths from 
circulatory diseases were statistically significantly lower among Marine Corps 
Vietnam veterans than marines who did not serve in Vietnam and all non-Vietnam 
veterans. Marine Corps Vietnam veterans also had significant excesses for lung 
cancer and skin cancer compared with all non-Vietnam veterans. Proportionate 
mortality ratios for deaths due to respiratory and digestive diseases were statisti-
cally significantly lower among marine Vietnam veterans than all non-Vietnam 
veterans. Compared with the standardized U.S. population, deaths from many 
of the major categories of organ systems were statistically significantly lower 
among both the Vietnam-deployed and non-deployed veterans. However, can-
cers overall were higher among the Vietnam-deployed and non-deployed Army 
veteran groups and the Marine Corps non-Vietnam veteran group. Lung cancer 
deaths were significantly higher among both Army veteran groups and the Marine 
Corps Vietnam-deployed group compared with the U.S. population. Using the 
U.S. population for comparison, proportionate mortality ratios were statistically 
significantly higher for prostate cancer in Army non-deployed veterans and skin 
cancer for Marine Corps veterans that served in Vietnam. 
National Vietnam Veterans Readjustment and Longitudinal Studies
In response to concerns about the health and well-being of Vietnam veter-
ans, in 1983 Congress passed PL 98-60, which directed VA to contract for an 
independent national study looking at the frequency and effects of posttraumatic 
stress disorder (PTSD) and related postwar psychological issues. In 1984 the con-
tract for the National Vietnam Veterans Readjustment Study was awarded to the 
Research Triangle Institute (RTI). Several publications resulted from that work 
(Currier and Holland, 2012; Schlenger et al., 2015a; Yager et al., 2016) but given 
the focus on mental health, most are not relevant to the VAO series.
In 2000 Congress passed PL 106-419, which directed VA to contract for a 
follow-up study, the National Vietnam Veterans Longitudinal Study, to determine 
the effects of PTSD over a 25-year period and postservice adjustment. The study 
was awarded to Abt Associates (VA, 2018b). A total of 1,450 veterans partici-
pated in at least one of the study phases of the National Vietnam Veterans Longi-
tudinal Study, which included a self-administered paper health questionnaire, 
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a computer-assisted telephone health interview, and a telephone mental health 
interview conducted by a professional clinical interviewer (Marmar et al., 2015). 
Results from this second effort have been recently published (Marmar et al., 
2015; Schlenger et al., 2015b, 2016; Steenkamp et al., 2017). But because the 
focus of this research is mental health outcomes, the results are not considered 
by VAO update committees. The data collected from veterans who participated in 
both the National Vietnam Veterans Readjustment Study and the National Viet-
nam Veterans Longitudinal Study are now part of the National Vietnam Veterans 
Longitudinal Study Registry, which was acquired in 2015 and is housed at VA’s 
Seattle Epidemiologic Research Information Center in Seattle, Washington (VA, 
2018a). However, as noted previously, VAO committees do not consider mental 
health conditions in their review of health outcomes of Vietnam veterans.
Most recently, VA has undertaken a new research initiative to assess the 
current health of Vietnam veterans who served on the ground, Blue Water Navy 
veterans, and veterans who served elsewhere during the Vietnam Era (1961–1975). 
The Vietnam Era Health Retrospective Observational Study (VE-HEROeS) is 
designed to compare the overall health, lifestyle characteristics, and aging-related 
conditions of these veterans with similarly aged U.S. residents who never served 
in the military. The committee invited the lead investigator, Dr. Victoria Davey, to 
discuss the project. The study was designed to compare a retrospective cohort of 
Vietnam veterans, with all service branches represented, with Vietnam-era veter-
ans who were deployed to countries other than Vietnam, Cambodia, or Laos and 
with members of the U.S. general population who never served in the military. 
Recruitment was based on a sampling frame that was constructed to be a randomly 
selected sample of persons from VA’s database of all veterans (both users of VA 
health care or benefits and those not using VA services). The questionnaire col-
lected information on the following topics: military service (combat experience, 
chemical and other exposures, re-entry into civilian life, or no military service), 
general health (neurologic conditions, infections, presumptive conditions, cancer, 
hypertension, and mental health conditions), experience with aging, lifestyle fac-
tors (tobacco use, health care use, living arrangements), and health experiences of 
descendants (nine questions on birth defects and other conditions of children and 
grandchildren). A medical records review is being conducted of a small subset of 
participants (n = 4,000) to validate the questionnaire information (Davey, 2017). 
The data are being analyzed, and although some abstracts and posters containing 
a few findings have been submitted to VA research and outside conferences, no 
results had been published in the peer-reviewed literature as of January 31, 2018.
Other VA Studies
VA also conducted studies that focused on specific health outcomes, using 
data from VA’s Agent Orange Registry, a computer database containing health 
information on Vietnam veterans who voluntarily undergo examinations in a 
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VA hospital. This registry was established in 1978 to monitor health complaints 
or problems of Vietnam veterans that potentially could be related to herbicide 
exposure during their military service in Vietnam, but it was not intended to be 
a research program (Dick, 2015). The registry was established also as a means 
to facilitate increased access of Vietnam veterans to the VA health care system. 
Veterans are eligible to participate if they had any active military service in the 
Republic of Vietnam between 1962 and 1975 and express a health concern re-
lated to herbicide exposure. Beginning in 2011, eligibility has been expanded to 
include veterans who served along the Korean Demilitarized Zone between 1968 
and 1971, veterans who served in certain units in Thailand, and veterans who 
were involved in the testing, transporting, or spraying of herbicides for military 
purposes (Dick, 2015). The examinations that these veterans undergo consist of 
an exposure history (based on self-reports that are not verified by DoD records), 
a medical history, laboratory tests if indicated, and an examination of the organ 
systems most commonly affected by toxic chemicals. The quality, consistency, 
and usability of data from this registry—and indeed from all registries with 
voluntary participation that rely on self-reported information—are limited. As of 
July 6, 2017, this registry contained information on 676,774 veterans who had un-
dergone an initial examination and there had been 79,846 follow-up evaluations, 
for a total of 756,620 examinations (VA, 2017b). Some VA investigators have 
used participation in the registry as a surrogate of herbicide exposure (Clemens 
et al., 2014; Nosrati et al., 2014; Ovadia et al., 2015).
Other VA analyses have relied on self-reported exposure to herbicides (Beard 
et al., 2016, 2017; Krishnamurthy et al., 2016; Le et al., 2016; Q. Li et al., 2013). 
Two other VA studies (Baumann Kreuziger et al., 2014; Mescher et al., 2018) de-
termined exposure to Agent Orange (or presumably other herbicides) by review-
ing claims of exposure submitted by veterans that were reviewed by VA benefits 
and compensation officers who used service records to confirm that locations and 
timeframes of deployment corresponded to sprayed areas.
VA has evaluated specific health outcomes, including carrying out case-control 
studies of soft-tissue sarcoma (STS) (Kang et al., 1986, 1987), NHL (Dalager 
et al., 1991), Hodgkin lymphoma (HL) (Dalager et al., 1995b), testicular cancer 
(Bullman et al., 1994), and lung cancer (Mahan et al., 1997). Each study created 
and applied a different measure of surrogate herbicide exposure because objective 
measures, such as serum TCDD analyses, were not available. Other VA  studies 
included a post-service mortality analysis (separate from the proportionate mor-
tality cohort) of marines that compared those who served in Vietnam (n = 10,716) 
with Vietnam-era marines (n = 9,346) (Watanabe and Kang, 1995), and a small 
case-control study that compared dioxin and dibenzofuran concentrations in the 
adipose tissue of 36 Vietnam veterans and 79 non-Vietnam veterans and a sample 
of U.S. men born in 1936–1954 (Kang et al., 1991). All tissue samples were 
archived specimens from the EPA’s National Human Adipose Tissue Survey and 
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had been collected by hospitals and medical examiners from men who died from 
external (non-combat) causes or surgical procedures.
VA has examined other outcomes in Vietnam veterans: PTSD (Bullman et al., 
1991; Goldberg et al., 1990; True et al., 1988), suicide and motor-vehicle crashes 
(Bullman and Kang, 1996; Farberow et al., 1990), tobacco use (McKinney et al., 
1997), and self-reported physical health (Eisen et al., 1991). The studies have 
been included for completeness, but the outcomes that they address are outside 
the purview of this committee. VAO and Update 1998 discussed them in detail; 
most did not deal with exposure to herbicides specifically, and the exposure to 
“combat” was evaluated as the risk factor of interest. As noted VA has also initi-
ated a study to update the mortality experience of Vietnam veterans. This update 
is expected to update the rates, causes, and patterns of overall and cause-specific 
mortality from 1979 through 2014 of all Vietnam veterans compared with all 
Vietnam-era veterans and the general U.S. population (Davey, 2017).
Centers for Disease Control and Prevention Studies
Surveys of U.S. Vietnam veterans who were not part of the Ranch Hand or 
ACC groups indicated that 25% to 55% believed they were exposed to herbicides 
(CDC, 1989b; Erickson et al., 1984a,b; S. D. Stellman and J. M. Stellman, 1986). 
Several attempts have been made to estimate the exposures of Vietnam veterans 
who were not part of the Ranch Hand or ACC groups. CDC has undertaken a 
series of studies to examine various health outcomes in Vietnam veterans as 
directed by Congress in the Veterans Health Programs Extension and Improve-
ment Act of 1979 (PL 96-151) and the Veterans’ Health Care, Training, and Small 
Business Loan Act of 1981 (PL 97-72). The first of these CDC studies was a 
case-control interview study of birth defects in the offspring of men who served 
in Vietnam, which included developing an exposure opportunity index to score 
herbicide exposure (Erickson et al., 1984a,b).
Agent Orange Validation Study
The CDC Agent Orange study (CDC, 1985) was initiated in response to a 
1983 request by the U.S. government to conduct a study of possible long-term 
health effects in Vietnam veterans exposed to herbicides. The study attempted 
to classify veterans’ service-related exposures to herbicides by determining the 
proximity of troops to herbicide spraying through the use of military records 
to track troop movement and the use of the HERBS tapes1 to locate herbicide-
spraying patterns.
1 The HERBS tapes were a digital record of herbicide spray missions compiled by the Department of 
Defense in the early 1970s. Information on them is presented in the original VAO report (IOM, 1994).
Veterans and Agent Orange: Update 11 (2018)
Copyright National Academy of Sciences. All rights reserved.
138 VETERANS AND AGENT ORANGE: UPDATE 11
In 1987, CDC conducted the CDC Agent Orange Validation Study to test 
the validity of the various indirect methods used to estimate the exposure of 
ground troops to herbicides in Vietnam. The study measured serum TCDD in a 
non-random sample of Vietnam veterans and in Vietnam-era veterans who did not 
serve in Vietnam (CDC, 1988b). Vietnam veterans were selected for the study on 
the basis of the number of herbicide exposure events that they were thought to 
have experienced, based on the number of days their unit was within 2 kilometers 
and 6 days of a recorded herbicide-spraying event. Blood samples were obtained 
from 66% of 646 Vietnam veterans and from 49% of the eligible comparison 
group of 97 veterans. More than 94% of those whose serum was obtained had 
served in one of five battalions.
The median serum TCDD concentration in Vietnam veterans in 1987 was 
4 ppt (range: < 1 to 45 ppt, but only two veterans had concentrations above 
20 ppt). The “low” exposure group consisted of 298 Vietnam veterans, the 
“ medium” exposure group 157 veterans, and the “high” exposure group 191 
veterans. The distribution of TCDD measurements was nearly identical to that 
in the control group of 97 non-Vietnam veterans. The CDC validation study 
concluded that study participants could not be distinguished from controls on the 
basis of serum TCDD. In addition, neither record-derived estimates of exposure 
nor self-reported exposure to herbicides could predict which Vietnam veterans 
would have high serum TCDD at the time of the study (CDC, 1988b, 1989a). The 
report concluded that it was unlikely that military records alone could be used 
to identify a large number of veterans who might have been heavily exposed to 
TCDD in Vietnam. The serum TCDD measurements in Vietnam veterans also 
suggested that the exposure to TCDD in Vietnam was substantially lower, on 
average, than that of persons exposed as a result of the industrial explosion in 
Seveso, Italy,  or that of the heavily exposed occupational workers who have been 
the focus of many of the studies evaluated by VAO committees. The assessment 
of average exposure does not eliminate the possibility that some Vietnam veterans 
had heavy exposures.
Vietnam Experience Study
Using exposure estimates from the Agent Orange Validation Study, CDC 
conducted the CDC Vietnam Experience Study, a historical cohort study of the 
health experience of Vietnam veterans (CDC, 1989b). The study was divided into 
three parts: physical health, reproductive outcomes and child health, and psycho-
social characteristics (CDC, 1988a,c,d). CDC examined post-service mortality 
(through 1983) in a cohort of 9,324 U.S. Army veterans who served in Vietnam 
and in 8,989 Vietnam-era Army veterans who served in Germany, Korea, or 
the United States (Boyle et al., 1987; CDC, 1987). In other studies using the 
data collected from the Agent Orange Validation Study, O’Brien et al. (1991) 
combined the mortality and interview data to identify veterans who developed 
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NHL. Decoufle et al. (1992) evaluated the influence of self-reported exposure to 
herbicides on self-reported adverse health outcomes. Finally, in a follow-up of 
CDC’s Vietnam Experience Study cohort, Boehmer et al. (2004) reported findings 
on mortality from 1965 through 2000.
Selected Cancers Study
The CDC Selected Cancers Study (CDC, 1990a) was designed to investigate 
the effects of military service in Vietnam and of exposure to herbicides on the 
health of American veterans, with a specific focus on the risk of developing NHL 
(CDC, 1990b), STS and other sarcomas (CDC, 1990c), HL (CDC, 1990d), and 
nasal, nasopharyngeal, and primary liver cancers (CDC, 1990d).
Other U.S. Vietnam-Veteran Studies
American Legion Study
The American Legion, a voluntary service organization for veterans, con-
ducted a cohort study of the health and well-being of Vietnam veterans who were 
members. The studies examined physical health and reproductive outcomes, social- 
behavioral consequences, and PTSD in veterans who had served in Southeast 
Asia and elsewhere (Snow et al., 1988; J. M. Stellman et al., 1988; S. D. Stell-
man et al., 1988a,b). No additional studies have been published on the cohort.
State Studies
Several states have conducted studies of Vietnam veterans, most of which 
have not been published in the scientific literature. The VAO and Update 1996 
committees reviewed studies of veterans of Hawaii (Rellahan, 1985), Iowa 
(Wendt, 1985), Maine (Deprez et al., 1991), Massachusetts (Clapp, 1997; Clapp 
et al., 1991; Kogan and Clapp, 1985, 1988; Levy, 1988), Michigan (Visintainer et 
al., 1995), New Jersey (Fiedler and Gochfeld, 1992; Kahn et al., 1988, 1992a,b,c), 
New Mexico (Pollei et al., 1986), New York (Greenwald et al., 1984; Lawrence 
et al., 1985), Pennsylvania (Goun and Kuller, 1986), Texas (Newell, 1984), West 
Virginia (Holmes et al., 1986), and Wisconsin (Anderson et al., 1986a,b). Chamie 
et al. (2008) examined the association between herbicide exposure and prostate 
cancer in Vietnam-era veterans using the VA health system in northern California; 
the reliability of this study of about 13,000 men is limited by its reliance on self-
reported exposure status and by the exclusion of prostate cases diagnosed before 
1998, before computerized records became available. No additional single-state 
studies have been identified.
Grufferman et al. (2014) evaluated the role of parental military service in 
Vietnam and service-related exposures and the risk of rhabdomyosarcoma in 
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offspring using data from the Intergroup Rhabdomyosarcoma Study Group clini-
cal trial, which included hospitals in 46 U.S. states and the District of Columbia 
from 1982 to 1988.
Australian Vietnam-Veteran Studies
The Australian government has commissioned a number of studies to follow 
the health outcomes of Australian veterans who served in Vietnam. Although the 
Australians did not participate in herbicide spraying, there is a possibility that 
they may have been exposed to the herbicides if stationed or passing through 
areas that were sprayed. 
Australian Vietnam Veterans
The Australian Vietnam veterans study population corresponds to the cohort 
defined by the Nominal Roll of Vietnam Veterans, which lists Australians who 
served on land or in Vietnamese waters from May 23, 1962, to July 1, 1973, 
including military and some non-military personnel of both sexes. People who 
served in any branch of service in the defense forces and citizen military forces 
(such as diplomatic, medical, and entertainment personnel) were considered. The 
comprehensive studies, however, are limited to male members of the military, and 
most of the analyses focus on men in the defense forces—the Army (41,084), 
the Navy (13,538), and the Air Force (4,570). One investigation examined the 
possibility of an association between Vietnam service and cancer incidence by 
comparing diagnoses from 1982 to 2000 among male Vietnam veterans with 
those in the general population of Australia (ADVA, 2005a). The results in that 
report supersede those reported by the Australian Department of Veterans’ Affairs 
(CDVA 1998a). Morbidity in female Vietnam veterans had also been studied 
(CDVA, 1998b). Additional case-control studies of the incidence of adrenal gland 
cancers, leukemias, and NHL were conducted in this population (AIHW, 1999, 
2000, 2001).
There have been several studies of mortality among Australian Vietnam 
veterans (CDVA, 1997; CIH, 1984a,b,c; Crane et al., 1997a,b; Evatt, 1985; 
Fett et al., 1987a,b; Forcier et al., 1987). The latest one (ADVA, 2005b), which 
considered the causes of death of men in all branches of service through 2001 
compared with that of the general Australian population and reported by branch 
of service, supersedes the others.
Australian Vietnam Veterans Family Study
The Australian Department of Veterans’ Affairs has published four large 
volumes that summarize the results of studies conducted among family members 
of Vietnam-era veterans (ADVA, 2014a,b,c,d). The purpose of this study was to 
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better understand the long-term impacts of service on the health and welfare of 
the families of Australian Vietnam veterans. The first volume (2014a) provided 
an overview of the entire effort. The second (2014b) assessed the health of the 
family members with more emphasis placed on the details of psychological 
and social well-being, rather than adverse impacts on physical health. The third 
(2014c) investigated mortality among members of the veterans’ families, while 
the final volume (2014d) discussed qualitative information gathered in the course 
of the entire study. Although responses were collected on spouses and partners of 
the veterans, the analyses focused on outcomes reported by the children of the 
veterans. The wide range of outcomes examined for the family members them-
selves included mental health outcomes, pregnancy and birth defect outcomes, 
physical health, social functioning, and mortality. Because many of the health 
outcomes reported for these family members are not central to the charge of the 
committee (e.g., mental health and social functioning), minimal consideration 
was given to these publications.
From the roster of Australian Vietnam veterans, more than 10,000 Austra-
lians who had served in the Vietnam War were randomly selected and contacted, 
along with their family members, for potential participation in the study. The 
Vietnam veterans who were identified and ultimately selected included 3,940 
who were randomly selected and 2,569 who self-selected into the study based on 
media publications announcing that the study would be conducted.
The primary comparison group consisted of family members of non- 
deployed Vietnam-era personnel. These personnel comprised 3,967 randomly 
selected non-deployed era veterans and 418 who self-selected into the study. 
Thus, there were far more Australian Vietnam veterans who self-selected into 
the study than non-deployed Australian Vietnam-era veterans who self-selected, 
and the percentage of the Vietnam veterans who self-selected was much higher 
than the percentage of non-deployed Vietnam-era veterans who self-selected. In 
total, the family members of Vietnam veterans included 2,199 sons and daughters, 
of whom 1,385 were examined for pregnancy and birth defect–related outcomes.
When there is no specific exposure information provided, the VAO series has 
considered these comparisons of deployed versus non-deployed groups to cover 
potential exposure to all the COIs and thus the most relevant measures for their 
task. Such contrasts, however, also cover all aspects of the deployment experi-
ence, and in this set of Australian studies there was considerably more concern 
about the psychological effects on the veterans (especially PTSD) and their sec-
ondary impact on the veterans’ family members, which would not be expected to 
be an effect of herbicide exposure. Some analyses have been conducted among 
all study participants, and some analyses were stratified by the type of enroll-
ment (random versus self-selected). The committee fully recognized the potential 
reporting biases that may have emanated from the self-selected cohort, and thus it 
placed considerably more weight on the results derived for the randomly selected 
cohort, as did the researchers themselves.
Veterans and Agent Orange: Update 11 (2018)
Copyright National Academy of Sciences. All rights reserved.
142 VETERANS AND AGENT ORANGE: UPDATE 11
Australian Conscripted Army National Service
The Australian Conscripted Army National Service study population is a 
subset of the veterans considered in the overall Australian Vietnam Veterans 
study group. The 19,240 conscripted male Army veterans deployed to Vietnam 
(“National Service” veterans) were compared with 24,729 non-deployed coun-
terparts (“National Service non-veterans”). The results on death and cancers 
in the Australian conscripted Army National Service veterans (ADVA, 2005c) 
supersede those of earlier internal comparisons of deployed and non-deployed 
Vietnam War–era National Service veterans (CIH, 1984a,b,c; Crane et al., 1997b; 
Fett et al., 1987a,b). Those government-sponsored studies of Australian Vietnam 
veterans did not characterize the veterans’ exposure to the herbicides sprayed in 
Vietnam beyond the fact that they had served on land or in Vietnamese waters 
from May 23, 1962, through July 1, 1973. It is the convention of VAO commit-
tees to regard Vietnam veterans in general as being more likely to have received 
higher exposures to the COIs than the general public, but ideally that assumption 
should have been validated by more objective measurements of exposure, such 
as serum measurements, in a sample of Australian Vietnam veterans.
Sample of 1,000 Australian Vietnam Veterans
O’Toole et al. (1996a,b,c) studied a broad spectrum of health issues in a 
random sample of 1,000 Australian Vietnam veterans (both regular enlisted and 
conscripted Army National Service members) selected from Australia’s compre-
hensive roster of 57,643 service members who were deployed to Vietnam. In 
wave 1, conducted in 1990–1993, 641 members of the sample were located and 
interviewed. In wave 2, conducted in 2005–2006, O’Toole et al. (2009) obtained 
responses from 450 (51.4% of those not known to have died). A total of 391 
veterans responded to both waves. The Australian Bureau of Statistics’ National 
Health Survey was administered in both waves, and additional data were col-
lected on combat experience, PTSD, and general psychiatric status. The veterans’ 
self-reported health status was compared with that of the general male Australian 
population gathered during the government’s administration of the same survey in 
1989–1990 and 2004–2005; it is not clear that this instrument was administered 
to the two groups under comparable conditions. The low response rates make the 
findings vulnerable to nonresponse bias, and the self-report measures of health 
conditions might be of low validity and subject to recall bias. The committee for 
Update 2010 was skeptical about the reliability of the nearly uniform findings of 
statistically increased prevalence of nearly 50 health conditions.
O’Toole et al. (2010) reported on mortality in the sample through 2004 as 
related to previously gathered information on psychosocial factors that are not 
within the scope of VAO reviews. It is of interest, however, that they found that 
11.7% of the veterans in the sample had died by the end of 2004. Additional 
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publications using the survey results from waves 1 and 2 have been published on 
the course of combat-related PTSD (O’Toole and Catts, 2017) and the intergen-
erational transmission of PTSD in the offspring of these veterans (O’Toole et al., 
2017). However, as mental health outcomes related to combat cannot easily be 
teased apart from any potential effects of herbicide exposure, such publications 
are not reviewed in depth.
Birth Defects in Australian Infants
The Australian government sponsored a case-control study of 8,517 infants 
with congenital anomalies born in 1966–1979 at 34 hospitals in New South 
Wales, Victoria, and in the Australian Capital Territory; the infants were matched 
by period of birth, mother’s age, hospital, and means of hospital payment to live-
born infants without diagnosed birth defects (Donovan et al., 1983, 1984; Evatt, 
1985). The fathers of infants in both groups were identified and their names 
compared with those on the roster of men who had served in the Australian Army 
in 1962–1972; additional means of verification were used to determine whether 
a child’s father was in the Army during this interval (329 cases and 338 controls) 
and also whether the father was deployed to Vietnam (127 cases and 123 con-
trols). After adjustments were made for maternal age, infant sex, multiple births, 
and father’s place of birth, conditional logistic regression was used to compare 
the Vietnam veterans (National Service or regular Army) to other era veterans 
and to all other fathers for all birth anomalies and for seven diagnostic groups.
Korean Vietnam-Veteran Studies
Military personnel of the Republic of Korea served in Vietnam from 1964 
through 1973. Studies of the health of these personnel have been pursued by 
several researchers.
Study of TCDD Concentrations in Korean Vietnam Veterans
J. S. Kim et al. (2001) attempted to use serum dioxin concentrations to vali-
date an index for estimating group exposure. The study involved 720 veterans 
who served in Vietnam and 25 veterans who did not. The exposure index was 
based on herbicide-spraying patterns in military regions where Korean personnel 
served, time and location data on the military units stationed in Vietnam, and an 
exposure score derived from self-reported activities during service. A total of 13 
pooled samples were submitted to CDC for serum dioxin analyses. One analytic 
sample was prepared from the pooled blood of the 25 veterans who did not serve 
in Vietnam. The remaining 12 samples were intended to correspond to 12 expo-
sure categories; each was created by pooling blood samples from 60 veterans. The 
12 exposure categories ultimately were reduced to four exposure groups, each 
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representing a quartile of 180 Vietnam veterans but characterized by only three 
serum TCDD measurements.
The paper by J. S. Kim et al. (2001) reported highly significant Pearson 
correlation coefficients and results of multiple logistic-regression analysis. The 
statistical analyses apparently were based on the assignment of the pooled serum 
dioxin value to each individual in the exposure group. The multiple regression 
analysis evaluated such variables as age, BMI, and consumption of tobacco or 
alcohol. In a later report on the same exposure groups and serum dioxin data, 
the authors corrected their analysis (J. S. Kim et al., 2003). A correlation was 
observed between serum dioxin concentrations and ordinal exposure categories, 
but the correlation was not statistically significant. The authors attributed the lack 
of statistical significance to the small sample size, and they noted that the data 
exhibited a distinct monotonic upward trend; the average serum dioxin concen-
trations were 0.3, 0.6, 0.62, 0.78, and 0.87 pg/g (lipid-adjusted) for, respectively, 
exposure categories 0 through 4. The decision to pool blood samples from a 
large number of persons in each exposure set (J. S. Kim et al., 2001) greatly 
reduced the power of the validation study. Instead of 180 samples in each of the 
final exposure categories, the pooled analysis produced only three samples in 
each category. The lipid-adjusted serum TCDD concentrations in the 12 pooled 
samples from Vietnam veterans ranged from 0.25–1.2 pg/g, whereas the single 
sample from the non-Vietnam veterans contained 0.3 pg/g. The narrow range of 
results makes the biologic relevance of any differences questionable.
Thus, it appears that there was not a clear separation in terms of TCDD levels 
between Korean Vietnam veterans and non-Vietnam veterans. Furthermore, the 
range of mean values in the four Vietnam veteran exposure categories was nar-
row, and all concentrations were relatively low (less than 1 pg/g). The relatively 
low serum dioxin concentrations observed in the 1990s in those people are the 
residuals of substantially higher initial concentrations, as has been seen in other 
Vietnam veteran groups. However, the concentrations reported in the Korean 
veterans study are significantly lower than those reported in American Vietnam 
veterans in the 1988 CDC Agent Orange Validation Study, which was nonetheless 
unable to distinguish Vietnam veterans from non-Vietnam veterans on the basis of 
serum dioxin (CDC, 1988b). The Korean authors were able to construct plausible 
exposure categories based on military records and self-reporting, but they were 
unable to validate the categories with serum dioxin measurements.
Korean (Vietnam) Veterans Health Study
Six publications have been reviewed from an exceptionally large epidemio-
logical study of more than 180,000 Korean Vietnam veterans, denoted herein 
as the “Korean study.” It is much larger in scope than all of the other published 
epidemiological studies conducted among Vietnam veterans. The Korean study 
provides results for a very large set of health outcomes, including rare conditions, 
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as well as non-fatal outcomes and cause-specific mortality. The research method-
ology used in the Korean study was very carefully evaluated by the Update 2014 
committee (the first committee to examine these publications) because the study 
used multiple methods of exposure ascertainment and health outcome ascertain-
ment. The careful evaluation was done so that across all health outcomes, com-
mittee members would weigh the results from the Korean study in a consistent 
manner and take into account the strengths and limitations from this large body 
of data.
For the Assessment of the Potential Exposure to Herbicides Publications on 
the Korean study have relied on multiple methods for the exposure assessment 
(referred to imprecisely in the Yi articles as Agent Orange). First, a self-report 
perceived exposure index was used to query Korean veterans as to how they 
might have been exposed to herbicides in Vietnam (Yi et al., 2013a,b). Responses 
to six questions on a postal survey were used to derive a four-tiered categoriza-
tion of self-perceived herbicide exposure (Yi et al., 2013a); see Table 5-1. The 
initial four-tier scale (high, moderate, low, and none) was further compressed into 
simply “high” or “low” for many analyses. The perceived herbicide exposure 
estimates were highly correlated with the health outcomes, indicating the pos-
sibility of recall bias.
In the second method, an objective exposure opportunity index (EOI) score 
of exposure potential was calculated for each veteran based on the proximity of 
the veteran’s military unit to herbicide-sprayed areas (Yi et al., 2014a,b). The 
Korean investigators obtained locations and calendar date histories for the mili-
tary units represented in their cohort and used this information as input to obtain 
EOI scores from its model (J. M. Stellman et al., 2003b), which consolidates 
all the temporal and spatial information gathered from the original military re-
cords on the herbicide spray missions conducted in Vietnam. The investigators 
classified the resulting EOI scores using two- and four-group categorizations 
TABLE 5-1 Distribution of Perceived Herbicide Exposure Among 114,562 
Korean Vietnam Veteransa
2 Groups Exposure Questions 4 Groups Prevalence
High
Low
1. Sprayed herbicides
2. Handled herbicide spray equipment
3. Present during herbicide spraying
4. Got herbicide on skin or clothing
5. Walked through sprayed area
6. Exposed in other ways (not listed above)
Answered “no” to all six questions
High
Moderate
Low
None
16.1%
35.7%
13.2%
34.9%
aExposure assigned based on their self-reported responses to a postal survey.
SOURCE: Adapted from Yi et al., 2013a.
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and multiple aggregations of military units. The initial four-tier scale (high, 
moderate, low, and none) was further compressed into simply “high” or “low” 
for many analyses, the details of which are presented in Tables 5-2 and 5-3. The 
self-reported perceived exposures are not directly comparable to the objective 
EOI scores, which were designed to assess the exposure opportunity that would 
result from unintended proximity to herbicide spraying and not the direct result 
of duties that required handling or applying herbicides (IOM, 2008).
TABLE 5-2 Distribution of EOI Scores on Two-Level Scale in Epidemiology 
Studies Among Korean Vietnam Veteransa
Exposure Category
(log10 EOI Score)
Yi et al. (2014a)b
Division/Brigade or Battalion/Company
(n = 111,726)d
Yi et al. (2014b)c
Division/Brigade
(n = 180,251)e
Low (< 4.0) 62.0% 52.4%
High (≥ 4.0) 38.0% 47.6%
aDetails of the two-level exposure classification is described in the Ohrr et al. (2006, publication 
in Korean).
bBattalion/company level EOI score assigned for combat units only.
cThe overall range of log EOI scores in Yi et al. (2014b) is 0.0–5.8.
dYi et al. (2014a), 111,726 veterans analyzed for disease prevalence.
eYi et al. (2014b), 180,251 veterans analyzed for cancer outcomes.
SOURCES: Adapted from VAO Update 2014 (NASEM, 2016a).
TABLE 5-3 Distribution of EOI Scores on Four-Level Scalea
Source Yi et al. (2013a) Yi et al. (2014a)
Exposure Category  
(log10 EOI score)
Division/ 
Brigade  
(n = 96,126)b
Battalion/
Company  
(n = 96,126)
Division/Brigade 
or Battalion/ 
Companyc  
(n = 111,726)d
Division/ 
Brigade  
(n = 180,251)e
None (< 0.1) 20.1% 26.1% 30.9% 25.2%
Low (0.1 ≤ EOI < 4.0) 28.2% 33.1% 31.2% 27.2%
Medium (4.0 ≤ EOI 
< 5.0)
31.1% 21.5% 20.1% 28.3%
High (≥ 5.0) 20.6% 19.3% 17.9% 19.3%
aDetails of the four-level exposure classification is described in Ohrr et al. (2006, publication in 
Korean).
bYi et al. (2013a), 96,126 veterans analyzed for self-reported disease prevalence. Log (EOI score) 
mean and range not reported.
cBattalion/company level EOI score assigned for combat units only.
dYi et al. (2014a), 111,726 veterans analyzed for disease prevalence. Log (EOI score) mean 2.6 
± 2.2 (range 0.0–6.2).
eYi et al. (2014b), 180,251 veterans analyzed for cancer outcomes. Log (EOI score) range 0.0–5.8.
SOURCE: Adapted from VAO Update 2014 (NASEM, 2016a).
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In developing the EOI scores, military units were aggregated at two levels: 
the larger brigade/division level and the smaller battalion/company level. The 
distributions of EOI scores are similar across the Korean study publications, 
regardless of military unit aggregation. The Update 2014 committee noted that 
the proportion of veterans in the “high” exposure category may be too large and 
the individuals too similar to the lower categories to detect the true strength of 
associations between exposure and adverse health conditions. The committee 
proposed that an exposure classification that put only the top 10% or 15% of 
individuals in the “high” category would have been better for the purpose of 
identifying adverse health effects due to exposure.
The Korean study overcame significant logistical challenges in applying the 
EOI model to a large-scale epidemiologic study of a broad spectrum of health 
effects. The Update 2014 committee found that although there were likely sources 
of error in the EOI method for modeling herbicide exposures of Vietnam veterans, 
there was no indication of systematic bias in the rank ordering of exposure scores 
developed by this method. Furthermore, since nondifferential misclassification 
of exposure would bias measures of association toward the null, the observed 
statistically significant relationships found between EOI scores and health effects 
are likely to be real.
For the Assessment of the Health Outcomes of Interest As with exposure 
assessment, multiple methods were used to ascertain health outcomes in the 
Korean study. First, veterans self-reported all current and physician-diagnosed 
diseases. The diseases were classified into seven groups of diseases: cancers, 
circulatory diseases, respiratory diseases, digestive diseases, neuromuscular dis-
eases, endocrine diseases, and other diseases. Within the major disease groups, 
self-reporting was further provided for 17 cancers (including stomach cancer, 
liver cancer, and lung cancer), 13 circulatory diseases (including hypertension, 
myocardial infarction, and angina), 5 respiratory diseases (including chronic 
bronchitis and emphysema), 6 digestive diseases (including gastritis and peptic 
ulcer), 4 neuromuscular diseases (including central nervous system disorders and 
peripheral neuropathy), 2 endocrine diseases (diabetes and hypothyroidism), and 
4 other diseases (including renal failure and skin disease).
Second, incidence data for the specific types of cancer reported in the cohort 
were obtained from the Korean Cancer Incidence Database (1992–2003) and 
classified according to ICD-10.
Third, prevalent cases of individual disease conditions were identified by 
extracting claims data from the Korea National Health Insurance service during 
the period January 1, 2000, to September 30, 2005. Data on health outcomes 
were also obtained through a review of medical care covered directly by the 
Korean government through the Veterans Health Service during the same period. 
The health outcomes that were examined included the prevalence of endocrine 
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diseases (ICD-10 E00–E90), neurologic diseases (G00–G99), circulatory diseases 
(I00–I99), respiratory diseases (J00–J99), and digestive diseases (K00–K93).
Fourth, vital status of Korean Vietnam veterans and the underlying causes of 
deaths were ascertained by use of the 1992–2005 death records of the National 
Statistical Office. Categories included all causes of death, 23 specific cancers, and 
36 specific causes other than cancer.
Using these multiple methods for exposure classification and health outcome as-
certainment, associations between metrics of herbicide exposure potential and health 
outcomes were derived. First, in some analyses, the health experiences of Korean 
Vietnam veterans, as a function of their exposure status, was compared to the health 
status of age-matched adults in the Korean general population. This method is known 
as an “external” control group. Second, some analyses were performed among Ko-
rean Vietnam veterans with the lowest herbicide exposure classification serving as 
the comparison group. This method is known as an “internal” control group.
The above variations in exposure assessment, health outcome ascertain-
ment, and the use of internal and external comparison groups have significant 
implications for the appropriate interpretation of results from the Korean study. 
In considering these variations, the committee kept in mind the following meth-
odological principles and empirical observations:
1. Whereas self-reported exposure may be reliable and valid in some re-
search circumstances, it is generally considered less reliable and valid 
than objectively obtained estimates of exposure (Zajacova and Dowd, 
2011). The potential for recall bias is of particular concern, and the like-
lihood of this bias occurring increases with the length of time from the 
potential exposure to the incidence of disease.
2. In acquiring health outcome data, objective sources (e.g., a cancer registry or 
health claims system) are generally preferred over self-report outcome data, 
assuming that the objective source of outcome data is largely comprehensive.
3.  For morbidity and mortality analyses, the estimation and validity of rela-
tive risk may be more prone to bias when an external control group is used 
(e.g., the general population) than when an internal control group is used 
(Monson, 1990). This may be due to the “healthy warrior” effect. That 
is, in order to be accepted to military service and deploy, members must 
meet a high standard of general and physical fitness, whereas the general 
population includes some individuals of poor health. Using an internal 
control group, so long as the veteran groups are similar or adjusted for 
potential confounding variables, alleviates concerns of bias due to the 
healthy warrior effect.
4. Relative risk estimates that are only slightly above (e.g., 1.1) or below 
(e.g., 0.9) the null value of 1.0 may achieve statistical significance be-
cause of the large number of subjects in the study population, but may 
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still reflect bias (e.g., selection or confounding bias) and be of less clinical 
significance than relative risk estimates of larger magnitude.
Therefore, when reviewing results within and across publications from the 
Korean study, the Update 2014 committee gave very limited overall weight to 
self-reported exposure data and self-reported health-outcomes data compared 
to objective measurements of the chemicals and health outcomes of interest. 
Also, more weight was given to the relative risk estimates of mortality and can-
cers derived from the use of an internal control group than from the use of the 
general population in order to minimize concern about a healthy warrior effect. 
Finally, less weight was afforded to statistically significant associations close to 
the null value (e.g., ranging from 0.9 to 1.1) than to those further from the null 
in order to account for differences of questionable clinical significance arising 
from this large study’s statistical power and to account for modest selection bias 
and confounding.
Brief Reviews of Individual Publications on 
the Korean Veterans Health Study
No new publications on the Korean study were identified for the current 
update. Relevant results from these publications are presented in each of the 
applicable health outcome sections under the heading of Conclusions from VAO 
and Previous Updates. However, to avoid redundancy, each of the publications 
is reviewed here, with a focus on the methods used.
In Yi (2013), a total of 185,265 Korean men, who had served in Vietnam 
from 1964 to 1973 and who were alive in 1992 were followed for cancer inci-
dence from 1992 to 2003. Cancer diagnoses were ascertained via linkage with 
the Korean National Cancer Incidence Database, whereas cancer deaths were 
identified using National Statistical Office records. Cancer incidence and cancer 
mortality were not examined in terms of the veterans’ herbicide exposure during 
military service in Vietnam. Age-adjusted incidence and standardized incidence 
ratios were calculated using the Korean male population during 1992 to 2003 as 
the reference population (Yi, 2013). The overall cancer incidence among Vietnam 
veterans was not higher than in the general male population. However, when the 
incidence was analyzed by cancer type, Vietnam veterans and subgroups of the 
study population classified by military rank (enlisted; non-commissioned officer; 
officer) experienced a higher incidence of several cancers, including prostate 
cancer, T-cell lymphoma, lung cancer, bladder cancer, kidney cancer, and colon 
cancer, than the general Korean population. In Yi et al. (2013a), exposure of 
114,562 Korean Vietnam veterans was assessed using two methods, as previously 
described in the section For the Assessment of the Potential Exposure to Her-
bicides. The first method was perceived self-report herbicide exposure in which 
veterans were categorized as having either “low” or “high” perceived exposure. 
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The second method used to estimate herbicide exposure was more objective and 
based on the proximity of each veterans’ military unit to herbicide-sprayed areas 
using the EOI model developed by J. M. Stellman et al. (2003b) and veterans 
were again classified using “high” and “low” group exposure categorizations. 
Associations were reported between self-reported diseases and high versus low 
exposures. All disease outcomes were based on self-report and classified into 
seven groups of diseases: cancers, circulatory diseases, respiratory diseases, 
 digestive diseases, neuromuscular diseases, endocrine diseases, and other dis-
eases. Subtypes of disease were reported for each disease condition. The Update 
2014 committee was concerned about the reliability of self-reported exposure and 
health data because the use of such data in Yi et al. (2013a) uniformly yielded 
highly significant statistical associations across an exhaustive spectrum of disease 
conditions, while the use of the objective EOI method of exposure classification 
and documented reports of adverse health outcomes in the later publication on 
this population produced more variable results. The observation of inconsisten-
cies when theoretically more reliable measures of health and exposure were 
analyzed reinforced the concern about the findings based on self-report in the 
Korean study.
Yi et al. (2013b) examined the serum levels of TCDD in 102 of these Korean 
Vietnam veterans for three purposes:
1. to assess their use as a potential objective tool for herbicide exposure;
2. to determine their correlation to self-reported exposure (six-item question-
naire); and
3. to evaluate how they related to age, BMI, and smoking.
In 2002 serum samples were collected, and a health examination was performed. 
For an objective assessment of herbicide exposure, EOI scores were again de-
rived using the model by J. M. Stellman et al. (2003b), and veterans were clas-
sified as low versus high exposure or in four categories consisting of none, low, 
moderate, or high exposure. The serum TCDD concentrations among the Korean 
Vietnam veterans were lower than those reported in other studies of Korean and 
U.S. Vietnam veterans, and concentrations were not associated with herbicide 
exposure indices or with age, BMI, or smoking. The net value of this study is the 
observation that the assessment of serum levels of TCDD among veterans long 
after service in Vietnam (e.g., 40 years or more) may be of very limited value 
as a metric for herbicide exposure unless individuals were exposed to very high 
levels during military service.
Yi and Ohrr (2014) examined the incidence of cancer among 180,251 Korean 
Vietnam veterans from 1992 through 2003 using EOI scores for exposure assess-
ment. The incidence of cancer was determined through a review of records from 
the Korea National Cancer Incidence Database. Overall, the veterans classified 
with high exposure had a small yet statistically significant higher risk of cancer 
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than the veterans classified with low exposure. Compared with low exposure, 
high herbicide exposure appeared to be most related to an elevated risk of can-
cers of the mouth, salivary glands, stomach, and small intestine. The objective 
classification of both herbicide exposure and cancer incidence is considered a 
strength of this study over other publications from this cohort that used self-report 
data for analyses.
Again, using EOI scores to estimate herbicide exposure, Yi et al. (2014a) 
examined the prevalences of a wide range of disease conditions, specifically, 
those pertaining to the endocrine, nervous, circulatory, respiratory, and digestive 
systems. Health information was derived through a review of claims data from 
the Health Insurance Review and Assessment Service of Korea from January 1, 
2000, to September 30, 2005. Overall, and compared with low exposure, high 
herbicide exposure was associated with a statistically significantly higher preva-
lence of hypothyroidism, autoimmune thyroiditis, other endocrine gland disorders 
including pituitary gland disorders, as well as amyloidosis and Alzheimer disease. 
As with Yi and Ohrr (2014), the objective classification of both herbicide expo-
sure and disease prevalence is considered a strength of this study.
Finally, Yi et al. (2014b) used objective classifications of both herbicide ex-
posure and cause-specific mortality to analyze cause-specific mortality in 180,639 
Korean Vietnam veterans. The EOIs were used as the basis for two characteriza-
tions of herbicide exposure: as “low” versus “high” and as per unit increase based 
on a log-transformed scale. The incidence of mortality and cause of death were 
ascertained by the use of death records from the National Statistical Office for 
the period 1992–2005. Veterans with high herbicide exposure were found to have 
10% increased long-term risk of mortality and 13% increased cancer mortality. 
The observed cause-specific cancer mortality estimates were very imprecise, but 
were highest for thyroid cancer, chronic myeloid leukemia, small intestine cancer, 
and bladder cancer.
Other Studies of Korean Vietnam Veterans
Epidemiologic studies have also looked at immunotoxicologic outcomes (H. 
A. Kim et al., 2003) and skin and general disease patterns (Mo et al., 2002) in 
Korean Vietnam veterans who were exposed to herbicides during the Vietnam 
War. One case-control study of the association between exposure to TCDD and 
recovery outcomes (hypertension, hyperlipidemia, and the rate and severity of 
major adverse coronary events) in male veterans who presented with acute coro-
nary syndrome was also examined, but the study findings are not informative 
about associations between TCDD and acute coronary syndrome itself. Two new 
studies of Korean veterans who served in Vietnam were identified for the cur-
rent update. Y. S. Yang et al. (2016) used a case-control design to examine the 
association between exposure to Agent Orange and Parkinson disease. Han et al. 
(2016) conducted a small hospital-based case-control study of acute ischemic 
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stroke to compare vascular features among those presumed to have been exposed 
to Agent Orange (based on deployment in Vietnam) and those veterans who did 
not serve in Vietnam.
New Zealand Vietnam-Veteran Studies
McBride et al. (2013) followed 2,783 male veterans from New Zealand who 
served in Vietnam between 1964 and 1972. Their status with respect to cancer 
incidence and mortality was determined from 1988 through 2008. This cohort 
included 84% of all 3,322 Vietnam veterans from New Zealand who had survived 
service in Vietnam. Standardized incidence and mortality ratios were generated 
by comparing the observed incident cases and deaths in this cohort with the cor-
responding expected numbers of new cases and deaths rates from the general 
male population of New Zealand. For all-cause mortality, the Vietnam veterans 
had significantly lower rates than the New Zealand general population. Cancer 
mortality and overall incidence were similar between Vietnam veterans and the 
New Zealand general population, as was heart disease mortality. In contrast, 
New Zealand Vietnam veterans appeared to be at higher risk of cancers of the 
head and neck and oral cavity, pharynx, and larynx as well as of incident chronic 
lymphoid leukemia (also known as chronic lymphocytic leukemia) than was the 
New Zealand general population. Although the follow-up of this cohort was long 
(20 years), the study did not have information on cancer incidence and mortality 
in the time period immediately after the service (i.e., between 1972 and 1988). 
It also lacked an internal comparison group, and information on potential con-
founding factors including smoking, drinking habits, and human papilloma virus 
status was not available, which limits the interpretation of the data, particularly 
regarding incident cancers. Moreover, it was assumed that any veteran who had 
been deployed had been exposed to the herbicides, and the presumed exposure 
was not validated through more objective measures such as serum concentrations 
or even more targeted self-reported questions of exposure.
For the current report, one new follow-up publication of the New Zealand 
Vietnam veteran cohort was identified. Cox et al. (2015) used hospital discharge 
records from 1988 to 2009 to report the prevalent health conditions among the 
same cohort of 2,783 New Zealand Vietnam veterans used by McBride et al. 
(2013). For participants 30 years of age or older, person-years of follow-up were 
calculated by 5-year age categories. Age-specific hospitalization rates were calcu-
lated using the total number of annual hospitalizations published by the Ministry 
of Health and the average annual resident population. The comparison group was 
the standardized general population of New Zealand. Standardized hospitaliza-
tion ratios and 99% confidence limits were calculated and reported as a means to 
control for the multiple tests performed for various outcomes. Overall, this study 
found that hospital admissions due to all causes combined was slightly higher for 
Vietnam veterans than for the standardized population of New Zealand. Multiple 
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outcomes by system and specific conditions were reported; however, several of 
the outcomes are not generally conditions for which an individual would be hos-
pitalized (e.g., diabetes, cataract, anxiety disorder), thereby limiting the utility of 
some of the findings reported. This study is also subject to the same limitations 
discussed for McBride et al. (2013).
OCCUPATIONAL STUDIES
Several occupational groups in the United States and elsewhere have been 
exposed to the COIs. Exposure characterization in studies of these groups var-
ies widely in the metric used, the extent of detail, confounding exposures, and 
whether individual, surrogate, or group (ecologic) measures are used. Some 
studies reviewed in earlier VAO reports used job titles as broad surrogates of 
exposure; others rely on disease-registry data.
The VAO committees have reviewed many epidemiologic studies of occu-
pationally exposed groups for evidence of an association between exposure to 
TCDD or to the herbicides used in Vietnam and health risks. In reviewing the 
studies, the committee considered two types of exposure separately: exposure 
to 2,4-D or 2,4,5-T and exposure to TCDD from 2,4,5-T or other sources. That 
separation is necessary because some health effects could be associated with 
an exposure to 2,4-D or 2,4,5-T in the absence of substantial TCDD exposure. 
After the dioxin contamination of phenoxy herbicides was recognized, produc-
tion conditions were modified to minimize that contamination, and the use of the 
products most likely to contain TCDD (2,4,5-T and Silvex) was banned. As a 
result, workers who were exposed to phenoxy herbicides only after the late 1970s 
are not assumed to have been at risk for exposure to TCDD. The distinction is 
particularly important for workers in agriculture and forestry, including farmers 
and herbicide appliers, whose exposure is primarily the result of mixing, loading, 
and applying herbicides.
The committee also considered studies of occupational exposure to dioxins, 
focusing on workers in chemical plants that produced phenoxy herbicides or 
chlorophenols, which tend to be contaminated with PCDDs. Waste-incineration 
workers were also included in the occupation category because they can come 
into contact with dioxin-like chemicals while handling the byproducts of in-
cineration. Other occupationally exposed groups included were pulp-and-paper 
workers exposed to dioxins through bleaching processes that use chlorinated 
compounds and sawmill workers exposed to chlorinated dioxins, which can be 
contaminants of the chlorophenates used as wood preservatives.
Because no new information has been published on several of these cohorts 
for years or decades and detailed information on them is available in previous 
volumes of the series, this section offers only a brief overview of those major 
occupational cohorts and studies that have contributed to the evidence base on 
potential health outcomes stemming from exposure to the COIs but for which no 
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new information for the current volume is available. Instead, the focus here is on 
the design and methodology of studies for those occupational cohorts for which 
new information is available in this report.
Studies of Herbicide Production Workers
International Agency for Research on Cancer (IARC)
A multisite study by IARC involved 18,390 production workers and  phenoxy 
herbicide sprayers working in 10 countries (Saracci et al., 1991). The full  cohort 
was established by using the International Register of Workers Exposed to 
 Phenoxy Herbicides and Their Contaminants. Twenty cohorts were combined 
for the analysis: one each in Australia, Austria, Canada, Finland, and Sweden; 
two each in Denmark, Italy, the Netherlands, and New Zealand; and seven in 
the United Kingdom. There were 12,492 production workers and 5,898 sprayers 
in the full cohort. Several studies published using data from this cohort were 
reviewed by the first few VAO committees and contributed to conclusions on 
some cancers (Kogevinas et al., 1992, 1993, 1995, 1997), but no new studies of 
the IARC cohort have been published since Update 1998.
Several of the subcohorts that make up the IARC cohort have generated inde-
pendent reports that have been evaluated separately by VAO committees to garner 
additional insights, such as the results associated with TCDD concentrations 
measured in various subjects: Austrian production workers (Jäger et al., 1998; 
Neuberger et al., 1998, 1999), British production workers (Coggon et al., 1986, 
1991, 2015), Danish production workers (Lynge, 1985, 1993), Dutch production 
workers (Boers et al., 2010, 2012; Bueno de Mesquita et al., 1993; Hooiveld et 
al., 1998), German production workers (Becher et al., 1992, 1996; Flesch-Janys, 
1997; Flesch-Janys et al., 1995, 1996; Manz et al., 1991), and New Zealand pro-
duction workers (Burns et al., 2010; Collins et al., 2009a; McBride et al. 2009a,b; 
't Mannetje et al., 2005, 2017, 2018). Several of the component cohorts have 
not been the subject of any separate publications: Australian herbicide sprayers, 
Canadian herbicide sprayers, Finnish production workers, two cohorts of Italian 
production workers, and Swedish production workers. The U.S. NIOSH cohort 
was added to the IARC cohort as of the 1997 publication by Kogevinas et al. and 
is discussed after the international production-worker cohorts.
Previous committees have examined studies of several international production- 
worker or herbicide-using worker cohorts, including many that were subcohorts 
of IARC. No new studies were identified by the committee for inclusion in the 
current report on many of these groups, including
• BASF Ludwigshafen Plant workers, Germany, who were involved in an 
accident in 1953 when some of the workers experienced extremely high 
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exposures to TCDD during the manufacture of trichlorophenol (TCP), or 
as a result of the accident, or following the accident during reactor cleanup, 
maintenance, or demolition (Ott and Zober, 1996; Thiess et al., 1982; 
Zober et al., 1990, 1994, 1997). (This group was not in the IARC cohort.)
• Two Dutch subcohorts of the IARC cohort consisting of 2,106 male 
workers employed in two manufacturing factories producing and formu-
lating chlorophenoxy herbicides: 2,4,5-T in factory A from 1955 through 
1985, and 2-methyl-4-chlorophenoxyacetic acid (MCPA), 2-(2-methyl-4- 
chlorophenoxy) propionic acid (Mecoprop, MCPP), and 2,4-D in factory 
B from 1965 through 1986. Accordingly, members of both subcohorts 
had potential exposure to phenoxy herbicides, but only those in factory 
A would have been exposed to TCDD. Several analyses have been made 
using the entire cohort population or subsets of workers from chemical 
production factory A and factory B—these have examined different end-
points and applied different methods and measures to estimate exposure 
to TCDD (Boers et al., 2010, 2012; Bueno de Mesquita et al., 1993; 
Hooiveld et al., 1998; Saberi Hosnijeh et al., 2011, 2012a,b,c, 2013a,b).
• German production workers consisting of four German cohorts added to 
the IARC cohort as of 1997: the Boehringer–Ingelheim cohort, which 
had a high potential for TCDD exposure from the production of TCP and 
2,4,5-T from 1951 to 1954 and from 1957 to 1984 (Flesch-Janys, 1997; 
Flesch-Janys et al., 1995; Manuwald et al., 2012; Manz et al., 1991), a co-
hort in the BASF Ludwigshafen plant that did not include those involved 
in the 1953 accident, and cohorts in two Bayer plants (Becher et al., 
1992, 1996). All the plants were involved in the production of phenoxy 
herbicides or chlorophenols.
• Workers in Czechoslovakia (n > 80) who were exposed to TCDD during 
the production of 2,4,5-T (Pazderova-Vejlupková et al., 1981; Pelclová et 
al., 2001, 2002, 2007, 2009, 2011; Urban et al., 2007).
New Zealand Production Workers Two new studies on this cohort were iden-
tified ('t Mannetje et al., 2017, 2018). The Dow AgroSciences plant in New Plym-
outh, New Zealand, produced phenoxy herbicides from the late 1950s through 
the mid-1980s. This plant also produced picloram, one of the COIs about which 
very little information is available. The New Zealand cohort was incorporated 
into the original IARC cohort.
Complete employment records for 1969–1984 (referred to as the 1984 cohort) 
were available and 't Mannetje et al. (2005) used them to report on the mortal-
ity experience through 2000 of the 713 men and 100 women who had worked at 
least 1 month in that period. McBride et al. (2009a) conducted expanded analyses 
and updated previous analyses of cause-specific mortality from both cancers and 
other conditions. The cohort was increased to 1,599 participants (the 1988 cohort), 
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including a substantial number of people who had minimal opportunity for expo-
sure, by extending the employment period for eligibility to November 1, 1988, and 
removing the requirement that employment lasted at least 1 month. A subsample 
of the 1988 cohort participated in a serum-dioxin analysis that found that 70% 
had been exposed. McBride et al. (2009b) further expanded the cohort to 1,754 
participants (the 2003 cohort) by further extending eligibility to anyone who had 
worked at the site at any time until October 1, 2003. Both enlarged cohorts were 
followed through 2004. The New Zealand Health Information Service Mortality 
Collection was used to identify deaths, and exposure status was classified accord-
ing to work experience. Collins et al. (2009a) described the group’s serum TCDD 
concentrations overall, and Burns et al. (2010) performed analyses to determine 
what factors might predict serum TCDD: age, BMI, and employment history were 
found to be significant determinants. Both Collins et al. (2009a) and C. J. Burns et 
al. (2010) reported standardized mortality ratios adjusted for age, sex, and calendar 
age and used the New Zealand general population as the reference population. For 
the 1988 cohort, effect estimates were stratified by exposure status (ever exposed 
and never exposed) and by predicted cumulative exposure categories. For the 
2003 cohort, standardized mortality ratios were reported for the entire cohort and 
stratified by employment duration (less than 3 months and at least 3 months) and 
by latency (15 years of latency and less than 15 years of latency). For the 1988 
cohort, proportional-hazards survival analysis was also used to test the association 
between mortality and predicted cumulative exposure categories.
The New Zealand studies have several important limitations. The sample loss 
was substantial: 13% were lost to follow-up in both cohorts, and 8% of the 1988 
cohort and 9% of the 2003 cohort emigrated. If subject loss was nonrandom, then 
the study findings might be vulnerable to sample selection bias. In addition, the 
inclusion in the 2003 cohort of the employees hired as recently as 2003 is ques-
tionable. It appears that no deaths were observed in the increment between the 
1988 cohort and the 2003 cohort (those hired since 1988), presumably because 
these participants were relatively young. The inclusion of the incremental partici-
pants might dilute the power of the study to detect the effects of TCDD exposure 
on health outcomes that require a long latent period; participants who have not yet 
“matured” through the latent period might be contributing noise rather than signal 
to the analyses. The Update 2010 committee, therefore, did not give substantial 
weight to the dose–response findings of McBride et al. (2009b). The serum con-
centrations of dioxins and furans observed in a subset of the workers in the Dow 
phenoxy-herbicide plant in New Zealand have been used in estimating individual 
exposure (Aylward et al., 2010; Collins et al., 2009a).
National Institute for Occupational Safety and Health (NIOSH) Studies
NIOSH has collected data on and followed several groups of U.S. 
 workers exposed to the committee’s COIs, including the dioxin registry; the 
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pentachlorophenol (PCP) cohort (Ruder and Yiin, 2011); the cross-sectional med-
ical study of workers in plants producing 2,4,5-TCP and 2,4,5-T or 2,4,5-TCP, 
2,4,5-T, and hexachlorophene (Alderfer et al., 1992; Calvert et al., 1991, 1992, 
1994, 1998, 1999; Egeland et al., 1994; Halperin et al., 1995, 1998;  Kayajanian, 
2002; Lawson et al., 2004; Sweeney et al., 1993, 1996, 1997–1998); and the 
TCDD mortality cohort. The NIOSH cohort was added to the IARC cohort as of 
the 1997 publication by Kogevinas et al. No new studies on the entire NIOSH 
cohort have been published since those reviewed in Update 2006.
NIOSH TCDD Mortality Cohort Since 1978, NIOSH has compiled an exten-
sive set of data on chemical production workers potentially contaminated with 
TCDD in 1942–1984. More than 5,000 workers who were involved in produc-
tion or maintenance in any of 12 companies were identified from personnel and 
payroll records; 172 additional workers identified previously by their employers 
as being exposed to TCDD were also included in the study cohort (Suskind and 
Hertzberg, 1984). The employees’ possible exposure resulted from working with 
various substances of which TCDD was a contaminant: 2,4,5-TCP, 2-(2,4,5- 
trichlorophenoxy) propionic acid (Silvex, 2,4,5-TP), 2-(2,4,5-trichlorophenoxy) 
ethyl 2,2-dichloropropionate (Erbon), O,O-dimethyl O-(2,4,5-trichlorophenyl) 
phosphorothioate (Ronnel®), and hexachlorophene. The 12 plants involved were 
large manufacturing sites of major chemical companies, so many of the partici-
pants were potentially exposed to many other compounds, some of which could 
be toxic and carcinogenic.
Exposure status was determined initially through a review of process oper-
ating conditions, employee duties, and analytic records of TCDD in industrial 
hygiene samples, process streams, products, and waste (Fingerhut et al., 1991). 
Occupational exposure to TCDD-contaminated processes was confirmed by mea-
suring serum TCDD in 253 cohort members. The duration of exposure, defined 
as the number of years an employee had worked in processes contaminated with 
TCDD, was used as the primary exposure metric in the study. The use of duration 
of exposure as a surrogate for cumulative exposure was based on a correlation 
(Pearson correlation efficient, 0.72) between log-transformed serum TCDD levels 
and the number of years worked in TCDD-contaminated processes. The dura-
tion of exposure of individual workers was calculated from work records, and 
exposure-duration categories were created: < 1 year, 1–<5 years, 5–<15 years, 
and ≥15 years. In some cases, information on the duration of exposure was not 
available, so a separate metric, duration of employment, was defined as the total 
time that each worker was employed at the study plant. Fingerhut et al. (1991) 
used the exposure measures in assessing mortality through 1987.
A follow-up study (Steenland et al., 1999) examined the association between 
TCDD exposure and cause of death through 1993; it examined specific health 
outcomes, including cancers (all and site-specific), respiratory disease, cardio-
vascular disease, and diabetes. The researchers used a more refined exposure 
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assessment than had previous analyses. It excluded workers whose records were 
inadequate to determine the duration of exposure, and this reduced the number 
of study participants to a subcohort of 3,538 workers (69% of the overall cohort). 
The exposure assessment for that subcohort was based on a job–exposure matrix 
that assigned each remaining worker a quantitative exposure score for each year 
of work (Piacitelli and Marlow, 1997).
Subcohorts of the NIOSH TCDD Mortality Cohort
Monsanto The NIOSH study cohort (Fingerhut et al., 1991) included employ-
ees of the Monsanto facility in Nitro, West Virginia, which produced 2,4,5-T in 
1948–1969. Zack and Suskind (1980) examined the mortality experience of the 
121 men who had chloracne associated with an unintentional release that oc-
curred on March 8, 1949. Other studies considered mortality and other health 
outcomes in additional workers involved in numerous aspects of 2,4,5-T pro-
duction at the Monsanto plant (Collins et al., 1993; Moses et al., 1984; Suskind 
and Hertzberg, 1984; Zack and Gaffey, 1983). No additional studies on those 
participants alone have been published; they have since been followed as part of 
the NIOSH and IARC cohorts.
Dow Production Workers At the Dow plant in Midland, Michigan, 2,4-D, 
TCP, and PCP were manufactured over different, overlapping time periods and 
exposed different populations of workers. The cohort of TCP workers who were 
potentially exposed specifically to TCDD is one of the eight cohorts in the 
NIOSH cohort of dioxin-exposed U.S. workers that were entered into the IARC 
phenoxy herbicides cohort. Dow PCP workers who were not exposed to TCDD 
are not in the IARC or NIOSH cohorts for TCDD, but this group is one of four 
cohorts included in NIOSH’s PCP cohort (Fingerhut et al., 1984; Ruder and Yiin, 
2011). Dow assembled a large cohort at the Midland, Michigan, plant (Bond et 
al., 1989a; Cook et al., 1986, 1987). TCDD exposure in the cohort was defined 
by chloracne diagnosis (Bond et al., 1989b). Within the cohort, a subcohort study 
of women (Ott et al., 1987) and a case-control study of STS (Sobel et al., 1987) 
were conducted. The Dow cohorts have been followed as part of the NIOSH and 
IARC cohorts since 1991 and 1997, respectively.
C. J. Burns et al. (2011) reported on cancer incidence in 2,4-D production 
workers in the Dow Midland plant. The exposed cohort consisted of 1,316 men 
who worked in 2,4-D operations from 1945 through 1994 and who were alive 
on January 1, 1985, when the Michigan statewide cancer registry was initiated. 
Exposure was considered both as a discrete category (exposed cohort members 
versus a non-exposed reference population) and as a cumulative variable esti-
mated as (job-specific exposure estimate) × (duration on the job) summed over 
all jobs held since 1945. Workers were stratified into three categories according 
to their estimated cumulative exposure. The cohort was followed from 1985 
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through 2007. Cancer incidence was ascertained from the Michigan statewide 
cancer registry, and data were linked to two other states where cohort members 
might reside. Three nested cohorts were used for statistical analyses in order to 
address potential problems with missing data due to migration outside the three 
states, with data linkage. Cohort 1 consisted of the entire exposed cohort regard-
less of residency (1,316 people who had 25,267 person-years of follow-up). 
Cohort 2 required Michigan residency: follow-up was terminated when a person 
was no longer a Michigan resident because company records showed a permanent 
non-Michigan address (those who died were classified as residents if Michigan 
was listed as the state of residency on their death certificates) (1,256 who had 
23,354 person-years). Cohort 3 was the most restrictive and required Michigan 
residency; follow-up was terminated as soon as a person was no longer known to 
be a Michigan resident (1,108 who had 18,897 person-years). People of unknown 
residency status were assumed to remain Michigan residents and were included 
in the follow-up for Cohort 2 but were excluded from Cohort 3. Standardized 
incidence ratios were derived for all three cohorts, with Michigan white males as 
the reference population; Fisher’s exact confidence intervals were used to char-
acterize the uncertainty. For Cohort 2, additional analyses were conducted by us-
ing the National Cancer Institute’s Surveillance, Epidemiology, and End Results 
registry population and a regional population as the reference populations. The 
cohort was stratified according to cumulative duration and cumulative exposure 
categories. There were several concerns that the study findings might be biased. 
First, the study cohort might be healthier than the general population being used 
as the reference population. Second, the lack of a latency period in the study 
design might lead to an attenuation effect on the risk estimates. Third, Cohort 2, 
which was the researchers’ focus in the study, might be vulnerable to an attenua-
tion effect because of the uncertainty in residency status. The results on Cohort 3 
are considered the least subject to bias and therefore the most reliable. Although 
Cohort 3 was the smallest group and as such is also subject to the most variabil-
ity, consistency in results among the three cohorts was considered confirmatory.
All Dow TCP-Exposed Workers TCP was produced in Dow’s Midland facil-
ity from 1942 to 1979, and 2,4,5-T was produced there from 1948 to 1982. 
Collins et al. (2009b) reported on the vital status through 2003 of 1,615 people 
who worked with TCP or 2,4,5-T from 1942 through 1982; 58,743 person-years 
were accumulated, and 662 deaths were observed. Standardized mortality ratios 
for cause-specific mortality in the cohort—with and without the overlap of 
196 people who were also part of the PCP cohort (reviewed in Collins et al., 
2009c)—were calculated by using the U.S. population as the reference popu-
lation and using the Occupational Mortality Analysis Program. Work history 
records were used to determine length of exposure. Serum samples used for 
measuring the levels of six types of dioxins were collected for 431 TCP and 
PCP workers. Historic concentrations for each dioxin congener were calculated 
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from the median concentrations from the serum samples and the known half-
lives associated with each congener. A job exposure matrix was created for both 
the TCP and PCP production facilities based on measured concentrations for 
workers in different jobs. A pharmacokinetic model was applied to job-specific 
concentrations to the work history of each member of the study group to esti-
mate their time-dependent serum concentration profiles for each dioxin congener 
(i.e., TCDD, as well as Hexa-CDD, Hepta-CDD, and Octa-CDD). Collins et al. 
(2016) reported the results of an additional follow-up of vital status to TCP and 
PCP production workers. Vital status was determined for the cohort through 
December 2011; a total of 1,198 deaths since 1979 were found.
Dow PCP Production Workers These workers were engaged in the manu-
facture of PCP from 1937 to 1980 in the same plant where the TCP cohort 
worked. Unlike TCP, PCP did not contain TCDD, but it did contain other highly 
chlorinated dioxin congeners, and 20% of the PCP workers had suffered from 
chloracne. Dow performed an exposure risk assessment on the subset of its manu-
facturing workers who were exposed to PCP (Ramlow et al., 1996). The exposure 
assessment evaluated the available industrial-hygiene and process data, including 
recollections from employees about their job, processes, and changes in processes 
as well as data from engineering controls, measurements from surface wipes, and 
exposure-monitoring data from area sampling and personal breathing zones. Jobs 
in the “flaking/prilling/packaging area” were determined to have a higher poten-
tial exposure because of dermal exposure to airborne PCP; the industrial-hygiene 
data suggested a difference of about a factor of 3 between the areas of highest 
and lowest potential exposure. An estimated exposure-intensity score of between 
1 and 3 (from lowest to highest potential exposure intensity) was assigned to 
each job. Information concerning the use of personal protective equipment was 
deemed to be unreliable. For each participant, cumulative PCP and TCDD ex-
posure indexes were calculated by multiplying the duration of each exposed job 
by its estimated exposure intensity and then summing across all exposed jobs.
Collins et al. (2009c) conducted a mortality study of the Dow PCP produc-
tion workers with the accrual of years at risk starting at the beginning of 1940 
and followed through 2003; the TCP workers were followed over the same years 
(Collins et al., 2009b). The cohort consisted of 773 PCP workers; 27,035 person-
years were accumulated, and 370 deaths were observed. Standardized mortality 
ratios for the PCP cohort (with and without the overlap of 196 people in the TCP 
cohort) were reported for cause-specific mortality, with the U.S. population as 
the referent population. Proportional-hazards survival analysis was also used to 
assess the association between mortality and predicted cumulative exposure as 
a function of the total TCDD TEQ. An updated mortality analysis that follows 
the cohort of PCP and TCP workers though 2011 and reports cause-specific 
mortality on several cancers and other diseases (Collins et al., 2016) is reviewed 
in the current update.
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Dow TCDD-Exposed Production Workers Dow conducted a study of 204 
workers engaged in the production of 2,4,5-T (Ott et al., 1980) and another 
study of 61 TCP manufacturing workers who had chloracne (Cook et al., 1980). 
Industrial hygienists developed a job-exposure matrix that ranked employee ex-
posures as low, moderate, or high on the basis of available air-monitoring data 
and professional judgment. The matrix was merged with employee work histories 
to assign an estimate of exposure to each job. A cumulative dose was then de-
veloped for each of the 878 employees by multiplying the representative 8-hour 
time-weighted average exposure value for each job by the number of years in 
the job and then adding the products for all jobs. A 2,4-D time-weighted average 
of 0.05 mg/m3 was used for low, 0.5 mg/m3 for moderate, and 5 mg/m3 for high 
exposure. The exposure estimates do not appear to have taken into account the 
role of dermal exposure in the facilities. It is not clear to what extent the use of 
air measurements alone can provide accurate classification of workers into low-, 
moderate-, and high-exposure groups. The study apparently did not include bio-
logic monitoring of 2,4-D.
Bond et al. (1983) investigated potential exposure to TCDD and morbidity 
in the sets of workers reported on by Cook et al. (1980) and Ott et al. (1980). Po-
tential TCDD exposure and reproductive outcomes were studied in the offspring 
of 930 men who worked with chlorophenol from 1939 through 1975 (Townsend 
et al., 1982). Dow employees who had a diagnosis of chloracne or who were 
classified as having chloracne on the basis of a clinical description were fol-
lowed prospectively for mortality (Bond et al., 1987). There was a succession of 
mortality studies of workers involved in 2,4-D production in several of the plants 
(Bloemen et al., 1993; Bond et al., 1988; C. J. Burns et al., 2001). These studies 
also used the same exposure-assessment procedures.
Bodner et al. (2003) published a 10-year follow-up of the work of Cook et al. 
(1986), comparing the mortality experience of 2,187 male workers at Dow who 
were potentially heavily exposed to dioxin before 1983 with that of the NIOSH 
and IARC cohorts. Dow researchers have published a study of serum dioxin 
concentrations measured in 2002 in former chlorophenol workers (Collins et al., 
2006). Most of the workers in the study were included in the NIOSH and IARC 
cohorts. The authors used their data to estimate worker exposure at the time of 
exposure termination by using several pharmacokinetic models. They concluded 
that their findings were consistent with those of other studies that reported high 
serum dioxin concentrations in chlorophenol workers after occupational exposure.
Aylward et al. (2013) examined the elimination rates of dioxin congeners in 
former chlorophenol workers from the Midland plant. Blood samples from 56 
former chlorophenol workers were taken and examined in 2004–2005 and then 
resampled in 2010. The purpose of this analysis was to estimate half-life reduc-
tions for TCDD TEQs, which, in aggregate, were 9.3 years for the dioxin conge-
ners analyzed. This analysis is informative with respect to estimating elimination 
rates over time for the COIs as the Vietnam-veteran cohort continues to age.
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Studies of Other Industrial Cohorts
VAO committees have reviewed several other occupational cohorts and studies 
of industrial workers over the series. The countries and industries have included
• Chinese automobile foundry workers (L. Wang et al., 2013);
• pulp and paper workers exposed to TCDD and other dioxins that can be 
generated by the bleaching process during the production and treatment of 
paper and paper products in the United States (Henneberger et al., 1989; 
Robinson et al., 1986; Solet et al., 1989), Finland (Jäppinen and Pukkala, 
1991), Denmark (Rix et al., 1998), and an IARC cohort of paper and pulp 
workers in 11 countries (McLean et al., 2006);
• sawmill workers with dermal and inhalation exposure through the use 
of pentachlorophenates (which are contaminated with higher-chlorinated 
PCDDs [Cl6–Cl8]) in British Columbia, Canada (Dimich-Ward et al., 
1996; Heacock et al., 1998; Hertzman et al., 1997), and New Zealand 
(McLean et al., 2009), or to tetrachlorophenates (which are less con-
taminated with higher-chlorinated PCDDs) (McLean et al., 2009) in New 
Zealand; and
• waste incineration workers in Japan (Yamamoto et al., 2015; Yoshida et 
al., 2006) and Korea (Oh et al., 2005).
Studies of U.S. workers in other chemical plants have also included studies 
of 2,4-D and 2,4,5-T production workers (Poland et al., 1971), white men em-
ployed at a chemical plant that manufactured flavors and fragrances (Thomas, 
1987), and workers producing PCP, lower-chlorinated phenols, and esters of 
chlorophenoxy acids (Hryhorczuk et al., 1998).
International cohorts of chemical workers exposed to the COIs have included 
UK chemical workers exposed to TCDD as a result of an industrial accident in 
1968 (Jennings et al., 1988; May, 1973, 1982, 1983), 2,4-D production workers 
in the former Soviet Union (Bashirov, 1969), and Croatian workers exposed to 
a complex mixture of pesticides (atrazine, alachlor, cyanazine, 2,4-D, and mala-
thion) during the production process (Garaj-Vrhovac and Zeljezić, 2002). Some of 
these worker populations, such as the Chinese automobile foundry workers, were 
reported on only once, and others were prospectively or retrospectively followed 
for years, such as waste incineration workers in Japan (Yamamoto et al., 2015; 
Yoshida et al., 2006). Summaries of these studies are included in the update in 
which they were first identified. For the current volume, morbidity and mortality 
outcomes of worker cohorts at an electric arc furnace in Italy (Cappelletti et al., 
2016) and at a transformer and capacitor recycling plant in Germany (Fimm et 
al., 2017; Haase et al., 2016; Putschogl et al., 2015) are reviewed.
Inadequate occupational hygiene at a recycling plant for capacitors and 
transformers in Dortmund, Germany, led to a significant body burden of PCBs 
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in workers, their family members, and people working or living in the imme-
diate  vicinity of the plant. A medical surveillance program, Health Effects in 
High-Level Exposure to PCB, was initiated to provide biomonitoring to identify 
potential health risks related to PCB exposure for the affected population (Kraus 
et al., 2012). Workers of and residents around this plant were exposed to both 
dioxin-like (PCBs 105, 114, 123, 156, 157, 167, and 189) and non-dioxin-like 
PCBs as a result of contamination of the area. Participation in the surveillance 
program was voluntary, and data and blood samples were collected at three time 
points: immediately (beginning in 2010), 1 year, and 2 years after exposure. 
PCB congeners were measured in serum using blood samples collected from the 
participants, and urine samples were also collected at the three time points. Of 
the eligible 294 adults, 148 participated at all three time points. Three studies 
using these data were published and are reviewed in this update. Putschogl et al. 
(2015) studied associations with neurotransmitter metabolites of dopamine and 
 norepinephrine in urine as markers of targeted effects on these specific neuro-
transmission pathways, and Haase et al. (2016) confirmed that PCB exposure can 
modify lymphocyte profiles. However, neither of these analyses of metabolites or 
immune cells is diagnostic of a specific health outcome, and they are therefore 
only of tangential relevance to the committee’s charge. Fimm et al. (2017) exam-
ined a broad range of cognitive functions covering attention, executive process-
ing, reasoning, memory, and motor performance in this cohort.
Studies of Herbicide-Using Workers
The original VAO committee and committees up through Update 2006 were 
more inclusive of identified studies from the literature searches. Several of the 
early studies reviewed and included in the updates had nonspecific, inferred 
exposure characterizations based on “usual occupation” from death certificates, 
self-reported “current occupation,” or census tract or area of residence (e.g., rural 
or farming areas). The studies focused primarily on farmers and people employed 
in the agricultural industry, but workers in forestry and other outdoor occupations, 
such as highway-maintenance workers, are also likely to have been exposed to 
herbicides and other chemicals. The problem with using such nonspecific surro-
gates of exposure is that it will influence and change the effect estimates (either 
toward or away from the null depending on the types of bias present) making it 
impossible to know the true effect of the COIs. Occupation or job titles do not 
provide information on the duration or the intensity of the exposure, and they 
cannot be used to determine whether a worker was exposed to a specific agent. 
Even those studies that collected more details on the number of years of employ-
ment in the agriculture industry, broad categories of the chemicals used (e.g., 
herbicides, insecticides, fungicides, etc.), specific classes of chemicals or names, 
the frequency of application, the use of personal protective equipment, and the 
method of application may be limited by recall or information bias (depending on 
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whether other records are available) and do not provide much evidentiary weight 
if the specific agents and chemicals used are not collected.
Since the first VAO report, exposure assessments in epidemiology studies 
have been increasingly exact in both specificity and amount, enabling the com-
mittees of the more recent updates to establish stricter criteria for accepting ex-
posure as sufficiently specific for results to be added to the evidentiary database. 
The current committee now seeks results expressed in terms of the five COIs for 
this project or their analogues, and it regards classification based only on job title 
as inadequate. Data derived from studies in which exposure is described non-
specifically as “herbicide” can at most be used as supportive evidence. According 
to the policy established by the Agent Orange Act of 1991, studies of Vietnam 
veterans are presumed to involve relevant exposure, as are studies of workers 
at a particular plant during a period when it is known to have been producing 
phenoxy herbicides or other chemicals recognized as having been contaminated 
with TCDD.
The most reliable information on health effects among American herbicide 
applicators and users exposed to the COIs has come from prospective investiga-
tions of the Agricultural Health Study (AHS). More than 200 publications have 
reported on outcomes from this cohort, although not all have focused on the use 
of 2,4-D or other COIs. Several new publications from the AHS were reviewed 
in the current update. VAO and update committees have also reviewed studies 
of other populations of farmers and agricultural workers conducted among state 
populations and as part of larger cohorts such as the CropLife America Farm 
Family Exposure Study (Mandel et al., 2005) and the California United Farm 
Workers of America Study (Mills and Yang, 2005, 2007; Mills et al. 2005). In 
addition to studies of herbicide users in the United States, several international 
publications have been reviewed by VAO committees.
Agricultural Health Study
The AHS is a prospective investigation of cohorts of private pesticide appli-
cators (farmers), their spouses, and commercial pesticide applicators in Iowa and 
North Carolina, with a total of 89,658 participants, including 57,311 applicators 
(82% of those seeking licensing) and 32,347 spouses (75% of all spouses). The 
applicators are predominantly male, and the spouses are predominantly female. 
The AHS is sponsored by the National Cancer Institute, the Environmental Pro-
tection Agency, and the National Institute of Environmental Health Sciences. 
Enrollment in the study was offered to applicants for applicator certification in 
Iowa and North Carolina. The project’s website (www.aghealth.nih.gov) provides 
many details about the study, including a specification of which pesticides were 
the subject of information gathered from the enrollment forms and mailed ques-
tionnaires (Alavanja et al., 1994).
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In phase I (1993–1997), the enrollment form for both commercial (8.6%) and 
private (largely farmers) applicators asked for details on the use of 22 pesticides 
(10 herbicides, including 2,4-D; 9 insecticides; 2 fungicides; and 1 fumigant) 
and yes–no responses as to whether 28 other pesticides (8 herbicides, including 
2,4,5-T and Silvex; 13 insecticides; 4 fungicides; and 3 fumigants) had ever been 
used. A subset of 24,034 applicators also completed and mailed back a take-home 
questionnaire (response rate 42%). The questionnaire asked for details about use 
of the 28 pesticides with yes–no information on the enrollment form and for yes–
no responses as to whether 108 other pesticides (34 herbicides, including organic 
arsenic, which would cover cacodylic acid; 36 insecticides; 29 fungicides; and 9 
fumigants) had ever been “frequently” used. Although no pronounced differences 
in demographics, medical histories, or farming practices were found between 
those who completed the questionnaire and those who did not (Tarone et al., 
1997), it is still possible that selection bias might have compromised the validity 
of any studies based on the questionnaire because of differences that might not 
have been captured in the enrollment form. Dosemeci et al. (2002) published 
an algorithm designed to characterize the personal exposures of that popula-
tion. Weighting factors for the key exposure variables were developed from the 
literature on pesticide exposure. This quantitative approach has the potential to 
improve the accuracy of exposure classification for the cohort, but the published 
epidemiologic studies reviewed as part of the VAO series do not appear to have 
used that method.
Phase II was a 5-year follow-up conducted in 1999–2003. Computer-assisted 
telephone interviews were completed by 60,138 participants. The interviews 
specified “pesticides” in general to include herbicides. They asked about specific 
pesticides on individual crops; for several crops, only if atrazine or 2,4-D was 
specified was a participant asked whether it had been used alone or as part of 
the manufacturer’s mixture. A full pesticide list was not posted on the website 
with the follow-up questionnaire. In addition, dietary histories were completed 
by 35,164 respondents, and buccal-cell samples were gathered from 34,810 
participants. The rate of response to the phase II survey—67% overall and 63% 
of the original cohort of 55,748 male applicators—was modest and leaves some 
room for selection bias to compromise the validity of studies based on the survey. 
In phase III (2005–2010), responses to an updated computer-assisted telephone 
interview were provided by 43,426 participants.
Numerous reports on the AHS cohort have been considered in the VAO se-
ries, and several new published studies have been reviewed in the current update 
(Bonner et al., 2017; Christensen et al., 2016; Henneberger et al., 2014; Koutros 
et al., 2016; LaVerda et al., 2015; Lebov et al., 2015, 2016; Parks et al., 2016). All 
have developed pesticide-exposure estimates or exposure categories from self-
administered questionnaires, but only those studies that have considered exposure 
to the COIs are considered most relevant to VAO committees. The results on the 
relative rates of individual conditions seem comparable in exposure specificity 
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with findings in production cohorts in which not all of the workers included were 
necessarily exposed to the COIs and may have had additional toxic exposures. 
The AHS questionnaire collected detailed information regarding herbicide use; 
2,4-D was the most commonly reported herbicide. Because all relevant studies 
have been reviewed in detail in the VAO report that corresponded to their publi-
cation date, only an overview is presented here. Details of the studies reviewed 
for the first time in the current volume are presented in the section corresponding 
to the health outcome of interest. Using various subsets of the study population, 
they have addressed a variety of health outcomes associated with one or more of 
the COIs, including
• all-cause and cause-specific mortality (Blair et al., 2005a; Waggoner et al., 
2011) and morbidity (Alavanja et al., 2005; Blair et al., 2005b);
• incidence of prostate cancer (Alavanja et al., 2003, 2005), lung cancer 
(Alavanja et al., 2004), breast cancer (Engel et al., 2005), colorectal can-
cer (W. J. Lee et al., 2007), cutaneous melanoma (Dennis et al., 2010), 
all cancers (Alavanja et al., 2005; Koutros et al., 2010a, Samanic et al., 
2006), and risk factors for pancreatic cancer (Andreotti et al., 2009);
• neurotoxicity of chronic exposure to modest amounts of pesticides (Kamel 
et al., 2005), neurologic symptoms including memory and concentration 
problems (Kamel et al., 2007a), Parkinson disease (Kamel et al., 2007b, 
2014; Tanner et al., 2011), and amyotrophic lateral sclerosis (Kamel et 
al., 2012);
• reproductive effects (Farr et al., 2004, 2006) and cancer risk in the 21,375 
children of pesticide appliers born in 1975 or later (Flower et al., 2004);
• diabetes in applicators and their wives (Montgomery et al., 2008; Starling 
et al., 2014) and history of gestational diabetes (Saldana et al., 2007);
• incidence of and mortality from myocardial infarction (Mills et al., 2009) 
and mortality from stroke (Rinsky et al., 2013);
• respiratory symptoms and disorders: chemical predictors of wheeze 
(Hoppin et al., 2002, 2006b), hypersensitivity pneumonitis (Hoppin et 
al., 2007b), chronic bronchitis (Hoppin et al., 2007a; Valcin et al., 2007), 
atopic and nonatopic asthma in women (Hoppin et al., 2008), and allergic 
and nonallergic adult-onset asthma (Hoppin et al., 2009);
• thyroid disease among AHS female spouses (Goldner et al., 2010) and 
male pesticide applicators (Goldner et al., 2013); and
• genetic markers (single nucleotide polymorphisms and candidate genes) 
and outcomes of prostate cancer risk (Andreotti et al., 2012; Barry et al., 
2011, 2012; Karami et al., 2013; Koutros et al., 2010b, 2011), and telo-
mere length (Hou et al., 2013).
Health outcomes examined by a single study that have accounted for and pre-
sented results on relevant COI exposures include doctor visits resulting from 
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pesticide exposure (Alavanja et al., 1998), rheumatoid arthritis (De Roos et al., 
2005b), hearing loss (Crawford et al., 2008), and rhinitis in the past 12 months 
(Slager et al., 2009).
Several additional publications have discussed pesticide-use patterns in the 
population (Hoppin, 2005; Hoppin et al., 2006a; Kirrane et al., 2004; Samanic et 
al., 2005), estimated amounts of absorption of 2,4-D and chlorpyrifos exposures 
(Thomas et al., 2010), and have developed (Dosemeci et al., 2002) or refined 
(Coble et al., 2011) an algorithm for estimating pesticide exposure intensity. 
Other studies have focused on examining a variety of exposure issues, including 
the effect of exposure misclassification in the AHS (Blair et al., 2011) and using 
multiple imputation methods to assign pesticide use values for nonresponders and 
other missing data (Heltshe et al., 2012).
International Studies of Herbicide Users
Several studies have been reviewed in the VAO series that have published 
results of health effects on herbicide users in many different countries. In some 
countries, large studies were designed and large cohorts were followed, producing 
several publications that have been reviewed in the VAO series; those cohorts are 
described in brief by country of origin.
The Canadian Ontario Farm Family Health Study examined exposure to 
phenoxyacetic acid herbicides, including 2,4-D, and several fertility, reproduc-
tive, and pregnancy outcomes (Arbuckle et al., 1999a,b, 2001; Curtis et al., 
1999; Savitz et al., 1997) and birth defects (Weselak et al., 2008). Biomonitoring 
was conducted in a subset of participants to evaluate the validity of the self-
reported predictors of exposure (Arbuckle and Ritter, 2005; Arbuckle et al., 2002, 
2005) and to examine other potential indirect sources of exposure to herbicides 
(Arbuckle et al., 2006). A second large cohort of 156,242 Canadian male farm-
ers from three provinces, known as the Canadian Farm Operator Study, was as-
sembled, and information on herbicide use in the cohort was used to determine 
the risk of specific causes of death in that population: NHL (Morrison et al., 
1994; Wigle et al., 1990), prostate cancer (Morrison et al., 1993), brain cancer 
(Morrison et al., 1992), multiple myeloma (Semenciw et al., 1993), and leukemia 
(Semenciw et al., 1994). Other Canadian studies of agricultural workers have 
evaluated immune, neurobehavioral, and lung function of farmers who mixed 
and applied commercial formulations that contained chlorophenoxy herbicides 
and of residents in an agricultural area of Saskatchewan, Canada (Faustini et al., 
1996), as well as asthma and pesticide use among male farmers in Saskatchewan 
(Senthilselvan et al., 1992). Mortality in men employed by a Canadian public 
utility, who were likely exposed to herbicides similar to those used in Vietnam, 
has also been reviewed (Green, 1987, 1991).
In Denmark, three studies reported on a cohort of Danish gardeners who 
had been exposed to herbicides (E. S. Hansen et al., 1992, 2007; Kenborg et 
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al., 2012), and one study examined cancer incidence among Danish farmers 
(Ronco et al., 1992). Danish gardeners were identified from union worker records 
on May 1, 1975. Most of the women (n = 859) worked in greenhouses, where 
herbicides are not routinely used; the men (n = 3,156), however, were known 
to be highly exposed to pesticides and herbicides, which included the phenoxy 
herbicides 2,4-D, 2,4,5-T, and MCPA. Vital status of the entire cohort through 
1984 was achieved. Person-years at risk were calculated and reported for a latent 
period of 10–15 years. E. S. Hansen et al. (1992) determined the incidence of 
cancer in this cohort from 1975 to 1984 and compared those numbers with ex-
pected numbers calculated from incidence rates in the general Danish population. 
E. S. Hansen et al. (2007) used analogous methods to extend the follow-up period 
for the men through 2001 but used year of birth as a surrogate for intensity of 
exposure, with high exposures assumed for those who had been born before 1915, 
low exposures for those born in 1934 or later, and intermediate exposure for those 
born in between. Using this same cohort of Danish gardeners but restricted to 
men alive and living in Denmark at the beginning of 1977 (n = 3,124), Kenborg et 
al. (2012) reported on the incidence of Parkinson disease as a primary diagnosis 
from 1977 through 2008 and compared the results with the observed incidence of 
Parkinson disease in all Danish men by calendar period and age group. Kenborg 
et al. (2012) also reported on the incidence of lung, larynx, and bladder cancers 
in the cohort compared with the incidence in the general male Danish population. 
For the current update, a study of parental employment in farming and agricul-
ture and cryptorchidism in offspring using the Danish National Patient Registry 
(Jorgensen et al., 2014) was identified and reviewed.
Three studies reporting on or updating mortality or cancer morbidity in Finn-
ish men who had applied 2,4-D and 2,4,5-T for at least 2 weeks in 1955–1971 
through work removing brush have been reviewed in the VAO series (Asp et al., 
1994; Riihimaki et al., 1982, 1983).
Studies of Italian herbicide users have primarily been conducted among 
farmers in particular regions. Gambini et al. (1997) examined cancer mortality 
in a cohort of rice growers in northern Italy. Two studies reported on a cohort of 
male farmers in Italy’s southern Piedmont region who were licensed to use agri-
cultural pesticides in 1970–1974, and the use of phenoxy herbicides in the area 
was reported to be twice the national average. Corrao et al. (1989) evaluated can-
cer incidence in the 25,945 men in the cohort on the basis of new diagnoses from 
hospital admissions in 1976–1983. In a continuation of that study, Torchio et al. 
(1994) reported on mortality through 1986 in the 23,401 men who were residents 
of the Piedmont area at the time of registration, stratified by the location of their 
residences (lived near arable land, near woodlands, and near mixed-use land).
The original VAO committee reviewed several studies that used data from the 
Swedish Cancer-Environment Register, which contained data from the Swedish 
Cancer Registry and individual responses from the 1960 and 1970  national cen-
suses, including data on current occupation. Publications that used the Swedish 
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Cancer-Environment Register included a study of cancer incidence and farm work 
(Wiklund, 1983); studies of STS and malignant lymphoma in agricultural and for-
estry workers (Wiklund and Holm, 1986; Wiklund et al., 1988a); and a study of the 
risk of multiple myeloma in relation to various occupational activities (Eriksson 
and Karlsson, 1992). Two studies of cancer mortality in Swedish railroad workers 
who were exposed to 2,4-D, 2,4,5-T, and other herbicides were also examined 
(Axelson and Sundell, 1974; Axelson et al., 1980). Other studies reviewed by 
the committee addressed mortality and cancer incidence in a cohort of Swedish 
lumberjacks (Thörn et al., 2000) and cancers in Swedish pesticide and herbicide 
applicators (Dich and Wiklund, 1998; Wiklund et al., 1987, 1988b, 1989a,b).
For some countries, only one or two studies have been published on exposure 
to the COIs and health outcomes (mortality, prevalence, or incidence) among 
herbicide handlers. Many of these studies were small and, especially the earlier 
studies, lacked adequate or specific exposure information. These have included: 
Argentinian farmers (Butinof et al., 2015; Lerda and Rizzi, 1991); Australians 
exposed to phenoxy herbicides (Fritschi et al., 2005); Dutch forestry workers 
exposed to 2,4,5-T (van Houdt et al., 1983) and Dutch male herbicide appli-
cators (Swaen et al., 1992, 2004); German male agricultural plant-protection 
workers in the former German Democratic Republic who spent at least 5 years 
during 1948–1972 applying pesticides, some of which were phenoxy herbicides 
(Barthel, 1981); Icelanders whose occupation may have exposed them to 2,4-D 
(Zhong and Rafnsson, 1996); Indian herbicide sprayers and warehouse employ-
ees (Linga Reddy et al., 2015); Mexican agricultural workers (Carbajal-López 
et al., 2016); New Zealand forestry workers (Reif et al., 1989); and offspring of 
Norwegian farmers (Kristensen et al., 1997).
ENVIRONMENTAL STUDIES
Industrial accidents have led to the evaluation of long-term health effects in 
non-worker populations that live near areas with fairly high environmental con-
centrations of the COIs. Effects on residents around normally operating industrial 
operations, such as waste incinerators, and even on people exposed only to “back-
ground” concentrations have also been studied. The systematic follow-up studies 
that have been conducted on the Seveso population and the numerous analyses of 
the population-level data collection effort of NHANES have contributed promi-
nently to the evidence base considered by VAO committees.
Environmental exposures to the COIs almost never occur in isolation. Ex-
posures to dioxin-like chemicals generally occur as part of mixtures that also 
include non–dioxin-like chemicals that tend to correlate with the dioxin-like 
chemicals, so it is not surprising that specific chemicals measured in a person’s 
serum also tend to correlate with one another; this collinearity means that it is 
difficult for epidemiologic studies to attribute any observed association to a par-
ticular chemical configuration (Longnecker and Michalek, 2000).
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Environmental studies are presented below, beginning with the United States, 
then summarizing major international cohorts.
U.S. Environmental Studies
Several populations with environmental exposures to the COIs have been 
reviewed in the course of the VAO series. Descriptions of those populations and 
cohorts for which no new information has been identified since the last VAO up-
date report (e.g., Anniston, Alabama, Community Health Survey; the Great Lakes 
Fish Consumption Study; the Iowa Women’s Health Study; and Times Beach 
and Quail Run, Missouri) can be found in Chapter 6 of Update 2014 (NASEM, 
2016a) and the volume that first reviewed the study following its publication. 
Studies of U.S. populations that the committee identified and that have not been 
the focus of multiple ongoing follow-up or publications are summarized in the 
chapters related to the health outcome of interest.
National Health and Nutrition Examination Survey
In the early 1960s the CDC National Center for Health Statistics began the 
NHANES program as a means of monitoring and assessing the health and nutri-
tional status of people of all ages living in the United States. In 1999 the survey 
became a continuous program that has a changing focus on a variety of health and 
nutrition measurements in order to meet emerging needs. A rich variety of data—
demographic and socioeconomic data; dietary information; medical, dental, and 
physiologic assessments; and the serum concentrations of persistent organic pol-
lutants (POPs), including specific congeners of dioxins, furans, and PCBs—are 
collected through in-person interviews, health examinations, and blood samples 
obtained from a nationally representative sample of adults and children in the 
noninstitutionalized U.S. population. Information obtained from NHANES data 
is used to determine the prevalences of diseases, to assess nutritional status, and 
to establish national standards of height, weight, and blood pressure. Researchers 
also conduct analyses of the NHANES data for epidemiologic studies and medi-
cal research on various health outcomes using serum concentrations of various 
compounds to determine associations.
Starting with the preparation of Update 2008, VAO committees began seeing 
a stream of publications addressing the possible association of some pesticides 
and various individual and grouped dioxin-like chemicals with the occurrence of 
a  variety of health outcomes as assessed by the surveys for particular temporal 
spans. NHANES data from 1999 to 2002 were used to evaluate the relationships 
of the COIs with cardiovascular disease (Ha et al., 2007); diabetes, metabolic 
syndrome, insulin resistance, and arthritis (D. H. Lee et al., 2006, 2007a,b,c); 
peripheral neuropathy and poor glycemic control (A1C ≥ 7.0%) (D. H. Lee et 
al., 2008); obesity via BMI and waist circumference (Elobeid et al., 2010); and 
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thyroid-hormone concentrations (Turyk et al., 2007). Hypertension over this time 
period was examined by Ha et al. (2009) and Everett et al. (2008a), but Everett et 
al. also provided additional information for the years 2003–2004 in a subsequent 
commentary (Everett et al., 2008b). Peters et al. (2014) added NHANES data 
for 2005–2008 to the sets for 1999–2002 and 2003–2004 previously analyzed 
by Everett et al. (2008a,b) for the association of blood pressure with blood 
concentrations of dioxin-like PCBs 126 and 169 and mono-ortho PCBs 118 and 
156. Using this expanded data set, they developed a model to predict blood PCB 
concentrations using generally available variables (age, sex, ethnicity, and blood 
lipid levels). However, because only a single mono-ortho dioxin-like PCB was 
used in combination with PBCs having no dioxin-like activity, this work does 
not augment the results previously published by Everett et al. (2008a,b) for VAO 
purposes.
As additional cycles of NHANES were conducted and became available for 
research, new analyses used data collected over multiple cycles. For example, 
serum samples collected from NHANES participants between 1999–2004 were 
analyzed for organochlorine pesticides, POP residues, and dioxin-like chemicals, 
including PCDDs, PCDFs, and PCBs. M. R. Cho et al. (2011) reported on the 
asso ciations between bone mineral density and exposures to POPs and organo-
chlorine pesticides. Y. S. Lin et al. (2012) examined samples for levels of dioxin-
like chemicals (PCDDs, PCDFs, and PCBs based on TEQs) and their associations 
with total and cause-specific (cardiovascular and cancer) mortality, through 2006, 
based on ICD-10 codes. Everett and Thompson (2014) examined the relationship 
between dioxins (including TCDD) and dioxin-like PCBs (TEQs were calculated 
for six different dioxins and eight dioxin-like PCBs) and the prevalence of diabetic 
nephropathy. Using 2003–2004 NHANES data, Y. M. Lee et al. (2013) evaluated 
the associations between toxic equivalency factors (TEFs) for organochlorine 
pesticides as well as PCDDs, PCDFs, and PCBs and the risk of hyperuricemia 
in subjects 20 years of age and older. Jones et al. (2011) examined the associa-
tion between urinary arsenic and hypertension and blood pressure in NHANES 
2003–2008 participants. Each of the relevant NHANES studies and their results 
have been summarized in detail previously. For the current update, 1999–2004 
NHANES data were used to examine the relationship of serum concentrations of 
dioxin-like PCBs and other relevant chemicals with cancer (S. A. Kim et al., 2015; 
Morgan et al., 2017), diabetes and nephropathy (Everett and Thompson, 2016), 
cardiovascular outcomes (S. A. Kim et al., 2015), and possible indicators of im-
mune dysfunction (Serdar et al., 2014). NHANES data from cycles 1999–2000 
and 2001–2002 were used to examine the correlation between serum concentra-
tions of dioxin-like PCBs and cognitive impairment in adults (Przybyla et al., 
2017), and NHANES data from the 2011–2012 cycle were used to study whether 
different sets of urinary environmental chemical concentrations are risk factors of 
high blood pressure (Shiue et al., 2014).
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Priority Toxicant Reference Range Study The study population for the Prior-
ity Toxicant Reference Range Study was a subgroup of participants aged 20–59 
years in NHANES III (1988–1994), which was established to characterize the 
levels of 44 environmental toxicants (including 2,4-D and its metabolite 2,4- 
dichlorophenol) in urine and blood (regarded as indicators of internal dose). Un-
like overall NHANES samples, which were established by rigorous statistical 
sampling procedures to be representative samples of the U.S. population, this 
study sample is regarded as a convenience sample because its 1,338 members had 
voluntarily provided an additional 20 ml of blood and had responded to an extra 
questionnaire during their regular NHANES medical examination (Needham 
et al., 1995).
Schreinemachers (2010) examined the association in 727 healthy adults be-
tween exposure to 2,4-D, as indicated by its presence in urine, and biomarkers that 
are linked to the pathogenesis of acute myocardial infarction and type 2 diabetes, 
namely, serum high density lipoprotein, triglycerides, total cholesterol minus high 
density lipoprotein, insulin, C-peptide, plasma glucose, and thyroid-stimulating 
hormone. Urinary 2,4-D was detectable in 102 (14%) samples, with concentrations 
of 1–28 mg/dL. The outcome variables were compared between participants with 
and without detectable urinary 2,4-D by using Wilcoxon’s rank-sum test.
Krieg (2013) performed a limited assessment of cognition in 700 adults. 
Twelve pesticide metabolites were measured in the urine, including two 
chemicals found in the urine after 2,4-D exposure: unmetabolized 2,4-D and 
2,4- dichlorophenol. The analysis investigated the association of urine pesticide 
metabolite concentrations with the results of three neurobehavioral tests (simple 
reaction time, symbol-digit substitution, and serial digit learning).
Longitudinal Investigation of Fertility and the Environment Study
The Longitudinal Investigation of Fertility and the Environment (LIFE) Study 
examined environmental influences on human fecundity and fertility. Participants 
were 501 male partners of couples discontinuing contraception for the purposes of 
becoming pregnant who were recruited in Michigan and Texas during 2005–2009. 
Upon enrollment, in-person interviews were conducted with each male partner 
to ascertain health, demographic, and reproductive histories. All data and bio-
specimens were collected in the home, and baseline interviews were followed by a 
standardized anthropometric assessment for the determination of BMI conducted 
by research nurses who also obtained non-fasting blood (10 mL) for quantifica-
tion of serum chemicals and lipids. The quantification of POPs in serum included 
polybrominated biphenyl 153, 9 organochlorine pesticides, and 10 polybrominated 
diphenyl ethers. PCBs with TEFs included 105, 114, 118, 156, 157, 167, and 
189. A baseline semen sample was obtained followed by a second sample ap-
proximately 1 month later irrespective of couples’ pregnancy status. A total of 35 
semen  parameters were measured including 5 that reflected general characteristics 
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(volume, straw distance, sperm concentration, total sperm count, hypo-osmotic 
swollen), 8 motility measures, 12 morphometry measures, 8 morphology measures, 
and 2 sperm chromatin stability assay measures. Two publications from this study 
were identified and are reviewed in detail in Chapter 8: Mumford et al. (2015) 
examined the relationship between exposure to a number of persistent organic 
pollutants and semen quality, and Robledo et al. (2015) used blood samples from 
adult couples to characterize the relationship between the concentrations of a 
number of persistent organic pollutants and birth outcomes.
International Environmental Studies
Several studies of international populations that were environmentally ex-
posed to the COIs have been reviewed by VAO committees. As this chapter 
is not intended to be a compendium of every study ever reviewed in the VAO 
series, only those cohorts and groups with environmental exposures that have 
contributed more than one study for review by VAO committees and for which 
new information is available are considered here. A number of reviewed stud-
ies have used data analyzed from birth cohorts. For example, results from the 
Norwegian Mother and Child Cohort Study on prenatal exposure to dioxin-like 
PCBs and health outcomes have been previously reviewed (Papadopoulou et 
al., 2013; Stølevik et al., 2011). The Norwegian Mother and Child Cohort Study 
is a prospective, population-based pregnancy cohort that recruited more than 
100,000 pregnant women (resulting in about 114,000 children) and more than 
75,000 fathers from 1998 to 2008 to study the causes, variability, and trajectories 
of diseases over the life course. The participation rate was relatively low (41%), 
perhaps due, in part, to the requirement to be able to fluently read Norwegian. 
Questionnaires were administered to collect health data, demographic factors, 
lifestyle exposures, and developmental progress (Magnus et al., 2016). Blood 
samples were collected twice from the mothers (first at the ultrasound appoint-
ment at 17–18 weeks of gestation and later after delivery) and were processed 
and stored. A single blood sample was collected from fathers at the ultrasound 
appointment. A sample from the cord blood was drawn at delivery (Paltiel et 
al., 2014). New results from Caspersen et al. (2016) are presented in Chapter 8.
A second birth cohort for which several published studies have been re-
viewed in the VAO series is the Duisburg Birth Cohort Study (Nowack et al., 
2015; Rennert et al., 2012; Winneke et al., 2014). This cohort consists of 232 
healthy mother–infant pairs, in which the mothers were recruited between 2000 
and 2002 in Duisburg, Germany; had no serious complications or illnesses during 
pregnancy or parturition; and gave birth to children who were born at term (weeks 
38–42 of pregnancy). Maternal blood samples were taken during weeks 28–43 
of gestation, and samples of maternal milk were collected from nursing mothers 
during the first 3 weeks after parturition. Both samples were tested for dioxins, 
dioxin-like PCBs, and six indicator PCBs (Wilhelm et al., 2008).
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Other prenatal exposures studies have examined exposure to endocrine-
disrupting chemicals (including dioxins) in Belgian children (Delvaux et al., 
2014) and birth weight and development (Halldorsson et al., 2009; Olsen et al., 
2001) and childhood growth (Wohlfahrt-Veje et al., 2014) in Danish children 
who were exposed prenatally to dioxins and dioxin-like chemicals. Two pub-
lications that used data from the Danish Fetal Origins 1988–1989 Cohort, in 
which offspring were followed for 20 years, were identified for the current 
update. The first study examined prenatal levels of maternal POPs in serum 
and the risk of asthma in offspring (S. Hansen et al., 2014), and the second 
examined allergic sensitization and lung function in offspring (S. Hansen et 
al., 2016). The effects of prenatal and lactational dioxin and PCB exposure on 
several neurodevelopment and functioning parameters have been examined in a 
longitudinal assessment of Dutch children (Berghuis et al., 2014; ten Tusscher 
et al., 2014). However, these Belgian, Danish, and Dutch studies have poten-
tial relevance only to female Vietnam veterans with pregnancy subsequent to 
military service.
In addition to the many studies that used birth cohorts to examine point-in-
time or longitudinal health effects of prenatal exposure to dioxins and dioxin-
like chemicals, several cohorts of people who were exposed as adults to the 
COIs from their residential environments have been established and followed. 
These have included studies from the Dutch LifeLines cohort study, a multidis-
ciplinary prospective population-based cohort study examining health and health-
related behaviors of persons living in the northern region of the Netherlands 
(de Jong et al., 2014); Finnish fishermen and their wives who were exposed to 
higher amounts of dioxins and PCBs through consumption of contaminated fish 
(Turunen et al., 2008, 2012); and French residents in the vicinity of municipal solid-
waste incinerators that had high levels of TCDD emissions, who were examined 
for cancer (Floret et al., 2003; Viel et al., 2000, 2008a,b, 2011) or birth defects 
(Cordier et al., 2004, 2010). For the current update, the subjects of studies of the 
effects of environmental exposures have included populations in Belgium (Den 
Hond et al., 2015; Van Larebeke et al., 2015), Brazil (Cremonese et al., 2017; 
Ueker et al., 2016), Canada (Singh and Chan, 2017; Thomas et al., 2015), China 
(J. Z. Yang et al. 2015; X. L. Yang et al., 2015; J. Zhang et al., 2014), France 
(Danjou et al., 2015; Kalfa et al., 2015; Mayhoub et al., 2014; Nicolle-Mir, 2014; 
Ploteau et al., 2017), Germany (Fimm et al., 2017; Haase et al., 2016; Putschogl 
et al., 2015), Greece (Vafeiadi et al., 2017), Hong Kong (Hui et al., 2016), Italy 
(Cappelletti et al., 2016), Korea (Lim et al., 2017), Nicaragua (Raines et al., 
2014), Norway (Koutros et al., 2015), Russia (Galimova et al., 2015), and Spain 
(Martínez-Zamora et al., 2015; Paul et al., 2017).
Some environmental exposures, such as the large accidental release of TCDD 
in Seveso, Italy, have been the subject of multiple studies and long-term follow-
up. For many of these populations new studies continue to be published, and 
those that have adequate exposure specificity and assessment are reviewed by 
Veterans and Agent Orange: Update 11 (2018)
Copyright National Academy of Sciences. All rights reserved.
BACKGROUND ON SELECTED EPIDEMIOLOGIC STUDIES AND POPULATIONS 175
VAO committees. Additional background on those groups is summarized in more 
detail below.
Seveso, Italy
On July 10, 1976, a large industrial accident caused by an uncontrolled reac-
tion during TCP production in Seveso, Italy, resulted in chemical release to the 
surrounding area that created an environmental exposure to TCDD. The degree 
of TCDD contamination in the soil has been used extensively as a means of 
imputing exposures of members of the population. Three areas were defined on 
the basis of soil sampling: Zone A (556 people), the most heavily contaminated, 
from which all residents were permanently evacuated within 20 days; Zone B 
(3,920), an area of lower contamination that all children and women in the first 
trimester of pregnancy were urged to avoid during daytime; and Zone R (26,227), 
a region with some contamination in which the consumption of local crops was 
prohibited (Bertazzi et al., 1989a,b). The sample sizes differ among follow-up 
studies, presumably because of migration; the sample sizes given above were 
reported in Bertazzi et al. (1989b).
Cohort of Entire Exposed Population
Data on serum TCDD concentrations in Zone A residents have been pre-
sented by Mocarelli et al. (1990, 1991) and by CDC (1988e). In the 10 residents 
who had severe chloracne, TCDD concentrations were 828–56,000 ppt of lipid 
weight (median 16,600 ppt). In 9 residents without chloracne (one sample was 
lost), TCDD concentrations were 1,770–10,400 ppt (median 4,540 ppt). TCDD 
was undetectable in all control participants but one. The highest of the concen-
trations exceeded any that had been estimated at the time for TCDD-exposed 
workers on the basis of backward extrapolation and a half-life of 7 years. Data 
on nearby soil concentrations, the number of days that a person stayed in Zone 
A, and whether local food was consumed were considered in evaluating TCDD, 
but none of those data correlated with serum TCDD, which suggested strongly 
that the important exposure was from fallout on the day of the accident. The pres-
ence and degree of chloracne correlated with TCDD. Adults seemed much less 
likely than children to develop chloracne after acute exposure, but surveillance 
bias could have affected that finding. More recent updates (Bertazzi et al., 1998, 
2001) have not changed the exposure-assessment approach.
A number of studies of the Seveso population have used lipid-adjusted serum 
TCDD concentrations as the primary exposure metric (Baccarelli et al., 2002; 
Eskenazi et al., 2002a,b, 2003, 2004, 2005, 2007, 2010, 2014; Landi et al., 2003). 
Fattore et al. (2003) measured the current air concentrations of PCDDs in Zones 
A and B and compared them with measurements in a control area near Milan. 
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The authors concluded that a release from PCDD-contaminated soil did not add 
appreciably to air concentrations in the Seveso study area. Finally, Weiss et al. 
(2003) collected breast milk from 12 mothers in Seveso and compared TCDD 
concentrations in the milk with concentrations in a control population near Milan, 
and they found that the TCDD concentrations in milk from mothers in Seveso 
were twice as high as in controls. The authors concluded that breastfed children in 
the Seveso area were likely to have higher body burdens of TCDD than children 
in other areas.
Several cohort studies have been conducted using the Zone A, Zone B, and 
Zone R exposure categories. There have been multiple long-term follow-up inves-
tigations of the health outcomes, especially cancers, of Seveso residents. Bertazzi 
and colleagues, for example, conducted 10-year mortality follow-up studies of 
adults (Bertazzi et al., 1989a) and children who were 1–19 years old at the time 
of the accident (Bertazzi et al., 1989b, 1992), 15-year follow-up studies (Bertazzi 
et al., 1997, 1998), and a 20-year follow-up study (Bertazzi et al., 2001). Pesatori 
et al. also conducted a 15-year follow-up study to update non-cancer mortal-
ity (1998), and a 20-year follow-up of incident cancers (2009). Consonni et al. 
(2008) reported on the 25-year follow-up (through 2001) vital status of residents 
(“present”) in the Seveso area and reference territory at the time of the Seveso 
accident and of immigrants and newborns (“non-present”) in the 10 years there-
after. Cause-specific mortality was determined for each zone, compared with that 
in the comparison cohort, and adjusted for presence at the accident, sex, age, and 
time since the Seveso accident. Most recently, Eskenazi et al. (2018) published a 
review summarizing the results of research studies conducted in this population 
over the 40 years since the explosion as well as areas of continuing investigation, 
including effects in children and grandchildren of both men and women exposed 
to dioxin in the three zones of exposure.
In addition to a 2-year prospective controlled study of workers potentially 
exposed to TCDD during the cleanup of the most highly contaminated areas 
after the accident (Assennato et al., 1989a), other studies have examined specific 
health effects associated with TCDD exposure in Seveso residents—chloracne, 
birth defects, and spontaneous abortion—as well as crude birth and death rates 
(Bisanti et al., 1980); the distribution of chloracne in Seveso children (Caramaschi 
et al., 1981); chemicals in the blood and urine of children who had chloracne 
(Mocarelli et al., 1986); chloracne and peripheral nervous system conditions 
(Barbieri et al., 1988); dermatologic and laboratory tests in a group of the children 
who had chloracne and in a group of controls (Assennato et al., 1989b); health 
status and TCDD concentrations in chloracne cases and non-cases (Baccarelli 
et al., 2005a) that had been recruited previously by Landi et al. (1997, 1998); 
hepatic enzyme–associated conditions (Ideo et al., 1982, 1985); abnormal preg-
nancy outcomes (Mastroiacovo et al., 1988); cytogenetic abnormalities in ma-
ternal and fetal tissues (Tenchini et al., 1983); neurologic disorders (Boeri et al., 
1978; Filippini et al., 1981); cancers (Bertazzi et al., 1993; Pesatori et al., 1992, 
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1993, 2008, 2009); the sex ratio of offspring who were born in Zone A (Mocarelli 
et al., 1996); birth weight and neonatal thyroid function (Baccarelli et al., 2008); 
immunologic effects (Baccarelli et al., 2002); effects on reproductive hormones 
and sperm quality (Mocarelli et al., 2008, 2011); aryl hydrocarbon receptor 
(AHR)-dependent pathway and toxic effects of TCDD in humans (Baccarelli et 
al., 2004); effects of TCDD-mediated alterations in the AHR-dependent pathway 
in people who lived in Zones A and B (Landi et al., 2003); and NHL-related 
(14;18) translocation prevalence and frequency in dioxin-exposed healthy people 
in Seveso (Baccarelli et al., 2006). Baccarelli et al. (2005b) reviewed statistical 
strategies for handling non-detectable readings or readings near the detection 
limit in dioxin-measurement datasets. They recommended that a distribution-
based multiple-imputation method be used to analyze environmental data when 
substantial proportions of observations have non-detectable readings.
Seveso Women’s Health Study
The Seveso Women’s Health Study (SWHS) was undertaken to evaluate the 
association between individual serum TCDD concentrations and reproductive 
effects in women who resided in Seveso at the time of the 1976 accident. From a 
pool of 1,271 eligible women who were between infancy and 40 years old at the 
time of the accident, who had resided in Zone A or B at that time, and for whom 
adequate serum remained from the samples collected shortly after the explosion, 
981 were enrolled in the study group in 1996–1998 (80% participation rate). All 
the women were interviewed by a nurse blinded to their exposure status, and each 
subset received gynecologic examinations. Medical records of those who reported 
ever having received a diagnosis of cancer were obtained and subjected to blind 
review by a pathologist. The stored samples were used for new TCDD analyses 
with improved analytic techniques that had become available.
As an initial step in the SWHS, Eskenazi et al. (2001) tested the validity of 
exposure classification by zone. Investigators measured serum TCDD in samples 
collected in 1976–1980 from 601 residents (97 in Zone A and 504 in Zone B). A 
questionnaire that the women completed in 1996–1998 included age, chloracne 
history, animal mortality in the vicinity, consumption of homegrown food, and 
the woman’s location at the time of the explosion. Participants did not know their 
TCDD concentrations at the time of the interview, but most knew their zones 
of residence. Interviewers and TCDD analysts were blinded to the participants’ 
zones of residence. The zone of residence explained 24% of the variability in 
serum TCDD. Adding the questionnaire data improved the regression model to 
the point that it explained 42% of the variability. Those findings demonstrate a 
significant association between zone of residence and serum TCDD, but much of 
the variability in TCDD concentration is still unexplained by the models. Warner 
et al. (2005) used a chemical-activated luciferase-gene expression bioassay and 
a high-resolution isotope-dilution gas-chromatography mass-spectrometry assay 
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to measure PCDDs, PCDFs, and PCBs in the serum of 78 women who resided 
near Seveso in order to determine average total dioxin-like chemical TEQs; the 
two methods produced similar results. Warner et al. (2014) compared the con-
centrations of TCDD in serum samples taken in 1976 and in 1996 to examine 
characteristics that could be used to predict 1996 TCDD concentrations. They 
also presented an updated estimate of the TCDD elimination half-life over the 
20-year period since the uncontrolled release took place.
In one study, the women enrolled in the SWHS were assessed for cancer 
incidence in the 20 years following the accident (Warner et al., 2002). Warner et 
al. (2011) later added more than 10 years of observations on cancer incidence in 
the women in the SWHS, covering the period from the 1976 explosion through 
2009. Of the 981 women who had participated in the first study, 833 were located, 
alive, and willing to participate in the second. Each was re-interviewed, provided 
clinical measurements, and consented to a medical record review to confirm her 
cancer diagnosis. A subset underwent bone-density testing. The average age was 
50.8 years. An additional 45 cancers had been diagnosed, for a total of 66 cases, 
of which 33 were breast cancers. Thyroid cancer was the next most prevalent, 
with 7 cases, and the 15 other types of cancer observed had at most 3 cases. After 
adjusting for the women’s age at the time of the accident and for marital status, 
the researchers found that the association between the risk of any cancers and 
the lipid-adjusted, log-transformed serum TCDD concentrations at the time of the 
accident was significantly higher in the subjects than in controls. The availability 
of serum TCDD concentrations measured from blood samples gathered fairly 
soon after the single-substance accident (which minimizes uncertainty about 
what exposure had been experienced and reduces the need for back-extrapolation) 
contributes substantially to the value of the results.
A series of studies have examined the associations between serum TCDD and 
a variety of endpoints related to female reproductive functioning: menstrual cycle 
(Eskenazi et al., 2002a), endometriosis (Eskenazi et al., 2002b), pregnancy out-
come (Eskenazi et al., 2003a), age at menarche and age at menopause (Eskenazi 
et al., 2005), and age at menarche in women who were premenarcheal at the time 
of the explosion (Warner et al., 2004). Eskenazi et al. (2007) and Warner et al. 
(2007) examined the incidence of fibroids and ovarian function, respectively, in 
SWHS participants.
Eskenazi et al. (2010) examined the relationship between serum TCDD 
around the time of the accident and time to pregnancy in 463 SWHS participants 
who had attempted pregnancy since the accident and who were no more than 40 
years old at the time of the accident. The main analysis was restricted to the 278 
women who had delivered live births that were not the results of contraceptive 
failure. Effect estimates for the associations between TCDD and fecundity and 
between TCDD and infertility were adjusted for several factors including mater-
nal age, maternal smoking in the year before conception, parity, menstrual-cycle 
irregularity, oral-contraceptive use in the year before attempt, paternal age near 
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the time of conception, and the history of reproductive and endocrine conditions. 
Wesselink et al. (2014) examined the risk of adverse pregnancy outcomes in 
relation to TCDD concentrations (measured in 1996) in the SWHS among 1,211 
post-chemical-explosion pregnancies through the 2008–2009 follow-up assess-
ment. The birth outcomes that were examined included gestational age, pre-term 
delivery, and birth weight. Of note, only 35% of women in the analysis were age 
21 or older at the time of explosion, thereby limiting the inference of this work 
to female veterans who served in Vietnam.
Several publications from the SWHS have been reviewed by the committee 
that examined health outcomes in addition to reproductive and pregnancy out-
comes. These have included risk for the development of diabetes and metabolic 
syndrome 30 years after the accident (Warner et al., 2013), thyroid hormone 
levels (and disruption) in relation to TCDD concentrations measured over time 
(Chevrier et al., 2014), and TCDD concentrations measured in 1996 versus the 
bone mineral density of the spine and hip measured in 2008 (Eskenazi et al., 
2014). A study of neurocognitive and physical functioning among the SWHS 
participants is reviewed in the current volume (Ames et al., 2018).
Japanese Environmental Studies
Several population-based studies of relevant exposures in Japan have been 
considered by VAO committees, including investigations of serum concentrations 
of PCDDs, PCDFs, and dioxin-like PCBs relative to the prevalence of diabetes 
(Uemura et al., 2008a), distributions with respect to various demographic char-
acteristics (Uemura et al., 2008b), and the prevalence of metabolic syndrome 
(Uemura et al., 2009). In a separate analysis representative of the Japanese 
population, Nakamoto et al. (2013) gathered fasting blood samples from a cross-
sectional sample of 1,063 men and 1,201 women (aged 15–76 years) who were 
living in 125 areas of 45 prefectures throughout Japan and who were not occupa-
tionally exposed to dioxins (including TCDD). The full WHO 2005 set of dioxin-
like PCDDs, PCDFs, and PCBs were measured in the samples and assessed in 
relation to a range of self-reported history of diseases, including allergic diseases, 
hypertension, diabetes, hyperlipidemia, gout, thyroid disease, kidney disease, 
gastric ulcer, and gynecological disease. Fukuda et al. (2003) examined mortality 
and incinerator dioxin emissions in municipalities in Japan. The associations of 
adverse pregnancy outcomes and proximity of maternal residence (10 kilometers 
or fewer) with municipal solid waste incinerators with high dioxin emission levels 
at the time of birth have also been examined (Tango et al., 2004).
The emphasis of environmental studies in Japan has been on the long-term 
follow-up of the 1968 Yusho rice oil poisoning accident. The accident occurred in 
western Japan, where the rice oil intended for cooking was contaminated during 
processing with PCBs and PCDFs, exposing more than 1,900 people (Kuratsune 
et al., 1972). Based on unusual symptoms following exposure, a total of 1,961 
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cases of “Yusho Disease” were registered and subsequently followed for more 
than 40 years. Because of changes in the symptoms and advances in analytic 
techniques, the diagnostic criteria have changed several times since they were 
first published in 1968 (Akahane et al., 2017). Several studies have considered 
exposure status based on designation as a Yusho case, but VAO committees have 
generally not reviewed such studies unless the concentrations of dioxins and 
dioxin-like chemicals were presented, such as in Tsukimori et al. (2012, 2013) 
(reviewed in Update 2012), and M. C. Li et al. (2015) and Mitoma et al. (2015), 
which are both reviewed in the current update.
Hokkaido Study on Environment and Children’s Health
The Hokkaido Study on Environment and Children’s Health is a prospec-
tive birth cohort study that began in 2002 and includes two cohorts (Kishi et al., 
2017). The first is the Sapporo (Toho Hospital) cohort with one obstetric hospital, 
and the second cohort is the much larger Hokkaido cohort, which has 37 hospi-
tals and clinics. The primary study goals are to examine the effects of low-level 
environmental chemical exposures on birth outcomes; to follow the development 
of allergies, infectious diseases, and neurobehavioral developmental disorders 
and perform a longitudinal observation of child development; to identify high-
risk groups based on genetic susceptibility to environmental chemicals; and to 
identify the additive effects of various chemicals, including tobacco smoking 
(Kishi et al., 2017).
The Sapporo cohort consists of 514 women who enrolled at 23–35 weeks 
of gestation and who had planned to deliver at Toho Hospital in Sapporo city 
between July 2002 and October 2005 (participation rate of 26.6%). A self-
administered questionnaire was completed at the time of enrollment to obtain 
parental baseline information. Various specimens, including maternal and cord 
blood, maternal hair, and breast milk, were collected for the assessment of expo-
sures to 29 dioxin and dioxin-like PCB congeners, 58 other PCB congeners, and 
5 hydroxylated PCB congeners. Maternal medical and infant birth records were 
obtained from the hospital. Follow-ups and the administration of neurobehavioral 
developmental tests were conducted at ages 6 and 18 months and 3.5 and 7 years. 
The focus of investigations using the Sapporo cohort are on child neurobehavioral 
development, but the development of asthma, allergies, and infectious diseases 
is also examined.
The Hokkaido cohort enrolled 20,926 pregnant women before 13 weeks of 
gestational age who visited one of the associated hospitals or clinics in the Hok-
kaido prefecture between February 2003 and March 2012 (participation rate of 
55%). A simultaneous analysis of 11 perfluorinated alkyl substances in maternal 
plasma collected during the third trimester of pregnancy was conducted. The 
Hokkaido cohort focuses on rare diseases such as birth defects and developmen-
tal disorders as well as on the prevalence of complicated pregnancies and birth 
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outcomes, such as miscarriage, stillbirth, low birth weight, preterm birth, and 
small for gestational age. Follow-ups of the children were conducted at 18 months 
and 3 years of age and began in October 2013 and January 2015, respectively. 
The follow-ups of 5- and 6-year-old participants started in October 2014 (Kishi 
et al., 2017).
Previous VAO volumes have reviewed publications from the Sapporo and 
Hokkaido cohorts. Four publications using subsets of the cohort data were iden-
tified and reviewed in this volume. Kobayashi et al. (2017) obtained maternal 
blood samples during the third trimester or within a week of delivery. The 
samples were tested for total dioxin levels (as the sum of 29 congeners) and 
genotyping for genes coding three enzymes involved in dioxin metabolism. 
The genotype status was previously shown to be related to birth weight in 484 
children in the  Hokkaido cohort. Miyashita et al. (2015a,b) investigated 70 PCB 
congeners, including dioxin-like PCBs, in the blood of 367 mother–child pairs 
from the Hokkaido Study cohort and the relationship with newborn anthropo-
metric measurements of birth weight (small for gestational age), length, chest 
circumference, and head circumference. Finally, Nakajima et al. (2017) examined 
sex-specific differences in the effect of prenatal exposure to dioxin-like chemicals 
on neurodevelopment in children who were participants in the Sapporo cohort; 
190 mother–infant pairs in the 6-month-old group and 122 mother–child pairs in 
the 18-month-old group were studied.
Russian Environmental Studies
Chapaevsk
Several studies in the Samara region of Russia have identified the Middle 
Volga Chemical Plant (also known as SZVH or Khimprom) in Chapaevsk, about 
950 kilometers southeast of Moscow, as a major source of TCDD pollution 
( Revazova et al., 2001; Revich et al., 2001). From 1967 to 1987 the plant pro-
duced γ-hexachlorocyclohexane (lindane) and its derivatives, and many of the 
workers experienced chloracne. Since then, it has produced various chlorinated 
products. Dioxins were detected in the small number of air, soil, drinking-water, 
and cow’s-milk samples gathered in the region, but no description of how these 
media were sampled was given. When Revich et al. (2001) compared the samples 
with measurements from four other Russian cities that had industrial facilities, the 
TCDD concentrations observed in Chapaevsk exceeded all reported maximums. 
Revich et al. (2001) presented rudimentary comparisons of cancer incidence and 
mortality and reproductive outcomes with regional and national rates; residence 
in the city of Chapaevsk was used as a surrogate for exposure, and no attempt 
was made to create exposure categories based on factors that might have influ-
enced the degree of TCDD exposure. The analyses of chromosomal aberrations 
and other cytologic indicators of genetic damage partitioned the women studied 
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into three groups on the basis of worker status or distance of residence from the 
factory (Revazova et al., 2001).
Chapaevsk Children’s Study Later research efforts on Chapaevsk residents 
have focused on quantifying the serum concentrations of dioxins and TEQs 
associated with furans and PCBs. Akhmedkhanov et al. (2002) reported on a 
convenience sample of 24 volunteers. The Russian Children’s Study was de-
signed to assess the effect of in utero and childhood exposure on development. 
Although 516 peripubertal boys (identified through health insurance and clinic 
records) were enrolled, the final cohort consisted of 499 boys and 449 mothers. 
This prospective longitudinal study enrolled boys at age 8–9 years (in 2003–2005) 
who then underwent a physical exam and blood sampling and who, together with 
the mother or guardian, completed a questionnaire. Annual follow-up examinations 
were also conducted (9-year retention rate of 73%), blood is collected biennially, 
urine is collected annually, and semen collection began in 2012. Serum samples 
were used to measure 7 PCDDs, 10 PCDFs, 4 non-ortho-substituted PCBs, 6 
mono-ortho-substituted PCBs, and 31 other non-dioxin-like PCBs.2 Although the 
design does not allow researchers to isolate possible in utero exposure and post natal 
exposure and its utility is further limited by the fact that subjects were exposed to 
dioxins in a different period of their lives (infancy, childhood, and adolescence) 
than Vietnam veterans, the exposures are well characterized. The information 
generated by this cohort will be relevant to VAO reports only in conjunction with 
effects in offspring after maternal exposure to the extent that the consequences 
of gestational and childhood exposure can be distinguished. The published find-
ings have detailed the characterizations of serum concentrations in the boys (J. S. 
Burns et al., 2009) and their mothers (Humblet et al., 2010), and the first papers 
that examine semen parameters are detailed in Chapter 8 (Mínguez-Alarcón et al., 
2017). The committee also heard an invited presentation from the lead researcher, 
Dr. Russ Hauser, and is able to offer a bit more detail regarding initial findings 
based on his presentation.
Swedish Environmental Studies
Most Swedish environmental studies have focused on results from the Pro-
spective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study. 
Participants were recruited within 2 months after their 70th birthdays randomly 
from the registry of residents of the community of Uppsala, Sweden, between 
April 2001 and June 2004. The primary aim was to investigate cardiovascular 
disease (CVD) in an elderly population. Of the 2,025 subjects who were invited 
to participate, 1,016 were included, for a participation rate of about 50%; half 
2 Dr. Russ Hauser, Harvard T.H. Chan School of Public Health, presentation to the committee 
November 30, 2017.
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of the participants were female. All participants answered a questionnaire about 
their medical history, medications, diet, and smoking habits. The burden of POPs, 
including several dioxin-like PCBs, was assessed from blood serum or plasma. 
However, the results are limited by the fact that participants were recruited in the 
2-month period after their 70th birthday. This potentially imparts a survival bias, 
meaning that persons from the catchment area with very high levels of POPs may 
have been disproportionately excluded from the study sample. In addition, results 
are limited by the relative non-specificity of the POPs examined, although the 
battery of congeners did include octachlorodibenzo-p-dioxin, which is relevant 
to Vietnam veterans.
VAO committees have reviewed several studies from the PIVUS data or 
subsets of it. The subjects of these studies have included sex differences in the 
concentrations of 17 of 21 POPs (Salihovic et al., 2012a); a new method for 
extracting POPs from human blood (Salihovic et al., 2012b); and associations 
between POPs and type 2 diabetes (D. H. Lee et al., 2011), fat mass and abdomi-
nal obesity (D. H. Lee et al., 2012a; Rönn et al. 2011), stroke (D. H. Lee et al., 
2012b), and carotid atherosclerosis (Lind et al., 2012). Many other studies from 
the PIVUS cohort have examined relationships between POPs and surrogate 
health outcomes, including CVD measures and risk factors; examples include 
left ventricular systolic and diastolic dysfunction (Sjöberg Lind et al., 2013b), 
left ventricular hypertrophy (Sjöberg Lind et al., 2013a), and carotid atheroscle-
rosis (Lind et al., 2012). In addition to these health outcomes, changes in weight 
(Lind et al., 2013), inflammatory markers, complement system, and oxidative 
stress (Kumar et al., 2014a,b,c) have also been studied. These studies augment 
previous publications from PIVUS that examined a range of indicators related to 
CVD and cardiovascular health. The topics of new publications from the PIVUS 
cohort reviewed in this volume include outcomes of hypertension (Lind et al., 
2016), circulating lipid levels (Penell et al., 2014), and cognitive impairment (D. 
H. Lee et al., 2014).
Other studies of Swedish cohorts have also been included in the VAO series 
when the exposures have been relevant.
Taiwanese Environmental Studies
Two populations with environmental exposures in Taiwan have been ex-
amined by VAO committees: residents of contaminated areas and mother–child 
studies. The first type of studies primarily examined people who resided near a 
closed factory in the An-nan District of Tainan City in southwestern Taiwan that 
had manufactured PCP, which left the area highly contaminated with dioxin. 
Na-PCP, a widely used pesticide, had been used in the production process at the 
abandoned factory, and after the factory shut down, a large quantity was improp-
erly stored and later released into the environment. A cross-sectional study was 
conducted in 2005–2007 using subjects recruited from a health center near the 
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factory, and the final sample consisted of about 80% of the invited residents of the 
community. A series of publications using these data have been reviewed by prior 
VAO committees, an overview of which is provided here. The general limitations 
for all those studies include an unknown age at first exposure to PCDDs and 
PCDFs; an unknown duration of exposure; the cross-sectional design; an adjust-
ment for obesity as one element of metabolic syndrome, rather than BMI; and 
some arbitrary choices inherent in factor analysis. J. W. Chang et al. (2010) used 
these data to report on the relationship between exposure to PCDDs and PCDFs 
and hypertension in metabolic syndrome in 1,490 non-diabetic people residing in 
this area. In addition, an analysis of the association between each congener and 
the prevalence of metabolic syndrome was conducted. J. W. Chang et al. (2011a) 
then reported on the same cross-sectional study, restricted to 1,449 non-diabetic 
residents, to investigate the joint effects of exposure to dioxins (from the factory) 
and mercury (from eating contaminated seafood from the reservoir near the fac-
tory) on pancreatic endocrine function; the committee noted several limitations 
with the study’s analysis and methods for assessing insulin-resistance. Using 
the same cross-sectional study with enrollment extended to December 2009, 
J. W. Chang et al. (2011b) investigated the association between PCDD and PCDF 
exposure and continuous measures of CVD within 10 years as measured by the 
Framingham Risk Score, a formula for combining established risk factors into a 
single number, using a sample of 914 residents who did not have CVD and who 
were 30–45 years old. One limitation is the use of the Framingham score; other 
factors are associated with risk but were not included in the score, such as socio-
economic position, genetics, and imaging biomarkers. A fourth publication using 
this cross-sectionally collected data involved 1,167 residents who were more than 
50 years old and had fasting blood samples available to investigate the biochemi-
cal profiles of those exposed to PCDDs and PCDFs (J. W. Chang et al., 2012). For 
this analysis, there were three exposure groups of retired Na-PCP workers: those 
who still lived locally, those who lived locally but did not knowingly eat polluted 
fish, and those who had moved away. Three control groups did not include any 
Na-PCP workers and consisted of local residents who had eaten polluted fish, 
local residents who had not eaten polluted fish, and “background participants” 
in Taiwan’s general population. The first two of the control groups made up the 
1,167 in the study population. The limitations of the study include the unknown 
PCDD and PCDF concentrations in retired workers who moved away and knowl-
edge about when the exposure ceased. There may also be important unmeasured 
confounders related to which workers moved away and which ones did not.
Three new studies among the residential population near this factory were 
identified and reviewed in the current volume. The outcomes examined are type 
2 diabetes (C. Y. Huang et al., 2015), chronic kidney disease (C. Y. Huang et al., 
2016), and hyperuricemia (J. W. Chang et al., 2013).
The second type of relevant environmental exposure studies conducted in the 
Taiwanese population are mother-and-child studies, which have been reviewed 
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in Chapter 8. These have included findings from a prospective study of healthy 
Taiwanese mothers and their children recruited during the mothers’ pregnancy 
to study the associations between exposures to PCDDs, PCDFs, and PCBs and 
health outcomes (Chao et al., 2004, 2007; P. H. Su et al., 2010, 2012; S. L. Wang 
et al., 2004, 2005). The study enrolled pregnant women who had no clinical 
complications, were 25–35 years old, and delivered in the period December 1, 
2000, to November 30, 2001, in a medical center in central Taiwan, the location 
of a solid-waste incinerator. Participants completed a questionnaire concerning 
maternal age, occupation, disease history, cigarette smoking, alcohol consump-
tion, dietary habits, and the baby’s stature. Biologic samples (including placenta, 
umbilical cord blood, mother’s venous blood, and breast milk) were collected 
for analysis of PCDDs, PCDFs, and PCBs. A total of 610 women were enrolled 
(80% of those invited). The placenta was collected from and the questionnaire 
completed by 430 participants. Of those, 250 provided sufficient venous blood for 
the chemical analyses. Of the 250, 175 provided adequate breast-milk samples. 
S. L. Wang et al. (2004) reported on PCDDs, PCDFs, and PCBs in the biologic 
samples and on correlations among specimens. Chao et al. (2004) reported on 
PCDDs, PCDFs, and PCBs in breast milk and the cumulative dose derived for 
infants exclusively breastfed versus those formula-fed. In a follow-up analysis, 
S. L. Wang et al. (2005) examined the association between high and low in utero 
exposures to PCDDs, PCDFs, and PCBs and the thyroid and growth hormones in 
the newborns overall and by sex. S. L. Wang et al. (2006) examined the associa-
tion between PCDDs, PCDFs, and PCBs measured in the placenta and estrogens 
and metabolites measured in mothers’ blood. P. H. Su et al. (2010) reported on 
the 2-year and 5-year follow-ups of the mother–child pairs of S. L. Wang et al. 
(2005). Children’s anthropomorphic measures were obtained, including height, 
weight, BMI, head circumference, chest girth, bone age, and the ratio between 
bone age and chronologic age. Thyroid, sex-hormone, and growth-factor concen-
trations were measured in venous blood samples obtained from those children 
whose mothers’ serum PCDD and PCDF TEQs were available. The anthropo-
morphic measures and the thyroid, sex-hormone, and growth-factor concentra-
tions were compared in children with high (≥15 pg-TEQ/g of lipid) versus low 
(< 15 pg-TEQ/g of lipid) in utero PCDD and PCDF concentrations. Comparisons 
were made by sex and by pooling all children. P. H. Su et al. (2012) reported 
on the 8-year follow-up of the same cohort in a subset of 23 boys and 33 girls. 
In addition to anthropomorphic measures used in previous waves, reproductive 
development (breast, genital, and armpit stages) was assessed. P. H. Su et al. 
(2015) conducted a study of 56 children from the cohort stratified into high- and 
low-exposure groups based on maternal PCB and PCDD/F concentrations to 
examine hormone levels and other measures of blood chemistry.
Other studies of health effects in offspring prenatally exposed to the COIs in 
Taiwan have been reviewed, but they have been from different population samples.
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Vietnamese Environmental Studies
Various epidemiologic studies have been conducted in subsets of the Vietnam-
ese population who were exposed to the herbicide spraying that occurred during 
the Vietnam War. In a review paper, Constable and Hatch (1985) summarized the 
unpublished results of studies conducted by researchers in Vietnam. They also 
examined nine reports that focused primarily on reproductive outcomes (Can et al., 
1983a,b; Huong and Phuong, 1983; Khoa, 1983; Lang et al., 1983a,b; Nguyen, 
1983; Phuong and Huong, 1983; Trung and Chien, 1983). Vietnamese researchers 
later published the results of four additional studies: two on reproductive abnor-
malities (Phuong et al., 1989a,b), one on mortality (Dai et al., 1990), and one on 
hepatocellular carcinoma (Cordier et al., 1993). Ngo et al. (2006) published a meta-
analysis that addressed an association between exposure to herbicides in Vietnam 
and birth defects and that covered some reports reviewed previously by Constable 
and Hatch (1985), some new Vietnam studies, and studies on U.S. and Australian 
veterans who served in Vietnam.
In general, three types of environmental studies have been conducted in 
Vietnam and reviewed by VAO committees: those that have measured environ-
mental concentrations of contaminants in soil or animals (food) in “hot spot” 
areas such as Bien Hoa City (Schecter et al., 2003), studies of mother–child pairs 
and concentrations of dioxins in breast milk, and surrogate measures of health 
outcomes in adults in contaminated areas. In total, 10 new studies of outcomes in 
the Vietnamese population were identified and reviewed for the current volume.
C. H. Nguyen et al. (2017) examined serum TCDD levels and the expression 
of AHR and a variety of pro-inflammatory cytokines in people living in areas that 
were sprayed with herbicides and in areas that were not. Two studies (S. Hansen 
et al., 2009; Nhu et al., 2009) examined maternal concentrations of organochlorine 
chemicals and dioxins in communities known to have been sprayed with herbicides 
during the war compared with communities that were not sprayed. However, no 
results were reported on associations between the concentrations of these chemicals 
in mothers and health status in mothers or infants. Two new studies of mothers and 
their children in different herbicide-contaminated and non-contaminated areas in 
Vietnam were reviewed in the current volume (Anh et al., 2017; Van Tung et al., 
2016).
Several studies have examined mother–infant pairs who were living near 
the Da Nang airbase, the site of a former U.S. airbase, which is an area of docu-
mented high exposures to TCDD and other PCDD/Fs. The Da Nang Birth Cohort 
consists of 216 mother–infant pairs recruited in 2008–2009. The recruitment and 
residence area includes two districts in a surrounding area of 10 kilometers from 
the former air base. This is because the residents outside the immediate area of the 
airbase have also been shown to have high dioxin levels suspected to have been 
caused by the ingestion of contaminated food and water originating from the air-
base. Breast-milk samples were collected from each nursing mother 1 month after 
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she gave birth in order to quantify the levels of 17 different 2,3,7,8-substituted 
PCDD and PCDF congeners, and TEQs were calculated.
 Tai et al. (2013) examined 216 mother–infant pairs and relationships be-
tween the dioxin levels in breast milk and infant neurodevelopment parameters 
(based on the Bayley Scales of Infant and Toddler Development) at 4 months of 
age. Tai et al. (2016) followed the birth cohort longitudinally for neurodevelop-
ment and physical growth during the first 3 years of life. In Pham et al. (2015), 
the Bayley Scales of Infant Development, 3rd edition, was administered at age 
12 months to examine differences in overall cognition, language composite, 
receptive language and expressive language, and motor skills. Nishijo et al. 
(2014) examined 153 mother–infant pairs in the Da Nang birth cohort to evalu-
ate potential associations between perinatal dioxin exposure and autism spectrum 
disorders in the children. Nishijo et al. (2015) focused on urinary metabolite 
 levels in 26 children who were part of the study cohort and examined associations 
with dioxin-exposure-induced neurodevelopmental deficits. Using this same birth 
cohort, Tran et al. (2016) investigated effects of early life exposure to dioxins in 
176 children. Dioxins were measured at birth and 5 years of age and compared 
with outcomes of the Movement Assessment Battery for Children-2 test and other 
tests of pattern reasoning, planning ability, and neurodevelopmental skills.
Although they are not a primary health outcome of interest per se, X. Sun 
et al. (2013) compared prostate-specific antigen levels (which may be indicative 
of a risk for prostate cancer, but is not a surrogate of prostate cancer) in a cross-
sectional study of men over the age of 50 years residing in the Phu Cat district 
(a presumed contamination hot spot, n = 101) with those residing in the Kim 
Bang district (presumed non-sprayed, n = 97). Analyses were adjusted for age 
and included stratification by occupation, including farmers and other non-farm 
occupations. Results of this study are limited by its cross-sectional design and, in 
particular, the relatively crude measurement of exposure assessment many years 
after the time when herbicide spraying would have occurred. In a second study 
by X. L. Sun et al. (2014) that used similar methodology and surrogate indicators 
of health (and thus has similar limitations), serum dioxin and steroid hormone 
levels were compared between 48 men in the presumed hot spot area (Phu Cat 
district) and 36 men in the non-sprayed area (Kim Bang district). Five dioxin 
congeners expressed as TEQs were calculated along with the levels of nine serum 
steroid hormones, including testosterone, cortisol, estradiol, and others. Multiple 
linear-regression analyses were conducted with statistical adjustments made for 
age, BMI, employment status, and tobacco use.
Using the same study population as in prior studies (X. L. Sun et al., 2013, 
2014), two new publications compared steroid hormone levels and other blood 
chemistry between men residing in the presumed hot spot area and men residing 
in the non-sprayed area (X. L. Sun et al., 2016, 2017). However, these studies are 
somewhat limited in that these measures do not serve as indicators or even sur-
rogates of health conditions or diseases of primary concern to Vietnam veterans.
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CASE-CONTROL STUDIES
Numerous case-control studies have been reviewed in previous updates, 
some of which have produced multiple publications on the same population 
or dataset. For example, several case-control studies of specific cancers, such 
as STS, HL, and NHL, in Sweden were carried out to investigate exposure to 
phenoxyacetic acids and other relevant COIs (Eriksson et al., 1979, 1981, 1990; 
Hardell, 1977, 1979, 1981; Hardell and Bengtsson, 1983; Hardell and Eriksson, 
1988, 1999; Hardell and Sandström, 1979; Hardell et al., 1980, 1981, 2002; Olsson 
and Brandt, 1988; Persson et al., 1989, 1993; Wingren et al., 1990). Similarly, 
overlapping case-control studies have been conducted among New Zealanders 
exposed to phenoxy herbicide and chlorophenols examining incidence and mor-
tality from specific cancers (Pearce et al., 1985, 1986a,b, 1987; Smith and Pearce, 
1986; A. H. Smith et al., 1983, 1984). Other case-control studies conducted inter-
nationally have addressed the connection between the COIs and various cancers 
in England (Balarajan and Acheson, 1984; Magnani et al., 1987), France (Aras 
et al., 2014; Orsi et al., 2009), Italy (Amadori et al., 1995; Donna et al., 1984; 
LaVecchia et al., 1989; Musicco et al., 1988; Nanni et al., 1996; Vineis et al., 
1986), Canada (McDuffie et al., 1990; Ng et al., 2010; Spinelli et al., 2007), Aus-
tralia (Smith and Christophers, 1992), and Denmark (Mellemgaard et al., 1994).
Case-control studies have been conducted in various U.S. populations look-
ing for associations of herbicides with cancers. Studies have included leukemia 
mortality among white farmers in Nebraska (Blair and Thomas, 1979; Blair and 
White, 1985), Iowa (Burmeister, 1981; Burmeister et al., 1982), and in Iowa and 
Minnesota (L. M. Brown et al., 1990). Another study investigated associations 
of leukemia and NHL with 2,4-D in eastern Nebraska (Zahm et al., 1990). Other 
lymphohematopoietic cancer outcomes investigated as case-control studies in 
U.S. populations include NHL (Cantor, 1982; Cantor et al., 1992; Czarnota et 
al., 2015; Hartge et al., 2005; Tatham et al., 1997; Zahm et al., 1993), multiple 
myeloma (Boffetta et al., 1989; L. M. Brown et al., 1993; Morris et al., 1986), and 
NHL and HL (Dubrow et al., 1988). Other studies have assessed, generally using 
occupation or residence as surrogates for exposure, multiple cancer outcomes, 
such as gastric cancer, prostate cancer, NHL, and multiple myeloma (Burmeister 
et al., 1983); STS, HL, and NHL (Hoar et al., 1986); and STS and NHL (Woods 
and Polissar, 1989; Woods et al., 1987). In a subset of participants in the Hartge et 
al. (2005) study, De Roos et al. (2005a) studied associations between the overall 
TEQs of PCBs, furans, and dioxins but not TCDD alone.
Non-cancer health outcomes have also been investigated in case-control 
studies: birth defects and congenital anomalies (Blatter et al., 1997; García et al., 
1998; Nurminen et al., 1994), spontaneous abortion (Carmelli et al., 1981), mor-
tality from neurodegenerative diseases associated with occupational risk factors 
(R. M. Park et al., 2005; Schulte et al., 1996), and Parkinson disease (Firestone 
et al., 2005, 2010; Liou et al., 1997; Seidler et al., 1996; Semchuk et al., 1993).
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Again, as this chapter is not intended to be a compendium of every study ever 
reviewed in the VAO series, only those cohorts and groups that have contributed 
more than one study for review by VAO committees and for which new informa-
tion is available are considered here. A full account of every study ever reviewed 
in the VAO series that has provided evidentiary weight for an association between 
exposure to the COIs and a health outcome can be found in the supplementary 
tables (available at www.nap.edu/catalog/25137), and details of the studies can 
be found in the corresponding report for which they were first identified and re-
viewed by a VAO committee. Some additional information may be found in the 
subsections of “Conclusions from VAO and Previous Updates” for an outcome 
throughout the chapters.
National Birth Defects Prevention Study
The National Birth Defects Prevention Study (NBDPS) is a population-based 
case-control study conducted cooperatively by CDC and eight monitoring centers 
throughout the United States (in Arkansas, California, Georgia, Iowa, Massachu-
setts, New Jersey, New York, and Texas) using a standardized study methodology 
(Yoon et al., 2001). Starting in October 1, 1997, the individual centers began 
monitoring births in their respective areas for the occurrence of more than 30 
types of birth defects (excluding cases attributable to single-gene conditions 
or chromosomal abnormalities) for comparison with randomly selected sets of 
live-born babies without malformations. Information about demographics and 
possible exposures is abstracted from an extensive telephone interview that the 
mothers complete within 24 months of delivery. On the basis of the work his-
tories, job classifications are assigned by an industrial hygienist and processed 
using a job-exposure matrix and expert opinion used to derive occupational ex-
posures. Buccal epithelial samples are gathered for DNA testing from the infant 
and its parents. Major limitations of the study are the lack of exposure specificity 
(e.g., using general categories of insecticides, herbicides, and fungicides), crude 
exposure histories (ever/never), lack of exposure concentrations or durations, and 
the use of self-report, which may introduce recall bias especially among mothers 
whose child has been diagnosed with a birth defect. Despite those limitations 
and the fact that the results are only potentially relevant to child-bearing female 
Vietnam veterans, several publications using data from all of the NBDPS or just 
subsets of the NBDPS have been reviewed by VAO committees.
Rocheleau et al. (2011) reported on the association between maternal oc-
cupational pesticide exposure and the risk of hypospadias in the NBDPS using a 
sample of 647 cases of hypospadias and 1,496 controls with estimated delivery 
dates of October 1997–December 2002. Most exposure was to insecticides only 
or to three types of pesticides (insecticides, herbicides, and fungicides), but there 
was generally a low level of occupational pesticide exposure in the study popu-
lation. The lack of exposure specificity made it difficult to make an association 
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between the birth defects and any pesticide exposure or an individual pesticide 
exposure, and other exposures of the population could have contributed to the 
outcome in question. In a separate analysis of NBDPS data, Kielb et al. (2014) 
analyzed the occurrence of isolated craniosynostosis, gastroschisis, diaphrag-
matic hernia, or transverse limb deficiencies in children born to employed women 
with due dates between October 1, 1997, and December 31, 2002. Cases included 
871 live-born, stillborn, or electively terminated fetuses, which were compared 
to 2,857 live-born control infants. The odds of the appearance of these musculo-
skeletal malformations were examined in relation to periconceptional maternal 
occupational exposure to insecticides, herbicides, or fungicides (classified as 
yes/no) for each job held during the period of 1 month pre-conception through 
3 months post-conception.
Several papers from the California Center (in the San Joaquin Valley) of the 
NBDPS have been published, although many of the same limitations apply as for 
analyses with the full NBDPS. The center has monitored deliveries from 1997 
to 2006 and has invested considerable effort toward developing time-specific 
estimates of exposure to individual pesticides by women residing in the area at 
the time of delivery. Carmichael et al. (2014) evaluated 569 medically confirmed 
congenital heart defect cases (8 different types) and 785 non-malformed controls 
born during 1997–2006. Maternal pesticide exposure was crudely classified as 
“any” versus “no exposure” based on the commercial application of pesticides 
within a 500-meter radius of the mother’s address during a 3-month periconcep-
tion window (determined by data obtained from the California Pesticide Use 
 Report record system). Exposure to individual pesticides was examined, includ-
ing the dimethylamine salt of 2,4-D. Analogous investigations were conducted on 
neural tube defects and orofacial clefts (W. Yang et al., 2014) and on gastroschisis 
(Shaw et al., 2014).
Several new publications from the NBDPS were identified for the current 
update. Makelarski et al. (2014) and Pettigrew et al. (2016) both examined asso-
ciations of spina bifida with parental non-specific herbicide exposure. Rocheleau 
et al. (2015) examined the association between maternal occupational exposure 
to fungicides, insecticides, and herbicides and the risk of congenital heart defects 
among offspring. Specific publications from the California Center of the NBDPS 
included studies of gastroschisis (Shaw et al., 2014) and anotia/microtia, anorec-
tal atresia/stenosis, transverse limb deficiency, craniosynostosis, and diaphrag-
matic hernia (Carmichael et al., 2016).
Upper Midwest Health Study
The Upper Midwest Health Study (UMHS) was initiated by NIOSH as a 
population-based case-control study of cancer risk in a non-metropolitan Mid-
western U.S. population. Several reports from the study were reviewed in previ-
ous updates. Chiu et al. (2004) and W. J. Lee et al. (2004a) conducted pooled 
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analyses of two earlier case-control studies of NHL carried out by the UMHS in 
Iowa and Minnesota (Cantor et al., 1992) and in Nebraska (Zahm et al., 1990). 
Chiu et al. (2004) examined the association of NHL with agricultural pesticide 
use and familial cancers, and W. J. Lee et al. (2004a, 2006) looked at NHL in 
asthmatic people who reported pesticide exposure. Data from Nebraska (B. C. 
Chiu et al., 2006, based on Zahm et al., 1990, 1993) were used to determine if the 
risk of NHL was driven by any specific subtypes. Tissue samples were analyzed 
from 172 of 385 cases for the presence of a specific chromosomal translocation 
(t(14;18)(q32;q21)). Two studies focused on pesticide use and the risk of adeno-
carcinomas of the stomach and esophagus (W. J. Lee et al., 2004b) and the risk 
of gliomas (W. J. Lee et al., 2005) in white Nebraska residents over 21 years old 
who were identified from the Nebraska Cancer Registry and matched to controls 
drawn from an earlier study by Zahm et al. (1990). Other publications evaluated 
farm pesticide exposure in men (Ruder et al., 2004) and women (Carreon et al., 
2005) in Iowa, Michigan, Minnesota, and Wisconsin in relation to gliomas as part 
of the UMHS. Ruder et al. (2006) reported a follow-up of Ruder et al. (2004) 
that evaluated gliomas in UMHS participants, but the new analyses provided 
no evidence of a greater use of pesticides in cases than in controls, and agents 
were not specified. Ruder et al. (2009) reported another follow-up in the same 
group, which had similar findings and, again, provided no specificity of agents. 
Finally, Yiin et al. (2012) has reported findings from new analyses of the UMHS 
sample that incorporated more detailed exposure information that was not used 
in previous analyses, including years of use and estimated cumulative exposures 
to categories of pesticides, including phenoxy herbicides, and the use of specific 
agents, including 2,4-D and dicamba.
Cross-Canada Study of Pesticides and Health (Rare Tumors Study)
The Cross-Canada Study of Pesticides and Health (Rare Tumors Study) was 
designed as a full population-based case-control study of men in six Canadian 
provinces to address the relation of four relatively uncommon malignancies—HL, 
NHL, multiple myeloma, and STS—with occupational and domestic exposure 
to pesticides (McDuffie et al., 2001). A target number of cases of each cancer 
type was preset for each province. Researchers gathered incident cases that were 
diagnosed starting on September 1, 1991, from the provincial cancer registries 
(or hospital records) in Québec until the end of 1994 or until the target number 
was reached. People who had Kaposi sarcoma or who were HIV positive were 
excluded. Physician consent was obtained, and diagnoses were confirmed with 
pathology reports and a review of preserved tissues. Consent forms and question-
naires were sent to the cases. The controls were men at least 19 years old identified 
in the health-insurance records of Alberta, Manitoba, Saskatchewan, and Québec; 
from telephone listings for Ontario; and from voter lists in British Columbia. The 
controls were selected randomly to obtain a stratified age distribution matching 
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that of the cases, and they were sent consent forms and questionnaires. All 1,506 
controls who responded were used in comparisons for each of four cancer groups: 
316 HL cases, 517 NHL cases, 342 multiple myeloma cases, and 357 STS cases.
The postal questionnaire gathered standard demographic information, per-
sonal and family medical histories, employment history, smoking behavior, and 
basic data on pesticide exposure. The pilot study tested the reliability of self-
reported pesticide use by comparison with purchase records. Any subject who 
reported at least 10 hours of pesticide exposure per year was asked to complete 
a telephone questionnaire on the details of the pesticide exposure; in addition, 
15% of the remaining subjects were randomly selected to answer the telephone 
survey. A conditional logistic regression stratified on age and province and ad-
justed for all covariates found to be associated with the outcome at the 0.05 level 
of significance was used to estimate odds ratios for specific active ingredients, 
including dicamba and the phenoxy herbicides 2,4-D, Mecoprop, MCPA, and 
diclofop-methyl. Dose–response relationships were investigated for the cumula-
tive time spent in mixing or applying particular products.
A series of publications have addressed the relationship between each of the 
cancers and various risk factors. Those pertaining to herbicides overall or to the 
particular ones of interest are as follows:
• HL: Karunanayake et al. (2012); P. Pahwa et al. (2003)
• NHL: Hohenadel et al. (2011); McDuffie et al. (2001)
• Multiple myeloma: P. Pahwa et al., (2003, 2012)
• STS: P. Pahwa et al., (2003, 2011)
A number of other publications arising from that dataset have addressed top-
ics somewhat more tangential to the interests of the VAO reports. For instance, 
McDuffie et al. (2005) and P. Pahwa et al. (2006) considered the possible role 
of exposure to insect repellents, particularly DEET and phenoxy herbicides, in 
the genesis of the malignancies in question. McDuffie et al. (2009) examined 
family histories of cancers in first-degree relatives of the study participants to 
assess the interaction between family history and pesticide exposure. Hohenadel 
et al. (2011) investigated how various combinations of pesticide exposures influ-
enced the occurrence of NHL. Ghosh et al. (2011) investigated the association 
of occupational exposures other than pesticides with the occurrence of multiple 
myeloma. M. Pahwa et al. (2012) examined the interactions between self-reported 
pesticide exposures and self-reported measures of immune suppression (asthma, 
allergies, hay fever) and the risk of NHL, but this analysis is limited by the use 
of self-reported measurements of immunologic conditions and the non-specific 
and crude self-report classification of pesticide use, which did not characterize 
exposure use by duration, intensity, or frequency. Similarly, Navaranjan et al. 
(2013) examined HL relative to the number of pesticides to which an individual 
reported exposure and to estimates of work-related exposure and home-related 
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exposure, grouped by class (herbicides, insecticides, and fungicides). This study 
is also limited by the relatively nonspecific and crude self-report classification of 
pesticide use, which significantly limits direct inference to the effects of herbicide 
exposure during military service in Vietnam.
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Immune System Disorders
Chapter Overview
Based on new evidence and a review of prior studies, the current committee 
did not find any new associations between the relevant exposures and immune 
outcomes that warranted a change in level of evidence of association. Current 
evidence supports the findings of earlier studies that there is inadequate or insuf-
ficient evidence to determine whether there is an association between exposure 
to the chemicals of interest (COIs) and any specific diseases involving immune 
suppression, allergy, autoimmunity, or inflammation.
Immune-system disorders affect more than 23.5 million Americans (NIEHS, 
2012), with some sources estimating that as many as 50 million Americans are 
currently affected by immune-system disorders (AARDA, 2018). The causal 
factors for immune-system disorders are mainly unknown; however, it has been 
hypothesized that they most likely reflect both genetic and environmental factors. 
The immune system plays three important roles in the body:
• It defends the body against infectious pathogens, including viruses, bac-
teria, and other disease-producing microorganisms.
• It helps defend against cancer by destroying mutated cells that may other-
wise develop into tumors and providing immunity against tumors.
• It provides resident immune cells that are specially adapted for different 
tissues and organs (such as microglia in the central nervous system and 
Kupffer cells in the liver) to help regulate the functional activity and 
integrity of those tissues.
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This chapter begins with an overview of the various types of health problems 
that can arise as a result of a malfunction of the human immune system, such as 
immune suppression, allergic diseases, autoimmune diseases, and inflammatory 
diseases. Outcomes related to infectious agents would be included in this chapter, 
but no studies had specific enough information on exposure to warrant inclusion. 
Following the brief description of the types of immune dysfunction, the findings 
from previously reviewed literature and the conclusions from prior updates are 
summarized regarding the epidemiologic evidence concerning an association 
between exposure to any one of the COIs, that is, 2,4-dichlorophenoxyacetic 
acid (2,4-D); 2,4,5-trichlorophenoxyacetic acid (2,4,5-T); picloram; dimethyl-
arsinic acid (DMA or cacodylic acid); and 2,3,7,8-tetrachlorodibenzo-p-dioxin 
(TCDD). As described in Chapter 3, studies of exposure to polychlorinated bi-
phenyls (PCBs) and other dioxin-like chemicals were also considered informative 
if their results were reported in terms of TCDD toxic equivalents (TEQs) or as 
concentrations of specific congeners of dioxin-like chemicals. Studies that report 
TEQs based only on mono-ortho PCBs (which are PCBs 105, 114, 118, 123, 156, 
157, 167, and 189) are considered even though their TEQs are several orders of 
magnitude lower than those of the non-ortho PCBs (77, 81, 126, and 169), based 
on the revised World Health Organization (WHO) toxicity equivalency factor 
(TEF) scheme of 2005 (La Rocca et al., 2008; van den Berg et al., 2006). Epide-
miologic findings from five newly identified studies are reviewed. Biologic plau-
sibility data on the effects of the COIs on the immune system are summarized. 
The chapter ends with a synthesis of the studies and what they contribute to the 
evidence base and then the committee’s conclusion regarding the association of 
exposure to the COIs and effects on the immune system. The studies reviewed 
in this chapter are limited to those investigating effects on the immune system 
from exposures that occurred to adults. Immune effects stemming from perinatal 
exposures are discussed in Chapter 8. Table 1, which can be found at www.nap.
edu/catalog/25137, summarizes the results of studies reviewed in the VAO series 
related to immune disorders.
CATEGORIES OF IMMUNE DYSFUNCTION
There are four major categories of immune dysfunction, which are not 
mutually exclusive: immune suppression, allergy, autoimmunity, and inflam-
matory dysfunction (inappropriate or misdirected inflammation). Most times, 
immune suppression manifests itself as an increased incidence of infections or 
an increased risk of neoplasia. Allergic, autoimmune, and inflammatory disorders 
can be manifested as diseases that affect virtually any tissue. It is often difficult 
to diagnose such diseases, so they may not always be medically categorized as 
immune disorders.
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Immune Suppression
The suppression of immune responses can reduce resistance to infectious dis-
ease and increase the risk of cancer. Infection with the human immunodeficiency 
virus (HIV) is a well-recognized example of an acquired immune deficiency 
in which a specific type of lymphocyte (CD4+ T cell) is the target of the virus 
(Okoye and Picker, 2013). The decline in the number of CD4+ T cells after HIV 
infection correlates with an increased incidence of infectious diseases, including 
fatal opportunistic infections, and with an increased incidence of several types of 
cancer (Davis, 1998). The treatment of the cancer with toxic chemotherapeutic 
drugs suppresses the immune system by inhibiting the generation of new white 
blood cells by the bone marrow and blocking proliferation of lymphocytes during 
an immune response. Both of those examples represent severe immune suppres-
sion in which the adverse outcome is easily detected with clinical measurements.
Immune suppression can also result from exposure to chemicals in the 
workplace or in the environment and can manifest as recurrent infections, op-
portunistic infections, a higher incidence of a specific category of infections, or a 
higher incidence of many forms of cancer (Saberi Hosnijeh et al., 2013; Warren 
et al., 2000). However, unless the immune suppression is severe (as occurs in 
rare cases of genetic disorders of immunity), it is often difficult to obtain clinical 
evidence that directly links chemically induced changes in immune function to 
increases in infectious diseases or cancers because many confounding factors and 
effect modifiers can influence a person’s ability to combat infection. These factors 
include age, vaccination status, the virulence of the pathogen, the presence of 
other diseases (such as diabetes), stress, smoking, and the use of drugs or alcohol. 
Therefore, immunotoxicology studies are often conducted in laboratory animals 
to understand the scope and mechanism of chemical-induced immune suppres-
sion. The results of such studies can be used to develop biomarkers to assess the 
effects in human populations. Infectious disease models in animals can also be 
used to determine whether the pattern of disease changes with chemical exposure.
Allergic Diseases
The immune system sometimes responds to a foreign substance that is 
not pathogenic; such immunogenic substances are called allergens. Like most 
immune-based diseases, allergic diseases have both environmental and genetic 
risk factors. Their prevalence has increased in many countries in recent decades 
(Linneberg et al., 2000; Simpson et al., 2008; Sly, 1999). The major forms of 
allergic diseases are asthma, allergic rhinitis, atopic dermatitis, and gastrointes-
tinal responses. In immediate hypersensitivity, the response to some allergens, 
such as pollen and bee venom, results in the production of immunoglobulin E 
(IgE) antibodies. Once produced, IgE antibodies bind to mast cells, which are 
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specialized cells that are found in tissues throughout the body, including the 
lungs, the intestinal wall, and blood-vessel walls. When a person is exposed once 
again to the allergen, it binds to the antibodies on the mast cells and causes them 
to release histamine and leukotrienes, which produce the symptoms associated 
with an allergic response. In delayed-type hypersensitivity reactions, also known 
as cell-mediated immunity, other allergens, such as poison ivy and nickel, activate 
allergen-specific lymphocytes (memory T cells) at the site of contact (usually the 
skin) that release substances that cause inflammation and tissue damage. Some 
allergic responses, such as those to food allergens, may involve a combination 
of allergen-specific lymphocyte-driven and IgE-driven inflammation. Allergic 
responses may manifest in specific tissues (such as the skin, eyes, airways, and 
gastrointestinal tract) or may result in a system-wide response called anaphylaxis.
Autoimmune Diseases
The National Institutes of Health’s Autoimmune Diseases Coordinating Com-
mittee recognizes 80 different autoimmune diseases and conditions that affect the 
cardiovascular, respiratory, nervous, endocrine, skin, gastrointestinal, hepatic, and 
excretory systems (NIH Autoimmune Diseases Coordinating Committee, 2005). 
These diseases affect both men and women, but most of them affect more women 
than men (Fairweather et al., 2008). Genetic predisposition, age, hormone status, 
and environmental factors, such as the presence of infectious diseases and stress, 
are known to affect the risk of developing autoimmune diseases. Different autoim-
mune diseases can occur in the same person and tend to cluster in families. The de-
velopment of one autoimmune condition is also a risk factor for the development of 
other immune-related diseases and for some types of cancer (Landgren et al., 2010).
Autoimmunity occurs when an individual’s immune system fails to rec-
ognize self and attacks tissues as though they were foreign. Inappropriate im-
mune responses that cause autoimmunity originate with either cell-mediated or 
humoral-mediated immune systems and can be directed against a wide variety 
of tissues or organs. For example, the autoimmune reaction in multiple sclerosis 
targets the myelin sheath of nerve axons; in Crohn’s disease, the intestinal epithe-
lium; in type 1 diabetes mellitus, the insulin-producing islet cells of the pancreas; 
and in rheumatoid arthritis, the joint synovium and other proteins associated with 
connective tissue.
Other systemic autoimmune diseases also occur. Systemic lupus erythemato-
sus is an autoimmune disease in which multiple organs are targeted by a variety 
of autoantibodies. Patients display a variety of non-specific signs and symptoms 
such as joint pain or fatigue that makes timely diagnosis challenging. A charac-
teristic rash across the cheeks and nose and a sensitivity to sunlight are common 
symptoms, but oral ulcers, arthritis, pleurisy, proteinuria, and neurologic signs 
may also be present. Almost all of those affected with systemic lupus erythema-
tosus test positive for antinuclear antibodies, specifically antibodies directed at 
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double-stranded DNA. The cause of systemic lupus erythematosus is unknown, but 
environmental and genetic factors have been implicated. The environmental factors 
that are thought to trigger it include infections, antibiotics (especially those in the 
sulfa and penicillin groups) and some other drugs, ultraviolet radiation, extreme 
stress, and hormones (Kamen, 2014). Occupational exposures to such chemicals as 
crystalline silica, solvents, and pesticides have also been associated with systemic 
lupus erythematosus (Cooper and Parks, 2004; Parks and Cooper, 2005).
Inflammatory Diseases
Inflammatory diseases (also referred to as auto-inflammatory diseases) make 
up a more recently identified category of immune-related disorders and are charac-
terized by exaggerated, excessively prolonged, or misdirected dysfunctional inflam-
matory responses (usually involving immune cells). Tissue disease can result from 
this inappropriate inflammation, which can affect virtually any organ. Examples 
of the diseases and other conditions that are most often included in other disease 
categories but that are also considered to be inflammatory diseases are: coronary 
artery disease, asthma, eczema, chronic sinusitis, hepatic steatosis, psoriasis, celiac 
disease, and prostatitis. Inflammatory diseases often co-occur with one another, 
which has resulted in the categorizing of different but linked inflammatory diseases 
together as a single chronic inflammatory disorder (Borensztajn et al., 2011). Ordi-
narily, inflammation is advantageous in fighting infection. It is one component of 
the normal host response to infection and is mediated by innate and adaptive immu-
nity. Innate inflammatory responses involve the rapid mobilization of macrophages, 
granulocytes, and natural killer cells to the area of infection, where they produce 
toxic metabolites that kill pathogens. The adaptive immune response follows with 
specific antibodies and cell-mediated immunity that add to the inflammatory pro-
cess. Interactions among innate immune cells and epithelial and endothelial cells are 
important in regulating the magnitude of inflammation, and improperly regulated 
inflammation can contribute to diseases that arise in non-lymphoid tissues, such as 
the lungs, skin, nervous system, endocrine system, and reproductive system.
Inappropriate inflammation also appears to play a role in promoting the 
growth of neoplasms (Bornschein et al., 2010; Hillegass et al., 2010; Landgren 
et al., 2010; Porta et al., 2011; Winans et al., 2010); examples can be seen in the 
higher prevalence of specific cancers in patients who have such inflammatory 
diseases as inflammatory bowel disease (Lucas et al., 2010; Viennot et al., 2009; 
Westbrook et al., 2010), prostatitis (Sandhu, 2008; W. Wang et al., 2009), and 
psoriasis (Ji et al., 2009).
CONCLUSIONS FROM VAO AND PREVIOUS UPDATES
The studies reviewed in this section are limited to effects on the immune 
system due to exposures that occurred to adults. Immune effects stemming from 
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perinatal exposures are discussed in Chapter 8: Reproductive Health Effects and 
Effects on Descendants.
Two studies of Vietnam veterans reported a statistically significant differ-
ence of single immune measures of veterans exposed to Agent Orange compared 
with veterans without diseases and with age-matched healthy controls. Among 
Air Force Health Study (AFHS) veterans, Ranch Hands with the highest TCDD 
levels had statistically significantly elevated absolute counts of CD20 cells, the 
sum of natural killer (NK) cell antigens (CD16 and CD56) and total CD3+ cells 
compared with the AFHS controls (Michalek et al., 1999b). H. A. Kim et al. 
(2003) conducted an immunotoxicologic study of Korean Vietnam veterans who 
had been deployed to areas that were known to be sprayed with Agent Orange and 
found elevated levels of IgE and IgG1 among exposed veterans compared with 
age-matched healthy controls. Other studies of Vietnam veterans and populations 
exposed to the COIs did not find similar elevations for these immune markers. 
Thus, there were no consistent findings indicative of immunosuppression, an 
increased risk of autoimmunity (usually as measured with autoantibodies), or 
biomarkers of atopy or allergy (such as increased IgE concentrations). Much of 
the focus of the studies was on measuring CD4+:CD8+ T-cell ratios (T4:T8). The 
T4:T8 ratio is an effective biomarker of the progression of HIV-induced AIDS 
(acquired immune deficiency syndrome), but the TCDD-exposure animal data 
indicate that it is not an immunologic index that is expected to be altered. The 
results of a survey of Australian Vietnam veterans (O’Toole et al., 2009) showed 
purportedly significant increases in the prevalence of a number of conditions in 
which immune function may play a prominent role, but the study’s methods were 
deemed unreliable.
The occupational exposure studies evaluated by VAO committees have ex-
amined the concentrations of lymphoid populations in circulation, such as CD4+ 
T cells, CD8+ T cells (and their ratio), and NK cells; cell-mediated immunity 
(the delayed-hypersensitivity response); serum concentrations of immunoglobu-
lins, such as IgM, IgG, and IgA; concentrations of complement, such as C3 
and C4; and concentrations of cytokines, such as IL-1, IL-2, interferon-γ, IL-4, 
IL-6, and tumor necrosis factor (TNF)-α. A few studies also included disease or 
condition endpoints, such as rheumatoid arthritis, systemic lupus erythemato-
sus, immune suppression, and sensitivity to fungal infection. Ex vivo analyses 
included measures of NK activity, lymphoid mitogen-induced proliferation, and 
the mixed lymphocyte response against allogeneic cells. Some studies identi-
fied one or more dioxin-related shifts in immune measures, but many reported 
no significant differences in the same measures. Saberi Hosnijeh et al. (2012a) 
reported a positive correlation between plasma TCDD concentrations and de-
creased levels of cytokines, chemokines, and growth factors in Dutch workers 
who produced and formulated chlorophenoxy herbicides. In additional studies, 
Saberi Hosnijeh et al. (2012b, 2013a) assessed TCDD levels with respect to sev-
eral other immunological parameters and found no differences in hematologic 
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measurements other than an increase in the T4:T8 ratio (p = 0.05) when high- and 
low-exposure groups were compared. In the third study, Saberi Hosnijeh et al. 
(2013a) reported on the levels of interleukin 1 receptor antagonist (IL-1RA) as 
well as of the soluble forms of CD27 and CD30, immunomodulatory members 
of the TNF receptor superfamily. In this case they found no association of TCDD 
level with CD27 or CD30; however, IL-1RA was significantly decreased in 
those with higher TCDD levels after adjusting for concurrent chronic disease. 
This result is also consistent with a degree of immune system impairment being 
associated with high exposure to TCDD. Similarly, the occupational exposure 
studies that examined NK concentrations reported the full spectrum of results: 
no alterations (Halperin et al., 1998), a decrease (Faustini et al., 1996), and even 
an increase in NK numbers (Jennings et al., 1988) in different populations of 
people exposed to dioxin.
Several environmental exposure studies have been published, with inconsis-
tent findings. Some studies reported alterations in immune measures associated 
with dioxin exposure. For example, Van den Heuvel et al. (2002) reported a 
negative correlation between increased serum TEQ levels and eosinophil counts, 
NK-cell counts, and levels of cat dander, house dust mite, and grass pollen IgEs 
(measured by radioallergosorbent tests); but a positive correlation with IgA lev-
els. These alterations, however, were not seen consistently in other studies. Bac-
carelli et al. (2002) found no changes in IgA levels but saw changes in IgG levels 
in the Seveso population. Svensson et al. (1994) found that NK-cell numbers 
were reduced with increasing concentrations of persistent organic chemicals, but 
Lovik et al. (1996) found no difference in NK numbers or activity.
Some early studies of the Quail Run Mobile Home Park population who 
were exposed to TCDD-contaminated soil reported that dioxin exposure was as-
sociated with a reduction in a specific type of cell-mediated immune response, 
the delayed type hypersensitivity response (Andrews et al., 1986; Hoffman et 
al., 1986; Knutsen et al., 1987; Stehr-Green et al., 1987). However, several studies of 
the Times Beach population, another dioxin-exposed population, did not find any 
alteration of the delayed type hypersensitivity response (Knutsen, 1984; Stehr et 
al., 1986; Webb et al., 1987). An analysis of National Health and Nutrition Ex-
amination Survey (NHANES) data found that exposure to dioxin-like PCBs was 
associated with an increase in self-reported arthritis (D. H. Lee et al., 2007a), but 
De Roos et al. (2005b) did not find this association. Spector et al. (2014) assessed 
immune function in 109 postmenopausal women who participated in a year-long 
study of exercise and health in Seattle. At baseline, the concentrations of mono-
ortho PCBs 105, 118, and 156 were not associated with changes in lymphocyte 
proliferation assays; after 1 year, however, a decrease in lymphocyte proliferation 
was associated with increased levels of this group of PCBs (p = 0.039).
Nakamoto et al. (2013) gathered fasting blood samples to assess environ-
mental exposure to dioxin-like polychlorinated dibenzo-p-dioxins (PCDDs), 
polychlorinated dibenzofurans (PCDFs), and PCBs and found an association of 
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exposure to dioxins with differential leukocytes and a significantly decreased 
incidence of reported atopic dermatitis. Gallagher et al. (2013) examined the 
link between environmental exposures to the COIs and autoimmunity in women. 
Among women, after adjustments for mercury blood level, race, menopausal sta-
tus, diet, and body mass index (BMI), the total TEQs for PCBs were significantly 
associated with antinuclear antibody positivity (intensity ≥ 3) for each higher 
quartile compared with the lowest and as an overall trend (p < 0.001). After 
adjusting for mercury blood level, race, menopausal status, diet, and BMI, total 
TEQs for PCBs were significantly associated with antinuclear antibody positiv-
ity for each quartile compared with the referent group, and the overall trend was 
significant (p < 0.001). Turunen et al. (2012) derived the total toxic equivalence 
for 17 PCDD/F and 37 PCB congeners in blood samples from 123 men and 132 
women from a population with high fish consumption and analyzed their rela-
tionship with C-reactive protein, an indicator of inflammation. No evidence of 
a trend across the tertiles of overall TEQ concentration was seen for either the 
men or the women.
Based on these mixed results, the variety of endpoints assessed, and the 
poor methods used in some studies, VAO committee have concluded that epi-
demiologic data were either insufficient or inadequate to determine an associa-
tion between exposure to the COIs and immunosuppression, allergic disease, or 
autoimmune disease.
UPDATE OF THE EPIDEMIOLOGIC LITERATURE
Since Update 2014, five new published studies have been identified: one 
focused on New Zealand Vietnam veterans, three among occupational cohorts, 
and one on environmental exposures in Vietnam.
Vietnam-Veteran Studies
Cox et al. (2015) used hospital discharge records from 1988 to 2009 to 
identify prevalent health conditions in 2,783 male New Zealand veterans who 
served in Vietnam during 1964 to 1972. Age-specific hospitalization rates were 
calculated using the total number of annual hospitalizations published by the 
Ministry of Health and the average annual resident population. Standardized 
hospitalization rates and 99% confidence intervals (CIs) were calculated for the 
veteran cohort and the general population for several noncancerous conditions 
and a standardized hospitalization ratio (SHR) was calculated using the two rates. 
Results were presented for three categories of arthritis: rheumatoid arthritis, in-
fective arthritis, and osteoarthrosis. A statistically significant increased risk was 
observed for rheumatoid arthritis (n = 25; SHR = 1.70, 99% CI 1.03–2.36) and 
osteoarthrosis (n = 179; SHR = 1.32, 99% CI 1.12–1.51) but not for infective ar-
thritis (n = 26; SHR = 1.39, 99% CI 0.85–1.92). However, arthritis is not usually 
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a condition that requires hospitalization, so this study likely underestimates 
the prevalence or detects only persons with an unusually complicated disease 
process. In addition, hospitalization for systemic lupus erythematosus was not 
statistically significantly increased among veterans (n = 5; SHR = 1.82, 99% 
CI 0.22–3.41). Exposure to the COIs was not validated through serum measure-
ments, and the study did not control for smoking or ethnicity or other potentially 
important risk factors.
Occupational Studies
Parks et al. (2016) used data collected from the prospective, longitudinal 
Agricultural Health Study (AHS) to examine the associations between rheuma-
toid arthritis and pesticide exposures among the spouses of licensed pesticide 
applicators from Iowa and North Carolina who were part of the AHS. Specific 
pesticide exposures included exposure to herbicides 2,4-D and dicamba and to 
several insecticides and fungicides; only 2,4-D and dicamba are considered rel-
evant to committee’s charge. Details of the AHS study design and data collections 
are found in Chapter 5. Cases of rheumatoid arthritis were identified based on 
self-report. Cases in which disease-modifying antirheumatic drugs or other medi-
cations for rheumatoid arthritis were identified were considered to be probable 
instances of rheumatoid arthritis, and those individuals for whom a medical re-
cord review allowed confirmation of the diagnosis were considered to be definite 
cases of rheumatoid arthritis. Surveys collected information on age, tobacco use, 
menopausal status, childhood farm exposure, non-specific household and specific 
farm pesticide exposure, farm activities related to pesticides and other activities 
such as sun exposure, exposure to solvents and exposure to pesticides through 
mixing or application. A total of 275 cases of rheumatoid arthritis were identified 
among the 24,018 women participants, of which 132 were incident cases (that is, 
they developed after the start of the study, having been reported in phase II or III 
surveys but not phase I). Cases reported in phase I were considered prevalent, that 
is, as having developed before the start of the study. After adjusting for age, state 
of residence, and smoking history, the researchers found a statistically significant 
association between all-cases rheumatoid arthritis (incident and prevalent) and 
any specific pesticide exposure (odds ratio [OR] = 1.4; 95% CI 1.0–1.8; p < 0.05). 
Incident cases of rheumatoid arthritis were not associated with any exposure 
(OR = 1.4; 95% CI 0.93–2.1). A decreased association was observed for rheuma-
toid arthritis and exposure to 2,4-D with all cases (OR = 0.75; 95% CI 0.51–1.1) 
and incident cases (OR = 0.69; 95% CI 0.39–1.2). Likewise, a decreased asso-
ciation was observed for rheumatoid arthritis and exposure to dicamba based on 
7 cases (OR = 0.68; 95% CI 0.32–1.5). The effect estimate was not presented for 
incident cases of rheumatoid arthritis and dicamba exposure because there were 
fewer than 5 cases. The only individual pesticide to demonstrate a statistically 
significant association with rheumatoid arthritis was glyphosate (OR = 1.4; 95% 
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CI 1.0–2.1; p < 0.05). Thus, this study does not support an association of 2,4-D in 
the development of rheumatoid arthritis. The strengths of the study are the sample 
size, duration of follow-up, and specific pesticide data. The self-reported nature 
of the exposure without quantification could lead to under- or over-estimation as 
well as a misclassification of the agents of exposure. Para-occupational exposure 
and agricultural drift were not considered. Though the statistical methods for 
handling missing data were sound, there was a variety of missing data.
't Mannetje et al. (2018) conducted a morbidity survey among a subset of 
workers who were employed at the New Plymouth, New Zealand, phenoxy her-
bicide production plant for at least 1 month between 1969 and 1984. The plant 
produced 2,4,5-T, and workers were potentially exposed to 2,4,5-T, intermediates 
of trichlorophenol and other chlorophenols, and TCDD. Workers had previously 
been recruited and examined as part of the international cohort of producers of 
phenoxy herbicides led by the International Agency for Research on Cancer 
(IARC; Kogevinas et al., 1997); see Chapter 5 for more details on the IARC co-
hort and the New Zealand phenoxy producers. The 't Mannetje et al. (2018) study 
extended the follow-up period of these workers to approximately 30 years from 
their last 2,4,5-T production exposure. From the original cohort of 1,025 workers, 
631 were living, had a current address in New Zealand, and were below 80 years 
of age on January 1, 2006. For the current follow-up, 430 of the 631 workers were 
randomly selected and invited to participate in the morbidity survey, of which 
245 (57%) participated. The survey, which was administered in 2007–2008 by 
face-to-face interview, collected information on demographic factors and health 
information, including doctor-diagnosed conditions and year of diagnosis. A 
blood sample was also collected at that time to be analyzed for TCDD, lipids, 
thyroid hormones, and other parameters. For 111 of the participants, a neurologi-
cal examination was also conducted. Associations between exposure and health 
outcomes were assessed using logistic regression models that controlled for age, 
gender, smoking, BMI, and ethnicity using two methods: (1) working in a TCDD-
exposed job (based on occupational records), and (2) serum TCDD concentration 
≥10 pg/g lipid (18%). Mean TCDD concentrations were 19 pg/g lipid in the 60 
men directly involved in phenoxy or trichlorophenol production and 6 pg/g lipid 
in 141 men and 43 women who worked in other parts of the plant. Compared 
with the 124 people in the non-highly exposed jobs, the 121 people who had ever 
worked in a highly exposed job were no more likely to have doctor-diagnosed 
nasal allergies, including hay fever (n = 21; OR = 1.00; 95% CI 0.48–2.08). When 
compared by serum TCDD concentration ≥10 pg/g lipid, no difference in nasal 
allergies was found (n = 7; OR = 0.80; 95% CI 0.27–2.37).
Cappelletti et al. (2016) performed a retrospective study of 331 male electric 
arc foundry workers at a single plant in Trentino, Italy, to determine if they had 
experienced excess mortality from all causes or were at an increased risk for sev-
eral other diseases, including rheumatoid arthritis, due to occupational exposures 
to foundry dust. An analysis of the dust found that it contained metals (including 
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iron, aluminum, zinc, manganese, lead, chromium, nickel, cadmium, mercury, 
and arsenic), polycyclic aromatic hydrocarbons (PAHs), PCBs, and PCDD/Fs (re-
ported as TEQs). Therefore, the authors could not determine which of the agents 
were associated with a specific outcome or to what extent. Each of the men had 
worked at the factory for at least 1 year, and, for the rheumatoid arthritis analysis, 
they were compared with 32 presumed non-exposed workers (clerks, managers, 
and watchmen) or the standardized general population of Region Trentino-Alto 
Adige (where the factory was located) because there were few non-exposed 
foundry workers and high attrition rates. Company and medical records were 
used to determine vital status; cause of death was determined from death certifi-
cates or other registries. Requests for exemption health care fees were used as a 
surrogate measure to identify the most prevalent morbid conditions in the general 
population, which were then applied to the cohort to compute relative risks for 
each of the conditions. The workers were followed from March 19, 1979 (or their 
first day of employment), through December 31, 2009, or their date of death. The 
analysis for rheumatoid arthritis was limited to 235 workers, and effect estimates 
were calculated using Mantel-Haenszel tests. Although a statistically significant 
increase of rheumatoid arthritis was found among the workers compared with the 
age-adjusted provincial population, it was based on three cases, which resulted in 
an imprecise effect estimate (RR = 6.18, 95% CI 2.00–19.02). This study is most 
limited by the fact that foundry dust is a complex mixture, which results in an 
inability to discern the impact of the specific contaminants of the foundry dust on 
the health outcomes of those exposed workers. Estimates were only adjusted for 
age group and were not adjusted for other risk factors such as tobacco use, BMI, 
or other jobs or activities that could also influence health outcomes. The exposure 
to foundry dust by the general population that was used for comparison was not 
discussed, although the foundry appears to be in the local vicinity, and emissions 
from it were reported to be present within a 2-kilometer radius of the foundry.
Environmental Studies
C. H. Nguyen et al. (2017), studied serum TCDD levels, the expression of 
AHR, and a variety of pro-inflammatory cytokines in Vietnamese who were ei-
ther exposed or not exposed to TCDD-like chemicals. The exposed individuals 
(36 women and 24 men) had lived near the Da Nang Air Base for more than 10 
years. The controls were healthy men and women recruited from unsprayed areas 
in northern Vietnam. Serum levels of TCDD and “other” types of dioxins were 
measured using a chemical-activated luciferase gene-expression bioassay. RNA 
was isolated from whole blood for quantitative real-time polymerase chain reaction 
assays that were used to examine gene expression for AHR, IL-1β, TNFα, IL-6, 
IL-22, and β-actin. Dioxin levels, presented as bioanalytic equivalents (BEQ)/g 
fat (1.5 interquartile range), were significantly higher in the TCDD-exposed par-
ticipants than in the controls—62.03 (40.74–89.42) versus 17.45 (12.05–35.57), 
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respectively. AHR expression was 16.39 times higher in the exposed versus un-
exposed controls, which was statistically significant. To determine if there was an 
association between AHR expression and rheumatoid arthritis in the dioxin-ex-
posed subjects, AHR expression was measured and the 6 people with rheumatoid 
arthritis were compared to the 54 people without rheumatoid arthritis. While the 
dioxin-exposed group had higher levels of AHR expression than controls, there 
were no differences in AHR expression levels between the exposed subjects with 
and without rheumatoid arthritis. Because of the role they play in the pathogene-
sis of autoimmune conditions, IL-1β, TNFα, IL-6, and IL-22 were expression lev-
els measured in TCDD-exposed and unexposed populations. The median increase 
and 1.5-interquartile range for IL-1β was 11.18-fold (6.76–20.72, p < 0.05); for 
TNFα, 6.64-fold (3.43–13.67, p < 0.05); and for IL-6, 2.93-fold (1.80–5.18, 
p < 0.05). IL-22 was decreased 0.05-fold (0.01–0.11, p < 0.01). There was, how-
ever, no association between cytokine levels and dioxin levels. There was a weak 
positive correlation between AHR expression and IL-6 and IL-22 expression.
Next the investigators looked at the range of conditions reported in the 
exposed subjects. Cardiac disease was the most common, affecting 18%. Rheu-
matologic conditions affected 16.7%, and rheumatoid arthritis affected 10%. The 
rate for rheumatoid arthritis in the general Vietnamese population was 0.05%. 
The main strength of this study of Vietnamese individuals living near the Da 
Nang Air Base is the availability of serum dioxin levels. While the levels of pro-
inflammatory cytokines were significantly elevated in the exposed population, 
they did not correlate with serum dioxin levels. While there were more cases of 
rheumatoid arthritis in the exposed population than in the general population, 
neither the dioxin levels nor pro-inflammatory cytokines were compared between 
exposed people with and without rheumatoid arthritis. The study demonstrates 
an increased expression of pro-inflammatory cytokines in persons exposed to 
dioxins, but there is no information on lifestyle habits, tobacco, obesity, or other 
rheumatologic disorders or family history that may confound the findings.
Other Identified Studies
Several other studies were identified by the committee but either lacked suf-
ficient exposure specificity or examined biologic markers of effect on the immune 
system that do not relate to a diagnosable health outcome; these studies were not 
considered further. Akahane et al. (2017) examined the prevalence of a variety of 
self-reported conditions, including several connective tissue disorders, in people 
exposed to PCBs, dioxins (e.g., PCDD/Fs), and dioxin-like chemicals through the 
ingestion of contaminated rice bran oil following the Yusho accident. Because 
neither TEQs nor any other quantification of relevant exposures was presented, 
this study was not considered further.
A study of people who either worked at a transformer and capacitor recy-
cling plant in Dortmund, Germany, or lived in the immediate area and might 
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have been exposed to dioxin-like (PCBs 105, 114, 118, 156, 157, 167, and 189) 
and non-dioxin-like PCBs as a result of contamination of the area by the facility 
confirmed that exposure can modify lymphocyte profiles, but this was not linked 
with specific health outcomes (Haase et al., 2016). The results are consistent 
with the literature suggesting that PCB exposure may alter the immune profile, 
but these data do not provide any evidence of any consistent abnormality. This 
study did not detect any functional immunodeficiency, and the problems with its 
design and analysis (detailed in Chapter 5) seriously limit its contribution to the 
scientific evidence on the effects of exposure to the COIs.
Serdar et al. (2014) used data from the 2003–2004 cycle of NHANES to 
examine the association of serum, lipid-adjusted PCB levels, and organochlorine 
pesticide levels (including PCDDs, PCDFs, and dioxin-like PCBs) with hema-
tology and blood chemistry profiles that measured electrolytes, liver and renal 
function, globulin, total protein, and other factors. Although some statistically 
significant differences were found between counts and levels in the highest- and 
lowest-exposed quartiles, all were within the normal ranges and limits for those 
markers. These measures are indicators, not health outcomes, thus limiting their 
interpretability concerning immune system conditions.
BIOLOGIC PLAUSIBILITY
Given the growing recent understanding of the role of AHR in immune func-
tions (Abe et al., 2014; Biljes et al., 2017; Bock et al., 2017a; Chinen et al., 2015; 
Huai et al., 2014; Kado et al., 2016; Kimura et al., 2014; Y. H. Lee et al., 2015; 
Liao et al., 2017; Murray and Perdew, 2016; Stockinger et al., 2014), it is not 
surprising that there is an extensive body of evidence from experimental studies 
in cultured cells and animal models indicating that TCDD and other dioxin-like 
chemicals are immunotoxic to a variety of leukocytes (Kerkvliet, 2009, 2012; 
Kreitinger et al. 2016). Given that most of the cell types involved in the immune 
system express the AHR, there are many potential pathways to immunotoxicity. 
TCDD-induced immunotoxicity is due primarily to changes in adaptive immune 
responses resulting in the suppression of both antibody-mediated and cell-mediated 
immunity. Dioxin and other AHR agonists may also reduce the clearance of infec-
tions and promote tumor growth through alterations in immune function. TCDD 
exposure alters macrophages and neutrophils so as to exacerbate some types 
of inflammation during infections, and it may contribute to the development of 
chronic inflammatory lung disease (Teske et al., 2005; P. S. Wong et al., 2010). 
Although there are many examples of dioxin and dioxin-like chemicals having 
immunosuppressive effects, these chemicals also appear to influence autoimmune 
diseases, which are viewed as an inappropriate increase in immune function. 
Therefore, these chemicals may be best described as immunomodulatory.
TCDD has been shown to be a potent immunosuppressive chemical in 
laboratory animals and cell culture models. Data show that the relative potencies 
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of TCDD and dioxin-like chemicals on leukocytes are predicted by their TEFs 
(Frawley et al., 2014; Smialowicz et al., 2008). The exposure of animals to dioxin 
not only suppresses some adaptive immune responses, but also has been shown 
to increase the incidence, progression, and severity of various infectious diseases 
and to increase the development of cancers (Choi et al., 2003; Elizondo et al., 
2011; Fiorito et al., 2010, 2011, 2014; Head and Lawrence, 2009; Jin et al., 2010; 
Sanchez et al., 2010). Also, developmental exposure to TCDD (in utero and via 
suckling) in mice reduces immune response capacity to the influenza virus in 
adulthood (Boule et al., 2014). Consistent with its immunosuppressive effects, 
TCDD exposure suppresses the allergic immune response of rodents; this in 
turn results in decreased allergen-associated pathologic lung conditions and has 
been shown to suppress the development of experimental autoimmune disease 
(Quintana et al., 2008), to induce the suppression of autoimmune uveoretinitis 
(L. Zhang et al., 2010), and to affect colitis (Ji et al., 2015; Takamura et al., 
2011), arthritis (Nakahama et al., 2011), and inflammatory lung diseases, such as 
silicosis (Beamer et al., 2012).
Experimental studies indicate that the AHR pathway plays an integral role 
in B-cell maturation, and that exposure to TCDD and other dioxin-like chemicals 
may alter B-cells and result in critical changes in the immune response (Baba et 
al., 2012; Sibilano et al., 2012; Simones and Shephard, 2011; Singh et al., 2011). 
Feng et al. (2016) found that chronic TCDD exposure impaired both B- and T-
cell differentiation in a mouse model. Working with human B cells in vitro, Al-
lan and Sherr (2010) demonstrated a new AHR-dependent mechanism by which 
exposure to environmental PAHs suppressed humoral immunity by blocking the 
differentiation of B cells into plasma cells. This finding was confirmed by data 
from human hematopoietic stem cells and knockout Ahr mouse models showing 
that the Ahr is critical in the maturation and differentiation of hematopoietic stem 
cells (Bock, 2017b; Fracchiolla et al., 2011; J. Li et al., 2017; Singh et al., 2011; 
Vaidyanathan et al., 2017). Furthermore, data from a B-cell specific Ahr knockout 
showed that the receptor pathway is required for efficient B-cell proliferation 
(Villa et al., 2017). Using a novel pluripotent stem cell–based culture system, 
B. W. Smith et al. (2013) demonstrated that AHR expression and activity can di-
rect human hematopoietic progenitor cell proliferation and differentiation. These 
data show that pluripotent hematopoietic human cells express AHR and that AHR 
agonists enhance erythroid differentiation, whereas the antagonism of AHR fa-
vors the expansion of megakaryocyte cells. This finding supports previous work 
indicating that B-cell activation results in increased AHR expression and that an 
exposure of B-cells to benzo[a]pyrene, a PAH, suppresses B-cell differentiation 
(Allan and Sherr, 2010). H. Lu et al. (2010) demonstrated that although human 
B cells appeared less responsive to TCDD in increasing the expression of AHR 
battery genes, TCDD’s ability to decrease IgM production was similar in both 
mouse and human B cells. Data from Q. Zhang et al. (2013) suggest that this 
decrease in IgM production is the result of a TCDD-mediated decrease in B-cell 
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terminal differentiation, which results in fewer IgM-producing cells. Recent 
data from Kovalova et al. (2017) identify other species-specific gene expression 
in TCDD-exposed mouse, rat, and human B cells. In addition, Kovalova et al. 
(2016) found that certain AHR polymorphisms altered the sensitivity of human 
B cells to TCDD-mediated suppression of IgM secretion, consistent with AHR 
levels mediating this suppression.
TCDD not only alters hematopoietic stem cell maturation but also alters 
activation, proliferation, and migration in vivo and in vitro (Casado et al., 2011; 
Fader et al. 2015; Phadnis-Moghe et al., 2016), which indicates that exposure to 
it may have multiple effects on immune-cell function. Recent data have linked 
TCDD activation of the AHR with altered regulation of BCL-6 in human B-cells, 
which in turn is linked to non-Hodgkin lymphoma and diffuse large B-cell lym-
phomas (Phadnis-Moghe et al., 2015, 2016), providing a suggestive mechanistic 
link between TCDD exposure and some lymphomas.
Cellular immunity, which is mediated by the thymus and T cells, is also a 
target of TCDD and dioxin exposure and the AHR pathway (Baricza et al., 2016; 
Feng et al., 2016; Kuwatsuka et al., 2014). Early evidence indicated that dioxin 
and dioxin-like chemicals alter cellular immunity because it was observed that 
exposure to these chemicals resulted in thymic involution and suppressed cyto-
toxic T-lymphocyte activity (Hanieh, 2014). Recently attention has focused on 
the ability of the AHR to induce regulatory T cells, or Tregs (Bruhs et al., 2015; 
Kerkvliet, 2012; Marshall and Kerkvliet, 2010; Mohinta et al., 2015). A recent 
paper elucidates one potential molecular mechanism of AHR activation of Tregs, 
using real-time imaging to show the migration of AHR-Tr1 Tregs in the small in-
testine and the colon (Ehrlich et al., 2017). Tregs have potent suppressive activity 
in the immune system, and their inappropriate induction by TCDD could account 
for much of the immune suppression (Funatake et al., 2008; Kerkvliet, 2012; 
Marshall et al., 2008; Quintana et al., 2008; Stockinger et al., 2011; Yamamoto 
and Shlomchik, 2010). AHR activation in dendritic cells has also been shown to 
promote the development of Tregs by inducing tryptophan metabolism. Further-
more, a recent study shows a role for the AHR pathway in promoting gut Tregs 
(Ye et al., 2017).
One ultimate effect of the dysregulation of the immune system is an al-
teration in autoimmunity. Data from animal models and cell cultures indicate 
that exposure to dioxin and dioxin-like chemicals alters the development of 
autoimmune disorders. Boule et al. (2015) found that developmental exposure 
to TCDD exacerbated the severity of autoimmune disease in a genetically sus-
ceptible mouse model. In another example, antagonism of the AHR repressed the 
expression of cytokines and chemokines in primary human synovial fibroblasts 
(Lahoti et al., 2013), indicating a potential contribution to the inflammatory 
process of rheumatoid arthritis. N. T. Nguyen et al. (2013) hypothesized that the 
inflammatory process may occur when AHR stimulation of IL-17 production in 
Th17 cells overwhelms the immune suppressive effects of the inhibition of Treg 
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differentiation. TCDD has also been shown to induce apoptosis in rabbit chon-
drocytes, which supports a potential role of TCDD in contributing in a novel way 
to arthritis (Yang and Lee, 2010). A recent study indicates that sub-chronic low-
dose TCDD exposure can show immunomodulatory effects in a mouse model of 
experimental autoimmune encephalitis (E. J. Yang et al., 2016). Recent work by 
L. Cheng et al. (2017) in a hospital-based study of Han Chinese patients suggests 
that a polymorphism in the AHR repressor gene may increase an individual’s 
susceptibility to rheumatoid arthritis. Exposure to TCDD was also shown to 
induce the reactivation of the latent form of the Epstein Barr virus in 19 patients 
with Sjögren syndrome, an autoimmune disease, when compared with 19 healthy 
patients (Inoue et al., 2012). AHR activation by ultraviolet light may play a role 
in the exacerbation of systemic lupus erythematosus symptoms by reducing DNA 
methylation in CD4+ T cells (Z. Wu et al., 2017). Taken together these studies 
suggest mechanisms by which TCDD may alter the incidence and progression of 
autoimmune disorders.
Allergies and allergic-induced asthma are also linked to TCDD exposure. 
A study of 18 people who had allergic asthma, 17 people whose asthma was 
controlled, and 12 controls showed that the plasma concentrations of IL-22 and 
the expression of the AHR in peripheral blood mononuclear cells were associ-
ated with the severity of allergic asthma; this finding strengthened the possibility 
that the AHR is involved in allergic asthma, thereby implying a role for dioxin 
exposure in this condition (Zhu et al., 2011). X. M. Li et al. (2016) studied a 
mouse model of non-allergic asthma and found that TCDD exposure reduced the 
airway infiltration of neutrophils and airway hyperresponsiveness and inhibited 
Th17 differentiation. Thus, depending on the disease, TCDD exposure could 
exacerbate or ameliorate symptoms.
SYNTHESIS
Previous VAO committees have concluded that the data were inadequate 
or insufficient to support an increased risk of immune suppression, allergy, or 
autoimmune disease. The studies reviewed by these committees were at times 
poorly designed and often inconsistent and used a variety of biomarkers, making 
comparisons difficult. Most of the studies used biomarkers rather than health 
outcomes as endpoints.
The new studies reviewed here do not change this conclusion, as the results 
continue to be inconsistent and inconclusive. Cox et al. (2015) used hospital dis-
charge records from New Zealand Vietnam veterans to examine the prevalence 
of inflammatory and autoimmune conditions. Although there was an increase in 
the standard hospitalization rate for rheumatoid arthritis but not systemic lupus 
erythematosus among veterans, no serum or tissue levels of dioxin-like chemicals 
were provided to confirm exposure. Rheumatoid arthritis incidence and preva-
lence were examined by Parks et al. (2016) in the female spouses of licensed 
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pesticide applicators in the AHS and found to be associated only with glyphosate, 
not 2,4-D or dicamba. Again, exposure was not confirmed with blood or tissue 
levels. Cappelletti et al. (2016) studied electric arc foundry workers exposed 
to the COIs. Results showed a statistically significant increase in rheumatoid 
arthritis among workers exposed to foundry dust. In a comparison of high- and 
low-exposure areas in Vietnam, C. H. Nguyen et al. (2017) showed that persons 
living in the high-exposure area had higher levels of AHR expression and some 
pro-inflammatory cytokines. They also had a higher prevalence of rheumatoid 
arthritis, but no data were provided linking the higher levels of pro-inflammatory 
cytokines in persons with rheumatoid arthritis. Among New Zealand workers in 
a plant that produced 2,4,5-T, comparisons of high- versus low-exposed workers 
by job and by serum measurements showed no difference in doctor-diagnosed 
nasal allergies, including hay fever.
It is biologically plausible for dioxins to influence immune dysfunction, but 
because of the variety of methods and endpoints used in studies to date, it is hard 
to confirm specific mechanisms by which the COIs induce immune suppression 
and auto-immunity. TCDD has been shown to suppress both limbs of the adaptive 
immune response, reduce the clearance of infection, and promote tumor growth 
(Bruhs et al., 2015; Kerkvliet, 2009, 2012; Kreitinger et al., 2016; Marshall and 
Kerkvliet, 2010). Exposure to dioxin-like chemicals has been shown to induce 
immune suppression via T regulatory cells (Bruhs et al., 2015; Kerkvliet, 2012; 
Marshall and Kerkvliet, 2010; Mohinta et al., 2015) in animal models. Animal 
models also support the development of inflammatory conditions, especially rheu-
matoid arthritis, following exposure to dioxin, through the AHR and downstream 
increased production of IL-17 (N. T. Nguyen et al., 2013). AHR polymorphisms 
have been associated with an increased susceptibility to rheumatoid arthritis in 
exposed persons (L. Cheng et al., 2017) and AHR activation by ultraviolet light 
may exacerbate systemic lupus erythematosus via reduced methylation in CD4+ 
T cells (Z. Wu et al., 2017). The data are inconsistent for allergic asthma.
CONCLUSION
On the basis of the evidence reviewed here and in previous VAO reports, 
the committee concludes that there is inadequate or insufficient evidence to 
determine whether there is an association between exposure to the COIs and 
any specific diseases involving immune suppression, allergy, autoimmunity, or 
inflammation.
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Cancer
Chapter Overview
Based on new evidence and a review of prior studies, the current committee deter-
mined that epidemiologic results concerning an association between exposure 
to any one of the chemicals of interest (COIs; 2,4-dichlorophenoxyacetic acid 
 (2,4-D), 2,4,5-trichlorophenoxyacetic acid (2,4,5-T), picloram, dimethylarsinic 
acid [DMA or cacodylic acid], and 2,3,7,8-tetrachloro dibenzo-p-dioxin [TCDD]) 
and monoclonal gammopathy of undetermined significance (MGUS) met the cri-
teria for sufficient evidence of an association. No other changes in association 
level between the relevant exposures and other cancer types were made as either 
there were no published studies or the new evidence supported the findings of ear-
lier updates. Thus, the current findings on cancer can be summarized as follows:
• There is sufficient evidence of an association between the COIs and soft tis-
sue sarcomas, B-cell lymphomas (Hodgkin lymphoma, non-Hodgkin lym-
phomas, chronic lymphocytic leukemia, hairy-cell leukemia), and MGUS.
• There is limited or suggestive evidence of an association between 
the COIs and bladder cancer; laryngeal cancer; cancers of the lung, 
 bronchus, or trachea; prostate cancer; multiple myeloma; and AL 
amyloidosis.
• There is inadequate or insufficient evidence to determine whether there 
is an association between the COIs and any other specific type of cancer.
Cancers are the second-leading cause of death in the United States (CDC, 
2017a), with heart disease being the leading cause of death. However, among 
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men 55–79 years old, the group that includes most Vietnam veterans, the risk of 
dying from cancer exceeds the risk of dying from heart disease (CDC, 2017b). 
According to estimates from the National Cancer Institute (NCI), 1,735,350 new 
cases of cancer were expected to be diagnosed and 609,640 people of all ages 
were expected to die from cancer in the United States in 2018 (NCI, 2018a).
The objective of this chapter is to provide an assessment of whether the 
occurrence of cancers in Vietnam veterans may be associated with exposures 
to herbicides that they may have experienced during their military service. This 
chapter summarizes and presents conclusions about the strength of the evidence 
from epidemiologic studies regarding associations between exposure to the COIs 
and various cancer types. As described in Chapter 3, studies of exposure to poly-
chlorinated biphenyls (PCBs) and other dioxin-like chemicals were also consid-
ered informative if their results were reported in terms of TCDD toxic equivalents 
(TEQs) or concentrations of specific congeners of dioxin-like chemicals. Studies 
that report TEQs based only on mono-ortho PCBs (which are PCBs 105, 114, 
118, 123, 156, 157, 167, and 189) are considered even though their TEQs are 
several orders of magnitude lower than those of the non-ortho PCBs (77, 81, 
126, and 169), based on the revised World Health Organization (WHO) toxicity 
equivalency factor (TEF) scheme of 2005 (La Rocca et al., 2008; van den Berg 
et al., 2006). The lower TEQs of the mono-ortho PCBs, however, may be coun-
terbalanced by their abundance, which is generally many orders of magnitude 
higher than the non-ortho PCBs (H.-Y. Park et al., 2010).
A compendium of all of the studies reviewed by the various Veterans and 
Agent Orange (VAO) and VAO Update committees can be found at www.nap.
edu/catalog/25137. In this update, if a new study reported on only a single type 
of cancer and did not revisit a previously studied population, then its design 
information is summarized here with its results; design information on studies 
that are updates of or new analyses on populations or cohorts that have been 
previously studied can be found in Chapter 5. Studies of childhood cancers in 
relation to parental exposure to the COIs are discussed in Chapter 8, which ad-
dresses possible adverse effects in the veterans’ offspring. Studies that consider 
only childhood exposure are not considered relevant to the committee’s charge.
In evaluating possible connections between herbicide exposure and the risk 
of cancer, the approach used to assess the exposure of study subjects is of critical 
importance in determining the overall relevance and usefulness of findings. There 
is great variation in the detail and the accuracy of exposure assessments among 
studies, which can distort the true relationship between exposure and disease. A 
few studies used biologic markers of exposure, such as the presence of a chemical 
in serum or tissues; others developed an index of exposure from employment or 
activity records; and still others used other surrogate measures of exposure, such 
as an individual’s presence in a locale when herbicides were used.
Each section on a specific cancer type opens with background information, 
including data on its incidence in the general U.S. population and its known 
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or suspected risk factors. Cancer incidence in the general U.S. population is 
included in the background material to provide a context for consideration of the 
cancer risk in Vietnam veterans; the numbers presented are estimates of incidence 
in the entire U.S. population, not predictions for the Vietnam veteran cohort. The 
data on the expected numbers of new cases and deaths for specific types of can-
cerin 2017 are based on estimates from NCI’s Surveillance, Epidemiology, and 
End Results (SEER) program or, if estimates for a particular cancer type were 
not available from NCI, on estimates by the American Cancer Society. Using the 
most recent SEER data available when this was written (SEER-18; 2000–2014), 
incidence data were derived for all races combined and separately for blacks and 
whites using age groups likely to include most Vietnam-era veterans. Incidence 
data are presented by sex, age, and race, all of which can have profound effects 
on risk (NCI, n.d.a). For example, the incidence of prostate cancer is about 2.6 
times higher in men who are 70–74 years old as in men 60–64 years old and about 
75% higher in blacks 60–64 years old than in whites in the same age group (NCI, 
2015). Many other factors can influence cancer incidence, including screen-
ing methods, tobacco and alcohol use, diet, obesity, genetic predisposition, and 
medical history. Those factors can modify the risk of developing a given kind of 
cancer; they also need to be taken into account in epidemiologic studies of the 
possible contributions of the COIs.
Each section of this chapter pertaining to a specific type of cancer includes a 
summary of the findings described in the previous 10 VAO reports. That is followed 
by a discussion of the most recent scientific literature, and, when appropriate, the 
literature is discussed by exposure type (service in Vietnam, occupational exposure, 
or environmental exposure). A summary of biologic plausibility, which corre-
sponds to the third element of the committee’s congressionally mandated Statement 
of Task, follows the description of newly identified epidemiologic studies. In fact, 
the degree of biologic plausibility itself influences whether the committee per-
ceives positive findings to be indicative of an association or the product of statisti-
cal fluctuations (chance) or bias. Following a synthesis of the material reviewed, 
each section ends with the committee’s conclusion regarding the strength of the 
evidence from epidemiologic studies. The categories of association and the com-
mittee’s approach to categorizing the health outcomes are discussed in Chapter 3.
Chapter 4 contains information on the general biologic mechanisms by 
which exposure to TCDD and the other COIs contribute to malignant transforma-
tion. Toxicology studies use a variety of methods and animal or cellular models to 
derive results on the interactions of the COIs with the cellular machinery known 
to be important in the development of cancer at any site. When biologic plausi-
bility is discussed in each section, this generic information is implicit, and only 
experimental data specific to carcinogenesis at the site in question are presented. 
There is increasing evidence that TCDD and the COIs may disturb cellular pro-
cesses through epigenetic mechanisms, and reference to this evidence as it applies 
to specific cancers is included where it exists.
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Considerable uncertainty remains about the magnitude of the risk posed by 
exposure to the COIs. Many of the veteran, occupational, and environmental 
studies reviewed by the committee did not fully control for important confound-
ers. There is not enough information about the exposure experience of individual 
Vietnam veterans to permit combining exposure estimates for them with any 
potency estimates that might be derived from scientific research studies to quan-
tify risk. The committee therefore cannot accurately estimate the risk to Vietnam 
veterans that is attributable to exposure to the COIs. The significant challenges 
in deriving useful quantitative estimates of the risks of various health outcomes 
in Vietnam veterans are explained in Chapter 2 of this report.
ORGANIZATION OF CANCER GROUPS
Consistent with the previous report in this series, the organization of cancer 
groups follows the major and minor categories of cause of death related to cancer 
sites established by the National Institute for Occupational Safety and Health 
(NIOSH; Robinson et al., 2006). For the present update, the committee gave 
more attention to the WHO’s classification of lymphohematopoietic neoplasms 
(WHO, 2008), which stresses partitioning of the disorders first by the lymphoid 
or myeloid lineage of the transformed cells, rather than categorizing into lym-
phomas and leukemias.
The system of organization used by the committee simplifies the process for 
locating a particular cancer type for readers. For any cancer type for which no 
epidemiologic research findings have been identified, the default category has 
always been “inadequate or insufficient evidence” of association with exposure 
to the COIs. A failure to review a specific cancer or other condition separately 
reflects the paucity of information concerning that cancer, so there is indeed 
inadequate or insufficient information to categorize an association with such a 
disease outcome.
BIOLOGIC PLAUSIBILITY
The studies considered by the committee that speak to the biologic plausi-
bility of associations between human cancers and exposure to 2,4-D, 2,4,5-T, 
picloram, cacodylic acid, and TCDD have been performed primarily in laboratory 
animals (rats, mice, hamsters, and monkeys) or in cultured cells.
The animal studies examining the carcinogenicity of 2,4-D, 2,4,5-T, and 
picloram have, in general, produced negative results, although some bioassays 
used in those studies would not meet current standards. For example, there is 
a question of whether the highest doses (generally 30–50 mg/kg) used in some 
of the experiments reached a maximum tolerated dose or represented the doses 
that are capable of inducing carcinogenesis. Therefore, it is not possible to have 
absolute confidence that these chemicals have no carcinogenic potential at higher 
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doses. Additional evidence of a lack of carcinogenic potential comes from nega-
tive findings on the genotoxic effects of assays conducted primarily in vitro that 
indicate that 2,4-D and 2,4,5-T are genotoxic only at very high concentrations.
There is evidence in laboratory animals that cacodylic acid is carcinogenic, 
based on studies that have shown that it can induce neoplasms of the kidney 
(Yamamoto et al., 1995), bladder (Arnold et al., 2006; Cohen et al., 2007b; A. 
Wang et al., 2009; Wei et al., 2002; Yamamoto et al., 1995), liver, and thyroid 
gland (Yamamoto et al., 1995). Treatment with cacodylic acid induced the forma-
tion of neoplasms of the lung when administered to mouse strains that are geneti-
cally susceptible to developing those tumors (Hayashi et al., 1998; Yamanaka 
et al., 2009). Other studies have used the two-stage model of carcinogenesis in 
which animals are exposed first to a known genotoxic agent and then to a sus-
pected tumor-promoting agent; with this model, cacodylic acid has been shown 
to act as a tumor promoter with respect to lung cancer (Yamanaka et al., 1996). 
These studies are further discussed in Chapter 4.
Collectively, the evidence obtained from studies of TCDD supports a con-
nection between human exposure and cancers. The effects of TCDD on cellular 
function make carcinogenesis biologically plausible, and evidence from model 
systems indicate that TCDD can enhance carcinogenesis. This will be discussed 
in a generic sense below and more specifically in the biologic plausibility sections 
on individual cancers. Several reviews have affirmed the well-established mecha-
nistic roles of the aryl hydrocarbon receptor (AHR) in TCDD-induced cancers 
(S. Ahmed et al., 2014; Androutsopoulos et al., 2009; Barouki and Coumoul, 
2010; Dietrich and Kaina, 2010; Ide et al., 2017; Murray et al., 2014; Ray and 
Swanson, 2009; Rysavy et al., 2013; Tsay et al., 2013). The effect can be both 
cancer promoting—by activating oncogenes (Gardella et al., 2016) or blocking 
apoptosis (Bekki et al., 2015)—or protective, depending on the tissue type and 
timing of the exposure (Y. Li et al., 2014; Moore et al., 2016). The role of the 
AHR is further established by:
• its activation of several proteins of the P450 system of enzymes that play 
crucial roles in detoxification and drug metabolism (Al-Dhfyan et al., 
2017a,b);
• activation of the paraoxanase antioxidant enzymes (Shen et al., 2016); and
• activation of the transforming growth factor (TGF)-β pathway (Silginer 
et al., 2016);
all of which are important in oncogenesis. TCDD can disrupt circadian rhythms 
via the AHR, and chronic disruption of circadian rhythms is associated with an 
increased incidence of cancer, suggesting a potential additional pathway by which 
TCDD increases cancer risk (C. Wang et al., 2014; C. X. Xu et al., 2013). TCDD 
increases the incidence or progression of human cancers through a variety of cel-
lular mechanisms, and the biologic plausibility of an association between TCDD 
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exposure and cancer has been firmly established in a mechanistic sense. Data also 
indicate that AHR can play a protective role in cancer (reviewed in Kolluri et al., 
2017; Murray et al., 2014), and its role as a therapeutic target for cancer therapy is 
being investigated. However, cancer therapies were considered beyond the scope 
of the committee’s charge, and not included in this report.
TCDD is considered a non-genotoxic carcinogen, as reviewed by Hernández 
et al. (2009), because it does not produce changes is DNA sequences. However, 
because of the oxidative stress it produces, TCDD does have some genotoxic 
potential. In vitro work with mouse hepatoma cells has shown that activation 
of the Ahr results in increased concentrations of 8-hydroxy-2-deoxyguanosine 
 (8-OHdG), a product of DNA-base oxidation and a marker of DNA damage. The 
induction of cytochrome P4501A1 (CYP1A1) in these cells by TCDD or indolo 
(3,2-b) carbazole is associated with oxidative DNA damage (Park et al., 1996). 
In vivo experiments in mice corroborated those findings by showing that TCDD 
caused a sustained oxidative stress, as determined by measurements of urinary 
8-OHdG (Shertzer et al., 2002), and that it involves AHR-dependent uncou-
pling of mitochondrial respiration (Senft et al., 2002). Mitochondrial reactive-
oxygen production depends on the AHR. Electronics-dismantling workers who 
experienced complex exposures, including exposure to polychlorinated dibenzo-
p- dioxins and dibenzofurans (PCDD/Fs), were shown to have increased con-
centrations of urinary 8-OHdG, indicative of oxidative stress and genotoxicity; 
however, this finding cannot be ascribed confidently to these compounds (Wen 
et al., 2008). Other than these observations of 8-OHdG formation and oxidative 
stress, there is little evidence that TCDD is genotoxic, and it appears likely that 
some of its mechanisms of action may involve epigenetic modifications of the 
DNA or  chromatin (described in Chapter 4).
The ability to induce oxidative stress contributes to TCDD’s recognized 
activity as a potent tumor promoter and as a weak initiator in two-stage initiation–
promotion models for ovarian cancer (Davis et al., 2000), liver cancer (Beebe et 
al., 1995), and skin cancers (Wyde et al., 2004). Work with a mouse lung cancer 
model suggests that in addition to increasing cell division, the tumor-promoting 
activities of TCDD include blocking apoptosis (R. J. Chen et al., 2014a). Early 
studies demonstrated that TCDD is two orders of magnitude more potent than the 
“classic” promoter tetradecanoyl phorbol acetate and that its skin-tumor promo-
tion depends on AHR (Poland et al., 1982).
Laboratory animals exposed to TCDD show an increase in the incidence 
of several neoplasms, most notably of the liver, lungs, thyroid, and oral mucosa 
(Kociba et al., 1978; NTP, 2006). In long-term bioassays in both sexes of several 
strains of rats, mice, hamsters, and fish, TCDD increases the incidence of tumors, 
including those at sites distant from the site of treatment, at doses well below the 
maximum tolerated dose (Rysavy et al., 2013). TCDD exposure has also been 
shown to cause hyperplasia or metaplasia of epithelial tissues. In both laboratory 
animals and cultured cells, TCDD has been shown to exhibit a wide array of effects 
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on growth regulation, hormone systems, and other factors associated with the 
regulation of cellular processes that involve growth, maturation, and differentia-
tion, in most cases via its interaction with AHR (Murray et al., 2014; Rysavy et 
al., 2013). In rat liver, TCDD downregulates reduced folate carrier (Rfc1) mRNA 
and protein, whose normal levels are essential in maintaining folate homeostasis 
(Halwachs et al., 2010). Reduced Rfc1 activity and a functional folate deficiency 
may contribute to the risk of carcinogenesis posed by TCDD exposure, perhaps 
via an epigenetic effect of interfering with DNA methylation levels (Davis and 
Uthus, 2004; Williams, 2012).
Tissue-specific protective cellular mechanisms may also be important to the 
response to TCDD and may complicate our understanding of its site-specific car-
cinogenic effects. For example, studies reviewed by this committee (and further 
described in specific cancer outcome sections below) include investigations of 
TCDD and other AHR ligands that found anti-proliferative and anti-metastatic 
activity in cell lines of different cancers, including breast, ovarian, and prostate 
(Hanieh, 2015; Hanieh et al., 2016; Ide et al., 2017; Y. Li et al., 2014).
In humans, the cancer-causing effects of TCDD (and the other COIs) have to 
be evaluated with respect to inherent genetic susceptibility or resistance, which 
can vary considerably across human beings. Several polymorphisms in the AHR 
gene have been identified in humans, although the functional significance remains 
uncertain. One genome-wide association study found a weak association with 
between the AHR locus and cutaneous squamous cell carcinoma (Chahal et al., 
2016), and another study (Spink et al., 2015) found that the (GGGGC)n repeat 
polymorphism in the human AHR was overrepresented in a small sample size 
of lung cancers, compared to a neonatal population in New York thought to 
represent a the incidence in the general population. Variants of the DNA repair 
gene XRCC1 have been associated with urothelial cancer risk and this risk was 
increased with arsenic exposure (Chiang et al., 2014). Some of these genes exert 
their effect by modulating the cellular exposure to COIs, such as the effects of the 
CYP1A1, GSTM1, and p53 on polycyclic aromatic hydrocarbon (PAH) exposure 
(Gao et al., 2014). Genetic variants can also be associated with non-neoplastic 
health effects; for example, common polymorphisms in some cytochrome P450 
genes (CYP1A1, CYP1B1, CYP17) are associated with benign prostatic hyper-
plasia related to organochlorine pesticide exposure (V. Kumar et al., 2014) and 
may have an impact on chronic kidney disease and dioxin levels in an endemic 
area of exposure (C. Y. Huang et al., 2016). Thus, identical exposures can have 
non-identical effects in different individuals, making it challenging to perform 
genotype/phenotype assessments of TCDD effects for specific cancers.
Several potential pathways for TCDD carcinogenesis have been proposed. 
TCDD may contribute to tumor progression via the inhibition of p53 tumor 
suppressor activity induced by genotoxic agents (Gardella et al., 2016). This 
inhibition may occur through AGR2 (Ambolet-Camoit et al., 2010) or through 
interaction with the AHR and FHL2 (four and a half LIM protein domains 2) 
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(Kollara and Brown, 2009). A study in fish by Calò et al. (2018) suggests that 
dioxin-like PCB 126 may promote the degradation of tumor suppressor p53 
through the proteasome ubiquitin system. (In related work, Luecke-Johansson et 
al. [2017] explored the mechanism of activating AHR function as E3 ubiquitin 
ligase.) Borlak and Jenke (2008) demonstrated that AHR is a major regulator 
of c-Raf and proposed that there is cross-talk between AHR and the mitogen-
activated protein kinase signaling pathway in chemically induced hepatocarcino-
genesis. TCDD inhibits ultraviolet-C radiation-induced apoptosis in primary rat 
hepatocytes and in Huh-7 human hepatoma cells, supporting the hypothesis that 
TCDD acts as a tumor promoter by preventing exposed cells from undergoing 
apoptosis (Bekki et al., 2015; R. J. Chen et al., 2014b; Chopra et al., 2009). AHR 
activation by TCDD in human breast and endocervical carcinogenic cell lines 
induces sustained high concentrations of the cytokine interleukin (IL)-6. IL-6 
has tumor-promoting effects in numerous tissues—including breast, prostate, 
and ovary—which opens the possibility that TCDD may promote carcinogenesis 
in these and possibly other tissues (Hollingshead et al., 2008). However, recent 
work in normal mammary cells indicates that AHR may function as inhibitors 
of mammary tumors (Hall et al., 2010; Hanieh, 2015; Hanieh et al., 2016; S. 
Zhang et al., 2009, 2012), supporting work indicating that TCDD’s effect is 
cell-type specific. More recent work has shown an interaction between the AHR 
and ADM (adrenomedullin) oncogene in cell lines and lung tissue (Portal-Nunez 
et al., 2012), and AHR repression experiments in gastric and head and neck 
cancers suggest that AHR expression leads to increased cancer cell growth and 
invasion (DiNatale et al., 2012; X. F. Yin et al., 2013). In cell culture studies of 
mechanisms of cancer progression and metastasis, TCDD exposure increased the 
epithelial-to-mesenchymal transition and the loosening of cell–cell contacts (Diry 
et al, 2006; Gao et al., 2016).
Genetic disturbances arising from confirmed exposure to herbicides were 
evaluated by analyzing sister-chromatid exchanges in lymphocytes from a group 
of 24 New Zealand Vietnam War veterans and 23 matched control volunteers 
(Rowland et al., 2007). The results showed a highly significant difference (p < 
0.001) between the veterans and the control group in the mean frequency of 
sister-chromatid exchanges, which is thought to be an indicator of genetic dam-
age. The distribution was skewed left, and the Vietnam veterans also had a much 
higher proportion of cells with sister-chromatid exchanges frequencies above the 
95th percentile (≥17 sister chromatid exchanges per cell) than the controls (11.0% 
versus 0.07%). A study of sister-chromatid exchanges frequencies in blood sam-
ples taken from Vietnamese women from high- and moderate-TCDD-sprayed 
areas also showed increased sister-chromatid exchanges of 2.40 per cell and 2.19 
per cell, respectively, compared with Vietnamese women from unexposed areas 
(1.48 per cell, p < 0.001) (Suzuki et al., 2014).
The weight of evidence that TCDD and dioxin-like PCBs make up a group of 
chemicals with carcinogenic potential includes unequivocal animal carcinogenesis 
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and biologic plausibility based on mechanistic mode-of-action data. Although the 
specific biological and genetic mechanisms by which dioxin causes cancer remain 
to be elaborated, the intracellular factors and mechanistic pathways involved in 
dioxin’s cancer-promoting activity all have parallels in animal and human studies. 
Nevertheless, the extrapolation of animal studies to humans should be viewed 
with caution since there are many biological differences among these species. 
The International Agency for Research on Cancer (IARC) has classified TCDD 
in group 1 as carcinogenic to humans. The strongest evidence for carcinogenicity 
was observed when all cancers sites were aggregated, but a positive association 
between TCDD exposure and soft-tissue sarcomas, non-Hodgkin lymphomas, 
and lung cancer has also been found (IARC, 2012b), which likely contributes 
to the strong association of all cancers combined. Risks for specific cancers 
in  reports of TCDD-exposed workers and in the TCDD-exposed population in 
Seveso have been sporadic and inconsistent (J. Xu et al., 2016b), diluting the 
strength of the evidence for anything more than an aggregation of all cancers.
Thus, the toxicologic evidence indicates that a connection of TCDD and per-
haps cacodylic acid with cancer in humans is, in general, biologically plausible. 
However, as discussed in the next section, whether such carcinogenic potential 
contributes to an individual type of cancer must be evaluated on a case-by-case 
basis. Experiments with 2,4-D, 2,4,5-T, and picloram in animals and cells have 
not provided a strong biologic basis for the presence or absence of carcinogenic 
effects for those COIs.
CURRENT VIEWS OF CANCER MECHANISMS
To address its charge, the committee weighed the scientific evidence link-
ing the COIs to specific individual cancer sites. Before considering each site 
individually, it is important to address the concept that cancers share some 
characteristics among organ sites. All cancers share phenotypic characteristics: 
unregulated cell proliferation, increased cell survival, invasion outside normal 
tissue boundaries, and eventual metastasis. The current understanding of cancer 
development holds that a cell must acquire a series of specific genetic mutations 
that release it and its progeny from regulated growth in order to establish growth 
independence. These mutations can occur in a variety of genes that positively 
(oncogenes) or negatively (tumor suppressor genes) control cell growth, cell 
death (apoptosis), or the repair of genes when mutations do occur (Hanahan and 
Weinberg, 2000). Hanahan and Weinberg further add that for a tumor to survive, 
four other changes are necessary: changes in metabolism that give cells a selec-
tive growth advantage, evasion of the immune system, genetic instability leading 
to additional mutations, and local inflammation. In addition to mutational events, 
non-mutational or epigenetic events contribute to malignant transformation by al-
tering the expression of genes that contribute to malignant transformation. How-
ever, some researchers have hypothesized that whatever the triggers, the earliest 
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cancer cells have recognizable somatic mutations and establish clonality (Burgio 
and Migliore, 2015). Also, angiogenesis, or the formation of new blood vessels, 
allows a developing malignancy to obtain nutrients and enable the cells of that 
malignancy to invade the local normal tissue. Recent work has drawn attention 
to the interaction of cancer cells and the tumor microenvironment. Derbal (2017) 
has described how dysregulation of cellular metabolism locks cancer cells into a 
“state of mutual dependence with the tumor microenvironment and deepens the 
tumor’s inflammation and immune-suppressive state,” therefore making it more 
difficult to treat.
Both genetic (mutational) and epigenetic (non-mutational) effects of carci-
nogenic agents can further contribute to and stimulate oncogenesis. Genotoxic 
damage by environmental exposures, such as the committee’s COIs, can affect 
tumor establishment through many non-carcinogenic processes, such as those 
that take place in the the metabolic and immune systems. As discussed above 
and in Chapter 4, 2,4-D, 2,4,5-T, and picloram have shown little evidence of 
genotoxicity in laboratory studies, except at very high doses, and little ability 
to induce carcinogenesis in laboratory animals. However, cacodylic acid and 
TCDD—acting more like promoters than genotoxic initiators—have been shown 
to induce tumors in laboratory animals. Extrapolating organ-specific results from 
animal experiments to humans is problematic because of important differences 
among species in the overall susceptibility of various organs to cancer develop-
ment and in organ-specific responses to putative carcinogens. While experiments 
using animal models can be carefully designed to control for confounding risk 
factors, this is often not possible in human studies. Therefore, conclusions about 
the potential carcinogenicity of a chemical in humans rely heavily on the results 
of epidemiologic studies that examine evidence of an excess cancer risk for indi-
vidual or multiple organ sites. As the evaluations of specific types of cancer in the 
remainder of this chapter indicate, the committee finds that TCDD appears to be 
a multisite carcinogen. That finding is in agreement with IARC, which has placed 
TCDD as a category 1 “known human carcinogen” (Baan et al., 2009; IARC, 
2012b); with the U.S. Environmental Protection Agency (EPA), which has con-
cluded that TCDD is “likely to be carcinogenic to humans” (EPA, 2004); and with 
the National Toxicology Program (NTP), which regards TCDD as “known to be a 
human carcinogen” (NTP, 2011). It is important to emphasize that the goals and 
methods of IARC and EPA in making their determinations were different from 
those of the present committee: Those organizations focus on anticipating hazards 
to minimize future exposure, whereas this committee focuses on risk after expo-
sure. Furthermore, the recognition that TCDD and cacodylic acid are multisite 
carcinogens does not imply that they cause human cancer at every organ site.
The distinction between a general carcinogen and a site-specific carcinogen 
is more difficult to make because of the common practice of beginning analyses 
of epidemiologic cohorts with a category of “all malignant neoplasms,” a rou-
tine first screen for increased cancer activity in a study population without any 
Veterans and Agent Orange: Update 11 (2018)
Copyright National Academy of Sciences. All rights reserved.
CANCER 223
test of a biologically based hypothesis. When the distribution of cancers among 
anatomic sites is not provided in the report of a cohort study, a statistical test for 
an increase in all cancers is not meaningless, but it is usually less scientifically 
supportable than analyses based on specific sites for which more substantial 
biologically based hypotheses can often be developed. The size of a cohort and 
the length of the observation period often constrain the number of cancer cases 
that are observed and which specific cancers have enough observed cases to per-
mit analysis. For instance, an analysis of the cumulative results on diabetes and 
cancers in the prospective Air Force Health Study (AFHS; Michalek and Pavuk, 
2008) produced important information summarizing previous findings on diabe-
tes, a fairly common condition, but the cancer analysis does not go beyond “all 
cancers.” The committee does not interpret the cancer findings as an indication 
that exposure to herbicides increases the risk of every variety of cancer, but rather 
as an indication that the agent is carcinogenic to humans. For example, the com-
mittee acknowledges that the results of the highly stratified analyses conducted in 
the AFHS found an increased incidence of certain cancers as well as all cancers 
combined in the Ranch Hand subjects. It views the result of all cancers combined 
as a conglomeration of information on individual malignancies. However, it also 
recognizes that melanoma and prostate cancer are two malignancies for which 
increased risk has been published (Akhtar et al., 2004; Pavuk et al., 2006), and 
therefore, that these conditions merit continued individual longitudinal analysis 
to resolve outstanding questions and to confirm the association with TCDD.
OVERVIEW OF STUDIES THAT REPORT 
MULTIPLE CANCER OUTCOMES
To avoid needless redundancy, the current committee made the decision to 
summarize those studies that reported separate results on five or more individual 
cancer outcomes here, at the beginning of the chapter. Two studies met this 
criterion: Collins et al. (2016) and Coggon et al. (2015). The discussion of the 
relevant study in each individual cancer section only includes the study popula-
tion and specific effect estimates as well as any nuances of which the reader 
should be aware.
Collins et al. (2016) provides additional follow-up to a retrospective analysis 
of a cohort of 2,192 workers (only 5 of whom were female) exposed to dioxins 
during trichlorophenol (TCP) and pentachlorophenol (PCP) production at a Dow 
chemical manufacturing plant in Midland, Michigan (see Chapter 5). The U.S. 
population was used as the comparator for standardized mortality ratio (SMRs). 
Work history records were used to determine the length of exposure. Serum sam-
ples to measure levels of six types of dioxins were collected for 431 TCP and PCP 
workers. Historic concentrations for each dioxin congener were calculated from 
the median concentrations from the serum samples and the known half-lives as-
sociated with each congener. A job exposure matrix was created for both the TCP 
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and PCP production facilities based on the measured concentrations for workers 
in different jobs. A pharmacokinetic model was applied to job-specific concentra-
tions based on the work history of each member of the study group to estimate 
their time-dependent serum concentration profiles for each dioxin congener (i.e., 
TCDD as well as Hexa-CDD, Hepta-CDD, and Octa-CDD). Complete vital status 
follow-up through December 2011 was achieved for the cohort, and there were 
1,198 decedents through the entire study period (1979–2011); 1,615 TCP work-
ers and 773 PCP workers (196 workers were exposed to both TCP and PCP and 
were included in both groups). SMRs were reported for more than 20 types of 
cancer and other health outcomes. Estimates were reported for all workers, TCP 
workers (196 of whom were also exposed to PCP), and PCP workers (196 who 
also had TCP exposure). This study is referred to throughout the chapter as the 
Dow Midland, Michigan, plant workers.
Coggon et al. (2015) extended the follow-up period of a large IARC-sponsored 
study and examined the carcinogenicity of phenoxy herbicides and their associa-
tions with, primarily, Hodgkin lymphoma (HL), STS, and chronic lymphocytic 
leukemia, but other types of cancers were also included as outcomes. The origi-
nal IARC study, a nested case-control study within a large international cohort 
study included 36 subcohorts, 6 of which were made up of men who worked at 
5 factories in the United Kingdom manufacturing or formulating a variety of 
phenoxy herbicides or else were contract workers spraying the compounds. The 
IARC study followed workers from 1947 through 1990/1991, and Coggon et al. 
(2015) extended the follow-up of the six UK cohorts to December 2012. Data 
were derived from individual employment and health care system records as well 
as from cancer registries and death records to detect additional cases. SMRs were 
reported, and the effect estimates were reported for all workers, workers exposed 
to herbicide levels above background, and workers exposed for more than 1 year 
at levels above background. The many results on specific cancer mortality in this 
group are referenced as the UK phenoxy herbicide manufacturers and sprayers.
STUDIES OF OVERALL CANCER MORTALITY OR INCIDENCE
The literature search for this update identified a number of publications on 
populations with relevant exposures that included risk estimates for overall mor-
tality from any cancer (Cappelletti et al., 2016; Coggon et al., 2015; Collins et al., 
2016; Kashima et al., 2015; S. A. Kim et al., 2015) or overall cancer incidence or 
prevalence (Ljunggren et al., 2014; Van Larebeke et al., 2015). However, group-
ing all cancer incidences or deaths is not informative for determining specific 
health effects that may be due to an exposure to the COIs versus those attribut-
able to many other factors. This method also imposes the assumption of homo-
geneity of association across the combined deaths or cancer types. For example, 
Van Larebeke and colleagues (2015) assessed the prevalence of all cancer based 
on a self-reported affirmative response to the question, “Do you suffer or have 
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you suffered from one or another form of cancer?” The committee believed that 
this was not specific enough to be useful for the assessment of cancer and the 
 potential effects from the COIs and excluded it from further review in the cancer 
chapter. Likewise, Ljunggren et al. (2014) assessed the distribution of dioxin-like 
chemicals in the lipoprotein fractions of cancer patients and controls but did not 
distinguish the specific types of cancer diagnoses.
The committee identified four studies that examined the association be-
tween the COIs and cancer mortality. Among the Dow Midland, Michigan, plant 
 workers exposed to TCP or PCP or both, Collins et al. (2016) found that there 
was no difference in mortality for all cancer when the 1,615 TCP workers were 
compared with the standardized U.S. population (SMR = 0.98, 95% confidence 
interval [CI] 0.86–1.11). Similarly, there was no difference found for mortality 
from all cancer sites for the 773 PCP workers (SMR = 1.04, 95% CI 0.86–1.24). 
Additional results for site-specific cancer mortality are covered in each applicable 
section.
S. A. Kim et al. (2015) used serum concentrations of persistent organic pol-
lutants, including dioxin-like and non-dioxin-like PCBs (n = 633) and organo-
chlorine pesticides (n = 675) collected within the 1999–2004 National Health 
and Nutrition Examination Survey (NHANES) and adjusted for fat mass to make 
associations with overall mortality, mortality from all cancers combined, and 
mortality from cardiovascular diseases in people aged 70 years and older. Models 
were adjusted for age, sex, race, cigarette smoking, and physical activity. When 
fat mass was not included in the analysis, no association was found between 
any of the persistent organic pollutants and total mortality. When fat mass was 
included in the analysis, PCBs were inversely associated with total mortality in 
persons with high fat mass, but not in those with low fat mass. Organochlorine 
pesticides were found to be positively associated with total mortality for low fat 
mass, but the association was weaker with higher fat mass. Cancer mortality was 
highest among persons with fat mass less than the 25th percentile and who had 
the highest tertile concentration of PCB and organochlorine pesticides. None of 
the hazard ratios for cancer mortality were statistically significant. The analysis 
is limited by the low numbers of deaths in the follow-up period, which reduces 
the power to calculate cause-specific mortality. One possible explanation for the 
observed association may be that persistent organochlorine pesticides influence 
disease pathogenesis but not mortality, which may be influenced by a number of 
other factors.
The extended follow-up study of UK phenoxy herbicide manufacturers and 
sprayers found that of the total 4,093 deaths reported among this cohort of work-
ers, 1,205 deaths were attributable to cancer (Coggon et al., 2015). However, 
neither overall mortality nor cancer-specific mortality were elevated among all 
workers (SMR = 1.0, 95% CI 0.97–1.03 and SMR = 0.99, 95% CI 0.94–1.05, 
respectively) or among workers potentially exposed to phenoxy herbicide levels 
above background (SMR = 1.02, 95% CI 0.99–1.06 and SMR = 1.02, 95% CI 
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0.96–1.09, respectively). Additional results for site-specific cancer mortality are 
covered in each applicable section.
Cappelletti et al. (2016) performed a retrospective study of 331 male electric 
arc foundry workers at a single plant in Trentino, Italy, to determine if they expe-
rienced excess mortality from all causes, all cancers, and specifically respiratory 
cancers, or if they experienced increased risk for other morbidities. An analysis 
of the dust emissions found that the dust contained metals (including iron, alumi-
num, zinc, manganese, lead, chromium, nickel, cadmium, mercury, and arsenic), 
PAHs, PCBs, and PCDD/Fs (reported as TEQs). Therefore, the authors could 
not determine which of the agents were associated with a specific outcome or to 
what extent. The men had worked at the factory for at least 1 year and, for the 
mortality analysis, were compared with the standardized general population of 
Region Trentino-Alto Adige (where the factory was located) because there were 
few non-exposed foundry workers and high attrition rates. Company and medical 
records were used to determine vital status; the cause of death was determined 
from death certificates or other registries. The workers were followed from March 
19, 1979 (or their first day of employment), through December 31, 2009, or the 
date of death. No difference between exposed workers and the general population 
was found for all causes of mortality (SMR = 1.13, 95% CI 0.76–1.62, p = 0.53) 
or for all deaths from cancer (SMR = 1.36, 95% CI 0.75–2.29, p = 0.238). No 
differences in the mortality rates of all causes or all cancers were found when the 
cause of death was stratified by years of employment or time since first exposure. 
This study is most limited by the fact that foundry dust is a complex mixture, 
which makes it difficult to discern the impact of the specific contaminants of the 
foundry dust on the health outcomes of those exposed workers. Estimates were 
adjusted only for age group and not for other risk factors such as tobacco use, 
body mass index (BMI), or other jobs or activities that could result in similar 
exposures. Exposure to foundry dust by the general population, which was used 
for comparison, is not discussed, although the foundry appears to be in the local 
vicinity and emissions were reported to be present within a 2-kilometer radius.
The remainder of this chapter deals with the committee’s review of the evi-
dence on each individual cancer site in accordance with its charge to evaluate 
the statistical association between exposure and cancer occurrence, the biologic 
plausibility and potential causal nature of the association, and the relevance to 
U.S. veterans of the Vietnam War. For each outcome, the relevant studies are 
presented for populations of Vietnam veterans and then for other exposed, non-
veteran subjects (occupational cohort studies, environmental studies, and case-
control studies).
A number of studies of populations that received potentially relevant expo-
sures were identified in the literature search for this review but did not character-
ize exposure with sufficient specificity for their results to meet the committee’s 
criteria for inclusion in the evidentiary database (see Chapter 3). For instance, 
this rubric would apply to the occupational study conducted by Ruder et al. 
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(2014) in which 24,865 eligible workers from capacitor manufacturing, repair, 
and maintenance sites in the United States were exposed to arochlor 1254, 1242, 
and 1016, among others (mixed PCBs), and the authors sought to examine the 
relationship between PCB exposure and different causes of mortality. However, 
specific dioxin-like PCBs were not named, and no TEQs or other quantification 
of relevant exposures was presented. Similarly, the hospital-based case-control 
study by Niu et al. (2016) that examined hepatocellular carcinoma and risk 
factors including environmental exposures such as exposure to pesticides (not 
further defined) did not measure the levels of dioxins in serum samples and, as a 
result, lacked the necessary specificity to contribute to the weight of the evidence 
of an association between the COIs and hepatobiliary cancer; it was therefore 
excluded from further consideration. In previous updates as well as in the cur-
rent update, numerous cancer studies have been identified that used case-control 
design and had exposure characterizations that were no more specific than job 
titles, farm residence, or herbicide exposure. The committee acknowledges that 
those studies were identified and presents briefly the reasons that they were not 
further considered and did not contribute to the evidentiary weight for an outcome 
under the heading of “Other Identified Studies.”
ORAL, NASAL, AND PHARYNGEAL CANCERS
Oral, nasal, and pharyngeal cancers develop in anatomical sites of the head 
and neck: the structures of the oral cavity (inside lining of the lips, cheeks, gums, 
tongue, and hard and soft palate: International Classification of Diseases, 9th 
Revision (ICD-9) codes 140–145; ICD-10 codes C00–C08), oropharynx (ICD-9 
146; ICD-10 C09–C10), nasopharynx (ICD-9 147; ICD-10 C11), hypopharynx 
(ICD-9 148; ICD-10 C13), other buccal cavity and pharynx (ICD-9 149; ICD-10 
C14), and nasal cavity and paranasal sinuses (ICD-9 160; ICD-10 C30–C31). 
The salivary glands may or may not be included. The oropharynx includes the 
soft palate, the tonsils, the side walls, and the posterior tongue. The nasopharynx 
is made up of the structures from the part of the throat that is behind the nose, 
whereas the hypopharynx consists of the area from the hyoid bone to the cricoid 
cartilage. The larynx refers to only the laryngeal structures and is covered sepa-
rately. Although the above cancers are classified together in the same category, 
the epidemiological risk factors for cancers that occur in the oral cavity and oro-
pharynx are different from the risk factors for cancer of the nasopharynx.
Tobacco and alcohol use are well-established risk factors that contribute 
synergistically to the incidence of oral cavity and oropharyngeal cancers and, to 
a certain degree, nasopharyngeal cancers. Infection with human papilloma virus 
(HPV), particularly HPV16, is a relatively newly recognized major risk factor for 
oropharygeal cancers (Gillison and Shah, 2001; Gillison et al., 2012; Hashibe et 
al., 2007, 2009; Kreimer et al., 2013; Marur et al., 2010; Michaud et al., 2014; 
Oliveira et al., 2012; Szentirmay et al., 2005). Some evidence has also been found 
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linking HPV to tonsillar and base-of-tongue cancers (Ramqvist et al., 2015). The 
risk factors for nasal cavity cancer include occupational exposure to nickel and 
chromium compounds (d’Errico et al., 2009; Feron et al., 2001; Grimsrud and 
Peto, 2006), wood dust (d’Errico et al., 2009), leather dust (Bonneterre et al., 
2007), and high doses of formaldehyde (Nielsen and Wolkoff, 2010). Nasopha-
ryngeal cancer is a very specific malignancy, and although alcohol, tobacco, and 
other environmental pollutants are risk factors, infection with the Epstein–Barr 
virus in combination with certain genetic predispositions and the consumption of 
poorly preserved food (Chang and Adami, 2006) constitutes the biggest attribut-
able risk factor, especially in Africa, China, and other Asian countries.
Ecological studies in the United States have shown that between 2001 and 
2010 the incidence of cancers of the oral cavity decreased (possibly because of 
the decreasing prevalence of smoking), whereas the incidence rates for oropha-
ryngeal cancers increased annually by 2.9%, which has been attributed to HPV 
infection (Chaturvedi et al., 2011). In the United States in 2018 there were an 
estimated 51,540 new cases of and 10,030 deaths from oral cavity and pha-
ryngeal cancers (NCI, n.d.b). Nasopharyngeal cancers occur very rarely in the 
United States (less than 1 case per 100,000 individuals); an estimated 3,200 cases 
were reported in 2015 (ACS, 2016). Most oral, nasal, and pharyngeal cancers 
are squamous-cell carcinomas. Nasopharyngeal carcinoma is the most common 
malig nant epithelial tumor of the nasopharynx and can be further classified into 
one of three types: keratinizing squamous-cell carcinoma, nonkeratinizing carci-
noma, and undifferentiated carcinoma.
The median age of diagnosis of oral cavity and pharynx cancers is 63 years, 
and 30.8% of new cases are diagnosed among people 55–64 years old, and 24.5% 
of cases are diagnosed among people 65–74 years old. Men of all races and eth-
nicities are at greater risk than women. Age-adjusted incidence rates were highest 
among white males and females and lowest among Hispanic men and women.
Conclusions from VAO and Previous Updates
The committee responsible for the original VAO report concluded that there 
was inadequate or insufficient information to determine whether there is an as-
sociation between exposure to any of the COIs and oral cavity, nasal, and pharyn-
geal cancers. Additional information available to the committees responsible for 
Update 1996 through Update 2014 did not change that conclusion.
In Update 2006, a separate evaluation of tonsil cancer cases was performed. 
In the United States an estimated 70% of oral cavity and oropharyngeal cancers 
are caused by HPV infection. Therefore, if herbicide exposure had inhibitory 
or suppressive effects on cell-mediated or humoral-mediated immunity, then 
 Vietnam veterans with HPV16 infection might be at increased risk for the devel-
opment of these cancers through the persistence of a high-risk oncogenic virus. 
The Update 2006 committee concluded that, based on the three identified studies 
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that provided the number of tonsil cancer cases in their populations, there was not 
sufficient evidence to determine whether an association existed between exposure 
to the COIs and tonsil cancer. No new published studies have offered any impor-
tant additional insight into this specific question. The present committee strongly 
reiterates the recommendation repeatedly made in Updates 2006, 2008, 2010, 
2012, and 2014 that the Department of Veterans Affairs (VA) develop a strategy 
that uses existing databases to evaluate tonsil cancer in Vietnam-era veterans.
Subsequent committees reviewed studies of U.S. and international cohorts of 
Vietnam veterans. No statistically significant increase in oral cavity and pharyn-
geal cancers was found between deployed and nondeployed Vietnam-era Army 
Chemical Corps veterans (Cypel and Kang, 2010); such findings were consistent 
with a prior report on mortality through 1991 (Dalager and Kang, 1997). Among 
the cohort of 2,783 New Zealand veterans who served in Vietnam and were fol-
lowed prospectively beginning in 1988 for cancer incidence and mortality, no 
statistically significant increased risk of head and neck cancers overall and spe-
cifically cancers of the oral cavity, pharynx, and larynx was observed compared 
with the general population of New Zealand. Based on 11 cases each, statistically 
significant increased risks of death from head and neck cancers and from cancers 
of the oral cavity, pharynx, and larynx were observed among the New Zealand 
Vietnam veteran cohort compared with the general New Zealand population 
(McBride et al., 2013). However, that study had several limitations, including 
the lack of observation until 15 years post-conflict and missing information on 
(and therefore the inability to adjust for) known confounding factors, including 
smoking, drinking habits, and HPV status, which limits the interpretation of the 
data. The Update 2014 committee concluded that the greater than two-fold excess 
risks of mortality from head and neck cancers as well as from cancers of the oral 
cavity, pharynx, and larynx cannot be completely attributed to confounding by 
smoking because excess risks were not found in this cohort for deaths from other 
smoking-related diseases such as lung cancer, chronic obstructive pulmonary 
disease, or coronary artery disease.
The Korean Veterans Health Study followed 185,265 male Vietnam veterans 
who were alive in 1992 for cancer incidence through 2003 (Yi, 2013; Yi and 
Ohrr, 2014) and for mortality through 2005 (Yi et al., 2014b) from cancers of 
the oral cavity, nasal cavity, and pharynx. For the internal comparison analysis 
of high- versus low-exposure categories derived from the exposure opportunity 
index (EOI) scores generated by the EOI model, Yi and Ohrr (2014) found a 2.54 
increase in hazard ratio for cancers of the mouth and a relative risk of nearly 7.0 
for salivary glands (though the estimate was very imprecise) as well as a non-
statistically significant increase in the risk of oropharyngeal cancer. No difference 
between the high- and low-exposure groups was found for tonsil cancer, and no 
differences in incidence were observed for the other head and neck cancers ana-
lyzed separately: lip, tongue, nasopharynx, hypopharynx, and nose and sinuses. 
Yi et al. (2014b) reported only on head and neck cancers as a group defined by 
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ICD-10 codes C00–C14 and found no association when comparing the high- ver-
sus low-exposure categories, nor in the analysis based on the logarithms of the 
individual EOI scores.
Several studies of occupational cohorts that reported on cancers of the oral 
cavity or pharynx were examined by previous committees, but the evidence was 
inconsistent. Specifically, studies of workers at Dow’s plant in Midland, Michi-
gan, and in the NIOSH PCP cohort reported no increases in incidence (C. J. Burns 
et al., 2011) or mortality (Ruder and Yiin, 2011) from oral cavity and pharyngeal 
cancers. Likewise, McBride et al. (2009a) reported on mortality through 2004 in 
the New Zealand cohort of 1,599 workers who had been employed in manufac-
turing phenoxy herbicides from TCP; picloram was also produced in the plant. 
The researchers reported a non-significant excess in mortality from buccal cavity 
and pharyngeal cancers, but there were no deaths from nasopharyngeal cancers in 
either group. By contrast, Manuwald et al. (2012) reported a more than two-fold 
increase in mortality from cancers of the lip, oral cavity, or pharynx in a cohort 
of male and female chemical plant workers versus Hamburg’s general population. 
Squamous cell oral cancer risk was also found to be elevated, but the estimate 
was imprecise, in Sweedish workers who worked for the pulp industry and with 
wood or wood products and workers who were exposed to phenoxyacetic acids 
(Schildt et al., 1999).
Update of the Epidemiologic Literature
No new studies of Vietnam veterans or published environmental or case- 
control studies of exposure to the COIs and oral, nasal, or pharyngeal cancers 
were identified for the current update. Reviews of the relevant studies are pre-
sented in the earlier reports. Table 2, which can be found at www.nap.edu/cata-
log/25137, summarizes the results of studies related to oral, nasal, and pharyngeal 
cancer.
Occupational Studies
Cancers of the lip, tongue, and mouth were addressed by Coggon et al. 
(2015) in an extension of the follow-up of UK phenoxy herbicide manufacturers 
and sprayers. No deaths were due to cancer of the lip. Tongue cancer mortality 
was not statistically significant, and effect estimates were imprecise (wide CIs) 
for all workers (n = 8; SMR = 1.93, 95% CI 0.83–3.80), for workers exposed 
to herbicide levels above background (n = 5; SMR = 1.63, 95% CI 0.53–3.80), 
or for persons exposed for more than 1 year at levels above background (n = 3; 
SMR = 2.16, 95% CI 0.45–6.32). The estimates for mouth cancer showed a 
decreased risk that was likewise not statistically significant, with even more 
imprecise estimates for each of the groups: all workers (n = 2; SMR = 0.53, 95% 
CI 0.06–1.90), workers exposed to herbicide levels above background (n = 1; SMR 
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= 0.36, 95% CI 0.01–1.99), and workers exposed for more than 1 year at levels 
above background (n = 0; SMR = 0.00, 95% CI 0.00–2.89). A decreased risk of 
pharynx cancer was found, but the estimates were imprecise and not statistically 
significant across the three groups of workers: all workers (n = 4; SMR = 0.49, 
95% CI 0.13–1.25), workers exposed to herbicide levels above background (n = 4; 
SMR = 0.66, 95% CI 0.18–1.68), and workers exposed for more than 1 year at 
levels above background (n = 0; SMR = 0.00, 95% CI 0.00–1.34). These data do 
not support an association between exposure to phenoxy herbicides and cancer 
of the lip, tongue, or mouth.
Other Identified Studies
Although Ruder et al. (2014) examined U.S. workers exposed to mixed 
PCBs and reported SMRs from all buccal cavity and pharynx neoplasms overall 
as well as those specifically for the tongue, pharynx, and other parts of buccal 
cavity, the authors did not state the specific dioxin-like PCBs at issue, and no 
TEQs or other quantification of relevant exposures were presented. Akahane 
et al. (2017) examined the prevalence of many long-term health effects, in-
cluding tongue cancer, of people exposed to PCBs, dioxins (e.g., PCDD/Fs), 
and dioxin-like chemicals through the ingestion of contaminated rice bran oil 
(Yusho accident) compared with a group of age-, sex- and residential-area-
matched individuals. Because TEQs or other quantification of relevant exposures 
were not presented, the study was not considered further.
Biologic Plausibility
Long-term animal studies have examined the effects of exposure to the 
COIs on tumor incidence (Charles et al., 1996; Stott et al., 1990; Walker et al., 
2006; Wanibuchi et al., 2004). The National Institute of Environmental Health 
Sciences conducted a 2-year study of female Harlan Sprage Dawley rats treated 
with TCDD and other dioxin-like PCBs (Nyska et al., 2005; Yoshizawa et al., 
2005a). Yoshizawa et al. (2005a) reported an increase in the incidence of gingival 
squamous-cell carcinoma in the rats treated orally (by gavage) with TCDD only 
at doses as low as 3 ng/kg and average severities increased with higher dosing 
levels. In the groups receiving 46 ng/kg or greater of TCDD, the incidence of 
oral squamous-cell carcinoma increased, and a statistically significant difference 
occurred in the highest dosed group (incidence rate: 19%) compared to the con-
trol group (2%). In the 100 ng/kg for 5 days/week for 104 weeks stop group, the 
incidence of oral gingival squamous hyperplasia was also increased significantly, 
and increased occurrence of squamous-cell carcinoma was observed (incidence 
rate 10% versus 2% among controls). When a mixture of TCDD, PCB 126, and 
2,3,4,7,8-pentachlorodibenzofuran was administered, all doses (ranging from 
6 ng/kg to 200 ng/kg) induced gingival squamous hyperplasia significantly with 
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no differences in severities, but the incidence of oral squamous-cell carcinoma, 
however, did not increase. A second publication from this study examined ol-
factory epithelial metaplasia and hyperplasia outcomes (Nyska et al., 2005). 
 Squamous-cell carcinoma of the oral mucosa of the palate was increased. This 
study did not, however, find any pathologic effect of TCDD on nasal tissues 
(Nyska et al., 2005). Increased neoplasms of the oral mucosa had previously been 
observed and described as carcinomas of the hard palate and nasal turbinates 
(Kociba et al., 1978). Kociba et al. (1978) also reported a small increase in the 
incidence of tongue squamous-cell carcinoma.
DiNatale et al. (2012) used head and neck squamous-cell carcinoma cell 
lines to investigate mechanisms for tumor progression associated with AHR 
activation. This tumor type typically produces large amounts of cytokines, and 
its IL6 expression levels correlate with disease aggressiveness. In this model, 
AHR activation by TCDD enhances IL-6 production induced by another cytokine 
(IL-1β), so TCDD may play a role in head and neck squamous-cell oncogenesis. 
The potential impact of AHR activation on oral squamous cell carcinoma was 
recently described in a study by Stanford et al. (2016), which demonstrated that 
exposure to AHR ligands resulted in enhanced stem-cell-like properties of the 
human oral cells in culture and which used a novel orthotypic xenograft model to 
demonstrate the ability of AHR inhibitors to inhibit oral squamous-cell carcinoma 
progression.
Synthesis
Tonsil cancers, or more generally squamous-cell carcinomas of the oro-
pharynx, remain of interest to Vietnam veterans and the committee, but no new 
information on them with respect to possible herbicide exposure was available 
for this update. Previous studies on Vietnam veterans from the Korean Veterans 
Health Study did not find an association between herbicide exposure and the risk 
of tonsillar cancers. Several previous studies have reported on oropharyngeal 
cancers broadly, but few have examined tonsil cancer as a distinct outcome.
The existing evidence from all published studies conducted among Vietnam 
veterans or various occupational cohorts reporting on the incidence of or mor-
tality from cancers of the nose, oral cavity, or pharynx is largely inconclusive. 
Most of these studies have reported no association or else non-significant modest 
excesses in risk, while not characterizing exposure as specifically as needed for 
the committee’s decision making. The one new study that extended the follow-up 
period of men who worked at five factories in the United Kingdom manufactur-
ing or formulating a variety of phenoxy herbicides or who were contract workers 
spraying the compounds also found no association with exposure to phenoxy 
herbicides and mortality from cancer of the lip, tongue, or mouth (Coggon et 
al., 2015).
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The small numbers of oral, nasal, or pharyngeal cancer cases reported, in 
combination with a general lack of information on the smoking and drinking 
habits or HPV status of the tumors, limit the interpretation of the data. The other 
issue affecting the interpretation of the data is that this group of cancers is often 
grouped with respiratory cancers, most of which are cancers of the trachea, lung 
parenchyma, or bronchus. Because of the relatively small numbers of head and 
neck cancers, no meaningful conclusions can be drawn. Thus, in combination 
with the previously reviewed literature, the new information does not support an 
association between the cancers of oral cavity, nose, or pharynx with the herbi-
cides sprayed in Vietnam.
Conclusion
Given the lack of new evidence, the committee concurs with the conclusion 
in Update 2014 and concludes that there is inadequate or insufficient evidence 
to determine whether there is an association between exposure to the COIs and 
oral, oropharyngeal, or nasopharynx cancers.
CANCERS OF THE DIGESTIVE ORGANS
Esophageal cancer (ICD-9 150; ICD-10 C15), stomach cancer (ICD-9 151; 
ICD-10 C16), colon cancer (ICD-9 153; ICD-10 C15), rectal cancer (ICD-9 
154; ICD-10 C19–C21), hepatobiliary cancers (ICD-9 155; ICD-10 C22), and 
 pancreatic cancer (ICD-9 157; ICD-10 C25) are the major cancers arising in the 
digestive organs. NCI estimated that 17,290 people would receive diagnoses of 
esophageal cancers in the United States in 2018 and that 15,850 people would die 
from esophageal cancers (NCI, n.d.c). The corresponding 2018 estimates of U.S. 
diagnoses and deaths for the other digestive organ cancers are: stomach cancer 
(incident diagnoses, 26,240; deaths, 10,800) (NCI, n.d.d), colon and rectal cancer 
(incident diagnoses, 140,250; deaths, 50,630) (NCI, n.d.e), pancreatic cancer (in-
cident diagnoses, 55,440; deaths, 44,330) (NCI, n.d.f), and hepato biliary cancers 
(incident diagnoses, 42,220; deaths, 30,200) (NCI, n.d.g), with other digestive 
cancers—for example, small intestine and anal cancers—adding an estimated 
19,050 new diag noses and 2,610 deaths (NCI, n.d.h, n.d.i). Collectively, tumors 
of the digestive organs were expected to account for 17.4% of new cancer diag-
noses and 25% of cancer deaths in 2017.
The incidences of esophageal, stomach, colon, rectal, and pancreatic cancers 
increase with age. In general, the incidences are higher in men than in women and 
higher in blacks than in whites (NCI, 2018a). Risk factors for the cancers vary 
but always include a family history of the same form of cancer, some diseases of 
the affected organ, and diet. Tobacco use is a risk factor for pancreatic cancer and 
possibly for stomach cancer (Maisonneuve and Lowenfels, 2015; Stewart et al., 
2008). An infection with the bacterium Helicobacter pylori increases the risk of 
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stomach and pancreatic cancers. Type 2 diabetes is associated with an increased 
risk of colorectal and pancreatic cancers (Berster and Göke, 2008).
Some studies of digestive cancers combine and report statistics on all diges-
tive organ cancers rather than separating the data by types. For example, in a 
study of disease-related mortality through 2005 in Army Chemical Corps (ACC), 
veterans who handled or sprayed herbicides in Vietnam were compared with their 
non-Vietnam veteran peers or with U.S. men in general, with all gastrointestinal 
cancers reported collectively (Cypel and Kang, 2010). Adjusted estimates did 
not show any statistically significant excess in mortality from all cancers of the 
digestive tract in ACC Vietnam veterans compared with non-Vietnam veterans. 
Several other studies identified in Update 2014 also combined several diges-
tive cancers for their analyses, making the results not particularly informative 
for individual cancers in the group (Boers et al., 2012; C. J. Burns et al., 2011; 
Manuwald et al., 2012).
Esophageal Cancer
Epithelial tumors of the esophagus (squamous-cell carcinomas and adeno-
carcinomas) are responsible for more than 95% of all esophageal cancers; 17,290 
newly diagnosed cases and 15,850 deaths were estimated for 2018 in the United 
States (NCI, n.d.c). In the United States, adenocarcinoma of the esophagus has 
slowly replaced squamous-cell carcinoma as the most common type of esopha-
geal malignancy; although squamous-cell carcinoma continues to be the most 
common form of esophageal cancer worldwide (Rubenstein and Shaheen, 2015). 
The incidence of esophageal cancer is higher among men than women, higher in 
black women than white women for all age groups from 60 to 74 years, but higher 
for white men than black men for all age groups from 65 to 74 years.1
Smoking and heavy alcohol ingestion are associated with the development 
of squamous-cell carcinoma (Dong and Thrift, 2017; Matejcic et al., 2017). For 
esophageal adenocarcinoma, smoking is an established risk factor, but alcohol 
consumption does not appear to be strongly associated (Dong and Thrift, 2017). 
Some data suggest that gastroesophageal reflux disease and Barrett esophagus 
are associated with an increased risk of esophageal adenocarcinoma. The rapid 
increase in obesity in the United States has been linked to increasing rates of gas-
troesophageal reflux disease, and the resulting rise in chronic inflammation has 
been hypothesized as explaining the link between gastroesophageal reflux disease 
and esophageal adenocarcinoma (Rubenstein and Shaheen, 2015).
1 As calculated on the site https://seer.cancer.gov/faststats/selections.php?#Output by choosing 
SEER 18 dataset, age-adjusted rates, esophageal cancer, and age ≥ 50 years. Data were displayed by 
choosing race and sex then separately by age.
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Conclusions from VAO and Previous Updates
The committee responsible for VAO explicitly excluded esophageal cancer 
from the group of gastrointestinal tract tumors, and it was not separately evaluated 
or categorized with this group until Update 2004, when it was formally placed 
into the inadequate or insufficient category. No additional studies of esophageal 
cancer were reviewed until Update 2010.
Most evidence on the potential effects of the COIs and esophageal cancer had 
come from occupational cohorts until Update 2014, when three studies of inter-
national Vietnam veteran cohorts were published. The strongest evidence of an 
association between the COIs and esophageal cancer came from an occupational 
cohort of workers at a chemical plant in Hamburg, Germany, which reported a 
statistically significant increase in esophageal cancer mortality relative to men in 
the general population of Hamburg (SMR = 2.56, 95% CI 1.27–4.57) (Manuwald 
et al., 2012). Several papers on mortality in TCP and PCP workers employed by 
Dow Chemical Company in Midland, Michigan, from 1937 to 1980 have been 
reviewed. Collins et al. (2009b) followed 1,615 workers who worked at least 1 day 
in a department that had potential TCDD exposure; 5 esophageal cancer deaths 
were observed but no statistically significant associations were found. Among the 
773 PCP workers who were exposed to chlorinated dioxins that did not include 
TCDD, there were two observed deaths from esophageal cancer (Collins et al. 
2009c). In the Agricultural Health Study (AHS), Koutros et al. (2010a), found a 
statistically significant decrease in the incidence of esophageal cancer among the 
private applicators (52 cases, standardized incidence ratio [SIR] = 0.64, 95% CI 
0.48–0.85) compared with the general population, which could indicate a healthy 
worker effect.
Other than the study of chemical plant workers in Hamburg (Manuwald 
et al., 2012), studies conducted outside the United States found no statisti-
cally significant associations between the COIs and esophageal cancer. McBride 
et al. (2009a) reported on a mortality follow-up of the workers in the Dow 
AgroSciences plant in New Plymouth, New Zealand, who were potentially ex-
posed to TCDD; neither the SMR for esophageal cancer deaths in exposed work-
ers nor the never-exposed group was statistically significant compared with the 
general New Zealand population. A follow-up analysis on cancer incidence in the 
men and women exposed to dioxin in the Seveso accident found no esophageal 
cancers in the high-exposure zone and no exposure-related pattern in the occur-
rence of esophageal cancer in the medium- and low-exposure areas (Pesatori et 
al., 2009).
Among studies of esophageal cancer in Vietnam veterans, two were related 
to incidence (Yi, 2013; Yi and Ohrr, 2014), and one examined cancer-specific 
mortality (Yi et al., 2014b) in the Korean Veterans Health Study, a large prospec-
tive cohort of 185,265 male Vietnam veterans alive in 1992, who were followed 
for cancer incidence through 2003 and for mortality through 2005. Comparing the 
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Vietnam veterans to the general Korean population, Yi (2013) reported a statisti-
cally significant decrease in the incidence of esophageal cancer (SIR = 0.70, 95% 
CI 0.64–0.85). However, in the internal comparison of those with high versus 
low EOI scores, Yi and Ohrr (2014) reported a statistically significant increased 
risk for esophageal cancer (hazards ratio [HR] = 1.36, 95% CI 1.00–1.85). This 
result was based on 184 incident esophageal cancers observed during follow-
up, of which 113 cases were among veterans in the high-exposure category. Yi 
et al. (2014b) reported a non-statistically significant increase in mortality from 
esophageal cancer when comparing those in the higher exposure category (n 
= 98) with those with lower estimated exposure (n = 64). Similarly, mortality 
from esophageal cancer was not found to be associated with the individual, log-
transformed EOI scores (Yi et al., 2014b). Information on smoking and alcohol 
consumption was not available, leading to concerns that some of the association 
could be due to confounding.
Update of the Epidemiologic Literature
No studies of Vietnam veterans or published environmental or case-control 
studies of exposure to the COIs and esophageal cancer were identified for the 
current update. Reviews of the relevant studies are presented in the earlier reports. 
Table 3, which can be found at www.nap.edu/catalog/25137, summarizes the 
results of studies related to esophageal cancer.
Occupational Studies Among the Dow Midland, Michigan, worker cohort that 
was compared with the standardized U.S. population, Collins et al. (2016) found 
no differences in mortality for esophageal cancer for the TCP workers (n = 8; 
SMR = 1.09, 95% CI 0.47–2.14) or the PCP workers (n = 5; SMR = 1.52, 95% 
CI 0.49–3.54).
Cancers of the digestive organs were addressed by Coggon et al. (2015) in 
an extension of the follow-up of UK phenoxy herbicide manufacturers and spray-
ers. No statistically significant associations between exposure to phenoxy acids 
and esophageal cancer were found for all groups of workers: all workers (n = 
55; SMR = 0.99, 95% CI 0.74–1.28), workers exposed to herbicide levels above 
background (n = 46; SMR = 1.11, 95% CI 0.81–1.48), and workers exposed 
for more than 1 year at levels above background (n = 17; SMR = 0.89, 95% CI 
0.52–1.43). These data do not support an association with phenoxy herbicides 
and cancer of the esophagus.
Other Identified Studies Two other studies of esophageal cancer were identi-
fied but were limited by a lack of exposure specificity (Ruder et al., 2014; Yildirim 
et al., 2014). A third study (Akahane et al., 2017) examined the prevalence of 
self-reported long-term health effects (including esophageal cancer) in people 
exposed to PCBs, dioxins (e.g., PCDD/Fs), and dioxin-like chemicals through the 
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ingestion of contaminated rice bran oil (Yusho accident) compared with an age-, 
sex- and residential-area-matched group. Because no TEQs or other quantification 
of relevant exposures was presented, the study was not considered further.
Biologic Plausibility
Long-term animal studies have examined the effect of exposure to the COIs 
on tumor incidence (Charles et al., 1996; Stott et al., 1990; Walker et al., 2006; 
Wanibuchi et al., 2004), and no increase in the incidence of esophageal cancer 
has been reported in laboratory animals after exposure. A previous biomarker 
study analyzed esophageal-cell samples from patients who had been exposed to 
indoor air pollution of different magnitudes and who did or did not have high-
grade squamous-cell dysplasia or a family history of upper gastrointestinal-tract 
cancer (Roth et al., 2009). AHR expression was higher in patients who had a 
family history of upper gastrointestinal-tract cancer, but it was not associated 
with indoor air pollution, esophageal squamous-cell dysplasia category, age, sex, 
or smoking. These results might be interpreted to suggest that an enhanced ex-
pression of AHR in patients who had a family history of upper gastrointestinal-
tract cancer may contribute to upper gastrointestinal-tract cancer risk associated 
with AHR ligands—such as PAHs, which are found in cigarette smoke—and 
with TCDD.
In a small series of studies, AHR expression was found to be higher in 
esophageal tumors than in corresponding normal mucosa and, somewhat surpris-
ingly, played a role in the suppression of metastatic potential, in contrast to many 
other cancers (Safe et al., 2013). The significance of these observations and the 
mechanism underlying increased AHR expression was not determined (J. Zhang 
et al., 2012). No new mechanistic or biologic plausibility studies on esophageal 
cancer have been published since Update 2014.
Synthesis
In this update, two studies were reviewed that increased the follow-up period 
of workers exposed to dioxins (Collins et al., 2016) and phenoxy herbicides 
(Coggon et al., 2015) and examined the relationship of a variety of cancers, 
including esophageal, with mortality. Neither study provided additional evidence 
for a potential association between esophageal cancer overall and exposure to 
the COIs. Because the risk factors and etiologies for adenocarcinomas and squa-
mous-cell carcinomas differ to some extent, it would have been more informative 
if the analyses were stratified by type. In combination with the studies reviewed 
previously, findings from the additional follow-up times do not provide adequate 
new evidence of the relationship between exposure to the COIs and esophageal 
cancer. No toxicologic studies provide evidence of the biologic plausibility of an 
association between the COIs and tumors of the esophagus.
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Conclusion
On the basis of the evidence reviewed here and in previous VAO reports, 
the committee concludes that there is inadequate or insufficient evidence to 
determine whether there is an association between exposure to the COIs and 
esophageal cancer.
Stomach Cancer
The incidence of stomach cancer increases with age. NCI estimated that 
26,240 people would receive a diagnosis of stomach cancer in the United States 
in 2018 and that 10,800 people would die from it. The incidence is almost twice 
as high in men than in women and is higher among all other race and ethnicity 
groups than in whites (NCI, n.d.d). Other risk factors include a family history of 
this cancer, some diseases of the stomach, and diet. Infection with Helicobacter 
pylori increases the risk of stomach cancer. Tobacco or alcohol use and the con-
sumption of nitrite- and salt-preserved food may also increase the risk (Ang and 
Fock, 2014; Brenner et al., 2009; Key et al., 2004). The incidence rate of stom-
ach cancer has been decreasing since 1975 when SEER began tracking it, and is 
estimated to be 7.2 per 100,000 men and women per year (NCI, n.d.d). Among 
men over age 65 years (the age group of Vietnam veterans), the age-adjusted 
modeled incidence rate of stomach cancer for all races combined was 36.7 per 
100,000 for 2000–2014.2
Conclusions from VAO and Previous Updates
Stomach cancer was first considered independently in Update 2006, and that 
committee concluded that there was inadequate or insufficient evidence to deter-
mine whether there is an association between exposure to the COIs and stomach 
cancer. That conclusion has been maintained by the committees responsible for 
subsequent updates.
Case-control studies reviewed in previous updates examined agricultural 
exposures and stomach cancer. Both Ekström et al. (1999) and Mills and Yang 
(2007) found an association with herbicides and with phenoxy herbicides in 
particular. A study that compared mortality from stomach cancer among Iowa 
farmers versus other occupations found that the proportional mortality ratio of 
farmers was significantly higher (Burmeister et al., 1981, 1983). Occupational 
cohort studies reported little evidence of an exposure-related increase in stomach 
cancer. Updated mortality findings from Seveso concerning TCDD exposure 
2 As calculated on the site https://seer.cancer.gov/faststats/selections.php?#Output by choosing 
SEER 18 dataset, age-adjusted rates, stomach cancer, all races, male, and over age 65.
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(Consonni et al., 2008; Pesatori et al., 2009) found no evidence of an increase 
in stomach cancer.
Update 2014 reviewed cohort studies of Vietnam veterans from New Zealand 
and Korea that reported on stomach cancer. Stomach cancer mortality (Yi et al., 
2014b) and incidence (Yi and Ohrr, 2014) were assessed among Korean veterans 
who had served in Vietnam between 1964 and 1973. Yi and Ohrr (2014) reported 
a modestly increased risk of incident stomach cancer in the internal comparison 
of the high- and low-exposure groups based on the EOI scores. Similarly, for 
stomach cancer mortality, Yi et al. (2014b) reported a similar modestly increased 
risk for the high- versus low-exposure groups and a positive association with 
the individual log-transformed EOI scores. Among 2,783 New Zealand Vietnam 
veterans who served in Vietnam between 1964 and 1975, McBride et al. (2013) 
reported that stomach cancer mortality was slightly elevated in the cohort, while 
stomach cancer incidence was slightly less than expected; however, neither esti-
mate was statistically significant.
Update of the Epidemiologic Literature
No studies of Vietnam veterans or published environmental or case-control 
studies of exposure to the COIs and stomach cancer were identified for the current 
update. Reviews of the relevant studies are presented in the earlier reports. Table 
4, which can be found at www.nap.edu/catalog/25137, summarizes the results of 
studies related to stomach cancer.
Occupational Studies Among the Dow Midland, Michigan, worker cohort 
that was compared with the standardized U.S. population, Collins et al. (2016) 
found no differences in mortality from stomach cancer for the TCP workers 
(n = 11; SMR = 1.58, 95% CI 0.79–2.83) or the PCP workers (n = 5; SMR = 1.30, 
95% CI 0.42–3.04).
Cancers of the digestive organs were addressed by Coggon et al. (2015) in 
an extension of the follow-up of UK phenoxy herbicide manufacturers and spray-
ers. Mortality from stomach cancer was lower than expected for all groups of 
workers: all workers (n = 66; SMR = 0.78, 95% CI 0.61–1.00), workers exposed 
to herbicide levels above background (n = 43; SMR = 0.73, 95% CI 0.53–0.99), 
and workers exposed for more than 1 year at levels above background (n = 21; 
SMR = 0.75, 95% CI 0.46–1.15).
Other Identified Studies Two other studies of stomach and gastric cancer 
were identified but lacked sufficient exposure specificity to be included as con-
tributing to the evidence base of the potential effects of the COIs (Ruder et al., 
2014; Yildirim et al., 2014). A third study (Akahane et al., 2017) examined the 
prevalence of self-reported long-term health effects (including stomach cancer) 
in people exposed to PCBs, dioxins (e.g., PCDD/Fs), and dioxin-like chemicals 
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through the ingestion of contaminated rice bran oil (Yusho accident) compared 
with an age-, sex- and residential-area-matched group. Because no TEQs or other 
quantification of relevant exposures was presented, the study was not considered 
further.
Biologic Plausibility
Long-term animal studies have examined the effect of exposure to 2,4-D 
and TCDD on tumor incidence (Charles et al., 1996; Stott et al., 1990; Walker 
et al., 2006; Wanibuchi et al., 2004). No increase in the incidence of gastro-
intestinal cancers has been reported in laboratory animals. However, studies of 
laboratory animals have observed dose-dependent increases in the incidence 
of squamous-cell hyperplasia of the forestomach or fundus of the stomach after 
an administration of TCDD (Hebert et al., 1990; Walker et al., 2006). Similarly, 
in a long-term TCDD-treatment study in monkeys, hypertrophy, hyperplasia, 
and metaplasia were observed in the gastric epithelium (Allen et al., 1977). A 
transgenic mouse bearing a constitutively active form of the Ahr has been shown 
to develop stomach tumors (Andersson et al., 2002); the tumors are neither dys-
plastic nor metaplastic, but are indicative of both squamous-cell and intestinal-
cell metaplasia (Andersson et al., 2005). The validity of the transgenic-animal 
model is indicated by the similarities in the phenotype of the transgenic animal 
(increased relative weight of the liver and heart, decreased weight of the thymus, 
and increased expression of Ahr target gene CYP1A1) and of animals treated 
with TCDD (Brunnberg et al., 2006). Recent cell culture work consistent with 
the in vivo studies showed that decreased AHR expression in two human gastric 
cancer cell lines was associated with decreased cell growth, migration, and inva-
sion, all of which are hallmarks of malignant potential (X. F. Yin et al., 2013). In 
a biomarker study of cancer patients, AHR expression and nuclear translocation 
were significantly higher in stomach-cancer tissue than in precancerous tissue 
(Peng et al., 2009a). The results suggest that AHR plays an important role in 
stomach carcinogenesis. AHR activation in a stomach-cancer cell line has also 
been shown to enhance stomach-cancer cell invasiveness, potentially through a 
c-Jun-dependent induction of matrix metalloproteinase-9 (Peng et al., 2009b). No 
new mechanistic or biologic plausibility studies on gastrointestinal cancers have 
been published since Update 2014.
Synthesis
Studies that examined the association between the COIs and stomach cancer 
that were reviewed in previous VAO Updates reported mixed findings. Among the 
studies of Vietnam veterans, analyses from the AFHS did not report a statistically 
significant association of increasing serum levels of TCDD and stomach cancer 
(Pavuk et al., 2005). Other mortality studies of U.S. Vietnam veterans also did 
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not report an increased risk of death from stomach cancer. A modestly increased 
risk of stomach cancer was reported in Korean veterans, but there was inconsis-
tent evidence in New Zealand Vietnam veterans. Whereas case-control studies of 
agricultural exposures reported evidence of an association with stomach cancer, 
studies of occupational cohorts—including the two reviewed above—found little 
evidence of an exposure-related increase in stomach cancer. Moreover, Collins et 
al. (2016) reported an increased but not statistically significant risk of stomach 
cancer among the U.S. TCP and PCP manufacturing workers, but Coggon et al. 
(2015) reported a statistically significant decreased risk of stomach cancer among 
the entire cohort and short-term UK phenoxy herbicide workers or sprayers.
There is some evidence of biologic plausibility in animal models, but overall 
the epidemiologic studies do not support an association between exposure to the 
COIs and stomach cancer.
Conclusion
Based on the evidence reviewed here and in previous VAO reports, the com-
mittee concludes that there is inadequate or insufficient evidence to determine 
whether there is an association between exposure to the COIs and stomach cancer.
Colorectal Cancers
Colorectal cancers include malignancies of the colon (ICD-9 153; ICD-10 
C18) and of the rectum and anus (ICD-9 154; ICD-10 C19–C21); less preva-
lent tumors of the small intestine (ICD-9 152; ICD-10 C17) are often included. 
Colorectal cancers account for 8% of all incident cancers; NCI estimated that 
140,250 people would receive diagnoses of colorectal cancer in the United States 
in 2018 and that 50,630 would die from it. Colon and rectum cancer is the second 
leading cause of cancer death in the United States (NCI, n.d.e).
The incidence of colorectal cancers increases with age; the median age of 
diagnosis is 67 years. Incidence is higher in men than in women, and highest in 
blacks and lowest in Hispanics and Asians/Pacific Islanders. Between 2000 and 
2013, incidence rates in adults aged 50 years and older declined by 32%, with the 
drop largest for distal tumors in people aged 65 years and older. Over this same 
period, colorectal cancer incidence rates increased by 22% among adults aged 
less than 50 years, driven solely by tumors in the distal colon and rectum (Siegel 
et al., 2015). (Screening can affect the incidence, and screening is recommended 
for all persons over 50 years old.) Among men over age 65 years (the age group of 
Vietnam veterans), the age-adjusted modeled incidence rate of colorectal cancer 
for all races combined was 203.6 per 100,000 for 2000–2014.3 Other risk factors 
3 As calculated on the site https://seer.cancer.gov/faststats/selections.php?#Output by choosing 
SEER 18 dataset, age-adjusted rates, colorectal cancer, all races, age ≥ 65 years, and male sex.
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include a family history of this form of cancer, obesity, a lack of physical exer-
cise, and diet (Johnson et al., 2013; Kamangar et al., 2006). Type 2 diabetes is 
associated with an increased risk of colorectal cancers (Berster and Göke, 2008). 
Additional risk factors that have been studied include having a personal history 
of chronic ulcerative colitis or Crohn disease for 8 years or longer, smoking ciga-
rettes, and having three or more alcoholic drinks per day (NCI, 2018c).
Conclusions from VAO and Previous Updates
Until Update 2006, colorectal cancers were considered as a group with 
gastrointestinal-tract cancers. Beginning with Update 2006, colorectal cancers 
were considered independently, but each update committee has concluded that 
the available evidence has not been sufficient to reassign the association be-
tween exposure to the COIs and colorectal cancers from inadequate or insufficient 
evidence.
Studies of veterans from New Zealand and Korea who served in Vietnam 
and reported colorectal cancer outcomes, in general, found no statistically sig-
nificant associations. McBride et al. (2013) reported on mortality among 2,783 
male New Zealand veterans who had served in Vietnam between 1964 and 1975, 
were alive in 1988, and were followed through 2008. Based on 20 deaths from 
colorectal cancer, the effect estimate (SMR) was not statistically significantly 
elevated compared with the general New Zealand population, and the all-cause 
mortality estimate was statistically significantly lower in the cohort. Colorectal 
cancer incidence, based on 63 cases, was not statistically significantly different 
than the general population.
Among Korean veterans who served in Vietnam, Yi and Ohrr (2014) found a 
lower incidence of colon cancer among the more highly exposed compared with 
the less exposed as well as a small excess of rectal cancer, but neither was statisti-
cally significant. Regarding mortality from colorectal cancers, Yi et al. (2014b) 
reported no evidence of an increase in mortality from these cancers combined 
for high- versus low-exposure opportunity groups or in association with the 
 individual log-transformed EOI scores.
Update of the Epidemiologic Literature
No studies of Vietnam veterans or published environmental or case-control 
studies of exposure to the COIs and colorectal cancer were identified for the cur-
rent update. Reviews of the relevant studies are presented in the earlier reports. 
Table 5, which can be found at www.nap.edu/catalog/25137, summarizes the 
results of studies related to colon cancer.
Occupational Studies Among the Dow Midland, Michigan, worker cohort 
that was compared with the standardized U.S. population, Collins et al. (2016) 
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reported SMRs for colon and rectal cancers separately. Only 4 total deaths from 
rectum cancer were reported (3 among the TCP workers and 1 among the PCP 
workers), making the risk estimates unreliable. Compared with the standardized 
U.S. population, no statistically significant difference in mortality for colon can-
cer was found for the TCP workers (n = 22; SMR = 1.11, 95% CI 0.69–1.67) or 
the PCP workers (n = 12; SMR = 1.23, 95% CI 0.64–2.15).
Coggon et al. (2015) extended the follow-up of a cohort of UK phenoxy 
herbicide manufacturers and sprayers to examine the carcinogenicity of phenoxy 
herbicides. Mortality from colon and rectal cancers was reported separately. No 
difference in colon cancer mortality was found for all workers (n = 77; SMR = 
0.97, 95% CI 0.77–1.22), for workers exposed to herbicide levels above back-
ground (n = 50; SMR = 0.87, 95% CI 0.65–1.15), or for persons exposed for more 
than 1 year at levels above background (n = 23; SMR = 0.86, 95% CI 0.54–1.29), 
although the all effect estimates indicated decreased risk. The estimates for rectal 
cancer were similarly not statistically significant and lower than expected for 
each of the groups: all workers (n = 39; SMR = 0.76, 95% CI 0.54–1.04), work-
ers exposed to herbicide levels above background (n = 31; SMR = 0.84, 95% CI 
0.57–1.19), and workers exposed for more than 1 year at levels above background 
(n = 14; SMR = 0.81, 95% CI 0.44–1.36).
Other Identified Studies Three other studies of colon and rectal cancers were 
identified. One lacked sufficient exposure specificity to be included as contributing 
to the evidence base of the potential effect of the COIs (Ruder et al., 2014). The 
second study examined disparities in colorectal cancer incidence in communities 
around Ontario, Canada, but did not collect information on the COIs (Sitharan 
et al., 2014). A third study (Akahane et al., 2017) examined the prevalence of 
self-reported long-term health effects (including bowel cancer) in people exposed 
to PCBs, dioxins (e.g., PCDD/Fs), and dioxin-like chemicals through ingestion 
of contaminated rice bran oil (Yusho accident) compared with an age-, sex- and 
residential-area-matched group. Because no TEQs or other quantification of rel-
evant exposures was presented, the study was not considered further.
Biologic Plausibility
Long-term animal studies examining the effect of exposure to the COIs on 
tumor incidence (Charles et al., 1996; Stott et al., 1990; Walker et al., 2006; 
Wanibuchi et al., 2004) have reported no increase in the incidence of  colorectal 
cancers. Xie et al. (2012) reported that AHR activation by TCDD induces  robust 
proliferation in two human colon-cancer cell lines through Src-mediated epider-
mal growth factor receptor activation. That novel finding suggests that TCDD 
and other AHR ligands may contribute to an increased proliferation of colonic 
cells, but more studies are needed to understand the relation of increased prolif-
eration of these cells to colorectal cancers, if any, and the potential role of AHR 
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activation in colorectal and intestinal carcinogenesis. Yin et al. (2016a) found 
keratinocyte growth factor (KGF), AHR, and CYP1A1 are overexpressed in 
colorectal cancer tissues. KGF promoted colon cancer cell growth in vitro and 
also upregulated and activated AHR. Furthermore, KGF promoted cell prolifera-
tion through the AHR–cyclin D1 pathway in colon cancer cells.
In another study, Yin et al. (2016b) found that an endogenous AHR agonist 
(6-formylindolo [3, 2-b] carbazole, or FICZ) inhibited LoVo colon cancer cell 
proliferation by inducing cell cycle arrest. Ahr activation by TCDD was anti-
inflammatory in a mouse model of colon cancer by inducing acetylcholinesterase-
targeting micro RNA-132, which suppressed production of TNF-α, IL-1β and 
IL-6 (Alzahrani et al., 2017). These studies support a plausible mechanism by 
which TCDD may influence colorectal cancers.
Synthesis
Epidemiologic findings for colorectal cancers have not been particularly 
suggestive of an association with exposure to the COIs. None of the studies of 
U.S. Vietnam veterans found an elevated risk of colorectal cancer, and similar 
results have been reported for Vietnam veterans from Australia, Korea, and New 
Zealand. In line with previous follow-up studies of the U.S. Dow chemical plant 
workers, Collins et al. (2016) found few deaths from rectal cancer, and colon 
cancer was not found to be elevated in either TCP or PCP workers compared 
with the standardized U.S. population. Coggon et al. (2015) reported decreased, 
but not statistically significant risks among the UK factory workers or sprayers of 
phenoxy herbicides. Limited evidence is available on the biologic plausibility of 
an association between exposure to any of the COIs and tumors of the colon or 
rectum. Overall, the available evidence does not support an association between 
the COIs and colorectal cancers.
Conclusion
Based on the evidence reviewed here and in previous VAO reports, the commit-
tee concludes that there is inadequate or insufficient evidence to determine whether 
there is an association between exposure to the COIs and colorectal cancers.
Hepatobiliary Cancers
Hepatobiliary cancers include cancers of the liver (ICD-9 155.0, 155.2; 
ICD-10 C22) and the intrahepatic bile duct (ICD-9 155.1; ICD-10 C22.1). NCI 
estimated that 42,220 men and women would receive diagnoses of liver cancer or 
intrahepatic bile duct cancer in the United States in 2018 and that 30,200 people 
would die from these cancers (NCI, n.d.g). Gallbladder cancer and extrahepatic 
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bile duct cancer (ICD-9 156; ICD-10 C23–C24) are uncommon and, when they 
are addressed, are often grouped with liver cancer.
In the United States, liver cancers account for 2.4% of new cancer cases 
and 4% of cancer deaths. Misclassification of metastatic cancers as primary liver 
cancer can lead to an overestimation of the number of deaths attributable to liver 
cancer (Chuang et al., 2009). Liver cancer is the second most common cause 
of death from cancer worldwide and it is estimated that it will be responsible 
for nearly 782,000 deaths in 2018 (Globocan, 2018). Liver cancers are most 
common and are among the leading causes of death in less developed countries 
and regions, especially those in Northern Africa, Micronesia, and Eastern and 
Southeastern Asia (Globocan, 2018). Known risk factors for liver cancer include 
chronic infection with the hepatitis B or hepatitis C virus and exposure to the 
carcinogens aflatoxin and vinyl chloride. Alcohol cirrhosis and obesity-associated 
metabolic syndrome may also contribute to the risk of liver cancer (Chuang et 
al., 2009; Farazi et al., 2006). In the general population, the incidence of liver 
and intrahepatic bile duct cancers is higher in men than in women and higher in 
blacks than in whites but highest among Asian/Pacific Islanders and American 
Indians/Alaska Natives (NCI, n.d.g). Among males of all races aged 65 years and 
older, the age-adjusted modeled incidence rate of hepatobiliary cancers was 53.3 
per 100,000 for 2000–2014.4
Conclusions from VAO and Previous Updates
The committee responsible for VAO concluded that there was inadequate 
or insufficient information to determine whether there is an association between 
exposure to the COIs and hepatobiliary cancers. Additional information avail-
able to the committees responsible for subsequent updates did not change that 
conclusion.
The committee for Update 2014 reviewed two studies of Korean veterans 
who served in Vietnam and were part of the Korean Veterans Health Study. When 
compared to the general Korean population, there was no evidence of increased 
liver cancer risk (Yi, 2013). In the internal comparison of the high- versus 
low-exposure-opportunity group, Yi and Ohrr (2014) reported a nonstatistically 
significant elevation in liver cancer for the high-exposure group. The risk of 
liver cancer mortality was slightly increased in the internal comparison and 
from the analysis of the individual EOI scores (Yi et al., 2014b). The committee 
for  Update 2014 also reviewed an occupational study of 3,529 employees of a 
Chinese  automobile foundry that reported a statistically significantly elevated 
risk of liver cancer mortality, based on 32 cancer deaths (L. Wang et al., 2013). 
However, these studies did not change the committee’s conclusion that there is 
4 As calculated on the site https://seer.cancer.gov/faststats/selections.php?#Output by choosing 
SEER 18 dataset, age-adjusted rates, hepatobiliary cancer, all races, age ≥ 65 years, and male sex.
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inadequate or insufficient evidence to determine whether there is an association 
between exposure to the COIs and hepatobiliary cancers.
Update of the Epidemiologic Literature
No environmental or case-control studies of the COIs and hepatobiliary 
cancers have been identified since Update 2014. Reviews of the relevant studies 
are presented in the earlier reports. Table 6, which can be found at www.nap.edu/
catalog/25137, summarizes the results of studies related to hepatobiliary cancer.
Vietnam-Veteran Studies Krishnamurthy et al. (2016) conducted a retrospec-
tive study in the Dayton, Ohio, Veterans Administration Medical Center to inves-
tigate all patients carrying dual diagnoses of both cirrhosis and hepatitis C virus 
(verified by viral genotype) at this facility from January 2000 to December 2013. 
Of the 509 patients with both diagnoses, 119 did not have genotype results and 
were excluded from the analysis. A total of 390 patients confirmed to have both 
cirrhosis and hepatitis C virus were identified, and 311 had follow-up informa-
tion; there were 79 confirmed hepatocellular carcinomas among the 390 patients 
with dual diagnoses. Exposure to Agent Orange was determined by self-report. 
Effect estimates were adjusted for smoking, alcohol “addiction” (ill defined), and 
race. Alcohol addiction and African American race were associated with hepa-
tocellular carcinoma among the patient sample (OR = 2.17, 95% CI 1.07–4.43 
and OR = 2.07, 95% CI 1.22–3.51, respectively). The association between self-
reported exposure to Agent Orange and hepatocellular carcinoma was not statisti-
cally significant (OR = 1.76, 95% CI 0.85–3.64).
Occupational Studies Among the Dow Midland, Michigan, worker cohort 
that was compared with the standardized U.S. population, only four deaths from 
hepatobiliary cancers were reported during the entire follow-up period (Collins 
et al., 2016). All four deaths occurred in the TCP workers, and although the 
estimate showed decreased risk, it was not statistically significantly different from 
the comparison population (SMR = 0.62, 95% CI 0.17–1.58).
Cancers of the digestive organs were addressed by Coggon et al. (2015) in 
an extension of the follow-up of UK phenoxy herbicide manufacturers and spray-
ers. Mortality from liver and gall bladder cancers was reported separately, but 
the effect estimates from gall bladder cancer (two deaths among all workers) are 
unreliable because of the small number of cases. The risk for liver cancer mortal-
ity was not different for any of the groups of workers: all workers (n = 20; SMR = 
1.24, 95% CI 0.76–1.91), workers exposed to herbicide levels above background 
(n = 14; SMR = 1.14, 95% CI 0.62–1.91), or for workers exposed for more than 
1 year at levels above background (n = 4; SMR = 0.72, 95% CI 0.20–1.85).
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Other Identified Studies Four other studies of hepatobiliary cancers were iden-
tified but lacked sufficient exposure specificity (Niu et al., 2016; Ruder et al., 
2014; VoPham et al., 2015) and either did not collect serum samples to measure 
levels of dioxins (Ruder et al., 2014; VoPham et al., 2015) or did not measure 
the dioxin levels in collected samples (Niu et al., 2016). Therefore, these studies 
were not considered as contributing to the evidence base of the potential effect of 
the COIs. A fourth study (Akahane et al., 2017) examined the prevalence of self- 
reported long-term health effects (including liver and gallbladder cancers) in people 
exposed to PCBs, dioxins (e.g., PCDD/Fs), and dioxin-like chemicals through the 
ingestion of contaminated rice bran oil (Yusho accident), compared with an age-, 
sex- and residential-area-matched group. Because no TEQs or other quantification 
of relevant exposures was presented, the study was not considered further.
Biologic Plausibility
Long-term animal studies have examined the effect of exposure to the COIs 
on tumor incidence (J. F. Brown et al., 2007; Charles et al., 1996; Stott et al., 
1990; Walker et al., 2006; Wanibuchi et al., 2004). Studies performed in labora-
tory animals have consistently demonstrated that long-term exposure to TCDD 
results in the formation of liver adenomas and carcinomas (Knerr and Schrenk, 
2006; Walker et al., 2006). Furthermore, TCDD increases the growth of hepatic 
tumors that are initiated by treatment with a complete carcinogen. Pathologic 
liver changes have been observed after exposure to TCDD, including nodular 
hyperplasia and massive inflammatory cell infiltration (Kociba et al., 1978; NTP, 
2006; Walker et al., 2006; Yoshizawa et al., 2007); inflammation can be important 
for the development and progression of many cancers, including liver cancers 
(Mantovani et al., 2008). In monkeys treated with TCDD, hyperplasia and an 
increase in cells that stain for alpha-smooth muscle actin have been observed 
(Korenaga et al., 2007). Positive staining for alpha-smooth muscle actin is thought 
to indicate a process (the epithelial–mesenchymal transition) that is associated 
with the progression of malignant tumors (Weinberg, 2008). Zucchini-Pascal et 
al. (2012) showed that TCDD exposure induced an epithelial-to-mesenchymal 
transition in primary cultured human hepatocytes.
Bile duct hyperplasia (but not tumors) has been reported in rodents fol-
lowing chronic treatment with TCDD (Knerr and Schrenk, 2006; Walker et al., 
2006; Yoshizawa et al., 2007). Similarly, monkeys treated with TCDD developed 
metaplasia, hyperplasia, and hypertrophy of the bile duct (Allen et al., 1977). 
Hollingshead et al. (2008) showed that TCDD-activated AHR in human breast 
and endocervical cell lines induces sustained high concentrations of the IL-6 
cytokine, which has tumor-promoting effects in numerous tissues, including 
cholangiocytes; thus, TCDD might promote carcinogenesis in biliary tissue.
TCDD may contribute to tumor progression by inhibiting p53 regulation 
(phosphorylation and acetylation) triggered by genotoxicants through the increased 
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expression of the metastasis marker AGR2 (Ambolet-Camoit et al., 2010) and a 
functional interaction between the AHR and FHL2 (Kollara and Brown, 2009). 
AHR has also been shown to be a regulator of c-Raf and proposed cross-talk 
between AHR and the mitogen-activated protein kinase signaling pathway in 
chemically induced hepatocarcinogenesis (Borlak and Jenke, 2008). TCDD in-
hibits ultraviolet-C radiation-induced apoptosis in primary rat hepatocytes and 
Huh-7 human hepatoma cells, which supports the hypothesis that TCDD acts 
as a tumor promoter by preventing damaged cells from undergoing apoptosis 
(Chopra et al., 2009). TCDD inhibited the proliferation of isolated mouse oval 
cells, which are liver precursor cells, via an Ahr-dependent pathway, suggesting 
that these cells are not the precursor for TCDD-induced tumors in the mouse 
(Faust et al., 2013a).
Elyakim et al. (2010) found that human microRNA miR-191 was upregu-
lated in hepatocellular carcinoma and that miR-191 was also upregulated after 
TCDD treatment, which may contribute to the mechanism of the carcinogenic 
activity of TCDD. Ovando et al. (2010) used toxicogenomics to identify genomic 
responses that may contribute to the development of hepatotoxicity in rats treated 
chronically with the AHR ligands, TCDD, or PCB 126. The researchers identi-
fied, respectively, 24, 17, and 7 genes that were differentially expressed in the 
livers of rats exposed to those Ahr ligands and in human cholangiocarcinoma, 
human hepatocellular adenoma, and rat hepatocellular adenoma. These findings 
may help elucidate the mechanisms by which dioxin-like chemicals induce their 
hepatotoxic and carcinogenic effects.
In rodents, TCDD may promote hepatocarcinogenesis through cytotoxic-
ity, chronic inflammation, and liver regeneration and through hyperplastic and 
hypertrophic growth due to the sustained activation of Ahr (Köhle and Bock, 
2007; Köhle et al., 2008). For example, TCDD exposure has been reported to 
increase liver fibrosis in mice via an Ahr-dependent pathway (Andreola et al., 
2004). Kennedy et al. (2014) used transgenic mouse strains to measure dioxin-
induced liver cancers in a model in which TCDD was used as a tumor promoter. 
One set of experiments showed that the number of TCDD-induced liver tumors 
was significantly higher in mice that expressed Ahr with high-binding affinity 
to TCDD than in an isogenic strain that expressed a low-binding-affinity Ahr. 
A second set of experiments showed that the genetic ablation of inflamma-
tory cytokines significantly reduced TCDD-induced liver tumors. Likewise, the 
genetic ablation of AHR reduced TCDD-induction of the inflammatory cyto-
kines (Pierre et al., 2014). Species differences governing AHR activation are 
demonstrated by the divergence in the transcriptomic responses to TCDD in 
mouse, rat, and human liver (Boutros et al., 2008, 2009; Carlson et al., 2009; 
S. E. Kim et al., 2009), but it should be noted that the in vitro human hepatocyte 
studies may not reflect the in vivo response of human liver to TCDD. In vitro 
studies with transformed cell lines and primary hepatocytes cannot replicate the 
complexity of a tissue response that is important in eliciting the toxic responses 
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observed in vivo (Dere et al., 2006). Finally, AHR expression was shown to be 
significantly elevated in human liver cancers, although the absolute level of in-
crease is only about 30% to 40%, but the biological significance of this observa-
tion is not known (Z. Liu et al., 2013).
In a study of gene-expression changes in adult female primary human and 
rat hepatocytes exposed to TCDD in vitro, Black et al. (2012) used whole-
genome microarrays to show that TCDD produced different gene-expression 
profiles in rat and human hepatocytes, both on an ortholog basis (conserved 
genes in different species) and on a pathway basis. For commonly affected 
orthologs or signaling pathways, the human hepatocytes were about one-fifteenth 
as sensitive as rat hepatocytes. Such findings are consistent with epidemiologic 
studies that show humans to be less sensitive to TCDD-induced hepatotoxicity. 
A study of gene-expression changes in cultured rat liver cells (the WB-F344 
cell line) showed that AHR agonist PCB 126 identified hundreds of dysregu-
lated genes that increased in number as a function of time after exposure from 
6 to 72 hours; these included the Wnt and TGF-β signaling pathways, which 
are involved in tumorogenesis (Faust et al., 2013b). Peyre et al. (2014) studied 
TCDD activity in human HepG2 hepatocarcinoma cells and demonstrated pro-
carcinogenic activity (anti-apoptosis and induction of epithelial to mesenchymal 
transition) via dysregulation of the TGF-β pathway. Reyes-Reyes et al. (2016) 
described another mechanism of cancer progression in HepG2 cells involving 
TGF-β; the long interspersed nuclear element-1 (L1) damages DNA and was 
activated in HepG2 cells via TGF-β signaling in a study of AHR activation 
by benzo[a]pyrene. L. T. Wang et al. (2017) found a high correlation between 
 histone deacetylase 8 (HDAC8) and AHR expression as mRNA and protein 
levels. Expression of both HDAC8 and AHR was significantly upregulated in 
hepatocellular carcinoma cell lines and tumor tissues compared with normal 
hepatocytes; inhibition of HDAC8 inhibited hepatoma cell proliferation and 
transformation.
The chronic exposure of rats to TCDD was associated with fatty liver degen-
eration and necrosis (X. Chen et al., 2012). Another group reported that the hepa-
totoxic effects of TCDD were exacerbated in mice that had glutathione deficiency 
(Y. J. Chen et al., 2012). The combined exposure to PCBs and TCDD induced 
significant hepatotoxicity in rats (C. Lu et al., 2010). Brown et al. (2007) care-
fully evaluated the mechanisms by which dioxin-like PCBs caused liver cancer 
in rats suggesting a process involving the net activity of multiple mixed-function 
oxidases, redox cycling quinones, and reactive oxygen species.
Cacodylic acid (DMAIII and DMAV) is carcinogenic and has been shown to 
induce renal cancer. In F344/DuCrj rats treated with a mixture of carcinogens for 
4 weeks, a subsequent exposure to DMA (not indicated whether this was DMAIII 
or DMAV) via their drinking water for 24 weeks caused tumor promotion in the 
liver, kidney, urinary bladder, and thyroid gland but inhibited induction of tumors 
of the nasal passages (S. Yamamoto et al., 1995). More recent studies have also 
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found that oral exposure of adult mice to 200 ppm DMAV in addition to fetal 
arsenic exposure can act as a promoter of renal and hepatocellular carcinoma, 
markedly increasing tumor incidence beyond that produced by fetal arsenic expo-
sure alone (Tokar et al., 2012).
Synthesis
Epidemiologic findings for hepatobiliary cancers have not suggested an asso-
ciation with exposure to the COIs. Since the previous update, one new study of 
U.S. Vietnam veterans who attended a VA Medical Center examined hepatocel-
lular carcinoma comorbid with dual diagnoses of cirrhosis and hepatitis C virus 
and exposure to Agent Orange (determined by self-report) (Krishnamurthy et 
al., 2016). Although the risk estimate was elevated, no statistically significant 
association was found between exposure to Agent Orange and hepatocellular 
carcinoma. Such null findings are consistent with studies of other cohorts of U.S. 
Vietnam veterans as well as those from Australia and Korea. Two occupational 
cohort studies that extended the long-term follow-up period of their cohorts were 
reviewed. Similar to findings from previous follow-ups, few deaths from hepato-
biliary cancers were reported among the U.S. Dow chemical plant workers, and 
the risk estimate was lower for the workers than in the general U.S. population 
(Collins et al., 2016). Among the UK factory workers or sprayers of phenoxy 
herbicides that was followed since 1947, Coggon et al. (2015) also reported a 
decreased, but not statistically significant risk of hepatobiliary cancer.
Although one new study (Krishnamurthy et al., 2016) reported modest evi-
dence of excess liver cancer among Vietnam veterans using VA medical center ser-
vices, the weak design, nonspecific exposure, and confounding remain a concern 
for interpreting its results. The lack of evidence of association between exposure 
and hepatobiliary cancers in the well-designed and exposure-characterized occu-
pational studies does not support an association. Despite the evidence of TCDD’s 
activity as a hepatocarcinogen in animals, the evidence from epidemiologic stud-
ies remains inadequate to link the COIs with hepatobiliary cancers, which has a 
relatively low incidence in Western populations. Overall, the available evidence 
does not support an association between the COIs and hepatobiliary cancers.
Conclusion
On the basis of the evidence reviewed here and in previous VAO reports, 
the committee concludes that there is inadequate or insufficient evidence to 
determine whether there is an association between exposure to the COIs and 
hepatobiliary cancers.
Veterans and Agent Orange: Update 11 (2018)
Copyright National Academy of Sciences. All rights reserved.
CANCER 251
Pancreatic Cancer
The incidence of pancreatic cancer (ICD-9 157; ICD-10 C25) increases with 
age, and the median age of diagnosis is 70 years. NCI estimated that there would 
be 55,440 new diagnoses of pancreatic cancer in the United States in 2018, and 
that 44,330 people would die from it (NCI, n.d.f). The incidence is higher in men 
than in women. The age-adjusted modeled incidence rate of pancreatic cancer for 
men 50–64 years old of all races combined was 23.1 per 100,000 in 2014 and 
increased to 62.5 for 65- to 74-year-olds and 100.2 for men over 75 years.5 Blacks 
have the highest incidence rates for both men and women, and American Indians/
Alaska Natives and Asians/Pacific Islanders have the lowest incidence rates. Risk 
factors include chronic pancreatitis (Yadav and Lowenfels, 2013), family history, 
diet, tobacco use, obesity, and type 2 diabetes (Huxley et al., 2005).
Conclusions from VAO and Previous Updates
Like other digestive organ cancers, pancreatic cancer was considered inde-
pendently for the first time in Update 2006. In reviewing the existing evidence 
concerning an association between herbicide exposure and pancreatic cancer, the 
committee for Update 2006 noted a report of increased rates of pancreatic cancer 
in U.S. female Vietnam nurse veterans (Dalager et al., 1995a) but concluded that 
it alone did not constitute limited or suggestive evidence of an association. That 
increase persisted in the follow-up study of the American female veterans cohort 
(Cypel and Kang, 2008), but committees for subsequent updates have concurred 
with the decision of the committee for Update 2006, which concluded that there 
is inadequate or insufficient evidence of an association of exposure to any of the 
COIs and pancreatic cancer.
Four studies of Vietnam veterans were reviewed in Update 2014: a follow-up 
study of U.S. women veterans (H. K. Kang et al., 2014a), the cohort from New 
Zealand (McBride et al., 2013), and two studies of Korean veterans (Yi, 2013; Yi 
and Ohrr, 2014). Pancreatic cancer incidence was lower among the New Zealand 
and Korean veterans than in their respective general populations, but the differ-
ence was not statistically significant. Among the mortality analyses, deaths from 
pancreatic cancer were lower, but not statistically significantly so, among the 
New Zealand cohort veterans compared with the standardized general population 
of New Zealand. The risk of death from pancreatic cancer was higher among the 
other Vietnam veteran cohorts that were followed, but again the differences were 
not statistically significant. Among the U.S. women veterans, deployed women 
were compared with Vietnam-era women who remained in the United States, 
and no statistically significant differences in pancreatic cancer mortality were 
5 As calculated on the site https://seer.cancer.gov/faststats/selections.php?#Output by using the 
SEER 18 dataset and choosing age-adjusted rates, pancreatic cancer, all races, age ≥ 65 years, and 
stratifying the results by sex.
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observed overall or when the analyses were limited to deployed and nondeployed 
nurses. Among Korean veterans, neither pancreatic cancer incidence nor risk of 
mortality from pancreatic cancers in association with herbicide exposure from 
either the internal comparison of the high- and low-exposure-opportunity groups 
or the analysis of the individual EOI scores was statistically significant. However, 
none of the veteran studies controlled for smoking status, a known risk factor of 
pancreatic cancer.
Update of the Epidemiologic Literature
No studies of Vietnam veterans or environmental studies of the COIs and 
pancreatic cancer have been identified since Update 2014. Reviews of the relevant 
studies are presented in the earlier reports. Table 7, which can be found at www.nap.
edu/catalog/25137, summarizes the results of studies related to pancreatic cancer.
Occupational Studies Two occupational cohort studies were identified since 
Update 2014 that examined the relationship between phenoxy herbicides and 
pancreatic cancer. Among the Dow Midland, Michigan, worker cohort that was 
compared with the standardized U.S. population, no differences in mortality for 
pancreatic cancer were found for the TCP workers (n = 7; SMR = 0.55, 95% CI 
0.22–1.14) or the PCP workers (n = 6; SMR = 1.00, 95% CI 0.37–2.18) (Collins 
et al., 2016).
Mortality from pancreatic cancers was one of the outcomes addressed by 
Coggon et al. (2015) in an extension of the follow-up of UK phenoxy herbicide 
manufacturers and sprayers. No difference in risk of mortality from pancreatic 
cancer was found for any of the groups of workers: all workers (n = 54; SMR = 
1.04, 95% CI 0.78–1.35), workers exposed to herbicide levels above background 
(n = 39; SMR = 1.03, 95% CI 0.73–1.40), or workers exposed for more than 1 
year at levels above background (n = 13; SMR = 0.74, 95% CI 0.39–1.26).
Case-Control Studies One population-based case-control study of occupa-
tional exposure to pesticides, including phenoxy herbicides, and pancreatic can-
cer has been published since Update 2014. Fritschi et al. (2015) recruited 504 
confirmed pancreatic cancer cases and 643 controls between January 2007 and 
June 2011 as part of the Queensland [Australia] Pancreatic Cancer Study. All 
participants were Queensland residents and at least 18 years old. Controls were 
randomly selected from the Australian electoral roll and frequency matched to 
cases by sex and 5-year age group at diagnosis. Participants completed face-to-
face or telephone interviews that collected information about sociodemographic 
and lifestyle factors (including detailed smoking behaviors and history), medi-
cal history, history of cancer in first-degree relatives, and detailed lifetime job 
histories (including job title, industry, location, main tasks, and ages at start and 
finish). Additional questions were asked for people who reported ever working in 
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industries that are associated with nitrosamine exposure and the occupational or 
direct use of pesticides on animals or crops. An occupational hygienist, who was 
blinded to case status, reviewed the job history information to assess the likeli-
hood of exposure to N-nitrosamines and pesticides and estimated level and fre-
quency of such exposures. Pesticide assessments were made for organochlorine 
insecticides, organophosphate insecticides, phenoxy herbicides, other herbicides, 
fumigants, fungicides, and other pesticides. Risk estimates were adjusted for age 
and sex. No statistically significant associations were found with exposure to 
any of the individual pesticide groups. Specifically examining ever versus never 
exposure to phenoxy herbicides (19 cases and 24 controls reported ever exposure), 
no statistically significant association with pancreatic cancer was found (OR = 
0.93, 95% CI 0.50–1.74). Among non-smokers the odds of pancreatic cancer with 
exposure to pesticides was 1.00 (95% CI 0.48–2.06), and among ever smokers it 
was 0.82 (95% CI 0.51–1.32).
Other Identified Studies Two other studies of pancreatic cancer were identi-
fied. The first lacked sufficient exposure specificity to be included as contributing 
to the evidence base of the potential effect of the COIs (Ruder et al., 2014). The 
second study (Akahane et al., 2017) examined the prevalence of self-reported 
long-term health effects (including pancreatic cancer) in people exposed to PCBs, 
dioxins (e.g., PCDD/Fs), and dioxin-like chemicals through the ingestion of 
contaminated rice bran oil (Yusho accident) compared with an age-, sex- and 
residential-area-matched group. Because no TEQs or other quantification of rel-
evant exposures was presented, the study was not considered further.
Biologic Plausibility
Long-term animal studies have examined the effect on tumor incidence of 
exposure to each of the COIs: 2,4-D and 2,4,5-T (Charles et al., 1996), TCDD 
(Walker et al., 2006), picloram (Stott et al., 1990), and DMA (Wanibuchi et al., 
1996, 2004). No increase in the incidence of pancreatic cancer in laboratory 
animals after the administration of cacodylic acid, 2,4-D, or picloram has been 
reported. A 2-year study of female rats reported increased incidences of pancre-
atic adenomas and carcinomas after treatment at the highest dose of TCDD (100 
ng/kg per day) (Nyska et al., 2004). Other studies have observed chronic active 
inflammation, acinar-cell vacuolation, and an increase in the proliferation of the 
acinar cells surrounding the vacuolated cells (Yoshizawa et al., 2005b). As previ-
ously discussed, chronic inflammation and hyperproliferation are closely linked 
to the formation and progression of cancers, including cancers of the pancreas 
(Hahn and Weinberg, 2002; Mantovani et al., 2008). Also, metaplastic changes in 
the pancreatic ducts were observed in female monkeys treated with TCDD (Allen 
et al., 1977). No new mechanistic or biologic plausibility studies on pancreatic 
cancer have been published since Update 2014.
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Synthesis
Although prior studies of Vietnam veterans from the United States and Aus-
tralia had reported an excess of pancreatic cancer, studies of New Zealand and 
Korean veterans who served in Vietnam did not report an association between 
service and pancreatic cancer, although none of them controlled for smoking. In 
the current update, two studies of occupational cohorts that produced phenoxy 
herbicides or were exposed to TCDD did not find elevated risks of pancreatic 
cancer mortality and often did not report consistent directions of any effect. The 
population-based case-control study of Fritschi et al. (2015) explored exposure 
to organochlorine insecticides and herbicides and also found no evidence for an 
association of exposure to these compounds with pancreatic cancer. Limited evi-
dence is available on the biologic plausibility of an association between exposure 
to any of the COIs and tumors of the pancreas; long-term animal studies of expo-
sure to each of the COIs have not found increased incidence of pancreatic cancer. 
Overall, the existing evidence does not support a conclusion that exposures to the 
COIs are associated with the occurrence of pancreatic cancer.
Conclusion
On the basis of the evidence reviewed here and in previous VAO reports, 
the committee concludes that there is inadequate or insufficient evidence to 
determine whether there is an association between exposure to the COIs and 
pancreatic cancer.
Other Digestive Cancers
Findings on cancers of the small intestine (ICD-9 152; ICD-10 C17), ill- 
defined intestine, rectosigmoid junction, gallbladder (ICD-9 156; ICD-10 C23), 
retroperitoneum (ICD-9 158; ICD-10 C48), and other unspecified digestive organs 
(ICD-9 159; ICD-10 C26.8, C26.9, C48.8) are considered in this category.
Some studies have reported the risk of small intestine cancer separately, and 
others have grouped it under “other digestive cancers.” Epidemiologic findings 
for cancer of the small intestine and the COIs have not been encountered in any 
of the VAO updates except in analyses of the Korean Veterans Health Study, re-
viewed by the Update 2014 committee. In a mortality analysis, Yi et al. (2014b) 
found a statistically significant elevated risk for the internal comparison but not 
for the analysis of the individual EOI scores of mortality from cancer of the small 
intestine. Yi and Ohrr (2014) found a statistically significant increase in incidence 
of cancers of the small intestine when comparing the high- versus low-exposure 
opportunity groups, but the estimate was imprecise.
Since Update 2014, the committee has identified three studies, one that 
reported on mortality from small intestine cancer specifically, one that reported 
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mortality from “other digestive sites” that would include the small intestine and 
others as defined above, and a third that presented “malignant neoplasms of the 
peritoneum and other and unspecified of digestive organs” as a single group.
Among the Dow Midland, Michigan, worker cohort that used the standard-
ized U.S. population for comparison, only four deaths were reported from other 
digestive cancers during the follow-up period (Collins et al., 2016). The small 
number of deaths resulted in a slightly elevated but imprecise risk estimate for 
all reported categories of workers: all TCP/PCP workers (SMR = 1.37, 95% CI 
0.37–3.51), TCP workers (n = 3; SMR = 1.91, 95% CI 0.52–4.89), and PCP work-
ers (n = 1; SMR = 0.94, 95% CI 0.02–5.25).
In an extension of the follow-up of UK phenoxy herbicide manufacturers and 
sprayers examining the carcinogenicity of phenoxy herbicides, Coggon et al. (2015) 
reported that there were four deaths due to cancers of the small intestine over the 
entire follow-up period. The risk estimates were not statistically significant and were 
imprecise for all three groups of workers presented: all workers (SMR = 1.67, 95% 
CI 0.65–4.28), workers exposed to phenoxy herbicides above background (n = 4; 
SMR = 2.26, 95% CI 0.62–5.80), and workers exposed to phenoxy herbicides above 
background levels for 1 year or longer (n = 2; SMR = 2.48, 95% CI 0.30–8.96).
A third identified occupational study (Ruder et al., 2014) reported SMRs 
from many types of malignant neoplasms in the digestive organs using a category 
of “malignant neoplasms of the peritoneum and other and unspecified of digestive 
organs” but lacked the necessary exposure specificity to be considered further.
Given the small number of studies and, in some cases, non-specific catego-
rization of the outcomes, these data do not allow the committee to reach any 
definitive conclusions regarding the association of exposure to the COIs and other 
digestive cancers, including cancers of the small intestine.
LARYNGEAL CANCER
The larynx is a part of the throat between the base of the tongue and the 
trachea, and it contains the vocal cords, epiglottis, supraglottis, glottis, and sub-
glottis. NCI estimated that in the United States in 2018, 13,150 people would 
receive a new diagnosis of and 3,710 men and women would die from laryngeal 
cancer (ICD-9 161; ICD-10 C32) (NCI, n.d.j). It is the 20th most common cancer 
diagnosis. The incidence of laryngeal cancer increases with age; the age-adjusted 
modeled incidence rate of laryngeal cancer for men 65 years and older (the age of 
Vietnam veterans) for all races combined was 25.1 per 100,000 for 2000–2014.6 
It is more common in men than in women and in blacks than in whites. Exposure 
to tobacco smoke, paint fumes, metalworking fluids, and asbestos have been 
associated with laryngeal cancer, as has alcohol and occu pational exposures 
6 As calculated on the site https://seer.cancer.gov/faststats/selections.php?#Output by using SEER 
18 dataset, choosing age-adjusted rates, laryngeal cancer, all races, male sex, and age ≥ 65 years.
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to wood dust and employment in the petroleum, plastics, and textile industries 
(ACS, 2012a; IOM, 2006a).
Conclusions from VAO and Previous Updates
The original VAO committee reviewed five studies that presented data on 
laryngeal cancers separately and concluded that “although the numbers are too 
small to draw strong conclusions, the consistency of a mild increase in relative 
risk is suggestive of an association for laryngeal cancer.” The weight of evidence 
regarding laryngeal cancer has increased since the original VAO committee 
review, particularly with the addition of epidemiological studies of workers 
employed in manufacturing herbicides potentially contaminated with TCDD. 
An elevated rate of laryngeal cancer deaths in workers who were exposed to any 
phenoxyacetic acid herbicide or chlorophenol was found (SMR = 1.6, 95% CI 
1.0–2.5, based on 21 deaths), especially in workers who were exposed to TCDD 
or higher- chlorinated dioxins (SMR = 1.7, 95% CI 1.0–2.8, based on 15 deaths) 
(Kogevinas et al., 1997). Ongoing updates have continued to indicate an increase 
in laryngeal cancer in the occupational cohorts making up this IARC cohort. An 
environmental study of residents of Chapaevsk, Russia, which was heavily con-
taminated by many industrial pollutants, including dioxin, showed an association 
with laryngeal cancer in men (relative risk [RR] = 2.3, 95% CI 1.2–3.8) (Revich 
et al., 2001).
Among the studies of Vietnam veterans, a positive association was found in 
the study of veterans in Australia that compared mortality from laryngeal can-
cer with that in the general population (ADVA, 2005a) but not in the study that 
compared Australian veterans who served in Vietnam with non-deployed soldiers 
(ADVA, 2005c). In contrast, Watanabe and Kang (1996) found a statistically 
significant 40% excess of mortality from laryngeal cancer in U.S. Army person-
nel deployed to the Vietnam theater. The AFHS did not have sufficient power to 
detect whether an association existed. The New Zealand cohort of 2,783 Vietnam 
veterans reported a total of five incident cases and two deaths from larynx can-
cers, but the study was insufficiently powered to provide reliable estimates (Mc-
Bride et al., 2013). The Korean Veterans Health Study identified a large number 
of incident cases (n = 157) and deaths (n = 82) from larynx cancer during a 20-
year follow-up (Yi, 2013; Yi and Ohrr, 2014; Yi et al., 2014a,b). Despite the large 
sample size, the modestly increased risks of both incidence and mortality from 
larynx cancer were not statistically significant. Although additional studies of 
laryngeal cancers and exposure to the COIs have been reviewed, the update com-
mittees have continued to conclude that there is limited or suggestive evidence of 
an association between exposure to at least one COI and laryngeal cancer.
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Update of the Epidemiologic Literature
No studies of Vietnam veterans and laryngeal cancer have been published 
since Update 2014. Furthermore, no environmental or case-control studies of the 
COIs and laryngeal cancer have been identified since Update 2012. Reviews of 
the relevant studies are presented in the earlier reports. Table 8, which can be 
found at www.nap.edu/catalog/25137, summarizes the results of studies related 
to larangeal cancer.
Occupational Studies
Coggon et al. (2015) reported on mortality from laryngeal cancer as part of 
their follow-up study that examined the carcinogenicity of phenoxy herbicides 
among UK phenoxy herbicide manufacturers and sprayers. Fewer deaths than 
expected from laryngeal cancer were found for all groups of workers, but none 
of the estimates were statistically significantly different from the comparison 
population: all workers (n = 7; SMR = 0.66, 95% CI 0.26–1.35), workers exposed 
to herbicide levels above background (n = 7; SMR = 0.91, 95% CI 0.36–1.87), 
and workers exposed for more than 1 year at levels above background (n = 3; 
SMR = 0.84, 95% CI 0.17–2.44). These data do not support an association with 
phenoxy herbicides and cancer of the larynx.
Other Identified Studies
One other study of laryngeal cancer was identified. However, it lacked suf-
ficient exposure specificity to be included as contributing to the evidence base of 
the potential effect of the COIs (Ruder et al., 2014).
Biologic Plausibility
Long-term animal studies have examined the effect of exposure to the COIs 
on tumor incidence (Charles et al., 1996; Stott et al., 1990; Walker et al., 2006; 
Wanibuchi et al., 2004). No increase in the incidence of laryngeal cancer in 
laboratory animals after the administration of any of the COIs has been reported.
Synthesis
Overall, most reports reviewed in previous updates suggested an increased 
risk of laryngeal cancer, although the individual studies often were based on small 
numbers of cases and did not control for smoking. In addition, there is evidence 
of an excess risk of laryngeal cancer among those who experienced chloracne—a 
marker of high exposure to dioxins. The literature provides a reasonable level 
of consistency regarding evidence of a moderate increase in the relative risk of 
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laryngeal cancer. In larger occupational studies with good exposure characteriza-
tions that focus on the COIs, the associations are generally strong for laryngeal 
cancer; however, in the extended follow-up time of the UK phenoxy herbicide 
workers and sprayers, Coggon et al. (2015) found decreased risk estimates of 
mortality from laryngeal cancer for all categories of exposure in workers. Studies 
of Vietnam veterans have provided modest, generally not statistically significant, 
associations.
Conclusion
Based on one additional study reviewed for the current update, the commit-
tee concurs with prior VAO committees and concludes that there is limited or 
suggestive evidence of an association between exposure to at least one COI and 
laryngeal cancer.
LUNG CANCER
Lung cancer (carcinoma of the lung or bronchus, ICD-9 162.2–162.9; ICD-
10 C34) is the second most common diagnosed cancer and the leading cause of 
cancer death (accounting for about 26% of all cancer deaths) in the United States. 
An estimated 234,030 people will receive diagnoses of lung cancer in the United 
States in 2018, and 154,050 people will die from it (NCI, n.d.k). The principal 
types of lung neoplasms are identified collectively as bronchogenic carcinoma 
and carcinoma of the lung. Cancer of the trachea (ICD-9 162.0) is often grouped 
with cancers of the lung and bronchus under ICD-9 162.2, but it is a rare cancer. 
The lung is also a common site of metastatic tumors from other organ sites, but 
only studies of primary cancer sites are reviewed.
The incidence of lung cancer increases with age, and the median age of diag-
nosis is 70 years. The age-adjusted modeled incidence rate of lung and bronchus 
cancers for men 50–64 years old of all races combined was 83.3 per 100,000 
in 2014 and increased to 298.6 for 65–74 year olds and 447.5 for men over 75 
years. The increased incidence rate with age is similar for women, though not 
as high as it is for men of the same age groups.7 The incidence of lung cancer is 
consistently higher in black men than in white men, but slightly lower in black 
women compared with white women. It is lowest among Hispanic men and 
women (NCI, n.d.k).
Smoking is a major risk factor for lung cancer and increases the risk of all 
histologic types of this disease, but the associations with squamous-cell and 
small-cell carcinomas are the strongest. CDC’s 2014 Surgeon General report esti-
mated that 82% of lung cancer deaths are attributable to cigarette smoking (CDC, 
7 As calculated on the site https://seer.cancer.gov/faststats/selections.php?#Output by using SEER 
18 dataset and choosing age-adjusted rates, lung cancer, all races, age ≥ 65 years, and male sex.
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2014a). Other risk factors include exposure to asbestos, uranium, vinyl chloride, 
nickel chromates, coal products, mustard gas, chloromethyl ethers, gasoline, 
diesel exhaust, and inorganic arsenic. The risk posed by arsenic does not imply 
that cacodylic acid, which is a metabolite of inorganic arsenic, can be assumed 
to be a risk factor for lung cancer. Important environmental risk factors include 
exposure to secondary tobacco smoke and radon (Lantz et al., 2013; NRC, 1999; 
Samet et al., 2009).
Conclusions from VAO and Previous Updates
The committee responsible for VAO concluded that there was limited or 
suggestive evidence of an association between exposure to at least one COI and 
lung cancer. Additional information available to the committees responsible for 
subsequent Updates did not change that conclusion.
The most compelling evidence of an association with lung cancer has come 
from studies of heavily exposed occupational cohorts, including British 2-methyl-
4-chlorophenoxyacetic acid (MCPA) production workers (Coggon et al., 1986), 
German production workers (Becher et al., 1996), a BASF cohort (Ott and Zober, 
1996), a NIOSH cohort (Fingerhut et al., 1991; Steenland et al., 1999), and Dan-
ish production workers (Lynge, 1993). The methodologically sound AHS did not 
show any increased risk of lung cancer. Although there was substantial 2,4-D 
exposure in the AHS cohort (Blair et al., 2005b), the dioxin exposure of the 
contemporary farmers was probably negligible. In large part, the environmental 
studies have not been supportive of an association, although in the cancer- 
incidence update from Seveso (Pesatori et al., 2009), the highest risks of lung 
cancer occurred in the most exposed.
In studies of U.S. veterans, a significantly increased risk of lung-cancer risk 
was found in ACC veterans who used herbicides in Vietnam (Cypel and Kang, 
2010; Dalager and Kang, 1997), and an increased risk of lung cancer was associ-
ated with increased serum TCDD concentrations in AFHS Ranch Hand veterans 
(Pavuk et al., 2005). The Australian cohort studies of Vietnam veterans (ADVA, 
2005a,b,c), which presumably cover a large proportion of exposed soldiers, 
showed higher than expected incidence of and mortality from lung cancer. The 
main limitations of the Australian and American ACC studies are that there was 
no assessment of exposure and that some potential confounding variables, notably 
smoking, could not be accounted for. Additionally, the Korean Veterans Health 
Study (Yi, 2013; Yi and Ohrr, 2014; Yi et al., 2014b) found modestly elevated, but 
not statistically significant, relative risks of both lung cancer incidence and mortal-
ity compared with the general population and high- versus low-exposure groups. 
The results were not adjusted for smoking, but earlier self-reported information 
from a large portion of the cohort indicated that smoking behavior did not appear 
related to the extent of a veteran’s exposure to herbicides.
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Despite evidence of an association with lung cancer incidence and mortality 
in the male Vietnam veteran studies, data from the U.S. veteran women showed 
no excess lung cancer mortality in comparison to the U.S. cohort of non-deployed 
women or those from the U.S. general population. Similar results were observed 
also among male Vietnam veterans in New Zealand. Despite their limitations, 
these studies of Vietnam veterans are largely suggestive of modest associations 
between herbicide exposure and lung cancer incidence and mortality.
Update of the Epidemiologic Literature
No new studies of Vietnam veterans (U.S. or international) and lung cancer 
have been identified since Update 2014. No environmental or case-control studies 
of the COIs and lung cancer have been identified since Update 2012. Reviews 
of the relevant studies are presented in the earlier reports. Table 9, which can be 
found at www.nap.edu/catalog/25137, summarizes the results of studies related 
to lung, bronchus, or trachea cancer.
Occupational Studies
Among the Dow Midland, Michigan, worker cohort that was compared with 
the standardized U.S. population, two estimates were presented––all cancers 
of the respiratory system combined (ICD-10 C30–C39) and also a subgroup of 
bronchus, trachea, and lung cancers (ICD-10 C33–C34) (Collins et al., 2016). For 
all cancers of the respiratory system combined, no differences in mortality were 
found for the TCP workers (n = 77; SMR = 0.88, 95% CI 0.69–1.10) or the PCP 
workers (n = 42; SMR = 1.05, 95% CI 0.76–1.42). Likewise, after restricting 
the analysis to the subgroup of bronchus, trachea, and lung cancers, no differ-
ences in mortality was found for the TCP workers (n = 72; SMR = 0.86, 95% CI 
0.67–1.08) or the PCP workers (n = 39; SMR = 1.02, 95% CI 0.73–1.40).
A recent analysis of lung cancer incidence was conducted using data col-
lected from the U.S. AHS (Bonner et al., 2017). The sample included 57,310 
pesticide applicators from Iowa and North Carolina who were enrolled in the 
study between 1993 and 1997; vital status was updated through 2011. Exposure 
was assessed by extensive questionnaire, allowing for estimates of intensity and 
duration of exposure, and the information was updated from 1999 to 2005. In 
the 43 pesticides chosen for assessment of risk, there was considerable variation 
in the risk estimates associated with exposure estimates, with dicamba expo-
sure estimated to be inversely related to lung cancer risk when modeled both 
as quartiles of lifetime days of exposure and as quartiles of intensity-weighted 
lifetime days of exposure and compared with the non-exposed group (p trend 
= 0.007 and 0.001, respectively). Similar results were found for 5-year and 15-
year lagged lifetime-days of dicamba exposure presented as quartiles and again 
compared with no exposure (p trend = 0.001 and < 0.001, respectively). Robust 
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data collection allowed for an adjustment of confounders and common risk fac-
tors, including lag time from first exposure. However, the committee notes that 
the authors did not control for multiple comparisons (although there is some dis-
agreement in the literature concerning such methods), the number of lung cancer 
cases is small, and the exposure data are based only on recall.
In an extension of the follow-up of UK phenoxy herbicide manufacturers 
and sprayers to examine the carcinogenicity of phenoxy herbicides, Coggon et 
al. (2015) reported deaths from lung cancer. Their analyses were not adjusted 
for smoking status, but mortality from lung cancer was not elevated for any of 
the groups of workers: all workers (n = 392; SMR = 1.01, 95% CI 0.91–1.11), 
workers exposed to herbicide levels above background (n = 298; SMR = 1.07, 
95% CI = 0.95–1.20), or workers exposed for more than 1 year at levels above 
background (n = 138; SMR = 1.05, 95% CI 0.88–1.24).
Cappelletti et al. (2016) performed a retrospective study of 331 male electric 
arc foundry workers at a single plant in Trentino, Italy, to determine if they expe-
rienced excess mortality from all causes, all cancers, and specifically respiratory 
cancers or if they experienced increased risk for other morbidities. Their analysis 
of the dust emissions found that the dust contained metals (including iron, alumi-
num, zinc, manganese, lead, chromium, nickel, cadmium, mercury, and arsenic), 
PAHs, PCBs, and PCDD/Fs (reported as TEQs). Therefore, the authors could not 
determine which of the agents were associated with a specific outcome or to what 
extent. The men had worked at the factory for at least 1 year and, for the mortal-
ity analysis, were compared with the standardized general population of Region 
Trentino-Alto Adige (where the factory was located) because there were few non-
exposed foundry workers and high attrition rates. Company and medical records 
were used to determine vital status; the cause of death was determined from death 
certificates or other registries. The workers were followed from March 19, 1979 
(or their first day of employment), through December 31, 2009, or date of death. 
Compared with the general population, workers exposed for more than 1 year 
were at increased risk of mortality from malignant tumors of the larynx, trachea, 
bronchi, and lungs (reported as a group) (n = 8; SMR = 3.35, 95% CI 1.45–6.60, 
p = 0.01). When workers were stratified by the number of years of exposure, there 
were three individuals or fewer in each of the strata, resulting in large and imprecise 
effect estimates, but none was statistically significant. This study is most limited 
by the fact that foundry dust is a complex mixture, which results in an inability to 
discern the impact of the specific contaminants of the foundry dust on the health 
outcomes of those exposed workers. Estimates were only adjusted for age group 
and not adjusted for other risk factors such as tobacco use, BMI, or other jobs or 
activities that could result in similar exposures. Exposure to foundry dust by the 
general population that was used for comparison is not discussed, although the 
foundry appears to be in the local vicinity and emissions from it were reported to 
be present in a 2-kilometer radius of it.
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Other Identified Studies
Two other studies of respiratory cancers were identified. The first lacked suf-
ficient exposure specificity to be included as contributing to the evidence base of 
the potential effect of the COIs (Ruder et al., 2014). The second study (Akahane 
et al., 2017) examined the prevalence of self-reported long-term health effects 
(including lung cancer) in people exposed to PCBs, dioxins (e.g., PCDD/Fs), and 
dioxin-like chemicals through the ingestion of contaminated rice bran oil (Yusho 
accident) compared with an age-, sex- and residential-area-matched group. Be-
cause no TEQs or other quantification of relevant exposures was presented, the 
study was not considered further.
Biologic Plausibility
Long-term animal studies have examined the effect on tumor incidence of 
exposure to each of the COIs: 2,4-D and 2,4,5-T (Charles et al., 1996), TCDD 
(Walker et al., 2006), picloram (Stott et al., 1990), and DMA (Wanibuchi et 
al., 1996, 2004). As noted in previous VAO reports, there is evidence of an in-
creased incidence of squamous-cell carcinoma of the lung in male and female rats 
 exposed to TCDD at high concentrations (Kociba et al., 1978; Van Miller et al., 
1977). A significant increase in neoplastic and non-neoplastic lung lesions was 
found in female rats exposed to TCDD for 2 years (Kociba et al., 1978; NTP, 
1982a,b, 2006; Walker et al., 2006, 2007). The most common non-neoplastic 
lesions were bronchiolar metaplasia and squamous metaplasia of the alveolar 
epithelium. Cystic keratinizing epithelioma was the most commonly observed 
neoplasm. The lung was also identified as a target organ in an NTP tumor- 
promotion study, which examined the presence of tumors after 60 weeks of 
expo sure to TCDD in ovariectomized female Sprague Dawley rats initiated with 
a single dose of diethyl-N-nitrosamine (Beebe et al., 1995; Tritscher et al., 2000). 
Those studies reported increased incidences of alveolar epithelial hyperplasia 
and alveolar–bronchiolar metaplasia—results that were similar to those found 
in the earlier NTP studies (Tritscher et al., 2000). A study with female mice in 
the lung-cancer-sensitive A/J strain background showed that estrogen exposure 
increased lung tumor incidence significantly in ovariectomized mice treated with 
a chemical carcinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), 
known to induce these tumors. However, TCDD exposure did not increase lung 
tumor formation further in these ovariectomized and estrogen-treated mice (R. J. 
Chen et al., 2014a). TCDD by itself had little lung tumor–promoting activity 
in intact female A/J mice, but it exhibited a significant synergistic effect when 
combined with a low dose of NNK. Cell-culture experiments suggested that the 
TCDD effect was via the inhibition of apoptosis (R. J. Chen et al., 2014b). The 
AHR has been implicated in both the chemical induction of lung tumors (Tsay et 
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al., 2013) and the inhibition of their metastasis (Zhang et al., 2012) but has not 
been linked specifically at this time to TCDD or the other COIs.
Cacodylic acid (DMAIII and DMAV) is carcinogenic, but results from studies 
of DMA exposure and lung cancer in laboratory animals have not been consistent. 
In the mouse lung, cacodylic acid (DMAV) was been shown to act as a tumor ini-
tiator (Yamanaka et al., 1996, 2009) and as a tumor promoter (Mizoi et al., 2005). 
DMAV can also act as a complete carcinogen, inducing lung tumors in susceptible 
strains of mice, including those with deficient DNA-repair activity (Hayashi et 
al., 1998; Kinoshita et al., 2007). However, a 2-year study of F344 rats exposed 
to cacodylic acid at 0–100 ppm and B6C3F1 mice exposed at 0–500 ppm failed to 
detect lung neoplasms at any dose (Arnold et al., 2006). 2,4-D causes lung dam-
age, and a recent report provided evidence that this effect occurs via disruption 
of the microtubule network (Ganguli et al., 2014).
Synthesis
Epidemiologic findings for the incidence and mortality of lung, bronchus, 
and trachea cancers have been suggestive of an association with exposure to the 
COIs. The several toxicologic studies of mechanistic activity provide further sup-
port for the conclusion that the evidence of an association is limited or suggestive.
Since Update 2014, four occupational studies have been published. Three 
of them extended the follow-up period of their respective, well-characterized 
cohorts. Consistent with the prior follow-ups of the Dow Midland, Michigan, 
plant workers, TCP workers had a slightly decreased risk of all respiratory 
system cancers combined and also when restricted to only lung, bronchus, and 
trachea cancers, but neither estimate was statistically significant. PCP workers 
had slight but not statistically significant increased risks of all respiratory system 
cancers combined as well as for lung, bronchus, and trachea cancers (Collins et 
al., 2016). Among the UK factory workers or sprayers of phenoxy herbicides 
who have been followed since 1947, Coggon et al. (2015) reported a slightly 
increased, but not statistically significant, risk of lung cancer mortality for all 
groups of workers; however, the analyses were not adjusted for smoking status. 
Although it was a relatively small cohort of male steel workers, Cappelletti 
et al. (2016) found that workers exposed for more than 1 year were at increased 
risk of mortality from malignant tumors of the larynx, trachea, bronchi, and lungs 
compared with the general population of the area. However, neither smoking nor 
residential proximity to the plant was considered in the analysis.
An analysis of lung cancer incidence in the U.S. AHS found that dicamba 
exposure, measured as both lifetime days and years of lag time, showed an in-
verse relationship with lung cancer (Bonner et al., 2017). However, the analysis 
is limited by the small number of lung cancer cases and the fact that exposure 
data are based only on recall.
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Conclusion
On the basis of the evidence reviewed here and in previous VAO reports, the 
committee concludes that there is limited or suggestive evidence of an associa-
tion between exposure to at least one COI and carcinomas of the lung, bronchus, 
and trachea.
BONE AND JOINT CANCERS
Primary bone and joint cancers (ICD-9 170; ICD-10 C40–C41) are relatively 
rare, with an estimated 3,450 new diagnoses and 1,590 expected deaths in the 
United States in 2018 (NCI, n.d.l). Primary bone and joint cancers refer to ma-
lignancies that originate in the bone joint; cancers that metastasize from another 
site are excluded from the discussion. Bone and joint cancers are most commonly 
diag nosed in persons less than 20 years of age, and these cancers are rare in adults, 
including those in the youngest age group of Vietnam veterans (62–70 years). 
Risk factors for bone and joint cancers in adults are gender, ethnicity, genetic and 
familial factors, exposure to ionizing radiation in treatment for other cancers, and a 
history of some non-cancer bone diseases, including Paget disease (Chung and 
Van Hul, 2012; Ottaviani and Jaffe, 2009).
Conclusions from VAO and Previous Updates
The committee responsible for VAO concluded that there was inadequate 
or insufficient information to determine whether there is an association between 
exposure to the COIs and bone and joint cancers. Very few studies of bone and 
joint cancers were conducted in veteran populations, and none found statistically 
significant associations. Additional information available to the update commit-
tees, in general, did not have adequate power or detailed information concerning 
exposures to the COIs to change that conclusion.
Update of the Epidemiologic Literature
Two studies that examined the prevalence of osteosarcoma (Akahane et al., 
2017) and the mortality outcomes of bone and joint cancers (Ruder et al., 2014) 
have been identified since Update 2014. The first study examined the prevalence of a 
variety of self-reported conditions, including osteosarcoma, in Yusho patients (known 
to be exposed to PCBs, PCDD/Fs, and dioxin-like chemicals) and an age-, sex-, 
and residence-matched comparison group. Because TEQs or other quantification of 
relevant exposures were not presented, the study was not considered further. The 
study by Ruder et al. (2014) lacked sufficient exposure specificity to be included as 
contributing to the evidence base of the potential effect of the COIs. No environmen-
tal or case-control studies of exposure to the COIs and bone and joint cancers have 
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been published since Update 2012. Reviews of the relevant studies are presented 
in the earlier reports. Table 10, which can be found at www.nap.edu/catalog/25137, 
summarizes the results of studies related to bone and joint cancers.
Biologic Plausibility
No animal studies have reported an increased incidence of bone and joint 
cancers after exposure to the COIs.
Synthesis
There is a paucity of literature on bone and joint cancers to explain the bio-
logical plausibility or population-level risk from exposure to the COIs. This is 
not surprising, given the low frequency of these tumors in the adult population. 
The newly identified studies (Akahane et al., 2017; Ruder et al., 2014) either 
lacked exposure specificity or a quantification of exposure and, therefore, were 
not considered further by the committee.
Conclusion
Given the absence of new evidence for the current update, the committee 
concurs with prior VAO committees and concludes that there is inadequate or 
insufficient evidence to determine whether there is an association between expo-
sure to at least one COI and bone and joint cancers.
SOFT-TISSUE SARCOMAS
Soft-tissue sarcomas (STSs) (ICD-9 164.1, 171; ICD-10 C38.0, C47, and 
C49) arise within organs and in the tissue between organs, such as fat, muscle, 
nerves, fibrous tissues, blood vessels, or deep skin tissues, and can be found 
in any part of the body. There are more than 50 types of STSs, but the three 
most common types are undifferentiated pleomorphic sarcoma (malignant  fibrous 
 histiocytoma), leiomyosarcoma, and liposarcoma (ACS, 2018a). Because of the 
diverse histological features of STS, accurate diagnosis and classification can be 
difficult. The American Cancer Society estimated that 13,040 new diagnoses of 
STS and 5,150 deaths were expected in the United States in 2018 (ACS, 2018a).
The incidence of STS increases with age. The age-adjusted modeled inci-
dence rate of STS for men 65 years and older for all races combined was 15.4 per 
100,000 for 2000–2014 and increases to 19.9 for men over 75 years. The increase 
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in incidence rate with age is similar for women, but it is not as high as it is for 
men of the same age groups.8
Among the risk factors for STS are exposure to ionizing radiation during 
treatment for other cancers, some inherited genetic conditions (including neuro-
fibromatosis and Li-Fraumeni syndrome), chronic conditions including lymph-
edema and immune deficiency (Kaposi sarcoma), and exposure to chemicals 
such as phenoxyacetic acids (herbicides), and woods preservatives that contained 
chlorophenols (Cormier and Pollock, 2004).
Conclusions from VAO and Previous Updates
The committee responsible for VAO concluded that there was sufficient epi-
demiologic data to support an association between exposure to the COIs and STS. 
Additional information available to the committees responsible for subsequent 
updates has reaffirmed that conclusion.
The available epidemiologic evidence suggests that phenoxy herbicides 
rather than TCDD may be associated with developing STS. Some of the stron-
gest evidence of an association between STS and exposure to phenoxy herbicides 
comes from a series of case-control studies conducted in Sweden (Eriksson et 
al., 1979, 1981, 1990; Hardell and Eriksson, 1988; Hardell and Sandström, 1979; 
Wingren et al., 1990). The studies, involving a total of 506 cases, show an asso-
ciation between STS and exposure to phenoxy herbicides, chlorophenols, or both. 
The VAO committee concluded that although those studies have been criticized, 
there is insufficient justification to discount the consistent pattern of increased 
risks in these well-designed and conducted studies. Furthermore, a reanalysis of 
the data by Hardell (1981) to evaluate the potential influence of recall bias and 
interviewer bias confirmed the original results. Other studies among male Danish 
gardeners (Hansen et al., 2007) and forestry workers (Reif et al., 1989) also sup-
ported the association with STS. Case-control studies evaluating the association 
between phenoxy herbicide and chlorophenol exposure and STS incidence and 
mortality in New Zealand found the risk of STS to be elevated but not statistically 
significant so (A. H. Smith et al., 1983, 1984; Smith and Pearce, 1986). Other 
international case-control studies of STS and the COIs have been conducted in 
England (Balarajan and Acheson, 1984), northern Italy (Vineis et al., 1986), and 
Australia (Smith and Christophers, 1992).
Additional support for an association between exposure to the COIs and STS 
comes from a NIOSH study showing increased risk for STS in those production 
workers who were most highly exposed to TCDD (Fingerhut et al., 1991). Simi-
larly, an increased risk of death 10–19 years after first exposure was seen in the 
8 As calculated on the site https://seer.cancer.gov/faststats/selections.php?#Output by using the 
SEER 18 dataset and choosing age-adjusted rates, soft-tissue sarcoma, all races, age ≥ 65 years, and 
male sex, and using the modeled incidence rate.
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IARC cohort (Kogevinas et al., 1992; Saracci et al., 1991) according to a fairly 
crude exposure classification. An updated and expanded study of the IARC cohort 
by Kogevinas et al. (1997) found risk of STS was not statistically significantly 
increased when follow-up was extended to 1992. The NIOSH and IARC cohorts 
are among the largest and the most highly exposed occupational cohorts. Smaller 
studies of workers that are included in the multinational IARC cohort—Danish 
herbicide manufacturers (Lynge et al., 1985, 1993) and Dow production workers 
in Midland, Michigan (Collins et al., 2009b), and in New Zealand ('t Mannetje et 
al., 2005)—showed an increased risk of STS, but the results were often not sta-
tistically significant, possibly because of the small samples (related to the relative 
rarity of STS in the population). Several studies have reported on STS in relation 
to living near waste incinerators that release dioxin as a contaminant; each of 
those studies found a statistically significant excess of STS, but none showed any 
objective evidence of human exposure. No cases of STS have been reported in 
zones A (highest exposure) and B (intermediate exposure) in the Seveso cohort 
(Consonni et al., 2008); the incidence of STS was slightly, but not significantly, 
increased in Zone R (lowest exposure) (Pesatori et al., 2009).
Case-control studies have also been conducted in various U.S. populations 
looking for associations of herbicides with STS and other lymphohematopoietic 
cancers (Hoar et al., 1986; Woods and Polissar, 1989; Woods et al., 1987) but no 
statistically significant associations were reported for STS. Case-control studies 
conducted among international populations have, for the most part, reported null 
associations.
Studies of Vietnam veterans have not found significant increases in STS. 
No increase was seen in Ranch Hand veterans (AFHS, 1996, 2000; Michalek 
et al., 1990) or in VA studies of U.S. Vietnam veterans (Breslin et al., 1986, 
1988; Bullman et al., 1990; Watanabe and Kang, 1995; Watanabe et al., 1991). 
A nonstatistically significant increase in mortality from STS was seen in state 
studies of veterans in Massachusetts, Michigan, and New York. A slight increase 
in the incidence of STS was seen in Australian Air Force veterans compared with 
the general Australian population but not in Army or Navy personnel (ADVA, 
2005a), and no increase in mortality was seen in Australian veterans who served 
in any of the military branches (ADVA, 2005b). No differences in incidence of or 
mortality from connective and soft-tissue cancers was found in the New Zealand 
veteran cohort (McBride et al., 2013), nor among the Korean veteran cohort (Yi 
and Ohrr, 2014).
Update of the Epidemiologic Literature
No studies of Vietnam veterans or environmental studies of the COIs and 
STS have been identified since Update 2014. Reviews of the relevant studies are 
presented in the earlier reports. Table 11, which can be found at www.nap.edu/
catalog/25137, summarizes the results of studies related to STS.
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Occupational Studies
Among the Dow Midland, Michigan, worker cohort that was compared with 
the standardized U.S. population (Collins et al., 2016), few deaths from STSs 
were reported (four among TCP workers and one among PCP workers), and risk 
estimates for the total worker population were imprecise (SMR = 2.31, 95% CI 
0.63–5.91). When examined by the specific dioxin congener and exposure level, 
an increased risk for STS was found with increasing exposure level of TCDD, 
but the test for trend was not statistically significant (p = 0.32). None of the 
individual exposure-level risk estimates reached statistical significance, and all 
estimates were imprecise. The one caveat the authors present is that they knew 
that one of the four deaths at the highest exposure level of TCDD was determined 
to be misclassified and, in fact, was not an STS. Because this determination was 
discovered during the pathology review of an earlier study and the rest of the 
cases in this study were not reviewed, this finding was ignored, and the death 
was counted as an STS death. The authors concluded that any increased risk of 
STS with TCDD should be interpreted with caution, given the small numbers of 
cases of STS and the uncertainty of the diagnosis.
In an extension of the follow-up of UK phenoxy herbicide manufacturers and 
sprayers to examine the carcinogenicity of phenoxy herbicides and their associa-
tion primarily with HL, STS, and chronic lymphocytic leukemia, Coggon et al. 
(2015) reported four cases of STS among all the workers. The highest risk esti-
mate for STS was in workers with exposure above background and for more than 
1 year (n = 3; SMR = 2.05, 95% CI 0.42–5.98), while the effect for all  workers 
regardless of the extent and duration of exposure was less than 1.0 (n = 4; SMR 
= 0.92, 95% CI 0.25–2.36). Neither estimate was statistically significant, and 
both were imprecise. A nested case-control analysis was performed within the 
cohort that showed a protective effect for workers exposed to above background 
levels for less than 1 year (OR = 0.77, 95% CI 0.17–3.50) but an increased risk 
for workers exposed above background for more than 1 year (OR = 1.30, 95% 
CI 0.30–5.62), but again both estimates were imprecise. Stratifying the  workers 
with above-background levels into low- and high-exposure groups resulted in 
decreased and imprecise risk estimates (OR = 0.79, 95% CI 0.16–3.89 and 
OR = 0.95, 95% CI 0.19–4.88, respectively). No clear link between phenoxy 
herbicides and STS was observed in this study. The authors concluded that if 
there is an association, it is very small, and it is unlikely that phenoxy herbicides 
were responsible for the increased risk of STS.
Case-Control Studies
In a Finnish study, Tuomisto et al. (2017) compared the odds ratios for STS 
calculated from survey data versus tissue TEQs for dioxin congeners. Previously, 
the authors had performed a prospective study in which patients undergoing 
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STS surgery or appendectomy (no cancer) consented to have a subcutaneous 
fat sample taken at the time of surgery. Fat samples were tested for 17 PCDD/F 
congeners. All participants filled out a survey regarding exposure history to wood 
preservatives, fungicides and herbicides, and insecticides. The data were col-
lected prospectively, and this analysis included 87 STS patients age-matched to 
308 controls who underwent an appendectomy. When exposure information from 
questionnaires was used to compute effect estimates, wood preservatives (n = 8; 
OR = 6.7, 95% CI 1.4–33), fungicides and herbicides (n = 7; OR = 16.0, 95% 
CI 1.9–138), and reported exposure to any of the chemical groups (n =15; OR = 
7.0, 95% CI 2.2–22) were statistically significant but not precise. However, when 
the exposure assessment was based on the actual levels of PCDD/Fs in the same 
patients, none of the classes of chemicals were statistically significantly associ-
ated with STS. One reason for the differences between the survey results and 
the objective measures in the fat samples may be that cancer patients are more 
prone to recall bias than controls. A second factor for the difference in results 
between questionnaires and tissue samples may be that the risk for STS is not the 
contaminant dioxin, but rather the primary chemical exposure. Dioxin is poorly 
absorbed and, in order to accumulate a high level, an individual is also likely to 
have accumulated a high level of the primary chemical, which perhaps is more 
likely to be the real carcinogen. The authors concluded that the number of cases 
of STS was so low that it is unlikely that chlorophenols or phenoxy herbicides 
were major risk factors for STS. While this study contradicts the earlier literature 
supporting an association between exposure to the COIs and STS (Eriksson et 
al., 1981, 1990; Hardell and Eriksson, 1988; Hardell and Sandström, 1979), it 
has too few cases of STS to reverse the previous VAO committees’ conclusions. 
This study does, however, demonstrate the strength of using tissue levels versus 
questionnaires to overcome recall bias among cancer patients.
Other Identified Studies
One other study that reported on mortality of STSs was identified, but it 
lacked sufficient exposure specificity to be included as contributing to the evi-
dence base of the potential effect of the COIs (Ruder et al., 2014).
Biologic Plausibility
In a 2-year study, dermal application of TCDD to Swiss-Webster mice led 
to an increase in fibrosarcomas in females but not in males (NTP, 1982b). There 
is some concern that the increase in fibrosarcomas may be associated with the 
treatment protocol rather than with TCDD. The NTP gavage study (NTP, 1982a) 
also found an increased incidence of fibrosarcomas in male and female rats and 
in female mice. No new mechanistic or biologic plausibility studies on STS have 
been identified by VAO committees.
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Synthesis
Previous committees have concluded that the occupational, environmental, 
and Vietnam-veteran studies showed sufficient evidence to link herbicide expo-
sure to STS. Mechanistic data from animal studies continue to be sparse and not 
compelling. Two new occupational studies that extended the follow-up period 
of established cohorts (Coggon et al., 2015; Collins et al., 2016) reported small 
numbers of STS cases and imprecise risk estimates, which do not provide enough 
evidence to refute the previous conclusion that there are sufficient data to link 
STS with one of the COIs. The findings from Tuomisto et al. (2017), which show 
sizable differences in risk estimates when using questionnaires versus tissue 
levels to determine exposure to the COIs, raise important methodological issues 
for future studies.
STS is a rare tumor that is frequently misclassified. In a small study, even a 
single death can have a large impact on effect estimates. The findings from the 
three studies reviewed for the current update are not as supportive of an associa-
tion between STS and the COIs. This may be due to flaws in design in earlier 
studies, or it may reflect the possibility that the risk for this malignancy occurs 
within a shorter latency period than other malignancies. Therefore, the conclusion 
of sufficient evidence of an association between exposure to at least one of the 
COIs and STS remains unchanged.
Conclusion
On the basis of the evidence reviewed here and in previous VAO reports, the 
committee concludes that there is sufficient evidence of an association between 
exposure to at least one of the COIs and STS.
SKIN CANCERS
Skin cancers are generally divided into two broad categories: malignant 
melanoma (or simply melanoma) and non-melanoma skin cancers. The two most 
common non-melanoma skin cancers are squamous-cell carcinomas, which are 
derived from the squamous epithelium, and basal-cell carcinomas, which are de-
rived from stem cells. Melanomas are derived from melanocytes. Non-melanoma 
skin cancers have a far higher incidence than melanoma but are less likely to 
metastasize and are more easily cured with primary resection.
The committee responsible for Update 1998 first chose to address melanoma 
studies separately from those of non-melanoma skin cancers. Some researchers 
report results by combining all types of skin cancers without specifying type. 
Although there is a general supposition that high mortality figures refer pre-
dominantly to melanoma and high-incidence figures refer to non-melanoma skin 
cancers, the committee believes that combined information is not interpretable, 
Veterans and Agent Orange: Update 11 (2018)
Copyright National Academy of Sciences. All rights reserved.
CANCER 271
and therefore, it is interpreting data only when the results specify melanoma or 
non-melanoma skin cancers.
Melanoma
Melanoma is the fifth most commonly diagnosed cancer; with an estimated 
91,270 new diagnoses (ICD-9 172; ICD-10 C43) expected in the United States in 
2018 accounting for 5.3% of all new cancer diagnoses. It is estimated that 9,320 
people will die from melanoma in 2018 (NCI, n.d.m). Because non-melanoma 
skin cancers are not required to be reported to registries, the estimated number of 
cases is not as precise as those of other cancers. Although melanoma accounts for 
less than 5% of skin cancer cases, it is responsible for about 75% of skin cancer 
deaths (Siegel et al., 2017). The incidence of melanoma is higher in men than 
in women and increases with age. The age-adjusted modeled incidence rate of 
melanoma for men 50–64 years old of all races combined was 47.5 per 100,000 
for 2000–2014 and increased to 118.3 for 65–74 year olds and 184.7 for men over 
75 years. The increasing incidence rate with age is similar for women, though not 
as high as it is for men of the same age groups.9
Melanoma occurs more frequently in fair-skinned people than in dark-
skinned people; the risk in whites is roughly 20 times higher than it is in blacks. 
Other risk factors include the presence of large numbers of moles (> 50) or dys-
plastic nevi (also called atypical moles), having a suppressed immune system, 
and excessive exposure to ultraviolet (UV) radiation, typically from the sun but 
also from artificial sources, such as tanning beds. A family history of the disease 
has been identified as a risk factor, but it is unclear whether that is attributable to 
genetic factors or to similarities in skin type and sun-exposure patterns (Rastrelli 
et al., 2014). There is a genetic predisposition to melanoma, known as BK Mole 
syndrome (also called familial atypical multiple mole melanoma syndrome), 
which is characterized by a mutation in the CDKN2A gene. In addition to the 
dermal forms of melanoma, these tumors occur much more infrequently in vari-
ous tissues of the eye.
Conclusions from VAO and Previous Update
The committee responsible for VAO concluded that there was inadequate 
or insufficient information to determine whether there is an association between 
expo sure to the COIs and skin cancers. The Update 1998 committee considered 
the literature on melanoma separately from that of non-melanoma skin cancers 
and found that there was inadequate or insufficient information to determine 
9 Modeled incidence rate as calculated on the site https://seer.cancer.gov/faststats/selections.
php?#Output using SEER 18 dataset and by choosing age-adjusted rates, melanoma of the skin, all 
races, age ≥ 50 years, and male sex.
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whether there is an association between the COIs and melanoma. Additional 
evidence reviewed by update committees has not changed the conclusion.
Few studies of melanoma among veteran populations have been conducted. 
In a comparison of cause-specific mortality between the deployed and the non-
deployed veterans who served in the U.S. ACC, a moderate but not statistically 
significant increase in the risk of malignant skin cancer was observed in the 
deployed cohort (Cypel and Kang, 2010). Few cases of melanoma were reported 
among the AFHS participants, and when stratified by serum TCDD exposure 
level, the risk estimates were elevated but imprecise and not statistically sig-
nificant (Pavuk et al., 2005). An analysis using quartiles of years of service in 
Southeast Asia also failed to find an association with melanoma among Ranch 
Hands (Akhtar et al., 2004). Data from the final AFHS examination cycle indicate 
that many more melanoma cases were diagnosed in the comparison veterans than 
in the Ranch Hand subjects. Consequently, the committee responsible for Update 
2006 (the report in which these studies were reviewed) recommended that a uni-
form TCDD-based analysis be performed on the on the most recent melanoma 
data for all subjects in the AFHS (Pavuk, 2005). These data would possibly 
support or contradict the suggestive findings of the Ranch Hand cohort (Akhtar, 
2004). Such a comprehensive analysis of the most current melanoma data from 
the AFHS has not yet been published.
In a study of 2,783 New Zealand veterans who served in Vietnam, both 
melanoma mortality and incidence risk estimates were less than 1.0 but neither 
was statistically significant (McBride et al., 2013). Likewise, findings from the 
Korean Veterans Health Study showed that the incidence of melanoma in high-
exposed veterans was lower, but not to the point of statistical significance, than in 
the low-exposed group, based on the calculated EOI scores (Yi and Ohrr, 2014). 
No statistically significant difference was observed for melanoma mortality be-
tween high- and low-exposed groups.
Studies of mortality from melanoma related to occupational exposures have 
also been reviewed. In TCP workers in New Zealand (McBride et al., 2009a) and 
in the Dow cohort in Midland, Michigan (Collins et al., 2009b), no evidence of an 
association between the COIs and melanoma was found. In evaluating the use of 
specific pesticides and melanoma in the AHS, Dennis et al. (2010) found that only 
an exposure to arsenic-based pesticides, among the COIs, was correlated with any 
increase in risk, which was weak and not statistically significant. Updates of cancer 
incidence in the Seveso cohort for the period 1977–1996 (Pesatori et al., 2009) 
continued to provide evidence that melanoma is associated with exposure to TCDD.
Update of the Epidemiologic Literature
No new studies of Vietnam veterans (U.S. or international) and melanoma 
or environmental studies of melanoma and the COIs have been identified since 
Update 2014. Reviews of the relevant studies are presented in the earlier reports. 
Veterans and Agent Orange: Update 11 (2018)
Copyright National Academy of Sciences. All rights reserved.
CANCER 273
Table 12, which can be found at www.nap.edu/catalog/25137, summarizes the 
results of studies related to melanoma.
Occupational Studies Among the Dow Midland, Michigan, worker cohort that 
was compared with the standardized U.S. population, Collins et al. (2016) found 
only two deaths from malignant melanoma during the follow-up period. Although 
the calculated estimate showed decreased risk, because of the few cases it is 
unreliable and imprecise (SMR = 0.36, 95% CI 0.04–1.30), and no conclusions 
should be made based on this finding.
In an extension of the follow-up of UK phenoxy herbicide manufacturers 
and sprayers to examine the carcinogenicity of phenoxy herbicides, Coggon et 
al. (2015) reported a total of seven deaths from melanoma among all the work-
ers. Melanoma mortality was lower than expected for each of the three groups 
of workers presented, but no estimates were statistically significant: all workers 
(n = 7; SMR = 0.66, 95% CI 0.26–1.35), workers exposed to herbicide levels 
above background (n = 6; SMR = 0.73, 95% CI 0.27–1.59), or workers exposed 
for more than 1 year at levels above background (n = 2; SMR = 0.55, 95% CI 
0.07–2.00). This study does not support an association between pheonxy herbi-
cide exposure and melanoma.
Other Identified Studies Three other studies were identified that reported on 
the outcomes of melanoma or skin cancer. The first was a mortality study of an 
occupational cohort of capacitor manufacturers exposed to mixed PCBs as well 
as several other chemicals and metals; this study lacked sufficient exposure speci-
ficity to be included as contributing to the evidence base of the potential effect 
of the COIs and melanoma (Ruder et al., 2014). The second study was a well-
designed case-control study to examine the association of pesticide use and the 
risk of cutaneous melanoma in Brazil (Segatto et al., 2015). Although a validated 
structured questionnaire was used to collect detailed information on exposure fac-
tors (including domestic and occupational exposures to pesticides and herbicides, 
frequency, types, and commercial names), only 3.5% of pesticide exposures 
were to organochlorines, which were not specified further, and a small number 
of participants (7 cases and 3 controls) reported exposure to herbicides, for 
which an effect estimate was not provided. A third study (Akahane et al., 2017) 
examined the prevalence of self-reported long-term health effects, including 
skin cancer without further differentiation, in people exposed to PCBs,  dioxins 
(e.g., PCDD/Fs), and dioxin-like chemicals through ingestion of contaminated 
rice bran oil (Yusho accident) compared with an age-, sex- and residential-area-
matched group. Because no TEQs or other quantification of relevant exposures 
was presented, the study was not considered further.
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Biologic Plausibility
TCDD and related herbicides have not been found to cause melanoma in 
animal models. IARC considers DMA to be a Group 2B compound indicating 
that it is possibly carcinogenic to humans (IARC, 2012a). In general, rodents, 
which are used in most toxicology studies, are not a good model for studying 
melanoma. As discussed elsewhere in this chapter, TCDD and DMA are known 
tumor  promoters and could act as a promoter for skin cancer initiators, such as 
UV radiation (Morikawa et al., 2005). Ikuta et al. (2009) examined the physi-
ologic role of the AHR in human skin and theorized that over-activation can lead 
to skin cancers, but they provided no evidence that melanoma incidence is 
increased after TCDD exposure. Ahr has been shown to mediate UVB-induced 
skin tanning in a  murine model through an action on melanocytes (Jux et al., 
2011), which suggests that TCDD may affect skin pigmentation and potentiate 
other pathways in the developmet of melanoma. Studies of human cells have also 
confirmed a role of the AHR in the regulation of keratinocytes and melanocytes. 
Kalmes et al. (2011) showed that AHR signaling in immortalized HaCaT cells 
is associated with cell-cycle progression. Borland et al. (2014) found that per-
oxisome proliferator-activated receptor beta/delta is involved in AHR-mediated 
tumorigenic activity in keratinocytes. In human melanocytes, Luecke et al. (2010) 
demonstrated that TCDD exposure induced tyrosinase and tyrosinase-related 
protein 2 gene expression—an indication that AHR signaling after TCDD expo-
sure modulates melanogenesis. O’Donnell et al. (2012) further showed that the 
activity of AHR was associated with the proliferation of melanoma cells. Finally, 
a study of a Han Chinese population (X. W. Wang et al., 2012) has shown that 
normal genetic variants of AHR are associated with the occurrence of vitiligo. 
Studies reviewed here strongly suggest that AHR is associated with melanocyte 
function and number in humans.
Synthesis
No association between the COIs and melanoma was observed in occupa-
tional studies that extended the follow-up period for their cohorts of interest 
(Coggon et al., 2015; Collins et al., 2016). For both studies, the total number of 
melanoma deaths in each cohort was less than five, leading to imprecise effect 
esti mates. Mechanistic data from animal studies are sparse and have not found 
asso ciations between the COIs and melanoma. As such, the committee maintains 
the previous conclusion of inadequate or insufficient evidence to determine whether 
there is an association between exposure to any one of the COIs and melanoma.
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Conclusion
On the basis of the evidence reviewed here and in previous VAO reports, 
the committee concludes that there is inadequate or insufficient evidence to 
determine whether there is an association between exposure to the COIs and 
melanoma (dermal or ocular).
Basal-Cell and Squamous-Cell Cancers (Non-Melanoma Skin Cancers)
Basal- and squamous-cell skin cancers are the most common type of cancer, 
with an estimated 5.4 million basal and squamous cell skin cancers diagnosed 
each year (occurring in about 3.3 million Americans since some people have 
more than one). About 80% of these are basal-cell cancers. The incidence of these 
cancers has been increasing for several years, and some possible explanations for 
the increase are better skin cancer detection, people getting more sun exposure, 
and people living longer (ACS, 2018b).
Excessive exposure to UV radiation is the most important risk factor for non-
melanoma skin cancers (ICD-9 173; ICD-10 C44); radiation exposure, HPV, im-
mune suppression, and a family history of non-melanoma skin cancers have also 
been identified as potential risk factors (Dubas and Ingraffea, 2013). Although 
exposure to inorganic arsenic is recognized as a risk factor for non-melanoma 
skin cancers (Bailey et al., 2010; Gilbert-Diamond et al., 2013), this does not 
imply that exposure to cacodylic acid (DMA), which is a metabolite of inorganic 
arsenic, can be assumed to be a risk factor. The relevance of aresenicals and DMA 
to the committee’s charge are discussed in Chapter 4.
Conclusions from VAO and Previous Updates
Until Update 1998, all skin cancers were considered together, and the evi-
dence of an association between the COIs and skin cancers was determined to 
be inadequate or insufficient. Update 1998 and all subsequent updates through 
Update 2014 concluded that there was inadequate or insufficient information, 
based on new evidence of studies of veterans, occupational cohorts, and case-
control studies, to determine whether there is an association between exposure 
to the COIs and basal-cell or squamous-cell cancers.
Update of the Epidemiologic Literature
Since Update 2014, no additional environmental or case-control studies of 
non-melanoma skin cancers and exposure to the COIs have been published. Re-
views of the relevant studies are presented in the earlier reports. Table 13, which 
can be found at www.nap.edu/catalog/25137, summarizes the results of studies 
related to non-melanoma skin cancers.
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Vietnam-Veteran Studies Nosrati et al. (2014) performed a retrospective 
 medical chart review of 1,499 non-melanoma skin lesions from 1,024 patients 
seen at a VA medical center from 2003 to 2013 in order to determine the rates 
of spontaneous regression of residual tumor left behind after biopsy. In patients 
with positive margins, the absence of tumor tissue in the re-resection sample 
implies spontaneous regression. The authors hypothesized that Agent Orange–
induced  tumors would behave more aggressively and be less likely to undergo 
spontaneous regression. Agent Orange exposure was determined by participa-
tion in the Agent Orange Registry (n = 100). The overall regression rates for all 
non- melanoma subtypes was 43% for the Agent Orange exposed and 41% for 
unexposed; there was no difference between groups (p = 0.28).
Occupational Studies In an extension of the follow-up of UK phenoxy her-
bicide manufacturers and sprayers to examine the carcinogenicity of phenoxy 
herbicides, Coggon et al. (2015) reported four deaths from “other skin” (not 
melanoma) cancers among all the workers (SMR = 1.15, 95% CI 0.31–2.93). Two 
deaths were reported among workers exposed to herbicide levels above back-
ground (SMR = 0.81, 95% CI 0.10–2.91), and no deaths were reported among 
workers exposed for more than 1 year at levels above background. Because of 
the small number of deaths, the effect estimates are imprecise, which limits their 
interpretation. This study does not support an association between pheonxy her-
bicide exposure and non-melanoma/other skin cancer.
Other Identified Studies One other study that reported on the mortality of non-
melanoma skin cancers was identified, but it lacked sufficient exposure specificity 
to be included as contributing to the evidence base of the potential effect of the 
COIs (Ruder et al., 2014).
Biologic Plausibility
There are no new studies on animal models of skin cancers that are relevant 
to this update. TCDD and DMA have been shown to produce non-melanoma 
skin cancers in animal models (Morikawa et al., 2000; Wyde et al., 2004). As 
discussed elsewhere in this chapter, TCDD and DMA are known tumor promoters 
and each could act as a promoter for skin cancer initiators, such as UV radiation.
Synthesis
The two new studies of non-melanoma skin cancer do not support any 
change in the conclusion of inadequate or insufficient evidence to determine 
whether an association with exposure to at least one of the COIs exists. In the 
study of veterans seen at a VA medical center, exposure was based on self-report 
and participation in the Agent Orange Registry (Nosrati et al., 2014). Tumors 
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among the Agent Orange–exposed participants were not more aggressive or less 
likely to undergo spontaneous regression than those in the unexposed group. In a 
study extending the follow-up period of UK men who worked in factories manu-
facturing or formulating a variety of phenoxy herbicides or who were contract 
workers spraying the compounds, Coggon et al. (2015) reported small numbers 
of non-melanoma skin cancer deaths (n = 4) among all workers, yielding unstable 
and imprecise risk estimates that do not support an association between pheonxy 
herbicide exposure and non-melanoma skin cancer. Although TCDD has been 
previously shown to produce non-melanoma skin cancers in animal models 
(Wyde et al., 2004), no new studies on animal models of skin cancers have been 
published.
Conclusion
On the basis of the evidence reviewed here and in previous VAO reports, the 
committee concludes that there is inadequate or insufficient evidence to deter-
mine whether there is an association between exposure to the COIs and basal-cell 
or squamous-cell skin cancers.
BREAST CANCER
Breast cancer (ICD-9 174 for females, ICD-9 175 for males; ICD-10 C50 
for both males and females) is the second most common type of cancer (after 
non-melanoma skin cancers) in women in the United States (ACS, 2018c). For 
2018, NCI estimated that in the United States, there would be 266,120 incident 
cases of breast cancer and 40,920 deaths from it (NCI, n.d.n). Overall, those 
numbers represent 15% of all new cancer diagnoses and 6.8% of all cancer 
deaths. Breast cancer in men is much less common; the American Cancer 
 Society estimated that in 2018 in the United States, there would be 2,550 inci-
dent cases of and 480 deaths from breast cancer in men (ACS, 2018d).
Breast cancer incidence generally increases with age; the median age of diag-
nosis is 62 years for females. In the age groups of most Vietnam veterans, the 
incidence in men is higher in blacks than in whites, while in women the incidence 
is generally higher in whites than blacks (NCI, n.d.n). The age-adjusted modeled 
incidence rate of breast cancers for women 50–64 years old of all races combined 
was 265.5 per 100,000 for 2000–2014 and increased to 448.6 for 65- to 74-year-
olds and drops to 412.1 for women over 75 years.10 The roughly 5,000–8,000 
female Vietnam veterans who were potentially exposed to herbicides in Vietnam 
would now be menopausal. Given the high incidence of breast cancer in older and 
10 As calculated on the site https://seer.cancer.gov/faststats/selections.php?#Output by using the 
SEER 18 dataset, and choosing age-adjusted rates, breast cancer, female, all races, and the appropri-
ate age range.
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postmenopausal women in general, it is expected on the basis of demographics 
alone that the breast cancer burden in female Vietnam veterans will be increasing 
in the near future.
The age-adjusted modeled incidence of breast cancers for men 65 years and 
older for all races combined was 6.4 per 100,000 for 2000–2014.11 Breast cancer 
incidence in men has increased over the past 30 years (Kamićska et al., 2015). 
However, as the majority of breast cancer epidemiologic studies involve women, 
although instances of male breast cancer are noted below when they have been 
reported, the committee’s conclusions are based on the studies in women.
Established risk factors for women other than age include a personal or 
family history of breast cancer, alcohol consumption, and some characteristics 
of reproductive history, specifically early menarche, late onset of menopause, 
and either no pregnancies or a first full-term pregnancy after the age of 30 years 
(Kamićska et al., 2015). In a meta-analysis of studies on alcohol consumption and 
female breast cancer, Corrao et al. (2004) reported that, in comparison to those 
who never drank, light drinkers (≤ 1 drink/day or 12.5 g/day) had an elevated 
pooled relative risk (RR = 1.25, 95% CI 1.20–1.29), and the risk was markedly 
increased (RR = 1.55, 95% CI 1.44–1.67) for heavy drinkers (≥ 4 drinks/day or 
50 g/day). Other post-menopausal lifestyle risk factors for breast cancer include 
high BMI/obesity and physical inactivity. In addition, breast cancer risk is in-
creased by the prolonged use of hormone-replacement therapy, particularly prepa-
rations that combine estrogen and progestins, whereas estrogen-only therapy 
(only applied in women without a uterus) slightly decreased the risk (Anderson 
et al., 2004; Chlebowski et al., 2003). The potential of other personal behavioral 
and environmental factors (including the use of exogenous hormones) to affect 
breast cancer risk is being studied extensively.
Conclusions from VAO and Previous Updates
The committee responsible for VAO concluded that there was inadequate 
or insufficient information to determine whether there is an association between 
exposure to the COIs and breast cancer. The additional information available to 
the committees through Update 2014 did not change that conclusion. Several 
studies with positive, but mostly not statistically significant, findings in differ-
ent populations and with different COI exposures have since been reviewed (for 
example, updates from the Seveso Women’s Health Study, women employed at 
an insecticide/herbicide plant in Hamburg, Dow’s Michigan plant cohort, the 
NIOSH PCP cohort). However, due to the null findings on mortality from breast 
cancer in the important cohorts of female Vietnam-era veterans (Cypel and Kang, 
11 As calculated on the site https://seer.cancer.gov/faststats/selections.php?#Output by choosing 
incidence by cancer site for the SEER 18 dataset and using age-adjusted rates, breast cancer, all races, 
male sex, and selecting 65 years and older. 
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2008; Dalager et al., 1995a; H. K. Kang et al., 2000b, 2014a; Thomas et al., 1991) 
as well as other U.S. and foreign cohorts of male Vietnam veterans (ADVA, 
2005b,c; CDVA, 1997; Yi and Ohrr, 2014) and the inconsistent findings of risk in 
studies of the incidence of breast cancer in several occupational cohorts and the 
Seveso study, the committees have maintained that breast cancer should remain 
in the category of inadequate or insufficient evidence to determine whether there 
is an association.
Update of the Epidemiologic Literature
No studies of breast cancer among Vietnam veterans or occupational cohorts 
of exposure to the COIs and breast cancer have been published since Update 
2014. Reviews of the relevant studies are presented in the earlier reports. Table 
14, which can be found at www.nap.edu/catalog/25137, summarizes the results 
of studies related to breast cancer.
Environmental Studies
Morgan et al. (2017) used 1999–2004 NHANES data to examine the asso-
ciation between breast cancer and environmental exposure to PCBs, bisphenol 
A (BPA), and phthalates. The study sample included women, ages 20–85 years, 
who participated in NHANES by completing questionnaires and for whom data 
were available on serum concentrations of PCBs and urinary phthalate and BPA. 
Cases were defined as women who self-reported breast cancer, and controls were 
chosen as those who had specifically responded that they did not have breast 
cancer. The women were grouped by age for analysis (20–59 years, 60–74 years, 
and 75 years and above). Serum levels of PCBs 74, 99, 118, 138, 153, and 180 
were measured, as were the sums of dioxin-like PCBs (PCBs 74 and 118) and 
non-dioxin-like PCBs for 2,007 women. Urinary BPA and seven urinary  phthalate 
metabolites were also analyzed (but the information is not presented, as these 
chemicals are not related to the COIs). Concentrations of all individual PCBs and 
sums of PCBs increased with age. When cases were compared with controls, the 
age-adjusted geometric means for individual PCB concentrations were signifi-
cantly higher in cases for the non-dioxin-like PCBs only. When stratified by age 
groups, non-dioxin-like PCBs were significantly higher in cases versus controls 
only for the 20- to 59-year age group. When examined by ethnic background, 
the women with breast cancer who identified race as “other” had significantly 
higher levels of all PCBs (including the dioxin-like PCBs) except PCB 180 in 
comparison to non-Hispanic whites with breast cancer, with a geometric mean 
(standard deviation) for PCB 74 of 27.4 (1.05) versus 13.5 (1.07), p < 0.05; and 
for PCB 118 of 32.8 (1.01) versus 16.4 (1.21), p < 0.05. To further examine the 
relationship of PCB concentration and breast cancer, cases and controls were 
divided into two groups, PCB levels ranging from below the limits of detection 
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to the 50th percentile (reference) and those above the 50th percentile (no cases 
had PCB concentrations below the limits of detection). The geometric means of 
the PCB concentrations were significantly higher in cases versus controls for all 
PCBs, but when this model was adjusted for age, BMI, race/ethnicity, lactation, 
and age of menarche, the concentrations of non-dioxin-like PCBs 138 and 180 
were imprecise, but significantly associated with breast cancer. For comparisons 
of the dioxin-like PCBs above the 50th percentile versus the reference, after full 
adjustment in the model, neither PCB 74 (OR = 2.64, 95% CI 0.59–12.0) or PCB 
118 (OR = 2.01, 95% CI 0.48–8.44) or their sum (OR = 1.58, 95% CI 0.29–8.53) 
was statistically significantly associated with breast cancer. The authors then per-
formed an analysis using the same reference group of women with PCB levels 
from below the limits of detection to the 50th percentile (reference) and compar-
ing them with two groups of higher PCB exposure: those between 50th and 75th 
percentile and those above the 75th percentile. This model included adjuments for 
age, BMI, and race/ethnicity, and only non-dioxin-like PCB 138 was significantly 
associated with breast cancer in the 50th to 75th percentile (OR = 2.93, 95% CI 
1.04–8.26) and the above 75th percentile groups (OR = 3.43, 95% CI 1.13-10.4). 
For the dioxin-like PCBs, neither the 50th to 75th nor the above 75th percentiles 
were statistically significant for PCB 74 (OR = 1.79, 95% CI 0.20–10.8 and OR = 
1.65, 95% CI 0.24–11.4, respectively) or PCB 118 (OR = 1.27, 95% CI 0.21–7.79 
and OR = 1.45, 95% CI 0.26–7.92, respectively). Likewise when the dioxin-like 
PCBs were summed and entered into the fully adjusted model, no statistically 
significant associations were found. Thus, in adjusted models that account for 
known risk factors for breast cancer, dioxin-like PCB were not associated with 
increased risk.
Danjou et al. (2015) reported findings from a prospective study of dioxin 
exposure through dietary intake and risk of breast cancer using a subset of women 
who participated in the French E3N study. Women in the E3N study were born 
between 1925 and 1950 and, when enrollment began in 1990, were members of a 
national teachers’ health insurance plan. Participants completed a dietary survey 
in 1993 and were followed through 2008, with additional questionnaires on life-
style, health status, and medical history completed every 2–3 years. The current 
analysis was limited to 63,830 women who did not have a cancer diagnosis (ex-
cept non-melanoma skin cancer) and for whom follow-up data were available (in-
cluding height and weight). Women who had never menstruated were excluded. 
The occurrence of breast cancer was ascertained by self-report from the health 
questionnaires, but 92% of cases were confirmed by pathology reports. The study 
team used the dietary questionnaires to calculate the amount and the frequency of 
various food groups (meat, seafood, fruits and vegetables, eggs, dairy) consumed 
by the individual women, and then dioxin levels in various foods were estimated 
using a database from a large public health study that had measured dioxin levels 
in various foods during a time period similar to that of the E3N study. During the 
14.9 years of follow-up, there were 3,465 incident cases of breast cancer. The 
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average daily dioxin exposure was 1.3+/− 0.4 pg TEQ/kg of bodyweight per day 
(range 0.1–5.7), which is below the acceptable WHO level of 2.3 pg TEQ/kg 
of bodyweight per day. Only 2.7% of the women in the study had higher levels 
of exposure. Hazard ratios were calculated for pre- and post-menopausal breast 
cancer risk per increased intake of 0.43 pg/kg/day (one standard deviation) and 
per quartiles of estimated dietary dioxin exposure. No increased risk of breast 
cancer was found. After adjusting for multiple factors, a decreased HR was found 
for all types of breast cancer in postmenopausal women at the highest quartile 
of exposure (HR = 0.77, 95% CI 0.54–1.06). For post-menopausal women in the 
highest quartile of exposure, the HR for ER+/PR+ (estrogen and progesterone 
receptor positive) tumors, corrected for multiple risk factors, was again decreased 
(HR = 0.91, 95% CI 0.75–1.10). Moreover, among postmenopausal women there 
was an inverse relationship between dioxin exposure and ER-/PR- breast cancer. 
This finding is not unique and has been reported by others. Signaling through 
AHR may have an antiproliferative effect, or the effect may depend on the timing 
of exposure. The analysis by Danjou et al. was well powered, had a long length 
of follow-up (which allowed for an adequate latency period), had few missing 
data, and used validated questionnaires. Limitations include recall bias for dietary 
history, the fact that the dioxin sampling did not include all foods consumed, and 
the source of the food was not considered. Some food could have been more con-
taminated if grown or produced near dioxin sources. Estimates of dietary dioxin 
exposure cannot be generalized to the French population as the exposure levels 
are highly dependent on the food groups consumed. There was no increased risk 
for breast cancer in this primarily post menopausal group of women who were 
apporoximate the age of the female Vietnam veterans. Most of the women had 
low levels of exposure (below what WHO has reported as safe), and even the 
women in the highest quartile of exposure (> 1.52 pg/kg of bodyweight per day) 
did not have an increased risk for breast cancer.
Case-Control Studies
Arrebola et al. (2015) performed a case-control study of incident non- 
metastatic female breast cancer cases in two cancer centers in Tunisia. In all, 
69 cases were recruited and age matched to 56 female visitors, blood donors, or 
staff from the two centers who served as the control group. Fasting serum was 
obtained before any therapeutic intervention, and concentrations of multiple 
chemicals including β-hexachlorocyclohexane (β-HCH), hexachlorobenzene, 
heptachlor (a metabolite of dioxin), and oxychlordane were measured by gas 
chromatography with micro-electron capture detection. Wet-basis models and 
lipid-basis models were both performed with no reported difference in results. 
Serum levels were presented in tertiles or, in the case of β-HCH, above or below 
the limits of detection. Adjustments were made for age, age at menarche, repro-
ductive history, breastfeeding history, tobacco and alcohol use, and BMI. Data 
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were collected on occupational status, urban-versus-rural residence, education 
levels, family history, and marital status. The cases were more likely to be less 
educated, rural dwellers, and postmenopausal than the controls. Serum concen-
tration levels of β-HCH and heptachlor were significantly higher in the cases: 
β-HCH mean (standard deviation) 25.17 (57.74) ng/g lipid versus below limits 
of detection in controls, p = 0.003; heptachlor, 22.49 (15.12) ng/g lipid versus 
14.48 (14.86) ng/g lipid in controls, p = 0.001. In adjusted models, β-HCH (OR = 
3.44, 95% CI 1.30–9.72) and the third tertile of hepatachlor (OR = 1.06, 95% 
CI 1.00–1.15) were elevated, but the estimate for β-HCH was imprecise. When 
heptachlor, β-HCH, and p,p’-DDE were included in a model that was adjusted 
for covariates and used all three chemicals as continuous variables, only β-HCH 
remained associated with elevated odds of breast cancer (OR = 1.18, 95% CI 
1.05–1.34). The results suggest a potential relationship between β-HCH levels 
and breast cancer, but the results should be interpreted with caution and require 
verification. Heptachlor has dioxin-like properties and is the chemical in this 
study most related to the COIs, but it was not associated with increased odds of 
breast cancer in the most rigorous model, and therefore, this analysis does not add 
sufficient data to the weight of the evidence regarding the association between 
exposure to the COIs and female breast cancer.
Yang et al. (2015) conducted a hospital-based case-control study of women 
in China to compare levels of organochlorine pesticides in serum and breast 
adipose tissue and infiltrating ductal carcinomas. The women were recruited 
over 19 months from 2005 through 2006, and the final study sample consisted 
of 75 women with infiltrating ductal carcinoma, 79 women with benign con-
ditions, and 80 healthy women (no breast conditions); the latter two groups 
served as controls. Pesticide residues were measured and included 4 isomers 
of 1,2,3,4,5,6-HCH (α,β,γ,δ), which exhibit dioxin-like properties, and other 
organochlorine pesticides and metabolites. β-HCH was one of two residues 
detected in the serum, and the concentration was statistically significantly 
higher in the women with breast cancer than in the women with benign breast 
disease or the healthy controls (3.42 mg/L versus 0.60 mg/L and 0.58 mg/L, 
respectively, p < 0.05). β-HCH, pp’-DDE, and PCTA residues were detected 
in breast adipose tissue, with the concentrations of β-HCH statistically sig-
nificantly higher in the women with breast cancer than in the women with 
benign breast tissue (219.34 mg/L versus 57.84 mg/L, p < 0.05). The serum 
concentration of β-HCH increased with differentiation and was significantly 
elevated for well-differentiated versus poorly-differentiated tumors (4.92 mg/L 
and 2.32 mg/L, p < 0.05, respectively). β-HCH was significantly elevated in breast 
adipose tissue in well-differentiated (303.6 mg/kg) compared with moderately-
differentiated (214.0 mg/kg) and poorly-differentiated tumors (147.8 mg/kg) 
(p < 0.05). When examined by estrogen receptor status, ER+ tumors had signifi-
cantly higher levels of β-HCH in the breast adipose: 238.78 mg/k versus 141.92 
mg/k (p < 0.05). The authors propose that organochlorine pesticides acting as 
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endocrine disruptors upset the normal estrogen–progesterone balance contrib-
uting to breast cancer. The higher levels of organochlorine pesticide residues 
in blood and breast adipose tissue imply an association with infiltrating ductal 
carcinoma, but further work is needed to determine causality.
Other Identified Studies
Four other studies that reported outcomes of breast cancer were identified, 
but all lacked sufficient exposure specificity to be included as contributing to the 
evidence base of the potential effect of the COIs. The first study examined breast 
cancer mortality in an occupational cohort of both women and men who worked 
in capacitor manufacturing and who were exposed to mixed PCBs as well as 
several other chemicals and metals, but no additional information was provided 
regarding the specific PCBs or objective measures of exposure (Ruder et al., 
2014). Benedetti (2017) conducted an ecologic analysis to determine breast 
cancer (and other cancer) incidence rates at 14 of Italy’s national priority con-
taminated sites and compared the rates among those sites. Although the known 
exposures at these sites consisted of mixtures of PCBs, furans, benzene and other 
solvents, arsenic, and cadmium, they were not measured or specified in enough 
detail to indicate which of the COIs were present and to what extent. Finally, two 
studies reported on breast cancer outcomes following the 1968 Yusho accident in 
Japan, where people were exposed to PCBs, dioxins (e.g., PCDD/Fs), and dioxin-
like chemicals through the ingestion of contaminated rice bran oil. Kashima et 
al. (2015) compared mortality rates from breast cancer using an ecologic design 
to define exposure (likely introducing selection bias) and did not use individual 
serum samples or previously published measurements. Akahane et al. (2017) 
examined the prevalence of self-reported long-term health effects, including 
breast cancer, in people exposed via the Yusho accident compared with an age-, 
sex- and residential-area-matched group. Because no TEQs or other quantifica-
tion of relevant exposures was presented, the study was not considered further.
Biologic Plausibility
The experimental evidence indicates that 2,4-D, 2,4,5-T, and TCDD are 
weakly genotoxic at most. However, TCDD is a demonstrated carcinogen in 
animals and is recognized as having carcinogenic potential in humans because 
of the mechanisms discussed in Chapter 4. There is no evidence from carcino-
genicity bioassays that TCDD causes breast cancer in laboratory animals (Baan 
et al., 2009; IARC, 2012c). However, studies performed in laboratory animals 
indicate that TCDD may modify the carcinogenic process in the mammary gland 
and that the effect of TCDD may depend on the age of the animal. Toxicology 
studies using different rat models have demonstrated that the fetal mammary 
gland is highly sensitive to dioxin, and severe and persistent mammary-gland 
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developmental abnormalities—including decreased ductal branching, delayed 
epithelial migration into the fat pad, and fewer differentiated terminal end 
buds—were evident after exposure to a single dose of dioxin during mammary 
bud development (N. M. Brown et al., 1998; Fenton et al., 2002; Lewis et al., 
2001). For example, a single oral exposure of 50-day-old Sprague Dawley 
rats to 10 μg/kg TCDD 3 days prior to a single administration of the chemical 
carcinogen dimethylbenzanthracene (DMBA) was found to inhibit mammary-
tumor induction (Holcombe and Safe, 1994), while a single 2.5-μg/kg dose of 
TCDD to 18-day-old rats slightly increased tumor induction when followed by 
a single injection of the carcinogen methylnitrosourea (MNU) at 21 days of age 
(Desaulniers et al., 2001).
In a 2015 review of the literature on TCDD and breast cancer, Fenton and 
Birnbaum suggested a mechanism that may be related to endocrine disruption 
and that might indicate a close association between the development of mam-
mary cancers and mammary gland differentiation. Agents capable of disrupting 
the ability of the normal mammary epithelial cell to enter or maintain its ap-
propriate status (a proliferative, differentiated, apoptotic state), to maintain its 
appropriate architecture, or to conduct normal hormone (estrogen) signaling are 
likely to act as carcinogens, co-carcinogens, or tumor promoters for the breast 
(Fenton, 2006; McGee et al., 2006). In that light, it is interesting that prenatal 
exposure of rats to TCDD was found to alter the proliferation and differentiation 
of cells in the mammary gland of the dams (Vorderstrasse et al., 2004) and of the 
offspring  (Birnbaum and Fenton, 2003). There is evidence that TCDD directly 
targets mammary epithelial cells and the surrounding stromal fat cells during 
pregnancy-induced mammary gland differentiation; this points to interference 
with stromal–epithelial cross-talk as one of several underlying pathways (Lew 
et al., 2011). Jenkins et al. (2007) used a rat carcinogen-induced mammary 
cancer model to show that prenatal exposure to TCDD alters mammary gland 
differentiation and increases susceptibility to mammary cancers by altering the 
expression of estrogen- receptor genes and of genes involved in oxidative-stress 
defense. Thus, the effect of TCDD may depend on the timing of the exposure 
and on the magnitude of gene expression at the time of exposure; TCDD may 
influence mammary-tumor develop ment only if exposure to it occurs during a 
specific window during breast development (Rudel et al., 2011). Susceptibility 
to breast cancer appears to peak in utero and at puberty, which would not be 
relevant for female Vietnam veterans, who were potentially exposed as adults. 
This finding would only be relevant to the female child of a female veteran 
exposed to the herbicides while pregnant, an unlikely scenario given that few 
women were stationed in areas where herbicides were known to be sprayed and 
that pregnant women were barred from duty in Vietnam. The breast is the only 
human organ that does not fully differentiate until it becomes ready for use; nul-
liparous women have less-differentiated breast lobules, which are presumably 
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more susceptible to carcinogenesis. Pregnancy is protective, particularly if car-
ried to full term.
Activation of AHR by dioxin or by the non-dioxin ligand indole-3-carbinol 
has also been shown to protect against experimental breast cancer by mechanisms 
that disrupt migration and metastasis (Bradlow, 2008; Hsu et al., 2007). The admin-
istration of TCDD to mice that harbored highly metastatic murine breast-cancer 
cells in the mammary fat pad reduced the rate of metastasis by 50% without sup-
pressing primary tumor size—an indication that TCDD’s protective effects are 
 selective to the metastatic process (T. Wang et al., 2011). In addition, AHR  agonists 
inhibit the formation of lung metastases by ER-negative breast cancer cells (S. 
Zhang et al., 2012). Hanieh (2015) and Hanieh et al. (2016) found that TCDD and 
other AHR agonists suppressed pro-metastatic SOX4 in breast cancer cell lines. 
However, Spink et al. (2013), using clones derived from the MCF-7 human breast 
cancer cell line that express different levels of AHR, showed that in nude mice, 
Ahr expression is not necessary for proliferation, migration, invasion, or tumor 
growth of ER-positive MCF-7 cells and that the knock-down of Ahr in wild-type 
MCF-7 cells did not affect the anti-proliferative effect of TCDD ( Yoshioka et 
al., 2012). Also, knock-down of AHR in triple-receptor- negative MDA-MB-231 
cells inhibited their in vivo growth and  metastases (Goode et al., 2013). Recently 
Go et al. (2017) showed that 17b-estradiol promoted AHR-dependent CPY1A1 
expression in MCF-7 clonal variant cells through an ER pathway.  Collectively, 
these findings suggest that there may be species differences, ER-specific mecha-
nisms, ER-independent mechanisms, or carcinogenic process-specific effects of 
AHR in breast carcinogenesis. It is possible that some protective effects may be 
mediated through the known cross-talk between AHR and ERα, which has been 
studied extensively at the molecular level for potential therapeutic benefit. There 
is evidence to indicate that AHR controls ERα-regulated gene expression through 
its effects on DNA methylation (Marques et al., 2013) or through the recruitment 
of receptor-interacting protein 140 (RIP140), which can both activate and repress 
ER actions (Madak-Erdogan and  Katzenellenbogen, 2012). In the presence of 
dioxin, AHR can repress specific estrogen-dependent genes in MCF-7 breast can-
cer cells (Labrecque et al., 2012) and in triple-receptor-negative MDA-MB-231 
cells (Goode et al., 2014). TCDD can also activate AHR-mediated G1cell-cycle 
arrest (Barhoover et al., 2010); however, in the presence of progesterone receptor, 
TCDD enriches the G2/M phase and stimulates the proliferation of MCF-7 cells 
(Y. J. Chen et al., 2012). Together, these results demonstrate a complicated inter-
play between the AHR and other nuclear transcription factors, including steroid 
hormone receptors, which can either stimulate or inhibit breast cancer growth 
in a manner that depends on cell context. The growth of MCF-7 cells as mam-
mospheres appears to be negatively regulated by AHR (Zhao et al., 2012), but in 
the context of an inflammatory microenvironment and HER2 overexpression, the 
opposite effect has been reported (Zhao et al., 2013). Saito et al. (2017) found that 
TCDD-activated AHR stimulated the estrogen-dependent progression of breast 
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carcinoma by inducing aromatase expression under some conditions; although 
AHR activation has also been shown to inhibit the ER pathway, the AHR-induced 
aromatase activity persisted for a longer duration than the ER inhibition in three 
breast carcinoma cell lines.
TCDD may affect breast carcinogenesis by silencing the Brca-1 tumor sup-
pressor gene through promoter hypermethylation, thereby impairing DNA repair 
(Papoutsis et al., 2012). TCDD has also been shown to modulate the induction 
of DNA-chain breaks in human breast cancer cells by regulating the activity of 
the enzymes responsible for estradiol catabolism and generating more  reactive 
intermediates, which might contribute to TCDD-induced carcinogenesis by alter-
ing the ratio of 4-OH-estradiol to 2-OH-estradiol, a marker of breast cancer risk 
(La Merrill et al., 2010; P. H. Lin et al., 2007, 2008). A similar imbalance in 
metabolite ratios has been observed in pregnant Taiwanese women, in whom the 
ratio of 4-OH-estradiol to 2-OH-estradiol decreased with increasing exposure to 
TCDD (S. L. Wang et al., 2006). The expression of CYP1B1, the cytochrome 
P450 enzyme responsible for 2-OH-estradiol formation, but not of CYP1A1, the 
one responsible for 4-OH-estradiol formation, was found to be highly increased 
in premalignant and malignant rat mammary tissues in which Ahr was constitu-
tively active in the absence of ligand (X. Yang et al., 2008). On the basis of recent 
mechanistic data, it has been proposed that AHR contributes to mammary-tumor 
cell growth by inhibiting apoptosis while promoting the transition to an invasive, 
metastatic phenotype (Marlowe et al., 2008; Schlezinger et al., 2006; Vogel et 
al., 2011). There is also evidence showing that AHR activation by TCDD in 
human breast and endocervical cell lines induces sustained high concentrations 
of the IL-6 cytokine, which has tumor-promoting effects in numerous tissues, 
including breast tissue, suggesting that TCDD might promote carcinogenesis in 
these tissues (DiNatale et al., 2010; Hollingshead et al., 2008). Similarly, TCDD 
induced IL-8 expression in an AHR-dependent manner and may contribute to 
inflammatory breast cancer (Vogel et al., 2011). Degner et al. (2009) have shown 
that AHR ligands can upregulate the expression of COX-2, which may lead to a 
proinflammatory local environment that can support tumor development.
Synthesis
In the early 1990s it was suggested that exposure to some environmental 
chemicals, such as organochlorine compounds, might play a role in the etiology 
of breast cancer through estrogen-related pathways. The relationship between 
organochlorines and breast cancer risk has been studied extensively, especially in 
the past decade; TCDD and dioxin-like chemicals have been among the organo-
chlorines so investigated.
Some well-designed environmental and case-control studies with good expo-
sure assessment found statistically significant increased risk of breast cancer 
(Bertazzi et al., 1993; Pesatori et al., 2009; Reynolds et al., 2005; Viel et al., 
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2008a; Warner et al., 2011). On the other hand, no increased risk of breast cancer 
mortality was observed in the cohorts of female Vietnam-era veterans (Cypel and 
Kang, 2008; Dalager et al., 1995a; Kang et al., 2014a; Thomas et al., 1991) and 
Seveso residents (Consonni et al., 2008). The data on male breast cancer from 
the Korean veterans study are sparse and imprecise mainly due to the very low 
incidence of breast cancer in men (Yi and Ohrr, 2014). The findings of breast 
cancer risk in follow-up studies of cancer incidence in Seveso were inconsis-
tent ( Pesatori et al., 2009; Warner et al., 2011). An increase in the SMR for 
breast cancer was observed in the Hamburg cohort of workers exposed to dioxin 
( Manuwald et al., 2012), while the study of the Dow 2,4-D production workers 
had null findings (C. J. Burns et al., 2011).
The two new environmental studies do not support an association with 
expo sure to dioxin and breast cancer incidence (Danjou et al., 2015) or exposure 
to dioxin-like PCBs and breast cancer (Morgan et al., 2017). The results of the 
case-control studies were mixed. Arrebola et al. (2015) did not find an association 
with dioxin-like chemicals, β-HCH and heptachlor, and breast cancer in adjusted 
models. But C. Y. Yang et al. (2015) showed higher levels of β-HCH in the serum 
of breast cancer patients versus controls as well as higher levels in ER+ versus 
ER- tumors and well-differentiated versus poorly differentiated tumors. The au-
thors propose a likely association between the endocrine disrupter organochlorine 
 pesticides in the breast adipose and serum and breast cancer. Furthermore, be-
cause several organo chlorine residues, not considered relevant to this study, were 
also measured and also found to have statistically significant positive associations 
with ER+ and well-differentiated tumors, it is not clear which (or if all) of these 
agents are responsible for the increased risk of breast cancer.
The main strength of these studies was the availability of organochlorine 
pesticide levels in blood (Morgan et al., 2017; C. Y. Yang et al., 2015) and breast 
adipose tissue (C. Y. Yang et al., 2015). The data from C. Y. Yang and colleagues 
showing significantly elevated concentrations of β-HCH in well-differentiated 
ER+ tumors aligned with the role of endocrine disrupters in breast cancer on-
cogenesis. However, Morgan et al. (2017) found a greater association with non-
dioxin-like PCBs than with dioxin-like PCBs and breast cancer. TEQ data were 
not presented for the dioxin-like PCBs, and of the dioxin-like PCBs measured, 
PCB 118, a mono-ortho is given low consideration as it contributes less than 10% 
to total TEQs.
Biological mechanistic data from cell lines and non-primate animal models 
have provided insight into a number of ways in which TCDD and related chemi-
cals may interact with AHR, ER, aromatase enzyme, inflammatory cytokines, 
DNA repair genes, and the stroma to modulate events leading to breast cancer. 
Pre-clinical studies have shown that the timing of the exposure to the COIs is 
critical, with in utero and pubertal breast tissue being most sensitive to carcino-
genic effects. Data also suggest that AHR agonists are protective against breast 
cancer via the modulation of signaling pathways involved in proliferation and 
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metastases. Despite the advances in understanding the various effects of TCDD 
and related chemicals on breast cell metabolism, there is no experimental evi-
dence to support the hypothesis that TCDD by itself is a breast tissue carcinogen 
or that it enhances breast carcinogenesis.
Conclusion
Having considered the new evidence and the results of studies reviewed in 
previous updates, the present committee concludes that there is inadequate or 
insufficient evidence to determine whether there is an association (either positive 
or negative) between exposure to the COIs and breast cancer.
CANCERS OF THE FEMALE REPRODUCTIVE SYSTEM
This section addresses cancers of the cervix (ICD-9 180; ICD-10 C53), 
endometrium (also referred to as the corpus uteri; ICD-9 182.0–182.1, 182.8; 
ICD-10 C54), and ovary (ICD-9 183.0; ICD-10 C56). Additional cancers of the 
female reproductive system that are infrequently reported separately are cancers 
of the uterus not otherwise specified (ICD-9 179; ICD-10 C55), placenta (ICD-9 
181; ICD-10 C58), fallopian tube and other uterine adnexa (ICD-9 183.2–183.9; 
ICD-10 C57.0–C57.4), and other female genital organs (ICD-9 184; ICD-10 C57, 
C58); findings on these cancers are included in this section. NCI estimates of the 
numbers of new female reproductive-system cancers in the United States in 2018 
are presented in Table 7-1; they represent roughly 12% of new cancer cases and 
11% of cancer deaths in women (NCI, n.d.o–r).
Cervical cancer occurs more often in blacks than in whites, but endometrial 
and ovarian cancers occur more often in whites. The incidence of endometrial and 
ovarian cancers is higher in older women and in those who have family histories 
of these cancers. The use of unopposed (without progestogen) estrogen-hormone 
therapy and obesity, which increases endogenous concentrations of estrogen, 
 increases the risk of endometrial cancer. HPV infection, particularly infection 
with HPV types 16 and 18, is the most important risk factor for cervical cancer 
(McGraw and Ferrante, 2014).
The age-adjusted modeled incidence rate of female genital system cancers 
(which includes the cervix uteri, corpus and uterus not otherwise specified, ovary, 
vagina, and vulva) for women 50–64 years old of all races combined was 114.2 
per 100,000 in 2015 and increased to 169.1 for 65–74 year olds and dropped to 
147.3 for women over 75 years.12 The roughly 7,500 female Vietnam veterans 
who were potentially exposed to herbicides in Vietnam would now be menopausal.
12 Modeled incidence rates as calculated on the site https://seer.cancer.gov/faststats/selections.
php?#Output by using the SEER 18 dataset and choosing age-adjusted rates, female genital system, 
all races, and age groups 50–64, 65–74, and ≥ 75 years.
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Conclusions from VAO and Previous Updates
The committee responsible for VAO concluded that there was inadequate 
or insufficient information to determine whether there is an association between 
exposure to the COIs and female reproductive cancers. Additional information 
available to the committees responsible for subsequent updates through Update 
2014 has not changed that conclusion.
Results from three cohorts of U.S. female veterans who were followed for 
overall and specific-cause mortality from 1992 through 2010 (H. K. Kang et al., 
2014a) were reviewed in Update 2014. Among the three cohorts of U.S. women 
veterans—those who served in Vietnam (n = 4,734), those who served in coun-
tries near Vietnam (n = 2,062), and those who did not deploy (n = 5,313)—very 
few deaths from cervical cancer were observed: five among those who served 
in Vietnam, one among those who served near Vietnam, and six among those 
who were non-deployed. Compared with the general population of U.S. women, 
SMRs were lower for each cohort (SMRs between 0.27 and 0.65) but the esti-
mates were imprecise due to the small number of cervical cancer deaths. In 
comparison with non-deployed female Vietnam-era veterans, those who served in 
Vietnam had no excess cervical cancer mortality. A further analysis restricted to 
female nurses, again using the non-deployed cohort as the referent, yielded virtu-
ally the same nonstatistically significant risk of mortality from cervical cancer. 
Similarly, there were also very few observed uterine cancer deaths of women who 
served in Vietnam, served near Vietnam, or were non-deployed, with 9, 4, and 
12 deaths, respectively, and no excess risk of uterine cancer mortality was found 
in any of the three cohorts when compared with the general population. In the 
internal comparison to non-deployed Vietnam-era veterans, uterine cancer mortal-
ity was not associated with service in Vietnam or near Vietnam. Similar results 
were observed in the analysis restricted to only nurses. There were more deaths 
from ovarian cancer in the entire cohort, but no differences in the risk of ovarian 
cancer mortality were found among those who served in Vietnam, served near 
Vietnam, or were non-deployed in comparison with the general population of U.S. 
women. In the internal comparison with the non-deployed veterans, ovarian cancer 
TABLE 7-1 Estimates of New Cases and Deaths from Selected Cancers of the 
Female Reproductive System in the United States in 2018
Site Estimated Incidence Estimated Deaths
Cervix 13,240  4,170
Endometrium 63,230 11,350
Ovary 22,240 14,070
Vagina and other female genital  6,190  1,200
SOURCES: NCI, n.d.o–r.
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mortality was increased among Vietnam veterans and among women who served 
near Vietnam, but neither was statistically significant. An analysis restricted to 
nurses revealed similar patterns of increased (albeit not statistically significant) 
ovarian cancer mortality, both for veterans who served in Vietnam and for veter-
ans who served near Vietnam, when compared with non-deployed nurses.
Update of the Epidemiologic Literature
Relevant studies on cancers of the female reproductive system include the 
cervix, uterus, ovary, and vagina. No studies of female reproductive cancers 
among Vietnam veterans have been published since Update 2014. No occupa-
tional cohort, environmental, or case-control studies of exposure to the COIs and 
female reproductive cancers have been published since Update 2012. Reviews 
of the relevant studies are presented in the earlier reports. Tables 15, 16, and 17, 
which can be found at www.nap.edu/catalog/25137, summarize the results of 
studies related to female cervical, uterine, and ovarian cancer.
Other Identified Studies
Three studies that reported outcomes of uterine or ovarian cancer were iden-
tified, but all lacked sufficient exposure specificity to be included as contributing 
to the evidence base of the potential effect of the COIs. The first study examined 
mortality from malignant neoplasms of female genital organs in an occupational 
cohort of capacitor manufacturers who were exposed to mixed PCBs as well as 
to several other chemicals and metals, but no additional infor mation was pro-
vided regarding the specific PCBs or objective measures of expo sure (Ruder et 
al., 2014). Two studies reported on mortality from (Kashima et al., 2015) or the 
prevalence of (Akahane et al., 2017) uterine or ovarian cancer outcomes related 
following the 1968 Yusho accident in Japan, where people were exposed to 
PCBs, dioxins (e.g., PCDD/Fs), and dioxin-like chemicals through the ingestion 
of contaminated rice bran oil. Both lacked the necessary exposure specificity to 
be considered further.
Biologic Plausibility
Yoshizawa et al. (2009) showed that the chronic administration of TCDD and 
other AHR ligands to adult female Harlan Sprague Dawley rats results in chronic 
inflammation and an increased incidence of reproductive-tissue preneoplasia 
and tumors, including cystic endometrial hyperplasia and uterine squamous-cell 
carcinoma. The mechanism of action might be related to endocrine disruption 
and chronic inflammation. Qu et al. (2014) observed increased mRNA and protein 
expression of AHR in human endometrial cancer tissue and human endome-
trial cancer cell lines (Ishikawa and ECC-1) compared with nonmalignant 
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endometrium; increased AHR expression in human endometrial cancer tissue 
compared to nonmalignant tissue has also been reported by D. Li et al. (2013).
Qu et al. (2014) showed that a polycyclic hydrocarbon known to be an AHR 
ligand inhibited the proliferation of Ishikawa and ECC-1 cells mediated in part 
by AHR. Wormke et al. (2000) reported that TCDD inhibited the proliferation 
of Ishikawa endometrial cancer cells stimulated by estradiol and also reduced 
estrogen receptor activity, but increased AHR-mediated gene expression in 
these cells, suggesting that the estrogen receptor, not the AHR, mediates the anti-
proliferative effect of TCDD in the Ishikawa endometrial cancer cells. Y. Li et 
al. (2014) showed that TCDD-AHR activation inhibited cell proliferation in 
human ovarian cancer (OVCAR-3) cells. Hollingshead et al. (2008) showed 
that TCDD activation of AHR in human breast and endocervical cancer cell lines 
induces sustained high concentrations of the IL-6 cytokine. It is noteworthy that 
the effects of TCDD treatment differed between MCF-7 breast cancer cells and 
ECC-1 endometrial carcinoma cells with respect to the activation and repression 
of genes; this  illustrates the role of cell context and organ specificity in responses 
to TCDD by cancer cells (Labrecque et al., 2012).
Synthesis
Compared with other cancer types, relatively few studies have reported on 
associations between any of the COIs and female reproductive cancers. The most 
relevant evidence came from a follow-up study on mortality among female U.S. 
Vietnam-era veterans that was reviewed in Update 2014. For both cervical and 
uterine cancers there was no evidence of increased mortality risk; however, the 
small observed number of deaths for these outcomes in all three cohorts limited 
the statistical power of the associations. With regard to ovarian cancer, there 
was some evidence of a slightly elevated mortality in veterans who served either 
in or near Vietnam, but for both risks the CIs were large and their point estimates 
imprecise. However, because the rate of ovarian cancer mortality was similar 
between veterans who served in Vietnam (with potential exposure to herbicides) 
and those who served near Vietnam (who presumably were not so exposed), this 
evidence is equivocal.
Most findings from occupational cohorts and environmental studies for 
which exposure was well characterized have not found increased risks for cervi-
cal, uterine, or ovarian cancers. Follow-ups of the Seveso cohort (where residents 
were exposed to TCDD following an explosion of the chemical plant) have not 
found increased incidence of or mortality from uterine cancer (Bertazzi et al., 
2001; Consonni et al., 2008; Pesatori et al., 2009). No new studies with sufficient 
exposure specificity were identified for the current update.
The results of mechanistic studies provide more plausibility for a reduced risk 
of female reproductive cancers than for an increased risk. Therefore, the conclusion 
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of inadequate or insufficient evidence of an association between the COIs and 
uterine, ovarian, or cervical cancers remains unchanged.
Conclusion
Based on the evidence reviewed here and in previous VAO reports, the com-
mittee concludes that there is inadequate or insufficient evidence to determine 
whether there is an association between exposure to the COIs and uterine, ovar-
ian, or cervical cancers.
PROSTATE CANCER
The prostate gland lies just below the urinary bladder and surrounds the 
urethra. It makes fluid that forms part of semen. NCI estimated that 164,690 new 
cases of prostate cancer (ICD-9 185; ICD-10 C61) would be diagnosed in the 
United States in 2018 and that 29,430 would die from it (NCI, n.d.s). That makes 
prostate cancer the second most common cancer in men (after non-melanoma 
skin cancers); it is expected to account for about 9.6% of all new cancer diag-
noses and 4.4% of all cancer deaths in 2017. The incidence of and mortality from 
prostate cancer varies widely with age and race. The  incidence rate of prostate 
cancer for all races combined more than doubles from the ages of 50–64 years 
(207.3 per 100,000) to the ages of 65–74 years (579.5 per 100,000). The inci-
dence rate of prostate cancer for men aged 75 years and older decreases slightly, 
but remains high (432.7 per 100,000). As a group, African American men have 
the highest recorded incidence of prostate cancer in the world (Jemal et al., 2011); 
their risk is roughly 40% higher than that of whites in the United States and three 
times that in “American Indians/Alaska natives” (NCI, n.d.s).
Little is known about the causes of prostate cancer. Other than race and age, 
the risk factors include a family history of the disease both in first- and second-
degree relatives (Bruner et al., 2003; Zeegers et al., 2003). A review of occupa-
tional factors found heavy metals, PCBs, and PAHs to be associated with prostate 
cancer but did not specify particular pesticides (Doolan et al., 2014). There is 
some evidence that some elements of the Western diet, including a high con-
sumption of red meat and saturated fats, may be a risk factor for prostate cancer, 
but these have not been conclusively identified. Of note, selenium and vitamin 
E s upplementation did not reduce, but rather slightly increased, prostate cancer 
incidence in a large clinical trial (Klein et al., 2011; Kristal et al., 2014; Lippman 
et al., 2009), and soy protein supplementation did not prevent the recurrence of 
prostate cancer after surgical treatment in a randomized study (Bosland et al., 
2013). The 5α-reductase inhibiting drugs finasteride and dutasteride, which are 
widely used to treat benign enlargement of the prostate, were found to decrease 
the prevalence of prostate cancer by about 25% in two major randomized trials 
Veterans and Agent Orange: Update 11 (2018)
Copyright National Academy of Sciences. All rights reserved.
CANCER 293
(Andriole et al., 2010; Thompson et al., 2003); however, in the finasteride trial, 
the risk of high-grade prostate cancer was increased. Finasteride acts by decreas-
ing the formation of the potent androgen metabolite 5α-dihydrotestosterone in 
the prostate.
Study of the incidence of and mortality from prostate cancer is complicated 
by various approaches to screening for the disease in different countries and 
populations. The widespread adoption of serum prostate-specific antigen (PSA) 
screening in the 1990s led to very large increases in reported prostate cancer 
incidence in the United States, which have recently subsided as exposure to the 
screening has become saturated. However, PSA screening has recently come 
 under scrutiny and is no longer uniformly recommended or consistently applied 
in the United States, following a D grade recommendation from the U.S. Preven-
tive Services Task Force in 2012 (Moyer et al., 2012).
Prostate cancer tends not to be fatal in many cases (NCI estimates a 98% 
5-year survival rate), particularly for screening-detected (i.e., localized stage/
well-differentiated grade) prostate cancer, so mortality studies may miss an 
increase in the incidence of the disease and thus potentially misclassify the 
outcome. In addition, findings that show an association between an exposure 
and prostate cancer mortality should be examined closely to determine whether 
the exposed group had poorer access to screening or treatment that would have 
decreased the likelihood of survival.
Conclusions from VAO and Previous Updates
The committee responsible for VAO concluded that there was limited or sug-
gestive evidence of an association between exposure to the COIs and prostate 
cancer, based on positive associations observed in occupational and environmental 
studies. Additional information from various epidemiologic studies— including the 
AFHS and ACC, veterans seen in VA medical facilities, and occupational cohorts 
of phenoxy chemical factory workers and pesticide applicators from the AHS—
reviewed in subsequent updates has not changed that conclusion.
Four studies of prostate cancer and Vietnam veterans were reviewed in Up-
date 2014, two among veterans at VA medical facilities and two international 
cohort studies of male Vietnam veterans from New Zealand and Korea. A study of 
U.S. Vietnam veterans who were referred to the Portland VA Medical Center with 
an elevated serum PSA and who underwent an initial prostate biopsy  reported 
a statistically significant association between herbicide exposure (7.5% of cases 
classified as herbicide-exposed) and the overall risk of prostate cancer after ad-
justment for age and the receipt of screening (Ansbaugh et al., 2013). Stratifying 
tumors by grade and characteristics led to a stronger association between herbi-
cide exposure and intermediate- to high-grade prostate cancer and an even stron-
ger association with more aggressive prostate cancer. Although this study had a 
relatively large sample size, it is limited by uncertainty about individual exposure 
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levels and potential selection/referral bias because men who were  referred for 
prostate biopsy probably had an elevated PSA and could possibly have had better 
access to health care in comparison with other veterans.
A small study using VA administrative databases to determine the relation-
ship between herbicide exposure (determined by self-report and military records 
confirming that Vietnam veterans had served in an area in which herbicides had 
been sprayed) and a biochemical recurrence of prostate cancer during an average 
of 5.3 years of follow-up after prostatectomy was conducted (Q. Li et al., 2013). 
Subcutaneous adipose tissue was obtained during prostatectomy and assayed for 
dioxin, and the measured TEQ levels of the 37 men with self-reported herbicide 
exposure were statistically significantly higher than those of the 56 men who did 
not report exposure. The proportions of men with biochemical recurrence were 
not statistically significantly higher for the veterans with self-reported herbicide 
exposure than for those who did not report exposure or for those with higher TEQ 
levels compared with those with lower TEQ levels.
In a follow-up study of 2,783 male New Zealand veterans who had served 
in Vietnam and were still alive as of 1988, McBride et al. (2013) reported that 
the incidence of prostate cancer was slightly but not statistically significantly 
increased among the veterans; the difference from the general male population of 
New Zealand was not statistically significant, nor was the rate of prostate cancer–
specific mortality. No information on potential confounding factors was included.
Among Korean veterans who served in Vietnam, a total of 125 incident cases 
and 53 deaths from prostate cancer were identified during the follow-up period in 
the cohort studied by Yi and colleagues (Yi, 2013; Yi and Ohrr, 2014; Yi et al., 
2014b). When compared with the general Korean population, there was a 22% 
statistically significant excess prostate cancer risk in the entire cohort (Yi, 2013), 
which was mostly due to a significant 2.5-fold elevated prostate cancer incidence 
among officers. In the internal comparison analysis, Yi and Ohrr (2014) reported 
an inverse association between the EOI scores and prostate cancer incidence, 
which was based on 53 cases in the high-exposure category. Yi and Ohrr (2014) 
did not stratify incident prostate cancer cases according to tumor characteristics 
(low- versus high-grade tumors) as is usually done in studies of prostate cancer 
incidence. Similarly, Yi et al. (2014b) reported a similar inverse association when 
examining exposure potential and prostate cancer–specific mortality.
Update of the Epidemiologic Literature
Several new studies reporting associations of prostate cancer or surrogate 
measures and the COIs were identified. Reviews of the relevant studies are 
presented in the earlier reports. Table 18, which can be found at www.nap.edu/
catalog/25137, summarizes the results of studies related to prostate cancer.
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Vietnam-Veteran Studies
Ovadia et al. (2015) conducted an analysis of the relationship between 
self-reported Agent Orange exposure (veterans submit a claim of exposure that 
is reviewed by VA using service records to confirm whether the veteran was 
stationed in an area that was sprayed with herbicides during the service period) 
and long-term outcomes among prostate cancer patients. Data for this analysis 
were drawn from the Shared Equal Access Regional Cancer Hospital database 
of 1,882 men undergoing radical prostatectomy for prostate cancer between 
1988 and 2011 at six VA health care facilities; 333 men (17.7%) were consid-
ered Agent Orange exposed. The clinical outcomes reported included pathologic 
Gleason Score, pathologic stage, and postoperative pathologic and treatment 
characteristics and prostate cancer–specific death. Cox proportional hazards 
 regression modeling was used to assess the relationship between exposure to 
Agent Orange and biochemical recurrence, secondary treatment, metastases, and 
prostate cancer–specific mortality. Models were adjusted for age, race, clinical 
stage, PSA level, BMI, center, and biopsy Gleason sum. Agent Orange exposure 
was not found to be associated with biochemical recurrence (HR = 1.21, 95% CI 
0.99–1.49), secondary treatment (HR = 1.21, 95% CI 0.97–1.5), metastases (HR = 
0.93, 95% CI 0.30–2.66), or prostate cancer–specific mortality (HR = 0.89, 95% 
CI 0.46–1.85). The study was generally well conducted, with excellent clinical 
data and follow-up available within the VA system. Although Agent Orange expo-
sure included an additional level of service location verification to self-report, 
this measure is still only a proxy for actual initial and subsequent exposure levels. 
However, a previous study by Q. Li et al. (2013) of 93 men showed good cor-
relation between self-reported Agent Orange exposure and dioxin TEQ levels in 
adipose tissue. The study’s negative results may be applicable to the relation-
ship between Agent Orange and prostate cancer progression, but do not directly 
address initiation and incidence.
Occupational Studies
Among the Dow Midland, Michigan, worker cohort that was compared with 
the standardized U.S. population, Collins et al. (2016) found no differences in 
mortality from prostate cancer for either the TCP workers (n = 21; SMR = 1.01, 
95% CI 0.62–1.54) or the PCP workers (n = 11; SMR = 1.05, 95% CI 0.53–1.87).
In a well-designed and conducted study and analysis, Christensen et al. 
(2016) examined the interactions among pesticide exposure, single nucleotide 
poly morphisms (SNPs) of genes in the steroid hormone synthesis, metabolism, 
or regulation pathway, and the risk of prostate cancer. Interactions with 39 pes-
ticides were examined using 776 cases and controls nested in the AHS cohort of 
private and commercial pesticide applicators. A total of 1,117 SNPs (in 56 genes) 
were evaluated. Cases were diagnosed from the period 1993–2004. Controls were 
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pesticide applicators frequency-matched 2:1 to cases by age. Lifetime pesticide ex-
posure information was obtained from multiple surveys. Several pesticide exposure 
metrics were constructed for each pesticide based on the duration and frequency 
of pesticide exposure. Estimates were adjusted for age and the study site; other 
covariates of smoking, BMI, and physical activity were also included but did not 
change the effect estimates. The final analysis included 39 pesticides. Only one 
multiple-comparisons corrected herbicide–SNP interaction was found—between 
the herbicide dicamba and a SNP in the testosterone metabolizing gene SRD5A. In 
the cohort, no association for 2,4-D or 2,4,5-T was found, and it appears there are 
no SNP interactions with these two herbicides. The results suggest that a  genetic 
variation may decrease the risk of prostate cancer with exposure to dicamba. 
However, this finding requires replication and is not directly useful in drawing any 
conclusions about the significance of potential positive associations of COIs and 
prostate cancer.
In an extension of the follow-up of UK phenoxy herbicide manufacturers 
and sprayers to examine the carcinogenicity of phenoxy herbicides, Coggon et al. 
(2015) reported deaths from several types of cancer. Prostate cancer was slightly 
elevated but was not statistically significant for any of the groups of workers: all 
workers (n = 120; SMR = 1.10, 95% CI 0.91–1.32), workers exposed to herbicide 
levels above background (n = 89; SMR = 1.14, 95% CI 0.92–1.14), or workers 
exposed for more than 1 year at levels above background (n = 43; SMR = 1.15, 
95% CI 0.83–1.55).
Environmental Studies
In a well-designed and conducted nested case-control study, Koutros et 
al. (2015) used prospectively collected serum to estimate associations between 
organocholorine exposures and metastatic prostate cancer in a population-based 
cohort from Norway. The study sample was identified from the Janus Serum 
Bank cohort, a population-based research biobank consisting of almost 317,000 
individuals with an average age at enrollment of 41 years. The Janus cohort was 
linked with to the Cancer Registry of Norway to identify new cases of prostate 
cancer. Only metastatic prostate cancer cases were included to avoid possible 
detection bias associated with PSA testing. Eligible cases consisted of incident 
metastatic prostate cancer cases with no history of cancer (except non-melanoma 
skin cancer) who were diagnosed from enrollment through December 31, 1999, 
and were diagnosed at least 2 years after serum collection. Controls (up to six per 
case) were randomly selected male members of the cohort who had no history 
of cancer (except for non-melanoma skin cancer) at the time of their matched 
case’s diagnosis. Cases (n = 150) and controls (n = 314) were matched on date 
of blood draw (1-year strata), age at blood draw (2-year strata), and region. Sera 
concentrations of 11 organochlorine pesticide metabolites and 34 PCB congeners 
(including five dioxin-like congeners PCB 118, PCB 156, PCB 157, PCB 167, 
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and PCB 189) were analyzed for cases and their matched controls in the same 
laboratory batch. Demographic data and other covariates, including BMI, as well 
as smoking habits were obtained from baseline questionnaire data at the National 
Institute of Public Health, and census data were obtained from Statistics Norway. 
No statistically significant pattern of association was found with regard to any of 
the dioxin-like PCBs analyzed. Comparing the highest exposure quartile to the 
lowest quartile, the odds ratios adjusted for country, age at collection, and date 
of collection, were: PCB 118 (OR = 1.07; 95% CI 0.56–2.02), PCB 156 (OR = 
0.80; 95% CI 0.42–1.52), PCB 157 (OR = 0.86; 95% CI 0.43–1.71), PCB 167 
(OR = 1.23; 95% CI 0.67–2.29), and PCB 189 (OR = 0.64; 95% CI 0.30–1.37). 
The power to detect more modest associations was limited in the higher exposure 
level categories.
Lim et al. (2017) conducted a case-cohort study to evaluate the relationship 
between serum concentrations of persistent organic pollutants and the incidence 
of prostate cancer using the Korean Cancer Prevention Study-II cohort. The 
case–cohort design consisted of 1,879 subjects who were randomly selected from 
the full Korean Cancer Prevention Study-II cohort of 270,514 individuals who 
visited 11 national health promotion centers from 1994 to 2013. After excluding 
women and men with missing data, the subcohort consisted of 831 subjects from 
which 256 controls and 110 incident cases of prostate cancer (identified through 
the  National Cancer Registry, a nationwide hospital cancer registry covering 99% 
of all cases diagnosed in South Korea) were selected. Serum concentrations of 
32 PCB congeners and 19 organochlorine pesticides were measured and were 
included individually and in sum in the analysis. The sum of dioxin-like PCBs 
(77, 81, 105, 114, 118, 123, 126, 156, 157, 167, 169, and 189) and the sum of 
non-dioxin-like PCBs was calculated. A TEQ was calculated based on the indi-
vidual TEF of each PCB congener, and tertiles of concentrations were calculated. 
 Hazard ratios for the association between the chemicals and incidence of prostate 
cancer were estimated using the weighted Cox regression models adjusted for 
age, BMI, smoking status, physical activity, and the age difference between age at 
enrollment and age at serum measurement. Elevated adjusted HRs were found for 
higher serum levels (tertile 3 versus tertile 1) of PCBs that have dioxin-like activ-
ity including PCB 118 (HR = 3.44, 95% CI 1.01–11.69), PCB 156 (HR = 2.26, 
95% CI 0.84–6.10), and PCB 167 (HR = 1.75, 95% CI 0.71–4.29) but the esti-
mates were imprecise. The model that used a continuous measure of chemicals 
(instead of grouping into tertiles) was statistically significant for PCB 156 (HR 
= 2.17, 95% CI 1.28–3.66) and PCB 167 (HR = 2.09, 95% CI 1.26–3.47). Using 
the sum of non-dioxin-like PCBs the upper tertile was statistically significantly 
elevated compared with the lowest tertile (HR = 3.47, 95% CI 1.21–9.98). The 
effect estimate using the sum of dioxin-like PCBs was elevated but not statisti-
cally significant (continuous HR = 1.39, 95% CI 0.89–2.19; tertile 3 versus tertile 
1 HR = 1.73, 95% CI 0.70–4.27). The TEQ continuous measure was statistically 
significantly elevated (HR = 1.40, 95% CI 1.21–1.62) as was the tertile 3 versus 
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tertile 1 comparison (HR = 1.83, 95% CI 0.75–4.46). The study is somewhat 
limited by the relatively small number of cases and by the fact that 89,169 of the 
full Korean Cancer Prevention Study-II cohort participants (56% of the original 
participating cohort) were excluded from selection because of insufficient serum 
samples for assay.
Case-Control Studies
Pi et al. (2016) conducted a hospital-based case-control study of prostate 
cancer with cases identified from a tertiary general hospital in Singapore. A total 
of 240 incident cases were identified, and 268 controls with other diseases (except 
cancer) were recruited and matched to cases on ethnicity and age. Sera samples 
from 60 cases and 60 controls were used to assess the presence of 74 organohalo-
gens. Other information was collected by interview. The mean concentration of 
PCB 118 was significantly higher (p < 0.05) in the serum of patients than in that 
of controls. Results were reported for two PCBs with dioxin-like activity. PCB 
118 at the highest tertile (> 67th) (OR = 1.71, 95% CI 0.79–3.71) had a significant 
trend test. For PCB 156 the trend test was significant, although the only elevated 
OR estimate was in the third tertile. Given that this is a small study that did not 
report information on case and control response rates, that control diagnoses were 
not known, and that it is not clear whether there was adjustment for potential 
confounders, this study is of limited utility.
Other Identified Studies
Several other studies of prostate cancer were identified. Among occupa-
tional cohorts, one examined mortality (Ruder et al., 2014), and one incidence 
 (Lemarchand et al., 2016). Both lacked sufficient exposure specificity to be 
included as contributing to the evidence base of the potential effect of the COIs. 
An Italian environmental study was also identified that performed an ecologi-
cal analysis to determine prostate cancer (and other cancer) incidence rates at 
14 of Italy’s national priority contaminated sites and compare the rates among 
those sites. Although the known exposures at these sites consisted of mixtures 
of PCBs, furans, benzene and other solvents, arsenic, and cadmium, they were 
not measured or specified in enough detail to indicate which of the COIs were 
present and to what extent. Akahane et al. (2017) examined the prevalence of self-
reported long-term health effects, including prostate cancer, in people exposed to 
PCBs, dioxins (e.g., PCDD/Fs), and dioxin-like chemicals through the ingestion 
of contaminated rice bran oil (Yusho accident) compared with an age-, sex- and 
residential-area-matched group. Because no TEQs or other quantification of rel-
evant exposures was presented, the study was not considered further.
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X. L. Sun et al. (2017) conducted a study of dioxin levels and steroid 
hormone levels (including PSA, testosterone, estradiol, DHEA, DHT, and 
3β-hydroxysteroid dehydrogenase and CYP17-lyase activity and 5α-reductase 
activity) among rural men residing in a dioxin “hot spot” located at a former 
U.S. Vietnam War–era air base and men in a non-sprayed region in the Kim 
Bang district (Ha Nam Province). Although serum dioxin levels were measured 
and the mean levels of most dioxins, furans, and non-ortho PCBs were signifi-
cantly higher in the hot spot area group than in the non-sprayed area group, this 
study was not given further consideration because it was not designed to directly 
estimate the risk of prostate cancer with dioxin exposure. The small number of 
participants, uncertainty about length of residence in the study areas, unknown 
response rate, and uncertainty on how the blood draw 2 years apart might have 
affected the results further limit this study’s utility to the committee.
Biologic Plausibility
In prostate cells and prostate cancer cell lines TCDD can lead to the induc-
tion of various genes, including those involved in drug metabolism. Simanainen 
et al. (2004) used different rats (TCDD-resistant Hannover/Wistar and TCDD-
sensitive Long Evans) and found that TCDD treatment resulted in a significant 
decrease in the weight of prostate lobes; the effect did not appear to be rat 
strain–specific. Different responses to TCDD in the human prostate cancer cell 
lines LNCaP and PC3 have been reported, including increased proliferation 
or no growth and stimulation or repression of AHR activity, which may be 
a function of coactivator–corepressor concentrations in the cells (Kollara and 
Brown, 2009, 2010). In addition, AHR activation has been shown to interfere 
with androgen receptor binding to androgen response elements in LNCaP cells 
via the upregulation of AP-1, resulting in a reduced expression of PSA (Kizu et 
al., 2003). However, the number of CAG repeats in the androgen receptor gene, 
which affects androgen receptor activity, did not significantly affect the induction 
of CYP1A1 by TCDD in androgen receptor–negative prostate cells transfected 
with androgen receptor constructs with different CAG repeat lengths (Björk and 
Giwercman, 2013). In that study, TCDD altered androgen receptor activity in a 
CAG repeat length–dependent manner in PC3 cells, but not in a non- tumorigenic, 
immortalized epithelial prostate cell line. AHR is upregulated in androgen recep-
tor–negative, hormone-independent prostate cancer cells compared with andro-
gen receptor–positive, hormone-dependent LNCaP cells, and the treatment of 
these cells (PC3, PC3M, and DU145) with an AHR agonist suppressed their 
growth (Richmond et al., 2014). In contrast, even though AHR is upregulated 
in castration-resistant C4-2 cells compared with the LNCaP cells from which 
they have been derived, the silencing of AHR caused a growth inhibition of 
these cells, perhaps because they retained androgen-receptor expression and 
are androgen-sensitive (C. Tran et al., 2013). TCDD suppressed expression of 
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genes associated with cell-cycle progression in LNCaP cells, but also suppressed 
DNA-repair genes and increased Wnt5a concentrations; these effects could lead 
to divergent responses in prostate cancer progression (Hruba et al., 2011). AHR 
overexpression and activation reduced induction of the expression of vascular 
endothelial growth factor in PC3 cells, raising the possibility of interference with 
angiogenesis by AHR ligands (P. Y. Wu et al., 2013). LNCaP cells under oxida-
tive stress have reduced viability and migration, and greater induced apoptosis; 
AHR activation exacerbates those changes (Yu et al., 2017). TGF-β suppressed 
AHR expression via SMAD4 and possibly also interfered with AHR signaling 
in a non-tumorigenic, but immortalized, epithelial prostate cell line (BPH-1) 
(Staršíchová et al., 2012); whether this also occurs in prostate cancer cells and 
has a bearing on prostate carcinogenesis is not known.
In utero and lactational exposure to TCDD increases aging-associated 
 cribiform hyperplasia in the murine prostate, which may be a pre-cancerous le-
sion (Fritz et al., 2005). In a follow-up, progeny of a genetic cross between Ahr-
null mice and the transgenic adenocarcinoma of the mouse-prostate (TRAMP) 
strain that models prostate cancer showed that the presence of Ahr inhibited 
the formation of prostate tumors that have a neuroendocrine phenotype (Fritz 
et al., 2008). As with breast cancer, these studies suggest that the timing of an 
exposure may be critical, with early-life exposures increasing prostate cancer 
susceptibility or risk and adult Ahr activation reducing it (recently demonstrated 
in TRAMP mice by Moore et al. [2016]). Because male Vietnam veterans were 
exposed to herbicides after adolescence, toxicologic findings concerning early-
life exposure are not particularly relevant to this population, although their 
exposure to herbicides could potentially influence risk of the prostate cancer 
later in life.
Taken together, there is some in vivo and in vitro laboratory evidence in 
support of a role of AHR in prostate cancer and suggesting that dioxin exposure 
could affect processes involved in prostate carcinogenesis or prostate cancer 
growth and progression. However, there is no substantial understanding of the 
importance of these mechanisms or how they could affect prostate cancer risk.
Synthesis
This update describes several newly published studies involving prostate 
cancer in Vietnam veterans being seen at VA medical centers, occupational 
 cohorts, and several other populations outside the United States. Most of the 
effect estimates were either below 1.0 or barely above 1.0 and were not statisti-
cally significant.
One new study of U.S. veterans was identified. Ovadia et al. (2015) 
 examined outcomes related to prostate cancer progression (not the incidence of 
 prostate  cancer) and found self-reported Agent Orange exposure was not associ-
ated with biochemical recurrence, secondary treatment, metastases, or prostate 
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cancer– specific mortality after adjusting for age, race, clinical stage, PSA level, 
BMI, health care center, and biopsy Gleason sum. However, studies among U.S. 
Ranch Hands and Australian Vietnam veterans that used better exposure assess-
ment support an association between exposure to the herbicides used in Vietnam 
and prostate cancer.
Several positive associations between exposure to specific herbicides or their 
contaminants and prostate cancer have been reported from previously reviewed 
occupational studies. In studies extending the follow-up period of workers who 
were exposed to dioxins during the manufacturing process of PCP and TCP 
(Collins et al., 2016) and workers who manufactured or sprayed phenoxy herbi-
cides (Coggon et al., 2015), no statistically significant difference in mortality for 
prostate cancer was found between the workers and the corresponding standard-
ized populations. Christiansen et al. (2016) conducted a well-designed nested 
case-control study of 776 cases and controls within the AHS that examined the 
interactions among exposure to 39 pesticides (including dicamba, 2,4-D, and 
2,4,5-T); 1,117 SNPs from 56 genes in the steroid hormone synthesis, metabo-
lism, or regulation pathway; and the risk of prostate cancer. Several pesticide 
exposure metrics were constructed for each pesticide based on the duration and 
frequency of pesticide exposure. After adjustment, the only interaction found 
was for a SNP with dicamba, which resulted in lower prostate cancer risk with 
dicamba exposure; no association for 2,4-D or 2,4,5-T was found, and it appears 
there are no SNP interactions with these two herbicides.
Environmental and case-control studies reviewed in this update each used 
sera samples to estimate TEQs for dioxins, organochlorine pesticide metabolites, 
or PCB congeners. A well-designed and conducted nested case-control study 
by Koutros et al. (2015) used prospectively collected serum to estimate asso-
ciations between organocholorine exposures and 34 PCB congeners (including 
five dioxin-like congeners) and metastatic prostate cancer in a population-based 
 cohort from Norway. After controlling for demographic factors, BMI, and smok-
ing habits, no statistically significant pattern of association was found with any 
of the dioxin-like PCBs analyzed. A hospital-based case-control study of prostate 
cancer in Singapore (Pi et al., 2016) used sera samples to assess the presence of 
74 organohalogens and found that the mean concentration of dioxin-like PCB 118 
was significantly higher (p < 0.05) in the serum of patients than in that of con-
trols. PCBs with dioxin-like activity (PCB 118 and PCB 156) showed increased, 
but generally not statistically significant, risk estimates. A Korean case-cohort 
analysis reported elevated hazard ratios for some dioxin-like PCBs and for the 
sum of dioxin-like PCBs (Lim et al., 2017).
There is some in vivo and in vitro laboratory evidence supporting the role 
of AHR in prostate cancer and suggesting that dioxin exposure could affect 
processes involved in prostate carcinogenesis or in prostate cancer growth and 
progression. However, there is no substantial understanding of the importance of 
these mechanisms or how they could affect prostate cancer risk.
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The existing body of epidemiologic evidence, including the new studies 
 reviewed here, provide mixed findings on an association between exposure to 
the COIs and prostate cancer. The epidemiologic evidence is robust enough and 
has support through biologic mechanisms that this committee finds no justifica-
tion for reversing the conclusion of prior VAO committees that there is limited or 
suggestive evidence of an association.
Conclusion
Based on the evidence reviewed here and in previous VAO reports, the com-
mittee concludes that there remains limited or suggestive evidence of an associa-
tion between exposure to at least one of the COIs and prostate cancer.
TESTICULAR CANCER
NCI estimated that 9,310 men would receive diagnoses of testicular cancer 
(ICD-9 186; ICD-10 C62) in the United States in 2018 and that 400 men would 
die from it (NCI, n.d.t). Other cancers of the male reproductive system that are 
infre quently reported separately are cancers of the penis (ICD-9 187.1–187.4; 
ICD-10 C60) and of other male genital organs (ICD-9 187.5–187.9; ICD-10 C63).
Testicular cancer occurs most often in men between the ages of 25 and 29. 
The modeled incidence rate of testicular cancer in 2014 for all races combined 
for men ages 65 years and over (which would include most Vietnam veterans) is 
1.2 per 100,000.13 On a lifetime basis, the risk in white men is about five times 
higher than in black men (Stevenson and Lowrance, 2015). Known risk factors 
for testicular cancer include cryptorchidism (undescended testes) and having a 
previous occurrence of testicular cancer, infertility, and HIV infection. Several 
other hereditary, medical, and environmental risk factors have been suggested, 
but the results of research are inconsistent (Michaelson and Oh, 2018; Mikuz, 
2015; Stevenson and Lowrance, 2015).
Conclusions from VAO and Previous Updates
After a published study indicated a potential association between testicular 
cancer in dogs and their service in Vietnam (Hayes et al., 1990), Tarone et al. 
(1991) conducted a case-control study of testicular cancer in male veterans, 
but the committee responsible for VAO concluded that there was inadequate or 
insufficient information to determine whether there was an association between 
exposure to the COIs and testicular cancer.
13 As calculated on the site https://seer.cancer.gov/faststats/selections.php?#Output by using SEER 
18 dataset and choosing age-adjusted rates, testicular cancer, all races, and age ≥ 65 years.
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Additional information available to the committees responsible for Update 
1996 through Update 2012 did not change that conclusion. Update 2014 reviewed 
a follow-up of the Korean Veterans Health Study through 2003 and found no 
difference in the incidence of testicular cancer (n = 5 cases) compared with the 
Korean general population (Yi, 2013) and maintained the conclusion of inad-
equate or insufficient evidence of an association between exposure to the COIs 
and testicular cancer.
Update of the Epidemiologic Literature
No studies of testicular cancer in Vietnam veterans (U.S. or those of other 
countries) or environmental studies of exposure to the COIs and testicular  cancer 
have been published since Update 2014. Reviews of the relevant studies are 
presented in the earlier reports. Table 19, which can be found at www.nap.edu/
catalog/25137, summarizes the results of studies related to testicular cancer.
Occupational Studies
Among the Dow Midland, Michigan, worker cohort that was compared 
with the standardized U.S. population, Collins et al. (2016) presented mortality 
for several cancers. For this outcome, results were presented as cancers of the 
testes and other male genital (excluding prostate), but only one death of a TCP 
worker was reported in this category. Therefore, given the single death from this 
outcome, no conclusions can be drawn.
In an extension of the follow-up of UK phenoxy herbicide manufacturers 
and sprayers to examine the carcinogenicity of phenoxy herbicides, Coggon et al. 
(2015) found only five deaths in the cohort from testicular cancer. Mortality effect 
estimates from testicular cancer were elevated but imprecise and not statistically 
significant for any of the groups of workers: all workers (SMR = 2.00, 95% CI 
0.65–4.67), workers exposed to herbicide levels above background (n = 4; SMR = 
2.10, 95% CI 0.57–5.37), or workers exposed for more than 1 year at levels above 
background (n = 3; SMR = 4.03, 95% CI 0.83–11.78).
Case-Control Studies
Paoli et al. (2015) conducted a small case-control study to examine the asso-
ciation between occupational and environmental endocrine disruptor exposure 
and testicular cancer. They recruited 125 testicular cancer (seminoma and non-
seminoma) patients attending the Laboratory of Seminology Sperm Bank at the 
University of Rome for semen cryobanking. All patients were studied about 1 
month after orchiectomy and before beginning chemo- or radiotherapy. The con-
trol group consisted of 103 healthy men undergoing an andrological examination 
and semen analysis in the same department as part of a nationwide preventive 
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screening campaign. Cases and controls completed an in-person interview to 
collect demographic information, residence prior to diagnosis and andrological 
medical history, occupational history, diet history, lifestyle, and other environ-
mental factors involving activities with suspected exposure to organochlorines. 
Serum samples were assayed for nine PCB congeners (including the dioxin-like 
congeners 77, 126, 169) and hexachlorobenzene. The associations between the 
organochlorine exposure and testicular cancer were estimated by logistic regres-
sion with adjustment for age and educational level. In the analysis, PCB and 
hexachlorobenzene values were grouped as being below or above the level of 
detection (0.2 ng/ml). Analyses of potential occupational pesticide exposure and 
possible maternal occupational exposure to pesticides (from interview data, but 
pesticides were not specified) both found nonstatistically significant associations. 
A detectable concentration of the sum of the nine PCB congeners (none of the 
congeners were analyzed separately) was found in 16 testicular cancer cases and 
no controls (p < 0.001). No effect measure was presented for this comparison, 
making this study of limited utility for the committee.
Other Identified Studies
An Italian environmental study was identified that performed an ecological 
analysis of testicular cancer incidence rates at 14 Italian priority contaminated 
sites and compared the rates among those sites (Benedetti et al., 2017); however, 
the study lacked sufficient exposure specificity to be included as contributing to 
the evidence base of the potential effect of the COIs.
Biologic Plausibility
No animal studies of the incidence of testicular cancer after exposure to 
any of the COIs have been published since Update 2012. That is undoubtedly 
due to the lack of a valid animal model of testicular cancer. SNPs of uncertain 
functional significance in the human AHR gene (11 SNPs) and the AHR repres-
sor gene (18 SNPs) were studied in a case-control study of 278 Swedish men and 
89  Danish men with testicular germ cell cancers (mean age 31 years) and 214 
 Swedish men without testicular cancer (mean age 18 years) (Brokken et al., 2013). 
There was no association between the risk of testicular germ cell cancer and any 
of the SNPs analyzed, but four SNPs in the AHR repressor gene were significantly 
associated with the risk of metastatic cancer compared to localized cancer.
Synthesis
The evidence from epidemiologic studies is inadequate to link herbicide ex-
posure and testicular cancer. The relative rarity of this cancer makes it difficult to 
develop risk estimates with any precision. Most cases occur in men 25 to 35 years 
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old, and men who have received such a diagnosis could have been excluded from 
military service; this could explain the slight reduction in risk observed in some 
veteran studies. In the analysis extending the follow-up period of workers who were 
exposed to dioxins during the manufacturing process of PCP and TCP (Collins et 
al., 2016), only one case of testicular cancer was reported. Among UK workers 
who manufactured or sprayed phenoxy herbicides (Coggon et al., 2015), five cases 
were reported, resulting in mortality effect estimates that, although elevated, were 
imprecise and not statistically significant for any of the groups of workers.
The committee considered one other study of testicular cancer, but exposure 
characterization was nonspecific, making it of limited value to the evidence base 
for determining associations with testicular cancer. Paoli (2015) recruited patients 
with testicular cancer who had not begun treatment and controls undergoing an 
andrological examination to examine the association between occupational and 
environmental endocrine disruptor exposure and testicular cancer. Serum samples 
were assayed for nine PCB congeners and hexachlorobenzene; however, results 
for specific congeners were not presented. Analyses of potential occupational 
pesticide exposure (pesticides not specified) and possible maternal occupational 
exposure to pesticides found no statistically significant associations.
No valid animal model has been identified for testicular cancer, which has 
 resulted in a paucity of biologic plausibility data for mechanisms relating expo-
sure to one of the COIs with testicular cancer. Based on the findings from studies 
 reviewed in the current and previous updates and the lack of supporting mechanistic 
data, the committee maintains the conclusion of inadequate or insufficient evidence 
for an association between exposure to at least of the COIs and testicular cancer.
Conclusion
Based on the evidence reviewed here and in previous VAO reports, the com-
mittee concludes that there is inadequate or insufficient evidence to determine 
whether there is an association between exposure to the COIs and testicular cancer.
BLADDER CANCER
Urinary bladder cancer (ICD-9 188; ICD-10 C67) is the most common uri-
nary tract cancer. Cancers of the urethra, and paraurethral glands and other or 
unspecified urinary cancers (ICD-9 189.3–189.9; ICD-10 C68) are infrequently 
reported separately; any findings on these cancers would be reported in this 
section. NCI estimated that 81,190 people would receive a diagnosis of bladder 
cancer in the United States in 2018 and that 17,240 people would die from it 
(NCI, n.d.u). For all races combined, the incidence of bladder cancer in males is 
four times higher than in females.
Bladder cancer risk rises rapidly with age. The median age of diagnosis is 
73 years. The age-adjusted modeled incidence rate of bladder cancer for men 
Veterans and Agent Orange: Update 11 (2018)
Copyright National Academy of Sciences. All rights reserved.
306 VETERANS AND AGENT ORANGE: UPDATE 11
 50–64 years old of all races combined was 36.1 per 100,000 in 2014 and  increased 
to 144.5 for 65–74-year-olds and 296.4 for men over 75 years.14 In men in the 
age groups that characterize most Vietnam veterans, bladder cancer incidence is 
nearly twice as high in whites as in blacks. The most important known risk factor 
for bladder cancer is tobacco smoke inhalation, which accounts for about one-half 
of the bladder cancers in men and one-third of them in women  (Cumberbatch 
et al., 2016; Ferrís et al., 2013a). Occupational exposure to hair dyes, aromatic 
amines (also called arylamines), PAHs, and some other organic chemicals used 
in the aluminum, rubber, leather, textile, paint-products, and printing industries is 
associated with higher incidence (Ferrís et al., 2013a,b). In some parts of Africa 
and Asia, infection with the parasite Schistosoma haematobium contributes to the 
high incidence (Ferrís et al., 2013a).
Exposure to inorganic arsenic is also a risk factor for bladder cancer. 
 Although cacodylic acid is a metabolite of inorganic arsenic, as discussed in 
Chapter 4, the data are insufficient to conclude that studies of inorganic-arsenic 
exposure are directly relevant to exposure to cacodylic acid, so the literature on 
inorganic arsenic is not considered in this section. Cacodylic acid constituted 
about 30% of the approximately 4 million liters of Agent Blue mixtures sprayed 
in Vietnam (see Table 2-2), as compared with approximately 44 million liters of 
100% phenoxy herbicide mixtures with various degrees of TCDD contamina-
tion. Moreover, other than studies of exposure in Vietnam, there have been no 
occupational or environmental epidemiologic studies investigating bladder cancer 
incidence or mortality involving direct exposure to cacodylic acid.
Conclusions from VAO and Previous Updates
The committee responsible for VAO concluded that there was limited or sug-
gestive evidence of no association between exposure to the COIs and urinary 
bladder cancer. The conclusion of no increased risk of bladder cancer was based 
largely on the null results from the overarching IARC cohort study of phenoxy 
herbicide production workers and sprayers  (Saracci et al., 1991) and the con-
sistently inconclusive results from studies of additional occupationally exposed 
cohorts, environmentally exposed populations, and two small studies of Vietnam 
veterans. Updates of the IARC cohort, augmented with 12 additional cohorts and 
updated through 1992 (Kogevinas et al., 1997), led the committee responsible for 
Update 1998 to move bladder cancer to the default category of inadequate or insuf-
ficient information to determine whether there is an association. The committees 
responsible for subsequent updates did not change that conclusion. A total of 264 
incident cases and 61 deaths from bladder cancer were reported during follow-up 
of the Korean Veterans Health Study, and the internal comparison analysis of the 
14 As calculated on the site https://seer.cancer.gov/faststats/selections.php?#Output by using SEER 
18 dataset and choosing age-adjusted rates, urinary bladder cancer, all races, and male sex.
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groups with high- versus low-exposure-opportunity scores (Yi and Ohrr, 2014) re-
vealed no difference in the risk of a bladder cancer diagnosis (RR = 0.99, 95% CI 
0.77–1.28). By contrast, Yi et al. (2014b) reported a statistically significant two-fold 
increase in bladder cancer–specific mortality in this same cohort (RR = 2.04, 95% 
CI 1.17–3.55), comparing the high- and low-exposure groups without adjustment 
for smoking. On the basis of those studies and the evidence reviewed in previous 
VAO reports, the Update 2014 committee concluded that there is limited or sugges-
tive evidence of an association between exposure to the COIs and bladder cancer.
Update of the Epidemiologic Literature
No studies of U.S. or international cohorts of Vietnam veterans have been 
published since Update 2014. No environmental or case-control studies of expo-
sure to the COIs and urinary bladder cancer have been published since Update 
2012. Reviews of the relevant studies are presented in the earlier reports. Table 
20, which can be found at www.nap.edu/catalog/25137, summarizes the results 
of studies related to urinary bladder cancer.
Occupational Studies
Among the Dow Midland, Michigan, worker cohort, Collins et al. (2016) 
combined deaths from bladder and other types of urinary cancer (ICD-10 C66–
C68). Compared with the standardized U.S. population, no difference in mortal-
ity for bladder or other urinary cancers was found for the TCP workers (n = 9; 
SMR = 1.26, 95% CI 0.57–2.38) or the PCP workers (n = 4; SMR = 1.13, 95% 
CI 0.31–2.90).
Koutros et al. (2016) used data collected by the AHS to report the associa-
tion of general exposure to herbicides, insecticides, and pesticides with bladder 
cancer. This is a prospective study of 57,310 pesticide applicators from Iowa 
and North Carolina who were enrolled between 1993 and 1997, and whose 
vital status was followed through 2011. Exposure was assessed by an extensive 
questionnaire, allowing for estimates of intensity and duration of exposure, 
and the information was updated from 1999 to 2005. A total of 321 incident 
bladder cancers were  reported. After adjusting for lifestyle and demographic 
factors (including age, race, state of residence, and smoking status), elevated, 
but not statistically significant, risks were associated with use of chlorphenoxy 
herbicides 2,4,5-T (n = 91; RR = 1.15, 95% CI 0.84–1.59), 2,4,5-TP (n = 40; 
RR = 1.07, 95% CI 0.74–1.56), 2,4-D (n = 245; RR = 1.46, 95% CI 0.98–2.18), 
and organochlorine insecticides. There was a decreased risk for exposure to 
dicamba after adjusting for the same factors as above (n = 125; RR = 0.84, 
95% CI 0.62–1.14). Never smokers with the highest use of 2,4,5-T and 2,4-D 
had higher risks of bladder cancer (RR = 2.64, 95% CI 1.23–5.68 and RR = 
1.88, 95% CI 0.94–3.77, respectively), and for both herbicides there was a 
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statistically significant trend of increasing risk with increasing exposure (p = 
0.02). As in other publications from the AHS, concerns included the lack of 
control for multiple comparisons, the small number of cases, and the assess-
ment of exposure based only on recall.
In an extension of the follow-up of UK phenoxy herbicide manufacturers 
and sprayers to examine the carcinogenicity of phenoxy herbicides, Coggon et al. 
(2015) found that mortality from bladder cancer was lower than expected but not 
statistically significant for any of the groups of workers: all workers (n = 44; SMR = 
0.92, 95% CI 0.67–1.23), workers exposed to herbicide levels above background 
(n = 30; SMR = 0.87, 95% CI 0.59–1.25), and workers exposed for more than 1 
year at levels above background (n = 16; SMR = 0.98, 95% CI 0.56–1.59).
Other Identified Studies
Two other studies of bladder cancer among occupational cohorts were identi-
fied: one examined mortality in U.S. workers exposed to mixed PCBs (Ruder et 
al., 2014), and the other examined risk factors among Egyptian agricultural work-
ers (Amr et al., 2015). However, both lacked sufficient exposure specificity to be 
included as contributing to the evidence base of the potential effect of the COIs. A 
third study (Akahane et al., 2017) examined the prevalence of self-reported long-
term health effects (including bladder cancer) in people exposed to PCBs, dioxins 
(e.g., PCDD/Fs), and dioxin-like chemicals through the ingestion of contaminated 
rice bran oil (Yusho accident) compared with an age-, sex- and residential-area-
matched group. Because no TEQs or other quantification of relevant exposures 
was presented, the study was not considered further.
Biologic Plausibility
Cacodylic acid (DMAIII and DMAV) is carcinogenic and has been shown 
to induce urinary bladder cancer in F344 rats (Arnold et al., 2006; Cohen et 
al., 2007b; A. Wang et al., 2009; M. Wei et al., 2002, 2005; S. Yamamoto et al., 
1995). A study by Z. Lin et al. (2015) suggests a carcinogenic process of chronic 
inflammation, bladder epithelium lesions, and proliferation in rat bladder follow-
ing DMAV exposures. Cao et al. (2015) exposed Wistar rats to DMAV and found 
increased TGF-β immunoreactivity in bladder epithelium and increased IL-1β 
secretion in urine.
No studies have reported an increased incidence of urinary bladder cancer 
in TCDD- or 2,4-D-treated animals. Working with tissues from urothelial cancer 
patients, Ishida et al. (2010) found that the activation of the AHR pathway by 
TCDD enhanced bladder cancer cell invasion through an upregulated expression 
of matrix metalloproteinases 1 and 9 and that reduced expression of AHR resulted 
in the inhibition of invasive behavior of urothelial cancer cells. They also found 
that the level of nuclear AHR expression in human upper urinary tract urothelial 
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cancers was positively associated with cancer grade and stage and that it predicted 
poor prognosis. In contrast, transgenic mice that have a deletion of Ahr exhibit 
immune-cell infiltration in bladder submucosa and the loss of e-cadherin in some 
epithelial cells in aged mice (Butler et al., 2012); although direct studies with 
TCDD were not undertaken, these findings suggest a protective effect of AHR 
signaling in bladder cancer.
Synthesis
This update describes three new published studies extending the follow-up 
period of occupational cohorts. Many of the studies reviewed in previous updates 
were characterized by low precision because of the small numbers of exposed 
cases, low exposure specificity, and a lack of ability to control for confounding, 
particularly cigarette smoking, which is a major risk factor for bladder cancer. 
Studies of U.S. Vietnam veterans (including AFHS Ranch Hands, Army veterans 
in the CDC Vietnam Experience Study, and state-specific studies of veterans) 
have not reported statistically significant increased risks of bladder cancer. More 
recent analyses of the Korean Veterans Health Study were well powered but did 
not control for smoking; however, self-reported information on smoking among 
surviving Korean veterans revealed that the distribution of smoking habits was 
similar in high and low EOI-score groups, indicating that the results for bladder 
cancer mortality are unlikely to have been majorly confounded by smoking (Yi et 
al., 2013b). Although Yi and Ohrr (2014) did not observe an increased incidence 
of bladder cancer, Yi et al. (2014b) reported a statistically significant difference in 
mortality from bladder cancer among veterans in the high-exposure-opportunity 
group relative to those in the low-exposure group.
Several positive associations between exposure to specific herbicides or 
their contaminants and bladder cancer mortality have been reported from previ-
ously reviewed occupational studies (Boers et al., 2010; Manuwald et al., 2012; 
 Steenland et al., 1999); however, several other studies of occupational cohorts 
have found minimal or no association with exposure to one of the COIs and blad-
der cancer (Boers et al., 2010; C. J. Burns et al., 2011; McBride et al., 2009a; 
Ruder and Yiin, 2011). Collins et al. (2016) extended the follow-up period of 
workers who were exposed to dioxins during the manufacturing process of PCP 
and TCP in Midland, Michigan, and found slightly elevated, but not statistically 
significant, differences in mortality for bladder or other urinary cancers compared 
with the standardized U.S. population. In contrast, additional follow-up of the 
UK workers who manufactured or sprayed phenoxy herbicides found decreased, 
though not statistically significant, risks for mortality from bladder cancer for all 
three groups of exposed workers (Coggon et al., 2015). An analysis of exposure 
to herbicides, insecticides, and pesticides relative to bladder cancer incidence, 
using data collected by the AHS, found that after an adjustment for lifestyle and 
demographic factors, elevated risks were associated with the use of chlorphenoxy 
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herbicides and organochlorine insecticides (Koutros et al., 2016). Never smokers 
with the highest use of 2,4,5-T and 2,4-D had higher risks of bladder cancer, and 
for both of these herbicides there was a statistically significant trend in increasing 
risk with increasing exposure.
Toxicologic and mechanistic data to support an association between the COIs 
and bladder cancer are limited. Cacodylic acid (DMAIII and DMAV) is carcino-
genic and has been shown to induce urinary bladder cancer in F344 and Wistar 
rats, but no studies have reported an increased incidence of urinary bladder cancer 
in TCDD- or 2,4-D-treated animals. The three new occupational cohort studies 
reviewed by the committee in combination with the prior reviewed literature con-
tinue to support the conclusion of limited suggestive evidence for an association 
of bladder cancer with exposure to the COIs.
Conclusion
Based on the evidence reviewed here and in previous VAO reports, the com-
mittee concludes that there is limited or suggestive evidence of an association 
between exposure to the COIs and urinary bladder cancer.
RENAL CANCERS
Cancers of the kidney other than the renal pelvis (ICD-9 189.0; ICD-10 
C64) and cancer of the renal pelvis (ICD-9 189.1; ICD-10 C65) are often 
grouped in epidemiologic studies; cancer of the ureter (ICD-9 189.2; ICD-10 
C66) is also sometimes included. Although diseases of these organs have dis-
tinct characteristics and could have different risk factors, there is some logic to 
grouping them: the structures are all exposed to filterable chemicals, such as 
PAHs, that appear in urine. NCI estimated that 63,990 men and women would 
receive diagnoses of kidney or renal pelvis cancer in the United States in 2018 
and that 14,400 men and women would die from it. The incidence of renal cancer 
increases with age, and median age of diagnosis is 64 years (NCI, n.d.v). Except 
for Wilms tumor, which is more likely to occur in children, renal cancers are 
more common in people over 50 years old.
In the age groups that include most Vietnam veterans, the age-adjusted mod-
eled incidence rate of kidney and renal pelvis cancers for men 50–64 years old 
of all races combined was 45.3 per 100,000 in 2014 and increased to 93.1 for 
65–74-year-olds and 105.1 for men over 75 years. The incidence rate for men 
is about twice as high as it is for women of the same race. Among men, blacks 
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have the highest incidence rate, whereas among women, both black and American 
Indian/Alaska Natives have the highest incidence rates.15
Tobacco use is a well-established risk factor for renal cancers (Qayyum 
et al., 2013). Obesity is also another risk factor for renal cell carcinoma, and a 
recently published meta-analysis of 21 cohort studies reported an elevated risk 
for renal cancers (RR = 1.77, 95% CI 1.68–1.87) when comparing obese to nor-
mal weight participants (Wang and Xu, 2014). Some rare syndromes—notably, 
von Hippel–Lindau syndrome and tuberous sclerosis—are associated with an 
elevated risk of renal cancer. Other potential risk factors include acetaminophen 
or non-aspirin non-steroidal anti-inflammatory drug use, organic solvents, and, 
in men, a history of kidney stones (Cheungpasitporn et al., 2015; Choueiri et al., 
2014; Qayyum et al., 2013). Firefighters, who are routinely exposed to numerous 
pyrolysis products, have a significantly increased mortality risk after 20 or more 
years of employment (Youakim, 2006).
Conclusions from VAO and Previous Updates
The committee responsible for VAO concluded that there was inadequate 
or insufficient information to determine whether there is an association between 
exposure to the COIs and renal cancers. Additional information available to the 
committees responsible for subsequent updates from Update 1996 through  Update 
2012 did not change that conclusion. Update 2014 identified a single study of renal 
cancer in a follow-up of the Korean Veterans Health Study. Results were reported 
separately for kidney cancer (n = 186 cases) and renal pelvis cancer (n = 23 cases), 
but no excess cancer risk for the kidney or renal pelvis was found when compared 
with the general Korean population (Yi, 2013) or when internal comparisons of 
high- versus low-exposure-opportunity scores were made (Yi and Ohrr, 2014). 
An inverse association for renal cancer risk (HR = 0.74, 95% CI 0.55–1.00) was 
reported, but no association for cancer of the renal pelvis (HR = 1.05, 95% CI 
0.44–2.50). A non-significant increased risk of ureter cancer (ICD-10 C66) was 
also reported. When kidney, renal pelvis, and ureter cancer deaths were combined 
for the internal cohort comparison of high versus low exposure, no excess cancer 
mortality was found (Yi et al., 2014b). Information on smoking or other lifestyle 
habits was not available for this cohort during the follow-up through 2003, and 
thus the modest associations could be due to confounding by smoking or obesity.
15 As calculated on the site https://seer.cancer.gov/faststats/selections.php?#Output by using the 
SEER 18 dataset and choosing age-adjusted rates, kidney and renal pelvis cancers, all races, age ≥ 
50 years, and male sex.
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Update of the Epidemiologic Literature
Two new published studies were identified that addressed exposure to the 
COIs from occupational settings and mortality from renal cancers. No studies 
of renal cancers in Vietnam veterans have been identified since Update 2014. 
Furthermore, no environmental studies or case-control studies of exposure to 
the COIs and renal cancers have been published since Update 2010. Reviews of 
the relevant studies are presented in the earlier reports. Table 21, which can be 
found at www.nap.edu/catalog/25137, summarizes the results of studies related 
to renal cancer.
Occupational Studies
Among the Dow Midland, Michigan, worker cohort that was compared with 
the standardized U.S. population, Collins et al. (2016) found no differences in 
mortality for kidney cancers (C64–C65) for the TCP workers (n = 4; SMR = 0.63, 
95% CI 0.17–1.61) or the PCP workers (n = 4; SMR = 1.37, 95% CI 0.37–3.51).
In an extension of the follow-up of UK phenoxy herbicide manufacturers 
and sprayers to examine carcinogenicity of phenoxy herbicides, Coggon et al. 
(2015) found that mortality from kidney cancer was not statistically significant 
for any of the groups of workers: all workers (n = 23; SMR = 0.87, 95% CI 
0.55–1.31), workers exposed to herbicide levels above background (n = 16; 
SMR = 0.81, 95% CI 0.46–1.32), or workers exposed for more than 1 year at 
levels above background (n = 11; SMR = 1.22, 95% CI 0.61–2.19).
Other Identified Studies
Two other studies that reported outcomes of renal cancer were identified, but 
both lacked sufficient exposure specificity to be included as contributing to the 
evidence base of the potential effect of the COIs (Akahane et al., 2017; Ruder 
et al., 2014).
Biologic Plausibility
Cacodylic acid (DMAIII and DMAV) is carcinogenic and has been shown to 
induce renal cancer. In F344/DuCrj rats treated with a mixture of carcinogens for 
4 weeks, subsequent exposure to DMA (not indicated whether this was DMAIII 
or DMAV) via their drinking water for 24 weeks caused tumor promotion in the 
kidney, liver, urinary bladder, and thyroid gland, but it inhibited induction of 
 tumors of the nasal passages (S. Yamamoto et al., 1995). More recent studies have 
also found that oral exposure of adult mice to 200 ppm DMAV in addition to fetal 
arsenic exposure can act as a promoter of renal and hepatocellular carcinoma, 
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markedly increasing tumor incidence beyond that produced by fetal arsenic ex-
posure alone (Tokar et al., 2012).
No animal studies with exposure to the other COIs have reported an  increased 
incidence of renal cancers.
Synthesis
The available analyses of an association between exposure to the COIs and 
renal cancer risk have been limited by the small number of cases and a lack of 
exposure specificity. Studies of Vietnam veterans have not found statistically 
significant associations between deployment and presumed exposure to the herbi-
cides and incidence or mortality of renal cancers. Similarly, no increases of risk or 
mortality from renal cancers have been reported among the several occupational 
cohorts, for which exposure was often better characterized. Collins et al. (2016) 
 extended the follow-up period of workers who were exposed to dioxins during the 
manufacturing process of PCP and TCP in Midland, Michigan, and reported four 
cases of renal cancer among PCP workers and four cases among TCP workers, 
but in neither group were the risk estimates statistically significant. Coggon et al. 
(2015) identified a total of 23 deaths from renal cancer in the additional follow-
up of the UK workers who manufactured or sprayed phenoxy herbicides, but the 
direction of the risk estimates for mortality from renal cancer was not consistent 
or statistically significant for any of the three groups of exposed workers.
Cacodylic acid (DMAIII and DMAV) is carcinogenic and has been shown to 
induce tumors in the kidneys of F344 rats, but no animal studies with exposure 
to the other COIs have reported an increased incidence of renal cancer. Results 
from two studies that extended the follow-up period of well-characterized occu-
pational cohorts in combination with the prior reviewed literature continue to 
support the conclusion of inadequate or insufficient evidence for an association 
of renal cancers with exposure to the COIs.
Conclusion
Based on the epidemiologic evidence reviewed here and in previous VAO 
reports, the committee concludes that there is inadequate or insufficient evidence 
to determine whether there is an association between exposure to the COIs and 
renal cancers.
BRAIN CANCER
Nervous-system cancers (ICD-9 191–192; ICD-10 C70–C72) involve the 
central nervous system (CNS) and include tumors of the brain and spinal cord, 
the cranial nerves, and the meninges (the outer coverings of the brain and spinal 
cord). Any of the cell types in the CNS can develop into cancer. Tumors of the 
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peri pheral nervous system and autonomic nervous system are considered soft-tis-
sue tumors (ICD-9 171; ICD-10 C38.0, C47, C49). Most cancers that are found in 
the CNS are not primary tumors arising from nervous system tissues, but instead 
represent metastases from other primaries, such as the lung or breast. This sec-
tion focuses on cancers that originate in the CNS. Cancer of the eye (ICD-9 190; 
ICD-10 C69) is included with the results on brain cancer because when cancer 
of the eye is reported, it is often grouped with brain cancer.
About 95% of primary CNS malignancies originate in the brain, cranial 
nerves, and cranial meninges. In people over 45 years old, about 90% of tumors 
that originate in the brain are gliomas—astrocytoma, ependymoma, oligodendro-
glioma, or glioblastoma multiforme. Although the committee was tasked with 
examining all health outcomes that may be associated with exposure to the COIs, 
VA specified that the committee should give particular attention to glioblastoma 
multiforme. Glioblastoma multiforme is the most common brain tumor and has 
the worst prognosis (Muth et al., 2016). Meningiomas make up 20% to 40% of 
CNS cancers; they tend to occur in middle age and are more common in women 
than in men. Most meningiomas are benign and can be removed surgically.
NCI estimated that about 23,880 people would  receive diagnoses of brain 
and other nervous-system cancers in the United States in 2018 and that 16,830 
people would die from them (NCI, n.d.w). Those numbers represent 1.4% of new 
cancer diagnoses and 2.8% of cancer deaths. An estimated 12,000 new cases of 
glioblastoma are diagnosed in the United States each year.16 The incidence of 
brain and other CNS cancers increases with age, and the median age of diagnosis 
is 58 years. The incidence rate for men is higher than for women of the same race. 
By race and sex, whites have the highest incidence rate and American Indian/
Alaska Natives have the lowest incidence rates (NCI, n.d.w). In the age groups 
that include most Vietnam veterans, the age-adjusted modeled incidence rate of 
brain and other nervous-system cancers for men 50–64 years old of all races com-
bined was 11.5 per 100,000 in 2014 and increased to 20.2 for 65- to 74-year-olds 
and 26.2 for men over 75 years.17
In reviewing the descriptive epidemiology of these cancers, it is important 
to recognize the variation with which specific cancers are included in published 
 reports, many of which distinguish between benign and malignant tumors. Another 
variation is whether cancers derived from related tissues (such as the pituitary 
or the eye) are included with CNS cancers. Several types of cancer are usually 
grouped together; although this may bias results in unpredictable ways, the most 
likely consequence is a dilution of risk estimates toward the null.
16 
 Paul Mischel, head of Laboratory of Molecular Pathology at Ludwig Institute for Cancer 
Research San Diego, presentation to the committee, November 30, 2017.
17 As calculated on the site https://seer.cancer.gov/faststats/selections.php?#Output using the SEER 
13 dataset and choosing age-adjusted rates, brain and other nervous-system cancers, all races, age ≥ 
50 years, and male sex.
Veterans and Agent Orange: Update 11 (2018)
Copyright National Academy of Sciences. All rights reserved.
CANCER 315
The only well-established environmental risk factor for brain tumors is 
expo sure to high doses of ionizing radiation (ACS, 2012b; Wrensch et al., 2002). 
Other environmental exposures—such as to petroleum products, electromagnetic 
fields, and cell-phone use—are unproven as risk factors (Gomes et al., 2011; 
Ostrom et al., 2015). The causes of most cancers of the brain and other portions 
of the nervous system are unknown.
Conclusions from VAO and Previous Updates
The committee responsible for VAO concluded that there was limited or 
suggestive evidence of no association between exposure to the COIs and brain 
cancer. The committees responsible for Update 1996, Update 1998, Update 2000, 
Update 2002, and Update 2004 did not change that conclusion.
The committee responsible for Update 2006 changed the classification for 
brain cancer (formally expanding it to include cancers of the eye and orbit) to 
inadequate or insufficient evidence to determine whether there is an association 
between exposure to the COIs and brain cancer. That committee considered one 
study that suggested a relationship between phenoxy acid herbicides and adult 
gliomas (W. J. Lee et al., 2005), studies that reported slightly but not statisti-
cally significantly higher risks of brain cancer in deployed versus non-deployed 
Australian Vietnam-era veterans (ADVA, 2005a,b) and in pesticide applicators in 
the AHS (Alavanja et al., 2005), and several studies that had essentially neutral 
findings (Carreon et al., 2005; Magnani et al., 1987; McLean et al., 2006; Ruder 
et al., 2004; Torchio et al., 1994).
The committees for Update 2008, Update 2010, and Update 2012 reviewed 
several new occupational, environmental (including updates of the Seveso 
cohort), case-control, and Vietnam-veteran studies, but maintained that brain 
cancer should remain in the inadequate or insufficient category, given the largely 
null findings and that several studies did not specify the chemicals of exposure.
The Update 2014 committee reviewed two studies of Vietnam veterans. 
In a retrospective study of mortality outcomes in three cohorts of U.S. military 
women—4,734 who served in Vietnam, 2,062 who served in countries near 
 Vietnam, and 5,313 who served primarily in the United States—no association 
was found between any cohort and brain or nervous-system cancers (H. K. Kang 
et al., 2014a). In a sub-analysis, nurses who served in Vietnam had a statisti-
cally significantly higher risk of brain cancer death than nurses who served in 
the United States (adjusted RR = 4.61, 95% CI 1.27–16.83), but nurses who 
served near Vietnam did not have an elevated risk (adjusted RR = 2.12, 95% CI 
0.42–10.83) although both estimates were imprecise. None of the other studies 
of U.S. or international Vietnam veterans found statistically significant associa-
tions between exposure to the COIs and brain cancer. The U.S. Vietnam veterans 
nurses study is limited by the issue of multiple comparisons, the possibility of 
false positives, and imprecise risk estimates.
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Update of the Epidemiologic Literature
Because glioblastoma multiforme was specifically noted as an outcome of im-
portance in the committee’s Statement of Task, a targeted literature search for this 
outcome was undertaken. No date or language parameters were applied, and a total 
of 153 articles were found. Each was reviewed for relevance against the COIs and 
checked against the previous VAO reports. Using those criteria, only two epidemio-
logic studies were identified that had exposure to one of the COIs, were published 
before 2014, and had not previously been reviewed. Both studies are summarized 
in this section. No new published literature of Vietnam veterans that addressed 
exposure to the COIs and brain cancers was identified by the committee for the 
current update. Furthermore, no environmental studies of exposure to the COIs 
and brain cancer have been published since Update 2012. Reviews of the relevant 
studies are presented in the earlier reports. Table 22, which can be found at www.
nap.edu/catalog/25137, summarizes the results of studies related to brain tumors.
Occupational Studies
Although the results are not brain-cancer specific, but rather presented as 
cancers of the CNS (C70–C72), Collins et al. (2016) reported on the causes of 
mortality among the Dow Midland, Michigan, worker cohort. Few cases of CNS 
cancers were identified: three among TCP workers and one among PCP workers, 
again making reported risk estimates unreliable. Compared with the standardized 
U.S. population, no differences in mortality for CNS cancers were found for the 
TCP workers (SMR = 0.47, 95% CI 0.10–1.38).
In the Coggon et al. (2015) extension of the follow-up of UK phenoxy 
herbicide manufacturers and sprayers to examine carcinogenicity of phenoxy 
herbicides, no differences in mortality from brain and CNS cancers were found 
for any of the groups of workers when compared with the standardized population 
of Great Britian: all workers (n = 33; SMR = 1.15, 95% CI 0.79–1.62), workers 
exposed to herbicide levels above background (n = 25; SMR = 1.15, 95% CI 
0.74–1.70), or workers exposed for more than 1 year at levels above background 
(n = 10; SMR = 1.04, 95% CI 0.50–1.92).
Case-Control Studies
Brownson et al. (1989) conducted a case-control study using data from 
the Missouri Cancer Registry to examine the association between employment 
in certain industries and specific occupations with brain cancer. A total of 312 
cases (all white males diagnosed with histologically confirmed brain and other 
CNS cancer between 1984 and 1988) were studied. Each case was frequency 
matched to four controls, white males diagnosed with other cancers who were 
randomly selected from each of six age strata and information on occupation 
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(usual or longest held) and tobacco smoking history (never, former, current). 
Odds ratios were calculated and adjusted for age and smoking status. Addi-
tional analyses were conducted for specific brain cancers, including unspeci-
fied astrocytomas, unspecified glioblastomas, anaplastic astrocytomas, and other 
(oligodendrogliomas, unspecified cell types, and unspecified ependymomas). 
Although specific exposures were not collected and many of the categories had 
small numbers of people, a statistically significant excess of brain cancer was 
associated with agricultural work (22 cases and 62 controls, OR = 1.5, 95% CI 
1.0–2.4) and printing and publishing work (6 cases and 36 controls, OR = 2.8, 
95% CI 1.0–8.3), although the effect estimate for the printing industry was quite 
imprecise. Comparisons by occupation found an excess risk associated with 
 social science professionals (6 cases and 4 controls, OR = 6.1, 95% CI 1.5–26.1) 
and police and fire protection professionals (12 cases and 22 controls, OR = 2.2, 
95% CI 1.0–4.7), but these estimates were imprecise and limited by specific 
exposure information and the small number of individuals reporting such occu-
pations. Furthermore, no excess of brain cancer was found for farming (21 cases 
and 80 controls, OR = 1.1, 95% CI 0.6–1.7), food production (3 cases and 8 
controls, OR = 1.6, 95% CI 0.3–6.8), or laborers other than construction (7 cases 
and 46 controls, OR = 0.6, 95% CI 0.2–1.4). Analyses by histologic type of brain 
cancer found elevated, but imprecise, risks of “other” cell types for workers in the 
agricultural industry (OR = 5.3, 95% CI 1.9–14.3) and for occupation of farmer 
(OR = 3.7, 95% CI 1.4–9.8). When cases and controls were compared by tobacco 
smoking status, no difference in risk for brain cancer was found. The study is 
limited by the lack of specific exposure information; industry and occupation 
information was incomplete in the registry (of the initially eligible subjects, 
34% of cases and 38% of controls were excluded from the final sample due to 
missing information), restricted to “usual” or “longest held” job, and obtained 
from the medical record at the time of diagnosis and subject to misclassification. 
Therefore, while these data are consistent with some other studies that suggest 
an agricultural chemical exposure risk for brain cancer, they are very nonspecific 
and must be considered exploratory.
Other Identified Studies
Three other studies of brain cancer were identified, but all lacked sufficient 
exposure specificity to be included as contributing to the evidence base of the 
potential effect of the COIs. One examined causes of mortality in U.S. workers 
exposed to mixed PCBs (Ruder et al., 2014). Bencko et al. (2009) was an ecologi-
cal study that compared the 10-year incidence of selected cancers, including brain 
cancer, in known PCB/TCDD-contaminated regions of the Slovak Republic and 
the Czech Republic. A third study (Akahane et al., 2017) examined the preva-
lence of self-reported long-term health effects, including brain tumors, in people 
 exposed to PCBs, dioxins (e.g., PCDD/Fs), and dioxin-like chemicals through the 
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ingestion of contaminated rice bran oil (Yusho accident) compared with an age-, 
sex- and residential-area-matched group. Because no TEQs or other quantification 
of relevant exposures was presented, the study was not considered further.
Invited Presentations to the Committee
Given the dearth of new studies that examined exposure to the COIs and 
brain cancer (particularly glioblastoma multiforme), and because this outcome 
was specified in the committee’s Statement of Task, the committee invited pre-
sentations by VA (to hear of their specific concerns, questions, and continuing 
research initiatives regarding glioblastoma multiforme), by experts on the epide-
miology and molecular pathology of glioma, and by veterans and their families. 
Hearing from the scientific experts ensured that the committee had information 
that was as complete and current as possible regarding the science of glioblas-
toma, whereas hearing from the families of veterans who had been diagnosed 
with glioblastoma provided a reminder of the burden of the disease. The com-
mittee appreciates the efforts of all presenters and members of the public who 
attended the open session and their willingness to provide information for the 
committee’s consideration.
Quinn Ostrom, Ph.D., from Case Western Reserve University, presented a 
review of the epidemiology of glioma, which included population estimates of 
its incidence and prevalence as well as its distribution by demographic factors. 
Although a relatively small number of all new cancer cases each year origi-
nate in the brain or nervous system for both men and women (1.6% and 1.2%, 
 respectively), they account for 3% of deaths from cancer each year. Dr. Ostrom 
reported that the overall incidence of primary brain and CNS tumors is 22.6 
per 100,000 and that almost one-third of these tumors (31.5%) are malignant. 
Gliomas are the most common type of malignant brain tumor, accounting for 
approximately 26.6% of all primary brain tumors and nearly 80% of malignant 
brain tumors. There are multiple subtypes of glioma, with glioblastoma being the 
most common (56.1%). The incidence of glioblastoma increases with age and 
peaks at 75–79 years for both males and females; the median age of diagnosis 
is 64 years. In the United States, incidence is about 50% higher in males than 
in females, highest for non-Hispanic whites, and associated with higher socio-
economic status. This review highlighted the stark fact that there has been little 
change in the incidence rate of glioblastoma since the 1990s and little progress 
eliciting clear risk factors. Consistent with the prior updates by VAO committees, 
this committee found that while numerous environmental risk factors have been 
studied, no environmental factors accounting for glioma have been identified. Of 
interest, about 25% of glioma risk is estimated to be genetic, and current research 
has identified 12 common genetic variants that explain appro ximately 27% of the 
genetic risk for glioblastoma. Accepted non-genetic risk factors include exposure 
to ionizing radiation and a history of respiratory allergies and atopic disease, 
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specifically asthma and eczema. While associations with other exposures have 
been studied, including herbicide exposure, no additional accepted risk factors 
(including immune suppression arising from various exposures) have been found.
A presentation by Paul Mischel, M.D., which highlighted the fast- moving 
research into the basic science of glioblastoma, concentrated on both new dis-
coveries and their implications for understanding controversies concerning the 
mechanisms responsible for the aggressive nature of this disease. Many fun-
damental characteristics of this tumor—one of the cancers that has been most 
well characterized genetically by NCI’s Cancer Genome Atlas initiative—have 
been well described, and research has identified some of the discrete pathways 
involved in its development and elucidated some of the factors underlying its 
mutational diversity, including copy number alterations and point mutations, 
insertions and deletions, and the role of extrachromosomal DNA. These novel 
mechanisms may fundamentally change how we think about the evolution of this 
(and other) cancers. At the same time, this understanding of the basic biology has 
so far not directly led to new treatment options.
VA representatives, who reiterated the origin of the VAO series and the cur-
rent committee’s specific charge, presented data on overall brain cancer incidence 
from VA administrative databases and summarized the results of selected studies of 
brain cancer in different populations of veterans. All of the published studies they 
presented had been reviewed by previous VAO Update committees. In the final part 
of its presentation, VA representatives informed the committee of the department’s 
current and planned studies of brain cancer in Vietnam veterans. The planned 
studies included an update of the causes of mortality of deployed and Vietnam-era 
veterans from 1979 through 2014 and an exploratory study of self-reported expo-
sures and different types of brain cancer using information, in part, from the Agent 
Orange Registry. VA has completed a new national survey on the current health of 
deployed and nondeployed Vietnam-era veterans ( VE-HEROeS); however, none of 
the results were published in time for the committee’s consideration. The commit-
tee supports VA’s continued research efforts and urges the department to continue 
to conduct rigorous and thorough epidemiologic investigations of veterans’ health 
issues, but cautions that these are unlikely to yield information on the association 
between exposure to the COIs and brain cancers..
Finally, the committee also heard from family members and widows of 
veterans who died from brain cancer and who are working to have VA recognize 
the diagnosis of brain cancer, specifically glioblastoma, as a presumptive disease 
associated with exposure to the herbicides used in Vietnam. Their presentations 
were compelling and heartfelt. One such effort discussed was Sierra Valley 
Cancer Registry Services, which is a registry that collects self-reported informa-
tion related to exposures and confirmed diagnosis of glioblastoma for Vietnam 
veterans. As of 2017, the registry contains information on 372 Vietnam veterans 
who have been diagnosed with glioblastoma.
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Biologic Plausibility
The committee did not identify any animal studies that have reported an 
asso ciation between exposure to the COIs and brain cancer.
In a study of the role of the AHR–MYCN oncogene in neuroblastoma, 
P. Y. Wu et al. (2014) reported that AHR was inversely correlated with MYCN 
expression in neuroblastoma tissues, but found AHR expression to be highly 
correlated with the histological grade of differentiation. This correlation was con-
firmed in a further study of 14 human neuroblastoma samples. Dever et al. (2012) 
found that AHR promotes proliferation in medulloblastoma cells.  Silginer et al. 
(2016) identified a signaling network comprising integrins, AHR, and TGF-β in 
a human glioma cell line. AHR mediates integrin control of the TGF-β pathway; 
TGF-β contributes to the malignancy of glioblastoma by “promoting invasive-
ness and angiogenesis, maintaining tumor cell stemness and inducing profound 
immunosuppression” (p. 3260).
Recent work relevant to glioblastoma elucidates a role for AHR activation 
by endogenous ligand kynurenine (Beischlag et al., 2016; Platten et al., 2012a,b). 
The activation of AHR by kynurenine resulted in tumor growth, invasiveness, and 
immunosuppression (Platten et al., 2012a). Genes that may mediate the promotion 
of tumor growth and invasiveness include interleukins 1β, IL-6, IL-8, epiregulin 
and aldehyde dehydrogenase 1 family, member A3 (Platten et al., 2012b).
Synthesis
Studies of Vietnam veterans have not found statistically significant associa-
tions between deployment and presumed exposure to the herbicides and incidence 
or mortality of brain or other nervous-system cancers. Many of the studies con-
ducted among U.S. Vietnam veteran cohorts were underpowered. Similarly, no 
increases of risk or mortality from brain and CNS cancers have been reported 
among the several occupational cohorts, for which exposure was often better 
characterized. Collins et al. (2016) extended the follow-up period of workers 
who were exposed to dioxins during the manufacturing process of PCP and TCP 
in Midland, Michigan, and reported four cases total of brain and other nervous- 
system cancers resulting in decreased risk estimates that were not statistically 
significant.  Coggon et al. (2015) identified a total of 33 brain and nervous-system 
cancer deaths in the additional follow-up of the UK workers who manufactured 
or sprayed phenoxy herbicides, but no increased risk was observed for any of the 
three groups of  exposed workers. Brownson et al. (1989), used a case-control de-
sign and reported some small but statistically significant elevations in risk associ-
ated with several occupations. However, the study lacked exposure estimates and 
was underpowered and potentially biased by missing data, and, ultimately, the 
committee considered it an exploratory analysis and did not give it full weight.
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Given the limited epidemiologic data available on glioblastoma, the com-
mittee heard invited presentations from two glioblastoma experts. While the 
presentations to the committee were helpful and impressive, demonstrating that 
the biological understanding of glioblastoma is rapidly advancing, they reinforced 
the absence of clear data suggesting that the COIs are associated with the occur-
rence of brain cancers.
The committee did not identify any animal studies that have reported an 
association between exposure to the COIs and brain cancer. AHR was found 
to be inversely correlated with MYCN expression but highly correlated with 
the histological grade of differentiation in neuroblastoma tissues in a small 
sample of  human cases. Recent research has shown that AHR mediates integrin 
control of the TGF-β pathway and that TGF-β contributes to the malignancy of 
 glioblastoma. The new epidemiologic and mechanistic data reviewed in this up-
date along with the presentations to the committee from experts in the field were 
not sufficient to alter the committee’s conclusion that the evidence is inadequate 
or insufficient to determine whether there is an association between exposure to 
the COIs and brain or other nervous-system cancers.
Conclusion
Based on the epidemiologic evidence from new and previously reported 
studies of populations that had potential exposure to the COIs, the committee 
concludes that there is inadequate or insufficient evidence to determine whether 
there is an association between exposure to the COIs and brain cancer or other 
nervous-system cancers.
The committee believes it is appropriate for VA to be mindful of the concerns 
raised about the possible association between Vietnam service and glioblastoma 
but observes that the outcome is so rare and the information concerning herbi-
cide exposures so imprecise that is doubtful that any logistically and economi-
cally feasible epidemiologic study of veterans—no matter how well designed or 
executed —would produce meaningful results. The committee therefore rec-
ommends that VA not seek to undertake such an epidemiologic study and 
instead to focus on fostering advancements in other areas that may be used 
to inform improved treatment options.
ENDOCRINE CANCERS
Cancers of the endocrine system have a disparate group of ICD codes: 
 thyroid cancer (ICD-9 193; ICD-10 C73) and other endocrine cancers including 
the thymus (ICD-9 164.0, 194; ICD-10 C37, C74, C75). According to NCI, in the 
United States in 2018 there would be an estimated 53,990 new diagnoses of and 
2,060 deaths from thyroid cancer (NCI, n.d.x). NCI does not report estimates of 
other endocrine cancers, but the American Cancer Society estimated that 1,210 
Veterans and Agent Orange: Update 11 (2018)
Copyright National Academy of Sciences. All rights reserved.
322 VETERANS AND AGENT ORANGE: UPDATE 11
men and 1,170 women would receive diagnoses of other endocrine cancers in 
2017 and that 520 men and 480 women would die from them (Siegel et al., 2017).
Thyroid cancer is the most prevalent endocrine cancer. The thyroid contains 
two main types of cells: follicular cells, which synthesize and store thyroid 
hormones and synthesize thyroglobulin, and C cells, which synthesize the hor-
mone calcitonin, which regulates calcium metabolism. Malignancy can develop 
from any cell type. The four main types of thyroid cancer are papillary cancer, 
follicular cancer, anaplastic cancer, and medullary carcinoma (Wiltshire et al., 
2016). Papillary carcinoma is the most common and accounts for the major-
ity of the increasing incidence rate (Lubitz and Sosa, 2016). It usually affects 
women of childbearing age; the most common variant of papillary carcinoma is 
the follicular subtype (also known as mixed papillary–follicular variant), which 
metastasizes slowly and is the least aggressive type of thyroid cancer. Follicular 
carcinoma (or follicular adenocarcinoma), which is associated with inadequate 
dietary iodine intake, accounts for about 10% of all cases and has greater rates 
of recurrence and metastasis. Medullary carcinoma, a cancer of the parafollicular 
cells in the thyroid, is less common (4% of all cases) and tends to occur in fami-
lies. Anaplastic carcinoma (also called giant-cell cancer and spindle-cell cancer) 
is rare but is the most aggressive form of thyroid cancer; it does not respond to 
radioiodine therapy and metastasizes quickly, invading such nearby structures as 
the trachea and causing compression and breathing difficulties.
Thyroid cancer can occur in all age groups, but the median age of diagnosis 
is 51 years (NCI, n.d.x). As radiation exposure is recognized as a risk factor for 
thyroid cancer, increased incidence is being observed in people who received 
radiation therapy directed at the neck (a common treatment in the 1950s for 
enlarged thymus, adenoids, and tonsils and for skin disorders) or who were 
exposed to iodine-125, for example, from the Chernobyl nuclear power-plant 
accident. If the radiation exposure occurred in childhood, then the risk of thyroid 
cancer is further increased. In the age groups that include most Vietnam veterans, 
the age-adjusted modeled incidence rate of thyroid cancer for men 50–64 years 
old of all races combined was 13.4 per 100,000 in 2014 and increased to 21.5 
for 65- to 74-year-olds before decreasing to 16.5 for men over 75 years.18 The 
incidence rate of thyroid cancer is about three times higher in women than in men 
of the same race. Whites and Asian/Pacific Islanders have the highest incidence 
rates for both sexes (NCI, n.d.x). Other risk factors are a family history of thyroid 
cancer and chronic goiter. Adrenal and pituitary cancers are much less common 
than thyroid cancers. Benign adenomas are more common than malignancies in 
these endocrine glands.
18 As calculated on the site https://seer.cancer.gov/faststats/selections.php?#Output by using the 
SEER 13 dataset and choosing age-adjusted rates, thyroid, all races, age, and male sex.
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Conclusions from VAO and Previous Updates
The committees responsible for VAO, Update 1996, Update 1998, Update 
2000, Update 2002, and Update 2004 did not report endocrine cancers as a sepa-
rate outcome and therefore reached no conclusion as to whether there was an 
association between exposure to the COIs and endocrine cancers. The committees 
responsible for Update 2006, Update 2008, Update 2010, and Update 2012 did 
consider endocrine cancers separately and concluded that there was inadequate 
or insufficient evidence to determine whether there is an association between 
the COIs and endocrine cancers. Analysis of incidence and mortality of cancers 
in the Korean Veterans Health Study was reviewed in Update 2014. There were 
no statistically significant differences in the incidence of or death from thyroid 
cancer when compared to the general Korean population; nor were there differ-
ences between the high- and low-exposure groups (Yi and Ohrr, 2014). However, 
based on 11 deaths, a statistically significant association between exposure and 
thyroid cancer–specific mortality was found both when analyzed in terms of log 
increments in the exposure opportunity scores and when comparing high- versus 
low-exposure groups (Yi et al., 2014b). The small number of cases and imprecise 
estimates did not change the conclusion that there was inadequate or insufficient 
evidence to determine whether there is an association between the COIs and 
endocrine cancers.
Update of the Epidemiologic Literature
No environmental or case-control studies of exposure to the COIs and thy-
roid or other endocrine cancers have been published since Update 2012. Reviews 
of the relevant studies are presented in the earlier reports. Table 23, which can be 
found at www.nap.edu/catalog/25137, summarizes the results of studies related 
to endocrine cancers (thyroid, thymus, and other).
Vietnam-Veteran Studies
Le et al. (2016) performed a retrospective review of the VA Corporate Data 
Warehouse database from all VA sites from October 1, 1999, to December 21, 
2013, to examine incident cases of thyroid cancer based on ICD-9 codes. No 
 pathology was available, and no clinical information on the patients was reported. 
A total of 19,592 thyroid cancer cases were identified, 42% of which were among 
Vietnam-era veterans. Agent Orange exposure was obtained from VA records and 
was determined by self-report at first visit to the VA system. The authors found a 
statistically significantly higher proportion of self-reported Agent Orange expo sure 
among thyroid cancer patients (10.0%) compared with the general VA health care 
population (6.2%) (p < 0.0001). However, this analysis is limited by the absence 
of pathology reviews of identified cases, no reporting of histological subtypes, and 
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no adjustment or inclusion of additional information on comorbidities or other 
risk factors. Furthermore, the exposure to Agent Orange was based on self-report.
Occupational Studies
In an extension of the follow-up of UK phenoxy herbicide manufacturers 
and sprayers to examine the carcinogenicity of phenoxy herbicides, Coggon et 
al. (2015) reported a total of 3 deaths from thyroid cancer. With limited deaths, 
mortality risk estimates were imprecise and not statistically significant for any 
of the groups of workers.
Other Identified Studies
Four other studies were identified that reported outcomes of thyroid cancer, 
but all lacked sufficient exposure specificity to be included as contributing to the 
evidence base of the potential effect of the COIs. The first examined  mortality 
from malignant neoplasms of the thyroid gland in an occupational cohort of 
 capacitor manufacturers who were exposed to dioxin-like and non-dioxin-like 
PCBs (Ruder et al., 2014). The second study (Benedetti et al., 2017) was an Ital-
ian environmental study that performed an ecological analysis of thyroid cancer 
(and other cancer) incidence rates at 14 Italian priority contaminated sites and 
compared the rates among those sites. The third study looked for clusters of thy-
roid cancer in an Andean town in Colombia using a spatial analysis of aggre gated 
data (smoothed standardized incidence ratios at census tracts) and point data 
(individual case location) to determine if clusters of thyroid cancer in this region 
were associated with industrial sources of air pollution, which included PCDD/
Fs (Arias-Ortiz et al., 2018). The final study (Akahane et al., 2017) examined the 
prevalence of self-reported long-term health effects (including thyroid cancer) 
in people exposed to PCBs, dioxins (e.g., PCDD/Fs), and dioxin-like chemicals 
through the ingestion of contaminated rice bran oil (Yusho accident) compared 
with an age-, sex- and residential-area-matched group. Because no TEQs or other 
quantification of relevant exposures was presented, the study was not considered 
further.
Biologic Plausibility
NTP conducted carcinogenesis bioassays in Osborne-Mendel rats and 
B6C3F1 mice that were exposed to TCDD by gavage (NTP, 1982a). The inci-
dence of follicular-cell adenoma, but not of carcinoma, increased with increasing 
TCDD dose in male and female rats; the increase was significant in male but 
not in female rats. There was a significant increase in follicular-cell adenoma 
in  female but not in male mice. NTP then carried out a similar study in female 
Sprague Dawley rats (NTP, 2006), and Walker et al. (2006) compared the data 
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from that study and the results of the Dow Chemical assessment of TCDD 
carcino genicity (Kociba et al., 1978). In the NTP and Dow studies, the incidence 
of C-cell  adenoma and carcinoma decreased with an increasing dose of TCDD. 
However, an increased incidence of mild thyroid follicular-cell hypertrophy was 
noted in rats that were given TCDD at 22 ng/kg of body weight or more. A more 
recent 2-year NTP study (Yoshizawa et al., 2010) treated female Sprague Dawley 
rats with TCDD, 2,3,4,7,8-pentachlorodibenzofuran, dioxin-like PCB  congeners 
(PCB 126 or PCB 118), a non-dioxin-like PCB (PCB 153), or mixtures of these 
chemicals; it did not find any increases in either thyroid adenoma or carcinoma. 
Thus, although human and animal studies showed that dioxin and dioxin-like 
chemicals alter thyroid hormones and increase follicular-cell hyperplasia, there is 
little evidence of an increase in thyroid cancer. There are some reports of thera-
peutic treatment with arsenic trioxide and later development of thyroid cancer 
(Au et al., 2014; Firkin, 2014), raising the possibility of an association between 
arsenic and a risk of this malignancy. DMA treatment via the drinking water for 
24 weeks caused increases in the incidence of thyroid hyperplasia and adenoma, 
but not of adenocarcinoma, in male F344/DuCrj rats that were first exposed for 
4 weeks to a mixture of five carcinogens to induce tumor initiation in a wide 
range of tissues (S. Yamamoto et al., 1995). These increases were statistically 
significant at DMA doses of 200 and 400 ppm, but not at 50 or 100 ppm. Animals 
treated with 200 and 400 ppm DMA but not given the carcinogens did not de-
velop thyroid lesions, which is consistent with the absence of elevated incidences 
of endocrine organ tumors in other bioassays with DMA (see Chapter 4).
As indicated in Chapter 4, 2,4-D and 2,4,5-T are at most weakly mutagenic or 
carcinogenic, and no studies that addressed a possible association between expo-
sure to those herbicides and thyroid cancer in animal models have been identified.
Synthesis
The studies of Vietnam veterans and of occupational cohorts reviewed in pre-
vious updates did not provide compelling evidence to determine whether there is 
an association between exposure to the COIs and cancers of the endocrine organs. 
Although Le et al. (2016) found an increased incidence of thyroid cancer among 
VA health care users who self-reported exposure to Agent Orange, the study had 
several limitations, including self-reported, unconfirmed Agent Orange exposure 
and a lack of pathology confirmation of thyroid carcinomas. The small number 
of thyroid cancer deaths and the imprecise risk estimates identified among the 
UK phenoxy herbicide manufacturers and sprayers limited those findings as well. 
Few animal studies have been conducted examining the association between 
TCDD, dioxin-like PCBs, or DMA and thyroid cancer, but the results were incon-
sistent. Consequently, given the limitations of the new epidemiologic studies 
and the inconsistent results of the animal studies, the committee maintains that 
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the evidence is inadequate or insufficient to determine an association between 
exposure to the COIs and thyroid and other endocrine cancers.
Conclusion
Based on the epidemiologic evidence reviewed here, the committee concludes 
that there is inadequate or insufficient evidence to determine whether there is an 
association between exposure to the COIs and thyroid or other endocrine cancers.
LYMPHOHEMATOPOIETIC CANCERS
Lymphohematopoietic cancers (LHCs) constitute a heterogeneous group 
of clonal hematopoietic disorders including leukemias, lymphomas, and mul-
tiple myeloma. They are among the most common types of cancer induced by 
environmental and therapeutic agents. As with other cancers that are subject to 
evolving and complex grouping in reports of the results of epidemiologic studies 
(notably, head and neck cancers and gastrointestinal cancers), the conclusions 
that the VAO committees have drawn about associations between exposure to the 
COIs and specific LHCs have been complicated by the lack of specificity and by 
inconsistencies in groupings in the available evidence. For LHCs, that has been 
a function not only of epidemiologists seeking to combine related cancers to pro-
duce categories that have enough cases to permit statistical analysis, but also of 
a continuous evolution of the system used by the medical community to classify 
these malignancies. The categorization of cancers of the lymphatic and hema-
topoietic systems has changed over time, guided by growing information about 
somatic mutation, gene expression, and subclonal lineage of the cancer cells that 
characterize each of a broad spectrum of neoplasms arising in these tissues (Jaffe, 
2009). The WHO categorization presented in the WHO Classification of Tumours 
of Haematopoietic and Lymphoid Tissue (WHO, 2008) bases its primary partition 
on whether the cancer cells are of myeloid or lymphoid origin (see Figure 7-1). 
This classification was updated in 2016 and reviewed by several academics and 
clinicians (Arber et al., 2016; Swerdlow et al., 2016), but the revised “blue book” 
has not yet been published.
Stem cells arising in the bone marrow generate two major lineages of leuko-
cytes: myeloid and lymphoid. Myeloid cells include monocytes and three types 
of granulocytes (neutrophils, eosinophils, and basophils). Lymphoid cells include 
T and B lymphocytes and a smaller set of cells called natural killer cells. All of 
these mature cells circulate in the blood and are collectively referred to as white 
blood cells or leukocytes. Monocytes move out of the bloodstream into inflamed 
tissues, where they differentiate into macrophages or dendritic cells. Progenitor 
cells that are destined to become T lymphocytes migrate from the bone marrow 
to the thymus, where they acquire antigen-specific receptors. Antigen stimulation 
induces the T cells to differentiate into several subtypes involved in cell-mediated 
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immunity, immune regulation, and the facilitation of B-cell function. Progeni-
tor or pre-B cells mature in the bone marrow into antigen-specific B cells. On 
 encountering their cognate antigens, B cells differentiate into antibody-secreting 
plasma cells involved in humoral immunity.
LHCs originate in specific pluripotent or lineage-restricted cells at differ-
ent stages in hematopoiesis and immune-cell development. The normal cells 
are transformed into a malignant cell population through a multistep process 
that involves genetic and epigenetic alterations. Traditionally, LHCs have been 
 divided into leukemias, lymphomas, myelomas, and so on, according to their cell 
type and site of origin (see Figure 7-1). Additional morphologic, cytochemical, 
and immunophenotypic data are used to characterize LHCs further and to further 
divide them into distinct subtypes.
Leukemias occur when a myeloid stem cell residing in the bone marrow 
becomes transformed, resulting in a failure of differentiation and a resistance to 
normal feedback on cellular proliferation. As the leukemic cells (blasts) fill the 
bone marrow, they actively secrete cytokines that prevent normal cellular prolif-
eration, leading to reduced circulating normal blood cells. In addition, changes in 
adhesion molecules allow the release of these immature cells into the peripheral 
blood. Leukemias are generally classified as myeloid or lymphoid, depending 
on the lineage of the malignant cell population. If the original mutated cell of 
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FIGURE 7-1 Hematopoiesis of stem cell differentiation.
SOURCE: © Winslow, 2007. U.S. government has certain rights.
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a cancer of the blood arises in a lymphoid progenitor, then the malignancy is 
termed lymphocytic leukemia; lymphocytic leukemias have been further parti-
tioned into acute lymphoblastic leukemia (ALL) (also known as acute lymphoid 
leukemia or acute lymphocytic leukemia), which is derived from precursor B 
or T lymphoid stem cells, and chronic lymphocytic leukemia (CLL), which is 
a “mature B-cell neoplasm” arising from a transformed B lymphocyte. Myeloid 
leukemias arise from a myeloid hematopoietic stem cell and are classified into 
acute (AML) and chronic (CML) forms.
Lymphoma is a general term for malignancies that arise from lymphocytes 
(B, T, or natural killer cells). Lymphomas generally present as solid tumors at 
lymphoid proliferative sites, such as lymph nodes and the spleen. As stem cells 
mature into B or T cells, they pass through several developmental stages, each 
with unique functions. The developmental stage of the malignant cell defines the 
subtype of lymphoma. About 85% of lymphomas are of B-cell origin, and 15% 
are of T-cell or natural killer–cell origin (Jaffe et al., 2001; Liao et al., 2012). 
There are two major types of B-cell lymphomas: HL, previously referred to 
as Hodgkin disease, and NHL. B cells give rise to a wide array of neoplasms, 
which are characterized by the stage at which B-cell development was arrested, 
as well as by the surface protein expression and the genetic characteristics of the 
 malignant cells. Follicular, large-cell, and immunoblastic lymphomas result when 
a malignancy develops after a B cell has been exposed to antigens. CLL is a 
tumor of antigen-experienced (memory) B cells (Chiorazzi et al., 2005); small 
lymphocytic lymphoma involves the same cells as CLL, but presents primarily in 
lymph nodes rather than in the bone marrow and blood and is therefore a variant 
of the same disease (Jaffe et al., 2008).
Multiple myeloma is a lymphohematopoietic malignancy derived from 
antibody -secreting plasma cells, which also have a B-cell lineage, that accumu-
late primarily in the bone marrow but may also infiltrate extramedullary sites. The 
related condition amyloid light chain (AL) amyloidosis also arises from B cell–
derived plasma cells and reflects an abnormal deposition of antibody-derived light 
chains. It occurs as a complication in 5–15% of patients with multiple myeloma, 
and may also occur without evidence of frank multiple myeloma. Monoclonal 
gammopathy of undetermined significance (MGUS) is a clonal proliferation of 
plasma cells condition that may progress to multiple myeloma.
The ICD system partitions these malignancies into leukemias and lympho-
mas based primarily on whether the cancer cells circulate in the blood (dissemi-
nated) or  appear in the lymphatic tissues, respectively, before subdividing by cell 
type. The emerging WHO classification of lymphohematopoietic malignancies 
(Campo et al., 2011; Jaffe, 2009) stratifies malignancies of the blood and lymph 
nodes into disease categories by their cell lineages—lymphoid or myeloid—as 
shown in  Figure 7-1. It represents a substantial advance in understanding the 
biologic paths by which these malignancies develop. Since the new WHO clas-
sification has not yet been definitively approved, the committee decided that it 
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would not be productive to reformulate this entire section to correspond to the new 
WHO categories. In practice, LHCs have routinely been reported in a variety of 
groupings, so it is a continuing challenge to parse out results, noting when results 
for broader groupings are presented in the supplementary tables for several more 
specific  diagnoses, while recognizing that the specific results may be confounded 
by being “misclassified” with other entities. Most epidemiologic studies already 
in the evidentiary database that specifed diseases precisely used codes from ICD-9 
or earlier versions, but some recent studies have applied ICD-10. Furthermore, 
the existing records that will serve as the basis of many current and even future 
studies will use earlier and evolving classifications, so a confounding of classifi-
cation is likely to remain, even in new literature. The nomenclature has become 
more uniform in recent studies, but the possibility of ambiguity remains if earlier 
 researchers did not use a unique code in accordance with some established system.
On occasion, the observed number of cases is so small that researchers can-
not perform useful analyses for each type of LHC and will instead provide sum-
mary statistics for the entire group of them. In updating mortality in the Hamburg 
cohort in 1952–2007, Manuwald et al. (2012) found non-significant increases in 
mortality from LHC in both men and women, which combined to give a signifi-
cant association between TCDD and all LHC deaths in the whole cohort (SMR = 
1.61, 95% CI 1.03–2.40). In a Dutch cohort of workers in two phenoxy-herbicide 
plants, Boers et al. (2012) assessed plasma TCDD concentrations at the time of 
the assumed last exposure and reported a modest but not statistically significant 
increase in the HR for LHC in the total cohort, but there was no increase in plant 
A, where workers were occupationally exposed to TCDD.
Because VAO committees aim to address disease entities as specifically as 
possible with the available data, the overall results on the broader grouping of 
LHCs are of little consequence for the conclusions of association that have been 
drawn for the more specific entities. The committee for Update 2010 noted, how-
ever, that the common biologic origin of LHCs that have been judged to have a 
substantial amount of evidence supporting asso ciation with the COIs (HL, NHL, 
CLL, hairy-cell leukemia [HCL], multiple myeloma, and AL amyloidosis) means 
that the WHO approach is supportive of and consistent with these decisions on 
the part of VAO committees. The Update 2014 committee familiarized itself 
with the classification systems that have been used for lymphoid malignancies, 
including hearing a presentation from the International Lymphoma Epidemiology 
Consortium (InterLymph) describing a proposed classification of these cancers 
into subtypes that are particularly appropriate for epidemiologic research, includ-
ing methods to harmonize data, standardized definitions of disease entities and 
rigorous quality control of these subtype assessments, and attempts to understand 
the implications of etiologic heterogeneity (Morton et al., 2014a,b). At the same 
time, as has been recognized by others (Saberi Hosnijeh et al., 2012c), given the 
type and quality of the historical data that constitute the majority of the material 
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available to the committee for review and judgement, little of that impressive 
effort can be applied to the committee’s assessment of association.
VA asked previous VAO committees to address CLL, AML, and HCL indi-
vidually. A scrutiny of the entire body of epidemiologic results on leukemias for 
findings on particular types (as had been the most common manner of grouping) 
revealed several studies that showed increased risks specifically of CLL but that 
did not provide support for an association of AML with exposure to the COIs. 
The committee for Update 2002 advised VA that CLL is recognized as a form 
of NHL, which is already recognized as a service-related condition, whereas the 
committee for Update 2006 did not recognize an association between the COIs 
and AML. Later, the committee responsible for Update 2008 advised VA that, 
like CLL, HCL should be grouped as a mature B-cell neoplasm. For the current 
update, VA has tasked the committee to specifically address myeloproliferative 
neoplasms (MPNs). In light of the history and in accord with the current WHO 
classification, the committee for this update has incorporated data specifically 
on CLL and HCL into the section on NHL. After a brief synopsis of biologic 
plausibility of the LHCs overall, the more common cancers of the lymphatic 
system are described in the sections below on HL, NHL, and multiple myeloma 
(with a section on the related condition, AL amyloidosis), and then evidence 
on  leukemias in general is discussed, with a focus on information regarding 
 leukemias of myeloid origin.
Biologic Plausibility
Studies in animal models have indicated that the AHR pathway plays an 
integral role in B-cell maturation and that TCDD and dioxin-like chemical 
expo sure may alter the function of these cells and lead to critical changes in the 
 immune response. The suppression of the immune response by TCDD and simi-
lar chemicals in rodents and primates has been known for more than 30 years, 
but the effect on human cells is less clear. Some reports indicate that TCDD and 
dioxin-like chemicals elicit similar effects in humans. The activation of non-
transformed human B cells results in an increase in the expression of AHR, and 
additional data indicate that this pathway has a role in normal B-cell function 
(Allan and Sherr, 2010; Sherr and Monti, 2013). Furthermore, treating these 
cells with benzo[a]pyrene suppresses B-cell differentiation. H. Lu et al. (2010) 
demonstrated that although human B cells appeared less responsive to TCDD in 
terms of increasing the expression of AHR pathway genes, the ability of TCDD 
to decrease immunoglobulin (Ig) M production is similar in both mouse and 
 human B cells. Research that modeled the mode by which TCDD suppresses the 
terminal differentiation of B cells offers distinct pathways whose action can be 
altered by exposure (Q. Zhang et al., 2013). Data on human hematopoietic stem 
cells and from the use of knockout Ahr mouse models show that Ahr is critical 
in hematopoietic stem cell maturation and differentiation (Ahrenhoerster et al., 
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2014; Fracchiolla et al., 2011; K. P. Singh et al., 2011, 2014; B. W. Smith et al., 
2013). TCDD not only alters hematopoietic stem cell maturation, but also alters 
proliferation and migration in vivo and in vitro (Casado et al., 2011). Finally, 
emblematic of the potential pleotropic  effects of TCDD, Hughes et al. (2014) 
demonstrated that AHR plays a critical role in promoting lymphocyte differentia-
tion into mature natural killer cells. Reviews have highlighted the complex and 
varied nature of the interaction of TCDD with the immune system (Gasiewicz 
et al., 2014; Lindsey and Papoutsakis, 2012).
Saberi Hosnijeh et al. (2012b, 2013a) assessed both the immune profile and the 
levels of soluble immune signaling proteins in TCDD-exposed workers. Consistent 
with data published on U.S. ACC veterans, in 47 highly TCDD-exposed and 38 low 
TCDD-exposed workers they found no effect of TCDD on major leukocyte subsets 
or on white blood cell counts. They did note a non-significant decrease in most 
lymphocyte subsets, which was most prominent for B cells. In these same workers, 
a study of soluble CD27 and soluble CD30 in sera found no clear dose–response 
relationship of TCDD with the level of these signaling proteins. However, there 
was a significant negative association of the serum  IL-1RA level with the TCDD 
serum level among workers without chronic disease. Taken together, these data 
indicate that exposure to TCDD (and the alteration of normal AHR function) may 
have multiple effects on immune cell differentiation and function.
No new mechanistic or biologic plausibility studies regarding lymphohema-
topoietic cells have been identified by the committee since Update 2014.
Hodgkin Lymphoma
HL (ICD-9 201; ICD-10 C81), also known as Hodgkin disease, is dis-
tinguished from NHL primarily based on its neoplastic cells, mononucleated 
 Hodgkin cells, and multinucleated Reed–Sternberg cells, derived from germinal-
center B cells (Küppers et al., 2002). NCI estimated that 8,500 people would 
receive a new diagnosis of HL in the United States in 2018 and that 1,050 men 
and women would die from it; it ranks 25th in most common cancer diagnoses 
(NCI, n.d.y).
The incidence of HL increases with age; the average age of diagnosis is 
39 years. Although the incidence rate is slightly higher in men than in women 
of the same race, it is about the same in whites and blacks (NCI, n.d.y). In 
the age groups that include most Vietnam veterans, the age-adjusted modeled 
incidence rate of HL for men 50–64 years old of all races combined was 3.2 
per 100,000 in 2014 and increased to 4.7 for 65–74-year-olds and 5.7 for men 
over 75 years.19
19 As calculated on the site https://seer.cancer.gov/faststats/selections.php?#Output by using the 
SEER 13 dataset and choosing age-adjusted rates, HL, all races, age ≥ 50 years, and male sex.
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The possibility that HL has an infectious etiology has been a topic of dis-
cussion since its earliest description. A higher incidence in people who have a 
history of infectious mononucleosis has been observed in some studies, and a 
link with Epstein–Barr virus has been proposed (Balfour et al., 2015; Murray 
and Bell, 2015). In addition to the occupational associations discussed below, 
higher rates of the disease have been observed in people who have suppressed or 
compromised immune systems.
Conclusions from VAO and Previous Updates
Based on the 32 studies it reviewed, the committee responsible for VAO 
determined that there were sufficient epidemiologic data to support an associa-
tion between exposure to the COIs and HL. Additional studies available to the 
committees responsible for subsequent updates have not changed that conclusion.
Two well-conducted Swedish studies with good exposure characteriza-
tion reviewed in VAO provide the most comprehensive information on the 
association between exposure to phenoxy herbicides (2,4-D and 2,4,5-T), 
 picloram, or chlorophenols and HL. Hardell et al. (1981) considered NHL and 
HL together, and Hardell and Bengtsson (1983) considered HL separately; they 
found statistically significant associations with exposure to phenoxy acids (after 
exclud ing people who were exposed to chlorophenols) and with exposure to 
 chlorophenols. In a study of 54 HL cases, Persson et al. (1989) found a large 
but imprecise and not statistically significant risk associated with exposure to 
phenoxy acids. Several of the other case-control and occupational-cohort stud-
ies in U.S. and international populations reviewed in VAO showed an increased 
risk of HL, but only a few of the results were statistically significant. As with 
NHL, even the largest studies of production workers who were exposed to 
TCDD did not indicate an increased risk. The few studies of HL in Vietnam 
veterans tended to show increased risks, but only one (Holmes et al., 1986) was 
statistically significant.
Among the studies of veterans reviewed throughout the VAO series, no sta-
tistically significant increased risk of HL was found. Publications from the AFHS 
showed no statistically significant increases in HL or lymphopoietic cancers 
(AFHS, 2000; Akhtar et al., 2004). Other populations of Vietnam-era veterans 
likewise did not find an association (Anderson et al., 1986a,b; Holmes et al., 
1986; Lawrence et al., 1985; Visintainer et al., 1995). A proportionate mortality 
ratio analysis that compared the experience of 33,833 U.S. Army and Marine 
Corps Vietnam veterans who died during 1965–1988 with that of 36,797 deceased 
non-Vietnam veterans found a statistically significant increase of deaths from 
HL in Marine Corps veterans—although not Army veterans—who had served in 
Vietnam (Watanabe and Kang, 1996). Cypel and Kang (2008) compared mortality 
from lymphopoietic cancers in female Vietnam veterans with that of female era 
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veterans and the U.S. population; deaths from lymphopoietic cancers were not 
higher in those who served in Vietnam.
Studies of Australian, New Zealand, and Korean veterans who served in Viet-
nam have also been reviewed. The incidence of HL was found to be statistically 
significantly higher than the general population when Australian veterans from all 
branches were combined (ADVA, 2005a), but when veterans were stratified by 
service branch, the only statistically significant association was between HL and 
service in the Army. However, no statistically significantly increased mortality 
from HL was found for all service branches combined, nor for any single branch 
(ADVA, 2005b). A comparison of deployed and non-deployed Vietnam- era Aus-
tralian conscripted Army National Service veterans found no asso ciation between 
deployment and the incidence of or mortality from HL (ADVA, 2005c). Among 
a cohort of male Vietnam veterans from New Zealand, McBride et al. (2013) 
reported one death from and three incident cases of HL resulting in imprecise 
and unstable effect estimates. Among the Korean veterans who had served in 
Vietnam, Yi and Ohrr (2014) reported no statistically significant difference in 
the risk of HL in the internal comparison of the high- and low-exposure groups 
based on the EOI scores.
Several occupational cohorts of workers from several countries who were 
exposed to phenoxy herbicides and other related chemicals have been followed 
long term. Studies of the IARC phenoxy-herbicide cohort showed no excess of 
HL incidence or mortality compared with national rates (Kogevinas et al., 1993). 
Additional follow-up showed a non-statistically significant increase in HL in 
workers who were exposed to TCDD or higher chlorinated hydrocarbons but 
no association was found between phenoxy herbicides or chlorophenols and HL 
(Kogevinas et al., 1997). In a multinational IARC cohort of 60,468 pulp-and-pa-
per-industry workers, McLean et al. (2006) found that death from HL was signifi-
cantly higher in those who had ever been exposed to nonvolatile organochlorine 
compounds (which would include TCDD) but not in those who had never been 
exposed compared with the national standardized populations.
In a retrospective cohort study of Dutch production and contract workers 
who were exposed to phenoxy herbicides, chlorophenols, and contaminants 
during 1950–1976, Hooiveld et al. (1998) reported a non-significant increase 
in HL. Rix et al. (1998) compared mortality in a cohort of Danish paper mill 
workers with mortality in the general Danish population and found a statisti-
cally significant increase in men but not women. Swaen et al. (2004) extended 
the follow-up of mortality by 13 years in a cohort of Dutch herbicide appliers 
and observed no additional deaths, causing the earlier mortality risk estimate of 
HL in the cohort to no longer be statistically significant (Swaen et al., 1992). 
Studies of German manufacturing workers found no association between expo-
sure to TCDD and HL (Becher et al., 1996). McBride et al. (2009a) examined 
mortality in TCP manufacturing workers in the Dow AgroSciences plant in New 
Zealand, but a single observed HL death yielded inconclusive results. A French, 
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hospital-based, case-control study of lymphoid neoplasms (Orsi et al., 2009) did 
not find a statistically significant increase in the risk of HL after occupational 
exposure to herbicides in general or after occupational exposure to phenoxy 
herbicides in particular.
Among U.S. production workers, the low numbers of deaths from HL and 
imprecise estimates limited the findings. In an update and expansion of cohorts 
involved in the NIOSH study, Steenland et al. (1999) observed three deaths attrib-
uted to HL, which was not statistically different from the comparison population. 
No deaths from HL were identified in Dow PCP workers in Midland, Michigan 
(Collins et al., 2009c; Ramlow et al., 1996), and only two deaths from HL 
 occurred among the TCP workers, resulting in imprecise risk estimates (Collins 
et al., 2009b). Additional updates of these occupational cohorts noted very small 
numbers of additional cases of HL, which did not produce substantive changes in 
prior findings. Burns et al. (2011) reported an additional case among Dow 2,4-D 
production workers. Ruder and Yiin (2011) likewise reported one additional HL 
death in the NIOSH cohort of PCP workers.
Studies of the Seveso cohort have found few cases and no increased inci-
dence or mortality of HL among men or women in zones A, B, or R. These find-
ings remained consistent at the 10-year follow-up (Bertazzi et al., 1993), 15-year 
follow-up (Bertazzi et al., 1997), 20-year update (Bertazzi et al., 2001; Pesatori 
et al., 2009), and 25-year update (Consonni et al., 2008).
Several studies of HL among agricultural workers have also been re-
viewed by the update committees. Whereas Persson et al. (1993) reported a 
significant increase in the odds of HL prevalence in Swedish farmers who 
were exposed to phenoxy acid herbicides, no excess of HL deaths was found 
in a death certificate review of U.S. farmers from 23 states (Blair et al., 1993). 
In a non specific analysis of exposure to “herbicides” in a Michigan farming 
community, Waterhouse et al. (1996) demonstrated a statistically significant 
 increase in the combined incidence of lymphopoietic neoplasms in a prospec-
tive study. Two reports from the AHS found no excess risk of HL in pesticide 
 applicators, commercial applicators, or their spouses, but herbicide exposures 
were not specific (Alavanja et al., 2005; Blair et al., 2005a). Updates of cancer 
incidence (Koutros et al., 2010a) and mortality (Waggoner et al., 2011) among 
participants in the AHS also did not find increases of HL in private applicators 
or their spouses.
In the Cross-Canada Study of Pesticides and Health, P. Pahwa et al. (2006) 
found no association of any exposure to phenoxy herbicides, 2,4-D, Mecoprop, 
or MCPA and HL. Nested case-control studies of data from the Cross-Canada 
study found no statistically significant associations of exposure to COIs with 
HL (Karunanayake et al., 2012; P. Pahwa et al., 2003). A follow-up analysis of 
the Cross-Canada study (Navaranjan et al., 2013) that examined the incidence 
of STS, NHL, multiple myeloma, and HL in men ages 19 years and older found 
no increased risk of HL in those exposed to one, two, or three or more phenoxy 
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herbicides after adjusting for age and the province of residence. However, ex-
posure specificity remains a major issue for this study.
Update of the Epidemiologic Literature
No new published literature of Vietnam veterans, environmental studies, or 
case-control studies that addressed exposure to the COIs and HL was identified 
by the committee for the current update. Reviews of the relevant studies are 
presented in the earlier reports. Table 24, which can be found at www.nap.edu/
catalog/25137, summarizes the results of studies related to HL.
Occupational Studies Among the Dow Midland, Michigan, worker cohort 
that was compared with the standardized U.S. population, Collins et al. (2016) 
found only two deaths from HL were reported during the follow-up period and 
both were among TCP workers, making the reported risk estimates unreliable.
In an extension of the follow-up of UK phenoxy herbicide manufacturers 
and sprayers to examine the carcinogenicity of phenoxy herbicides, Coggon et 
al. (2015) reported only three deaths from HL, and all were among the workers 
potentially exposed to phenoxy acids above background levels and for more than 
1 year (SMR = 1.71, 95% CI 0.35–4.99).
Other Identified Studies One other study that reported outcomes of mortality 
from HL was identified, but it lacked sufficient exposure specificity to be included 
as contributing to the evidence base of the potential effects of the COIs (Ruder 
et al., 2014).
Biologic Plausibility
HL arises from the malignant transformation of a germinal-center B cell and 
is characterized by malignant cells that have a distinctive structure and pheno-
type; these multinucleate cells are known as Reed–Sternberg cells (Jaffe et al., 
2008). No animal studies have shown an increase in HL after exposure to the 
COIs. Reed–Sternberg cells have not been demonstrated in mice or rats, so there 
is no good animal model of HL. Thus, there are no specific animal data to support 
the biologic plausibility of an association between the COIs and HL.
Synthesis
The relative rarity of HL complicates the evaluation of epidemiologic studies 
because their statistical power is generally low. Earlier studies (Eriksson et al., 
1992; Hardell et al., 1981; Holmes et al., 1986; LaVecchia et al., 1989; Persson et 
al., 1993; Rix et al., 1998; Waterhouse et al., 1996; Wiklund et al., 1988a) were 
generally well conducted and included excellent characterizations of exposure, 
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and they formed the basis of previous VAO committees’ conclusions. Subsequent 
findings have not contradicted those conclusions, especially given that most studies 
have had low statistical power, as was seen in the current extended follow-ups of 
occupational cohorts that reported two (Collins et al., 2016) and three (Coggon et 
al., 2015) deaths from HL. Although it has not been demonstrated in any animal 
models, a positive association between the COIs and the development of HL is bio-
logically plausible because of the common lymphoreticular origin of HL and NHL 
(which has been demonstrated in animal models) and their common risk factors.
Conclusion
Based on the evidence reviewed here and in previous VAO reports, the 
committee concludes that there is sufficient evidence of an association between 
exposure to at least one of the COIs and HL.
Non-Hodgkin Lymphoma
NHL (ICD-9 200.0–200.8, 201, 202.0–202.2, 202.8–202.9; ICD-10 C82–85, 
C96.3) is a general name for malignancies of the lymphatic system other than 
HL or plasma cell dyscrasias. NHL consists of a large group of lymphomas 
that can be partitioned into acute and aggressive (fast-growing) or chronic and 
indolent (slow-growing) types of either B-cell or T-cell origin. B-cell NHL 
 includes Burkitt lymphoma, diffuse large B-cell lymphoma, follicular lymphoma, 
large-cell lymphoma, precursor B-lymphoblastic lymphoma, and mantle-cell 
lymphoma. T-cell NHL includes mycosis fungoides and anaplastic large-cell 
lymphoma. Precursor T-lymphoblastic lymphoma is not considered a type of 
NHL and is considered instead part of T-lymphoblastic lymphoma/leukemia, a 
precursor lymphoid neoplasm included with the broad group of “acute lymphoid 
leukemias,” which can be of either T-cell or B-cell origin.
In response to requests from VA to address CLL, HCL, and AML specifi-
cally and individually, CLL and HCL have been recognized as subtypes of NHL 
(demonstrating B-cell origin and immunohistochemical properties consistent with 
B-cell lymphoma). The proposed WHO classification of NHL notes that CLL 
(ICD-9 204.1; ICD-10 C91.1) and its lymphomatous form, small lymphocytic 
lymphoma, are both derived from mature B cells (Chiorazzi et al., 2005; IARC, 
2001). The committee for Update 2012 determined that it is more appropriate to 
consider those lymphatic malignancies with other forms of NHL. Therefore, the 
discussion of CLL and HCL has been moved into the NHL grouping.
NCI estimated that 74,680 people would receive a new diagnosis of NHL 
in the United States in 2018 and that 19,910 men and women would die from 
it; it ranks as the seventh most common cancer diagnosis (NCI, n.d.z). The inci-
dence of NHL increases with age; the average age of diagnosis is 67 years. The 
incidence rate is about 50% higher in white and black men than in women of the 
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same race and is highest for whites. In the age groups that include most Vietnam 
veterans, the age-adjusted modeled incidence rate of NHL for men 50–64 years 
old of all races combined was 36.3 per 100,000 in 2014 and increased to 91.1 for 
65–74-year-olds and 147.8 for men over 75 years.20
In addition, NCI estimated that 20,940 men and women would receive a 
diagnosis of CLL in the United States in 2018 and that 4,510 people would die 
from it. Nearly all cases occur after the age of 50 years, and the median age of 
diagnosis is 70 years. The incidence rate is about two times higher in men than 
in women of the same race and is highest for whites (NCI, n.d.aa).
The causes of NHL are poorly understood. People who have suppressed or 
compromised immune systems are known to be at higher risk, and some studies 
show an increased incidence in people who have HIV, human T-cell leukemia 
virus type I, Epstein–Barr virus, surface antigen positive hepatitis B, or gastric 
Helicobacter pylori infections. The human retrovirus HTLV-1 causes adult T-cell 
lymphoma, but early reports that HTLV-2 might play a role in the etiology of 
HCL have not been substantiated. A broad spectrum of behavioral, occupational, 
and environmental risk factors have been proposed as contributors to the occur-
rence of NHL, but given the diversity of malignancies included under this name 
and the evolving classification of the subtypes (to date, minimal exploration of 
etiologic heterogeneity has been done), it is not too surprising that—aside from 
infectious agents, immune problems, and particular chemotherapies—specific 
risk factors have not been definitively established (Morton et al., 2008, 2014a,b; 
Wang and Nieters, 2010).
Conclusions from VAO and Previous Updates
The committee responsible for VAO concluded that there was sufficient 
evidence to support an association between exposure to at least one of the COIs 
and NHL. Additional information available to the committees responsible for 
later updates has not changed that conclusion. Update 2002 was the first to dis-
cuss CLL separately from other leukemias. The epidemiologic studies indicated 
that farming, especially with exposure to 2,4-D and 2,4,5-T, is associated with 
significant mortality from CLL. Many more studies support the hypothesis that 
herbicide exposure can contribute to NHL risk. Most cases of CLL and NHL 
reflect the malignant transformation of germinal-center B cells, so these diseases 
could have a common etiology.
As with HL, the epidemiologic data reviewed by previous VAO committees 
suggest that it is the phenoxy herbicides (including 2,4-D) rather than TCDD 
that may be associated with NHL. The original VAO committee concluded that a 
20 As calculated on the site https://seer.cancer.gov/faststats/selections.php?#Output using the SEER 
13 dataset and by choosing age-adjusted rates, non-Hodgkin lymphoma, all races, age groups 50–64, 
65–74, and ≥ 75 years, and male sex.
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positive association existed between exposure to herbicides and the development 
of NHL, and studies reviewed by later committees have continued to support 
that finding. A large, well-conducted case-control study in Sweden by Hardell 
(1981) examined NHL and HL together and found, on the basis of 105 cases, a 
statistically significantly increased risk associated with exposure to phenoxy acids 
or chlorophenols. Those results were replicated in further investigations of the 
validity of the exposure assessment and potential biases (Hardell, 1981). Hardell 
et al. (1994) also examined the relationship between occupational exposure to 
phenoxyacetic acids and chlorophenols and various characteristics related to 
NHL—including histopathologic measures, stage, and anatomic location—on the 
basis of the NHL cases in a previous study (Hardell et al., 1981). Similar data by 
Persson et al. (1989) showed, based on a logistic regression analysis of 106 cases, 
an increased risk of NHL in those exposed to phenoxy acids. Other case-control 
studies of NHL conducted in Sweden found a statistically significantly elevated 
risk of NHL (Eriksson et al., 2008; Hardell and Eriksson, 1999; Hardell et al., 
2001, 2002; Olsson and Brandt, 1988).
Several case-control studies of NHL incidence, risk, or mortality in other 
exposed populations have also been reviewed by VAO committees, including 
studies from New Zealand (Pearce et al., 1985, 1986b, 1987), Italy (Amadori et 
al., 1995; Nanni et al., 1996), and Canada (Ng et al., 2010; Spinelli et al., 2007). 
Various U.S. populations have also been studied for associations of herbicides 
with NHL (Cantor, 1982; Cantor et al., 1992; Colt et al., 2009; Hartge et al., 2005; 
Tatham et al., 1997; Zahm et al., 1993); NHL and multiple myeloma (Burmeister 
et al., 1983); and STS and NHL (Woods and Polissar, 1989; Woods et al., 1987).
Studies of production workers have shown some association between TCDD 
exposure and NHL. A larger study of 21,863 workers in the IARC phenoxy-
herbicide cohort followed from 1939 to 1992 found a non-significant increase in 
NHL risk (Kogevinas et al., 1997). Other studies of Danish and Dutch phenoxy- 
herbicide workers who were part of the IARC cohort have shown a non-signifi-
cant increased risk of NHL (Boers et al., 2010; Bueno de Mesquita et al., 1993; 
Hooiveld et al., 1998; Lynge, 1993). A cohort of 2,479 workers in four plants 
in Germany with exposure to phenoxy herbicide and contaminants (dioxins 
and  furans) had a significantly increased risk of NHL on the basis of five cases 
(Becher et al., 1996). Non-statistically significant increases in risk have also been 
found in the NIOSH mortality study (Steenland et al., 1999). Risks were not sig-
nificantly increased among the Dow Chemical Company Midland, Michigan, or 
Plymouth, New Zealand, chemical production workers, phenoxy-herbicide spray-
ers, or 2,4-D production workers (Bloemen et al., 1993; Bodner et al., 2003; C. J. 
Burns et al., 2001; Collins et al., 2009b,c; McBride et al., 2009a,b; Ramlow et 
al., 1996; 't Mannetje et al., 2005). A multinational IARC cohort study of paper-
and-pulp workers found a statistically significant increase in workers who were 
exposed to chlorophenols (McLean et al., 2006).
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Studies of farmers and agricultural workers have been generally positive 
for an association between herbicides or TCDD and NHL; however, only a few 
were statistically significant. A meta-analysis of several studies of the association 
between employment as a farmer in the central United States and NHL showed 
a statistically significant risk (Keller-Bryne et al., 1997). All of the studies of 
U.S. agricultural workers that were reviewed showed increased risk ratios, and 
two NCI studies of farmers in Kansas and Nebraska (Hoar et al., 1986; Zahm 
et al., 1990) showed patterns of an increased risk linked to use of 2,4-D. A third 
NCI study of NHL was conducted in four Surveillance, Epidemiology and End 
Results program centers (Detroit, Iowa, Los Angeles, and Seattle) from 1998 to 
2000 (Pronk et al., 2013). The researchers used residential history from 15 years 
prior to diagnoses to link residence to EPA databases of dioxin-emitting facilities, 
studying 969 cases and 749 controls. Proximity to any dioxin-emitting facility 
was not associated with NHL. A study of a subcohort of Hispanic workers in 
a larger cohort of 139,000 California members of the United Farm Workers of 
America (Mills et al., 2005) and a population-based case-control study in Italy 
of NHL and CLL cases (combined) identified during 1991–1993 (Miligi et al., 
2006) both showed statistically significant associations with 2,4-D. An additional 
occupational exposure study using the EPI-LYMPH multicenter study (conducted 
in the Czech Republic, France, German, Ireland, Italy, and Spain from 1998 to 
2004) assessed pesticide use in applying a crop-exposure matrix with lymphoma 
diagnoses in a case-control design (Cocco et al., 2012). No statistically significant 
association was observed between any kind of pesticide or herbicide use and lym-
phomas or its subtypes, including between exposure to phenoxy acids and CLL.
The Cross-Canada Study of Pesticides and Health, a large, well-conducted, 
population-based, case-control study, reported on pesticide use and NHL inci-
dence in men identified from cancer registries of six Canadian provinces from 
1991 to 1994. Statistically significant associations were found between exposure 
to phenoxy herbicides, 2,4-D, or  Mecocrop (MCPA) and NHL. A reanalysis of 
the data from that study confirmed the findings on phenoxy herbicides but found 
that the association with 2,4-D, although still increased, was no longer statisti-
cally significant (McDuffie et al., 2001). A study of the participants who had a 
first diagnosis of STS, NHL, multiple myeloma, or HL during the original study 
period were followed through mailed and telephone interviews to examine the 
joint effects of asthma, allergies, or asthma and allergies and hay fever combined 
with pesticide exposure in the genesis of NHL. Incident NHL cases (n = 513) 
diagnosed between 1991 and 1994 were compared with the experience of 1,506 
controls. Subjects with asthma, allergies, or hay fever had elevated risks that were 
not statistically significant associated with the use of phenoxy herbicides, MCPA, 
or 2,4-D. The results overall were not supportive of any major effect modification 
by these immune conditions.
A population-based case-control study conducted in 2000–2001 of men 
and women 20–74 years old living in New South Wales, Australia, found an 
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increased risk of NHL associated with “substantial” exposure to phenoxy herbi-
cides  (Fritschi et al., 2005). Spinelli et al. (2007) reported on a population-based 
case-control study in Vancouver and Victoria, British Columbia, which found 
strong monotonic increases in serum concentrations of two dioxin-like PCBs 
(PCB 118 and PCB 156). Chiu et al. (2004) and W. J. Lee et al. (2004a) con-
ducted a pooled analysis of two case-control studies that were carried out in three 
midwestern U.S. states—Iowa and Minnesota (Cantor et al., 1992) and Nebraska 
(Zahm et al., 1990)—and found that NHL risks were increased in farmers by the 
use of herbicides, including 2,4-D and 2,4,5-T. In a study of NHL incidence in 
people who lived near 13 French municipal waste incinerators, Viel et al. (2008b) 
found a small but statistically significant increase in the risk of NHL and evidence 
of a dose–response relationship with increased exposure to dioxin. A case-control 
study of NHL rates in people who lived near a municipal solid-waste incinerator 
in Bensaçon, France, found that the incidence of NHL was significantly increased 
in the area determined to have the highest dioxin contamination, but no increases 
were found in the low and intermediate categories (Floret et al., 2003). A French 
hospital-based case-control study of lymphoid neoplasms (Orsi et al., 2009) did 
not find the occurrence of NHL to be associated with occupational or domestic 
use of pesticides or phenoxy herbicides in particular. With 25 years of follow-up 
of the Seveso population and a relatively small number of observed cases, there is 
no evidence of an increased incidence of NHL or mortality in any of the exposed 
zones (Bertazzi et al., 1989b, 1993, 1997, 2001; Consonni et al., 2008; Pesatori 
et al., 1992, 2009).
The findings of several PCB-focused studies (Bertrand et al., 2010; Engel 
et al., 2007; Laden et al., 2010) are consistent with the associations with NHL 
repeatedly observed in connection with the COIs in the VAO series. However, the 
extent of intercorrelation of these persistent organic pollutants greatly curtails the 
degree to which any effect can be specifically attributed to dioxin-like activity.
Evidence of an association between the COIs and NHL in Vietnam veterans, 
the primary population of interest in the VAO updates, has been lacking. The CDC 
Selected Cancers Study (CDC, 1990a,b) showed a significantly increased risk of 
NHL in all Vietnam veterans; however, in an analysis that considered branch of 
service, Army and Air Force personnel were found not to be at  increased risk. 
Marine Corps veterans had a higher mortality in the CDC Selected Cancers Study 
and significantly increased risks in several other studies (Breslin et al., 1988; Burt 
et al., 1987; Watanabe and Kang, 1996; Watanabe et al., 1991), but the implica-
tions of these findings are unclear. No increased risk has been found in Ranch 
Hand veterans (AFHS, 2000; Akhtar et al., 2004; Michalek et al., 1990; Wolfe et 
al., 1990) or in members of the ACC (Boehmer et al., 2004).
In studies of Vietnam veterans from New Zealand and Korea, no statistically 
significant increased risk of NHL was found in either group. The New Zealand 
study also reported on lymphoid leukemia (which would include any cases of 
CLL) and found a statistically significant increase (McBride et al., 2013). Yi et 
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al. (2014b) reported a modestly increased risk for NHL mortality between the 
high- versus low-exposure groups of the Korean veterans and a small increased 
risk with the individual log-transformed EOI scores, but neither was statistically 
significant. Lymphoid leukemia showed a nonstatistically significant decreased 
risk based on nine low-exposure and five high-exposure deaths.
Update of the Epidemiologic Literature
Several new studies of exposure to the COIs and NHL were identified 
 including two studies of Vietnam veterans and CLL. Reviews of the relevant 
 studies are presented in the earlier reports. Table 25, which can be found at www.
nap.edu/catalog/25137, summarizes the results of studies related to NHL.
Vietnam-Veteran Studies A retrospective study of veterans diagnosed with 
CLL who attended the Minneapolis VA at least one time between 2001 and 2010 
was conducted to determine whether exposure to Agent Orange alters features of 
CLL disease presentation or its prognostic features, including stage at diagnosis, 
lymphocyte doubling time, or cytogenetics (Baumann Kreuziger et al., 2014). 
Of the 195 veterans identified as having a diagnosis of CLL, 33 (17%) were 
determined to have been exposed to Agent Orange. (Veterans submit a claim of 
exposure that is reviewed by VA using service records to confirm whether the vet-
eran was stationed in an area that was sprayed with herbicides during the service 
period.) Except for age at diagnosis, demographic factors and laboratory counts 
were similar between the veterans determined to have been exposed and those 
reported as unexposed. Compared with veterans who were reported as unexposed 
to Agent Orange, the exposed patients showed a statistically significantly lower 
age of presentation (61 versus 72 years; p = 0.001), and the time to first treatment 
was also shorter in the exposed patients (9.6 versus 30 months, p = 0.02), but the 
number of therapies and the rate of transformation were not different between ex-
posed and unexposed patients. However, providers were not blinded to exposure 
status, and, because patients were younger, these factors may have influenced the 
therapy paradigm used. Overall, survival was not statistically different between 
exposed and unexposed patients, and this remained the case after adjusting for 
age (HR = 1.8, 95% CI 0.7–4.5, p = 0.24).
A second retrospective study among U.S. Vietnam veterans was identified 
that examined CLL prognosis, treatment, and survival and their association with 
exposure to Agent Orange (determined by benefits and compensation officers who 
use service records to confirm if the locations and timeframes of deployment cor-
respond to sprayed areas). Mescher et al. (2018) identified 2,052 Vietnam veterans 
(20.4% determined to have been exposed to Agent Orange) who were diagnosed 
with CLL between 2009 and 2013 from the National VA Tumor Registry. Informa-
tion on demographics, laboratory and disease-related parameters at the time of the 
initial diagnosis, and the type and number of treatments received was taken from 
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medical records. Overall survival was defined as time from CLL diagnosis to death 
from any cause or else to date of last follow-up. The Cox proportional hazards 
model included age, Rai stage, and baseline laboratory parameters. Prognostic 
factors did not differ based on exposure. Compared with the unexposed, veterans 
exposed to Agent Orange were diagnosed at younger age (63.2 versus 70.5 years, 
p < 0.0001) and had longer overall survival (p < 0.001). CLL prognostic factors 
and cytogenetics did not differ between the groups, although more of the exposed 
group had cytogenetics available. Time to initial treatment was shorter in exposed 
patients. Median overall survival was longer in exposed patients—quite possibly 
because they were treated more aggressively because they were young.
Occupational Studies Among the Dow Midland, Michigan, worker cohort, 
Collins et al. (2016) found that compared with the standardized U.S. population, 
no differences in mortality for NHL were found for the TCP workers (n = 10; 
SMR = 1.08, 95% CI 0.52–1.99) or the PCP workers (n = 8; SMR = 1.92, 95% 
CI 0.83–3.79).
In an extension of the follow-up of UK phenoxy herbicide manu facturers 
and sprayers examining the carcinogenicity of phenoxy herbicides and their 
association primarily with HL, STS, and CLL,  Coggon et al. (2015) calculated 
standardized mortality ratios using person-years and the general populations of 
England and Wales as the comparison group. Nested case-control analyses com-
pared men with incident or fatal NHL/CLL (n = 74) and matched controls (up to 
10 per case). A total of 29 NHL/CLL deaths were reported. The risk of death from 
NHL/CLL was not statistically significantly elevated among all workers (SMR 
= 0.96, 95% CI 0.64–1.38) or among workers exposed to herbicide levels above 
background (n = 26; SMR = 1.15, 95% CI 0.75–1.68). However, death from NHL 
was statistically significantly higher for men who were exposed to phenoxy acids 
above background for 1 year or longer (n = 19; SMR = 1.85, 95% CI 1.12–2.89). 
No other statistically significant associations or trends were reported for mortality 
from other types of cancers. Although a statistically significant excess of deaths 
from NHL was reported, the authors believe that greater weight should be given 
to the nested case-control analysis, which included both non-fatal and fatal cases 
and men with CLL as well as solid lymphomas. That analysis found no statisti-
cally significant increased risk with exposure to phenoxy herbicides; the highest 
risk estimate was for workers with high exposure (OR = 1.22, 95% CI 0.61–2.46). 
The committee believes that the caveat here is that the researchers seem to use 
CLL as their surrogate for NHL, which may or may not be correct. A cleaner 
analysis would have been to look specifically at other lymphomas (diffuse large 
B cell, follicular lymphomas, etc.). However, as the data linking exposure to phe-
noxy herbicides and NHL have been inconsistent, the committee agrees with the 
authors that if there really is an increased risk of NHL/CLL, it is likely very small.
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Case-Control Studies Czarnota et al. (2015) conducted an analysis of 27 cor-
related chemicals (5 PCBs, 7 PAHs, and 15 pesticides) measured in house dust 
samples and NHL risk using data collected from 1998 to 2000 as part of the 
population-based case-control study of NHL in four SEER study sites (Detroit, 
Iowa, Los Angeles, and Seattle). Eligible cases were 20–74 years of age, diag-
nosed with a first primary NHL, and uninfected with HIV. The study recruited 
1,321 people with NHL who were frequency-matched to 1,057 controls by sex, 
age (within 5-year groups), race, and study site. Computer-assisted personal 
 interviews were conducted in the home of each participant and included ques-
tions on demographics, house characteristics, pesticide use in the home and 
garden, and residential and occupational histories. Dust samples were collected 
and analyzed from vacuum cleaners for participants who had used their vacuum 
cleaner within the past year and owned at least half of their carpets or rugs for 
5 years or more. The chemicals relevant to the work of the VAO committee that 
were analyzed were PCB 105, 2,4-D, and dicamba. Pairwise comparisons were 
performed to obtain a weighted quantile sum for an index of 27 environmental 
chemicals. The 27 chemicals were not weighted equally in the index, overall or 
by site. The weighted quantile sum index was statistically significantly associ-
ated with NHL (OR = 1.30, 95% CI 1.08–1.56). Concentrations of 2,4-D and 
dicamba were found to be elevated in the Iowa site. The only individual chemical 
that was associated with NHL was non-dioxin-like PCB 180. However, associa-
tions with NHL were negative and statistically significant for 2,4-D (OR = 0.36, 
95% CI 0.19–0.68) and dicamba (OR = 0.48, 95% CI 0.26–0.90) in the Iowa site 
and 2,4-D (OR = 0.53, 95% CI 0.29–0.97) and dicamba (OR = 0.41, 95% CI 
0.22–0.76) in the Seattle site.
Kelly et al. (2017) used data from the EnviroGenoMarkers study, which 
is nested within two prospective cohorts in Italy and Sweden, to determine the 
asso ciation between NHL and prediagnositic blood plasma concentrations of 10 
environmental pollutants, including two dioxin-like PCB congeners (118 and 
156). During 16 years of follow-up, 270 incident cases of B-cell NHL (includ-
ing 76 cases of multiple myeloma) were diagnosed. Cases were matched to 270 
healthy controls by center, age, gender, and date of blood collection. Cases were 
categorized into ordered quartiles of exposure for each persistent organic pollut-
ant based on the distribution of exposure in the control population. No difference 
in median exposure levels was observed between cases and controls for any of 
the chemical exposures (p > 0.05) or, specifically, for the dioxin-like PCBs: PCB 
118 (p = 0.991) and PCB 156 (p = 0.186). The quartile analysis similarly did not 
show an association between the dioxin-like PCBs and NHL (only the compari-
son of cases and controls in the third quartile was statistically significant, but 
there was no significant association in the test for trend). These were not heavily 
exposed individuals, so the levels may be uniformly low. Overall, this study does 
not provide evidence that higher body burden of the two dioxin-like PCBs (or 
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the other persistent organic pollutants measured) increases the risk of subsequent 
NHL diagnosis.
Other Identified Studies Six other studies of NHL in occupational cohorts 
were identified. Two examined participants of the AHS: in the first study none 
of the COIs were included in the analysis of exposures (Alavanja et al., 2014), 
and the second paper (Goodman et al., 2017) was an updated meta-analysis 
of 2,4-D and NHL that included 10 studies of the AHS but did not contribute 
original data. A third study examined cause-specific mortality, including NHL, 
among U.S. workers exposed to mixed PCBs (Ruder et al., 2014), the fourth 
study analyzed health outcomes among Brazilian agricultural workers exposed 
to unspecified pesticides (Boccolini et al., 2017), and the fifth study was a small 
case-control study designed to investigate the effects of exposure to pesticides 
(determined by occupation as a farm worker) on NADPH (nicotinamide adenine 
dinucleotide phosphate, a cofactor used in biochemical reactions), including its 
level and relationship with the Th1/Th2 ratio, in patients diagnosed with NHL in 
Algeria (Zahzeh et al., 2015). A sixth study (Aras et al. 2014) was a case-control 
study conducted at a cancer center in France to determine whether patient diag-
nosed with NHL had reported exposure to pesticides (types of insecticides and 
herbicides, if known; frequency; and duration), and other known or suspected 
risk factors. However, all these studies lacked sufficient exposure specificity to be 
included as contributing to the evidence base of the potential effect of the COIs.
Biologic Plausibility
The diagnosis of NHL encompasses a wide variety of lymphoma subtypes. In 
humans, about 85% are of B-cell origin and 15% of T-cell origin. In commonly 
used laboratory mice, the lifetime incidence of spontaneous B-cell lymphomas 
is about 30% in females and about 10% in males. Although researchers seldom 
note the subtypes of B-cell lymphomas observed, lymphoblastic, lymphocytic, 
follicular, and plasma-cell lymphomas are seen in mice and are similar to the 
types of NHL seen in humans. Laboratory rats, on the other hand, are less prone 
to develop lymphomas, although Fisher 344 rats do have an increased incidence 
of spontaneous mononuclear-cell leukemia of non-specific origin. The lifetime 
incidence of leukemia is about 50% in male rats and about 20% in female rats. 
Neither mice nor rats develop T-cell lymphomas spontaneously at a predict-
able incidence, but T cell–derived tumors can be induced by exposure to some 
carcinogens.
Several long-term feeding studies of various strains of mice and rats have 
been conducted over the past 30 years to determine the effects of TCDD on 
cancer incidence. Few of them have shown effects of TCDD on lymphoma 
or  leukemia incidence. NTP (1982a) reported no increase in the overall inci-
dence of lymphoma in female B6C3F1 mice exposed to TCDD at 0.04, 0.2, or 
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2.0 μg/kg per week for 104 weeks, but it did find that histiocytic lymphomas 
(now considered to be equivalent to large B-cell lymphomas) were more com-
mon in the high-dose group. No effects on lymphoma incidence were seen 
in Osborne–Mendel rats treated with TCDD at 0.01, 0.05, or 0.5 μg/kg per 
week. Sprague Dawley rats treated with TCDD at 0.003, 0.010, 0.022, 0.046, 
or 0.100 μg/kg per day showed no change in the incidence of malignant lym-
phomas. Nor has long-term exposure to phenoxy herbicides or cacodylic acid 
resulted in an increased incidence of lymphomas in laboratory animals. Thus, 
few laboratory animal data support the biologic plausibility of the promotion of 
NHL by TCDD or the other COIs, but it should be noted that the standard rodent 
models are not particularly sensitive for the detection of chemicals that cause 
lymphohematopoietic cancers.
In contrast, more recent studies at the cellular level indicate that activation 
of AHR by TCDD inhibits apoptosis, a mechanism of cell death that controls the 
growth of cancer cells. Vogel et al. (2007) studied human cancer cells in tissue 
culture and showed that the addition of TCDD inhibited apoptosis in histiocytic-
lymphoma cells, Burkitt-lymphoma cells, and NHL cell lines. The reduction in 
apoptosis was associated with an increase in the expression of Cox-2, C/EBP β, 
and Bcl-xL mRNA in the cells. Those genes code for proteins that protect cells 
from apoptosis. The effects of TCDD on apoptosis were blocked when an AHR 
antagonist or a Cox-2 inhibitor was added to the culture; this demonstrated the 
underlying AHR-dependent mechanism of the effects. More important, when 
C57Bl/10J mice were given multiple doses of TCDD over a period of 140 days, 
premalignant lymphoproliferation of B cells was induced before the appearance 
of any spontaneous lymphomas in the control mice. When the B cells were 
examined, they were found to manifest changes in gene expression similar to 
those induced by TCDD in the human cell lines, which provided support for 
this mechanism of lymphoma promotion by TCDD. Work by Phadnis-Moghe 
et al. (2015) found that TCDD exposure in human B-cell culture impairs B-cell 
lymphoma-6 activity, which may contribute to the development of NHL.
It is well established that AHR activation by TCDD in human breast and 
endocervical cell lines induces sustained high concentrations of the IL-6 cyto-
kine, which has tumor-promoting effects in numerous tissues (Hollingshead et 
al., 2008). IL-6 plays a role in B-cell maturation and induces a transcriptional 
inflammatory response. It is known to be increased in B-cell neoplasms, including 
multiple myeloma and various lymphomas, and especially diffuse large B-cell 
lymphomas (Hussein et al., 2002; Kato et al., 1998; Kovacs, 2006).
An alternative link that could help explain the association between TCDD 
and NHL has been explored in human studies. Chromosomal rearrangements, 
with the consequent dysregulation of the expression of various genes, are preva-
lent in B-cell lymphomas, and the t(14;18) reciprocal translocation, which jux-
taposes the BCL2 with the locus of the immunoglobin heavy chain, is found 
in tumor cells in most cases of follicular lymphoma. Roulland et al. (2004) 
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investigated the prevalence of the t(14;18) translocation, which is characteristic 
of most cases of follicular lymphoma, in 53 never-smoking and pesticide-using 
men in a cohort of French farmers whose pesticide exposures and confounding 
information had previously been well characterized; blood samples had been 
gathered from 21 of them during periods of high pesticide use, and samples from 
the other 32 had been collected during a period of low pesticide use. The authors 
found a higher prevalence of cells carrying the translocation in the farmers whose 
blood had been drawn during a period of high pesticide use than in those whose 
blood had been drawn during a low-use period. Baccarelli et al. (2006) reported 
an increase in t(14;18) chromosomal translocation in lymphocytes from humans 
who were exposed to TCDD in the Seveso accident. In most cases of follicular 
lymphoma, tumor cells carry the t(14;18) chromosomal translocation, and there 
is evidence that an increased frequency of lymphocytes from the peripheral blood 
carrying this tumor marker may be a necessary but not sufficient step toward the 
development of follicular lymphoma (Roulland et al., 2006).
More recently, Saberi Hosnijeh et al. (2011, 2012a,b, 2013a,b) have pub-
lished a series of papers examining factors associated with immune regulation 
and possibly related to B-cell neoplasms and serum TCDD levels in Dutch pro-
duction workers from a subcohort of the IARC study sample. The mortality status 
of the entire subcohort was updated, and blood samples were gathered in 2007–
2008 from a small number of survivors—45 who had TCDD exposure in factory 
A, 39 whose jobs in factory A did not expose them to TCDD, and 69 in factory 
B that produced phenoxy herbicides not subject to TCDD contamination (Boers et 
al., 2010). Boers et al. (2012) modeled the resulting contemporary TCDD serum 
levels to back-extrapolated TCDD concentrations at the end of employment for 
each worker. When examining immunoglobulin (IgG, IgA, IgM, IgD, and IgE) 
and complement (C3 and C4) concentrations measures of humoral immunity, 
Saberi Hosnijeh et al. (2011) found a consistent pattern only for C4, which was 
negatively associated with both measured current and estimated maximum TCDD 
serum concentrations. Limiting the analyses to workers from factory A and ex-
amining serum concentrations of 16 cytokines, 10 chemokines, and 6 growth 
factors, Saberi Hosnijeh et al. (2012a) found that most analytes were negatively 
associated with the current and estimated past maximum TCDD levels. Saberi 
Hosnijeh et al. (2012b) found that for both cell counts and lymphocytes, the re-
sults were similar between high- and low-exposed workers from factory A, except 
for a non-dose-dependent increase in the CD4/CD8 ratio among the high-exposed 
workers. Most lymphocyte subsets, in particular the B-cell compartment, showed 
decreases with higher levels of both current and estimated maximum levels of 
TCDD. Saberi Hosnijeh et al. (2013a) addressed plasma levels of CD27, CD30, 
and IL-1RA, which are proteins that regulate immune function and are thought to 
be involved in lymphopoeitic neoplasms, and they found a tendency toward de-
creased levels with increasing TCDD concentrations, which would be consistent 
with immune suppression. Similarly, Saberi Hosnijeh et al. (2013b) investigated 
Veterans and Agent Orange: Update 11 (2018)
Copyright National Academy of Sciences. All rights reserved.
CANCER 347
the possibility of a relationship between TCDD levels and serum metabolites, but 
they found no notable patterns. Overall, this set of findings in a group of workers 
with an elevated incidence of NHL at its most recent mortality update provides 
some insight into the biological processes, particularly immunological ones, that 
TCDD might stimulate on the path to this malignancy.
Synthesis
The first VAO committee concluded that there was sufficient evidence of an 
association between exposure to at least one of the COIs and NHL. The evidence 
was drawn from occupational and other studies in which subjects were exposed 
to a variety of herbicides and herbicide components. Although the new studies of 
NHL incidence and mortality that were reviewed in this update (Coggon et al., 
2015; Collins et al., 2016; Czarnota et al., 2015) mostly found increased, but not 
statistically significant, risks of NHL after exposure to at least one of the COIs, 
based on the results of studies previously reviewed, the committee maintains the 
conclusion of sufficient evidence of an association.
Individual findings on CLL are fairly few compared with the considerable 
number of studies supporting an association between exposure to the COIs 
and NHL. Two new studies of CLL in U.S. Vietnam veterans were reviewed. 
 Baumann Kreuziger et al. (2014) found that veterans who reported having been 
exposed to Agent Orange had a statistically significantly lower age of presenta-
tion and time to first treatment, but the number of therapies and the rate of trans-
formation were not different between exposed and unexposed patients. In the 
second study, Mescher et al. (2018) used data from the National VA Tumor Reg-
istry to identify cases of CLL. Similar to the findings of Baumann Kreuziger et 
al., veterans presumed to have been exposed to Agent Orange were diagnosed at 
a younger age and had shorter time to initial treatment, but in this analysis those 
exposed had significantly longer overall survival. Results of some high-quality 
studies show that exposure to 2,4-D and 2,4,5-T appears to be associated with 
CLL; these studies include the incidence study of Australian veterans (ADVA, 
2005a), the case-control study by Hertzman et al. (1997) of British Columbia 
sawmill workers who were exposed to chlorophenates, the Danish-gardener study 
(Hansen et al., 1992), and the population-based case-control study in two U.S. 
states by Brown et al. (1990) that showed increased risks to be associated with 
any herbicide use and, specifically, with the use of 2,4,5-T for at least 20 years 
before the interview. Other studies that showed positive associations have lacked 
exposure-specificity in the the populations studied.
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Conclusion
Based on the evidence reviewed here and in previous VAO reports, the 
committee concludes that there is sufficient evidence of an association between 
exposure to at least one of the COIs and NHL.
Plasma Cell Dyscrasias
Plasma cell dyscrasias are a heterogeneous group of disorders characterized 
by the presence of monoclonal immunoglobulins in the serum, which reflects a 
monoclonal proliferation of lymphoplasmacytic cells in the bone marrow (Wahed 
and Dasgupta, 2015). Plasma cell neoplasms are lymphoid neoplasms of termi-
nally differentiated B cells, all of which exhibit the expansion of a single clone of 
Ig-secreting plasma cells. Included in this group are MGUS, multiple myeloma, 
Waldenstrom’s macroglobulinemia, immunoglobulin deposition diseases (such 
as AL amyloidosis and primary amyloidosis), plasmacytoma, and plasma cell 
leukemia.
Monocolonal Gammopathy of Undetermined Significance
MGUS is a precursor condition of multiple myeloma. However, only an 
estimated 1% of MGUS cases progress to multiple myeloma each year (Kyle et 
al., 2018; Mateos and Landgren, 2016). It is a clinically silent condition, mean-
ing that there are no apparent signs or symptoms or other clinical manifesta-
tions, although MGUS has been associated with osteoporosis, hip fractures, and 
peripheral neuropathy (Bida et al., 2009). MGUS is defined by the presence of a 
monoclonal antibody, antibody heavy chain, or antibody light chain in the blood 
or urine of a person lacking the symptoms or signs of a more serious plasma cell 
dyscrasia. MGUS is categorized into subtypes based on the identity and levels of 
the myeloma proteins detected as well as the prognosis for progressive disease. 
IgG and IgA MGUS are precursor conditions of multiple myeloma, whereas IgM 
MGUS is a precursor of Waldenstrom’s macroglobulinemia and other lympho-
proliferative disorders (van de Donk et al., 2014). The condition is typically dis-
covered as an incidental finding when a protein electrophoresis test is performed 
for reasons unrelated to plasma cell dyscrasias.
A prospective longitudinal study of 1,384 (predominantly white) patients 
who were residing in southeastern Minnesota and who were diagnosed with 
MGUS at the Mayo Clinic from 1960 through 1994 were followed for progres-
sion to multiple myeloma or another plasma-cell or lymphoid disorder. The 
patients were stratified into IgM and non-IgM MGUS to determine their risk 
factors for progression. The presence of one of two factors (an abnormal serum 
free light-chain ratio and a high serum M protein level [≥ 1.5 g per deciliter]) was 
associated with a higher risk of progression in both groups; IgM MGUS patients 
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had an even higher risk than the non-IgM MGUS patients. After an adjustment 
for competing causes of death, the risk of progression was 10% at 10 years, 18% 
at 20 years, 28% at 30 years, 36% at 35 years, and 36% at 40 years (Kyle et al., 
2018). Using the same population in another analysis, the prevalence of MGUS 
in people 50 years and older was found to be 3.2% and 5.5% in people over 
70 years (Kyle et al., 2007).
A systematic review and meta-analysis of MGUS conducted in 2010 found 
that the prevalence of MGUS ranged from 0.05% to 6.1% in 11 different stud-
ies. The prevalence of MGUS increases with age and is affected by race (higher 
among blacks than whites and Japanese), sex (higher in men than women), family 
history, immunosuppression, and pesticide exposure (Wadhera and Rajkumar, 
2010).
The risk factors for the progression of clinical MGUS to multiple myeloma 
that have been reported are the size and type of serum M protein and the pres-
ence of an abnormal serum free light chain ratio (Rajkumar et al., 2005), immune 
status (with higher prevalence among immunosuppressed and immunocompro-
mised patients), hereditary or familial factors (Landgren et al., 2006; Vachon et 
al., 2009), and some occupational and environmental factors such as exposure 
to certain pesticides and fertilizers in the AHS (Landgren et al., 2009), but those 
associations have been inconsistent. Heavy tobacco smoking has also been asso-
ciated with the prevalence of MGUS (Pasqualetti et al., 1997).
Update of the Epidemiologic Literature MGUS was not considered as a 
separate outcome in any of the prior VAO updates primarily because most rel-
evant studies focused on multiple myeloma and did not include MGUS. The 
present committee determined that because it is a precursor condition of multiple 
 myeloma, it would be considered as a separate outcome with respect to expo-
sure to the COIs. It was felt that an increased incidence of MGUS, while itself 
clinically silent, could be a harbinger of an increase in the incidence of multiple 
myeloma; however, there are not yet any data to support this inference. One pub-
lished study that specifically examined the prevalence of MGUS in Vietnam vet-
erans who were responsible for spraying herbicides was identified and reviewed; 
no other studies of MGUS and the COIs were identified. Table 27, which can be 
found at www.nap.edu/catalog/25137, summarizes the results of studies related 
to plasma cell dyscrasias and includes the studies of MGUS.
In a new analysis using data and biospecimens collected from the AFHS, 
Landgren et al. (2015) examined the association between serum TCDD levels 
and the presence of MGUS. Data and biospecimens were collected prospectively 
from individuals to whom structured questionnaires and physical exams were 
given at set times over 20 years, with the final exam conducted in 2002. The 
study included 479 Ranch Hand veterans (who conducted aerial spray missions 
of the herbicides from 1962 to 1971) and 479 controls (comparison veterans 
who were also in the Air Force and had similar job duties and were deployed to 
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Southeast Asia during the same period) who participated in the 2002 follow-up 
examination and had given a serum specimen and were at least 50 years old at 
the 2002 follow-up. Individuals with a history of multiple myeloma, Waldenstrom 
macroglobulinemia, solitary plasmacytoma, or amyloidosis were excluded. All 
serum specimens were tested without knowledge of the exposure status. TCDD 
concentrations were either measured in the 1987 exam or reconstructed from the 
measurement in the nearest subsequent follow-up (1992, 1997, 2002 follow-ups). 
Logistic regression was used for analyses, and models were adjusted for age, 
race, BMI at the 2002 examination, and changes in BMI between 2002 and the 
time of blood draw for the TCDD measurement; additional variables of military 
occupation, smoking history, drinking history, and history of radiation therapy 
or chemotherapy for cancer treatments were also considered. The Ranch Hand 
veterans and comparison veterans had similar demographic and lifestyle charac-
teristics and medical histories. The crude prevalence of overall MGUS was 7.1% 
in Ranch Hand veterans and 3.1% in comparison veterans, which is equivalent 
to a 2.4-fold increased risk for MGUS in Ranch Hand veterans versus the com-
parison veterans, after adjustment (OR = 2.37, 95% CI 1.27–4.44, p = 0.007). 
The risk of MGUS was significantly increased in veterans younger than 70 years 
(OR = 3.4, 95% CI 1.46–8.13, p = 0.004), whereas no significant increase in the 
risk was seen in those 70 years or older (OR = 1.4, 95% CI 0.55–3.63, p = 0.63), 
although both estimates were imprecise. When compared with the veterans in 
the lowest TCDD level (≤ 3.65 ppt), the crude ORs for having MGUS were sta-
tistically significant for veterans with TCDD levels of 5.81–10.92 ppt and more 
than 10.92 ppt, but an adjustment eliminated the significant effect of TCDD at 
the highest level. In both Ranch Hand veterans and comparison veterans, the 
prevalence of MGUS increased with age. This study is the first to correlate 
objective measurement of levels of TCDD exposure with MGUS. This study was 
well designed and is strengthened by its use of objective measurements of serum 
TCDD levels in both exposure groups, long-term follow-up with prospective 
data and biospecimen collection, and the use of standard laboratory analyses. 
Although the serum samples taken to measure TCDD levels were collected at 
least 15 years after military exposure and it was not possible to measure exposure 
to 2,4-D or 2,4,5-T, TCDD levels may be used as a surrogate of exposure for the 
Ranch Hands and comparison veterans. However, the findings strongly support 
an asso ciation between TCDD exposure and MGUS, and therefore, multiple 
myeloma.
Multiple Myeloma
Multiple myeloma (ICD-9 203.0; ICD-10 C90.0) is characterized by a prolif-
eration of bone marrow cells that results in an excess of neoplastic plasma cells 
and in the production of excess immunoglobulin protein. Multiple myeloma is 
sometimes grouped with other immunoproliferative neoplasms (ICD-9 203.8; 
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ICD-10 C90.2). The American Cancer Society estimated that 16,400 men and 
14,370 women would receive diagnoses of multiple myeloma in the United States 
in 2018 and that 6,830 men and 5,940 women would die from it (ACS, 2018e).
The incidence of multiple myeloma is highly age-dependent and is relatively 
low in people under 40 years old. The incidence is slightly higher in men than in 
women; for all races the incidence rate for 2009–2013 was 8.0 per 100,000, and 
for women it was 5.2 per 100,000. The difference becomes more pronounced with 
age. In the age groups that include most Vietnam veterans, the age-adjusted mod-
eled incidence rate of myeloma for men 50–64 years old of all races combined 
was 13.1 per 100,000 in 2014, increasing to 39.0 for 65- to 74-year-olds and 61.1 
for men over 75 years.21
An increased incidence of multiple myeloma has been observed in several 
occupational groups, including farmers and other agricultural workers and those 
with workplace exposure to paint strippers, petroleum, and certain metals, min-
erals, and chemical substances (Sergentanis et al., 2015). People who have high 
exposure to ionizing radiation and those who have other plasma-cell diseases, 
such as MGUS or solitary plasmacytoma, are also at greater risk (Sergentanis 
et al., 2015).
Conclusions from VAO and Previous Updates The committee responsible for 
VAO concluded that there was limited or suggestive evidence of an association 
between exposure to the COIs and multiple myeloma. Few studies of multiple 
myeloma have been conducted among Vietnam veterans, and most of them have 
reported no cases of or decreased risks of multiple myeloma (Akhtar et al., 2004; 
Boyle et al., 1987; Breslin et al., 1988; Cypel and Kang, 2008; Goun and Kuller, 
1986; Wolfe et al., 1990). Follow-up analyses of the New Zealand cohort of veter-
ans who served in Vietnam found no statistically significant increase in the risk of 
deaths from or incidence of multiple myeloma when compared to the standardized 
general New Zealand population (McBride et al., 2013). Likewise, in the Korean 
cohort of veterans who served in Vietnam, there was no statistically significant 
increase in multiple myeloma in the internal comparison of the high- and low- 
exposure groups based on EOI scores (Yi and Ohrr, 2014). Similarly for multiple 
myeloma mortality, Yi et al. (2014b) reported a decreased risk for the high- versus 
low-exposure groups and with the individual log-transformed EOI scores.
However, several occupational cohort studies with well-characterized ex-
posures to one or more of the COIs found a statistically significant increased 
incidence or mortality of myeloma among agricultural workers and farm  workers 
(Blair et al., 1993; Boffetta et al., 1989; Brown et al., 1993; Burmeister et al., 
1983; Eriksson and Karlsson, 1992; La Vecchia et al., 1989; Morris et al., 1986). 
21 As calculated on the site https://seer.cancer.gov/faststats/selections.php?#Output using the SEER 
13 dataset and by choosing age-adjusted rates, myeloma, all races, age groups 50–64, 65–74, and ≥ 
75 years, and male sex.
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Additional studies reviewed since VAO have reported increased risks of incidence 
or mortality, but in general the findings have not been statistically significant. 
Most recently, a follow-up analysis of the Cross-Canada Study of Pesticides and 
Health was reviewed by the Update 2014 committee. The association between 
lifetime use of multiple pesticides and multiple myeloma risk was examined 
among men 19 years and older who worked in agriculture and had a first diag-
nosis of STS, NHL, multiple myeloma, or HL during the original study period 
of 1991–1994 (Kachuri et al., 2013). Pesticides were grouped by type, chemical 
class, and their carcinogenic potential. The investigators recruited 342 cases 
and 1,357 controls. Odds ratios were calculated and adjusted for age, residence, 
medical history, and smoking. A statistically significant increased risk of multiple 
myeloma was observed with exposure to Mecoprop but not with exposure to 
2,4-D. An evaluation of days per year of mixing or applying phenoxy herbicides 
was not statistically significant for any category (≤ 2 days per year, 2–5 days, 
and > 5 days).
Update of the Epidemiologic Literature No new studies of multiple myeloma 
in Vietnam veterans or environmental or case-control studies of exposure to the 
COIs and multiple myeloma have been published since Update 2014. Reviews of 
the relevant studies are presented in the earlier reports. Tables 26 and 27, which 
can be found at www.nap.edu/catalog/25137, summarize the results of studies 
related to CLL and plasma cell dyscrasias and include the studies of multiple 
myeloma.
Occupational Studies In an extension of the follow-up of UK phenoxy herbicide 
manufacturers and sprayers to examine the carcinogenicity of phenoxy herbicides 
and their association primarily with HL, STS, and CLL, Coggon et al. (2015) also 
reported mortality from other types of cancer, including multiple myeloma. A total 
of 18 deaths from multiple myeloma were reported, but although risk estimates 
were slightly elevated, none were statistically significant for any of the groups of 
workers: all workers (n = 18; SMR = 1.04, 95% CI 0.62–1.64), workers exposed 
to herbicide levels above background (n = 15; SMR = 1.18, 95% CI 0.66–1.94), 
or workers exposed for more than 1 year at levels above background (n = 6; SMR 
= 1.01, 95% CI 0.37–1.86).
Other Identified Studies One other study that reported mortality outcomes from 
multiple myeloma was identified, but it lacked sufficient exposure specificity to 
be included as contributing to the evidence base of the potential effect of the 
COIs (Ruder et al., 2014).
Biologic Plausibility No animal studies have reported an association between 
exposure to the COIs and multiple myeloma. AHR activation by TCDD in  human 
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breast and endocervical cell lines induces sustained high concentrations of  IL-6, 
which has tumor-promoting effects in numerous tissues (Hollingshead et al., 
2008). IL-6 plays a role in B-cell maturation and induces a transcriptional in-
flammatory response. It is known to be increased in B-cell neoplasms, including 
multiple myeloma and various lymphomas (Hussein et al., 2002; Kovacs, 2006).
In comparing the frequency of specific variants of several metabolic genes 
between multiple myeloma cases and controls, Gold et al. (2009) found some 
indication of differences, particularly in CYP1B1 and AHR alleles, that might re-
flect an increased susceptibility to multiple myeloma after exposure to particular 
chemicals. A biochemical link to the COIs, however, is far from being established.
Synthesis Previous VAO reports found limited or suggestive evidence of an 
association between exposure to at least one of the COIs and multiple myeloma. 
The evidence of an association between the COIs and lymphomas (NHL, HL, and 
CLL/HCL) has been classified as sufficient. Most of these cancers also arise from 
B cells, so the committee hypothesized that it would be etiologically  plausible 
for the association with multiple myeloma to belong with the lymphomas in the 
sufficient category. Although many studies of exposure to pesticides in general 
and multiple myeloma found strong or at least positive associations, a review of 
studies that addressed an association between exposure to the specific COIs and 
multiple myeloma found that the results were considerably weaker than those 
for the other B-cell neoplasms; in particular, the results did not justify advanc-
ing multiple  myeloma out of the limited or suggestive category. No animal 
 studies have reported an association between exposure to the COIs and multiple 
myeloma. However, given the close relationship between myeloma and other 
lymphoproliferative neoplasms, biologic and mechanistic studies implying a 
connection between the COIs and NHL likely link to similar pathways in plasma 
cell dyscrasias. Two well-designed studies of well-characterized cohorts were 
reviewed in the current update. In an analysis using data and preserved serum 
samples from the AFHS, Landgren et al. (2015) found a 2.4-fold increased risk 
of MGUS in Ranch Hand veterans compared with a matched group of veterans 
who did not participate in aerial herbicide spraying missions. In both Ranch Hand 
veterans and comparison veterans, the prevalence of MGUS increased with age. 
This study is the first to provide objective evidence of an association between 
higher levels of TCDD exposure and MGUS, and therefore, possibly multiple 
myeloma. In the extended follow-up of UK men who worked manufacturing or 
spraying phenoxy acids in the United Kingdom, Coggon et al. (2015) reported 
slightly increased, but not statistically significant, risks of multiple myeloma, and 
the increased risk was lowest in the most highly exposed group. No toxicologic 
studies on exposure to the COIs and MGUS or multiple myeloma have been 
identified.
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Amyloid Light Chain Amyloidosis
AL amyloidosis is a rare condition that is a complication of multiple 
 myeloma. The committee responsible for Update 2006 moved the discussion 
of AL  amyloidosis from the chapter on miscellaneous non-neoplastic health 
conditions to the cancer chapter to put it closer to related neoplastic condi-
tions, such as multiple myeloma and some types of B-cell lymphomas. The 
conditions share several biologic features, notably the clonal hyperprolifera-
tion of B cell– derived plasma cells and the production of abnormal amounts 
of immunoglobulins.
The primary feature of amyloidosis (ICD-9 277.3; ICD-10 E85) is the accu-
mulation and deposition in various tissues of insoluble proteins, or amyloids. 
Amyloid protein accumulates in the extracellular spaces of various tissues. 
The pattern of organ involvement depends on the nature of the protein; some 
 amyloid proteins are more fibrillogenic than others. Amyloidosis is classified 
according to the biochemical properties of the fibril-forming protein. Exces-
sive  amyloid protein can have modest clinical consequences, or it can produce 
 severe,  rapidly progressive multiple-organ-system dysfunction. The Amyloidosis 
Founda tion esti mates that approximately 4,500 new cases are diagnosed each 
year ( Amyloidosis Foundation, 2018). It usually affects people from ages 50 to 
80 years and occurs more often in males than in females.
AL amyloidosis is the most common form of systemic amyloidosis; the A 
stands for amyloid, and the L indicates that the amyloid protein is derived from 
immunoglobin light chains. AL amyloidosis results from the overproduction of 
immunoglobulin light-chain protein from a monoclonal population of plasma 
cells; some of these light chains can form a beta-pleated sheet, engendering 
protein deposition in tissue. Clinical findings can include excessive AL protein 
or immunoglobulin fragments in the urine or serum, renal failure with nephrotic 
syndrome, liver failure with hepatomegaly, heart failure with cardiomegaly, 
 marcroglossia, carpal tunnel syndrome, and peri pheral neuropathy. Bone marrow 
biopsies commonly show an increased density of plasma cells, which suggests 
a premalignant state. Historically, bone marrow biopsies emphasized routine 
histochemical analysis, but modern immunocytochemistry and flow cytometry 
now commonly identify monoclonal populations of plasma cells with molecular 
techniques. AL amyloidosis can progress rapidly and is often far advanced by the 
time it is diagnosed (Buxbaum, 2004).
Conclusions from VAO and Previous Updates The committees responsible 
for Update 2000, Update 2002, and Update 2004 concluded that there was 
inade quate or insufficient evidence to determine whether there is an associa-
tion between exposure to the COIs and AL amyloidosis. Although there are few 
epidemiologic data specifically on AL amyloidosis, the committee responsible 
for Update 2006 changed the categorization to limited or suggestive evidence 
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of an association on the basis of commonalities in its cellular lineage with mul-
tiple myeloma and B-cell lymphomas. Later committees have not changed that 
categorization.
Epidemiologic results for amyloidosis were reported for the first time in 
Vietnam veterans in the publication from the Korean Veterans Health Study (Yi 
et al., 2014a) on the prevalence of diseases as confirmed by insurance records. 
From the internal comparison of veterans in the category with high EOI scores 
(nine cases) to those in the low-potential-exposure group (six cases) with adjust-
ments for age, rank, smoking, drinking, physical activity, domestic herbicide use, 
education, income, and BMI, a statistically significantly elevated, but imprecise, 
risk of amyloidosis (OR = 3.02, 95% CI 1.02–8.93) was found. When regression 
with the same adjustments was performed on the logarithms of the individual 
EOI scores for the entire set of veterans, a statistically significant increased risk 
was again found but it was lower in magnitude (OR = 1.32, 95% CI 1.02–1.71).
Update of the Epidemiologic Literature No new studies of exposure to the 
COIs and AL amyloidosis (human or animal) have been identified since those 
reviewed in Update 2014. Reviews of the relevant studies are presented in the 
earlier reports. Table 27—contained in the supplementary tables available at 
www.nap.edu/ catalog/25137—summarizes the results of studies related to plasma 
cell dyscrasias and includes the studies of amyloidosis.
Biologic Plausibility A 1979 study reported the dose-dependent development 
of a “generalized lethal amyloidosis” in Swiss mice that were treated with TCDD 
for 1 year (Toth et al., 1979). That finding has not been validated in 2-year carci-
nogenicity studies of TCDD in mice or rats, but the use of different strains may 
explain the discrepancies. Thus, few animal data support an association between 
TCDD exposure and AL amyloidosis in humans, and no animal data support an 
association between the other COIs and AL amyloidosis.
It is known, however, that AL amyloidosis is associated with B-cell diseases, 
and 15–20% of cases of AL amyloidosis occur with multiple myeloma. Other 
diagnoses associated with AL amyloidosis include B-cell lymphomas (Cohen et 
al., 2004), MGUS, and agammaglobulinemia (Rajkumar et al., 2006).
Synthesis AL amyloidosis is very rare, and previous VAO committees have 
thought that it was unlikely that population-based epidemiology will ever pro-
vide substantial direct evidence regarding its causation. The assignment of this 
condition to the “limited or suggestive” category of association has been based 
on the biologic and pathophysiologic features linking AL amyloidosis, multiple 
myeloma, and some types of B-cell lymphomas—especially the clonal hyperpro-
liferation of plasma cells and abnormal immunoglobulin production—thus indi-
cating that AL amyloidosis is pathophysiologically related to these conditions. 
No new epidemiologic or mechanistic studies of exposure to the COIs and AL 
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amyloidosis have been identified since Update 2014, and therefore the commit-
tee maintains the conclusion of limited or suggestive evidence of an association.
Conclusion on Plasma Cell Dyscrasia
Based on new information from an analysis of the AFHS that examined 
MGUS and used objective measures of dioxin exposure in a well-characterized 
exposed group of Vietnam veterans, the committee concludes that there is suffi-
cient evidence of an association between exposure to at least one of the COIs and 
MGUS. However, the committee notes that the clinical and health implications 
of a diagnosis of MGUS are minimal and that only a small percentage of people 
with MGUS progress to multiple myeloma. Although an increase in MGUS may 
be inferred to predict an increased incidence of multiple myeloma, there is no 
scientific evidence at this time to confirm that the elevated rates of MGUS seen 
in the exposed population will translate to higher rates of multiple myeloma. 
Therefore, based on the evidence reviewed here and in previous VAO reports, 
the committee concludes that there remains limited or suggestive evidence of an 
association between exposure to at least one of the COIs and multiple myeloma 
and AL amyloidosis. The close association of these diagnoses to a previous 
diagnosis of MGUS strengthens this association; however, further study would 
be needed to establish definitively that the increased prevalence of MGUS will 
translate to higher levels of these clinically significant plasma cell neoplasms.
Leukemias
Leukemias (ICD-9 202.4, 203.1, 204.0–204.9, 205.0–205.9, 206.0–206.9, 
207.0–207.2, 207.8, 208.0–208.9; ICD-10 C90.1–C95.9) have traditionally been 
divided into four primary types: acute and chronic lymphocytic leukemias and 
acute and chronic myeloid leukemias. There are numerous subtypes of acute 
myeloid leukemia (ICD-9 205; ICD-10 C92), which is also called acute myelogenous 
leukemia, granulocytic leukemia, or acute non-lymphocytic leukemia.
NCI estimated that in the United States in 2018, 60,300 people would receive 
a new diagnosis of and 24,370 men and women would die from some form of 
leukemia. Collectively, leukemias were expected to account for 3.7% of all new 
diagnoses of malignancies and 4.1% of deaths from malignancy in 2017 (NCI, 
n.d.bb). Grouping all different forms of leukemias into a single group is not 
informative because the different forms have different patterns of incidence and 
different risk factors.
Myeloid Leukemias
In adults, the majority of acute leukemias are AML (ICD-9 205.0, 207.0, 
207.2; ICD-10 C92.0, 92.4–92.5, 94.0, 94.2). NCI estimated that 19,520 people 
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would receive a new diagnosis of AML in the United States in 2018 and that 
10,670 men and women would die from it. Overall, AML is slightly more com-
mon in men than in women of the same race and incidence is highest in whites 
and lowest in American Indians/Alaska Natives (NCI, n.d.cc). Risk factors asso-
ciated with AML include high doses of ionizing radiation, occupational exposure 
to benzene, and exposure to some medications used in cancer chemotherapy (such 
as melphalan) (Deschler and Lubbert, 2006; IARC, 2016). Several bone marrow 
failure syndromes (severe congenital neutropenia, Fanconi anemia, Schwachman-
Diamond syndrome, and dyskeratosis congenital) and Down syndrome are asso-
ciated with an increased risk of AML, and tobacco use is thought to account for 
about 20% of AML cases.
Vietnam veterans have expressed concern about whether myelodysplastic 
syndromes, which can transform to AML, are associated with Agent Orange 
exposure. However, no results on those conditions in conjunction with the COIs 
have been found in VAO literature searches. Epidemiologic research on those 
 hematologic disorders has been undertaken fairly recently; for instance, the 
LATIN case-control study (Maluf et al., 2009) has undertaken an investigation 
of aplastic anemia in South America, but the reported exposures have been only 
as specific as “herbicides” and “agricultural pesticides.”
The incidence of CML increases steadily with age in people older than 30 
years. NCI estimated that 8,430 people would receive a new diagnosis of CML in 
the United States in 2018 and that 1,090 men and women would die from it. Its 
lifetime incidence is roughly equal in whites and blacks and is slightly higher in 
men than in women of the same race and ethnicity (NCI, n.d.dd). CML  accounts 
for about one-third of cases of leukemias in people in the age groups that include 
most Vietnam veterans (60–80 years). It is associated with an acquired chromo-
somal translocation known as the Philadelphia chromosome, for which exposure 
to high doses of ionizing radiation is a known risk factor.
Lymphoid Leukemias
ALL is a disease of young children (peak incidence at the age of 2–5 years) 
and of people over 70 years old. NCI estimated that 5,960 people would receive 
a new diagnosis of ALL in the United States in 2018 and that 1,470 men and 
women would die from it (NCI, n.d.ee). The lifetime incidence of ALL is slightly 
higher in whites than in blacks and about the same for men and women. Exposure 
to high doses of ionizing radiation is a known risk factor for ALL, but there is 
little consistent evidence on other factors.
CLL is more appropriately classified as a form of B-cell NHL given its 
immuno histochemistry, B-cell origin, and progression to an acute, aggressive 
form of NHL. Therefore, the committee considers it in the section above on NHL, 
as classified in the WHO system.
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Conclusions from VAO and Previous Updates
The committee responsible for VAO concluded that there was inadequate 
or insufficient information to determine whether there is an association between 
exposure to the COIs and all types of leukemias. Additional information avail-
able to the committees responsible for Update 1996 through Update 2010 did not 
change that conclusion. The committee responsible for Update 2002, however, 
considered CLL separately and judged that there was sufficient evidence of an 
association with the herbicides used in Vietnam and CLL alone, and Update 2008 
noted that HCL is closely related to CLL.
The committee responsible for Update 2006 considered AML individu-
ally but did not find evidence to suggest that its occurrence is associated with 
exposure to the COIs, and there is still not sufficient evidence to support such 
an association, so AML has been retained with other non-CLL leukemias in the 
category of inadequate or insufficient evidence.
The Update 2014 committee assessed two cohorts of veterans who served 
in Vietnam. In the New Zealand cohort, McBride et al. (2013) reported four 
leukemia deaths, which was not statistically different from the general standard-
ized population. They also reported the incidence of 21 leukemias overall, which 
resulted in a statistically significantly elevated standaridized incidence ratio. 
 Results were stratified by incident non-lymphoid and lymphoid leukemias, but 
only the lymphoid leukemia standardized incidence ratio was statistically sig-
nificant. From the Korean Health Study, Yi et al. (2014b) reported 107 leukemia 
deaths, but neither the low-exposure nor the or high-exposure hazard ratios were 
statistically significant. That included 5 ALL, 46 AML, and 15 CML deaths. The 
small number of low-exposure deaths makes the reported estimates quite  unstable. 
When examined using EOI scores, the  adjusted hazard ratios for myeloid leuke-
mia in the low-exposure and high-exposure groups were not statistically signifi-
cant (Yi and Ohrr, 2014).
Update of the Epidemiologic Literature
No studies of leukemia of any type in Vietnam veterans have been pub-
lished since Update 2014. Likewise, no environmental or case-control studies 
of the COIs and leukemia were identified. Reviews of the relevant studies are 
presented in the earlier reports. Table 28, which can be found at www.nap.edu/
catalog/25137, summarizes the results of studies related to leukemia.
Occupational Studies Among the Dow Midland, Michigan, worker cohort, 
Collins et al. (2016) reported categories of leukemia and leukemia (C91–C95), 
total lymphoid leukemia (C91–C95), total myeloid leukemia (C92), acute non-
lymphatic leukemia (92.0, 93.0, 94.0), and all other leukemia (C93–C95). Com-
pared with the standardized U.S. population, an increased risk of mortality for 
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all leukemias was found for the TCP workers (n = 17; SMR = 1.78, 95% CI 
1.04–2.85) but not for the PCP workers (n = 3; SMR = 0.67, 95% CI 0.14–1.96). 
Likewise, an increased risk of death was seen among TCP workers for total 
 myeloid leukemia (C92) (n = 10; SMR = 2.42, 95% CI 1.16–4.46) and acute 
non-lymphatic leukemia (C92.0, 93.0, 94.0) (n = 9; SMR = 2.88, 95% CI 1.32–
5.47), but no difference was found for PCP workers, for which there were only 
two reported deaths from each of those leukemias. No differences in mortality 
for total lymphoid leukemia was found for either the TCP workers (n = 5; SMR 
= 1.99, 95% CI 0.64–4.64) or the PCP workers, for which there was only one 
death. Only two deaths among TCP workers and none among the PCP workers 
were found for all other leukemias.
Coggon et al. (2015) extended the follow-up period of a large IARC-spon-
sored study and examined the carcinogenicity of phenoxy herbicides and their 
association primarily with HL, STS, and CLL, but deaths from other types of 
cancer were also reported. A total of 40 leukemia deaths were reported. Although 
risk-of-death estimates from leukemia were slightly elevated for all three groups 
of workers, none reached statistical significance: all workers (SMR = 1.27, 95% 
CI 0.91–1.73), workers exposed to herbicide levels above background (n = 30; 
SMR = 1.29, 95% CI 0.87–1.84), and workers exposed to phenoxy acids above 
background for 1 year or longer (n = 11; SMR = 1.04, 95% CI 0.52–1.86). 
Mortality from myeloid leukemia specifically (n = 22) was also not statistically 
significant for any of the groups of workers: all workers (SMR = 1.21, 95% 
CI 0.76–1.84), workers exposed to herbicide levels above background (n = 15; 
SMR = 1.11, 95% CI 0.62–1.83), or workers exposed for more than 1 year at 
levels above background (n = 6; SMR = 0.98, 95% CI 0.36–2.13).
Other Identified Studies Several other studies (occupational, environmental, 
and case-control designs) were identified that examined leukemia outcomes, but 
all lacked sufficient exposure specificity (e.g., mixtures to several chemicals with 
no concentrations measured, general herbicide exposure, or exposure determina-
tion based on broad categories of occupation with no further details collected) to 
be included further as contributing to the evidence base of the potential effect of 
the COIs (Akahane et al., 2017; Levine et al., 2016; Maryam et al., 2015; Poynter 
et al., 2017; Punjindasup et al., 2015; Ruder et al., 2014).
Biologic Plausibility
Leukemia is a relatively rare spontaneous neoplasm in mice, but it is less rare 
in some strains of rats. A small study reported that 5 of 10 male rats fed TCDD at 
1 ng/kg per week for 78 weeks showed an increased incidence of various cancers, 
one of which was lymphocytic leukemia (Van Miller et al., 1977). Later studies of 
TCDD’s carcinogenicity have not shown an increased incidence of lymphocytic 
leukemia in mice or rats.
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Two studies that used cells in tissue culture suggested that TCDD exposure 
does not promote leukemia. The proliferation of cultured human bone marrow 
stem cells (the source of leukemic cells) was not influenced by the addition 
of TCDD to the culture medium (van Grevenynghe et al., 2005). Likewise, 
Mulero-Navarro et al. (2006) reported that the AHR promoter is silenced in 
ALL—an effect that could lead to a reduced expression of the receptor, which 
binds TCDD and mediates its toxicity. No reports of animal studies have noted 
an increased incidence of leukemia after exposure to the phenoxy herbicides or 
other COIs. AHR plays a role in hematopoetic stem cell expansion as well as in 
erythroid and megakaryocytic differentiation (B. W. Smith et al., 2013). In this 
context, information in a letter to the editor of the American Journal of Hematol-
ogy from Nguyen-Khac et al. (2014) is interesting. The researchers described 
a chromosomal translocation found in a human acute leukemia that  recombines 
the TEL gene with the ARNT (Arylhydrocarbon Receptor Nuclear Translocator) 
gene, producing a fusion gene product. This recent functional work strongly 
suggests that the translocation impairs the normal functions of ARNT, potentially 
contributing to leukemogenesis.
Synthesis
Several studies of the incidence of or mortality from leukemia have been 
reviewed in the VAO series. Among U.S. Vietnam veterans, findings have been 
null, and risk estimates have been less than 1.0; among international cohorts of 
Vietnam veterans (Australia, New Zealand, and Korea), risk estimates have been 
mixed in direction, but most continue not to be statistically significant. No new 
studies of leukemia in Vietnam veterans were identified for the current update. 
Two mortality updates of occupational cohorts were reviewed that examined all 
leukemia and subtypes. Collins et al. (2016) extended the follow-up period of 
workers who were exposed to dioxins during the manufacturing process of PCP 
and TCP in Midland, Michigan, and found a statistically significant elevated risk 
of mortality from all leukemias for the TCP workers, but not for PCP workers 
compared with the standardized U.S. population. Likewise, a statistically signifi-
cant increased risk of death compared with the standardized U.S. population was 
seen among TCP workers for total myeloid leukemia and acute non-lymphatic 
leukemia, but no difference was found for PCP workers for which there were only 
two reported deaths from each of those leukemias. A small number of deaths from 
total lymphoid leukemias and all other leukaemia were reported for both TCP and 
PCP workers, and neither estimate was statistically significant. In the follow-up 
study of UK workers who manufactured or sprayed phenoxy herbicides, SMR 
estimates from all leukemia and myeloid leukemia specifically were slightly 
elevated for all three groups of workers, but none reached statistical significance 
(Coggon et al., 2015). Given the new mixed findings from the well-characterized 
occupational cohorts and the lack of reported findings of increased incidence 
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of leukemia after exposure to the phenoxy herbicides or other COIs in animal 
models, the committee maintains the conclusion of inadequate or insufficient evi-
dence of an association between exposure to the COIs and leukemias in general.
Conclusion
Based on the evidence reviewed here and in previous VAO reports, the com-
mittee concludes that there is inadequate or insufficient evidence to determine 
whether there is an association between exposure to the COIs and leukemias in 
general. An exception is the specific leukemia subtypes of chronic B-cell hemato-
proliferative diseases, including CLL and HCL, which are more appropriately 
grouped with lymphomas.
Other Myeloid Diseases
Myelodysplastic syndromes (MDSs) are a collection of clonal diseases 
(ICD-9 238.7; ICD-10 D46) that involve dysplastic maturation and cytopenias. 
The malignant potential of MDS is variable, but with time, many patients will 
progress to AML. MDS was not required to be reported to cancer registries 
until 2001. U.S. incidence was estimated at 4.9 per 100,000 people per year for 
2007–2011, but this is thought to be an underestimate due to underreporting and 
underdiagnosis (Cogle, 2015). NCI has estimated the incidence rate of MDS to be 
even higher in older age groups: 13.5 per 100,000 in those aged 65–69 years to 
63.6 per 100,000 in those aged 85 years and older. The median age of diagnosis 
is 70 years (Montalban-Bravo et al., 2016). In addition to increasing incidence 
with older age, MDS is most prevalent in individuals who are white and male. 
It has been conservatively estimated that 10,000 new cases of MDS occur in the 
United States annually and that more than 60,000 individuals in the United States 
are currently living with MDS (Ma, 2012).
Various factors determine the prognosis for MDS, and several scoring sys-
tems are used. Most involve the number of cytopenias, dependence on transfu-
sion, cytogenetic abnormalities, and the number of blasts in the marrow. For 
low-risk disease, the median survival is about 7 years; for high risk, it is less than 
1 year. MDS does not always progress to AML, and the incidence of progres-
sion varies with the risk category. Of cases with high-risk MDS, around 25–35% 
progress to AML. More people die from complications of infection or bleeding 
related to cytopenias than through transformation to AML.
Myeloproliferative neoplasms (MPNs) (ICD-9 205.1, 238.4, 289.89, 289.9; 
ICD-10 D47.1) are clonal diseases of the myeloid lineage associated with hyper-
proliferation and elevated blood counts, usually associated with constitutive 
tyrosine kinase activation. These syndromes include polycythemia vera, essential 
thrombocytosis, myelofibrosis, and CML. The non-CML MPNs have a closely-
related pathogenesis. Nearly all of patients with polycythemia vera have a point 
Veterans and Agent Orange: Update 11 (2018)
Copyright National Academy of Sciences. All rights reserved.
362 VETERANS AND AGENT ORANGE: UPDATE 11
mutation in the JAK2 gene (JAK2V617F), which is also present in about half 
of patients with essential thrombocytosis and myelofibrosis. The majority of 
JAK2-negative essential thrombocytosis and myelofibrosis are associated with 
mutations in the calreticulin gene.
The non-CML myeloproliferative neoplasms are characterized by abnormal 
peripheral blood counts with increased reticulin fibrosis in the bone marrow; 
the degree to which the abnormalities relate to red cells (polycythemia vera), 
platelets (essential thrombocytosis), and fibrosis (myelofibrosis) determines the 
phenotype. All of these closely related illnesses are associated with increased 
clotting and bleeding risk, and all have the potential to progress to marrow failure 
(secondary to myelofibrosis) and AML.
Aplastic anemia (ICD-9 284; ICD-10 D60–D61) is a bone marrow failure 
syndrome associated with the primary loss of stem cells or the immunologic 
suppression of stem-cell proliferation and maturation leading to pancytopenia. 
Exposures to radiation, a number of drugs, and some industrial chemicals (such 
as benzene) are recognized as risk factors for this condition, but it may also arise 
from an autoimmune disease.
Conclusions from VAO and Previous Updates
MDS was not reviewed as a separate category until Update 2014, which 
reviewed only one paper that included MDS as an outcome. Yi and Ohrr (2014) 
assessed cancer incidence among Korean veterans who had served in Vietnam 
between 1964 and 1973 and reported a non-significant increased risk of MDS 
in the internal comparison of the high- and low-exposure groups, based on the 
EOI scores.
Update of the Epidemiologic Literature
Although VA charged the committee with specifically considering and 
review ing the evidence of exposure to the COIs and MPNs, no published stud-
ies were identified (in humans or in animals or cell lines). There have been no 
published data on the relationship between the COIs and MPNs; therefore no 
evaluation of the literature could be performed.
Biologic Plausibility
K. P. Singh et al. (2014) explored the relationship of the absence of the AHR 
locus and changes in hematopoetic stem cells associated with aging. They fol-
lowed Ahr-null mice, showing that they have diminished survival, splenomegaly, 
leukocytosis, and anemia. The hematopoetic stem cells showed diminished self-
renewal capacity, with somatic changes compatible with a profile of accelerated 
aging and hematopoetic stem cell exhaustion.
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Synthesis
There are minimal data to assess the role that specific COIs may play in the 
occurrence of the various nonmalignant bone marrow–derived diseases. Based on 
the one null study of Korean veterans who served in Vietnam that was reviewed 
in Update 2014 and the paucity of new studies, the committee maintains the 
conclusion of inadequate or insufficient evidence of exposure to any of the COIs 
and other myeloid diseases including MPNs.
Conclusion
Based on the available information, the committee concludes that there is 
inadequate or insufficient evidence to determine whether there is an association 
between exposure to the COIs and other myeloid diseases including myelo-
proliferative neoplasms.
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Reproductive Health Effects and 
Effects on Descendants
Chapter Overview
Based on new evidence and a review of prior studies, the current committee did 
not find any new associations between outcomes related to the reproductive health 
of veterans or effects on their descendants and exposure to the chemicals of inter-
est (COIs; 2,4-dichlorophenoxyacetic acid [2,4-D], 2,4,5-trichlorophenoxyacetic 
acid [2,4,5-T], picloram, dimethylarsinic acid [DMA or cacodylic acid], 2,3,7,8- 
tetrachlorodibenzo-p-dioxin [TCDD]).
Thus, the findings on these outcomes can be summarized as follows:
• None of the outcomes met the committee’s criteria for determining that 
there was sufficient evidence of an association with exposure to the COIs.
• None of the outcomes met the committee’s criteria for determining that 
there was limited or suggestive evidence of an association with exposure 
to the COIs.
• There is inadequate or insufficient evidence to determine whether there 
is an association between exposure to the COIs and endometriosis; 
decreased sperm counts or sperm quality, subfertility, or infertility; spon-
taneous abortion, stillbirth, neonatal death, or infant death; and low birth 
weight or preterm delivery, birth defects, childhood cancers, or other 
disease in their children as they mature or in later generations.
• There is limited or suggestive evidence of no association between paternal 
exposure to TCDD and spontaneous abortion.
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This chapter summarizes the scientific literature published since Veterans 
and Agent Orange: Update 2014, hereafter referred to as Update 2014 (NASEM, 
2016a), on the association between exposure to herbicides and adverse effects 
on the reproductive health of male and female Vietnam veterans and the health 
of their children and later generations. The literature considered in this chapter 
includes studies of a broad spectrum of reproduction-related effects in veterans 
and in other populations exposed occupationally or environmentally to the herbi-
cides sprayed in Vietnam or to TCDD. Because some polychlorinated biphenyls 
(PCBs), some polychlorinated dibenzofurans (PCDFs or furans), and some poly-
chlorinated dibenzodioxins (PCDDs) other than TCDD have dioxin-like biologic 
activity, studies of populations exposed to these chemicals were reviewed if their 
results were presented in terms of TCDD toxic equivalents (TEQs). As noted in 
Chapter 3, studies that report TEQs based only on mono-ortho PCBs (which are 
PCBs 105, 114, 118, 123, 156, 157, 167, and 189) are considered even though 
their TEQs are several orders of magnitude lower than those of the non-ortho 
PCBs (77, 81, 126, and 169), based on the revised World Health Organization 
(WHO) toxicity equivalency factor (TEF) scheme of 2005 (La Rocca et al., 2008; 
van den Berg et al., 2006). This is because the lower TEQs of the mono-ortho 
PCBs may be counterbalanced by their abundance, which is generally many 
orders of magnitude higher than the abundance of the non-ortho PCBs (H.-Y. 
Park et al., 2010).
The adverse outcomes evaluated in this chapter are male reproductive health 
effects such as alterations in sperm quality, semen, sex ratio, or hormonal levels; 
female reproductive health effects, including endometriosis and outcomes related 
to alterations in hormonal levels such as polycystic ovary syndrome and gesta-
tional diabetes; increased fetal loss (spontaneous abortion and stillbirth); neona-
tal and infant mortality; adverse gestational outcomes of low birth weight and 
preterm delivery; and the possibility of adverse health outcomes (birth defects, 
cancer; and changes in growth and physical parameters and in immune, allergic, 
motor development, cognitive, behavioral and socio-emotional outcomes) at any 
time during the lives of all progeny of Vietnam veterans. The committee respon-
sible for Updates 2012 and 2014 separated those outcomes most directly related 
to reproductive health and to the health of progeny into separate chapters. This 
report combines them because the committee believes that reproduction-related 
effects are best understood as a continuum.
Because the vast majority of Vietnam veterans are men, the primary focus 
of the Veterans and Agent Orange (VAO) series has been on potential adverse 
effects of herbicide exposure on men, and the etiologic importance of the 
expo sed party’s sex does not play the same dominant role in non-reproductive 
outcomes that it does in reproductive outcomes. However, an estimated 7,500 
women are thought to have served in Vietnam (VA, 2017a), so findings relevant 
to female reproductive health, such as those concerning endometriosis, are also 
included in the chapter. Whenever the information was available, an attempt has 
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been made to evaluate the effects of exposure on males and females separately. 
It should be kept in mind, though, that the amount of research providing reliable 
information on the consequences of paternal exposure is extremely sparse for 
the COIs in the VAO report series and also for the full array of environmental 
agents that may pose threats to the health of future generations.
In addition, for published epidemiologic or experimental results to be fully 
relevant to the evaluation of the plausibility of reproductive effects in Vietnam 
veterans, whether female or male, the veteran’s exposure needs to have occurred 
before the conception of the child. With the exception of female veterans who 
became pregnant while serving in Vietnam, pregnancies that might have been 
affected occurred after deployment, when primary exposure had ceased but fetal 
exposure via dioxin stored in maternal tissue was possible. In the case of pregnan-
cies of women who have previously been substantially exposed to the lipophilic 
dioxins, the direct exposure of the fetus throughout gestation is possible through 
the mobilization of toxicants from the mother’s adipose tissue. In contrast, adverse 
effects on offspring mediated by male veterans would be via alterations in the 
sperm genome and associated ribonucleic acids (RNAs) or semen that would have 
been transmitted after exposure and deployment.
The categories of association and the approach to categorizing the health 
outcomes are discussed in Chapter 3. To reduce repetition throughout the report, 
Chapter 5 characterized study populations and presents design information related 
to new publications that report findings or that revisit study populations consid-
ered in earlier updates.
BIOLOGIC PLAUSIBILITY OF REPRODUCTIVE HEALTH EFFECTS
There have been few studies of the effects on reproductive outcomes of 
exposure to the four herbicides in question, particularly picloram and cacodylic 
acid, and the available studies generally have shown toxicity only at very high 
doses. Much of the following discussion thus concerns TCDD, which, other than 
in controlled experimental circumstances, usually occurs in a mixture of dioxins 
(dioxin congeners in addition to TCDD).
TCDD is stored in fat tissue and has a long biologic half-life, so internal 
exposure at generally constant concentrations may continue after an episodic, 
high-level exposure to an external source is discontinued. If a person had a high 
exposure, then high amounts of dioxins may still be stored in fat tissue and be 
mobilized, particularly at times of weight loss. That would not be expected to be 
the case for nonlipophilic chemicals, such as cacodylic acid.
Dioxin exposure has the potential to disrupt male reproductive function by 
altering the expression of genes that are pertinent to spermatogenesis and by 
altering steroidogenesis (Wong and Cheng, 2011); it has the potential to disrupt 
female reproductive function by altering the expression of genes relevant to 
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ovarian follicle growth and maturation, uterine function, placental development, 
and fetal morphogenesis and growth (Bruner-Tran et al., 2017).
A father’s direct contribution to a pregnancy is limited to the contents of the 
sperm that fertilizes an egg; those contents had long been thought to consist of 
greatly condensed, transcriptionally inert deoxyribonucleic acid (DNA) consti-
tuting half the paternal genome (a haploid set of chromosomes). Consequently, 
it was once believed that paternally derived damage to the embryo or offspring 
could only result from changes in sperm DNA, and dioxins have not been shown 
to mutate the DNA sequence. However, as discussed in greater detail below, 
TCDD can have epigenetic effects that modify the expression of a cell’s genetic 
material, and those modifications persist in the daughter cells following cell 
division, whether the division involves an individual’s own somatic tissues or 
the production of his (or her) gametes. This provides an alternative pathway to 
creating permanent (heritable) changes in gene expression—a pathway that does 
not involve altering the DNA sequence. Epigenetic changes include chemical 
modifications made to DNA (usually involving methylation) or to other cellular 
components such as histones and RNAs (Jirtle and Skinner, 2007). As a sperm 
matures, most of its histones are replaced by protamines, which renders it tran-
scriptionally quiescent and permits extensive DNA compaction. The core histones 
that are retained in human sperm carry epigenetic modifications to maintain open 
nucleosomes, which permits the transcription of genes that are important during 
embryo development (Casas and Vavouri, 2014). Sperm also carry a considerable 
collection of RNA fragments (Kramer and Krawetz, 1997; Krawetz et al., 2011), 
including ribosomal RNAs, messenger RNAs, and small noncoding RNAs (Casas 
and Vavouri, 2014; Lane et al., 2014). Small RNAs have been found to play 
critical roles in fertilization (Amanai et al., 2006), early embryonic development 
(Hamatani, 2012; Suh and Blelloch, 2011), and epigenetic modifications (Gapp 
et al., 2014; Kawano et al., 2012). Therefore, male infertility or fetal loss associ-
ated with exposure to the COIs might be mediated by epigenetic modifications to 
components of sperm other than the DNA (Krawetz, 2005; Vecoli et al., 2016).
A mother’s contribution to a pregnancy is obviously more extensive, and 
damage to an embryo or offspring can result from epigenetic changes in the egg 
DNA or from the direct effects of exposure on placenta formation and on the fetus 
during gestation. The mobilization of dioxin during pregnancy may be increased 
because the body is drawing on fat stores to supply nutrients to the develop-
ing fetus. TCDD has been measured in human circulating maternal blood, cord 
blood, and placenta. Thus, dioxin in the mother’s bloodstream could cross the 
placenta and expose the developing embryo and fetus. Data indicate that dioxin 
can  accumulate in placental tissue and that dioxin can transfer from the placenta 
to the developing fetus (Mose et al., 2012).
On the basis of laboratory animal studies, it is known that TCDD can affect 
reproduction, so a connection between TCDD exposure and human reproduc-
tive and gestational effects is biologically plausible. However, making definitive 
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conclusions based on animal studies about the potential for TCDD to cause 
reproductive and gestational toxicity in humans is complicated by differences in 
sensitivity and susceptibility among different species, including strain-specific 
differences; by differences in the route, dose, duration, and timing of exposure 
between experimental protocols and real-world exposure; and by substantial dif-
ferences between laboratory animals and humans in the toxicokinetics of TCDD. 
Experiments with 2,4-D and 2,4,5-T indicate that these chemicals have subcellu-
lar effects that could constitute a biologically plausible mechanism for reproduc-
tive and gestational effects. However, the preponderance of evidence from animal 
studies indicates that these chemicals do not have reproductive effects. There is 
insufficient information on picloram and cacodylic acid to assess the biologic 
plausibility of their potential reproductive or gestational effects.
The sections on the biologic plausibility of the specific outcomes considered 
in this chapter present more detailed toxicologic findings that are of particular 
relevance to the outcomes discussed.
MALE REPRODUCTIVE HEALTH
Male reproductive function is under the control of a variety of compo-
nents whose proper coordination is important for normal fertility. Several of 
these components and some health outcomes related to male fertility, including 
repro ductive hormones and sperm characteristics, can be studied as indicators 
of fertility. The reproductive neuroendocrine axis involves the hypothalamus, 
the anterior pituitary gland, and the testis. Gonadotropin-releasing hormone is 
secreted from the hypothalamus in a pulsatile fashion and acts on the anterior 
pituitary gland, leading to the release of both follicle-stimulating hormone and 
luteinizing hormone. Both are secreted into the circulatory system in episodic 
bursts by the anterior pituitary gland and are necessary for normal spermato-
genesis. In the testis, luteinizing hormone interacts with receptors on Leydig 
cells, where it stimulates increased testosterone synthesis. Follicle-stimulating 
hormone and the testosterone from the Leydig cells interact with Sertoli cells in 
the seminiferous tubule epithelium to regulate spermatogenesis. A more detailed 
review of the male reproductive hormones can be found elsewhere (Strauss and 
Barbieri, 2013). Several agents, such as lead and dibromochloropropane, affect 
the neuroendocrine system and spermatogenesis (for reviews, see Schrader and 
Marlow, 2014; Sengupta, 2013). Reviews on the effects of various environmental 
toxicants, including TCDD, on testicular steroidogenesis and spermatogenesis 
provide insights into the potential underlying mechanisms, including reducing 
testosterone production in Leydig cells and inhibiting the formation of cyclic 
adenosine monophosphate (Mathur and D’Cruz, 2011; Svechnikov et al., 2010).
The committee responsible for the original VAO report (IOM, 1994) con-
cluded that there was inadequate or insufficient evidence of an association 
between exposure to 2,4-D, 2,4,5-T, picloram, cacodylic acid, or dioxin and 
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alterations in sperm characteristics or other male reproductive health parameters, 
finding, generally, that existing studies reported inconsistent or non-significant 
results. Additional information available to the committees responsible for subse-
quent updates did not change these conclusions. Reviews of the relevant studies 
are presented in the earlier reports. Table 29, which can be found at www.nap. edu/ 
catalog/25137, summarizes the results of studies related to male reproductive 
health outcomes.
Update of the Epidemiologic Literature
Environmental Studies 
Mumford et al. (2015) examined the relationship between exposure to a num-
ber of persistent organic pollutants (POPs) and semen quality as part of the Longitu-
dinal Investigation of Fertility and the Environment (LIFE) Study of environmental 
influences on human fecundity and fertility. Participants were 501 male partners 
of couples discontinuing contraception for the purposes of becoming pregnant, 
who were recruited in Michigan and Texas during 2005–2009. Upon enrollment, 
in-person interviews were conducted with each male partner to ascertain health, 
 demographic, and reproductive histories. All data and biospecimens were collected 
in the home, and baseline interviews were followed by a standardized anthropomet-
ric assessment for the determination of BMI conducted by research nurses, and the 
research nurse also obtained non-fasting blood (10 mL) for quantification of serum 
chemicals and lipids. The quantification of POPs in serum included 1 polybromi-
nated biphenyl (PBB 153); 9 organochlorine pesticides, and 10 polybrominated 
diphenyl ethers. PCBs with TEFs include 105, 114, 118, 156, 157, 167, and 189. 
PCDFs and the dioxin-like PCBs 77, 81, 123, 126, and 169 were not measured, 
leading to an underestimation of the TEQ. A baseline semen sample was obtained, 
followed by a second sample approximately 1 month afterwards, irrespective of 
the couples’ pregnancy status. A total of 35 semen parameters were measured, 
including five  reflecting general characteristics (volume, straw distance [a motility 
marker], sperm concentration, total sperm count, and percent hypo-osmotic  swollen 
[a marker of sperm quality]), 8 motility measures, 12 morphometry measures, 8 
morphology measures, and 2 sperm chromatin stability assay measures. The  models 
were  adjusted for age, BMI, cotinine (a marker of tobacco smoke exposure), re-
search site, total serum lipids, fish consumption, abstinence time, and sample age. 
A total of 468 men had measured chemical concentrations and semen quality and 
were included in the analysis. The levels of PBBs and some other chemicals were 
lower in this cohort than those observed in the U.S. National Health and Nutrition 
Examination Survey (NHANES) although the exposures were comparable. When 
males with chemical concentrations in the fourth quartile were compared with those 
in the first quartile, significant associations (at the 0.05 level) were found for several 
individual POPs and semen quality parameters. Although the majority of the com-
parisons were null, the researchers did observe associations between each chemical 
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class and each type of semen quality parameter, with results indicating both posi-
tive and negative associations with semen quality. At the 0.05 level of significance, 
among the PCBs with a TEF, only the 4th quartile of PCB 156 showed a positive 
association with a sperm morphology marker indicative of reduced semen quality. 
At the 0.01 level of statistical significance, PCBs 157 and 189 were associated with 
markers of improved semen quality. This report was based on a relatively large 
study cohort, and the results were adjusted for BMI and other potential confound-
ers. Without a direct measurement of TCDD, though, the report is of modest utility.
Den Hond et al. (2015) measured biomarkers of exposure in 163 men re-
cruited through academic fertility clinics in Belgium. All were under 50 years 
of age, with a body mass index (BMI) ≤ 35 and no known congenital, genetic, 
or acquired cause of infertility. Blood, urine, and two serially collected semen 
samples were obtained along with patient-provided information on smoking, 
food intake, physical activity, socioeconomic status, health status, and living 
conditions. Exposure characterization consisted of an evaluation of the serum 
for levels of endocrine-disrupting chemicals, including dioxins and dioxin-like 
PCBs. Men who had total motility counts of less than 20 million were classified 
as subfertile. The investigators found that elevated levels of PCDDs and PCDFs 
were associated with a non-significant increase in the risk of subfertility (1.59; 
95% CI 0.96–2.65; p = 0.07), and elevated levels of dioxin-like PCBs were 
 associated with a non-significant decrease in that risk (0.45; 95% CI 0.17–1.22; 
p = 0.12) after adjustment for confounders. This study was limited by its very 
small sample size and by a failure to use all of the semen quality markers avail-
able. It also had a confusing sampling frame with cases and controls sampled first 
based on an unsuccessful conception within 12 months status, and then further 
divided by total motile count. The generalizability of results from fertility clinic 
patients to Vietnam veterans is also uncertain. The report is thus of limited utility 
for the committee.
Galimova et al. (2015) measured PCDD/F levels in the semen of 168 infer-
tile and 49 fertile men in Ufa, Russia, a city close to a manufacturing plant that 
produced, among other herbicides, 2,4,5-T during the 1960s through the 1980s. 
All subjects were patients of reproductive health clinics. Testing found PCDD/F 
TEQ levels to be 2.2–2.3 times higher in the ejaculate of infertile men than in 
that of fertile men. The highest concentration of the 2,3,7,8-TCDD congener was 
found in the ejaculate of men with abnormal sperm. 2,3,7,8-TCDD did not make 
a material contribution to the total level of dioxin load—its share was 12% of the 
equivalent dose, whereas the major part of toxicity as measured by the TEQ was 
determined by the presence of PCDFs. Other congeners also showed consistently 
higher levels among the men in the infertile groups. The paper lacked many de-
tails on the recruitment of the men, the number of men was small, and no analysis 
of the impact of adjustment for other factors was presented.
Mínguez-Alarcón et al. (2017) examined a group of young Russian men 
to determine whether peripubertal serum organochlorine concentrations affect 
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semen parameters. The analysis was based on the Russian Children’s Study, 
which is an ongoing prospective study of 516 males. Boys were enrolled at age 
8–9 years and underwent a physical exam, blood sampling and, together with 
the mother or guardian, completed a questionnaire. Annual follow-ups were 
conducted. Because of loss to follow-up and other reasons, the analysis is based 
on 133 males (18–19 years) who had serum organochlorine concentration data 
collected and who provided one or two semen samples. One hundred twenty-three 
men provided two semen samples a week apart, and 10 provided one sample. Se-
men analysis included sperm motility, semen volume, and sperm concentration. 
Sera samples were used to measure 7 PCDDs, 10 PCDFs, 4 coplanar PCBs, 6 
mono-ortho-substituted PCBs, and 31 other PCBs (non-dioxin-like PCBs). The 
measured TCDD concentrations (pg TEQ/g lipid) were: minimum, 0.35; 25th 
percentile, 1.77; 50th percentile, 2.9; 75th percentile, 4.2; and maximum, 12.1. A 
general pattern of decreased semen quality (concentration, count, motile sperm) 
with increasing TCDD was found. In adjusted models, men in the highest quartile 
of serum TCDD TEQs had, on average, a lower sperm concentration, lower sperm 
count, and lower total motile sperm count than those in the lowest quartile. There 
were no significant associations for the summed concentration of PCDD, PCDFs, 
coplanar PCBs or ∑CBs. This report is based on a well-designed study, including 
a prospective follow-up and adjustment for multiple potential confounders. The 
study was not able to isolate possible in utero exposure and postnatal exposure. 
Moreover, its utility is limited by the fact that subjects were exposed to dioxins 
in a different period of their life (infancy, childhood, and adolescence) than the 
Vietnam veterans, and the generalizability of the results is open to question.
Case-Control Studies 
Paul and colleagues (2017) conducted a case-control study of the association 
between serum and semen levels of dioxin-like PCBs and post-testicular sperm 
maturation. The study group comprised 56 adult (aged 30–55 years) males from 
subfertile couples who were being evaluated for infertility at an in vitro fertiliza-
tion clinic in Alicante, Spain, from May 2012 to June 2014. Cases (n = 24) were 
men whose semen quality was considered low based on having at least an altera-
tion in at least one semen quality parameter as compared with baseline values. 
Controls (n = 26) were men with normal semen quality (all parameters above 
WHO 2010 cutpoints). Participants underwent a complete clinical examination; 
completed a questionnaire soliciting socioeconomic information, medical his-
tory, tobacco and alcohol consumption, and likely exposure to environmental 
chemicals; and gave blood and semen samples. The semen parameters that were 
measured included sperm concentration, volume, percentage of motile sperm, 
and percentage of sperm that were morphologically normal. The levels of 12 
non-ortho (77, 81, 126, 169) and mono-ortho (105, 114, 118, 123, 156, 157, 
167, 189) dioxin-like PCBs were measured in the serum samples. The authors 
also examined total TEQs as the sum of the TEQs obtained from the dioxin-like 
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PCBs. The mean levels (expressed at WHO-TEQ/g lipid) of the total dioxin-like 
PCBs and the non-ortho PCBs were higher in the low-semen-quality case group 
(22.32 ± 21.33 pg WHO-TEQ/g lipid and 22.52 ± 21.2 pg WHO-TEQ/g lipid, 
respectively) than in the control group (14.00 ± 10.82 pg WHO-TEQ/g lipid and 
13.85 ± 10.69 pg WHO-TEQ/g lipid, respectively), although the differences were 
not statistically significant. The levels of mono-ortho PCBs were statistically sig-
nificantly higher in low-semen-quality cases than in controls. When levels were 
expressed as pg/g lipid, all comparisons showed higher levels in the case group, 
which were statistically significant. Several specific PCBs had higher levels 
among cases than among controls, including PCB 126, but for only one (PCB 
105) was the difference statistically significant (p = 0.031). Significant decreased 
correlations were found between PCB 126 and viability (r = −0.645; p = 0.013) 
and between PCB 77 (r = 0.671; p = 0.009) and PCB 81 (r = 0.552; p = 0.041) and 
sperm morphology among the cases. Other PCBs showed a positive correlation 
with specific sperm parameters, while parameters such as sperm count and con-
centration showed no correlation with total PCB levels. The study results suggest 
an association between exposure to dioxin-like PCBs and semen quality, but it is 
limited by the small number of participants, and its generalizability is uncertain. 
Other Identified Studies
Cremonese and colleagues (2017) conducted a cross-sectional study of 99 
rural and 36 urban men aged 18–23 years living in southern Brazil. Occupational 
exposure to herbicides (not otherwise specified) and other agricultural chemicals 
was assessed via a structured questionnaire. Information was also gathered on 
demographics, occupation, and other factors. Whole blood and semen samples 
were collected. The investigators found a statistically significant dose–response 
relationship between higher reported herbicide use and both poorer sperm mor-
phology (p < 0.001) and reduced levels of luteinizing hormone (p = 0.002). The 
study’s strengths include the use of trained researchers to collect data on ran-
domly sampled subjects who were selected to be representative of the underlying 
population, while its primary weakness is the small size of that cohort and the 
lack of specificity of the exposures.
Among the newly reviewed studies, Tan et al. (2016) found that the introduc-
tion of 2,4-D to in vitro samples of ejaculated human sperm did not affect their 
viability, capacitation, or spontaneous acrosome reactions, but it inhibited total 
motility, progressive motility, the ability to penetrate viscous media, and pro-
gesterone-induced capacitation and acrosome reaction rates in a dose-dependent 
manner. Sun and colleagues (2016) measured levels of prostate-specific antigen, 
dioxins, and steroid hormones in the serum of 97 men who had resided in a dioxin 
“hot spot” in Vietnam near a former U.S. airbase. Eighty-five men from a non-
sprayed region in the north of the country served as controls. The investigators 
collected information on the subjects’ health status, residence history, smoking 
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habit, alcohol consumption, and occupation via a questionnaire. While dioxins, 
furans, and non-ortho PCBs levels were significantly higher in men in the hot 
spot region, prostate-specific antigen concentrations did not differ significantly 
between the groups. Levels of testosterone (p = 0.003) and estradiol (p = 0.024) 
were significantly higher in hot spot subjects and those of dehydroepiandrosterone 
(p = 0.047) significantly lower, but there were no significant differences for the 
other steroid hormones (androstenedione, cortisol, cortisone, dihydrotestosterone, 
 estrone, and progesterone) measured. The study’s primary weaknesses are its 
cross-sectional design, and its lack of control for possible confounders, and the 
fact that prostate-specific antigen level is not a health outcome.
Biological Plausibility
Although a study reported that doses of 2,4-D greater than 50 mg/kg/day 
produce acute testicular toxicity in male rats (Joshi et al., 2012), there is little 
evidence that lower doses of either 2,4-D or 2,4,5-T (when free of TCDD con-
tamination) given chronically have substantial effects on either the reproductive 
organs or fertility (Charles et al., 2001; Munro et al., 1992). The no-observed-
adverse-effect level for 2,4-D is recognized as 15 mg/kg/day (Gervais et al., 
2008). In contrast, many diverse laboratory studies have provided evidence that 
TCDD can affect reproductive-organ function and reduce fertility in both 
males and females.
The administration of TCDD to male animals elicits reproductive toxicity by 
affecting testicular, epididymal, prostate, and seminal vesicle weight and function 
and by decreasing the rate of sperm production (Foster et al., 2010; Rider et al., 
2010; Schneider et al., 2014). The mechanisms underlying those effects are not 
known, but the primary hypotheses are that the changes are mediated through 
the dysregulation of testicular steroidogenesis, altered Sertoli cell function, and 
increased oxidative stress. The exposure of cultured testicular Leydig cells to 
25 nM TCDD markedly alters gene expression (Naville et al., 2011), and the 
expo sure of cultured Sertoli cells to 5 nM TCDD decreases viability and increases 
markers of oxidative stress (Aly and Khafagy, 2011). The exposure of adult 
rats or mice to TCDD (2–7 μg/kg/week for 45–60 days) reduces testicular and 
reproductive function, and these effects can be attenuated by co-treatment with 
various antioxidants (Beytur et al., 2012; Ciftci et al., 2012; Sönmez et al., 2011; 
H. P. Yin et al., 2012). The results of those studies are supported by the transgenic 
mouse model that harbors a constitutively active aryl hydrocarbon receptor (Ahr) 
in which testicular and ventral prostate weights and sperm number are reduced 
(Brunnberg et al., 2011). 
The discussion of the influence of paternal exposures on outcomes in off-
spring later in the chapter contains additional information on the biologic plausi-
bility of COI exposure affecting male reproductive health.
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Synthesis
Reproduction is a sensitive toxic endpoint of TCDD and dioxin-like chemi-
cals in rodents, and there are several species and strains of animals for which the 
fetus is more sensitive than the adult rodent to the adverse effects of TCDD. The 
sensitivity of these endpoints in humans, however, is less apparent. Although 
AHR plays an important role in normal sperm development (D. A. Hansen et 
al., 2014), there remains little evidence that exposure to dioxin is associated 
with a reduction in sperm quality or a reduction in fertility. Some of the studies 
reviewed in this update found an association between dioxin or dioxin-like PCB 
exposure and one or more parameters associated with male reproductive health, 
primarily poor sperm morphology (Mínguez-Alarcón et al., 2017; Paul et al., 
2017). However, others reported only non-significant associations or none at all. 
The various weaknesses in these studies’ methodologies that were noted by the 
committee, including small sample sizes and difficulty in generalizing the results 
to the exposure experience of Vietnam veterans, greatly limits their usefulness.
Conclusion
On the basis of its evaluation of the evidence reviewed here and in previous 
VAO reports, the committee concludes that there is inadequate or insufficient 
evidence of an association between exposure to the COIs and alterations in se-
men quality or other male reproductive health markers.
FEMALE REPRODUCTIVE HEALTH
Studies of the relationship between chemicals and fertility are less common 
in women than in men. Some chemicals may disrupt the female hormonal bal-
ance necessary for proper functioning. Normal menstrual-cycle functioning is 
also important in the risk of hormonally related diseases, such as osteopenia, 
breast cancer, and cardiovascular disease. Generally speaking, chemicals can 
have multiple effects on the female system, including the modulation of hor-
mone concentrations that results in uterine-cycle or ovarian-cycle irregularities, 
changes in menarche and menopause, and the impairment of fertility (Bretveld 
et al., 2006a,b). Past and current literature reviews have found studies relevant 
to the committee’s Statement of Task addressing endometriosis, hormonal levels, 
polycystic ovary syndrome, and gestational diabetes.
The committee responsible for the original VAO report (IOM, 1994) con-
cluded that there was inadequate or insufficient evidence of an association  between 
 exposure to 2,4-D, 2,4,5-T, TCDD, picloram, or cacodylic acid and alterations in 
female reproductive health outcomes. Additional information available to the 
committees responsible for subsequent updates did not change the conclusion that 
exposure to the COIs had not been found to be associated with these outcomes. 
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Reviews of the relevant studies are presented in the earlier reports. Tables 30 and 
31, which can be found at www.nap.edu/catalog/25137, summarize the results of 
studies related to endometriosis and other female reproductive health outcomes 
reviewed in the VAO series. 
Endometriosis
Endometriosis (International Classification of Diseases, 9th revision [ICD-9] 
617; ICD-10 N80.8) affects more than 5 million women in the United States and 
Canada at any given time (NICHD, 2017). The endometrium, the tissue that lines 
the inside of the uterus, is built up and shed each month during menstruation. In 
endo metriosis, endometrial cells are found outside the uterus—usually in other 
parts of the reproductive system, in the abdomen or pelvis, or on surfaces near the 
repro ductive organs. The ectopic tissue develops into growths or lesions that continue 
to respond to hormonal changes in the body and break down and bleed each month 
in concert with the menstrual cycle. Unlike blood released during normal shedding 
of the endometrium, blood released from degenerating ectopic endometrium has no 
way to leave the body. The blood sets up an inflammatory reaction causing pain, 
adhesions (scars), infertility, intestinal problems, or hematuria (blood in urine).
There are several theories of the etiology of endometriosis, including one that 
posits a genetic contribution, but the cause remains unknown. Estrogen depend-
ence and immune modulation are established features of endometriosis, but they 
do not adequately explain its cause. It has been proposed that endometrium is 
distributed through the body via blood or the lymphatic system; that menstrual 
tissue backs up into the fallopian tubes, implants in the abdomen, and grows; and 
that all women experience some form of tissue backup during menstruation but 
only those who have immune-system or hormonal problems experience the tis-
sue growth associated with endometriosis. Despite numerous symptoms that can 
indicate endometriosis, definitive diagnosis is possible only through laparoscopy 
or a more invasive surgical technique. Several treatments for endometriosis are 
available, but there is no cure.
Endometriosis was first reviewed in Update 2002, which identified two 
relevant environmental studies. Additional studies considered in later updates 
did not change the conclusion that the evidence is inadequate or insufficient to 
support an association with herbicide or dioxin exposure. Table 30, which can be 
found at www.nap.edu/catalog/25137, summarizes the results of studies related 
to endometriosis.
Update of the Epidemiologic Literature
No Vietnam-veteran, occupational, or environmental studies of exposure to 
the COIs and endometriosis have been published since Update 2014. The new 
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case-control studies regarding this outcome that met the committee’s criteria for 
review are summarized below.
Case-Control Studies Martínez-Zamora et al. (2015) used a case-control  design 
to evaluate levels of dioxin-like chemicals in the adipose tissue in 30 women 
diagnosed with deep infiltrating endometriosis versus women in a control group 
who were undergoing laparoscopic surgery due to benign adnexal gynecological 
diseases other than endometriosis. All subjects were recruited from a univer-
sity hospital located in Catalonia, Spain. Seventeen dioxins (7 PCDDs and 10 
PCDFs) and 12 PCBs were analyzed. The investigators found that the TEQs and 
concentrations of both dioxins and PCBs were significantly higher in patients 
with deep infiltrating endometriosis than in the control group (p = 0.05), due 
primarily to significantly higher values of TCDD (odds ratio [OR] = 1.41, 95% 
confidence interval [CI] 1.12–2.10; p < 0.01) and 1,2,3,7,8-PeCDD (OR = 1.82, 
95% CI 1.36–7.14, p < 0.01), which the authors observed was suggestive of a 
potential role for dioxin-like chemicals in the pathogenesis of deep infiltrating 
endometriosis. A strength of the study was the measurement of dioxins and PCBs 
in adipose tissue and the calculation of TEQs; its limitations included the small 
sample size (30 cases; 30 controls) and the selection bias induced by the recruit-
ment of hospital surgery patients as subjects, which limits the generalizability of 
the results to other populations like female Vietnam veterans.
Ploteau et al. (2017) examined whether deep infiltrating endometriosis with 
or without concurrent ovarian endometrioma was associated with levels of POPs 
measured in the adipose tissue of cases and controls undergoing surgery in a clinic 
in the Pays de la Loire region of France during 2013–2015. Cases (n = 55) were 
18 to 45 years old with a surgical diagnosis of deep infiltrating endometriosis; 
controls (n = 44) were women of similar age and BMI who had presented for other 
benign gynecological conditions. All subjects were interviewed for information on 
their health, physical state, and other factors thought to be associated with POP 
exposure. Serum was collected the day before the surgical procedure that led to 
their participation in the study; parietal and omental fat samples were obtained 
during the procedure. Biospecimens were tested for a number of POPs, includ-
ing dioxins and dioxin-like PCBs. The investigators found statistically significant 
associations between deep infiltrating endometriosis and adipose tissue levels of 
four mono-ortho dioxin-like PCBs: 105 (adjusted odds ratio [aOR] = 2.09, 95% 
CI 1.24–3.77), 114 (aOR = 1.89, 95% CI 1.04–3.69]), 118 (aOR = 2.30, 95% CI 
1.31–4.36), and 123 (aOR = 2.47, 95% CI 1.42–4.66) versus controls. The statisti-
cal significance held up when subjects with deep infiltrating endometriosis with 
ovarian endometrioma were examined. No such association was observed for the 
dioxin-like PCB 169. The authors noted that the associations were stronger for the 
subjects with deep infiltrating endometriosis with ovarian endometrioma but that 
the small number of such cases complicated the interpretation of the results. They 
did not calculate a TEQ, limiting the usefulness of their findings. 
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Other Identified Studies A 2017 review article by Parazzini et al. concluded 
that there were few studies on endometriosis and exposure to dioxin and that the 
available literature had inconsistent findings. Soave and colleague’s 2015 review 
contains information on several endometrial studies referenced in Update 2014, 
plus the Martínez-Zamora paper reviewed above.
Biological Plausibility
As observed in Update 2014, laboratory studies that used animal models 
and examined gene-expression changes associated with human endometriosis 
provide evidence of the biologic plausibility of a link between TCDD exposure 
and endometriosis. Genetic polymorphisms in the AHR signaling complex have 
been associated with a susceptibility to advanced endometriosis in humans (D. Li 
et al., 2013; C. H. Wu et al., 2012), although another study found no association 
in Japanese women (Matsuzaka et al., 2012). The first suggestion that TCDD 
exposure may be linked to endometriosis came as a secondary finding of a study 
that exposed female rhesus monkeys (Macaca mulatta) chronically to low con-
centrations of dietary TCDD for 4 years (Bowman et al., 1989). Ten and 13 years 
after the exposure ended, the investigators documented an increased incidence of 
endometriosis in the monkeys that correlated with the TCDD exposure concen-
tration (Rier et al., 1993, 2001). The sample was too small to yield a definitive 
conclusion that TCDD was a causal agent of endometriosis, but this study led to 
additional studies of the ability of TCDD to promote the growth of pre-existing 
endometriotic lesions (Bruner-Tran et al., 1999; Johnson et al. 1997; J. Z. Yang 
et al., 2000).
There are a number of mechanisms by which TCDD may promote endome-
trial lesions, which provide additional support for the biologic plausibility of a 
link between TCDD and endometriosis. Human endometrial tissue and cultured 
human endometrial epithelial cells both express AHR; its dimerization partner, 
the aryl hydrocarbon nuclear translocator (Khorram et al., 2002); and three 
AHR target genes—CYP1A1, 1A2, and 1B1 (Bulun et al., 2000; Willing et al., 
2011). These findings suggest that endometrial tissue is responsive to TCDD. 
M. N. Singh et al. (2008) showed that CYP1A1 expression is greater in ectopic 
endometrial tissue than in eutopic uterine tissue in the absence of TCDD expo-
sure, which suggests that CYP1A1 may play a role in the etiology of the disease 
or that AHR and its signaling pathway have been activated by an endogenous 
ligand other than TCDD. Other mechanisms by which TCDD may promote 
endome triosis include altering the ratio of progesterone receptor A to proges-
terone receptor B and blocking the ability of progesterone to suppress matrix 
metalloproteinase expression—actions that promote endometrial-tissue invasion 
and that are observed in women who have endometriosis (Igarashi et al., 2005).
TCDD also induces changes in gene expression that mirror those observed 
in endometrial lesions. In addition to the induction of CYP1A1 noted above, 
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TCDD can induce expression of histamine-releasing factor, which is increased 
in endometrial lesions and accelerates their growth (Oikawa et al., 2002, 2003). 
TCDD disrupts cannabinoid signaling in endometrial stromal cells by inhibiting 
the progesterone-induced expression of cannabinoid receptor type 1, which is 
also observed in women with endometriosis (Resuehr et al., 2012). TCDD also 
stimulates the expression of RANTES (regulated on activation, normal T-cell–
expressed, and secreted protein) in endometrial stromal cells, and RANTES concen-
tration and bioactivity are increased in women who have endometriosis (Zhao et 
al., 2002). The two CC-motif chemokines (chemotactic cytokines), RANTES and 
macrophage-inflammatory protein-1α (MIP-1α), have been identified as potential 
contributors to the pathogenesis and progression of endometriosis. Previous studies 
have shown that the combination of 17β-estradiol and TCDD increases the secre-
tion of RANTES and MIP-1α in endometrial stromal cells (Yu et al., 2008), and a 
more recent study showed that the same combination suppresses the expression of 
tetraspanin CD82, a tumor-metastasis suppressor, and thus promotes the invasion 
of endometrial stromal cells (M. Q. Li, 2011). Those results support the idea that 
TCDD in combination with estradiol may contribute to the development of endo-
metriosis by increasing the invasiveness of endometrial cells. Despite that evidence, 
chronic exposure of rats to TCDD, non-dioxin-like PCB 153, dioxin-like PCB 118 
or PCB 126, or 2,3,4,7,8-PeCDF (the furan congener with the highest TEF), either 
individually or in various combinations, fails to alter endometrial histology in a 
consistent manner (Yoshizawa et al., 2009). The differences between  rodent and 
human endometrium could account for the lack of observed effects in rats.
In summary, experimental studies, particularly ones that used human eutopic 
and ectopic endometrial tissue, provide evidence of the biologic plausibility of a 
link between TCDD exposure and endometriosis. 
Synthesis
The human studies linking dioxin exposure with endometriosis are few and 
inconsistent; information related to exposures to 2,4-D, 2,4,5-T, TCDD, piclo-
ram, or cacodylic acid is lacking. Although animal studies support the biologic 
plausibility of an association, contemporary human exposures may be too low to 
show an association should one exist.
Conclusion
On the basis of the evidence reviewed here, in VAO, and in the previous 
VAO updates, the committee concludes that there is inadequate or insufficient 
evidence to determine whether there is an association between exposure to the 
COIs and endometriosis.
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Other Female Reproductive Health Outcomes
Update of the Epidemiologic Literature
Polycystic Ovary Syndrome (PCOS) PCOS is a hormonal disorder character-
ized by overproduction of the androgen testosterone. Three potentially relevant 
studies published since Update 2014 addressed this condition. Vagi et al. (2014) 
used a case-control pilot study design with Cedars Sinai Medical Center, Los 
Angeles, California, patients. Serum PCBs—including the dioxin-like PCBs 105, 
118, and 156—organochlorine pesticides, and other compounds were measured 
in the urine of 52 cases and 50 controls. None of the dioxin-like PCBs was sig-
nificantly elevated in cases compared to controls.
Q. Yang et al. (2015) used a case control design to evaluate serum PCBs, 
pesticides, and polycyclic aromatic hydrocarbons in 50 cases and 30 control eth-
nic Han females recruited from the Peking University Third Hospital in northern 
China. Exposure to dioxin-like PCBs was associated with an OR of 4.89 (95% CI 
1.81–13.2), which remained significant after adjusting for confounders including 
education and occupation (aOR = 5.52; 95% CI 1.51–20.2). Study limitations 
include a small sample size and metabolic differences between the cases and 
control that could affect the absorption, distribution, metabolism, and excretion 
of COIs.
J. Zhang et al. (2014) used a cross sectional stratified case control design to 
examine PCOS in females aged 12–44 years in Chengdu, China; 169 cases and 
338 controls were analyzed. Questionnaire responses were used to characterize 
expo sure. No exposures to COIs were measured, although they can be inferred for 
two categories characterizing a history of contact with polybrominated biphenyls: 
“pesticide,” which yielded an odds ratio of 1.76 (95% CI 1.09–2.87) and “eating 
fruit with pericarp” 5.00 (95% CI 2.67–9.48). However, the considerable uncer-
tainty  associated with this inference greatly limits the usefulness of the study 
results to the committee.
Gestational Diabetes Mellitus Vafeiadi et al. (2017) used a cross-sectional/
semi-prospective design to evaluate PCBs and other compounds in first-trimester 
maternal serum (dioxin-like PCBs 118 and 156 summed) with relation to ges-
tational diabetes mellitus measured at 24–28 weeks in 939 mother–infant pairs 
from the Rhea pregnancy cohort in Crete, Greece. Sixty-eight (7%) mothers pre-
sented with gestational diabetes mellitus. The adjusted odds ratio of gestational 
diabetes mellitus in women in the “medium” (middle) tertile of dioxin-like PCBs 
was 5.63 (95% CI 1.81–17.51) and for the high tertile 4.71 (95% CI 1.38–16-01). 
The study controlled for maternal fish consumption, but the authors could not rule 
out undiagnosed type 1 or type 2 diabetes or other unmeasured lifestyle factors 
as confounders, limiting the usefulness of the results.
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Alteration in Hormonal Levels Anh et al. (2017) examined the relationship 
between adrenal hormone disruption in lactating mothers and their children in 
two locations of Vietnam, one of which was known to be contaminated with 
dioxin. Thirty-seven mother–child pairs were recruited from the area near the 
former U.S. air base at Bien Hoa, which stored tactical herbicides during the 
Vietnam War and where at least four accidental releases of Agent Orange took 
place; 47 control pairs from a rural community in northern Vietnam—where no 
U.S. spraying took place—were also examined. Breast milk and blood samples 
were collected from all mothers 4–16 weeks after the birth of their first child. 
Data on subjects’ social characteristics, diseases (including hormonal therapy), 
and body measurements were obtained via questionnaire. The researchers found 
a statistically significant difference (p < 0.001) between serum androstenedione1 
levels in mothers who resided in the dioxin contaminated region (n = 37; 1.91 
ng/mol ± 1.00) versus the non-contaminated region (n = 47; 0.61 ng/mol ± 0.27). 
They also noted an association between maternal levels of several dioxin con-
geners and subsequent salivary dehydroepiandrosterone levels in children (total 
TEQ β = 0.42; p < 0.001). These results suggested to them that dioxin disrupts 
adrenal androgens in mothers and breastfeeding children through the same mech-
anism. However, since the children were exposed both before and after birth, this 
study is of limited relevance to the committee.
A cross-sectional study by Lignell and colleagues (2016) evaluated PBDE, 
PCB, and dioxin exposures in relation to thyroid hormone status early in preg-
nancy in randomly selected first-time mothers (1996–1999) from Uppsala County, 
Sweden. Maternal body burden of PCDD/Fs was inversely associated with first-
trimester T3 thyroid hormone levels. In fully adjusted models, no PCBs were 
associated with first-trimester thyroid hormone levels; however, in crude analysis 
di-ortho and mon-ortho PCB TEQ concentrations were negatively associated with 
serum lipids in the third trimester and T3 in the first trimester. This result was 
deemed noteworthy because maternal thyroid hormone status influences fetal 
development in early pregnancy. However, reverse causality cannot be discounted 
in this study as maternal T3 could influence the absorption, distribution, metabo-
lism, and excretion of toxicants.
Biological Plausibility
Many studies have examined the effects of TCDD on the female reproductive 
system. The two primary mechanisms that are believed to contribute to abnormal 
follicle development and decreased numbers of ova after TCDD exposure are 
the “cross-talk” of the AHR with the estrogen receptor and the dysregulation of 
the hypothalamic–pituitary–gonadal axis (Pocar et al., 2005; Safe and Wormke, 
1 Androstenedione and dehydroepiandrosterone are so-called “pro-hormones” that are precursors in 
the production of testosterone and estrogen.
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2003). Oocytes are directly responsive to TCDD, so TCDD’s effects on hormone 
concentrations, hormone-receptor signaling, and ovarian responsiveness to hor-
mones all probably contribute to TCDD-induced female reproductive toxicity. 
The data of Jung et al. (2010) in rats show that a single high-dose gavage treat-
ment of 32 μg/kg TCDD reduces the proliferation of granulosa cells and thus 
attenuates cell-cycle progression and potentially contributes to the reduction in 
ovulation rates observed in other studies. In contrast, Karman et al. (2012) found 
that 1 nM TCDD exposure in vitro did not reduce the rates of growth of murine 
antral follicles, but did reduce the secretion of progesterone and estradiol by the 
follicles. The concentrations of those hormones could be restored by the addition 
of the precursor pregnenolone, which suggests that TCDD acts upstream of preg-
nenolone formation. Baldridge et al. (2015) have also shown that rat granulosa 
cells are highly sensitive to low-level (femtomolar) TCDD, resulting in disrupted 
steroid hormone secretion. A similar result was demonstrated by Jablonska et al. 
(2014) in porcine granulosa cells. This would be consistent with previous obser-
vations in zebrafish that 10, 40, and 100 parts per billion TCDD in food depressed 
estradiol biosynthesis (Heiden et al., 2008).
Dioxin’s effects on early embryo development and on placenta formation 
are well documented (S. C. Chen et al., 2010; Ishimura et al., 2009; Tsang et al., 
2012). Petroff et al. (2011) used a rat in vitro fertilization model to demonstrate 
that 100 nM TCDD perturbs chromatin and cytoskeletal remodeling at the earliest 
stages of embryo development, but these changes failed to result in any apparent 
morphologic changes at later stages of development. The long-term potential 
effects of these early changes on pregnancy outcome are unknown. It has pre-
viously been shown that TCDD may have direct effects on human trophoblast 
formation at 0.2–2.0 nM in vitro and thus may have the capacity to influence 
the developing fetus (S. C. Chen et al., 2010). That idea is supported by a study 
showing the ability of 5 nM TCDD to activate the AHR signaling pathway in 
both rat and human placental trophoblasts (Stejskalova et al., 2011). Finally, a 
study has demonstrated that TCDD at 0.1, 1.0, and 10.0 nM reduces in a dose-
dependent fashion the ability of trophoblastic spheroids (which constitute an 
embryo surrogate) to attach to endometrial epithelial cells (Tsang et al., 2012). 
The more recent literature continues to support the biologic plausibility of TCDD 
having effects on male and female reproduction. 
Synthesis
Eskenazi et al. (2010)—reviewed in Update 2010—published the only study 
to date that has examined dioxin exposure in women with respect to time-to- 
pregnancy (number of contraceptive-free months before pregnancy) and infer-
tility (more than 12 contraceptive-free months to pregnancy). Dose–response 
relationships between TCDD serum levels in women who were less than 40 
years of age at the time of the Seveso accident and both time-to-pregnancy and 
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infertility were observed, which is consistent with published observations in the 
rat model. Epidemiologic studies have not provided sufficient data to interpret the 
effects of dioxin specifically on menstrual-cycle function in humans.
The studies reviewed for this update yielded inconsistent results regarding 
any association between exposure to the COIs and the outcomes studied, and they 
exhibited weaknesses such as the failure to measure dioxin levels or calculate 
TEQs that limit their applicability to the evaluation of outcomes for Vietnam 
veterans.
Conclusion
On the basis of its evaluation of the evidence reviewed here and in previ-
ous VAO reports, the committee concludes that there is inadequate or insuffi-
cient evidence of an association between exposure to the COIs and disturbances 
in hormonal levels in females and diseases that may be associated with such 
disturbances.
GESTATION AND NEONATAL EFFECTS IN OFFSPRING
The gestation and neonatal periods are uniquely vulnerable times in life. 
Data on health outcomes either occurring or first identified during these periods 
have been collected on the offspring of those exposed to the COIs. Information 
concerning spontaneous abortion, stillbirth, neonatal death, and infant death; sex 
ratio; birth weight and preterm delivery; and birth defects are discussed below.
General Biologic Plausibility
Influence of Paternal Exposure
James (2006) has interpreted the perturbation of sex ratios by dioxins and 
other agents as being an indicator of parental endocrine disruption and, indeed, a 
population-level finding of a paternally mediated effect would be a strong indica-
tor that dioxin exposure can interfere with the male reproductive process. If this 
observation were demonstrated to be true, then it would be concordant with a 
 reduction in testosterone in exposed men (Egeland et al., 1994). Another pathway 
to an altered sex ratio might involve male embryos experiencing more lethality 
from the induction of mutations due to their unmatched X chromosome. TCDD 
has not been thought to have genotoxic effects, but sex-specific adverse conse-
quences of the modified imprinting of gametes might be a possible mechanism 
leading to the observation of altered sex ratios at birth. To date, however, the 
proportion of sons among the children of fathers exposed to dioxin-like chemicals 
does not present a clear pattern of reduction.
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The idea that the exposure of either parent to a toxicant before conception 
could result in an adverse outcome in offspring is not new and remains a topic of 
much interest (Schmidt, 2013). Epidemiologic studies have reported occasional 
findings of paternally transmitted adverse outcomes associated with paternal 
exposures to certain agents, but none has been replicated convincingly. Even in 
instances in which an agent is recognized as mutagenic or potentially carcino-
genic for exposed men, adverse consequences have not been demonstrated in 
their children. For example, the hypothesis was extensively investigated in the 
early 1990s in relation to fathers’ exposure to ionizing radiation before concep-
tion and an increase in leukemias in their offspring. The initial study (Gardner et 
al., 1990) was conducted in men who worked at the Sellafield nuclear facility in 
West Cumbria, United Kingdom. It was presumed that the men were exposed to 
radiation as a result of working at Sellafield. An association was found between 
radiation exposures to fathers before their children’s conception and an increase 
in leukemias among those children. However, later studies failed to confirm that 
finding (Draper et al., 1997; Kinlen, 1993; Kinlen et al., 1993; Parker et al., 1993; 
Urquhart et al., 1991). Similarly, a rigorous follow-up of children of atomic-
bomb survivors has not demonstrated increased risks of cancer or birth defects 
 (Fujiwara et al., 2008; Izumi et al., 2003; Schull, 2003), and other studies of birth 
defects and cancer in the children of male cancer survivors after chemotherapy or 
radiation treatment have found little support for paternal transmission (Chow et 
al., 2009; Dohle, 2010; Howell and Shalet, 2005; Madanat-Harjuoja et al., 2010), 
although sperm and fertility clearly are adversely effected (Green et al., 2010).
An additional problem when trying to determine whether adult male expo-
sure of any type (including to the COIs) can lead to pathological effects in 
descend ants is that almost all experimental exposure studies designed to identify 
male transmission have been limited to developmental exposures in rodents 
(Guerrero-Bosagna and Skinner, 2014; Paoloni-Giacobino, 2014). An early 
exper iment examining male mice treated with simulated Agent Orange mixtures 
prior to breeding with unexposed females failed to find an increase in a variety of 
different birth defects in progeny compared with the progeny of untreated males 
(Lamb et al., 1981). 
Prior VAO committees have been unable to identify epidemiologic evidence 
that convincingly demonstrated paternal exposure to any particular chemical be-
fore conception that resulting in cancers or birth defects in offspring. However, 
few data exist to address the hypothesis of paternal exposure and adverse effects 
in human offspring in which the exposure occurred before conception only to the 
father, and what little information exists comes from the radiation effects litera-
ture. Thus, it is difficult to assert conclusively that the available epidemiologic 
evidence either supports or does not support paternal transmission; considerable 
uncertainty remains on many fronts and would presumably vary by agent and 
mode of exposure. Several systematic reviews of the topic have been conducted 
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(Chia and Shi, 2002; Weselak et al., 2007, 2008; Wigle et al., 2007, 2008), and 
none have established firm relationships between specific agents and particular 
effects in offspring. Paternal occupation (characterized by exposure to chemi-
cals via job title or job–exposure matrices) has been linked to an increased risk 
of selected birth defects (Desrosiers et al., 2012; Fear et al., 2007; Shaw et al., 
2002) and neuroblastoma (De Roos et al., 2001a,b). Moreover, increased risks 
of childhood brain cancer have been reported in relation to paternal exposure to 
selected pesticides, particularly herbicides and fungicides (van Wijngaarden et 
al., 2003), although the authors noted considerable uncertainty in the robustness 
of the findings. Therefore, the hypothesis that paternal preconception exposure 
to toxic agents may result in harm to a man’s children remains unresolved in sig-
nificant part because of the sparseness of epidemiologic research on the subject.
Paternal Preconceptual Exposure There is no evidence that dioxins can mu-
tate DNA sequences (see Chapter 4). Genetic changes in sperm genes due to 
preconception exposures to TCDD—as has been shown, for example, in con-
nection with irradiation or the anticancer drug cyclophosphamide (Codrington 
et al., 2004)—are thus unlikely. The potential does exist, however, for TCDD to 
alter the sperm cells of adults before fertilization through epigenetic pathways. 
The sperm epigenome is distinctive from that of the egg (oocyte) or somatic cells 
(all other non-gamete cells in the body). The mature sperm cell has less global 
methylation than  somatic cells, particularly at gene promoters, and has unique 
DNA methylation marks (particularly on paternally imprinted genes) that put the 
sperm genomes in a pluripotent-like state before fertilization (Hales et al., 2011). 
However, rapid demethyla tion of most of the remainder of the paternal genome 
occurs shortly after fertilization (Dean, 2014), suggesting that additional changes 
are required for the nascent embryo to become truly pluripotent. Chemical altera-
tions of DNA methylation foci of adult sperm have the potential to contribute 
to permanent effects in offspring, as has been suggested for male transmittance 
in fetal alcohol syndrome (Jenkins and Carrell, 2012a). During spermatogenesis 
in the adult, most sperm histones are replaced by protamines, which render the 
sperm transcriptionally quiescent and permit extensive DNA compaction. How-
ever, some core histones are retained in human sperm with appropriate epigenetic 
modifications in order to maintain open nucleosomes at sites that are important 
during embryo development (Casas and Vavouri, 2014), so their perturbation by 
exogenous chemicals remains a possibility. This is particularly important because 
although genome-wide DNA demethylation occurs in paternal DNA after fertil-
ization (Dean, 2014) and should erase most sites that have been reprogrammed 
by chemicals, histone modification patterns are retained and thus may transmit 
chemical-induced alterations across generations (Puri et al., 2010).
Despite the exclusion of almost all cytoplasm, mature sperm, as noted above, 
have been found to carry a diverse spectrum of RNAs, including messenger RNAs, 
ribosomal RNAs, and small noncoding RNAs, which may affect the developing 
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embryo (Casas and Vavouri, 2014; Hamatani, 2012; Kawano et al., 2012; Krawetz, 
2005; Krawetz et al., 2011; Lane et al., 2014; Suh and Blelloch, 2011). For ex-
ample, small RNAs of paternal origin may direct epigenetic modifications during 
embryo development and lead to changes in phenotype later in life (Hales et al., 
2011). When newborn male mice were stressed by unpredictable separation from 
their mothers, messenger RNAs in their sperm have been shown to transmit the 
effects of this early trauma for two generations (Gapp et al., 2014). Heavy metals 
interact with sperm’s nuclear proteins, and this mechanism is suspected to be a 
basis of the paternally mediated effects of lead (Quintanilla-Vega et al., 2000). 
Disturbances in the establishment of the epigenetic marks in mature sperm may 
change cell fate in the early embryo and have effects throughout development and 
postnatal life (Jenkins and Carrell, 2012b).
Direct evidence of dioxin-mediated changes in the epigenome of mature 
sperm is not available. However, dioxins have been shown to modify DNA meth-
ylation in somatic cells (Hou et al., 2012), so an epigenetic pathway is plausible. 
Paternal Postconceptual Exposure Contaminants such as TCDD that are 
present in the tissues and blood of exposed males can be transported as parent 
compounds or as metabolites into seminal fluid, the noncellular component of 
the ejaculate. Typically, the concentrations of contaminants in seminal fluid are 
lower than those in serum, but no direct assessments of the ratios of serum to 
seminal fluid in TCDD have yet been reported. Seminal-fluid contaminants can 
be transmitted to a female during sexual intercourse and be absorbed through 
the vaginal wall; if the concentrations are high, then they could potentially af-
fect a current pregnancy (Chapin et al., 2004; Klemmt and Scialli, 2005). TCDD 
and other POPs have been identified and quantified in the seminal plasma of 
exposed men, including Vietnam veterans (Schecter et al., 1996;  Schlebusch 
et al., 1989; Stachel et al., 1989); thus, this transmission route is theoretically 
possible. In the Schecter et al. (1996) study, serum TCDD was measured in 
50 Vietnam veterans from Michigan who had a confirmed or self-reported po-
tential for herbicide exposure and had blood drawn an average of 26 years 
after the possible exposure. Of those, six had TCDD levels greater than 20 parts 
per trillion (ppt) on a lipid-adjusted basis, which supports the idea that some 
veterans had high initial exposures. A subgroup of 17 men contributed semen at 
the time of blood draw, and dioxin congeners were analyzed in three randomly 
pooled samples—a process necessary to provide sufficient volume for chemi-
cal analysis. Although the measured concentrations were very low, the results 
documented the existence of dioxins and dibenzofurans in the seminal plasma of 
the veterans long after the possible herbicide exposure to TCDD-contaminated 
herbicides. Because the results on serum and semen concentrations could not 
be linked to individual veterans and because it is unknown whether any of the 
individuals who had high serum dioxin concentrations after 26 years contrib-
uted  semen for the seminal-fluid measurements, the value of this information is 
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minimal. Seminal-fluid concentrations of TCDD and related chemicals closer to 
the period of exposure in Vietnam have not been determined, so it is not possible 
to assess the clinical consequences of this exposure route for female partners and 
gestating offspring. Banked Ranch Hand specimens, however, might provide a 
valuable resource for comparing TCDD concentrations in serum and seminal 
fluid. A 2015 Institute of Medicine report describes the available data and bio-
specimens from the Air Force Health Study (AFHS) and the potential for future 
analyses (IOM, 2015).
Despite the potential for a seminal fluid route of exposure, the critical ques-
tion of dose sufficiency remains unanswered. That is, could absorbed TCDD 
concentrations be high enough to transmit adverse effects to the fetus? To answer 
that question, one must take into account several factors. First, the volume of 
seminal plasma is relatively low (1–5 mL) and, because of leakage, only a frac-
tion of seminal constituents is absorbed across the vaginal wall. Moreover, the 
dilution of absorbed chemicals in the female bloodstream before transmission 
across the placenta is estimated at 3 orders of magnitude or more (Klemmt and 
Scialli, 2005), which reduces a serum concentration of 20 ppt to a scale of parts 
per quadrillion (10–15). Although no studies have been undertaken to address 
the issue directly, the dilution factor makes it extremely unlikely that adverse 
fetal and offspring outcomes would occur as a consequence of seminal plasma 
exposures to TCDD during pregnancy. One caveat to this conclusion, however, 
is that seminal fluid is now known to play an important role in the metabolic 
phenotype of offspring because it stimulates embryotrophic factors (Bromfield, 
2014; Bromfield et al., 2014). Whether TCDD contamination of the seminal fluid 
can affect this function is not known and should be tested.
Influence of Maternal Exposure
Maternal exposures can affect a pregnancy and the resulting offspring far 
more extensively than can paternal exposures. Because of the long half-life of 
TCDD and its bioaccumulation in adipose tissues, women exposed to herbicides 
in Vietnam would have the potential to expose their offspring to TCDD directly 
during later pregnancies. Thus, damage to the resulting offspring or future genera-
tions could result from epigenetic changes in an egg before conception or from 
the direct effects of exposure on the fetus during gestation and on the neonate 
during lactation. Dioxin in the mother’s bloodstream can cross the placenta and 
expose the developing embryo and fetus. 
Furthermore, the mobilization of dioxin during pregnancy or lactation may 
be increased because the body is drawing on fat stores to supply nutrients to the 
develop ing fetus or nursing infant. TCDD has been measured in circulating human 
maternal blood, cord blood, placenta, and breast milk (G. Suzuki et al., 2005), and 
it is estimated that an infant breastfed for 1 year accumulates a dose of TCDD that 
is six times as high as an infant who is not breastfed (Lorber and Phillips, 2002). 
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The offspring effects of maternal exposures may not be manifested immediately 
and could be a result of a dioxin-mediated reprogramming of developing organs 
and lead to a disease onset later in life. As noted elsewhere, placental structure and 
function are believed to play a major role in fetal growth, and TCDD has been 
shown to alter placental vascular remodeling (Y. Wu et al., 2013, 2014).
As mentioned in conjunction with the role of the placenta in fetal develop-
ment, the developmental basis of adult disease (Barker et al., 2012) is being 
actively researched through the investigation of maternal nutritional exposures, 
stress, and alcohol exposure, and more recent studies have examined exposures to 
TCDD and other environmental toxicants. The molecular basis of the later-life ef-
fects is believed to be primarily epigenetic. Maladies that may be manifested later 
in life include neurologic and reproductive disorders, thyroid changes, diabetes, 
obesity, and adult-onset cancers. Furthermore, germ cells (eggs and spermatogo-
nia) in offspring pass through critical developmental stages during fetal life (D. 
A. Hansen et al., 2014), and emerging evidence demonstrates that fetal exposures 
are capable of altering the germ cells epigenetically, resulting in a transmission 
of adverse effects to future generations (intergenerational and transgenerational 
inheritance) (D. A. Hansen et al., 2014).
Spontaneous Abortion, Stillbirth, Neonatal Death, and Infant Death
Spontaneous abortion is the expulsion of a nonviable fetus—generally before 
20 weeks of gestation—that is not induced by physical or pharmacologic means. 
The background risk of recognized spontaneous abortion is generally 11–22% 
(Avalos et al., 2012), but it is established that many more pregnancies terminate 
before women become aware of them (Wilcox, 2010). Such terminations are 
known as subclinical pregnancy losses and generally are not included in studies of 
spontaneous abortion. The estimates of the risk of recognized spontaneous abor-
tion vary with the design and method of analysis. Studies have included cohorts 
of women asked retrospectively about pregnancy history, cohorts of pregnant 
women (usually those receiving prenatal care), and cohorts of women who are 
monitored for future pregnancies. The value of retrospective reports can be lim-
ited by the differential recall of details (exposure history, for example) specific 
to pregnancies that occurred long before the interview. Studies that enroll women 
who present for prenatal care require the use of life tables and specialized statisti-
cal techniques to account for differences in the times at which women seek medi-
cal care during pregnancy. The enrollment of women before pregnancy provides 
the theoretically most valid estimate of risk, but it can attract non-representative 
study groups because the study protocols are demanding for the women.
Countries and U.S. states have different legal definitions of the age of fetal 
viability and apply these terms differently. The American College of Obstetricians 
and Gynecologists defines “stillbirth” as the delivery of a fetus that shows no signs 
of life (that is, an absence of breathing and heartbeat; pulsations in umbilical cord 
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are absent; no voluntary movement of muscle) at 20 weeks or greater of gestation 
(if the gestational age is known) or at a weight greater than or equal to 350 g if 
the gestational age is not known (Da Silva et al., 2016). “Neonatal death” refers to 
the death of a live-born infant within 28 days of birth (WHO, 2006) and “postnatal 
death” refers to a death that occurs before the first birthday (Andrews et al., 2008).
The causes of stillbirth and early neonatal death overlap considerably, so 
they are commonly analyzed together in a category referred to as “perinatal 
 mortality” (Andrews et al., 2008). Stillbirths make up less than 1% of all births 
(CDC, 2000). The most common causes of mortality during the neonatal period 
are low birth weight (< 2.5 kg at birth), preterm delivery, congenital malforma-
tions, pregnancy or delivery complications, and placenta or cord conditions. The 
most common causes of postnatal death in infants is SIDS (sudden infant death 
syndrome) (Andrews et al., 2008). 
The committee responsible for the original VAO report concluded that there 
was inadequate or insufficient evidence of an association between exposure to 
2,4-D, 2,4,5-T, TCDD, picloram, or cacodylic acid and spontaneous abortion or 
perinatal death. Additional information available to the committees responsible 
for Update 1996, Update 1998, and Update 2000 did not change that conclusion.
The committee responsible for Update 2002, however, found that there was 
enough evidence available to conclude that there was “limited or suggestive evi-
dence of no association” between paternal exposure to TCDD and the risk of spon-
taneous abortion. That conclusion was based primarily on a National Institute for 
Occupational Safety and Health study (Schnorr et al., 2001) that investigated a large 
number of pregnancies fathered by workers whose serum TCDD concentrations 
were extrapolated back to the time of conception; no association was observed up 
to the highest-exposure group (1,120 ppt or higher). Indications of a positive as-
sociation were seen in studies of Vietnam veterans (CDC, 1989c; Field and Kerr, 
1988; S. D. Stellman et al., 1988b), but the committee responsible for Update 
2002 asserted that they might be due to an exposure to phenoxy herbicides rather 
than to TCDD and concluded that there was insufficient information to determine 
whether there is an association between maternal exposure to TCDD and the risk of 
spontaneous abortion or between maternal or paternal exposure to 2,4-D, 2,4,5-T, 
picloram, or cacodylic acid and the risk of spontaneous abortion.
The additional information (none of which concerned paternal exposure) 
reviewed by the committees responsible for the Update 2004 through Update 
2014 reports did not change these conclusions.
The relevant studies concerning perinatal death are reviewed in the earlier 
reports. Table 32, which can be found at www.nap.edu/catalog/25137, summa-
rizes the results of studies related to spontaneous abortion.
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Update of the Epidemiologic Literature
No Vietnam-veteran, occupational, environmental or case-control studies of 
exposure to the COIs and spontaneous abortion or perinatal death have been pub-
lished since Update 2014.
Biological Plausibility
Laboratory animal studies have demonstrated that TCDD exposure during 
pregnancy can alter the concentrations of circulating steroid hormones and dis-
rupt placental development and function and thus contribute to a reduction in the 
survival of implanted embryos and to fetal death (L. Huang et al., 2011; Ishimura 
et al., 2009; J. Wang et al., 2011; Y. Wu et al., 2013, 2014). There is no evidence 
of a relationship between paternal or maternal exposure to TCDD and spontane-
ous abortion. Exposure to 2,4-D or 2,4,5-T causes fetal toxicity and death after 
maternal exposure in experimental animals. However, that effect occurs only at 
high doses and in the presence of maternal toxicity. No fetal toxicity or death has 
been reported to occur after paternal exposure to 2,4-D.
Animal studies of maternal TCDD exposure during pregnancy have dem-
onstrated the induction of fetal death; neonatal death, however, is only rarely 
observed and is usually the result of TCDD-induced cleft palate, which leads to an 
inability to nurse. A single study by Y. Wu et al. (2016) suggests that AHR may be 
involved in unexplained recurrent spontaneous abortion without consideration of 
TCDD or other ligands. Further study in this area is warranted. Studies address-
ing the potential for perinatal death as a result of paternal exposure to TCDD or 
herbicides are at this point inadequate to support drawing any conclusions.
Synthesis
No studies concerning the COIs and spontaneous abortion, stillbirth, neona-
tal death, or infant death have been published since Update 2014, and available 
toxicologic studies do not provide clear evidence for the biologic plausibility of 
an association with paternal exposures.
Conclusion
On the basis of the evidence reviewed to date, the committee concludes that 
there is limited or suggestive evidence that paternal exposure to TCDD is not 
associated with risk of spontaneous abortion and that insufficient information is 
available to determine whether there is an association between maternal exposure 
to TCDD or either maternal or paternal exposure to 2,4-D, 2,4,5-T, picloram, or 
cacodylic acid and the risk of spontaneous abortion. The committee concludes 
that there is inadequate or insufficient evidence to determine whether there is an 
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association between exposure to the COIs and stillbirth, neonatal death, or infant 
death.
Sex Ratio
Although it would not constitute an adverse health outcome in an individual 
veteran, perturbations in the sex ratio of children born to an exposed population 
would suggest that the exposure had an impact on the reproductive process. Pre-
vious reports in the VAO series have reviewed the literature on this topic.  Update 
2014 contains a summary of this work, which is also cataloged in Table 33, which 
may be found in the supplementary tables available at www.nap.edu/catalog/ 
25137. In brief, studies have found an alteration—most often, a reduction —in 
the expected proportion of male infants at birth, but results are inconsistent and 
only some reach statistical significance.
Update of the Epidemiologic Literature
One occupational cohort study on TCDD exposure and sex ratio has been 
published since Update 2014 was released. 't Mannetje et al. (2017) conducted a 
retrospective study of workers employed for at least 1 month between 1969 and 
1984 at a phenoxy herbicide production plant in New Zealand. In 2007–2008, 
a sample of 430 workers out of 631 known to be alive under the age of 80 years 
and living in New Zealand was randomly selected. Of these, 244 responded, 
and 212 had a biological child. Blood samples were collected and a survey was 
conducted regarding biological children, their birthdates, sex, and medical condi-
tions. Logistic regression was conducted with the outcome of male versus female 
sex, with adjustment for the parent’s age at the time of birth, BMI at the time of 
blood draw, and smoking status. Both female and male employees were included, 
and analyses were conducted separately; however, the number of female employ-
ees was small. Exposures were estimated for the time of the child’s birth by back-
calculation using first-order toxicokinetics and a half-life of 7.6 years. Results 
showed reduced odds of a male birth when comparing high- versus low-TCDD 
exposure. For a father’s exposure in 2007–2008, reduced odds of a male birth 
(OR = 0.46, 95% CI 0.29–0.73) were observed for TCDD serum concentration ≥ 
4 versus < 4 pg/g lipid (OR = 0.49, 95% CI 0.30–0.79). Similarly, for a father’s 
exposure at time of the child’s birth, reduced odds of a male birth were observed, 
comparing TCDD concentration ≥ 20 versus < 20 pg/g lipid (OR = 0.49, 95% CI 
0.30–0.79). Additionally, a significant dose–response was observed, both for the 
TCDD as measured in 2007–2008 (p trend = 0.01) and for exposure estimated 
at time of the child’s birth (p trend = 0.007). In both of these analyses, the upper 
two exposure categories showed significant ORs of approximately half the prob-
ability of a male child compared with fathers whose exposure to TCDD was in 
the low-dose group. The study found that paternal serum TCDD concentrations in 
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excess of an estimated 20 pg/g lipid at time of conception were associated with a 
reduced sex ratio. No significant association was observed for the mother’s expo-
sure to TCDD, although the ORs were elevated, not reduced. These findings are 
consistent with a male-mediated reduction in sex ratio, which had been observed 
in some prior studies (del Rio Gomez et al., 2002; Hertz-Picciotto et al., 2008; 
Mocarelli et al., 1996, 2000). The lack of an association for maternal exposure is 
consistent with an endocrine-mediated outcome.
Biological Plausibility
In a previously unreviewed paper, Ishihara et al. (2007) found that male ICR 
mice administered TCDD orally with an initial loading dose of 2,000 ng TCDD/kg 
followed by a weekly maintenance dose of 400 ng/kg (T2,000/400) prior to mat-
ing produced a significantly lower proportion of male offspring than controls 
(controls: 53.1% ± 1.7; T2000/400: 46.2% ± 2.1) while there was no alteration 
in litter size. The authors speculated that TCDD might selectively reduce the 
fertility potential of Y-bearing gametes before conception but stipulated that no 
mechanism could be identified. 
An investigation by You et al. (2018) treated mouse spermatozoa with dif-
ferent concentrations of TCDD in vitro (0.25, 25, 2,500 ng/mol) and then per-
formed in vitro fertilization. The sex ratio of two-cell embryos was significantly 
decreased at all TCDD treatment groups compared with the control (p < 0.05). In 
addition, the sex ratio of blastocysts decreased significantly for the 25 and 2,500 
ng/ml of TCDD treatment groups (p < 0.01), and embryo sex ratios were nega-
tively correlated with live X sperm proportion (two-cell embryos, r = –0.697; 
blastocyst, –0.856; p < 0.05). The researchers concluded that TCDD may affect 
the fertility of Y spermatozoa more than X spermatozoa but asserted that further 
studies are needed to evaluate the source of the difference of fertilizing capability 
between X and Y spermatozoa exposed to TCDD.
Synthesis
Prior to this update, committees had not identified any experimental animal 
studies that specifically examined the effects of the COI on the sex ratios of off-
spring, nor had any alterations in sex ratio been reported in animal studies that 
examined the developmental effects of the COIs on offspring. However, the recent 
publication of You and colleagues’ (2018) study and the previously unreviewed 
Ishihara et al. (2007) paper yielded information for their consideration. The com-
mittee finds that the papers’ results are consistent with those observed in human 
studies but that the lack of an identified mechanism underlying the observations 
limits their usefulness. These data, along with the new 't Mannetje et al. (2017) 
retrospective study add incrementally to the body of knowledge on the topic but 
do not change any of the conclusions.
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Conclusion
On the basis of its evaluation of the evidence reviewed here and in previous 
VAO reports, the committee concludes that there is inadequate or insufficient evi-
dence of an association between exposure to the COIs and altered sex ratio.
Birth Weight and Preterm Delivery
Birth weight and the length of the gestation period can have important effects 
on neonatal morbidity and mortality and on health over the life span. Typically, 
low birth weight (LBW) is defined as a birth weight under 2,500 g (~5.5 lbs.) 
(UNICEF, 2004). In the absence of congenital malformations or chromosomal 
anomalies, LBW is the consequence of either preterm delivery or an intra uterine 
growth restriction. Preterm delivery is delivery at less than 259 days or 37 weeks 
of gestation from the date of the first day of the last menstrual period (Jones and 
Lopez, 2013). Intrauterine growth restriction is functionally defined in terms of 
LBW relative to gestational age when compared to local or national fetal-growth 
graphs (Romo et al., 2009). LBW occurs in about 7% of live births. When no 
distinction is made between intrauterine growth restriction and preterm delivery, 
the factors most strongly associated with LBW are maternal tobacco use during 
pregnancy, multiple births, and race or ethnicity. Other potential risk factors are 
low socioeconomic status, malnutrition, maternal weight, birth order, maternal 
complications during pregnancy (such as severe pre-eclampsia or intrauterine 
infection), obstetric history, job stress, and cocaine or caffeine use during preg-
nancy (Alexander and Slay, 2002; Alexander et al., 2003; Ergaz et al., 2005; Jones 
and Lopez, 2013; Peltier, 2003). Established risk factors for preterm delivery 
include race (black), extremes of maternal age, low socioeconomic status, previ-
ous LBW or preterm delivery, multiple gestations, tobacco use, and low maternal 
pre-pregnancy weight or poor pregnancy weight gain (Rubens et al., 2014).
The importance and interpretation of risk factors for associations with birth 
weight are often unclear and a subject of controversy among researchers (Barker 
et al., 2012; Wilcox, 2010). Across populations, the frequency distribution of birth 
weight is Gaussian, with an extended lower tail, or “residual distribution,” that 
includes preterm and LBW infants. The predominant, normal distribution cor-
responds largely to term births. In general, shifts in the predominant distribution 
do not tend to correspond to notable shifts in infant mortality (Wilcox, 2001). A 
number of factors may result in shifts in the predominant distribution; altitude, 
race or ethnicity, and maternal smoking are among the better studied, and these 
factors can produce either a larger or, sometimes, smaller percentage of LBW 
babies. However, populations that have a larger percentage of LBW infants do 
not always have higher infant mortality (Wilcox, 2001, 2010). While birth weight 
is tracked internationally as a public health indicator to identify opportunities for 
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intervention and to understand country-specific infant mortality (UNICEF, 2004), 
strategies to increase birth weight have not been effective in reducing mortality.
The committee responsible for VAO concluded that there was inadequate 
or insufficient evidence to determine whether there is an association between 
exposure to the COIs and LBW or preterm delivery, and additional information 
available to the committees responsible for the subsequent updates did not change 
that conclusion. Reviews of the relevant studies are presented in the earlier reports. 
Tables 34 and 35, which can be found at www.nap.edu/catalog/25137, summarize 
the results of studies related to birth weight after paternal and maternal exposure 
to the COIs.
Update of the Epidemiologic Literature
No Vietnam-veteran, occupational, or case-control studies of exposure to the 
COIs and LBW or preterm delivery have been published since Update 2014. Four 
new environmental studies are summarized below.
A study of 234 couples by Robledo et al. (2015) examined how birth size 
varied with maternal and paternal exposures to 63 POPs from five major classes, 
including 36 PCBs, seven of which were dioxin-like (PCBs 105, 114, 118, 156, 
157, 167, and 189). Exposure was measured in parental serum collected before 
conception. Differences in birth weight and other growth-related parameters were 
estimated using multiple linear regression per 1 standard deviation increase in 
natural log-transformed (ln-transformed) chemicals. The subjects were partici-
pants in the LIFE prospective cohort study,2 which was conducted in Michigan 
and Texas between 2005 and 2009. Models were estimated separately for each 
parent and adjusted for maternal age, maternal prepregnancy BMI, and other 
confounders, and all models included an interaction term between infant sex and 
each chemical. The authors found that for every 1 standard deviation increase in 
ln-transformed concentration of paternal serum levels of PCB 167, the mean birth 
weight among female newborns (n = 117) was 97.49 g lower (95% CI [–187.45, 
–7.54]), and mean length (β = −0.57 cm; 95% CI [–1.12, −0.02]) and head cir-
cumference (β = −0.45 cm; 95% CI [−0.86, −0.03]) were smaller. No statistically 
significant outcomes were observed for paternal exposures and male newborns 
(n = 113). For maternal serum PCB 167 levels, male newborn birth weight was 
significantly lower (−129.24 g, 95% CI [−228.16, −30.31]) and head circumfer-
ence smaller (−0.47 cm, 95% CI [–0.95, 0.00]), and there were no statistically 
significant outcomes for female newborns.
A birth cohort study of 484 children in Hokkaido, Japan, by Kobayashi et al. 
(2017)—the Hokkaido Study on Environment and Children’s Health—measured 
total dioxin levels as the sum of 29 congeners in maternal blood samples taken 
2 Cited earlier in this chapter in the review of a paper by Mumford et al. (2015) in the section on 
male reproductive health outcomes.
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either during the third trimester or within 1 week after delivery. (In Japan, the 
largest source of dioxin exposure is dietary, and of the total dioxin intake in this 
population, the main source is seafood.) This new study expanded results from a 
previous study conducted in the same birth cohort (Konishi et al., 2009;  reviewed 
in Update 2010) that reported a significant adverse effect on birth weight for 
total PCDDs TEQ levels (adjusted β = −231.5 g, 95% CI [−417.4, −45.6]) and 
total PCDFs TEQ levels (adjusted β = −258.8 g, 95% CI [−445.7, −71.8]). 
Sex-stratified analyses suggested that these reductions in birth weights were 
stronger in boys. Here, the investigators assessed polymorphisms in the women’s 
genes encoding the aryl hydrocarbon receptor (AHR [G > A, Arg554Lys]), cyto-
chrome P450 (CYP1A1) (T6235C), and glutathione S-transferase mu 1 (GSTM1; 
non-null/null), genes that code for three metabolizing enzymes that had previ-
ously been related to dioxin or birth weight.3 Linear regression analyses that were 
adjusted for confounding factors found that pregnant women with a GSTM1 null 
genotype—a genotype previously established to be associated with a high induc-
ibility of cytochrome P450 1A1 gene transcription—gave birth to infants with a 
345 g (95% CI [−584, −105]) reduction in birth weight for each 10-fold increase 
in total dioxin TEQ. They also noted birth weight reductions for the children of 
GSTM1-null mothers for some of the individual congeners. These results suggest 
that PCDDs and PCDFs may accumulate in the placenta and, through interference 
with placental function, affect birth weight.
Miyashita and colleagues (2015b) investigated 70 PCB congeners, includ-
ing dioxin-like PCBs, in the blood of a smaller subgroup of 367 woman–child 
pairs from the Hokkaido Study cohort cited above. Mothers completed self-ad-
ministered questionnaires on demographic characteristics, socioeconomic status, 
personal habits, and food consumption; medical records were used to extract 
details for the delivery and characteristics of the infants. The authors found no 
associations between the concentrations of dioxin-like PCBs (or non-dioxin-like 
PCBs) and newborn anthropometric measurements of birth weight (small for 
gestational age), length, chest circumference, and head circumference in analyses 
with multiple linear regression models with or without adjustment for confound-
ing factors. A reduction in birth weight and other measures of size was observed 
for dioxin-like PCBs, but these results were not statistically significant. 
A study by Van Tung et al. (2016) of residents of a dioxin hot spot area in 
Vietnam4 reported on 58 mother–infant pairs who were compared with 62 pairs 
from a region thought to be uncontaminated. Breast milk from lactating moth-
ers with infants ages 7 and 16 weeks at the time of sampling was analyzed for 
3 Research indicates that dioxins bind AHR and induce CYP1A1 expression (Harper et al., 2002) 
and absence of human glutathione S-transferase mu 1 (GSTM1; null genotype) is associated with 
increased induction of CYP1A1 expression (Vaury et al., 1995).
4 Males in this study cohort were reported on by Sun et al. (2016) in a paper addressed in the male 
reproductive outcomes discussion earlier in this chapter.
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dioxin congener levels. Samples from mothers living in the hot spot had fivefold 
higher levels of dioxin than breast milk from controls. Birth weight was inversely 
correlated with both 2,3,7,8-TCDD and 2,3,4,7,8-PeCDF congener levels. The 
rate of newborns with a birth weight less than 2,500 g was threefold higher in 
the hot spot (12%) than in the control region (4%). However, at 8–9 or 12–14 
weeks of age, no significant associations were observed between infant size and 
dioxin isomer levels.
Biological Plausibility
The available evidence from experimental animal studies indicates that 
TCDD exposure during pregnancy can reduce body weight at birth, but only at 
high doses. A study in human placental explants suggests that TCDD exposure 
may enhance placental inflammation and may increase the risk of preterm births 
associated with infection (Peltier et al., 2013). Laboratory studies of the potential 
male-mediated developmental toxicity of TCDD and herbicides resulting from 
the prior exposure of the fathers are inadequate to support conclusions. TCDD 
and herbicides are known to cross the placenta, which leads to the direct expo-
sure of the fetus. Data from studies of experimental animals also suggest that the 
pre-implantation embryo and developing fetus are sensitive to the toxic effects 
of 2,4-D and TCDD after maternal exposure.
Synthesis
Studies reviewed in this update continue the pattern observed in earlier 
research of identifying either no or small decrements in birth weight and size 
parameters for children born to parents with the highest levels of dioxin exposure. 
As has been noted by previous committees, there are a number of challenges 
in conducting these types of epidemiologic studies in a rigorous way. First, the 
prenatal and immediate postpartum period is not a stable pharmacokinetic state; 
there are substantial changes in body volume and fat mobilization during that 
time. Biomarker measures during pregnancy may be substantially affected by 
weight change during pregnancy. Moreover, the extrapolation of a more recent 
biomarker measure back many years to a more relevant period is complicated 
by intervening pregnancy and breastfeeding events, which result in a substantial 
uncertainty in the index exposure level. Overall, although the committee notes 
that the animal literature does support an effect of TCDD exposure at high doses 
on birth weight, the epidemiologic literature is insufficiently robust to allow a 
final determination.
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Conclusion
On the basis of the evidence reviewed here and in previous VAO reports, 
the committee concludes that there is inadequate or insufficient evidence to 
 determine whether there is an association between exposure to the COIs and 
LBW or preterm delivery.
Birth Defects
A birth defect is an abnormality of structure, function, or metabolism, 
whether genetically determined or resulting from an environmental influence 
during embryonic or fetal life (Christianson et al., 2006). Other terms for birth 
defect, often used interchangeably, are “congenital anomaly” and “congenital 
malformation.” Major birth defects, which occur in 2–3% of live births, are 
 abnormalities present at birth that are severe enough to interfere with viability or 
physical well-being. Birth defects are detected in another 5% of babies through 
the first year of life. Genetic factors, exposure to some medications, exposure to 
environmental contaminants, occupational exposures, maternal infections, and 
lifestyle factors have been implicated in the etiology of birth defects (Christian-
son et al., 2006), although the causes of the vast majority of birth defects are 
unknown. Most etiologic research has focused on the effects of maternal and fetal 
exposures, but, as discussed in the beginning of this chapter, it is theoretically 
possible that epigenetic alterations in the paternal gamete caused by preconcep-
tion exposures could result in paternally mediated effects. It should be noted that 
a substantial amount of epidemiologic research on suspect toxic agents has been 
conducted, but none of it has definitively established paternal preconception 
exposures as a contributing factor to the occurrence of birth defects (Chow et al., 
2009; Desrosiers et al., 2012; Dohle, 2010; Schull, 2003).
The committee responsible for VAO concluded that there was inadequate or 
insufficient evidence to determine whether there is an association between expo-
sure to 2,4-D, 2,4,5-T or its contaminant TCDD, picloram, or cacodylic acid and 
birth defects in offspring. Additional information from the AFHS available to the 
committee responsible for Update 1996 led it to conclude that there was limited 
or suggestive evidence of an association between at least one of the COIs and 
spina bifida in the children of veterans; there was no change in the conclusions 
regarding other birth defects. 
The Update 2002 committee, which reviewed a study of female Vietnam vet-
erans that reported significant increases in birth defects in their offspring (Kang 
et al., 2000a), did not find those results sufficient to modify prior conclusions. 
Nonetheless, Congress mandated that a number of birth defects in the children of 
female Vietnam veterans be assigned service-related status. Later committees have 
not encountered data that would merit changing the conclusion that the evidence 
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is inadequate to support an association between exposure to the COIs and birth 
defects (aside from spina bifida) in the offspring of either male or female veterans. 
The Update 2014 committee concluded that the new evidence it identified 
concerning the occurrence of birth defects in association with exposure to the 
COIs, in combination with existing evidence, was inadequate or insufficient to 
support an association for birth defects overall in the children of Vietnam veter-
ans. In light of the fact that evidence anticipated by the committee responsible 
for Update 1996 that would support an association between paternal exposure to 
the COIs and spina bifida had not materialized, that committee concluded that 
spina  bifida should be moved from the category of limited or suggestive evidence 
of an association to the default category of inadequate or insufficient evidence 
of an association. An increased scrutiny of mechanisms by which paternal expo-
sure might contribute to adverse effects in offspring has not definitively estab-
lished the biologic plausibility of this phenomenon, whereas the understanding of 
how maternal exposures may disrupt fetal development has grown substantially. 
There were, however, no epidemiologic results supporting an association between 
 maternal exposure to the COIs and spina bifida specifically, so spina bifida in 
association with exposure of either parent was moved to the inadequate or insuf-
ficient category of association. Chapter 10 of Update 2014 contains a detailed 
discussion of the evidence and reasoning underlying this determination.
Tables 36 and 37, which can be found at www.nap.edu/catalog/25137, sum-
marize the results of studies related to birth defects and specifically of neural-tube 
defects such as spina bifida.
Update of the Epidemiologic Literature
No Vietnam-veteran studies of exposure to the COIs and birth defects have 
been published since Update 2014. New occupational, environmental, and case-
control studies addressing neural-tube defects, cryptorchidism or hypospadias, 
gastrointestinal tract defects, cardiovascular defects, and general or multiple 
congenital anomalies are addressed below. All are classified as “Other Identi-
fied Studies” (as delineated in Chapter 3) because the exposures they addressed 
were not described in sufficient detail to allow the committee to determine their 
relevance to the experience of Vietnam veterans.
Other Identified Studies–Occupational Studies Makelarski et al. (2014) 
 report results from a case-control analysis of maternal periconceptional occupa-
tional exposure to pesticides and association with neural-tube defects in offspring. 
Cases and controls were derived from the U.S. National Birth Defects Preven-
tion Study (NBDPS), a large national case-control study of risk factors for birth 
defects. For any insecticide and herbicide use the odds ratio for spina bifida was 
2.1 (95% CI 1.0–4.1), based on 14 exposed. There was no dose–response gradient 
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for cumulative exposure to insecticide and herbicide and spina bifida. The study’s 
strengths include the national context of the study with a relatively large, well-
defined case group and extensive covariate information. The limitations include 
a lack of specific herbicide exposure information, the use of the general job-
exposure matrix for exposure assessment, and the fact that small sample sizes 
precluded analyses of exposure to herbicides only.
Using cases and controls from the NBDPS, Pettigrew and colleagues (2016) 
examined the joint effect of parental occupational exposure to pesticides on the 
risk of spina bifida in offspring (291 cases). The analysis included joint parental 
exposure to insecticides and herbicides and fungicides, which yielded an odds 
ratio of 0.8 (95% CI 0.4–1.5). There was only one case with joint parent herbicide-
only exposure (the odds ratio was not estimated). Herbicide exposure adjusted for 
other pesticides had decreased odds of spina bifida (OR = 0.6, 95% CI 0.3–125.0). 
The study’s strengths include the national context of the study with a well-defined 
case group and extensive covariate information. Its limitations include the lack of 
specific herbicide exposure information, the lack of paternal self-reported occupa-
tional history (it was reported by the mother), the use of the general job-exposure 
matrix for exposure assessment, and the very small sample sizes for herbicide 
exposure.
Rocheleau et al. (2015) examined the association between maternal occu-
pational exposure to fungicides, insecticides, and herbicides and the risk of 
congenital heart defects among offspring. Cases and controls were drawn from 
the NBDPS, a multisite case-control study. Maternal occupational exposure to 
pesticides was analyzed for 3,318 cases and 2,979 controls using data for births 
in 1997–2002. Only 3 case mothers and 3 control mothers were determined to 
have had exposure to only herbicides. Analyses of estimated high exposure to 
herbicides and insecticides found associations with any simple, isolated con-
genital heart defects (OR = 1.90, 95% CI 1.05–3.44), pulmonary valve stenosis 
(OR = 3.64, 95% CI 1.31–10.15), right ventricular outflow tract obstruction (OR 
= 3.40, 95% CI = 1.41–8.16), and hypoplastic left heart syndrome without ven-
tricular septal defect or anomalous pulmonary venous return (OR = 5.11; 95% 
CI 1.70–15.35). The study’s strengths include its use of a large population-based 
case-control design with careful ascertainment and classification of congenital 
heart defects, adjustment for multiple potential confounders, and an expert-based 
assessment of potential pesticide exposure. The major study limitation was the 
lack of information on exposure to specific pesticides.
Jorgensen and colleagues (2014) used the national Danish registries to de-
termine parental employment in farming or horticulture and to identify their 
male offspring born between 1980 and 2007. Boys were followed for a hospital 
diagnosis of cryptorchidism recorded in the Danish National Patient Registry. 
Hazard ratios (HRs) and 95% CIs were calculated using Cox regression to com-
pare the occurrence of cryptorchidism among the male children of mothers and 
fathers working as horticultural workers and farmers with the male children of 
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parents in other occupations. Adjustment was made for birth year, parental age, 
parity, and geographic region. A total of 618,081 boys born to actively employed 
mothers during 1980–2007 were identified, including 2,105 and 4,520 born to 
maternal horticultural workers and farmers, respectively. The adjusted HR for 
cryptorchidism showed an elevated risk among boys of maternal horticultural 
workers (HR = 1.20, 95% CI 0.95–1.52) and an increased risk among boys of 
maternal farmers (HR = 1.31, 95% CI 1.12–1.53) compared with boys of mothers 
in all other occupations. For fathers, a total of 708,283 boys were identified, and 
18,648 were diagnosed with cryptorchidism during follow-up. Fathers working 
in horticulture or farming had 2,157 and 24,348 sons, respectively, of whom 
72 (3.3 %) and 742 (3.0%), respectively, were diagnosed with cryptorchidism. 
The HRs for cryptorchidism were 1.20 (95% CI 0.96–1.51) for boys of paternal 
horticultural workers and 1.04 (95% CI 0.96–1.12) for boys of paternal farmers. 
The study’s strengths included a large national registry-based cohort of parental 
occupational information and outcome information for offspring. However, data 
on specific chemical exposures for the parents were not available, limiting the 
usefulness of the study for the evaluation of risks from the COIs.
Other Identified Studies–Environmental Studies Markel and colleagues 
(2015) conducted an ecologic study of hypertrophic pyloric stenosis identified 
by the Indiana Birth Defects Registry from 2005–2009. Birth defect cases were 
linked with their birth certificate record to obtain demographic and other infor-
mation. County-level pesticide use data from available from the U.S.  Geological 
Survey annual agricultural pesticide use database. The county-level pesticide 
data were categorized into high, moderate, and low level of use. Data were also 
subdivided into fungicides, fumigants, insecticides, and herbicides. Herbicides 
comprised 91% of all pesticides used. Total pesticide levels in the county of resi-
dence correlated significantly with the incidence of hypertrophic pyloric stenosis 
(r = 0.029, p = 0.004), as did herbicide use (r = 0.029, p = 0.005). This analysis 
is limited by the ecologic nature of the exposure data and outcome data. Although 
statistically significant, the correlation values were rather small and while logistic 
regression was used, the report only presents p-values and no effect estimates. 
There was no information on specific herbicides, other than to note that glypho-
sate and atrazine, which are not COIs, were the most heavily used.
A study on the island of Guam by Noel and colleagues (2015) examined the 
relationship between village-level estimates of alleged Agent Orange exposure 
and infant mortality due to congenital anomalies. Total births by village (n = 19) 
and infant mortality due to congenital anomalies for each year from 1970 to 
1989 were obtained from the Office of Vital Statistics in the Guam Department 
of Public Health and Public Services. Each birth and death was assigned to a 
village based on the usual residence of the mother. The 1980 U.S. Census was 
used to obtain data on the median age of the village females, village fertility 
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ratio, population density, persons per household, single-mother households, and 
the number of married females. Agent Orange exposure data were obtained from 
a U.S. Air Force veteran who conducted ground-level Agent Orange spraying for 
vegetation control. The veteran provided village-level spray estimates based on 
his recollection; however, there was no reported independent verification of this 
information. Eleven villages were classified as high risk (cause-specific death 
rate was 2.96 per 1,000 live births) and eight as low risk (1.31 per 1,000 live 
births). Twelve villages were considered to have Agent Orange spraying (10 high 
risk and 2 low risk, p = 0.006). In the multivariable linear regression model, 
which included an adjustment for the median age of village females, the associa-
tion between Agent Orange spraying area and infant mortality due to congenital 
anomalies was statistically significant (standardized regression coefficient β = 
2.02; 95% CI 0.08–3.96; p = 0.042) with the model explaining approximately 
51% of the variance. Models adjusting for other Census-based covariates yielded 
similar results. The study had several limitations, prominently the highly subjec-
tive nature of the exposure characterization. The assignment of potential village 
exposure to Agent Orange spraying was obtained from a single source and was 
not independently confirmed by records or biomarker data. Lacking congenital 
anomaly prevalence data, the study relied instead on mortality data, which may 
be affected by village-specific differences in infant survival due to differences in 
medical care and other factors.
Other Identified Studies–Case-Control Studies Shaw et al. (2014) examined 
cases and controls ascertained in the San Joaquin Valley in California. Cases 
were born from 1997 to 2006 with gastroschisis confirmed by clinical  geneticists; 
those with single-gene conditions or chromosomal abnormalities or with identifi-
able syndromes were ineligible. Controls were non-malformed live-born infants 
randomly selected from birth hospitals in the study area. Data were collected 
from maternal telephone interviews using a standardized, computer-based ques-
tionnaire. Interviews were conducted with mothers of 72% of eligible cases (n 
= 193) and 69% of controls (n = 974). Mothers with pregestational diabetes 
were excluded from the analyses. Exposure assessment was performed for 461 
individual chemicals and 62 physicochemical groupings that were applied at > 
100 lb. in any of eight San Joaquin Valley counties in any year during the study 
period. An exposure-time window of 1 month before to 2 months after the ma-
ternal reported date of conception was assigned for each case or control mother. 
Exposure assignments were made for 156 cases and 785 controls whose mothers 
lived in the geocoded addresses more than 68 days during the window. To esti-
mate pesticide applications, statewide pesticide use reporting records from the 
California Department of Pesticide Regulation describing agricultural pesticide 
applications occurring in the study period were obtained. Pesticide exposure was 
based on pounds of pesticides used during the relevant time window within a 
500-meter radius of a case or control’s geocoded address. Logistic regression was 
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used to estimate odds ratios for pesticide exposure (yes/no), with adjustments for 
race/ethnicity, prepregnancy BMI, any use of folic acid–containing supplements, 
and smoking during the month before and the first 2 months of pregnancy. 2,4-D 
dimethylamine salt exposure had an adjusted odds ratio of 1.7 (95% CI 0.7–4.1) 
based on 8 exposed cases. The study’s strengths include the population-based 
design, comprehensive case ascertainment and classification, and extensive co-
variate data. The exposure assessment was performed using pesticide applica-
tion data, although misclassification is expected because of the lack of data on 
individual factors that may influence exposure. Random error cannot be excluded 
when considering the result for 2,4-D dimethylamine salt.
Using the same study design as Shaw et al. (2014) above, Carmichael and 
colleagues (2016) examined the association between pesticide exposure and the 
risk of five different types of birth defects ascertained in the San Joaquin Valley 
of California. The analysis included 367 cases with one of five types of birth 
 defects and 785 controls without any identified malformations born in 1997–2006. 
The case groups (with at least 50 cases) included anotia/microtia, anorectal 
atresia/stenosis, transverse limb deficiency, craniosynostosis, and diaphragmatic 
hernia. Among the published results (the criteria for presentation were an odds 
ratio > 2.0 or < 0.5 or confidence intervals that excluded 1.0), the authors reported 
associations between dichlorophenoxy acid or ester exposure and transverse 
limb deficiency (7 exposed cases; OR = 2.5; CI 1.1–6.0) and anotia/microtia (12 
exposed cases; OR = 3.4; CI 1.6–7.6). The study’s strengths and limitations are 
similar to those of the Shaw et al. (2014) study, although the sample sizes for the 
defects in this study were relatively small and the estimate imprecise.
Rappazzo et al. (2016) conducted a case-control study using subjects drawn 
from a cohort of geocoded singleton live births (n = 335,729) in North Carolina 
between 2003 and 2005. Birth records were linked to the North Carolina Birth 
Defects Monitoring Program, an active birth defects surveillance system. Crop 
maps and pesticide application data were combined to estimate the quantities and 
types of pesticides applied during the time window of interest (1 month before 
pregnancy through the third trimester). Women who either had no crops within 
the buffer or who had no exposure during the relevant window of pregnancy were 
considered unexposed. The analysis included 6,358 cases and 298,548 controls. A 
total of 42 birth defects were ascertained, and 4,634 cases had a single (isolated) 
congenital anomaly. Logistic regression was used to estimate the odds ratio for 
exposure (yes/no) and each birth defect with adjustments made for race, educa-
tion, marital status, maternal age, and maternal smoking. Elevated adjusted odds 
ratios were observed for atrial septal defects (OR = 1.70, 95% CI 1.34–2.14) 
and for patent ductus arteriosus (OR = 1.50, 95% CI 1.22–1.85) for the highest 
(≥ 90th percentile) exposure subjects. The study used a population-based design 
with birth defects surveillance and linked crop and pesticide records. Its limita-
tions include the lack of individual-level pesticide exposure data for specific 
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pesticides, potential residual confounding due to the use of birth certificate data 
and unmeasured factors, and the small number of cases for some comparisons.
Koskenniemi and colleagues (2015) based their case-control study of 44 
cases of cryptorchidism and 38 controls on subjects who were operated on for 
inguinal or umbilical hernia or hydrocele at two hospitals: one in Turku, Finland 
(2002–2006), and the other in Copenhagen, Denmark (2004–2005). Twelve of 
the Finnish cases and two of the Danish were referred for surgical procedures 
from a prospective cohort study. A subcutaneous adipose tissue biopsy was taken 
during the operation, and samples were analyzed for 37 PCBs, 17 PCDD/Fs and 
14 PBDEs. Covariate data were obtained through parental interview and from 
medical records. Associations between adjusted and unadjusted chemical concen-
trations and the risk of cryptorchidism were calculated using logistic regression. 
The analysis included an adjustment of the chemical concentrations by factors 
influencing postnatal exposure (age at operation and duration of breastfeeding) 
by linear regression, but no adjustment was made for factors related to chemical 
concentrations in the mother (e.g., BMI, maternal age, parity). In a sensitivity 
analysis, cases and controls were excluded if the mother had gestational diabe-
tes. After adjustment for the country of origin, age at operation, and the duration 
of breastfeeding, total TEQ (OR = 3.2, 95% CI 1.3–9.1) and sum of PCDD/Fs 
(OR = 3.7, 95% CI 1.5–10.9) were associated with an increased risk of cryptor-
chidism. The sum of PCBs had an elevated, but non-significant, odds ratio (OR 
= 1.9, 95% CI 0.9–4.0). The sum of PBDEs was not associated with an elevated 
odds ratio of cryptorchidism (OR = 0.86, 95% CI 0.47–1.54). The effect estimates 
were not materially different after restricting to boys who were born full term, 
biopsied at less than 5 years of age, and whose mothers did not have gestational 
diabetes. The study provides some evidence of an association with dioxin-like 
chemicals (TCDD-specific results were not reported). However, the study was 
very small and some potential confounders were not adjusted. The study is of 
limited value to the committee’s assessment.
Kalfa et al.’s (2015) case-control study examined 408 boys with isolated 
hypospadias and 302 controls identified at multiple institutions in the south of 
France between 2009 and 2014. Control boys were matched by ethnic origin 
and had no congenital malformation; no urological, genital, or nephrological 
condition; and no inguinal hernia or endocrine disease. The reasons for hospi-
talization for the controls included acute appendicitis, idiopathic intussuscep-
tion, minor abdominal trauma, and pyloric stenosis. Information about maternal 
and paternal occupational and professional exposure to endocrine-disrupting 
chemicals was obtained using a standardized questionnaire and a job-exposure 
matrix. Environmental exposure was estimated by geocoding the residence postal 
code at the time of pregnancy and factoring in the types of surrounding hazards 
and their distance from that residence. The odds ratio for maternal exposure to 
herbicides (otherwise unspecified) was 1.00 (95% CI 0.007–13.97); the paper 
did not specify whether this imprecise estimate was adjusted. Environmental 
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exposure to intensive agriculture (residence within a 3-km radius) was statisti-
cally significantly different between cases and controls, as was residence in an 
industrial area or proximity to an incinerator or a waste area. The committee did 
not consider this study to be informative because results for specific COIs were 
not presented and there are concerns that the analysis and exposure information 
is based on questionnaire and a determination by simple distance to source for 
the environmental exposures.
A paper by Ueker and colleagues (2016) describes the results of a hospital-
based case-control study conducted in Cuiabá, Mato Grosso, Brazil in 2011. The 
cases were children aged less than 5 years with a diagnosis of a congenital mal-
formation in medical records who were identified at four referral institutions. The 
controls were children of those ages diagnosed with other conditions (respiratory 
diseases, infectious diseases, disorders of the perinatal period, and endocrine 
and metabolic diseases) at the same institutions. Controls were pair-matched 
with cases on sex. Information on parental exposure to pesticides (unspecified, 
except to note that glyphosate is the most commonly used) and other factors was 
collected by a maternal interview. The analysis group consisted of 137 cases and 
274 controls. In the unadjusted analysis, several maternal pesticide exposure 
variables had an elevated odds ratio for birth defects, including living close to 
crop spraying with pesticides (OR = 1.61, 95% CI 0.88–3.03) and pesticide use 
at work (OR = 1.52, 95% CI 0.65–3.53). Paternal application of pesticides was 
also associated with an elevated odds ratio for birth defects (OR = 2.75, 95% CI 
1.05–7.19). This study has several important limitations, including the lumping of 
all different birth defects into a single case group, a small sample, self-reported 
pesticide exposure (including maternal report of paternal exposures), no informa-
tion on specific pesticides, and no information on case and control response rates.
Biological Plausibility
As was noted in Update 2014, 2,4-D has been previously shown to be a 
teratogen, although at exposure levels that exceed maternal renal clearance and 
thus are not relevant to herbicide exposure in Vietnam. A 2011 study showed 
that late in utero and early postnatal 2,4-D exposure can result in nephrotoxicity 
in offspring at one-sixth of the LD505 (Troudi et al., 2011). Other herbicides of 
interest can induce fetal malformations but typically only at high doses that are 
toxic to pregnant women. TCDD is a potent teratogen in all laboratory species 
that have been studied, although the patterns of birth defects that are produced are 
often species-specific. However, specific mechanisms that link TCDD exposure 
to specific birth defects have not been fully elucidated.
5 Lethal dose 50%: the dose required to kill half of the test population, usually expressed as a func-
tion of body weight.
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A variety of animal model studies, including in utero exposures, work with 
cultured cells, and studies with zebrafish embryos, have investigated the mecha-
nisms underlying various TCDD-induced birth defects, including hydronephrosis, 
cleft palate, reproductive organ anomalies, neurogenesis, and perturbed heart, 
kidney, and lung development (Dong et al., 2010; Falahatpisheh et al., 2011; 
Jacobs et al., 2011; Lanham et al., 2012; Latchney et al., 2011; Neri et al., 2011; 
Tait et al., 2011; Yamada et al., 2014; Yoshioka et al., 2012; Yuan et al., 2012). In-
terestingly, AHR is required for TCDD-induced birth defects. In contrast, the in-
duction of cytochrome P450 1A1 is not required (Dragin et al., 2006; Jang et al., 
2007; Mimura et al., 1997). When pregnant Ahr-null mice are exposed to TCDD, 
the fetuses do not exhibit any of the typical developmental malformations associ-
ated with TCDD exposure, but fetuses of TCDD-exposed pregnant CYP1A1-null 
mice do. In addition, an Ahr antagonist can attenuate TCDD-induced birth defects 
in mice. Thus, the activation of Ahr by TCDD during development appears to be 
a key first step in mediating TCDD’s developmental toxicity, but this step does 
not depend on CYP1A1 activity. Although structural differences in AHR have 
been identified among species, it functions similarly in animals and humans. 
Therefore, a common mechanism mediated by AHR in which tissue growth and 
differentiation processes are affected probably underlies the developmental toxic-
ity of TCDD in humans and animals.
Antioxidant treatment provides protection against some TCDD-induced tera-
togenicity, which suggests that reactive oxygen species might be involved in the 
pathways that lead to these structural changes (Jang et al., 2008). A few studies indi-
cate that the stem cells and organ-specific progenitor cells may be direct targets and 
that maternal TCDD exposures interfere with proliferation and cell differentiation 
through AHR and result in defects in organ morphogenesis (Latchney et al., 2011; 
Neri et al., 2011). Few laboratory studies of potential male-mediated developmen-
tal toxicity (and specifically birth defects) attributable to exposure to TCDD and 
herbicides have been conducted. As noted, the feeding of simulated Agent Orange 
mixtures to male mice produced no adverse effects in offspring (Lamb et al., 1981).
In sum, studies with maternal exposure in animal models suggest that a role 
for TCDD and related chemicals in causing birth defects is plausible and also that 
AHR plays a causal role. However, translating these results to human populations 
has been difficult.
Synthesis
Given the long-standing concern of Vietnam veterans about the potential of 
the COIs to adversely affect the health of their children, birth defects have been 
among the outcomes considered by VAO committees since the first comprehen-
sive review was published in 1994. Embryonic and fetal development in some 
species including rodents are sensitive to the toxic effects of exposure to TCDD 
and dioxin-like chemicals, and there are several species and strains of animals for 
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which the fetus is more sensitive than the adult to the adverse effects of TCDD. 
Human data are generally lacking, however, and the sensitivity to developmental 
disruption in humans is less apparent, in part because contemporary studies of 
environmental dioxin exposure and birth defects have involved extremely low 
exposures. As noted, recent human population-based studies attempting to link 
TCDD or the other COI exposures to birth defects have provided mixed results. 
Moreover, the study of birth defects in any population is complicated by the 
relatively rarity of specific birth defects. Attributing any one defect to a specific 
exposure is often difficult, and it is extremely difficult to conduct rigorous epidemi-
ology studies assessing risks to children arising from their parents’ exposure, par-
ticularly when a distinction between maternal and paternal contributions is sought. 
These challenges are highlighted in the studies considered by the committee, which 
exhibit sometimes significant weaknesses that limit their usefulness—particularly in 
assessing the effects resulting from the exposures experienced by Vietnam veterans. 
The new epidemiologic studies considered by the committee were mostly not infor-
mative because of a small sample or the absence of exposure data on COIs, or both. 
There were two relatively rigorous epidemiologic studies that suggested an associa-
tion between two different COIs (2,4-D dimethylamine salt; dichlorophenoxy acid) 
and an increased risk of two unrelated birth defects. However, the recent studies 
did not change the previous conclusion of inadequate or insufficient evidence to 
support an association for birth defects overall in the children of Vietnam veterans.
Conclusion
The committee’s review of newly published studies in combination with 
existing information leads it conclude that evidence remains inadequate or insuf-
ficient to determine whether there is an association between exposure to the COIs 
and birth defects in the children of Vietnam veterans.
EFFECTS OCCURRING LATER IN OFFSPRING’S LIVES
Information is available concerning parental exposure to the COIs and sev-
eral outcomes occurring later in the lives of their offspring. Studies investigat-
ing cancers; growth and physical parameters; motor development, cognitive, 
behavioral, and socio-emotional outcomes; immune and allergic outcomes; and 
reproductive health are reviewed below.
Cancer in Offspring
The American Cancer Society estimates that 10,590 children under 15 years 
old will receive a new diagnosis of cancer in the United States in 2018 (ACS, 
2018f). The treatment and supportive care of children who have cancer continue 
to improve. The 5-year survival rate for children who receive a cancer diagnosis 
Veterans and Agent Orange: Update 11 (2018)
Copyright National Academy of Sciences. All rights reserved.
REPRODUCTIVE HEALTH EFFECTS AND EFFECTS ON DESCENDANTS 407
has increased from less than 60% in the 1970s to more than 80% in 2013, the 
most recent year for which data are available. Despite advances, cancers remain 
the second leading cause of death in children under 15 years old (after accidents); 
1,180 deaths are projected for 2018 (ACS, 2018f).
Leukemias are the most common cancer in children, accounting for about 
29% of all childhood cancer cases. The second-most common group of cancers 
in children is cancer of the brain and tumors of other parts of the central nervous 
system (CNS) (26%), followed by neuroblastomas (6%) and Wilms tumor (also 
called nephroblastoma; 5%) (ACS, 2018f). Other cancers in children include 
lymphomas, bone cancers, soft-tissue sarcomas, renal cancers, eye cancers, and 
adrenal cancers. In contrast with adult cancers, relatively little is known about 
the etiology of most childhood cancers, especially about potential environmental 
risk factors and the effects of parental exposures.
The committee responsible for VAO concluded that there was inadequate 
or insufficient evidence to determine whether there is an association between 
exposure to 2,4-D, 2,4,5-T, TCDD, picloram, or cacodylic acid and childhood 
cancers. The additional information available to the committees responsible for 
Update 1996 and Update 1998 did not change that conclusion. The committee 
responsible for Update 2000 reviewed the material in earlier VAO reports and in 
newly available published literature and concluded that there was limited or sug-
gestive evidence of an association between exposure to at least one of the COIs 
and acute myeloid leukemia (AML).6 However, after the release of Update 2000, 
 investigators involved in one study discovered an error in their published data. 
The Update 2000 committee reconvened to evaluate the previously reviewed and 
new literature regarding AML, and it produced Acute Myelogenous Leukemia 
(IOM, 2002). It reclassified AML from “limited/suggestive evidence of an asso-
ciation” to “inadequate evidence to determine whether an association exists.”
The committees responsible for Update 2002, Update 2004, Update 2006, 
Update 2008, Update 2010, Update 2012, and Update 2014 reviewed the material 
in earlier VAO reports and in newly available published literature and agreed that 
there remained inadequate or insufficient evidence to determine whether there is 
an association between exposure to the COIs and childhood cancers.
Table 38, which can be found at www.nap.edu/catalog/25137, summarizes 
the results of studies related to cancers in children.
6 AML (ICD-9 205; ICD-10 C92.A0) is also referred to as acute myelogenous leukemia, acute 
myeloblastic leukemia, and acute nonlymphocytic leukemia. For consistency, this report uses “acute 
myeloid leukemia,” or AML, regardless of the usage in the source materials.
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Update of Epidemiologic Literature
New Vietnam-veteran, occupational, environmental, and case-control studies 
addressing childhood leukemias, central nervous system tumors, rhabdomyosar-
coma, and retinoblastoma are addressed below.
Vietnam-Veteran Studies Grufferman and colleagues (2014) evaluated the 
role of parental military service in Vietnam and service-related exposures in the 
risk of rhabdomyosarcoma7 occurring in offspring. Cases of rhabdomyosarcoma 
diagnosed under the age of 20 years were identified from the Intergroup Rhabdo-
myosarcoma Study Group clinical trial, which included hospitals in 46 U.S. states 
and the District of Columbia from 1982 to 1988. Controls were identified by 
telephone random-digit dialing and were matched to cases on race, sex, and age. 
Case and control families were interviewed by telephone. The interview  included 
questions about childhood environmental exposures, parental occupational expo-
sures, family demographic characteristics, parental lifestyle and behav ioral char-
acteristics, and medical history. Questions related to military service focused 
on the Vietnam War period. Each parent was asked if he or she had ever served 
in the armed forces before the date of the index child’s diagnosis and, if so, in 
which years the service occurred. The parent was also asked if he or she was 
in contact with nuclear, chemical, and biological weaponry, radiation, radar 
or microwaves, or Agent Orange. Among the 440 cases that were eligible, 351 
completed interviews, and, of those, 319 eligible cases had available informa-
tion on parental occupation. Subjects were matched on age, sex, and race, and 
analyses were adjusted for family income, maternal education and recreational 
drug use, length of pregnancy, and maternal spotting/bleeding/cramping during 
pregnancy. The study reported that 3.4% of case mothers and 1.4% of control 
mothers reported a history of military service. Maternal history of military ser-
vice was associated with an elevated adjusted odds for rhabdomyosarcoma (OR 
= 2.75, 95% CI 0.71–10.62). There were too few cases to refine this analysis 
by time period of service. A history of paternal military service was not as-
sociated with rhabdomyosarcoma (OR = 0.85, 95% CI 0.58–1.25); restricting 
the time of paternal military service to 1962–1970 yielded an adjusted odds 
ratio of 0.78 (95% CI 0.50–1.21), based on 53 cases (18.5%) and 64 controls 
(22.3%). Only 9 cases (1.7%) and 5 controls (3.1%) reported potential Agent 
Orange exposure during Vietnam War service. The adjusted odds ratio was el-
evated for this exposure, but the estimate was not statistically significant (OR = 
1.72, 95% CI 0.55–5.41). This report was based on a nationally ascertained case 
groups and included a parental interview asking questions about a wide array 
of potential risk factors and confounders, with specific questions on military 
7 Rhabdomyosarcoma is a cancer of the muscle tissue. It is the most common form of soft-tissue sar-
coma in children. See https://www.cancer.gov/types/soft-tissue-sarcoma/patient/rhabdom yosarcoma-
treatment-pdq (accessed October 28, 2018).
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service and Agent Orange exposure. Concerns include the use of a control group 
based on telephone random-digit dialing and the recall of potential Agent Orange 
exposure. The analysis of paternal Agent Orange exposure was based on a very 
small number of exposed cases, and the confidence intervals associated with the 
odds ratios were correspondingly broad. This report found no association between 
paternal military service in Vietnam or Agent Orange exposure and an increased 
risk of rhabdomyosarcoma in offspring.
Other Identified Studies–Occupational Study Febvey et al. (2016) pooled 
three population-based case-control studies of childhood CNS tumors conducted 
from France, Germany, and the United Kingdom. Cases were children less than 
15 years of age with CNS tumors; controls were matched by gender and age. 
Interview data (telephone or in-person) on parental occupational histories were 
collected. Parental occupational data were harmonized, and an existing general 
population job-exposure matrix was used to assign pesticide exposure into no-, 
low-, or high-exposure categories for insecticides, herbicides, fungicides, and 
all pesticides combined. The analysis included 1,361 cases and 5,498 controls. 
Only 0.9% of mothers and 4.2% of fathers were found to have occupational ex-
posure to pesticides during the studied pregnancy. No association was observed 
between CNS tumors and maternal pesticide exposure (pooled OR = 0.76, 95% 
CI 0.41–1.41) and statistically significantly decreased odds were seen with pater-
nal occupational pesticide exposure (OR = 0.71, 95% CI 0.53–0.95). The study 
included a relatively large number of subjects and used a common job-exposure 
matrix to assign potential pesticide exposure across studies. However, the analysis 
was limited by the low prevalence of parental exposure, precluding examination 
of dose categories and a breakdown of pesticide categories. No information was 
available on specific pesticides.
Other Identified Studies–Environmental Study Bailey and colleagues 
(2015) used pooled individual-level data from 12 studies that participated in the 
Childhood Leukemia International Consortium to examine the association be-
tween home pesticide exposure and the risk of childhood leukemia. The analysis 
included data from 12 consortium studies conducted in North America, Europe, 
and Australasia over a 30-year period. Self-reported home pesticide exposure 
data were harmonized across studies. The time periods of potential exposure 
included the period prior to conception, during pregnancy, and after the child’s 
birth. Exposure could be to the mother, father, or child. A variety of factors were 
examined as potential confounders. The analyses were stratified by leukemia 
subgroups, including acute lymphoblastic leukemia (ALL) and AML, and cyto-
genetic data. Weakly elevated odds ratios for ALL were found for home herbicide 
use (otherwise unspecified) during the three time periods of interest: for example, 
the odds ratio for reported use within 1–3 months before conception was 1.23 
(95% CI 1.04–1.45), based on 5 studies. Home herbicide use during pregnancy 
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was associated with decreased odds of AML (OR = 0.84; 95% CI 0.56–1.26). 
These were the only two analyses with reported results for the herbicide expo-
sure group. The study’s strengths include a large pooled resource from multiple 
international studies. Limitations include self-reported home pesticide exposure 
and the inability to isolate effects of specific herbicides.
Other Identified Studies–Case-Control Studies Gunier et al. (2017) analyzed 
data from the California Childhood Leukemia Study, a population-based case 
control study conducted in 35 counties from 1995 to 2008. Cases were ascer-
tained within 72 hours after diagnosis at Northern and Central California hospi-
tals. Controls were randomly selected from California birth certificate files and 
individually matched to cases on the child’s age, sex, race, and Latino ethnicity, 
and on maternal race. In-person interviews collected information on occupational 
history for each parent. The interview also collected information on whether the 
parent worked regularly with pesticides, insecticides, fungicides, or herbicides, 
otherwise unspecified, and whether the parent worked in agricultural occupations. 
Detailed occupational information was collected using specific job module inter-
view questions for occupations with potential pesticide exposure, including farm 
or ranch worker; gardener, landscaper, nursery worker, or groundskeeper; agri-
cultural packer; and pesticide applicator. The analysis was based on 669 children 
diagnosed with ALL and 1,021 controls. After adjustment for child’s sex, age, 
ethnicity, mother’s race, and household income an increased odds ratio of ALL 
was found for paternal occupational exposure to any pesticides (OR = 1.7, 95% 
CI 1.2–2.5). A statistically significant odds ratio was found for paternal pesticide 
exposure and ALL in children diagnosed before 5 years of age (OR = 2.3, 95% 
CI 1.3–4.1). Maternal pesticide exposure had a weakly elevated odds ratio for 
ALL (OR = 1.3, 95% CI 0.8–2.4). The study strengths include a population-based 
design and a comprehensive in-person interview-based collection and assessment 
of parental occupational exposures, including occupations associated with pesti-
cide use. However, the study was not large enough to assess the effect of specific 
pesticides including the COIs.
Omidakhsh and colleagues (2017) conducted research based on data from a 
multi-center case-control study of retinoblastoma.8 Cases included patients with 
sporadic retinoblastoma who were diagnosed or treated at the Children’s Oncol-
ogy Group institution or at the Wills Eye Institute in Philadelphia, Pennsylvania, 
between 2006 and 2011. A total of 282 cases (186 unilateral and 96 bilateral) 
were recruited. Controls were selected based on friends or non-biological rela-
tives nominated by case families and with a child in the same age range as the 
index case child. Phone interviews were used to collect information on residential 
8 
“Retinoblastoma is a rare childhood cancer in which malignant (cancer) cells form in the tissues 
of the retina. The retina is a thin layer of nerve tissue that lines the inside of the back of the eye and 
is sensitive to light.” See https://www.cancer.gov/types/retinoblastoma (accessed October 28, 2018).
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pesticide use before conception and during pregnancy, including the use of pro-
fessional lawn or landscape services; the use of pest control professionals or ex-
terminators for their home; in-home use of insect or rodent killers; use of indoor 
foggers; home or garden use of herbicides, mold removal products, anti fungals, 
or weed killers; insect repellant; head lice treatment on the children; and, for 
pets, the use of flea collars or flea or tick shampoos. When parents indicated that 
they had applied a product themselves in the home or garden, they were asked to 
identify the name of the product. The investigators’ analysis was based parents 
of 99 unilateral and 56 bilateral case-control pairs. Odds ratios were adjusted 
for mother’s race, mother’s age, mother’s work status, and whether the father 
was living at home at the start of the pregnancy. Parental home use of a weed 
killer (OR = 2.3; 95% CI 0.9–5.4) was associated with an elevated odds ratio 
for unilateral retinoblastoma. The use of weed control products on the garden or 
lawn had an adjusted odds ratio of 2.3 (95% CI 0.9–5.4). Associations between 
maternal residential pesticide exposure in the month before or during pregnancy 
and bilateral retinoblastoma were very imprecise. For example, the use of profes-
sional lawn or landscape services had an odds ratio of 3.4 (95% CI 0.6–18.0), 
while the use of weed control products on a garden or lawn had an adjusted odds 
ratio of 1.0 (95% CI 0.3–3.3). The patterns of association were similar for dif-
ferent exposure factors, including the types of products, locations, timing, and 
frequency of pesticide use. When asked about the specific pesticide product used, 
about half of participants responded with a product name for which ingredients 
could be identified. Reported products used for weed control included 2,4-D, 
dicamba, glyphosate, and 2-methyl-4-chlorophenoxyacetic acid (MCPA). The 
study was based on national case and control groups and a detailed interview 
regarding residential pesticide use and other factors. In addition, cases could be 
divided into unilateral and bilateral subgroups. Limitations included the use of 
friend controls that may introduce selection bias based on shared geography and 
other factors, the relatively small number of cases, and the inability to analyze by 
specific herbicides that may have been used, including those of particular interest 
(2,4-D and dicamba).
Biologic Plausibility
Laboratory animal studies have established that TCDD can affect devel-
opment, so a connection between TCDD exposure and effects on offspring, 
including developmental disruption and disease onset in later life, is biologi-
cally plausible. It has been established in several animal studies that TCDD 
at high doses is a potent teratogen. Studies with rodent models have demon-
strated male, female, and sex-independent effects in the immediate offspring of 
females  expo sed during pregnancy. These include epigenetic modification of 
imprinted genes (Somm et al., 2013), increased DNA methylation of the BRCA1 
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tumor  suppressor gene in mammary tissue (Papoutsis et al., 2013), altered uter-
ine response to estradiol (K. A. Burns et al., 2013), the dysregulation of lipid 
metabolism in the presence of a high-caloric diet (Sugai et al., 2014), aberrant 
emotional behaviors (A. T. Nguyen et al., 2013), a reduced capacity for lympho-
cyte differentiation (Ahrenhoerster et al., 2014), testicular inflammation (Bruner-
Tran et al., 2014), and a variety of adult diseases, including kidney, prostate, 
ovarian primordial follicle loss, and polycystic ovarian disease (Manikkam et al., 
2012a). Transgenerational inheritance to the F3 generation was shown for the last 
two studies. However, definitive conclusions based on animal studies about the 
 potential for TCDD to cause later-life effects in human offspring are complicated 
by differences in sensitivity and susceptibility among individual animals, strains, 
and species; by differences in the route, dose, duration, and timing of exposure 
in experimental protocols and real-world exposure; and by differences in the 
toxicokinetics of TCDD between laboratory animals and humans. Experiments 
with 2,4-D and 2,4,5-T indicate that they have subcellular effects that could con-
stitute a biologically plausible mechanism for developmental effects, but only 
at very high doses. There is insufficient information on picloram and cacodylic 
acid to assess the biologic plausibility of their developmental or delayed effects 
in offspring.
Paternal or maternal exposure to xenobiotics potentially could increase the 
susceptibility of offspring to cancer through multiple mechanisms. Susceptibil-
ity could be increased by causing a tumor-promoting mutation in germ cells that 
would be present in all of the somatic cells of the child. This de novo mutation 
could then be passed on to subsequent generations via Mendelian inheritance, 
 assuming that the child survived to reproduce. However, as discussed earlier 
in this chapter and in earlier chapters, TCDD and other COIs are not genotoxic 
(i.e., they do not cause mutations), which makes the mutation-induction and 
inheritance scenario unlikely. Alternatively, a maternally mediated increase in 
susceptibility to childhood cancers could result from the direct exposure of a fetus 
in utero or of the newborn via lactation to a xenobiotic that induces epigenetic 
alterations that increase cancer susceptibility.
As noted elsewhere in this chapter, there are several pre- and post-conception 
scenarios for how toxicant exposures could cause disease in first-generation 
offspring and perhaps in later generations based on epigenetic mechanisms 
(Vaiserman, 2014). Perhaps the most straightforward scenario is in utero expo-
sure affecting the developing epigenome, predisposing the child to cancer. The 
best example of this happening is when otherwise very rare vaginal cancers arose 
in the daughters of women who took the estrogenic agent diethylstilbestrol to 
prevent miscarriage (Herbst et al., 1971). Thus, this scenario is plausible for hu-
mans. Although TCDD can have antiestrogenic effects, its toxicity via AHR likely 
involves transcriptional changes that could induce epigenetic mechanisms. With 
regard to cancers, if the affected gene or genes are involved in cancer pathways 
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and epigenetic modifications stabilize the gene-expression changes, then the 
susceptibility to cancer could increase.
Prenatal TCDD exposure of rats is associated with altered mammary gland 
differentiation and an increase in the number of mammary adenocarcinomas 
(Brown et al., 1998). Perhaps related, prenatal TCDD exposure led to increased 
DNA methylation at the BRCA1 (breast cancer) gene promoter in the female 
offspring of exposed pregnant rats (Papoutsis et al., 2013). The demonstration 
that early postnatal TCDD exposure does not increase mammary-cancer risk 
(Desaulniers et al., 2004) does not contradict the finding that TCDD-induced 
changes in utero mediate the increase in cancer susceptibility (Fenton et al., 
2000, 2002), and it is consistent with the ultimate carcinogenic effect being 
greatest when epigenomic changes are the most dynamic. Thus, developmental 
epigenetic alterations may be involved in the prenatal effects. TCDD has been 
shown to suppress the expression of two tumor-suppressor genes, p16Ink4a and 
p53, via an epigenetic mechanism that appears to involve DNA methylation (Ray 
and Swanson, 2004). Similarly, it was reported that prenatal TCDD exposure 
increases the DNA methylation of two growth-related imprinted genes, H19 and 
Ig f2, in the developing fetus (Q. Wu et al., 2004).
No direct evidence from animal models shows that TCDD increases the risk 
of childhood cancers, such as acute leukemia and germ-cell tumors; although a 
2014 study showed a reduced capacity of hematopoietic stem cells to undergo dif-
ferentiation in offspring (Ahrenhoerster et al., 2014). Emerging research suggests 
that prenatal TCDD exposure can disrupt epigenetic imprinting patterns and alter 
organ differentiation and thus could contribute to an increased susceptibility to 
cancer later in life. Smith et al. (2005) showed that chromosomal rearrangements 
associated with childhood ALL are evident in the neonatal blood spots, which 
suggests that childhood leukemias begin before birth, perhaps due to maternal 
exposures to carcinogenic xenobiotics.
Synthesis
Newly identified studies of cancer in children of parents potentially exposed 
to the COIs included a case-control study in which parents were asked about mili-
tary service and potential Agent Orange exposure. The study was small, and while 
an elevated odds ratio was found, the estimate was very imprecise and random 
error could not be ruled out. Other identified occupational and environmental 
studies had methodologic challenges and did not report results for specific COIs. 
In sum, the evidence is sparse and inconclusive.
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Conclusion
On the basis of the evidence reviewed here and in previous VAO reports, 
the committee concludes that there is inadequate or insufficient evidence to 
determine whether there is an association between exposure to the COIs and 
childhood cancers.
Growth and Physical Parameters
Since Update 2014, seven studies identified as relevant by the committee 
have examined exposure to the COIs and the subsequent growth and develop-
ment of children. 
A case control study by Hsieh et al. (2017) explored whether polymorphisms 
and haplotypes of arsenic methyltransferase (AS3MT), glutathione-S-transferase 
omegas (GSTOs), and purine nucleoside phosphorylase (PNP) affect arsenic 
methylation capacity and developmental delay. From 2010 to 2014, 179 chil-
dren with developmental delay and 88 children without delay were recruited 
from the Shin Kong Wu Ho-Su Memorial Teaching Hospital in Taiwan. Urinary 
arsenic species, including arsenite (AsIII), arsenate (AsV), monomethylarsonic 
acid (MMAV), and DMAV were measured using a high- performance liquid chro-
matography-linked hydride generator and atomic absorption spectrometry. The 
polymorphisms of AS3MT, GSTO, and PNP were analyzed using the Sequenom 
MassARRAY platform with iPLEX Gold chemistry. Polymorphisms of AS3MT 
genes were found to affect susceptibility to developmental delay in children, 
but GSTO and PNP polymorphisms were not. Participants with the AS3MT 
rs3740392 A/G+G/G genotype, when compared with those with the AS3MT 
rs3740392 A/A genotype, had a significantly lower secondary methylation index. 
This may result in an increased odds ratio for developmental delay. Participants 
with the AS3MT high-risk haplotype had a significantly higher OR than those 
with AS3MT low-risk haplotypes (OR = 1.59; 95% CI 1.08–2.34). This study 
shows a joint dose–response effect of an AS3MT high-risk haplotype with in-
efficient arsenic methylation capacity on developmental delay, but it does not 
constitute persuasive evidence that the AS3MT genotype causes developmental 
delay by affecting arsenic methylation.
Three European birth cohorts (Belgian, Norwegian, Slovak) that assessed 
dioxin exposures in cord blood or breast milk were pooled by Iszatt et al. (2016) 
to investigate the influence of perinatal exposure to dioxins and dioxin-like 
chemicals on infant growth and BMI in childhood. The exposure was highest 
in the Belgian and lowest in the Norwegian cohort (the median and interquar-
tile range of the pooled sample were 13 and 12.3 pg CALUX9 TEQ/g lipid 
9 CALUX (Chemical-Activated LUciferase gene eXpression bioassay) is a test that may used to 
determine dioxin-like activity. 
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respectively). Infant growth was defined as the cohort- and sex-specific change in 
weight-for-age z-score between birth and 24 months (n = 367). The investigators 
also calculated BMI at ~7 years of age in 251 children. Overweight was defined 
according to international standards for children equivalent to an adult BMI > 25 
kg/m2. In multivariate models based on generalized estimating equations, perina-
tal exposure to dioxins and dioxin-like chemicals appeared to be associated with 
increased growth between birth and 24 months (adjusted estimate for change in 
z-score: β = 0.07, 95% CI −0.01–0.14) and at age 7 years, and dioxin exposure 
was associated with a statistically significant increase in BMI in girls (adjusted 
estimate for BMI units β = 0.49, 95% CI 0.07–0.91) but not in boys (β = −0.03, 
95% CI −0.55–0.49) (p-interaction = 0.044). Furthermore, only girls had an 
increased risk of being overweight at age 7 (54%, 95% CI −6% –151%). While 
these studies suggest that perinatal exposure to dioxin and dioxin-like chemicals 
may increase early infant growth and contribute to increased BMI in school age 
girls, the studies were still quite small in size, and additional studies of larger 
sizes are needed to re-examine these associations.
Mayhoub and colleagues (2014) used data from the MecoExpo study to 
investigate the relationship between parental exposures to pesticides (as reported 
by the mother) and neonatal parameters. The study included 993 mother–newborn 
pairs from the Picardy region of northern France. In this cohort, each mother 
completed a questionnaire that probed potential occupational, domestic, envi-
ronmental, and dietary sources of parental exposure to pesticides during her 
pregnancy. Multivariate regression analyses found that maternal occupational 
exposure was associated with an elevated risk of low birth weight (OR = 4.2, 
95% CI 1.2–15.4). Paternal occupational exposure to pesticides was associated 
with a lower-than-average gestational age at birth (−0.7 weeks, p = 0.0002) and 
an elevated risk of prematurity (OR = 3.7, 95% CI 1.4–9.7).
A study of 234 couples by Robledo et al. (2015)—also reviewed above in 
the section regarding low birth weight and preterm delivery—examined how 
birth size varied with maternal and paternal exposures to 63 POPs from five 
major classes, including 36 PCBs, seven of which were dioxin-like (PCBs 105, 
114, 118, 156, 157, 167, and 189). Exposure was measured in parental se-
rum collected before conception. Differences in length, head circumference, 
and ponderal index were estimated using multiple linear regression per 1 stan-
dard deviation increase in natural log-transformed (ln-transformed) chemicals. 
The subjects were participants in the LIFE prospective cohort study, which 
was conducted in Michigan and Texas between 2005 and 2009. Models were 
estimated separately for each parent and adjusted for maternal age, maternal 
pre-pregnancy BMI, and other confounders, and all models included an in-
teraction term between infant sex and each chemical. Among girls (n = 117), 
mean length (β = −0.57 cm; 95% CI [−1.12, −0.02]) and head circumference 
(β = −0.45 cm; 95% CI [−0.86, −0.03]) were smaller in association, with a 1 
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standard deviation increase in ln-transformed maternal serum concentrations 
of the dioxin-like PCB 167. No statistically significant differences in length, 
head circumference, and ponderal index were noted among boys (n = 113) 
relative to maternal or paternal exposure to the COIs.
Tai et al. (2016) enrolled 217 mother–infant pairs living in a dioxin- 
contaminated area in Vietnam and collected data on the birth cohort’s physical 
growth during the first 3 years of life. Perinatal dioxin exposure of infants was 
estimated by the measurement of dioxin levels in the breast milk of the nursing 
mothers. Growth parameters—including weight, height, and head and abdominal 
circumferences—were measured at birth, 1 and 4 months, and 1 and 3 years of 
age. Multivariate mixed models were applied for analyzing repeated measures. 
All body size measures in boys were decreased in the high-exposure groups of 
TCDD (for example, head circumference age-adjusted z-score high- exposure: 
−0.87, 95% CI [−1.28, −0.46], versus low-exposure: −0.18, 95% CI [−0.29, 
−0.06]; p < 0.01). In girls, high TCDD exposure was associated with increased 
head circumference (age-adjusted z-score high-exposure: 0.18, 95% CI [−0.08, 
0.44], versus low-exposure: −0.28, 95% CI [−0.42, −0.15]; p < 0.01). This study 
suggests that perinatal dioxin exposure affects the physical growth of infants and 
children in the first 3 years of life in a sex-specific manner.
S. Thomas and colleagues (2015) measured arsenic and chemical levels in 
blood or urine samples from the first and third trimesters in 1,835 pregnant 
women from across Canada to study the association with fetal growth. The in-
vestigators adjusted for maternal age, parity, pre-pregnancy BMI, and smoking 
and examined potential effect modification by single nucleotide polymorphisms 
(SNPs) in GSTP1 and GSTO1 genes. No association was found for arsenic and 
small-for-gestational-age as an outcome, but the researchers found an increased 
risk for small-for-gestational-age for the highest compared to the lowest tertile 
of exposure for the organic arsenic species arsenobetaine (> 2.25 μg/L, RR = 
1.65, 95% CI 1.10–2.47) after adjusting for parity and smoking. A statistically 
significant interaction was  observed in the relationship between DMA levels in 
urinary arsenic and small-for-gestational-age between strata of GSTO1 A104A (p 
for interaction = 0.02). This study was deemed to be of limited usefulness to the 
committee because the relevance of the exposures to those experienced by Vietnam 
veterans is debatable.
Motor Development, Cognitive, Behavioral, and Socio-Emotional Outcomes
Since Update 2014, a number of studies identified as relevant by the com-
mittee have examined exposure to the COIs and cognitive or motor develop-
ment outcomes in children. 
Berghuis and colleagues (2014) reported on the results of a birth cohort study 
conducted in the Netherlands, with recruitment from 1998–2000. Maternal blood 
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samples were collected in the second or third trimester and analyzed for 10 PCB 
congeners and 6 hydroxylated metabolites. Three mono-ortho PCBs (105, 118, 
and 156), but no coplanar PCBs were measured; the hydroxylated metabolite for 
PCBs 105 and 118 was measured. These prenatal exposures were analyzed in 
 association with scores on the Touwen neurological examination administered at 
3 months of age. Many empirical analyses were conducted, with results showing, 
in general, that prenatal PCB exposures were associated with more optimal devel-
opment, both before and after adjustment for confounders of birth weight and 
child’s age at assessment. None of the results assessing the association  between 
prenatal exposure to mono-ortho PCBs and non-optimal development were sta-
tistically significant: PCB 105 (0.833 per 1 ng/g lipid weight, CI 0.550–1.262), 
118 (0.932, CI 0.728–1.191), or 156 (0.910, CI 0.831–1.019) (both genders; after 
adjustment). 
Braun and colleagues (2014) conducted an analysis of the effects of gesta-
tional exposure to endocrine-disrupting chemicals on 4- to 5-year-old children 
enrolled in the Health Outcomes and Measures of the Environment Study con-
ducted in the Cincinnati, Ohio, metropolitan area. The study examined a total of 
25 PCBs—including the dioxin-like PCBs 105, 118, 156, 157, 167, and 170—
along with many phthalates, PBDEs, pesticides, and polyfluorinated compounds 
in relation to scores on the Social Responsiveness Scale (SRS). No dioxin-like 
PCB was found to be associated with SRS scores (data were presented in graphs 
with no accompanying numbers). The authors cautioned, though, that their mod-
est sample size (n = 175) precluded them from dismissing possible effects from 
chemicals with null associations.
Caspersen et al. (2016) used data from the Norwegian Mother and Child 
Cohort Study, also known as MoBa, to estimate maternal dietary exposure to 
dioxins and PCBs using a validated food frequency questionnaire administered mid- 
pregnancy and a database of dioxin and PCB concentrations in foods.  Exposure to 
dioxins and dioxin-like PCBs was characterized in terms of TEQs. Children’s lan-
guage skills at age 3 were assessed by parental report, including a grammar rating 
scale and questions about communication skills from the Ages and Stages Ques-
tionnaire (ASQ). The total sample analyzed was 44,092 children, and a thorough 
control for confounders included maternal age, education, parity, pre-pregnancy 
BMI, household income, bilingualism, maternal smoking, alcohol, and folate 
supplement use, dietary fatty acids intake, and dietary exposure to methylmercury 
during pregnancy. Statistically significant results included associations of either 
high maternal TEQ exposure from the diet or high intake (above the 97.5th per-
centile) of the non-dioxin-like PCB 153, with higher odds of incomplete grammar 
in boys and girls (aORs 1.1 to 1.3) and severe language delay (aOR = 1.6, 95% 
CI 1.1–2.4 for dioxin-like chemicals, and aOR = 1.9, 95% CI 1.1–3.4 for PCB 
153). Higher exposure to dioxin-like chemicals was also associated with lower 
ASQ communication scores in girls (aOR = 1.4, 95% CI 1.1–1.9).
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Hui et al. (2016) recruited 161 mothers and their 11-year-old children living 
in Hong Kong to participate in a study of prenatal dioxin exposure and neuro-
cognitive development that was a follow-up to earlier work. Neuropsychological 
assessments were performed by clinical psychology trainees or senior research 
assistants with graduate training in psychology who were blinded to the partici-
pating children’s dioxin exposure. A registered clinical psychologist was respon-
sible for ensuring assessment quality and interpreting the assessment results. All 
children first completed the cognitive assessments, which took approximately 
3 hours, before other health assessments were performed. Most assessments were 
done in the research unit, but 15 were performed at home. Testing venues were 
required to be quiet and distraction free. No associations were found between any 
of the neurocognitive or behavioral tests administered with the TEQ levels from 
maternal breast milk obtained from their mothers 2 to 6 weeks postpartum, with 
p values for interaction ranging from 0.34 to 0.99 for children who were breastfed 
exclusively during infancy.
Kono and colleagues (2015) used a general population sample from an ongo-
ing breast milk survey that has been conducted in several prefectures and cities 
in Japan since 1997, from which TEQs are calculated based on PCDD/Fs and 
coplanar PCBs. When the children were 6 to 13 years of age, parents were asked 
to complete the extended Japanese version of the Strengths and Difficulties Ques-
tionnaire (SDQ), which consists of 25 items on specific strengths and difficul-
ties, with an overall rating of whether the child had behavioral or psychological 
problems. Four SDQ subscales were obtained—emotional symptoms, conduct 
problems, hyperactive/inattention, and peer problems—as well as a total diffi-
culties score (TDS) based on the four subscale scores. Analyses were conducted 
stratified by age and sex of the child. Few covariates were considered in the mul-
tivariate analysis—maternal age, birth weight, any history of maternal cigarette 
smoking, and age at SDQ assessment—raising concerns about lack of control for 
the socioeconomic status of the family. None of several different metrics estimat-
ing the dioxin exposure showed any association with the TDS score in any of 
the analyses of boys, girls, or different age groups: in linear regression analyses, 
breast milk TEQ level was not significantly related to the TDS in boys (partial 
regression coefficient = 2.29; 95% CI [−7.60, 12.18]), or in girls, (partial regres-
sion coefficient = −1.04; 95% CI [−9.24, 7.15]) after adjustment for covariates. 
According to the authors, levels of dioxins in this population were comparable 
to other studies from the same time period that estimated dioxin exposures from 
breast milk in Japan, the United Kingdom, and Eastern Europe.
Nakajima et al. (2017) examined sex-specific differences in the effect of 
prenatal exposure to dioxin-like chemicals on neurodevelopment in children who 
were participants in the Sapporo cohort of the Hokkaido Study on Environment 
and Children’s Health. Data included a blood draw from the mother in the sec-
ond trimester of the pregnancy; a self-administered questionnaire that collected 
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infor mation on the mother’s dietary habits, exposure to chemicals during daily 
life and at work site, home environment, smoking habit, and medical histories as 
well as the medical histories of the mother’s partners; maternal and child medi-
cal records information; and a neurodevelopmental test (Bayley Scales of Infant 
Development, 2nd Edition) administered to the child at either 6 or 18 months. 
The exposure assessment included levels of a number of dioxin-like chemicals 
and TEQ values. One hundred ninety mother–infant pairs in the 6-month-old 
group and 122 mother-child pairs in the 18-month-old group were studied. The 
investigators reported that levels of 10 dioxin-like chemicals in male children 
were significantly negatively associated with the Psychomotor Developmental 
Index (PDI) scores at 6 months of age after adjustment for potential confounding 
variables (−0.21 point change in developmental score per dioxin level [common 
logarithm], adjusted; p < 0.05) but that the associations disappeared at 18 months 
of age. For female children, the level of only one mono-ortho PCB isomer (PCB 
123) was significantly negatively associated with PDI at 6 months of age. How-
ever, in contrast to the males, levels of four dioxin-like chemicals (PCBs 114, 
156, 157, and 189) in 18-month-old female children were significantly positively 
associated (p < 0.05) with Mental Developmental Index scores.
An English-language abstract of a paper published in Chinese by Ni et al. 
(2016) reports the results of a study involving 3,771 children whose mothers 
were recruited during pregnancy. Maternal occupational and life exposures were 
assessed in the period 6 months prior to pregnancy, and the BRIEF (Behavior 
Rating Inventory of Executive Function–Preschool version) was used to assess 
the preschool children’s executive function. The investigators’ findings included 
that maternal exposure to pesticides in the 6 months before the pregnancy were 
associated with Inhibitory Self-Control Index dysplasia (OR = 3.60, 95% CI 
1.45–8.95), Flexibility Index dysplasia (OR = 6.72, 95% CI 2.50–18.07), and 
Global Executive Composite dysplasia (OR = 2.39, 95% CI 1.02–5.58) in the 
preschool children. No statistically significant associations between paternal 
pesticide exposures and adverse outcomes were reported. It is unclear from the 
abstract, however, whether any COI exposures were involved.
In a companion study to Pham et al. (2015), reviewed later in this section, 
Nishijo et al. (2014) examined 153 mother–infant pairs residing in a dioxin-
contaminated area near a former U.S. base in Vietnam to evaluate potential asso-
ciations between perinatal dioxin exposure and autism spectrum disorders in the 
children. Parents completed a full-length Autism Spectrum Rating Scale (ASRS) 
survey—which has not been validated in a Vietnam population but for which no 
comparable test was available—and researchers calculated several outcome and 
treatment scale scores from the results. These data were analyzed in conjunc-
tion with the Bayley-III neurodevelopmental battery test results described by 
Pham et al. The investigators found that high-TCDD-exposed (≥ 3.5 pg per g fat 
in mother’s breast milk sampled 1 month after birth) male and female children 
showed significantly higher ASRS scores than less-TCDD-exposed children, 
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without concomitant differences in their mental and psychomotor scores. In 
contrast, high TEQ level boys (≥ 17.9 pg-TEQ per g fat), had significantly lower 
neurodevelopmental scores than lesser-exposed boys without a comparable differ-
ence in their ASRS scores. These results suggest that perinatal TCDD exposure 
has an effect on autistic traits in childhood that is separate from neurotoxic effects 
of dioxin exposure in general.
A second follow-up to Pham et al. (2015) conducted by Nishijo et al. (2015) 
focused on urinary metabolite levels in 26 children who were part of their study 
cohort. The investigators found that urinary histidine is associated with dioxin 
 exposure–induced neurodevelopmental deficits, suggesting that it might be a use-
ful marker of dioxin-induced neurodevelopmental deficits. However, given the 
very small number of subjects and the very wide natural variability of urinary 
histidine (along with that of other urinary metabolites such as glycine and trypto-
phan), the results are not likely to be reliable and do not present data bearing on 
any direct evidence of a link between TCDD and clinical outcomes in descendants.
The Duisburg (Germany) birth cohort study by Nowack and colleagues 
(2015) recruited pregnant women from September 2000 to October 2002. 
 Maternal blood samples were collected primarily in the third trimester (a few 
in the immediate postnatal period) and used for the quantitation of PCDD/Fs 
and dioxin-like PCBs in order to obtain a final TEQ for PCDD/Fs, PCBs, and 
PCDD/Fs+PCBs. These TEQ values were then examined in relation to child 
scores on the SRS, a standardized instrument suitable for administration to 
the general population that collects data from the parent on symptoms re-
lated to autism spectrum disorders. Parents rated the children on 65 items that 
were grouped into five subscales. In this study, the children were 9–12 years 
of age when the SRS was completed. Results showed that SRS Social Com-
munication scores were significantly lower in male and female children exposed 
to higher TEQs from PCDD/Fs or from PCBs (p < 0.05). Autistic Mannerisms 
scores also correlated significantly with TEQs from PCDD/Fs or from PCDD/
Fs+PCBs (p < 0.05). In sex-stratified analysis, the only significant association 
in boys was between TEQ from PCDD/Fs and the Social Motivation subscale 
(p < 0.05). In girls, however, significant associations were found for PCDD/Fs 
alone or combined with PCBs in relation to the total SRS score (p < 0.05) and 
the Social Communication subscale score (p < 0.05); and for all three TEQs 
(PCDD/Fs, PCBs, and PCDD/Fs+PCBs) in relation to the Social Cognition (p 
< 0.05) and Autistic Mannerisms (p < 0.01) subscales. The study’s limitations 
were that postnatal exposures were not accounted for in the analysis of prenatal 
exposures and that the sample size for this follow-up was small (n = 100 for 
boys and girls combined). Also, other risk factors for autism spectrum disorder 
that have emerged were not measured: air pollution, maternal nutrition, maternal 
diabetes, and inter-pregnancy interval. However, the study’s major strengths were 
the measurement of TEQs from the prenatal period and its control for potential 
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confounders, such as maternal age, education, the presence of older siblings, the 
age of the child, alcohol and smoking during pregnancy, and nationality. Some 
factors were also associated with attrition, thereby reducing selection bias. 
In a paper related to the Nowack et al. (2015) research described above, 
Neugebauer et al. (2015) examined attention performance and attention-related 
behavior among 117 school-aged children who were part of the Duisburg cohort. 
Increased prenatal PCDD/F and PCB concentrations were significantly (p < 0.05) 
associated with a higher number of omission errors in the subtest Divided Atten-
tion (47% and 42%; 95% CI 1.08–2.00 and 1.07–1.89, respectively). Orenstein 
and colleagues (2014) evaluated verbal memory, visual memory, and learning 
in 393 children born to mothers residing in New Bedford, Massachusetts, near 
a Superfund Site. They calculated TEQs based on measurements of the dioxin-
like mono-ortho substituted PCBs 105, 118, 156, 167, and 189 in cord serum. 
Verbal memory, visual memory, and a learning index from the Wide-Range 
Assessment of Memory and Learning at 8 years of age were evaluated, with 
adjustments made for a broad array of confounders, including examiner, child’s 
age at examination, sex, birth year, school grade, parental education, maternal 
age at birth, maternal birth place, household income, prenatal tobacco smoke 
exposure, prenatal alcohol exposure, prenatal omega-3 exposure, and maternal 
IQ. No significant associations were found. 
A birth cohort studied by Pham et al. (2015) was established in Da Nang, 
Vietnam, in 2008–2009, at the site of a former U.S. air base, which is an area of 
documented high exposures to TCDD and other PCDD/Fs (Hatfield Consultants, 
2009a,b). The study includes two districts in a surrounding area of 10 kilometers 
from the former air base. Exposure measurements were made in breast milk 
collected at approximately 1 month after delivery, and the chemical measured 
included 17 PCDD/Fs, including 2,3,7,8-TCDD. The Bayley Scales of Infant 
Development, 3rd edition (Bayley-III), was administered at age 12 months by 
an examiner who was supervised by a pediatric psychologist experienced with 
the Bayley-III. Adjustments were made for the gender, parity, gestational week, 
age (in days), and birth weight of the infants; the age, education, and drinking 
habit during pregnancy and residential location of the mothers; and the family 
income and smoking status of family members. Analyses found that the TEQs 
for three different metrics of exposure (all PCDD/Fs, TCDD, and the daily dioxin 
intake) showed virtually no associations with the overall cognitive score; the 
language composite, receptive language and expressive language subscales; and 
the motor composite, fine motor and gross motor subscales. The one exception 
was the daily dioxin intake (in pg TEQ/kg/day), which was significantly associ-
ated with improved overall cognitive scores in each of the three upper levels 
of exposure—mild (102.8; p = 0.033), moderate (102.1; p = 0.042), and high 
(102.4; p = 0.041), as compared with low exposures (97.7). No adaptive behavior 
skills showed any association with the exposures examined. However, based on 
parent report (not observation), scores on a social–emotional scale that assesses 
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functional emotional skills and self-regulation were lower in the children with 
the highest category of prenatal overall TEQ and the highest category of the 
TCDD TEQ, as compared with the corresponding lowest-exposure categories 
(p = 0.09).
Tai et al. (2016)—whose results regarding physical growth in offspring 
are reviewed earlier in this chapter—enrolled 217 mother–infant pairs living 
in a dioxin-contaminated area in Vietnam and followed the neurodevelopment 
of the birth cohort longitudinally during the first 3 years of life. The perinatal 
dioxin exposure of infants was estimated by the measurement of dioxin levels in 
breast milk of the nursing mothers. The neurodevelopment of infants and chil-
dren, including cognitive, language, and motor development, was determined at 
4 months, 1 year, and 3 years of age. Multivariate mixed models were applied for 
analyzing repeated measures. In boys, composite motor (94.9, 95% CI 89.9–100, 
p = 0.49) and gross motor scores (9.1, 95% CI 7.9–10.2, p = 0.36) were signifi-
cantly decreased with increasing exposure of 2,3,7,8-TCDD. The high PCDDs/
PCDFs-TEQ group showed a significant decrease in expressive communication 
score compared with the low-exposure group, as measured by Bayley-III (8.4, 
95% CI 7.8–8.8, p = 0.30). In girls, there was no decreased score in any neuro-
development aspects in high-exposure groups. This study suggests that perinatal 
dioxin exposure  affects the neurodevelopment of infants and children in the first 
3 years of life in a sex-specific manner.
Tran et al. (2016) investigated the effects of early life exposure to dioxins 
in children living around Da Nang City, Vietnam, a location known to be con-
taminated with dioxin. Exposure was assessed via a breast milk sample from the 
nursing mother taken 1 month after birth. Demographic and confounding factors 
data were collected from the mother; physical measurements of the subjects—176 
children—were taken at birth and 5 years of age. In boys, the total test (7.7 ver-
sus 9.7; p = 0.018) and balance (7.3 versus 9.3; p = 0.013) scores of the Move-
ment Assessment Battery for Children-2 (Movement ABC-2) were significantly 
lower in the high-TEQ-PCDDs/Fs group compared with the moderate- and low-
exposure groups. Nonverbal Index scores (77.0 versus 98.1; p = 0.034) and the 
pattern reasoning subscale of the Kaufman Assessment Battery for Children, 2nd 
Edition (KABC-II) (5.3 versus 7.1; p = 0.041), which measures planning ability, 
were also significantly lower in the high-TCDD-exposure group compared with 
the low-exposure group of boys. However, in girls no significant differences in 
Movement ABC-2 or KABC-II scores were found among the different TEQ-
PCDDs/Fs and TCDD exposure groups. The five boys and one girl who were 
highly exposed to TEQ-PCDDs/Fs and TCDD were found to be at increased risk 
for difficulties in both motor coordination and cognitive function. Overall, these 
results suggest differing impacts of TEQ-PCDDs/Fs and TCDD exposure on 
motor coordination and higher cognitive ability, respectively. Moreover, high-TEQ- 
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PCDDs/Fs exposure combined with high-TCDD exposure may increase autistic 
traits combined with developmental coordination disorder.
Immune and Allergic Outcomes
Since Update 2014, five studies identified as relevant by the committee have 
examined exposure to the COIs and immune or allergic outcomes in children. 
P. H. Su et al. (2015) conducted a study of 56 8-year-old children from 
Taiwan. The subjects were stratified into high- and low-exposure groups based 
on maternal PCB and PCDD/F serum levels. No changes were found, although 
there were differences (t-test) in thyroid hormones, thyroxine binding globulin, 
IGFBP-3, and growth hormone.
El Majidi and colleagues (2014) used a procedure previously developed 
to standardize PCB biological concentration data between published studies to 
perform a systematic analysis of associations between PCB exposure and thyroid 
hormones (THs) (total and free T3 and T4) or thyroid-stimulating hormone (TSH) 
in pregnant women and newborns. The weight of evidence of a significant impact 
of PCB exposure on TSH and TH levels at the described biological levels in 
pregnant women and newborns (mean < 1,000 μg PCBΣEQ kg−1 lipids)  appeared 
low, according to this analysis.
S. Hansen et al. (2014) examined the association between maternal serum 
concentrations of the dioxin-like PCB 118 and the risk of asthma in their off-
spring. Compared with subjects in the first tertile of maternal PCB 118 concen-
tration, those in the third tertile had an adjusted HR of 1.90 (95% CI 1.12–3.23). 
Offspring were exposed in utero, and this is thus evidence of a developmental 
exposure leading to a later-life health impact. 
A second study by S. Hansen et al. (2016) examined a cohort of 965 (421 in 
the follow-up) pregnant women and measured POPs, including PCBs. Exposures 
were separated into tertiles for the analysis, based on week-30 POP levels. A clin-
ical evaluation of offspring took place at age 20. No association with asthma was 
found, but dioxin-like PCB exposure in the mother was associated with offspring 
airway obstruction (FEV1/FVC < 75%; OR = 2.96, 95% CI 1.14–7.70), with 9 
cases versus 20 cases. This is an interesting finding in that this condition may 
be associated with chronic obstructive pulmonary disease (COPD) later in life.
Nicolle-Mir (2014)—in a paper published in French—examined the associa-
tion between prenatal exposure to PCBs, hexachlorobenzene, and p-p′-DDE and 
the risk of asthma in children born to women included in a cohort of Danish births 
in 1988–1989 (the Danish Fetal Origins Cohort). The concentrations of POPs 
(congeners 118, 138, 153, 156, 170, and 180 for PCBs) were determined in a 
maternal serum sample taken at 30 weeks of pregnancy. Nine hundred sixty-five 
children in the cohort were contacted in 2008 to complete an online questionnaire 
covering their health status, lifestyle, and diet; 872 (90%) returned data that could 
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be included in the analysis. Their government personal identification numbers 
were cross-referenced with the national prescriptions file, and subjects who had 
been treated for asthma between the ages of 6 and 20 years were classified as 
asthmatics. Those who had received a single prescription of beta-2 mimetics or 
inhaled corticosteroids were excluded. Three secondary criteria were also used: 
the diagnosis of asthma made by a doctor, the use of asthma treatments during the 
past 12 months (questions asked in the follow-up questionnaire), and a hospital 
diagnoses of asthma (outpatient or emergency, based on a central admissions 
registry). The cross-tabulation of these different sources showed a good match 
between the data from the national prescription file and the responses to the ques-
tionnaire. The prevalence of asthma was equal to 12.7% according to the file and 
to 13.6% according the questionnaire; 76% of subjects classified as asthmatics 
on the basis of the file report had an asthma diagnosis, and 72% of those who 
reported having been diagnosed with asthma were identified in the file. Serum 
concentrations of POPs were divided into tertiles, and the HR of asthma was 
calculated for the second and third tertiles with reference to the first. Analyses 
included those carried out with each individual congener and the sum of the dioxin-
like congeners (PCBs 118 and 156). Models were adjusted to the child’s sex and 
birth weight as well as to several maternal parameters: age at birth, pre-pregnancy 
BMI, parity, smoking, alcohol consumption, education level, plasma concentra-
tions of triglycerides, and total cholesterol. The main analysis (asthma defined 
according to the national prescriptions file) showed an increase in the risk of 
asthma in the third tertile concentration of dioxin-like PCBs with reference to 
the first tertile (HR = 1.75, 95% CI 1.02–2.98), with significant dose–response 
trends. The association between dioxin-like PCBs and asthma is mainly due to 
the 118 congener (HR = 1.9, 95% CI 1.12–3.23). For PCB 156, PCBs with no 
dioxin activity, and the sum of the PCBs, the increases were not significant. The 
results of the secondary analyses were consistent: the strongest associations were 
observed with PCB 118 when the criterion “treatment of the asthma during the 
last 12 months” was used (HR in the last tertile respectively equal to 2.49 [95% 
CI 1.03–5.99] and 4.18 [95% CI 1.57–11.15]). The authors indicate, however, 
that the plasma levels of the dioxin-like PCBs and hexachlorobenzene were 
highly correlated (Spearman’s R-value 0.53–0.99), with the mutual adjustments 
weakening the associations observed in the main analysis to HR = 1.47 (95% 
CI 0.75–2.86) for PCB 118. In addition, in the absence of information about 
breastfeeding, it is unclear whether these associations are attributable to prenatal 
or postnatal exposures or a combination of both.
Other Outcomes
No studies identified as relevant by the committee have examined exposure 
to the COIs and reproductive function in offspring since the publication of  Update 
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2014. However, since this category was included in the Update 2014 report, it is 
noted here for completeness.
Li and colleagues (2015) conducted a study of the so-called “Yucheng 
 children,” descendants of mothers exposed to PCBs/PCDFS via a contaminated 
cooking oil incident in 1978–1979 in Taiwan, to evaluate the effect of this insult 
on their auditory function later in life. Exposed children were born June 1978–
December 1998; control children were matched by age, sex, neighborhood, moth-
er’s age, and parents’ educational level and occupation. Demographic data were 
collected via questionnaire, and pure-tone audiograms were obtained. Eighty-six 
Yucheng children and 97 controls participated in the study. Serum taken from the 
mothers during other studies had previously been screened for dioxins and PCBs. 
The study found that gestational exposure to 2,3,4,7,8-PeCDF was associated 
with an increase in hearing loss (increase in the pure tonal frequency threshold), 
although the frequency deficits were not the same in the right and left ears. Ex-
posures to 1,2,3,4,7,8-HxCDF were associated with hearing loss in the left ear 
at 4,000 Hz. There was no effect of PCB exposure on hearing, although the PCB 
levels as measured by TEQ were rather low. 
Biologic Plausibility
As noted in Update 2014, the results of studies in rodent models provide 
support for the idea that prenatal exposure to TCDD can result in adverse effects 
in offspring later in life, including immune disorders, behavioral disturbances, repro-
ductive impairment, kidney disease, and cancers (Foster et al., 2010; Prescott, 
2011; Puga, 2011; Takeda et al., 2012). Using two mouse models, investigators 
showed that prenatal TCDD (2.5–5.0 mg/kg) modified multiple immune sig-
natures in the adult offspring that were indicative of adult-onset autoimmunity 
(Holladay et al., 2011). Adult-onset inflammatory disease and lupus-like autoim-
munity were also observed in mice at 36 weeks of age after high-dose prenatal 
TCDD exposures (Mustafa et al., 2011). A single prenatal exposure of rats to 
TCDD (0.7 μg/kg of body weight) reduced brain developmental myelination and 
compromised remyelination potential in adults (Fernández et al., 2010), and in 
utero TCDD in mice altered neural progenitor differentiation (Mitsuhashi et al., 
2010). However, another study suggested that, in contrast to wild-type murine 
neural progenitor cells (mNPCs), “human NPCs and AhR-deficient mNPCs were 
insensitive to AhR agonism or antagonism” (Gassmann et al., 2010, p. 1571). 
Maternal exposure to TCDD (0.2–0.4 μg/kg of body weight) in pregnant rats 
perturbed neuroendocrine function as measured by thyrotropin and growth hor-
mone concentrations in exposed offspring through peripubertal postnatal day 
30, which supports the idea of continued later-life thyroid hormone disturbances 
(Ahmed, 2011, 2014). These disturbances include the epigenetic modification of 
imprinted genes (Somm et al., 2013), increased DNA methylation of the BRCA1 
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tumor suppressor gene in mammary tissue (Papoutsis et al., 2013), altered uterine 
response to estradiol (Burns et al., 2013), dysregulation of lipid metabolism in the 
presence of a high-caloric diet (Sugai et al., 2014), aberrant emotional behaviors 
(A. T. Nguyen et al., 2013), a reduced capacity for lymphocyte differentiation 
(Ahrenhoerster et al., 2014), testicular inflammation (Bruner-Tran et al., 2014), 
and a variety of adult diseases including kidney disease, prostate disease, ovarian 
primordial follicle loss, and polycystic ovarian disease (Manikkam et al., 2012a). 
Other studies have focused on neurobehavioral outcomes following perinatal 
exposure, which is of relevance in understanding the possible consequences in 
the offspring of Vietnam veterans, particularly the offspring of female veterans. 
Haijima et al. (2010) found that gavage treatment of pregnant mice with 3 μg /kg 
TCDD on gestation day 12.5 (resulting in in-utero and lactational exposure of the 
offspring) impaired memory in the male offspring. Mitsui et al. (2006) reported 
that hippocampus- dependent learning could be impaired in male rats exposed to 
TCDD in utero and that the impairment could affect fear conditioning. Curran et 
al. (2011) assessed the effect of CYP1A2 and Ahr genotypes on altered learning 
and memory in mice exposed to an environmentally relevant mixture of dioxin-
like (coplanar) and non-dioxin- like PCBs in utero and during lactation. They 
observed the most significant deficits in response to PCB treatment in Ahrb1 
CYP1A2(–/–) mice, including impaired novel object recognition and increased 
failure rate in the Morris water maze test. Studies in week- old rodents have also 
detected molecular effects of TCDD in cerebellar granule cells and neuroblasts, 
which may be relevant to motor function and cognitive processes (Kim and 
Yang, 2005; Williamson et al., 2005). Stürtz et al. (2008) found alterations in 
how female rats that had been fed on postpartum days 1–7 with diets containing 
15, 25, or 50 mg/kg 2,4 -D interacted with their pups. The specific relevance of 
these findings to neurobehavioral effects in humans exposed as adults is unclear.
Another mode of epigenetic change is the modification of the spatial arrange-
ment of chromosomes, which can influence gene expression and cell differ-
entiation. Oikawa et al. (2008), for example, found that TCDD—through the 
AHR—modifies the positions of chromosomes in the interphase nuclei of human 
preadipocytes.
The studies discussed above suggest that TCDD has the potential to influ-
ence the epigenome and therefore could promote changes in offspring that lead to 
disease later in life, although the research addressing this issue in model systems 
is still at an early stage.
Synthesis
Epidemiologic studies designed to examine the effects of the COIs in more 
mature offspring have evaluated a variety of growth and development, neurologic, 
immunologic, reproductive, and endocrine system health outcomes. More studies 
are required before conclusions can be reached as to whether such outcomes in 
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the offspring of exposed parents are replicable. In particular, it would be of inter-
est to obtain information on neuropsychiatric conditions, such as attention-deficit 
hyperactivity disorder and other clinically defined neurodevelopmental outcomes 
in children who were exposed in utero.
Conclusion
There is inadequate or insufficient evidence to determine whether there is an 
association between the exposure of men and women to 2,4-D, 2,4,5-T, TCDD, 
picloram, or cacodylic acid before conception or during pregnancy and the ad-
verse health outcomes in their children addressed in this section. Although the 
results of laboratory research support the plausibility of such clinical conditions, 
there are not yet sufficient human data to support an association between the COIs 
and such adverse outcomes in human offspring.
BIOLOGIC PLAUSIBILITY OF POSSIBLE EFFECTS 
IN SUBSEQUENT GENERATIONS
In response to a special request from the Department of Veterans Affairs, con-
tinuing inquiries from veterans and their families, and increasing attention in re-
search efforts, the committee responsible for Update 2010 explored the possibility 
of intergenerational or transgenerational effects resulting from exposure-related 
epigenetic changes in the parents or exposed fetuses that would lead to adverse 
health effects in later generations, such as grandchildren. Effects in persons ex-
posed in utero are not considered transgenerational because the fetus was likely 
exposed directly. This exception includes the children of women exposed in Viet-
nam even if they are conceived after their tour of duty was over because TCDD 
remains in the body for a long time and is mobilized during pregnancy. Likewise, 
the children of men exposed to TCDD in Vietnam and born after the soldiers’ tour 
of duty was over could possibly have health outcomes due in part to TCDD’s effect 
on the sperm epigenome. In contrast, any adverse health effects in grandchildren 
associated with exposure would be considered to be transgenerational. Figure 8-1 
illustrates the partitioning between intergenerational and transgenerational effects 
due to the exposure of a parent, delineating between those exposures that biologi-
cally persistent (like dioxin) and therefore dwell in the body long after exposure 
versus those that do not.
The Update 2010 committee did not identify any relevant scientific studies to 
review and concluded that there was inadequate or insufficient evidence to deter-
mine whether there is an association between exposure to the COI and diseases in 
grandchildren or later descendants of Vietnam veterans. Committees responsible 
for Updates 2012 and 2014 likewise failed to find any relevant human studies and 
affirmed the conclusion of inadequate or insufficient evidence.
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Congress put forward and passed the Jeff Miller and Richard Blumenthal 
Veterans Health Care and Benefits Improvement Act in 2016, and it became Pub-
lic Law 114-315. Among the law’s provisions is Section 632, which called on the 
Secretary of Veterans Affairs to enter into a contract with the  National Academies 
of Sciences, Engineering, and Medicine to conduct an assessment on scientific 
research relating to the descendants of individuals with toxic exposure. As part 
of its response to this directive, VA tasked this committee to “assess the current 
research available on possible generational health effects that may be the result 
of exposures to [the COIs]—including the biologic plausibility or potential for an 
exposure to lead to an increased risk of birth defects or other adverse conditions 
in the descendants of male Veterans.”10
Epidemiological Studies
No relevant studies of potential transgenerational effects of exposure to the 
COIs in humans have been reported to date. The only transgenerational effect 
shown in humans has been from a comparison of food supplies in  Sweden dur-
ing the 1800s and health outcomes in the children and grandchildren of men 
who were prepubescent when food supplies were relatively high or low. These 
studies found an association between high food supply levels in grandfathers 
and decreased longevity and increased risk of cardiovascular disease and dia-
betes in grandsons that was paternally transmitted, although no mechanistic 
information was obtained (Kaati et al., 2002, 2007). Whether transgenerational 
effects can occur in humans from chemical exposures is unknown at this time.
Biologic Plausibility
Research on the biologic mechanisms that might underlie the potential 
effects of exposure to the COIs experienced by grandchildren and later gen-
erations is still sparse, although it has greatly expanded in the past few years. 
Epigenetic effects have been shown for male gametes in adult mice exposed to 
an endocrine-disrupting pesticide (methoxychlor) and fungicide (vinclozolin) 
(Paoloni-Giacobino, 2014). However, the chemically induced DNA methylation 
changes in sperm DNA were not transmitted from one mouse generation to the 
next for imprinted genes; they were, presumably, lost during the period of active 
demethylation that occurs shortly after fertilization. This observation suggests 
that transgenerational effects on imprinted genes in mice that might be paternally 
transmitted may not necessarily involve DNA methylation (Iqbal et al., 2015). 
Nonetheless, a 2013 study showed that odor fear-conditioning in the father could 
be paternally transmitted to the F2 generation (as well as the F1) and implicated 
10 Gulf War and Health, Volume 11 (NASEM, 2018) addresses this mandate as it applies to expo-
sures experienced during the conflicts in the Southwest Asia theater of military operations.
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reduced DNA methylation in the responsible odor receptor gene (Dias and Ressler, 
2013). Thus, more research is required to understand better how transgenerational 
effects can be transmitted paternally once they have been demonstrated (Dias and 
Ressler, 2014).
A few animal studies have provided evidence of transmission of adverse 
effects to later generations. The mechanisms that could underlie later-life effects 
in offspring and effects in later generations (transgenerational inheritance) could 
involve epigenetic processes, as described earlier in this chapter. Research into 
dioxin’s potential as an epigenetic agent is in its early stages, but a few studies 
have suggested that dioxin has such properties that are, in significant part, linked 
to the AHR. Direct evidence, however, is limited to maternal exposures of the 
developing embryo or fetus during in utero growth, and no reports exist showing 
paternal TCDD exposure and later-life effects in offspring or paternally mediated 
transgenerational effects in humans. Q. Wu et al. (2004) demonstrated that TCDD 
exposure of mouse embryos before implantation in unexposed females resulted in 
epigenetic changes, including increased DNA methylation and a reduced expres-
sion of imprinted genes, which implied that early embryonic exposure alone was 
sufficient to alter gene expression in the resulting offspring. The transmission of 
effects to later generations would involve epigenetic alterations in the develop-
ing germ cells of a fetus that was directly exposed to maternal TCDD in utero.
Results of a few studies support a transgenerational inheritance due to in 
utero exposure to TCDD. Exposing pregnant mice to TCDD (at 10 μg/kg) re-
duced fertility and increased premature birth in three later generations (Bruner-
Tran and Osteen, 2011); effects were transmitted through both male and female 
offspring (Ding et al., 2011; McConaha et al., 2011). Exposing gestating female 
rats (F0) to dioxin (TCDD) at 100 ng/kg was shown to result in an earlier 
puberty in the offspring (F1) and in two later generations (F2 and F3) and to 
reduce ovarian follicle numbers in the females of the F3 generation; this implies 
transgenerational inheritance (Manikkam et al., 2012a). The F3 effects appear to 
be transmitted through the sperm that were initially exposed to maternal dioxin 
in utero. In a second paper by the same research team, additional diseases ap-
peared later in life in the first generation (directly exposed offspring), including 
prostate disease in males and ovarian follicle loss and polycystic ovarian disease 
in females (Manikkam et al., 2012b). Further third-generation effects were noted, 
including kidney disease in males and polycystic ovarian disease in females, 
which imply transgenerational inheritance. The latter appear to be transmitted 
through the sperm originally exposed to maternal dioxin in utero inasmuch as 
sperm DNA methylation changes were observed at 50 chromosomal sites in 
generations F1–F3. Testicular inflammation from TCDD exposure has also been 
reported to manifest in multiple generations (Bruner-Tran et al., 2014).
The zebrafish has been used as a model to examine transgenerational effects 
from dioxin exposure, although different groups have reported different aspects 
of these effects since Update 2012. One group reported that exposing zebrafish at 
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3 and 7 weeks old (during sexual development) to TCDD in water for 1 hour at 
50 pg/ml increased female-to-male ratios and skeletal abnormalities and reduced 
fertility in the F1 and F2 descendants (equivalent to F2 and F3 in mammals) 
(Baker et al., 2014a,b). Another group studying DNA methylation changes in the 
offspring of mothers fed 20 μg/kg TCDD in their food reported no changes in 
global methylation in offspring when looking at the total levels of DNA methyla-
tion in the genome. However, gene-specific increases or decreases in promoter 
DNA methylation were observed with a tiling array assay for a limited number of 
genes in the F1 generation. CYP1A1 transcription, a marker of TCDD exposure, 
was elevated in F1 offspring. Unfortunately, no F2 fish were generated from the 
TCDD exposure because the F1 fish died 1 to 2 weeks post hatching (Olsvik et 
al., 2014). Further work with this model will be helpful for providing targets for 
mammalian biologists as they continue to probe for transgenerational effects from 
TCDD and the other COIs.
Synthesis
No epidemiological information exists to evaluate whether paternal or mater-
nal exposure to the COIs results in health effects in grandchildren or subsequent 
generations of descendants of Vietnam veterans. The animal literature contains 
evidence that environmental agents mediated by maternal exposure affect later 
generations through fetal and germline modifications, but in the case of adult 
male exposures before the conception of the next generation, there is insufficient 
evidence on which to draw a conclusion regarding transgenerational effects.
Conclusion
On the basis of the evidence reviewed here and in previous VAO reports, the 
committee concludes that there is inadequate or insufficient evidence to deter-
mine whether there is an association between paternal or maternal exposure to 
the COIs and health effects in grandchildren or later generations of descendants 
of Vietnam veterans.
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Neurologic Disorders
Chapter Overview
Based on new evidence and a review of prior studies, the current committee did 
not find any new associations between the relevant exposures and neurologic 
disorders. Current evidence supports the findings of earlier updates that:
• There is limited or suggestive evidence of an association between the 
chemicals of interest (COIs) and Parkinson disease and diseases that 
present with Parkinson-like symptoms.
• There is inadequate or insufficient evidence to determine whether there is 
an association between the COIs and any of the other adverse neurologic 
outcomes.
This chapter considers the possible effects of toxic exposure to the her-
bicides used during the Vietnam War and specific clinical conditions associated 
with the central nervous system (CNS) and the peripheral nervous system (PNS), 
primarily brain dysfunctions. The COIs are 2,4-dichloro phenoxyacetic acid 
(2,4-D), 2,4,5-trichlorophenoxyacetic acid (2,4,5-T), picloram (4-amino-3,5,6-
trichloropicolinic acid), cacodylic acid (dimethyl arsenic acid [DMA]), and 
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), a contaminant of 2,4,5-T. As de-
scribed in Chapter 3, studies of the effects of exposure to polychlorinated biphe-
nyls (PCBs) and other dioxin-like chemicals were also considered informative if 
their results were reported in terms of TCDD toxic equivalents (TEQs) or concen-
trations of specific congeners of dioxin-like chemicals. Studies that report TEQs 
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based only on mono-ortho PCBs (which are PCBs 105, 114, 118, 123, 156, 157, 
167, and 189) are considered even though their TEQs are several orders of mag-
nitude lower than those of the non-ortho PCBs (77, 81, 126, and 169), based on 
the revised World Health Organization (WHO) toxicity equivalency factor (TEF) 
scheme of 2005 (La Rocca et al., 2008; van den Berg et al., 2006). The lower TEQs 
of the mono-ortho PCBs, however, may be counterbalanced by their abundance, 
which is generally many orders of magnitude higher than the non-ortho PCBs 
(H.-Y. Park et al., 2010).
Examples of the diseases that result from the degeneration of specific brain 
areas are Parkinson disease (PD), Alzheimer disease (AD), spinocerebellar de-
generation, and amyotrophic lateral sclerosis (ALS). These diseases may occur in 
the absence of any toxicant exposure, but all may be triggered by environmental 
factors, including toxicant exposure (Bronstein et al., 2009; Chin-Chan et al., 
2015; de la Monte and Ming, 2014; H. Kang et al., 2014b; Tanner et al., 2014; 
M. D. Wang et al., 2014).
Disorders of the PNS are generally referred to as neuropathies. Neuropathies 
can be purely motor, presenting as deficits in strength, but most often they present 
with the involvement of both motor and sensory fibers. Neuropathies are often 
symmetric and start with symptoms related to dysfunction of fibers that travel 
the greatest distance to their target organ. For that reason, the symptoms of neu-
ropathy often start in the digits and travel toward the torso. Many neuropathies 
also affect autonomic fibers and thus can result in changes in blood pressure and 
heart rate and in symptoms related to the control of digestion. Toxicant exposure 
can induce immediate (i.e., acute) damage to peripheral nerves, and previous 
updates found limited or suggestive evidence that dioxin exposure can cause 
such short-term effects. However, the overall focus of this chapter is on delayed 
adverse effects on both the PNS and the CNS.
The immediate effects of toxicants may involve all regions of the nervous 
system, whereas delayed effects are likely to be related to focal deficits. Diffuse 
damage to the CNS may cause alterations in thinking, consciousness, or atten-
tion, sometimes in combination with abnormalities of movement, while focal 
dysfunction can cause myriad syndromes, depending on which area of the brain 
is involved and the extent and severity of damage. For the purposes of this re-
view, neurologic deficits associated with Vietnam service are distinguished from 
psychiatric and psychologic conditions—such as posttraumatic stress disorder 
(PTSD), depression, and anxiety—and from chronic fatigue syndrome.
In the original Veterans and Agent Orange (VAO) report (IOM, 1994), at-
tention was focused on persistent neurobehavioral disorders. That focus was 
maintained through Update 2002 (IOM, 2003c). A slight change in emphasis 
toward chronic neurodegenerative disorders was reflected in the name change of 
this chapter to “Neurologic Disorders” in Update 2004 (IOM, 2005), which was 
carried forward in all subsequent updates. In this update, the chapter covers data 
pertinent to persistent neurologic disorders of all types.
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Many studies have addressed the possible contribution of various chemical 
exposures to neurologic disorders. However, for the purposes of the VAO com-
mittees, several of these studies have been limited by the use of nonspecific or 
mixed exposures and by a lack of adequate lag times between the exposure and 
the neurologic outcome of interest. Case identification of neurologic disorders 
is also an important consideration and is often difficult because there are few 
disorders for which there are specific diagnostic tests. Because the nervous sys-
tem is not readily accessible for biopsy, pathologic confirmation is usually not 
feasible. However, identifiable neurologic disorders always result in objective 
abnormalities that are reflected in anatomic or functional tests or discovered via 
clinical examination.
This chapter reviews the association between exposure to the COIs and neu-
robehavioral disorders, neurodegenerative disorders, and chronic PNS disorders. 
The scientific evidence supporting the biologic plausibility of each category of 
disorders is also reviewed here. More complete discussions of the categories of 
association and of this committee’s approach to categorizing health outcomes are 
presented in Chapter 3. For citations new to this update that revisit previously 
studied populations, the relevant details on the experimental design can be found 
in Chapter 5.
BIOLOGIC PLAUSIBILITY
Experimental data regarding the biologic plausibility of a connection be-
tween exposure to the COIs and various neurologic disorders continue to accrue. 
This section summarizes in a general way some of the information reviewed in 
the current update and, for completeness, includes pertinent information from 
prior updates.
Several studies have dealt with mechanisms of neurotoxicity that might be 
ascribed to the COIs, notably 2,4-D and TCDD. The molecular effects of the COIs 
are described in detail in Chapter 4. Some aspects of the biochemical activity of 
the COIs suggest pathways by which there could be effects on the neural systems. 
A number of studies suggest that the COIs, primarily 2,4-D, have neurologic ef-
fects, both neurochemical and behavioral, in animal models if exposure occurs 
during development or in cultured nerve cells (Konjuh et al., 2008; Pasandi et 
al., 2017; Rosso et al., 2000a,b; Stürtz et al., 2008); older references described 
the behavioral effects of a developmental exposure of rodents to a 2,4-D–2,4,5-T 
mixture (Mohammad and St. Omer, 1986; St. Omer and Mohammad, 1987). The 
exposure of zebrafish during development to the dioxin-like chemical PCB 126 
leads to behavioral deficits in adults and substantial gene expression changes in 
the adult brain (Aluru et al., 2017). Juvenile TCDD exposure in zebrafish has 
been shown to lead to lesions in the olfactory neuroepithelium and to dramatic 
changes in the expression of genes important for neurological function (Q. Liu 
et al., 2014). Perinatal exposures to TCDD and to coplanar, dioxin-like PCBs 
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have reportedly caused deficits in learning behavior in rats (Curran et al., 2011; 
Haijima et al., 2010; Hojo et al., 2008; Kakeyama et al. 2014). However, those 
studies should be interpreted with caution because the developing nervous system 
is different from the mature nervous system and may not be an appropriate model 
for the possible consequences of exposure to the COIs by adults, as was the case 
for Vietnam veterans.
Some studies further support suggestions that the concentration of reactive 
oxygen species could alter the functions of specific signaling cascades and be 
involved in neurodegeneration (Drechsel and Patel, 2008). Such studies do not 
specifically concern the COIs but they are potentially relevant to these chemi-
cals inasmuch as TCDD and herbicides have been reported to elicit oxidative 
stress (Byers et al., 2006; Celik et al., 2006; J. Kumar et al., 2014c; D. Shen et 
al., 2005; Wan et al., 2014). TCDD has been shown to affect phosphokinase C 
biochemistry in nerve cells and so could affect the integrity and physiology of 
nerve cells (S. Y. Kim et al., 2007; H. G. Lee et al., 2007). TCDD has also been 
shown to affect signaling pathways that regulate nitric oxide synthesis in neural 
and glial cells, leading to neurotoxicity, senescence, and cell death (Duan et al., 
2014; Jiang et al., 2014; Y. Li et al., 2013; Nie et al., 2015; Wan et al., 2014). 
Pellacani et al. (2014) found that PCB 126 reduced neuroblastoma cell viability. 
Zhao et al. (2016) exposed C6 glioma cell culture to TCDD and found dose- and 
time-dependent down-regulation of glutamate transporter-1 expression, which 
could contribute to neurotoxicity. Cytochrome P450 1A1, the aryl hydrocarbon 
receptor (AHR), and the AHR nuclear transporter occur in the brain, so TCDD 
may exert effects in the brain (P. Huang et al., 2000). In addition, earlier studies in 
hepatocytes indicated that 2,4-D affects aspects of mitochondrial energetics and 
mitochondrial calcium flux (Palmeira et al., 1994a,b, 1995a,b); if these effects 
occur in mitochondria of nervous-system cells, the energy balance and energy 
pathways of cells in the nervous system could be affected and disrupt nervous 
system function. This is supported by the work of Morales-Hernández et al. 
(2012), which showed that TCDD in cultured neuronal cells induces cell death 
by the disruption of intracellular calcium levels.
Laboratory-based studies have emphasized the importance of alterations in 
neurotransmitter systems as potential mechanisms underlying TCDD-induced 
neurobehavioral disorders (Jiang et al., 2014; H. Q. Xie et al., 2013). Neuronal 
cultures treated with 2,4-D exhibited decreased neurite extension associated with 
intracellular changes, including a decrease in microtubules, the inhibition of the 
polymerization of tubulin, disorganization of the Golgi apparatus, and the inhibi-
tion of ganglioside synthesis (Rosso et al., 2000a,b). Those mechanisms are im-
portant for maintaining the connections among nerve cells, which are necessary 
for neuronal function and are involved in axon regeneration and recovery from 
peripheral neuropathy. Early animal experiments have demonstrated that TCDD 
treatments affect the fundamental molecular events that underlie the neurotrans-
mission initiated by calcium uptake (Hong et al., 1998). Mechanistic studies 
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have demonstrated that 2,4,5-T can alter cellular metabolism and the cholinergic 
transmission necessary for neuromuscular transmission (Sastry et al., 1997).
TCDD treatment of rats at doses that do not cause general systemic illness or 
wasting produces electric changes in peripheral nerves that are associated with al-
tered functions and pathologic findings that are characteristic of toxicant-induced 
axonal peripheral neuropathy (Grahmann et al., 1993; Grehl et al., 1993). In cul-
tured cells, Jung et al. (2009) explored the mechanism by which TCDD inhibits 
neurite outgrowth and found it to be associated with a reduction in glutaminase.
As discussed in Chapter 4, extrapolating observations of cells in culture or 
in animal models to humans is complicated by differences in sensitivity and sus-
ceptibility among animals, strains, and species; by the lack of strong evidence of 
organ-specific effects occurring consistently across species; and by differences in 
the route, dose, duration, and timing of chemical exposures. Thus, although the 
toxicologic observations themselves cannot establish a conclusion that the COIs 
produced neurotoxic effects in humans, they establish biologic plausibility and 
point to potential mechanisms that might have come into play.
NERVOUS SYSTEM DISORDERS REPORTED OVERALL
The literature search for this update identified publications on populations 
with relevant exposures that examined overall mortality from any nervous system 
disorder (Collins et al., 2016) or hospitalization, again with all nervous system 
disorders combined, except epilepsy which was presented separately (Cox et 
al., 2015). However, while the results of grouping all nervous system disorders 
together are presented, they are not considered informative for assessing whether 
specific nervous system disorders may be due to an exposure to the COIs. There-
fore, such results were not considered by the committee when weighing the 
evidence for specific conclusions.
Cox et al. (2015) used hospital discharge records from 1988 to 2009 to report 
the prevalent health conditions among a cohort of 2,783 male New Zealand Viet-
nam veterans, who served during 1964 to 1972 and were presumed to be exposed 
to dioxin. For participants 30 years of age or older, person-years of follow-up were 
calculated by 5-year age categories. Age-specific hospitalization rates were calcu-
lated using the total number of annual hospitalizations published by the Ministry 
of Health and the average annual resident population. Standardized hospitalization 
rates were calculated for both the veteran cohort and the general population, and 
from these estimates a standardized hospitalization ratio (SHR) was calculated 
with 99% confidence limits as a means to address multiple tests performed for 
various outcomes. Results were presented for eight categories of mental and neu-
rologic disorders and a ninth category for “other nervous disorders.” Statistically 
significant increases in the hospitalization rates were observed for alcohol-related 
disorders (n = 89; SHR = 1.91, 99% confidence interval [CI] 1.39–2.43), which 
the authors note was often associated with PTSD, and other nervous disorders 
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(n = 135; SHR = 1.32, 99% CI 1.02–1.61). “Other nervous disorder” was the 
largest single category among mental and neurologic disorders, but it was unclear 
which disorders were included in that category with the exception of those disor-
ders listed under the general category of mental and neurological disorders; by a 
process of elimination, this category also likely included PD and ALS. However, 
hospitalization rates are not a good measure of PD and several other neurologic 
disorders because people with those conditions are not necessarily hospitalized 
for the symptoms. No difference in the hospitalization rates was seen for the 
category of “senility or organic mental illness” (n = 28; SHR = 0.95, 99% CI = 
0.49–1.41); the authors do not list specific neurologic disorders of interest, and 
senility may have included both vascular and non-vascular or Alzheimer-like de-
mentia. Overall, the results of this study for hospital admissions due to all causes 
combined showed a small increase in rates for Vietnam veterans compared with 
the population of New Zealand. However, exposure to the COIs was not validated 
through serum measurements, and the study did not control for smoking or eth-
nicity or other potentially important risk factors.
Collins et al. (2016) provides additional follow-up time to a retrospective 
analysis of a cohort of 2,192 workers (only 5 of whom were female) exposed to 
dioxins during trichlorophenol (TCP) and pentachlorophenol (PCP) production at 
a chemical manufacturing plant in Michigan. The U.S. population was used as the 
comparator to generate standardized mortality ratios. Work history records were 
used to determine the length of exposure. Serum samples to measure the levels of 
six types of dioxins were collected for 431 workers who had been exposed to TCP 
or PCP. Historic concentrations for each dioxin congener were calculated from 
the median concentrations of serum samples and the known half-lives associated 
with each congener. A job-exposure matrix was created for both the TCP and the 
PCP production facilities based on measured concentrations for workers in dif-
ferent jobs. A pharmacokinetic model was applied to job-specific concentrations 
and with the work history of each member of the study group to estimate each 
worker’s time-dependent serum concentration profiles for each dioxin congener 
(i.e., TCDD as well as Hexa-CDD, Hepta-CDD, and Octa-CDD). Complete 
vital status follow-up through December 2011 was achieved for the cohort, and 
there were 1,198 decedents through the entire study period (1979–2011); 1,615 
deaths were among TCP workers and 773 deaths occurred among PCP workers 
(196 workers were exposed to both TCP and PCP and are counted in each of 
those groups). Compared with the U.S. population, no difference in mortality 
from all diseases of the nervous system was found for all workers (n = 21; SMR 
= 0.74, 95% CI 0.46–1.13), and the SMRs were identical for TCP workers (n = 
17; SMR = 0.79, 95% CI 0.46–1.26) and PCP workers (n = 7; SMR = 0.79, 95% 
CI 0.32–1.63).
A second occupational study reported on pesticide applicators from Argentina 
who completed a questionnaire to document self-reported use of pesticides 
and general symptoms or consultations (signs of irritation, fatigue/tiredness, 
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headache, nervousness or depression, medical consultation, and hospitalization) 
(Butinof et al., 2015). Included among the pesticides were the herbicides 2,4-D, 
dicamba, and picloram—three of the COIs for Vietnam veterans. The percentage 
of completed questionnaires indicating the use of 2,4-D was 93.5%, with lower 
percentages for dicamba (69.4%) and picloram (46.0%). However, the survey 
respondents reported the use of 11 different pesticides on average, and effect 
estimates were based on grouped exposures or did not report any of the COIs 
separately, making this analysis of little utility for the purposes of the committee.
NEUROBEHAVIORAL, COGNITIVE, AND 
NEUROPSYCHIATRIC DISORDERS
This section summarizes the findings of VAO and previous updates on neuro-
behavioral disorders and incorporates information published since Update 2014 
into the evidence database.
Conclusions from VAO and Previous Updates
On the basis of the data available at the time, the committees responsible 
for VAO and all subsequent updates through Update 2014 concluded that there 
was inadequate or insufficient evidence to determine whether there is an associa-
tion between exposure to the COIs and neurobehavioral disorders. The data that 
informed that conclusion were mostly from the Air Force Health Study (AFHS, 
1991a,b, 1995, 2000; Barrett et al., 2001, 2003). Urban et al. (2007) confirmed 
that acute neurologic symptoms experienced shortly after an acute exposure to 
TCDD could be sustained more than 30 years after the exposure, but this study 
did not address delayed effects. In general, many of the studies reviewed by 
previous VAO Updates were found to be methodologically flawed (Dahlgren 
et al., 2003; Pazderova-Vejlupkova et al., 1981; Pelclová et al., 2001, 2002) or 
uninformative (ADVA, 2005c; Decoufle et al., 1992; Kamel et al., 2007a; R. M. 
Park et al., 2005; Sapbamrer and Nata, 2014; Solomon et al., 2007; Visintainer 
et al., 1995). Difficulties in case identification and diagnosis, misclassification of 
exposures because of a lack of quantitative measures, subject ascertainment and 
selection bias, and uncontrolled confounding from many comorbid conditions are 
common weaknesses in the studies reviewed. The variability of the test results 
over time, the weak and inconsistent associations, and a lack of consistent dose–
response relationships, also prevent those studies from supporting an association 
between the exposures of interest and neurobehavioral disorders.
More recent analyses using National Health and Nutrition Examination Sur-
vey (NHANES) data found no overall association between serum concentrations 
of PCBs with dioxin-like activity (mono-ortho PCBs 118 and 156 and non-ortho 
PCBs 126 and 169) and cognitive function scores in 708 adults aged 60–84 years, 
but a subgroup analysis demonstrated lower cognition with increasing serum 
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concentrations of dioxin-like PCBs (mono-ortho and non-ortho substituted PCBs) 
(Bouchard et al., 2014). Also using NHANES data, Krieg (2013) performed a 
limited assessment of cognition in 700 adults, aged 20–59 years, and associated 
scores with 12 pesticide metabolites measured in the urine of subjects, including 
two chemicals found in the urine after 2,4-D exposure: unmetabolized 2,4-D and 
2,4-dichlorophenol. No urinary marker of 2,4-D was associated with any deficit 
in any of the domains of neurobehavior that were tested. In contrast, increased 
urine levels of the trace metabolite 2,4-dichlorophenol were associated with an 
improved performance on the serial digit learning test (p = 0.0002).
Update of the Epidemiologic Literature
Since Update 2014, no new studies of Vietnam veterans or case-control 
studies that examined neurobehavioral, cognitive, or neuropsychiatric outcomes 
in relation to exposure to the COIs have been published.
Occupational Studies
In a study of workers exposed to PCBs from the Dortmund transformer 
and capacitor recycling plant in Germany, Fimm et al. (2017) examined a broad 
range of cognitive functions covering attention, executive processing, reasoning, 
memory, and motor performance. The cohort consisted of 237 individuals, half 
of whom were workers, and the other half were family members of the workers, 
employees of surrounding companies, and area residents. The mean age was 44 
years, and 17% had completed high school, that is, 12–13 years of education, with 
the vast majority having completed 8–10 years and a few having completed less 
than 8 years of education. Subjects were excluded primarily for lack of German 
fluency, leading to 187 individuals with complete data on the neuropsychological 
battery. Blood plasma PCB levels were determined and analyzed as three mutu-
ally exclusive classes: low chlorinated (PCB 28, 52, 101), high chlorinated (PCB 
138, 153, 180), and dioxin-like PCBs, which included mono- and non-ortho 
PCBs. However, fewer than 10% of the participants had detectable levels (limit 
of detection = 0.01 ug/L blood plasma) of the non-ortho (coplanar) PCBs (77, 
81, 126, and 169), and hence these PCBs were excluded from the analysis, leav-
ing the mono-ortho PCBs 105, 114, 118, 123, 156, 157, 167, and 189. Exposure 
was dichotomized into high and low, with the 95th percentile for each congener 
serving as the cutpoint. For each class (low, high, and dioxin-like), an individual 
was placed in the high category if his or her level of at least one congener in 
that class was elevated. With this definition, 72% of the original 237 people 
were classified as having high dioxin-like PCB exposure, though many of them 
also had high exposures to low- or high-chlorinated PCBs, or both. Forty of 
the participants had elevated levels for all of the dioxin-like PCB congeners. A 
structural equations model was fit to identify correlations among the various tests 
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and PCB burdens. In multiple linear regression models, adjusting for education, 
dioxin-like PCBs showed no associations with any of the cognitive (vocabulary 
and other achievement, non-verbal reasoning), visuo-spatial processing, word flu-
ency, flexibility, verbal and visual memory, nonverbal (geometric) learning, and 
several tests of attention and alertness. However, in the four sensorimotor tasks 
designed to assess fine motor coordination and the precision of arm/hand move-
ment, dioxin-like PCBs were associated with poorer line tracking; specifically, 
a significant decrease (β = –0.206, p = 0.002) in performance on this test of fine 
motor control was associated with a 10-fold increase in the sum of 8 dioxin-like 
PCBs. The high-chlorinated PCBs were associated with poorer aiming, another 
fine motor task; in contrast, the low-chlorinated PCBs were associated with re-
duced scores on verbal tests.
Environmental Studies
Przybyla et al. (2017) conducted an analysis of the associations of whole-
blood concentrations of four dioxin-like PCBs (118, 126, 156, and 169), six non-
dioxin-like PCBs, and two metals (lead and cadmium) with cognitive impairment 
in adults aged 60–84 years as measured by the Digit Symbol Coding Test of the 
Wechsler Adult Intelligence Scale. The study sample consisted of 498 men and 
women who participated in the 1999–2000 and 2001–2002 cycles of NHANES 
and had not had a stroke. The final model included only those five neurotoxins 
(including PCB 118) that were significantly (p ≤ 0.05) associated with cognitive 
functioning. Estimates were adjusted for poverty–income ratio, education, race, 
age, sex, and smoking status. Lower cognitive scores were found for older adults 
who had higher concentrations of PCB 146 (β = −0.16, 95% CI −0.29− –0.02; 
p = 0.02), whereas higher scores were observed for increased concentrations of 
PCB 153, both of these being non-dioxin-like PCBs. Lower cognitive scores 
were also found for older adults who had higher concentrations of PCB 118, but 
the association was not statistically significant (β = −0.06, 95% CI −0.20–0.08; 
p = 0.41). The results are difficult to interpret because PCBs are generally 
strongly correlated with one another (the substantial change in the beta coefficient 
comparing the fully adjusted model with the model with only the single PCB 153 
provides evidence of such correlations in these data). Adjusting the model for 
highly correlated variables can introduce a large bias in a non-predictable direc-
tion. Thus, it is difficult to interpret the findings of this study, although it should 
be noted that the cross-sectional nature is not a weakness, given that the half-lives 
of these compounds are generally a decade or longer.
Ames et al. (2018) reported on neurocognitive and physical functioning in 
the Seveso Women’s Health Study, which enrolled women who were between 
newborn and 40 years of age at the time of the explosion of the Seveso chemical 
plant in 1976 and who lived in the two closer exposure zones (A and B). The 
women were evaluated for their physical function in 1996 (n = 154) and with 
Veterans and Agent Orange: Update 11 (2018)
Copyright National Academy of Sciences. All rights reserved.
442 VETERANS AND AGENT ORANGE: UPDATE 11
neurocognitive tests in 2008 (n = 459). All the women assessed for physical func-
tion were post-menarche at the time of the explosion and post-menopausal at the 
time of testing. Archived serum samples collected in 1976 that were stored at 
−20° C were used for an analysis of TCDD. Serum TCDD levels were reported in 
pg/g lipid or parts per trillion. The physical function tests were a 10-foot walking 
test of functional mobility, a coin-flipping test of manual dexterity, a grip strength 
test, and a reach down test of lower-body mobility. Working memory was as-
sessed on the Wechsler Adult Intelligence Scale digit span and spatial span tests, 
each with both backward and forward tests. Multiple linear regression models 
were used to assess the dose–response relationship between TCDD concentration 
and the outcomes of interest, with a squared term to assess consistency with a 
linear relationship; they also conducted further sensitivity analyses using semi-
parametric methods to make fewer assumptions about functional forms. The po-
tential confounding variables included educational attainment, smoking, alcohol 
consumption, age at interview, age at explosion, menarche status at explosion, 
menopause status (pre versus post) at interview (> 12 months without a menstrual 
cycle or surgical menopause), body mass index (BMI) category (referent: BMI 
< 25 kg/m2, overweight: BMI ≥ 25 kg/m2 and < 30 kg/m2, and obese: BM ≥ 30 
kg/m2), and marital status. Directed acyclic graphs were used to inform covari-
ate selection into the initial adjusted model, which was pared down following 
a change-in-estimate approach, retaining variables if their exclusion caused > 
10% change in the TCDD coefficient. Results showed that serum TCDD was 
not associated with walking speed, upper-body mobility, or manual dexterity 
(p > 0.05 for these outcomes). An inverted U-shaped association was observed 
for grip strength, with poorer strength at both lowest and highest TCDD expo-
sure levels, with significance for both the linear and quadratic terms in the non- 
dominant arm, and borderline significance in the dominant arm.1 There was no 
association between TCDD and the Wechsler digit and spatial span tests (p > 0.05). 
Neither menopause status at assessment nor age at exposure modified the as-
sociations between TCDD and working memory, that is, the lack of association 
was observed in both the pre- and post-menopausal women and at all ages of 
exposure following the Seveso explosion.
1 p = 0.01 for both linear (positive) and quadratic (negative) beta coefficients in the non-dominant 
arm; in the dominant arm, p-values were reported as < 0.05 for both the linear and quadratic terms 
in the table of the paper, but 0.07 and 0.08, respectively, in the figure; this discrepancy was due to 
use of the robust variance estimates for the figure but not the table (personal communication with the 
first author, Jennifer Ames).
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Other Identified Studies
One additional study in this area was identified by the committee, but it 
examined biologic markers of effect of neurotransmission pathways that do not 
relate to a diagnosable health outcome, and therefore it was given limited con-
sideration. Putschogl et al. (2015) used health information and blood and urine 
samples collected from people who either worked at a transformer and capacitor 
recycling plant in Dortmund, Germany, or else who lived in the immediate area 
and might have been exposed to dioxin-like (PCBs 105, 114, 118, 156, 157, 167, 
and 189) and non-dioxin-like PCBs as a result of contamination of the area by 
the facility. The focus of the study was on determining associations with neu-
rotransmitter metabolites for dopamine (homovanillin acid) and norepinephrine 
(vanillylmandelic acid) in urine as markers of targeted effects on these specific 
neurotransmission pathways. All 13 dioxin-like and non-dioxin-like PCB conge-
ners examined were significantly associated with lower urinary metabolite levels 
of homovanillin acid after adjustment for creatinine. Moreover, highly chlori-
nated congeners were more strongly associated with increased concentration of 
homovanillin acid but significantly reduced concentration of vanillylmandelic 
acid, after adjustment for creatinine. These metabolites, however, are not specific 
to neuronal sources, as the dietary consumption of foods with high monoamine 
content (e.g., cheese, orange juice, and bananas) can also contribute to homova-
nillin. Only 12% of peripheral homovanillin acid derives from the brain, and 
vanillylmandelic acid is heavily influenced by hepatic function. Neither informa-
tion on diet nor diagnoses of hypertension were collected, which may confound 
the association. Nevertheless, these measured metabolites are a poor indicator of 
CNS neurotransmission, and the problems with the overall design and analysis of 
the study (detailed in Chapter 5) seriously limit its contribution to the scientific 
evidence on effects of exposure to the COIs.
Biologic Plausibility
Some toxicologic studies have suggested a possible involvement of the COIs 
in the occurrence of neurobehavioral effects. Akahoshi et al. (2009) produced a 
mouse neuroblastoma cell line that overexpressed the Ahr, a TCDD-induced pro-
tein hypothesized to be important in the synthesis of dopamine, whose perturba-
tion has been implicated in a number of neurobehavioral syndromes. An elevated 
expression of Ahr in these cells was associated with an increased production 
of neurotransmitters and augmented dopamine expression, but the implication 
of that finding is not clear. In vitro exposure of human CD34+ cells to TCDD 
has been associated with a modulation of gene expression of the GABAergic 
pathway, which may be associated with altered synaptic transmission, visual 
perception, and other neurologic conditions (Fracchiolla et al., 2011). Lensu 
et al. (2006) treated rats with 50 μg/kg TCDD or with leptin, a chemical with 
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well-recognized effects on food consumption. When certain brain areas of the 
two treated animal groups were compared 24 hours later, the results were not 
consistent with a primary role for the hypothalamus brain region in TCDD-
induced wasting syndrome.
Synthesis
There is not consistent epidemiologic evidence of an association between 
exposure to the COIs and neurobehavioral or cognitive disorders. One occu-
pational study (Fimm et al., 2017) and two environmental studies (Ames et al., 
2018; Przybyla et al., 2017) examined an array of neurocognitive tests, and none 
showed evidence of deficits in cognitive function or attention or alertness. An 
analysis of the Seveso Women’s Health Study cohort found reductions in grip 
strength, one of four measures of motor function (Ames et al., 2018). More re-
search on the COIs and these endpoints may be warranted, especially for adverse 
effects of the COIs on motor function.
Conclusion
On the basis of the evidence reviewed here and in previous VAO reports, 
the committee concludes that there is inadequate or insufficient evidence to 
determine whether there is an association between exposure to the COIs and 
neurobehavioral (cognitive or neuropsychiatric) disorders.
NEURODEGENERATIVE DISEASES
This section summarizes the findings on neurodegenerative diseases— 
specifically PD, ALS, and AD—discussed in previous VAO reports. While mul-
tiple sclerosis would also be considered in this section, until Update 2014 no 
published epidemiologic studies for it in relation to exposure to the COIs were 
identified. A publication by H. K. Kang et al. (2014a) found an elevated risk of 
death from multiple sclerosis among female Vietnam-era veterans; however, the 
estimate was imprecise due to the small number of cases. Among Korean veter-
ans, Yi et al. (2014a) found no association between prevalent multiple sclerosis 
and herbicide exposure, but this very large study with substantial statistical power 
did identify associations for a number of neurological conditions (paroxysmal 
disorders, nerve/plexus disorders, and paralytic syndromes), which are also con-
siderably more specific than the outcomes evaluated in previous VAO updates.
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Parkinson Disease and Parkinsonism
PD is a progressive neurodegenerative disorder that affects an estimated 
6.3 million people worldwide (EBC, 2018), and it is the second-most common 
neurodegenerative disease (after AD). Its primary clinical manifestations are bra-
dykinesia, resting tremor, cogwheel rigidity, and gait instability. These signs were 
first described as a single entity in 1817 by James Parkinson. Many non-motor 
manifestations of PD have been described, and they can precede the motor symp-
toms or present together with the motor symptoms of the disease. These include 
cognitive dysfunction that often progresses to frank dementia, sleep disturbances, 
hallucinations, psychosis, mood disorders, fatigue, and autonomic dysfunction 
affecting gastrointestinal, urinary, and heart function (Langston, 2006).
In the nearly two centuries since its initial description, much has been learned 
about some genetic predispositions and the pathophysiology of PD, but its etiol-
ogy in most patients remains largely unknown, with environmental risk factors 
being largely understudied. The diagnosis of PD is based primarily on a clinical 
examination, although in recent years magnetic resonance imaging and functional 
brain imaging have become increasingly useful. Idiopathic PD at its onset may be 
difficult to distinguish from a variety of Parkinsonian syndromes, including drug-
induced Parkinsonism, and neurodegenerative diseases, such as multiple systems 
atrophy, that present with Parkinsonian features but also develop additional brain 
abnormalities. Ultimately, a diagnosis of idiopathic PD can be confirmed with 
a postmortem pathology examination of brain tissue showing the characteristic 
loss of neurons from the substantia nigra and telltale protein aggregates known 
as Lewy body intracellular inclusions. Pathology findings in other forms of 
Parkinsonism show different patterns of brain injury and protein aggregation. 
Mortality and hospitalization records are systems with poor diagnostic standards 
for PD, and tend to under-report it. For example, on death records, PD is usually 
mentioned as a contributing cause instead of an underlying cause of death, and 
as such, leads to under-reporting. For PD, studies have shown that at best 60% 
of PD patients have PD mentioned on their death certificates (Benito-León et al., 
2014; Désesquelles et al., 2014; Moscovich et al., 2017). Hospitalizations for PD 
do not occur until very late in the disease process, if at all, and thus even though 
the accuracy of hospital records in terms of diagnosis might be better than death 
certificates, they may miss the less severe cases. However, unless the exposure 
also contributes to differential under-reporting of PD on death certificates or ad-
mission to hospitals (and there is no obvious reason why this would be the case, 
unless exposed subjects are followed for disease more carefully by their health 
care system) one would expect disease misclassification to be non-differential. 
Therefore, as long as the specificity of the diagnosis is close to perfect (those who 
are listed as PD truly have the disease, which is what would be expected from 
death certificates and hospital records) the effect estimate would not be biased. 
Although the gold standard of diagnosis is pathology of the protein aggregates 
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in the brain (Lewy-bodies), this standard is rarely, if ever, achieved in an epide-
miologic investigation due to the low rate of autopsies or brain collection. On the 
other hand, the longer the disease durations, the more likely it is that the diagnosis 
is accurate (Adler et al., 2014; Wermuth et al., 2012, 2015). Diagnosis is more 
accurate for patients who develop PD when they are younger than 80 years, and 
the youngest onset patients are likely the most accurately diagnosed. Clinical ac-
curacy also is much higher if patients are diagnosed in specialty clinics of tertiary 
care facilities (by movement disorder specialists).
Several studies have attempted to estimate the incidence and prevalence of 
PD, but methodological differences among the studies make direct comparisons 
of such estimates difficult. Overall prevalence estimates of PD range from 100 
to 200 per 100,000 people (von Campenhausen et al., 2005), but a recent meta-
analysis of 47 studies published between 1985 and 2014 estimated an overall 
PD prevalence of 315 (95% CI 113–873) per 100,000 people (Pringsheim et 
al., 2014). Restricting the analysis to the highest-quality studies, the estimated 
prevalence was 571 (95% CI 243–1,339) per 100,000 people, and the authors 
suggested that higher-quality studies may provide a more precise estimate of 
disease prevalence. Stratifying on age, the prevalence estimates clearly increase 
with increasing age: 41 per 100,000 in individuals 40–49 years; 107 per 100,000 
in individuals 50–59 years; 428 per 100,000 in individuals 60–69 years; 1,087 per 
100,000 in individuals 70–79 years; and 1,903 per 100,000 in individuals over 
age 80 years (Pringsheim et al., 2014). Meta-analyses and other data summaries 
suggest a slight male preponderance in the incidence and prevalence of PD, with 
PD starting earlier in men (Georgiev et al., 2017).
Similarly, the estimates of PD incidence in published studies vary consider-
ably, possibly because of methodological differences in case ascertainment and 
in which diagnostic criteria were applied. In a 2017 review, Tysnes and Storstein 
(2017) estimated that the annual incidence of PD per 100,000 inhabitants ranges 
from less than 10 to more than 20. A meta-analysis by age group and sex found 
that males had a higher incidence of PD in all age groups and that the overall inci-
dence rate of PD for people 40 years and older was 37.55 per 100,000 person-years 
(95% CI 26.20–53.83) for females compared with 61.21 (95% CI 43.57–85.99) 
in males (Hirsch et al., 2016). The incidence rate for both males and females 
increases with age. For females the incidence rates by age group were calculated 
as: 3.26 per 100,000 in individuals 40–49 years, 8.43 per 100,000 in individuals 
50–59 years, 30.32 per 100,000 in individuals 60–69 years, 93.32 per 100,000 in 
individuals 70–79 years, and 103.48 per 100,000 in individuals over age 80 years. 
For males, the incidence rates by age group were: 3.57 per 100,000 in individuals 
40–49 years, 14.67 per 100,000 in individuals 50–59 years, 58.22 per 100,000 
in individuals 60–69 years, 162.58 per 100,000 in individuals 70–79 years, and 
258.47 per 100,000 in individuals over age 80 years.
Research on the genetic, epigenetic, and environmental causes of PD sug-
gests multiple risk factors, including aging, environmental exposure, and genetic 
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predisposition (Gao and Hong, 2011; Kwok, 2010). The peak incidence and preva-
lence of PD are consistently found in people 60–80 years of age. A consensus state-
ment from a 2007 meeting of PD experts (Bronstein et al., 2009) concluded that, in 
addition to firm evidence that the toxicant 1-methyl-4-phenyl-1,2,4,6-tetrahydropyr-
idine (MPTP) can induce PD, there is substantial evidence that men are at greater risk 
than women, while smoking and coffee consumption are associated with a reduced 
risk. Of note, it has been proposed that the latter factors—especially smoking—may 
not be protective but rather a case of reverse causation (Ritz et al., 2014). Specifically, the 
higher rate of quitting smoking and reduction in caffeine intake observed among 
PD patients may be prodromal behavior changes in the long premotor phase of PD 
when many non-motor symptoms occur, such as the loss of smell, digestive prob-
lems, and sleep disturbances. Further evidence of environmental exposures playing 
a role in the development of PD has continued to accrue (Chin-Chan et al., 2015; 
Mostafalou and Abdollahi, 2017; Ritz et al., 2016; Tanner et al., 2014).
Heredity has long been suspected as an important risk factor for PD. Although 
risk estimates of PD for first-degree relatives of a person with PD vary from study 
to study and from country to country, among large studies in the United States 
first-degree relatives of an affected individual are 2.7–3.5 times more likely to 
develop PD than an individual without a family history of it. For these first-degree 
relatives, the cumulative lifetime risk of developing PD is between 3% and 7% 
(Farlow et al., 2014). An estimated 5–10% of people with PD have monogenic 
forms of it, which exhibit a classical Mendelian type of inheritance, but the ma-
jority of PD cases are sporadic (Kalinderi et al., 2016). All known monogenic 
forms of PD combined explain only about 30% of familial and 3–5% of sporadic 
cases (K. R. Kumar et al. 2011). At least 13 gene mutations have been identified 
in autosomal dominant PD, including mutations in parkin and α-synuclein (Klein 
and Lohmann-Hedrich, 2007). Mutations associated with an autosomal recessive 
inheritance pattern have also been described; however, these disease genes are 
found in only a handful of familial cases worldwide. More complex genetics that 
act to increase susceptibility to PD in conjunction with environmental risk factors 
may play a much more important role, and this has been the focus of much study 
in the recent decade (Ritz et al., 2016, 2017).
Conclusions from VAO and Previous Updates
The committees responsible for VAO, Update 1996, Update 1998, Update 
2000, Update 2002, Update 2004, and Update 2006 all concluded that there was 
inadequate or insufficient information to determine whether there is an associa-
tion between exposure to the COIs and PD. Five case-control studies reviewed by 
those committees had investigated the association between PD and “herbicide” 
exposure without providing further specificity and had reported mixed findings.
Two studies reviewed in Update 2008 examined the association specifically 
with chlorophenoxy acid and ester herbicides and found increased odds ratios 
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(Brighina et al., 2008; Hancock et al., 2008). The doubling in risk observed by 
Hancock et al. (2008), however, did not achieve formal statistical significance. 
Increases in the PD risk for the chemical class of chlorophenoxy acids or ester 
herbicides were reported by Brighina et al. (2008) in that patients with PD were 
52% more likely than control subjects to have used these pesticides. In the Agri-
cultural Health Study (AHS), incident PD was related in a dose–response manner 
to increasing days of pesticide use in general (Kamel et al., 2007b). In analyses of 
single pesticide exposures, 2,4-D did not increase PD incidence risk, but 2,4,5-T 
exposures did increase risk by 80% in adjusted hierarchical logistic regression 
models. On the basis of that evidence, the committee for Update 2008 concluded 
that there was limited or suggestive evidence associating exposure to the COIs 
with PD. Additional studies considered by the committees responsible for Update 
2010 and Update 2012 led them to affirm this conclusion.
The committee responsible for Update 2014 was charged specifically with 
determining whether various diagnoses with Parkinsonian symptoms should be 
included in the presumptive service-related category for PD. Because diagnostic 
specificity is improbable in both the studies on which the conclusion of limited 
or suggestive association with exposure to military herbicides was based and in 
the documentation for the claims submitted to the Department of Veterans Affairs 
(VA) by Vietnam veterans, the committee clarified that the finding for PD should 
be interpreted by VA to include all diseases with Parkinson-like symptoms unless 
those symptoms can be definitively shown to be secondary to an external agent 
other than the herbicides sprayed in Vietnam.
Update 2014 included three studies of Vietnam veterans: one U.S. and two 
from the Korean Veterans Health Study. Among three cohorts of U.S. Vietnam-
era military women—4,734 deployed to the theater of the war, 2,062 who served 
in countries near Vietnam, and 5,313 who were not deployed and served primarily 
in the United States—PD mortality, adjusted for age, race, duration of military 
service, officer status, and nursing status, was not different in those deployed 
to Vietnam from the non-deployed cohort, and there was no suggestion of an 
increase when this comparison was made for the subsets of only nurses (H. 
K. Kang et al., 2014a). In the Korean Veterans Health Study, 180,639 Korean 
veterans were followed for vital status and cause of death (Yi et al., 2014b). An 
exposure opportunity index (EOI) score was assigned to each veteran based on 
the proximity of his unit to the herbicide-sprayed areas. No association was found 
between PD mortality and the individual EOI scores or when the high-exposure 
group was compared with the low-exposure group. A second analysis compared 
the high- and low-exposure groups with respect to the prevalence of primary 
PD (International Classification of Diseases, 10th Revision [ICD-10] G20) and 
secondary Parkinsonism (ICD-10 G21). Effect estimates that were adjusted for 
age, rank, smoking, drinking, physical activity, the domestic use of herbicides, 
education, income, and BMI were less suggestive of an association with herbicide 
exposure than were the unadjusted results (Yi et al., 2014a).
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Environmental (Weisskopf et al., 2012) and occupational (van der Mark et 
al., 2014) exposure studies reviewed in Update 2014 did not support a statistically 
significant association between exposure to the COIs and PD.
Update of the Epidemiologic Literature
One new study of Parkinson disease or Parkinsonism among Korean veter-
ans who served in Vietnam was identified. No other studies of populations that 
specifically assessed exposure to the COIs have been published since Update 
2014. Table 39, which can be found at www.nap.edu/catalog/25137, summarizes 
the results of studies related to Parkinson disease and Parkinson-like conditions.
Vietnam-Veteran Studies Y. S. Yang (2016) conducted an analysis of the ef-
fect of exposure to Agent Orange on Korean veterans who served in Vietnam 
and had been diagnosed with PD. The study consisted of 143 PD patients with 
exposure and 500 PD patients without exposure to Agent Orange, as determined 
by self-report and a military record–verified “perceived exposure index.” Com-
paring these patients’ clinical characteristics and their radiolabeled 18F-FP-CIT 
PET uptake, this study found differences in clinical profile (p < 0.05) using motor 
subscales from the Unified Parkinson’s Disease Rating Scale III: tremor at rest, 
rigidity, finger taps, and rapid alternating movement. Findings from the use of 
FP-CIT PET showed lower uptake in basal ganglia and higher asymmetry in ex-
posed (p < 0.05) versus unexposed patients. The authors suggested the possibility 
that the PD in patients exposed to Agent Orange has a different pathophysiology 
from idiopathic PD.
Other Identified Studies The committee identified several additional studies 
that examined PD mortality or prevalence among occupational cohorts or in dif-
ferent populations with environmental exposures. However, each of them lacked 
the necessary exposure specificity to be considered further as contributing to the 
evidence base of the potential effect of the COIs. For example, although Ruder 
et al. (2014) examined U.S. workers exposed to mixed PCBs, the specific dioxin-
like PCBs were not investigated separately, and no TEQs or other quantification 
of relevant exposures was presented. Likewise, a case-control study of clinically 
confirmed PD among French male farmers assessed occupational pesticide and 
herbicide use, duration, intensity, and cumulative exposure but did not report the 
specific chemicals or classes (Moisan et al., 2015). Two environmental studies 
were also identified—one among the residents of rural central California (Narayan 
et al., 2015) and the other conducted in the Netherlands (Brouwer et al., 2015), 
but neither specified the herbicides used in enough detail or used objective mea-
sures of exposure, such as serum concentrations, to contribute to the evidence 
base of exposure to the COIs and PD.
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Biologic Plausibility
McDowell and Chesselet (2012) reviewed the literature on the ability of both 
toxicant-induced (6-hydroxydopamine, MPTP, rotenone, cycad) and genetically 
based animal models to reproduce the non-motor symptoms of PD. The very clear 
PD-like toxicity resulting from human exposure to MPTP indicates that select 
chemicals can produce the same type of damage to dopaminergic neurons as oc-
curs in classical PD, and MPTP has become an important toxicant in studies that 
use animal and in vitro models. It is notable that MPTP’s bioactive metabolite, 
MPP+, is similar in chemical structure to paraquat (a commonly used herbicide, 
but not one that was used in Vietnam), but structurally unrelated to any of this 
report’s COIs. Pesticides shown to produce PD-like toxicity in animal models in-
clude paraquat, rotenone, maneb, and dieldrin. Substantial research has gone into 
understanding the molecular mechanisms responsible for the toxicity, especially 
in connection with paraquat and rotenone (Blandini and Armentero, 2012; Di 
Monte et al., 2002; Drechsel and Patel, 2008; Duty and Jenner, 2011; Hatcher et 
al., 2008; Moretto and Colosio, 2013; Nunomura et al., 2007; Sherer et al., 2002; 
Yadav et al., 2012). The damage done to dopaminergic neurons in PD is probably 
caused by oxidative stress and inflammation and may well also involve damage 
to the mitochondria in the target cells (Anderson and Maes, 2014: Janda et al., 
2012; Liang et al., 2007; Littleljohn et al., 2011; Sarnico et al., 2008).
The COIs are known to be distributed to the CNS. Cholanians et al. (2016) 
showed that arsenic exposure leads to an accumulation of α-synuclein in both 
cultured cells and adult rats. The accumulation of α-synuclein plays a key role 
in the pathogenesis of PD, suggesting that exposure to arsenical herbicides may 
have an influence on PD progression. Bongiovanni et al. (2007) found that rat 
cerebellar granule cells in culture (an in vitro model using cells not involved in 
PD pathology) produce increased concentrations of reactive oxygen species when 
exposed to 2,4-D. González-Barbosa et al. (2017) showed that TCDD exposure 
causes dysregulation of the UbcH7–parkin complex in the ventral midbrain of 
the mouse, but further studies are needed to characterize the consequences for 
dopaminergic cells. The COIs have not been investigated in experimental systems 
such as those that have shown that paraquat and other compounds cause inflam-
mation and oxidative stress, so it is not known whether any of the COIs could 
produce these responses.
Research on the neurotoxicity of 2,4-D has been going on for a number of 
years, but most of it has focused on its effects on the developing rodent nervous 
system. The studies have often used high doses of 2,4-D that have resulted in 
adverse changes in the developing nervous system—both neurochemical (such as 
changes in D2 receptors, tyrosine hydroxylase, and dopamine beta-hydroxylase) 
and behavioral (for example, Bortolozzi et al., 1999, 2002, 2003, 2004; Duffard 
et al., 1996; Evangelista de Duffard et al., 1990, 1995; Garcia et al., 2004, 2006; 
Rosso et al., 2000a,b). The injection of 2,4-D directly into the rat brain results in 
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toxicity in the basal ganglia (Bortolozzi et al., 2001), but this route of adminis-
tration is highly artificial. The postpartum dietary exposure of females to 2,4-D 
results in adverse alterations in maternal behavior and neurochemical changes, 
including increases in dopamine and its metabolites 3,4-dihydroxyphenylacetic 
acid and homovanillic acid (Stürtz et al., 2008). Such an increase in dopamine 
is the reverse of what is seen in PD, in which a degradation of the dopaminergic 
system occurs. In addition, a study of mice and 2,4-D yielded no evidence of 
neurochemical damage to the dopaminergic system (Thiffault et al., 2001). Be-
cause most of the studies were on the developing nervous system, not the mature 
nervous system, and some studies yielded evidence of a lack of a role of 2,4-D 
in the development of PD, the existing studies do not support a role for the COIs 
in the etiology of PD.
Synthesis
Previously reviewed studies of PD in Vietnam veterans have not shown 
increased mortality or incidence of PD in U.S. or Korean Vietnam veterans. One 
new epidemiologic study of PD in Korean veterans who served in Vietnam was 
identified. Findings from the study suggested the possibility of a different patho-
physiology for PD in patients exposed to Agent Orange than for idiopathic PD in 
terms of its clinical characteristics and brain ligand measures (fluororidopa PET). 
A biologic mechanism by which the COIs may cause PD has not been demon-
strated. Nevertheless, the overall epidemiologic evidence continues to support 
an association between herbicide exposure and PD and to be consistent with an 
association with exposure to the phenoxy herbicides specifically.
Conclusion
On the basis of the lack of new evidence reviewed here supporting or refut-
ing an association with PD, and given the evidence presented in previous VAO 
reports, the committee maintains the conclusion that there is limited or sugges-
tive evidence of an association between exposure to the COIs and PD, includ-
ing Parkinson-like conditions such as Parkinsonism, in the setting of dementia, 
multiple system atrophy, and progressive supranuclear palsy.
Amyotrophic Lateral Sclerosis
ALS is a progressive, adult-onset, motor neuron disease that presents with 
muscle atrophy, weakness, and fasciculations and with signs that indicate the in-
volvement of motor neuron pathways in the CNS. The incidence of sporadic ALS 
is 1–2 per 100,000 person-years, and it peaks at the ages of 55–75 years (Brooks, 
1996). The incidence of ALS in European populations is 2–3 people per 100,000 
person-years (Johnston et al., 2006). The diagnosis of ALS is made through 
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clinical examination and electrodiagnostic testing and has a high degree of accu-
racy when performed by experienced neurologists (Rowland, 1998; Rowland and 
Shneider, 2001). ALS is generally more common in men than in women by a 
factor ranging from 1.2 to 1.5, depending on the age group (Manjaly et al., 2010). 
Established risk factors to date are older age, male gender, and a family history 
of ALS (Couratier et al., 2016).
In most cases the cause of ALS is unknown, but about 5–10% of cases are 
recognized as resulting from the inheritance of autosomal dominant or recessive 
genes (Wood, 2014); 20% of familial-ALS patients have mutations in the gene 
that encodes for superoxide dismutase-1 (Rosen et al., 1993). Many other possi-
ble etiologic factors have been investigated (Breland and Currier, 1967; Gallagher 
and Sander, 1987; Hanisch et al., 1976; H. Kang et al., 2014b; Kurtzke and 
Beebe, 1980; Mitchell and Borasio, 2007; Roelofs-Iverson et al., 1984; Sutedja 
et al., 2009a,b; M. D. Wang et al., 2014), including military service (Weisskopf et 
al., 2005), but no conclusive evidence has been found of an association with any 
of the environmental exposures addressed. Pesticides have also been suggested as 
a risk factor for ALS, but the results of individual studies and meta-analyses have 
been mixed depending how exposure was defined, and herbicides were seldom 
specified and not reported as a separate category (Kamel et al., 2012; H. Kang 
et al., 2014b; Malek et al., 2012). H. Kang et al. (2014b) expanded inclusion 
criteria for their meta-analysis of pesticide exposures to include the occupation 
of “farmer” and a rural residence. Although some of the pesticide exposures in-
cluded herbicides, they were not reported as separate estimates, and thus although 
an increased risk of ALS was associated with pesticide exposure and with having 
an occupation of farmer, these results are of limited usefulness.
Conclusions of VAO and Previous Updates
ALS was first evaluated as a disease that might be associated with the COIs 
by the committee for Update 2002. Pesticide or herbicide exposure has been 
associated with an increased risk of ALS, including a doubling of the risk after 
long-term occupational exposure to pesticides (Deapen and Henderson, 1986) 
and a tripling after exposure to agricultural chemical products (Savettieri et al., 
1991) and herbicides (McGuire et al., 1997), but none of the risk estimates was 
statistically significant. A population-based case-control study demonstrated as-
sociations between an exposure to agricultural chemical products and ALS in 
men, with an OR of 2.4 and a trend with duration of exposure that were both 
statistically significant (McGuire et al., 1997). A mortality study of Dow Chemi-
cal Company employees exposed to 2,4-D found three deaths from ALS, which 
resulted in a statistically significant—but imprecise—positive association (C. J. 
Burns et al., 2001). Weisskopf et al. (2005) followed the vital status of subjects 
in the American Cancer Society’s cohort for the Cancer Prevention Study II and 
found an increased risk of ALS in those who served in any of the armed services 
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during times of conflict. They adjusted for a variety of confounding variables in 
their model, including exposure to herbicides, and found that none of them sig-
nificantly altered their conclusions; thus, this large study indirectly suggests the 
lack of a strong effect of herbicide exposure on ALS risk. A latter analysis of the 
American Cancer Society’s Cancer Prevention Study II also found no associa-
tion between self-reported pesticide or herbicide exposure and ALS, but the lack 
of exposure specificity and the possibility of exposure estimation error limit the 
weight of this evidence (Weisskopf et al., 2009). Malek et al. (2014) compared 
66 ALS patients to 66 controls, administering a questionnaire on occupational, 
vocational, and avocational exposures, and found self-reported pesticide exposure 
to be associated with ALS. The association was even stronger after controlling for 
smoking and education in a multivariate model but quite imprecise. Additional 
analyses conducted on occupational exposure to insecticides, to herbicides, or to 
fungicides and fumigants, individually, found no associations with ALS, but the 
sample sizes were very small. None of the results is based on sufficiently specific 
exposure metrics to be fully informative for VAO purposes.
Studies of veterans who served in Vietnam have reported weak and generally 
not statistically significant associations with the risk of ALS. A case-control study 
of Australian Vietnam veterans reported an association between deployment in 
Vietnam and ALS (ADVA, 2005c) but did not specifically study exposure to 
pesticides or herbicides. In the Korean Veterans Health Study, Yi et al. (2014b) 
calculated individual EOI scores based on the proximity of the veteran’s unit to 
given areas when herbicides were sprayed and partitioned the veterans into high- 
and low-exposure groups. No association was found between spinal muscular 
atrophy and the EOI scores or when the high-exposure group was compared with 
the low-exposure group. However, in the analysis of disease prevalence among 
the same Korean Vietnam veteran cohort, after adjusting for age, rank, smoking, 
drinking, physical activity, domestic use of herbicides, education, income, and 
BMI, Yi et al. (2014a) found the risk for spinal muscular atrophy to be slightly 
elevated in both the analysis of the scores comparing high- and low-exposure 
group and as a continuous variable. The more specific diagnosis of motor neuron 
disease (ICD-10 G12.2), which includes ALS, had nearly the same risk estimate, 
but because these cases represented only about one-third of those in the entire 
spinal muscular atrophy grouping, estimates were more imprecise.
Update of the Epidemiologic Literature
Two studies of ALS in Vietnam veterans and one case-control study of oc-
cupational exposures and environmental toxicants on the odds of developing ALS 
have been identified since Update 2014. Table 40, which can be found at www.
nap.edu/catalog/25137, summarizes the results of studies related to ALS.
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Vietnam-Veteran Studies Beard et al. (2016) used the National Registry of 
Veterans with ALS to identify medical record–confirmed ALS cases from 2005 
to 2010 for veterans who consented at the time of enrollment in the registry to 
participate in further studies. Controls were selected from the Veterans Benefits 
Administration’s Beneficiary Identification and Records Locator System data-
base. A total of 958 controls who were located, screened, and found to be eligible 
to participate were frequency-matched to 621 cases based on diagnosis age within 
5 years and on socioeconomic status, as roughly estimated by the veteran’s use 
of the VA health care system before the date of diagnosis. All participants were 
followed until 2013. Clinical characteristics were extracted from medical records, 
and standardized telephone interviews were used to collect self-reported infor-
mation on military service (branch of the longest service, number of branches, 
rank, the total service time, and the end of the most recent service), deployments 
(number; locations; time in theater; ever received imminent danger pay, hardship 
duty, or combat zone tax exclusion benefits for deployment to 17 foreign coun-
tries or five sea regions [plus fill-in options]), and exposures that occurred before 
the diagnosis date (cases) or the interview date (controls) as well as on potential 
confounders. Self-reported information on 39 specific military exposures was 
also collected, some of which were conflict-specific (e.g., Agent Orange expo-
sure during the Vietnam War). For 31 of 32 war-specific exposures, participants 
were asked whether they had ever been exposed, days exposed (not exposed, 
≤ 5, 6–30, > 30), and whether they felt ill after exposure (not exposed, no, yes). 
Inverse probability weighting was used to adjust for potential bias from con-
founding, missing covariate data, and selection arising from a case group that 
disproportionately included long-term survivors and a control group that may 
or may not have differed from U.S. military veterans at large. The study popula-
tion consisted of 302 cases and 3,793 veterans who were aged 18–25 years dur-
ing the Vietnam War. War-specific exposures for these veterans were analyzed 
separately, although the authors did not present all such results independently 
from the analysis that included all veterans and not all veterans served in that 
war. For those results presented, 58 cases and 77 controls reported exposure to 
Agent Orange in the field (OR = 2.80, 95% CI 1.44–5.44), and 8 cases and 13 
controls reported mixing and application of Agent Orange (OR = 1.15, 95% CI 
0.38–3.44). Vietnam veterans diagnosed with ALS reported greater exposure to 
pesticides on clothing or bedding (OR = 1.83; 95% CI 0.99–3.40). Overall, ALS 
was positively associated with an exposure to herbicides for military purposes, 
nasopharyngeal radium, personal pesticides, exhaust from heaters or generators, 
high-intensity radar waves, contaminated food, explosions within 1 mile, herbi-
cides in the field, mixing and application of burning agents, burning agents in the 
field, and Agent Orange in the field.
In a second study using the same registry population of ALS veteran cases, 
Beard et al. (2017) examined associations between military-related factors and 
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ALS survival. A total of 616 medical record–confirmed cases were followed from 
enrollment in the registry (2005–2010) until death or July 25, 2013, whichever 
came first. Vital status information was obtained from several sources within VA, 
and information regarding military service, deployments, and 39 related expo-
sures was collected from self-report via a standardized telephone interview (see 
details above in Beard et al. [2016]). Inverse probability weights were used to 
adjust for potential confounding and missing covariate data biases as well as to 
adjust for potential selection bias among a case group that included a dispropor-
tionate number of long-term survivors at enrollment. In the study population, 137 
veterans diagnosed with ALS had reported service in Vietnam. The war-specific 
exposures for these veterans were analyzed separately, although the authors did 
not present all such results independently from the analysis that included all 
veterans. A total of 446 deaths occurred during 24,267 person-months of follow-
up (median follow-up: 28 months). For exposures constrained to deployment in 
Vietnam, longer survival was associated with exposure to Agent Orange in the 
field (n = 39 deaths; hazard ratio [HR] = 0.66, 95% CI 0.42–1.05) and mixing 
and application of Agent Orange (n = 6 deaths; HR = 0.62, 95% CI 0.32–1.20); 
however neither exposure estimate is statistically significant.
Case-Control Studies F. C. Su et al. (2016) conducted a case-control study to 
evaluate the association of occupational exposures and environmental toxicants 
with the odds of developing ALS in Michigan. ALS cases (n = 156) with a diag-
nosis of definitive, probable, probable with laboratory support, or possible ALS by 
revised El Escorial criteria were recruited from a tertiary referral center for ALS. 
Controls (n = 128) were recruited from postings and the University of Michigan 
clinical research volunteer database and were excluded if they were diagnosed 
as having ALS or another neurodegenerative condition or if they had a family 
history of ALS in a first- or second-degree blood relative. Participants completed 
a self-administered written survey that collected information on demographics, 
occupational and residential exposures, military service, and smoking history. Spe-
cifically, there were 58 identified exposure risk factors, 20 occupational groups, 
and 20 industrial groups queried for each job. Blood samples were collected from 
129 cases and 119 controls and measured for concentrations of 122 persistent 
environmental pollutants, including organochlorine pesticides, PCBs (and dioxin-
like PCB 118, specifically), and brominated flame retardants. Odds ratios and 95% 
CIs were calculated using standardized chemical concentrations from the imputed 
sample (n = 284, 10 imputations) and adjusted for age, sex, and educational levels. 
An effect estimate for PCB 118 was calculated only for the model that used indi-
vidual compounds as covariates, which showed exposure to be associated with a 
decreased risk of ALS (OR = 0.69, 95% CI 0.48–1.01).
Other Identified Studies One additional study of an occupationally exposed 
cohort and ALS was identified (Ruder et al., 2014), but it lacked the necessary 
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exposure specificity or quantification to be considered further as contributing to 
the evidence base of the potential effect of exposure to the COIs on ALS.
Biologic Plausibility
Several studies have addressed the mechanisms of neurotoxicity that might 
be ascribed to COIs, notably 2,4-D and TCDD. Some of those effects suggest 
possible pathways by which the COIs could disrupt neuronal systems. A number 
of the studies suggest that the COIs have had neurologic effects in animal models 
when exposure occurred during development. There also are studies that suggest 
reactive oxygen species could alter specific signaling cascades and be involved 
in neurodegeneration. Although they do not specifically concern the COIs, such 
studies are potentially relevant inasmuch as TCDD and herbicides have been 
reported to elicit oxidative stress (Celik et al., 2006; Shen et al., 2005). The 
mechanistic studies suggest avenues that might be pursued to determine link-
ages between the COIs and the neurologic outcomes that could result in adult 
humans. No toxicology studies concerning exposure to the COIs and ALS have 
been published since Update 2006.
Synthesis
There is overall inadequate or insufficient evidence of an association be-
tween pesticides and ALS in broad terms, but the studies published to date have 
had low power to detect associations, which has resulted in numerous studies 
with wide CIs and non-significant ORs for exposure to the COIs. Three studies 
have been published since Update 2014. Two analyses of Vietnam veterans used 
data from the National Registry of Veterans with ALS (Beard et al., 2016, 2017). 
Exposure to Agent Orange in the field was statistically significantly associated 
with increased odds of ALS, but mixing and application of Agent Orange was 
not associated with ALS. Overall, ALS was positively associated with exposure 
to herbicides for military purposes, contaminated food, explosions within 1 mile, 
herbicides in the field, mixing and application of burning agents, burning agents 
in the field, and Agent Orange in the field. The second analysis of this population 
examined associations between military-related factors and ALS survival; longer 
survival was associated with exposure to Agent Orange in the field and mixing 
and application of Agent Orange, but neither of these exposure estimates was 
statistically significant. The third study examined occupational exposures and 
122 environmental toxicants, including organochlorine pesticides and PCB 118 as 
measured in serum, on the odds of developing ALS. Exposure to PCB 118 was as-
sociated with a decreased risk of ALS in this population. The many epidemiologic 
studies reviewed in the series do not indicate a consistent association between 
ALS and herbicides as a class or, specifically 2,4-D or 2,4,5-T or dioxin-like 
PCBs, and the toxicology studies do not support an ALS mechanism specifically.
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Conclusion
On the basis of the evidence reviewed here and in previous VAO reports, the 
committee concludes that the evidence of an association between exposure to the 
COIs and ALS remains inadequate or insufficient.
Alzheimer Disease
AD is a progressive, neurodegenerative form of dementia that is char-
acterized by memory loss, confusion, mood changes, social withdrawal, and 
deteriorating judgment. The course of the disease is divided into four stages— 
pre-dementia, early, moderate, and advanced—depending on the level of cognitive 
and functional impairment. Diagnosis typically occurs in people over 60 years old 
as the symptoms develop, although pre-dementia and early AD are occasionally 
seen in people as young as 30 years old. AD is the sixth leading cause of death in 
the United States and the fifth leading cause of death in people over 65 years old 
(S. Singh et al., 2012). In 2017 an estimated 5.5 million Americans were living 
with the diagnosis. Mean life expectancy is 7 years after an AD diagnosis; about 
3% of people who receive the diagnosis live 14 years or more (Alzheimer’s Asso-
ciation, 2018). Although the etiology of the disease remains elusive, suspected 
risk factors for AD include diet, exposure to aluminum or solvents, and genetics 
(Chin-Chan et al., 2015; de la Monte and Tong, 2014; Tanner et al., 2014).
Similar to PD diagnosis, mortality and hospitalization records are poor in-
struments for identifying AD cases (Désesquelles et al., 2014; Romero et al., 
2014). AD is usually mentioned as contributing cause instead of the underlying 
cause of death, and therefore, is more prone to under-reporting. Death certifi-
cates for AD are further limited for diagnostic and research purposes because 
many times the type of dementia (vascular, AD, other) is not specified on death 
certificates. Like PD, hospitalizations for AD do not occur until very late in the 
disease process, if at all, and thus even though the accuracy of hospital records 
in terms of diagnosis might be better than death certificates, they may miss most 
of the less severe cases or those institutionalized in long-term care facilities who 
might avoid hospitalizations (Wilson and Truman, 2004). However, as long as 
the specificity of the AD diagnosis is close to perfect, the effect estimate would 
not be biased. The gold standard of AD diagnosis is pathology of the protein ag-
gregates in the brain (amyloid beta and tau aggregates) and this standard is rarely, 
if ever, achieved in an epidemiologic project due to the low rate of autopsies or 
brain collection. However, one can assume that the longer the disease duration 
the more accurate the AD diagnosis. Also it is known that patients are diagnosed 
more accurately when they develop the diseases before the age of 80 years and 
the youngest onset patients are likely the most accurately diagnosed. Clinical 
accuracy also is much higher if patients are diagnosed in specialty clinics of 
tertiary care facilities (by dementia specialists), which are not common outside 
of urban areas.
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Conclusions from VAO and Previous Updates
AD was first addressed directly in Update 2012. Until that time, literature 
searches had not identified epidemiologic studies that assessed the possible as-
sociation of AD with exposure to the specific COIs. However, an association 
with exposure to the broad classification of “pesticides” had been investigated. 
Because AD is a condition of considerable interest to aging Vietnam veterans, 
studies with peripherally related available information (including those with 
nonspecific exposure assessment) on this outcome were included. On the basis 
of two studies of nonspecific herbicide exposure or mixed exposure to herbicides 
and other pesticides and AD (Baldi et al., 2003; Gauthier et al., 2001) that found 
inconsistent associations, the Update 2012 committee concluded that there was 
inadequate or insufficient evidence to determine whether there is an association 
between exposure to the COIs and AD.
Two studies of Vietnam veterans and one environmental study of AD were 
reviewed in Update 2014. The analyses of mortality in the Korean Veterans 
Health Study found no association between AD (ICD-10 G30) and the EOI scores 
analyzed as a continuous variable or between the high- and low-exposure groups 
(Yi et al., 2014b). However, a separate investigation of disease prevalence among 
the Korean Vietnam veterans found the risk for AD to be elevated in both the 
analysis of the scores as a continuous variable and the high- versus low-exposure 
comparison after adjusting for age, rank, smoking, drinking, physical activity, 
domestic use of herbicides, education, income, and BMI (Yi et al., 2014a). A 
subanalysis using the Canadian Study of Health and Aging examined 2,023 
subjects for whom blood was available and who had a firm diagnosis of having 
dementia (n = 574, of which 399 were specifically diagnosed with AD) or not 
(n = 1,449) (Medehouenou et al., 2014). Among the 10 PCB congeners measured 
in the serum analyses were the mono-ortho PCBs 105, 118, and 156, which exhibit 
dioxin-like activity only to a modest extent. Two adjusted models were applied to 
the data, and of the 10 PCBs analyzed, only PCBs 105 and 118 showed an inverse 
association with dementia overall in the first model, but adjustment for additional 
confounders in the second model eliminated that negative association. Thus, 
no relationship with AD specifically was seen for any of the PCBs using either 
model. The Update 2014 committee reiterated that the evidence for an association 
between exposure to at least one of the COIs and AD is inadequate or insufficient.
Update of the Epidemiologic Literature
No studies of AD among Vietnam veterans or other populations that spe-
cifically assessed exposure to the COIs have been published since Update 2014.
Environmental Studies D. H. Lee et al. (2016) measured PCBs and organo-
chlorine pesticides in the participants of the PIVUS (Prospective Investigation 
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of the Vasculature in Uppsala Seniors) cohort of residents 70 years and older in 
Uppsala, Sweden, to examine cognitive impairment. Of 2,025 eligible subjects, 
only half (n = 1,016) agreed to participate and completed a questionnaire to 
assess medical history, smoking history, and medication use. In a subcohort of 
989 men and women, the investigators determined whether PCB or organochlo-
rine exposures were associated with cognitive impairment during 10 years of 
follow-up, relying on medical record review and death certificate information 
to ascertain disease status. General exposure to 16 PCBs and 3 organochlorine 
pesticides (p,p′-DDE, trans-nonachlor, and hexachlorobenzene) was quantified 
using high-resolution gas chromatography/mass spectrometry from stored serum 
samples collected at the time of entry into the PIVUS study, and these measure 
were normalized using individual lipid levels. The authors analyzed exposures 
using a compound summary score for the three organochlorine pesticides and the 
PCBs, grouping them according to the < 25th, 25th–75th, and > 75th percentile 
of exposure. Adjusted hazard ratios for the higher summary score PCB exposures 
compared with exposure < 25th percentile showed no associations with cognitive 
impairment, but the study did not distinguish between dioxin-like and non-dioxin-
like PCBs. For the highest exposure (> 75th percentile) of hexachlorobenzene, 
a chemical with dioxin-like activity, the weight-loss-adjusted HR was 2.4 (95% 
CI 1.0–5.8) in those who developed cognitive impairment after age 75, and the 
p-trend was statistically significant. These results suggest that exposure to hexa-
chlorobenzene may predispose to the development of cognitive impairment or 
AD.
Other Identified Studies Two additional studies of occupational exposures 
and mortality from AD and dementia (Ruder et al., 2014) or mortality from non-
vascular dementia (Koeman et al., 2015) were identified. However, both studies 
lacked the necessary exposure specificity or quantification to be considered fur-
ther as contributing to the evidence base of the potential effect of exposure to the 
COIs on AD or dementia.
Biologic Plausibility
There has been little toxicologic investigation of adult exposure to the COIs 
and endpoints relevant to AD.
Synthesis
The findings in the Korean Veterans Health Study (Yi et al., 2014a,b) remain 
the first in which the risk of AD has been investigated in association with a fully 
relevant exposure, but the findings were not consistent. Except for the analysis of 
the PIVUS cohort (D. H. Lee et al., 2016), which only suggested an association 
with cognitive impairment for hexachlorobenzene and only in subgroup analyses, 
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there are no new relevant epidemiologic studies on AD to add to the evidence base 
since the last update, and the toxicologic data remains sparse.
Conclusion
On the basis of the lack of new evidence reviewed here and that reviewed in 
previous VAO reports, the committee concludes that there is inadequate or insuf-
ficient evidence to determine whether there is an association between exposure 
to the COIs and AD.
CHRONIC PERIPHERAL NERVOUS SYSTEM DISORDERS
Peripheral neuropathies are an array of disorders caused by damage to nerve 
fibers (axonal neuropathies) or to the myelin sheath that surrounds many fibers 
(demyelinating neuropathies). The manifestations of neuropathy can include a 
combination of sensory changes, weakness, and autonomic instability. Clinically, 
various forms of peripheral neuropathy can be characterized by the distribution 
of nerve abnormalities and their patterns of progression.
Peripheral neuropathy resulting from toxic exposure usually affects nerve fibers 
in a symmetric pattern, beginning distally in the longest fibers (in the toes) and mov-
ing proximally (toward the spine). This kind of neuropathy is called symmetric axo-
nal sensorimotor polyneuropathy. Sensory deficits begin at the toes, progress above 
the ankles, and only later affect the hands. Motor symptoms show the same general 
pattern. Physiologically, various forms of peripheral neuropathy can be character-
ized by the results of electrodiagnostic testing to indicate which neural structures 
are affected. Most toxicant-induced neuropathies involve injury to the nerve-cell 
bodies or the axons, giving rise to changes in the amplitude of a nerve’s response to 
an electric stimulus. The clinical manifestations of most symmetric axonal neuropa-
thies are similar except for variations in the rates of progression and in whether pain 
is prominent. No specific signature distinguishes a toxicant-related neuropathy from 
one induced by other causes. As many as 30% of neuropathies are “idiopathic,” that 
is, no etiology is determined despite exhaustive clinical evaluation.
The most common toxicant-induced neuropathy occurs as a result of chronic 
alcohol exposure. Peripheral neuropathy also occurs commonly as a complication 
of diabetes; its reported prevalence in people who have chronic diabetes is up to 
50%. Thus, it is important to include an assessment of alcohol use and diabetes 
as covariates in epidemiologic studies because the neuropathies that are related 
to these conditions are clinically and physiologically indistinguishable from other 
toxicant-induced neuropathies.
Toxicant exposure can result in early onset (immediate) peripheral neuropa-
thy or delayed-onset peripheral neuropathy, which occurs years after the external 
exposure has ended. For classification purposes, the committee considers a neu-
ropathy early onset if abnormalities appear within 1 year after external exposure 
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ends and delayed-onset if abnormalities appear more than 1 year after external 
exposure ends. Because the exposures of interest for Vietnam veterans are long 
past (more than 40 years ago), the immediate effects of the COIs are no longer 
pertinent for this cohort. Such outcomes would include early onset peripheral 
neuropathy and porphyria cutanea tarda. Because early onset peripheral neuropa-
thy is not necessarily a transient condition, it may become a chronic condition 
that should be distinguished from delayed-onset peripheral neuropathy. The focus 
of this section is on data related to delayed-onset peripheral neuropathy.
Conclusions from VAO and Previous Updates
Several studies of Vietnam veterans have examined peripheral neuropathy. A 
study by the Centers for Disease Control and Prevention (CDC, 1988b) reported a 
slight excess in the signs or symptoms of peripheral neuropathy among deployed 
versus non-deployed Vietnam-era veterans. Decoufle et al. (1992) reported no 
association between self-reported exposure to herbicides in Vietnam and periph-
eral neuropathy. There was no indication of an increased incidence of peripheral 
neuropathy in the first examination of the Air Force Health Study (AFHS), which 
established the baseline for Ranch Hand veterans (AFHS, 1984a). Michalek et 
al. (2001c) described peripheral neuropathy in the AFHS cohort. In a primary 
analysis, the investigators had included diabetes as a potential confounder in the 
statistical model. In a secondary analysis, the subjects who had conditions that 
were known to be associated with neuropathy were excluded, and the subjects 
who had diabetes were enumerated. In both analyses, there were strong and sig-
nificant associations between serum dioxin concentrations and possible and prob-
able neuropathy, and significant trends were found with increasing concentrations 
of dioxin. However, there were too few nondiabetic subjects to produce useful 
estimates of risk in the absence of the contribution of diabetes. Thus, questions 
remained about the specific association between an exposure to the COIs and 
peripheral neuropathy in the absence of any effect of diabetes. The large veteran 
studies are limited by the confounding nature of concurrent diabetes and alcohol 
exposure, both of which are also related to neuropathy.
In the study of disease prevalence among the Korean Vietnam veterans, after 
adjusting for age, rank, smoking, drinking, physical activity, the domestic use of 
herbicides, education, income, and BMI, Yi et al. (2014a) found that the risk for 
polyneuropathies of the PNS (ICD-10 G60–G64) was slightly elevated in both 
the analysis of the EOI scores as a continuous variable and in the high- versus 
low-exposure comparison.
D. H. Lee et al. (2008) evaluated the association of exposure to a variety of 
toxicants to the presence of neuropathy in subjects who had either frank diabetes or 
impaired glucose tolerance. No evidence of an increased incidence of neuropathy 
or of a dose–response relationship was found for either group when stratified by 
high- versus low-hemoglobin A1c level that suggested a concentration-dependent 
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risk of neuropathy. However, this study was limited by the small sample size and 
a lack of information regarding the duration of diabetes.
Update of the Epidemiologic Literature
No studies of exposure to the COIs and chronic peripheral system disorders 
were identified for the current update.
Biologic Plausibility
No new toxicity studies directly pertinent to the COIs and peripheral neu-
ropathy were identified for the present update. However, it is worth reiterating 
findings from earlier updates. Neuronal cell cultures treated with 2,4-D showed 
decreased neurite extension associated with intracellular changes, including a 
decrease in microtubules, an inhibition of the polymerization of tubulin, dis-
organization of the Golgi apparatus, and an inhibition of ganglioside synthesis 
(Rosso et al., 2000a,b). The normal activity of those target processes is important 
for maintaining synaptic connections between nerve cells and for supporting 
the mechanisms involved in axon regeneration during recovery from peripheral 
neuropathy. Grahmann et al. (1993) and Grehl et al. (1993) reported observation 
of, respectively, electrophysiologic and pathologic abnormalities in the peripheral 
nerves of rats treated with TCDD. When the animals were sacrificed 8 months 
after exposure, there was pathologic evidence of persistent axonal nerve damage 
and histologic findings typical of toxicant-induced injury. These results constitute 
evidence of biologic plausibility for an association between exposure to the COIs 
and peripheral neuropathy.
Synthesis
The epidemiologic studies relating industrial or individual exposure to acute 
neuropathy were judged by the committee for Update 1996 and later updates to 
provide limited or suggestive evidence of an association between exposure to the 
COIs and early onset transient peripheral neuropathy. Beginning with Update 
2010, these acute outcomes were removed from this section to keep the focus on 
chronic and delayed-onset conditions. That committee concluded that no data sug-
gest that exposure to COIs can lead to the development of delayed-onset chronic 
neuropathy many years after the termination of exposure of those who did not 
originally complain of early onset neuropathy and concluded the evidence to be 
inadequate or insufficient. Since Update 2010, only one relevant study was identi-
fied and reviewed, and that study was reviewed in Update 2014. Among Korean 
Vietnam veterans, the prevalence of polyneuropathies was slightly elevated in 
high- versus low-exposure comparisons. Given the lack of new epidemiologic 
studies and toxicologic information, the committee agrees with the prior two 
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committees and concludes that the evidence does not support an association 
between exposure to the COIs and the development of delayed-onset chronic 
neuropathy.
Conclusion
On the basis of the lack of new evidence to date, the committee concludes 
that there is inadequate or insufficient evidence to determine whether there is an 
association between exposure to the COIs and delayed-onset chronic neuropathy.
HEARING LOSS
Hearing loss increases markedly with age, from approximately 3% among 
adults aged 20–29 years to an estimated 49% among people 60–69 years of age and 
more than 80% among people 85 years and older (NASEM, 2016b). These estimates 
are based on NHANES data and are likely to underestimate the true population 
prevalence of hearing loss because the NHANES sampling frame does not include 
people living in assisted care facilities, group homes, or nursing homes or those 
unable to come to the mobile examination center. Hearing loss is somewhat higher 
in men than in women (NASEM, 2016b). The most common forms of hearing im-
pairment in adults are presbycusis and tinnitus. Heritable factors may influence the 
susceptibility to hearing loss, but external agents can also contribute. Aspirin at high 
doses can cause reversible tinnitus, and permanent hearing loss may be induced 
by certain pharmaceuticals (particularly antibiotics and antineoplastic drugs) and 
by some environmental and industrial chemicals (primarily solvents and metals) 
(Cannizzaro et al., 2014). In occupational medicine, hearing loss is most often re-
garded as noise induced. Farmers and migrant or seasonal agricultural workers have 
also been found to have high rates of hearing loss compared with those who had the 
lowest levels of pesticide exposure (Crawford et al., 2008; Rabinowitz et al., 2005).
Conclusions from VAO and Previous Updates
Epidemiologic results on hearing loss in relation to service in Vietnam or to 
herbicide exposure more generally were first discussed in Update 2010, when 
two citations that addressed this health outcome were identified. O’Toole et al. 
(2009) re-examined the health status of a cohort of Australian Vietnam veterans; 
as for almost every health endpoint surveyed in that group, the incidences of 
self-reported complete or partial deafness and of tinnitus showed statistically sig-
nificant increases compared to the general population, but these results are likely 
compromised by methodologic problems with the study. Excesses in self-reported 
hearing loss were also found among licensed pesticide applicators in the AHS at 
the time of the 5-year follow-up interview (Crawford et al., 2008), but this effect 
was associated with insecticide exposure, not with herbicide use.
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Update of the Epidemiologic Literature
No epidemiologic studies addressing exposure to the COIs and hearing loss 
have been published since Update 2014.
Biologic Plausibility
Although no studies of hearing loss in adult animals directly exposed to 
the COIs were found, Crofton and Rice (1999) reported that perinatal maternal 
exposure to PCB 126 (a dioxin-like PCB) resulted in low-frequency hearing 
deficits in the offspring of exposed maternal rats. Increased auditory thresholds 
occurred in the group treated at 1.0 μg/kg/day for 0.5- and 1-kHz tones, but 
higher frequencies were not significantly affected. The frequency-specific deficit 
was hypothesized to be secondary to a postnatal hypothyroxinemia that occurred 
during a sensitive period for the development of the low-frequency regions of 
the cochlea, which was consistent with the finding that the pups had decreased 
T4 concentrations in their sera on postnatal day 21.
Synthesis
Two prior studies observed an increased prevalence of hearing loss in Vietnam 
veterans and pesticide applicators, but neither was able to examine exposure 
specifically to the COIs or to confirm hearing loss clinically. Furthermore, the 
report from the AHS (Crawford et al., 2008) observed an association only in 
insecticide applicators, not in herbicide applicators. Hearing loss among Austra-
lian Vietnam veterans was compared with the general Australian population, not 
veterans from the same era who were not deployed to Vietnam, so it could not 
distinguish between hearing loss that may be associated with noise that was re-
lated to military service and hearing loss potentially associated with exposures to 
toxic chemicals. In the absence of new studies, the conclusion remains unchanged 
since Update 2010.
Conclusion
On the basis of the evidence reviewed here, the committee concludes that 
there is inadequate or insufficient evidence to determine whether there is an as-
sociation between exposure to the COIs and hearing loss.
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Metabolic and Cardiovascular Disorders
Chapter Overview
Based on new evidence and a review of prior studies, the current committee found 
that new scientific evidence combined with previously reviewed studies has led to 
changes in the categorizations of association for two metabolic and cardiovas-
cular outcomes outcomes: type 2 diabetes and hypertension.
• After extensive deliberation concerning the new evidence and the results 
of studies reviewed in previous updates, the committee was unable to 
reach consensus as to whether the evidence of an association between 
exposure to the chemicals of interest (COIs) and diabetes met the criteria 
for being considered sufficient or whether concerns about chance, bias, 
and confounding lead to the conclusion that the evidence regarding dia-
betes is limited or suggestive.
• There is sufficient evidence of an association of hypertension with the COIs.
The committee found that the current evidence supports the conclusions reached 
by committees responsible for earlier updates concerning the other metabolic and 
cardiovascular outcomes reviewed in the Veterans and Agent Orange (VAO) series 
of reports:
• There is limited or suggestive evidence of an association between the 
COIs and ischemic heart disease and stroke.
• There is inadequate or insufficient evidence to determine whether there 
is an association between the COIs and any other adverse metabolic or 
cardiovascular outcome examined.
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This chapter summarizes and presents conclusions about the strength of the 
evidence from epidemiologic studies regarding an association between exposure 
to the COIs—2,4-dichlorophenoxyacetic acid (2,4-D), 2,4,5-trichlorophenoxy-
acetic acid (2,4,5-T) and its contaminant 2,3,7,8-tetrachlorodibenzo-p-dioxin 
(TCDD), picloram, and cacodylic acid—and metabolic and cardiovascular disor-
ders. The committee also considers studies of exposure to polychlorinated biphe-
nyls (PCBs) and other dioxin-like chemicals to be informative if their results were 
reported in terms of TCDD toxic equivalents (TEQs) or concentrations of specific 
congeners. Studies that report TEQs based only on mono-ortho PCBs (which are 
PCBs 105, 114, 118, 123, 156, 157, 167, and 189) are considered even though 
their TEQs are several orders of magnitude lower than those of the non-ortho 
PCBs (77, 81, 126, and 169), based on the revised World Health Organization 
(WHO) toxicity equivalency factor (TEF) scheme of 2005 (La Rocca et al., 2008; 
van den Berg et al., 2006). The lower TEQs of the mono-ortho PCBs, however, 
may be counterbalanced by their abundance, which is generally many orders of 
magnitude higher than that of the non-ortho PCBs (H. Y. Park et al., 2010).
The first part of the chapter covers the metabolic disorder type 2 diabetes and 
the second part reviews a variety of cardiovascular and blood disorders. Cardio-
vascular conditions explored in this chapter are based on the categories in the 9th 
and 10th revisions of the International Classification of Diseases (ICD; ICD-9 
390–459 and ICD-10 I00–I99, respectively) and include hypertension (ICD-9 
401–404; ICD-10 I10–I13), ischemic heart disease (ICD-9 410–414; ICD-10 
I20–I25), heart failure (ICD-9 428; ICD-10 I50), and cerebrovascular disease 
(ICD-9 430–438; ICD-10 I60–I69).
TYPE 2 DIABETES
Diabetes mellitus is a group of heterogeneous metabolic disorders charac-
terized by hyperglycemia and a quantitative or qualitative deficiency in insulin 
action (Orchard et al., 1992) and classified as E08–E13 by ICD-10. Although all 
forms of diabetes share hyperglycemia, the pathogenic processes involved in the 
development of the various types of diabetes differ. Most cases of diabetes mel-
litus are classified as being in one of two categories: type 1 diabetes or type 2 
diabetes. The long-term complications of both types can include cardiovascular 
disease (CVD), nephropathy, retinopathy, neuropathy, and increased vulnerability 
to infections.
When referring to diabetes, most research will not distinguish between type 1 
and type 2 because type 2 diabetes accounts for 90% to 95% of all cases. Type 1 
diabetes (ICD-10 E10) is characterized by a lack of insulin caused by the im-
munologically mediated destruction of insulin-producing cells in the pancreas 
(β cells), which often occurs during childhood but can occur at any age. As with 
many autoimmune diseases, genetic and environmental factors both influence its 
pathogenesis. Some viral infections are believed to be important environmental 
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triggers for the autoimmunity associated with type 1 diabetes. Type 1 diabetes 
most often occurs in children, which is only of relevance in offspring of adults 
exposed to the COIs.
Type 2 diabetes exhibits both resistance to the actions of insulin and inad-
equate secretion of insulin (called relative insulin deficiency). The prevalence of 
diabetes in the United States has been increasing among nearly all races and eth-
nic groups. In 2015 there were approximately 30.3 million people ages 18 years 
and older who had diabetes in the United States, or 9.4% of the U.S. population. 
Of these, 23.1 million had officially been diagnosed, whereas 7.2 million (23.8%) 
were considered to be prediabetic (CDC, 2017c). Although the modern ICD-10 
classification system recognizes that type 2 diabetes can occur in children and can 
require insulin treatment, most cases of type 2 diabetes occur in adults.
Onset can occur before 30 years of age, and the incidence increases with age. 
The main risk factors for type 2 diabetes are age, obesity, abdominal fat deposi-
tion, a history of gestational diabetes (in women), physical inactivity, ethnicity, 
and family history, but the relative contributions of each of those risks to the 
overall prevalence are not known. Type 2 diabetes affects women and men nearly 
equally (11.7 million versus 11.3 million, respectively); however, the Centers for 
Disease Control and Prevention (CDC) estimates that there are more undiagnosed 
diabetes cases among men than among women (4.0 million versus 3.1 million, 
respectively). Table 10-1 shows the estimated prevalence of diagnosed and undi-
agnosed diabetes among adults over 18 years by age and sex. The prevalence of 
type 2 diabetes among U.S. adults aged 18 years and older is greatest in Ameri-
can Indians/Alaska Natives (15.1%), followed by non-Hispanic blacks (12.7%) 
and Hispanics (12.1%). The lowest prevalence rates are for non-Hispanic whites 
(7.4%) and Asians (8.0%). As of 2015, an estimated 1.5 million new cases of 
diabetes are diagnosed annually, for an incidence rate of approximately 6.7 per 
1,000 persons. In non-Hispanic blacks the incidence was 9.0 per 1,000 persons 
and 8.4 per 1,000 persons among people of Hispanic origin (CDC, 2017c).
TABLE 10-1 Estimated Number and Percentage of Diagnosed and 
Undiagnosed Diabetes Among Adults, Aged ≥ 18 years, United States, 2015
Characteristic
Diagnosed Diabetes
# in Millions (95% CI)
Undiagnosed Diabetes
# in Millions (95% CI) Total Diabetes
Age in years
18–44 3.0 (2.6–3.6) 1.6 (1.1–2.3) 4.6 (3.8–5.5)
45–64 10.7 (9.3–12.2) 3.6 (2.8–4.6) 14.3 (12.7–16.1)
≥65 9.9 (9.0–11.0) 2.1 (1.4–3.0) 12.0 (10.7–13.4)
Sex
Women 11.7 (10.5–13.1) 3.1 (2.4–4.1) 14.9 (13.5–16.4)
Men 11.3 (10.2–12.4) 4.0 (3.0–5.5) 15.3 (13.8–17.0)
Total 23.0 (21.1–25.1) 7.2 (6.0–8.6) 30.2 (27.9–32.7)
SOURCE: CDC, 2017c.
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The etiology of type 2 diabetes is unknown, but three major components have 
been identified: peripheral insulin resistance in target tissues (muscle, adipose 
tissue, and liver), a defect in β-cell secretion of insulin, and the overproduction 
of glucose by the liver. When a person enters a state of insulin resistance, insulin 
secretion is initially higher for each concentration of glucose than in people who 
are not insulin resistant. This hyperinsulinemic state compensates for peripheral 
resistance and in many cases keeps glucose concentrations normal for years. 
Eventually, however, β-cell compensation becomes inadequate, and there is a 
progression to overt diabetes with concomitant hyperglycemia. Why the β cells 
cease to produce sufficient insulin is not known.
Pathogenic diversity and diagnostic uncertainty are some important problems 
in conducting epidemiologic studies of diabetes mellitus. There are multiple 
pathogenic mechanisms that are likely to play a role in the development of diabe-
tes mellitus, including various genetic susceptibilities (as varied as autoimmunity 
and obesity) and a variety of potential environmental and behavioral factors (such 
as viruses, nutrition, and physical activity). Because in some populations up to 
half of all cases of diabetes remain undiagnosed for an extended period of time, 
the potential for ascertainment bias in population-based surveys is high, and 
groups that are more intensively followed for signs and symptoms of diabetes 
or those with more frequent health care contact, in general, are more likely to 
be diagnosed in time to receive appropriate treatment; this points to the need for 
formal standardized testing to detect cases in epidemiologic studies.
Metabolic syndrome is a cluster of at least three of the following—in-
creased blood pressure or hypertension, insulin resistance, excess body fat 
around the waist, and abnormal serum cholesterol or triglyceride levels—that 
occur together, increasing the risk of heart disease, stroke, and diabetes. Al-
though it is not a disease entity itself, metabolic syndrome is associated with a 
five-fold increased risk of developing type 2 diabetes and a doubling of the risk 
of developing CVD (Alberti et al., 2009). Swaminathan et al. (2015) found that 
pesticide exposure was a contributing factor to hyperglycemia and type 2 diabetes 
even after adjusting for body mass index (BMI). There is a growing literature on 
the association between the COIs and metabolic syndrome and its components. 
Given its strong linkage with type 2 diabetes, studies on metabolic syndrome will 
be discussed in this section.
Conclusions from VAO and Previous Updates
The committee responsible for the first report in the VAO series (IOM, 1994) 
concluded that there was inadequate or insufficient information to determine 
whether there is an association between exposure to the COIs and diabetes mel-
litus. Additional information available to the committees responsible for Update 
1996 (IOM, 1996) and Update 1998 (IOM, 1999) did not change that conclusion.
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In 1999, in response to a request from the Department of Veterans Affairs, 
the Institute of Medicine convened a committee to conduct an interim review of 
the scientific evidence regarding exposure to the COIs and type 2 diabetes. That 
review focused on information published after the deliberations of the Update 
1998 committee and resulted in the report Veterans and Agent Orange: Herbicide/ 
Dioxin Exposure and Type 2 Diabetes (IOM, 2000b). The committee responsible 
for that report determined that there was limited or suggestive evidence of an 
association between exposure to at least one COI and type 2 diabetes, based on 
positive associations reported in several mortality studies (Pesatori et al., 1998; 
Steenland et al., 1992, 1999; Vena et al., 1998), which may underestimate the 
incidence of diabetes, and positive associations reported in most of the morbidity 
studies (AFHS, 2000; Calvert et al., 1999; CDVA, 1998a,b; Cranmer et al., 2000; 
Longnecker and Michalek, 2000; Michalek and Tripathi, 1999) reviewed by that 
committee. However, that committee also noted that the studies indicate that the 
increased risk, if any, from herbicide or dioxin exposure appeared to be small and 
that the known predictors of diabetes risk—family history, physical inactivity, 
and obesity—continued to greatly outweigh any suggested increased risk from 
wartime exposure to herbicides. The committees responsible for updates since 
that report have upheld that finding. Reviews of the considered studies are found 
in the earlier reports.
Several epidemiologic studies have been published that examined type 2 
diabetes in different populations of Vietnam veterans: Air Force Health Study 
(AFHS), female U.S. Vietnam-era veterans, and Korean Vietnam veterans. Pub-
lications from the AFHS have found a statistically significant increased risk of 
diabetes among the Ranch Hands (Henriksen et al., 1997; Kern et al., 2004; 
Longnecker and Michalek, 2000; Michalek and Pavuk, 2008). Most analyses of 
the Army Chemical Corps (ACC) veterans did not find increased risk of diabetes. 
Using mortality data on U.S. women veterans, Kang et al. (2014a) found that 
the adjusted relative risk of diabetes mortality was non-significantly lower for the 
female veterans deployed to Vietnam than for their non-deployed counterparts, 
and when the analysis was restricted to nurses only, the adjusted relative risk of 
diabetes mortality was effectively the same for deployed and non-deployed nurses.
No statistically significantly increased risk of diabetes was found in several 
studies of Australian Vietnam veterans. In an exceptionally large epidemiologic 
study of Korean veterans who served in the Vietnam War, using data from the 
Korea National Health Insurance Service, the risk of type 2 diabetes mellitus 
was found to be nominally higher for those with a high potential for herbicide 
exposure than for those with low–exposure opportunity index scores, and there 
was a small, but statistically significant association for veterans with non-insulin-
dependent diabetes mellitus (Yi et al., 2014a). In the mortality study of 180,639 
Korean Vietnam veterans, Yi et al. (2014b) found that after adjustment, high 
exposure (compared with low exposure) was not associated with mortality from 
all forms of diabetes (ICD-10 E10–E14).
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Occupational studies of diabetes have found slightly elevated but gener-
ally not statistically significant associations between exposure to the phenoxy 
herbicides or TCDD and a risk of diabetes. Results from the Agricultural Health 
Study (AHS) found an increased risk of developing diabetes in the wives of pes-
ticide applicators who themseleves had reported personally mixing or applying 
pesticides or the ever use of 2,4,5-T or 2(2,4,5-trichlorophenoxy) propionic acid 
(2,4,5-TP). Ever use of 2,4-D was much more prevelant, but it was not associated 
with a risk of diabetes (Starling et al., 2014). No difference or decreased risk of 
diabetes was found among the AHS pesticide applicators in both morbidity and 
mortality studies.
Several studies of environmental exposures to the COIs and diabetes have 
been reviewed in the VAO series. The findings are mixed, and the studies have 
used different designs and methods for adjusting effect estimates for confounding.
Update of the Epidemiologic Literature
Two new studies of Vietnam veterans and diabetes have been identified since 
Update 2014. Several occupational, environmental, and case-control studies of 
diabetes and exposure to the COIs were also identified for this update. Table 41, 
which can be found at www.nap.edu/catalog/25137, summarizes the results of 
studies related to diabetes and related health outcomes.
Vietnam-Veteran Studies
Using data from the AFHS, Mazur et al. (2014) studied 991 Ranch Hands 
and comparison veterans who completed all six medical examinations over the 
20 years of data collection (1982, 1985, 1987, 1992, 1997, 2002) to see if low 
testosterone is a risk factor for high fasting glucose and for a type 2 diabetes diag-
nosis. Subjects ranged from 32 to 68 years of age at the onset of the study. Fasting 
glucose was tested in the morning for all men at each exam. Hemoglobin A1c 
(HbA1c), which is indicative of blood glucose levels over the preceding 120 days, 
was measured for all men in cycles 4 and 5. Among the men, gradual increases 
in obesity, fasting glucose, and type 2 diabetes and a decline in mean testoster-
one levels occurred over the 20 years of study. The authors noted that men who 
would not be diagnosed with type 2 diabetes until cycles 5 or 6 already showed 
by cycle 1 that their mean fasting glucose was significantly higher than normal. 
A statistically significant (p < 0.001) correlation was found between fasting glu-
cose in all six cycles and both HbA1c in the fourth and fifth cycles and a diagnosis 
of type 2 diabetes in any of the six cycles. Men who had high testosterone levels 
and low BMI had a mean fasting glucose level of 100 mg/dl, whereas men with 
a high BMI and low testosterone levels had a fasting glucose level of 116 mg/dl. 
The multivariate analyses showed that testosterone was inversely related to 
glucose, independently of BMI and age, but its effect on glucose was small. The 
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study showed that levels of low testosterone were related to high fasting glucose, 
independent of the participant’s age or obesity. Results also indicated that low 
testosterone is a relatively poor predictor of a type 2 diabetes diagnosis. However, 
this study is of limited value to this update because the results were not stratified 
by exposure status (Ranch Hand versus comparison) and because serum concen-
trations of dioxin were not included in the analysis.
Cox et al. (2015) used hospital discharge records from 1988 to 2009 to 
identify prevalent health conditions in 2,783 male New Zealand veterans who 
served in Vietnam. Age-specific hospitalization rates were calculated using the 
total number of annual hospitalizations published by the Ministry of Health and 
the average annual resident population. Standardized hospitalization rates and 
99% confidence intervals (CIs) were calculated for the veteran cohort and the 
general population and reported for diabetes and other outcomes. Although the 
risk estimate was slightly elevated for diabetes (standardized hospitalization ratio 
[SHR] = 1.14, 99% CI 0.90–1.38), it was not statistically significant compared 
with the general population. However, diabetes is not usually a condition that 
requires hospitalization, thus likely only those with the most severe disease were 
identified, and the number of cases available for study would be expected to be 
low, limiting the statistical power for this type of analysis considerably. Exposure 
to the COIs was not validated through serum measurements, and the study did 
not control for smoking or ethnicity or other potentially important risk factors.
Occupational Studies
Collins et al. (2016) added follow-up time for a retrospective cohort of 2,192 
workers exposed to dioxins during trichlorophenol (TCP) and pentachlorophe-
nol (PCP) production at a chemical manufacturing plant in Midland, Michigan. 
Workers were compared to the U.S. population in order to calculate standardized 
mortality ratios (SMRs), and work history records provided information about 
the length of exposure. Serum samples used to measure levels of six types of 
dioxins were collected from 431 TCP and PCP workers. Concentrations for each 
dioxin congener were calculated based on the median concentration in the serum 
samples and the known half-lives associated with each congener. Complete vital 
status follow-up was achieved for the cohort, and there were 1,198 deaths dur-
ing the entire study period (1979–2011). Compared with the standardized U.S. 
population, no statistically significant difference in mortality for diabetes was 
found for the TCP workers (n = 19; SMR = 0.92, 95% CI 0.55–1.43) or the PCP 
workers (n = 9; SMR = 0.97, 95% CI 0.44–1.84). Among the combined 1,198 
TCP and PCP workers, there were 28 deaths from diabetes (SMR = 0.97, 95% 
CI 0.64–1.42). Additionally, there are other concerns with the diabetes outcome 
in this analysis. First, mortality data for diabetes likely under-reports disease 
prevalence because diabetes is often a contributing factor to but not the actual 
cause of a death. Second, using the general U.S. population as the comparison 
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is problematic because of the “healthy worker effect,” that is, some of the com-
parison subjects are not in the workforce and will typically have, on average, 
poorer general health than individuals in the workforce. In this case, it would 
imply a control group with rates of diabetes greater than those in the workforce. 
In contrast, an internal comparison of workers with high- versus low-dioxin 
concentrations, which was not presented by the authors, would have avoided this 
type of selection bias.
't Mannetje et al. (2018) conducted a morbidity survey among a subset of 
workers who were employed at the New Plymouth, New Zealand, phenoxy her-
bicide production plant for at least 1 month between 1969 and 1984. The plant 
produced 2,4,5-T, and workers were potentially exposed to 2,4,5-T, intermedi-
ates of TCP and other chlorophenols, and TCDD. Workers had previously been 
recruited and examined as part of the international cohort of producers of phe-
noxy herbicides led by the International Agency for Research on Cancer (IARC) 
(Kogevinas et al., 1997); see Chapter 5 for more details on the IARC cohort and 
the New Zealand phenoxy producers. This study extended the follow-up period of 
these workers to approximately 30 years from the last 2,4,5-T production expo-
sure. From the original cohort of 1,025 workers, 631 were living, had a current 
address in New Zealand, and were below 80 years of age on January 1, 2006. 
For the current follow-up, 430 of the 631 workers were randomly selected and 
invited to participate in the morbidity survey, of which 245 (57%) participated. 
The survey was administered in 2007–2008 by face-to-face interview, and it 
collected information on demographic factors and health information, including 
doctor-diagnosed conditions and the year of diagnosis. A blood sample was also 
collected at that time and analyzed for TCDD, lipids, thyroid hormones, and other 
parameters. For 111 participants, a neurological examination was conducted. 
Associations between exposure and health outcomes were assessed using logistic 
regression models that controlled for age, gender, smoking, BMI, and ethnicity 
using two methods: working in a TCDD-exposed job (based on occupational 
records) and serum TCDD concentration ≥ 10 pg/g lipid (18%). Mean TCDD 
concentrations were 19 pg/g lipid in the 60 men directly involved in phenoxy/
TCP production and 6 pg/g lipid in the 141 men and 43 women who worked in 
other parts of the plant. Compared with the people in the non-highly exposed 
jobs, the people who had ever worked in a highly exposed job at the plant had an 
elevated risk of doctor-diagnosed diabetes (n = 13; odds ratio [OR] = 3.98, 95% 
CI 1.03–15.4), although the estimate was imprecise. When compared by serum 
TCDD concentration, no difference in risk of diabetes was found for workers in 
the high- versus low-exposure groups (n = 7; OR = 3.05, 95% CI 0.87–10.67), 
although the estimate was again imprecise.
Cappelletti et al. (2016) performed a retrospective study of 331 male elec-
tric arc foundry workers at a single plant in Trentino, Italy, to determine if they 
experienced excess mortality from all causes or were at increased risk for several 
other diseases due to occupational exposures to foundry dust. An analysis of the 
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dust emissions found that it contained metals (including iron, aluminum, zinc, 
manganese, lead, chromium, nickel, cadmium, mercury, and arsenic), polycyclic 
aromatic hydrocarbons (PAHs), PCBs, and polychlorinated dibenzo-p-dioxin/
dibenzofurans (PCDD/Fs) (reported as TEQs). Therefore, the authors could not 
determine which of the agents were associated with a specific outcome or to what 
extent. The men had worked at the factory for at least 1 year and, for the diabetes 
analysis, were compared with 32 presumed non-exposed workers (clerks, man-
agers, and watchmen) or the general population of Region Trentino-Alto Adige 
(where the factory was located) because there were few non-exposed foundry 
workers and high attrition rates. Company and medical records were used to 
determine vital status; the cause of death was determined from death certificates 
or other registries. Requests for exemption health care fees were used as a sur-
rogate measure to identify the most prevalent morbid conditions in the general 
population, which were then applied to the cohort to compute relative risks for 
each of the conditions, which included diabetes. The workers were followed 
from March 19, 1979 (or their first day of employment), through December 31, 
2009, or date of death. The analysis for diabetes was limited to the 235 living 
workers, and effect estimates (prevalence ratios) were calculated using Mantel-
Haenszel estimator adjusted for age group (20–64, 65–74, ≥ 75 years). Compared 
with the age-adjusted provincial population, a statistically significant increased 
risk of diabetes was found among electric arc furnace workers (n = 25; relative 
risk [RR] = 2.39, 95% CI 1.67–3.41). This study is most limited by the fact that 
foundry dust is a complex mixture, resulting in an inability to discern the impact 
of the specific contaminants of the foundry dust on the health outcomes of those 
exposed workers. Estimates were adjusted only for age group and not for other 
risk factors, such as tobacco use, BMI, or other jobs or activities that could result 
in similar exposures. Possible exposure to foundry dust by the general population 
that was used for comparison is not discussed, although the foundry appears to 
be in the local vicinity, and emissions from it were reported to be present within 
a 2-kilometer radius of it.
Yamamoto et al. (2015) performed a cross-sectional study to investigate the 
health outcomes that 698 male workers sustained while employed at 36 munici-
pal and private waste incineration plants in Japan; serum dioxin measurements 
were obtained for 678 of the workers. These workers were employed from 2000 
to 2007. First, a questionnaire was distributed to the participants to determine 
their medical history. Blood samples were taken from each subject to evaluate 
serum dioxin and PCB levels. Both clinical and physiological examinations were 
also performed. Participants were then categorized into four groups: workers 
whose jobs did not involve working directly in an incineration facility, workers 
whose jobs did involve work inside the incineration facility (but only handling 
solidified fly ash and slag or residues that were nonflammable), workers whose 
jobs involved helping with incineration-related work inside an incineration facil-
ity, and workers whose jobs mainly involved operation and maintenance of an 
Veterans and Agent Orange: Update 11 (2018)
Copyright National Academy of Sciences. All rights reserved.
474 VETERANS AND AGENT ORANGE: UPDATE 11
incinerator including a furnace, electric dust collector, and wet scrubber inside 
an incineration facility. Subjects were tested for diabetes, hypertension, hyper-
lipidemia, and liver dysfunction. The total serum dioxin concentration level for 
incinerator workers was 13.7 (median) or 17.2 (arithmetic mean) pg TEQ/g lipid, 
while the (arithmetic mean) average total dioxin concentration was 19.4 pg TEQ/g 
lipid for the general population in Japan, indicating no real difference between 
the two groups. However, in the exposed workers, the duration of employment 
was positively associated with TEQ levels (9.8 and 21.7 pg TEQ/g lipid for those 
employed 9 years and 15.5 years, respectively). Coplanar PCBs were significantly 
correlated (p < 0.05) with 14 parameters of laboratory and physiological tests. 
Diabetes was statistically significantly associated with PCDDs, PCDFs, coplanar 
PCBs, and total dioxins based on adjusted odds ratios between the first and fourth 
quartile, and tests for trend were also significant for each of these COIs. Positive 
associations were found between serum levels of total dioxins and the prevalence 
of diabetes in the incinerator workers even though, as the healthy worker effect 
would predict, the overall diabetes prevalence in the workers was not as high as 
in the general Japanese population (6.6% versus 9.0%, p = 0.07).
Environmental Studies
Everett and Thompson (2016) measured three chlorinated dibenzo-p-dioxins, 
one chlorinated dibenzofuran, and four dioxin-like PCBs in human blood and 
assessed their cross-sectional associations with nephropathy, specifically diabe-
tes-related nephropathy using data collected between 1999 and 2004 from the 
National Health and Nutrition Examination Survey (NHANES). Two groups of 
people were included: the teen and young adult sample (12–30 years old) and 
the all-adult sample (≥ 20 years old). Nephropathy was defined as a urinary 
albumin-to-creatinine ratio > 30 mg/g, representing both microalbuminuria and 
macroalbuminuria. Diagnoses of diabetes were determined by individual, self-
reported answers to the NHANES question: “Other than during pregnancy, have 
you ever been told by a doctor or health professional that you have diabetes or 
sugar diabetes?” Those who answered “borderline” were considered to not have 
diabetes. Having undiagnosed diabetes was defined as participants who had A1c 
levels ≥ 6.5% but had not been diagnosed as having diabetes. Total diabetes was 
defined as either diagnosed or undiagnosed diabetes. Several differences were 
noted between the teen/young adult and the all-adult samples. One or more of 
the eight dioxin-like chemicals were elevated among 9.9% of the teen/young 
adult sample (at-risk population) and among 53.5% of the all-adult sample. The 
proportions for nephropathy and pre-diabetes were, respectively, 7.8% and 1.8% 
in the teen/young adult sample versus 5.5% and 9.7% in the all-adult sample. 
The unweighted number of people with nephropathy in the teen/young adult 
sample was 87 females and 35 males. Only three people had pre-diabetes with 
nephropathy in the teen/young adult sample, which was too few for analyses. 
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None of the eight dioxin-like chemicals were associated with pre-diabetes, but in 
most instances there were no cases of pre-diabetes in the elevated concentration 
range. In the highest TEQ8 category, which included 2.6% of the sample, there 
was a strong but very imprecisely estimated association with pre-diabetes among 
females (OR = 11.9, 95% CI 1.6–87.2), but no associations with pre-diabetes at 
any level of elevated TEQ8 in the entire sample.
Two reports from a study conducted by Aminov et al. (2016a,b) examined 
diabetes among 601 people of the Mohawk Nation between the ages of 18 and 
84 years living at Akwesasne, which spans New York, Ontario, and Québec. The 
most detailed reporting of this data is found in Aminov et al. (2016a). Serum 
samples were taken from the subjects to test for PCB and pesticide concentrations 
as well as to determine each individual’s fasting glucose levels. A subject in this 
study was considered to have diabetes if he or she had a fasting glucose concen-
tration of > 125 mg/dL or if it was reported that a physician had made a diabetes 
diagnosis. Several models were used to estimate risks. Model 1 adjusted for sex, 
age, BMI, and serum lipid concentrations. In model 2, the total concentrations 
of PCBs were adjusted for the variables in model 1 and also for total pesticides 
(the sum of the concentrations of 101 PCB congeners, DDE, hexachlorobenzene 
[HCB], and mirex). Multiple analyses were undertaken, and in the minimally 
adjusted model 1, both total PCBs (highest quartile OR = 3.45, 95% CI 1.4–8.5) 
and total pesticides (highest quartile OR = 3.12, 95% CI 1.12–8.65) showed 
statistically significant associations with diabetes. These associations were at-
tenuated in model 2, which adjusted for total pesticides, with total dioxin-like 
PCBs estimates having an odds ratio that was elevated but did not reach statistical 
significance (highest quartile OR = 1.82, 95% CI 0.61–5.40), while the total pes-
ticides estimate (highest quartile OR = 5.01, 95% CI 1.76–14.24) was statistically 
significantly elevated but quite imprecise. In model 3, PCB concentrations were 
divided into three groups by numbers of chlorines (3–4, 5–6, and ≥ 7) and by 
numbers of ortho-substitute chlorines and each pesticide was considered alone. 
In addition to adjustment for sex, age, BMI, and total lipids, each result was 
also adjusted for the concentrations of all other groups of contaminants. Results 
using model 3 suggested a low-dose effect. In general, there was an association 
between PCB exposure and diabetes, but this was reported to be mainly due to 
low-chlorinated, non-dioxin-like congeners.
Grice et al. (2017) assessed the association of type 2 diabetes with persistent 
organic pollutants (POPs), including dioxin-like PCBs (PCB 105, 118, 156, 157, 
and 167) and HCB, using a nested case-control design from a relatively small 
prospective study conducted in American Indians in Arizona. A sample of 100 
men and 200 women who were at high risk of diabetes were enrolled between 
1965 and 1974. Participants underwent a baseline examination that included a 
blood draw and took an oral glucose tolerance test. The oral glucose test was 
repeated at each follow-up. Levels of PCBs and pesticides in the serum samples 
were assessed by CDC. Over 8 years of follow-up, 149 people developed diabetes 
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(cases), and 151 remained non-diabetic (controls). Cases were followed from dia-
betes onset to end stage renal failure, death, or 2013. When models were adjusted 
for age, sex, BMI, 2-hour postload plasma glucose concentration, sample water 
loss, sample storage time, cholesterol, and triglycerides, the odds of diabetes 
were statistically significantly decreased for HCB exposure (OR = 0.64, 95% 
CI 0.41–0.99). In fully adjusted models, most dioxin-like PCBs were positively 
associated with incident diabetes, but none was statistically significant: PCB 105 
(OR = 1.14, 95% CI 0.81–1.60), PCB 118 (OR = 1.16, 95% CI 0.82–1.65), PCB 
156 (OR = 1.06, 95% CI 0.73–1.53), PCB 157 (OR = 1.06, 95% CI 0.75–1.49), 
and PCB 167 (OR = 1.11, 95% CI 0.80–1.55). This study is limited by the small 
sample size and the fact that serum concentrations of COIs were measured only 
once, yet the participants were followed for diabetes incidence for 8 years.
During 2007–2008, Singh and Chan (2017) conducted a cross-sectional 
survey study of 33 Canadian Inuit coastal communities and three inland commu-
nities. The survey included questions about health status, chronic diseases, and 
such behaviors as alcohol consumption, smoking, and exercise habits. Clinical 
tests such as fasting glucose and blood levels of PCBs and organochlorine pesti-
cides supplemented the survey. In total, 2,172 Inuit people aged 18 years or older 
participated and provided blood samples. Of the PCB congeners measured in the 
blood, the dioxin-like mono-ortho PCBs 105, 118, and 156 are of interest for the 
committee’s charge. Associations of diabetes with individual PCB congeners, 
the sum of dioxin-like PCBs, the sum of non-dioxin-like PCBs, and total PCBs 
were determined. Of the 2,172 respondents, 147 (5.7%) self-reported diabetes, 
with nearly the same proportions among males and females (5.5% and 5.8%, 
respectively). As expected, the percentage of people with diabetes increased as 
age increased (2.9% in the 31- to 50-year-old category and 22.1% in the 71- to 
90-year-old category), and diabetes was clustered within families (either parent 
having diabetes: 19.7% in diabetics versus 10.4% in non-diabetics; or having 
a sibling with diabetes: 20.4% in diabetics versus 4.5% in non-diabetics). All 
contaminant concentrations were higher in respondents with diabetes. The con-
centrations of congeners were divided into quartiles, and odds ratios—adjusted 
for age, sex, BMI, high density lipoprotein-C, omega-3/omega-6 ratio, and edu-
cation—were calculated for quartile 4 versus quartile 1 of self-reported diabetes. 
Statistically significant (p < 0.05) positive ORs were found for PCB 105, PCB 
118, and PCB 156 as well as for some of the non-dioxin-like PCBs. With lipid 
adjustment, statistically significant positive ORs were found for dioxin-like PCB 
118 and PCB 156 (information taken from graph; exact numbers not reported). 
The study also reported fasting glucose β coefficients for PCB congeners that 
were statistically significant based on lipid standardization or lipid adjustment; 
the congeners included PCB 105 and PCB 118. These models were adjusted for 
age, sex, BMI, high density lipoprotein-C, triglycerides, alcohol intake, smoking, 
omega-3/omega-6 ratio, selenium, and education. The β coefficients for wet-
weight analyses were positive and were statistically significantly associated with 
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an increase in fasting glucose for PCB 105 (6%, 95% CI 3%–9%) and PCB 118 
(7%, 95% CI 4%–10%). The primary limitation of this study is its cross-sectional 
design, but the half-lives of these two congeners are estimated at 4.5–5.5 years 
(Grandjean et al., 2008), and the results of this study agree with other similar 
studies that found positive associations between PCBs and diabetes in different 
exposed populations.
Using data collected as part of cross-sectional health study of Taiwan resi-
dents living near a closed PCP-producing factory, C. Y. Huang et al. (2015) 
conducted an analysis of exposure to PCDD/Fs in order to evaluate the asso-
ciation between such exposures and type 2 diabetes. More details on the fac-
tory, exposure, recruitment, and collection of health information are provided 
in Chapter 5, but, briefly, the environmental contamination took place 25–40 
years prior to the study. Of the 2,898 participants included in this analysis, 1,143 
had a serum dioxin level between 20 and 63 pg WHO98-TEQDF/g lipid, which 
was considered a “high dioxin level”; and 284 subjects had a dioxin level of 
64 pg WHO98-TEQDF/g lipid or higher. Of the 2,898 participants included in this 
analysis, 425 had diabetes, defined as having a fasting plasma glucose level above 
126 mg/dL or an existing diagnosis. Subjects who had diabetes were compared 
with those who did not have diabetes; these two groups were comparable with 
regard to sex and reported family history of diabetes, but differed in age and BMI 
(high BMI was defined as ≥ 24 kg/m2), factors that were controlled in analyses. 
Serum dioxin levels of 20–63 pg WHO98-TEQDF/g were associated with sta-
tistically significantly increased odds of diabetes (OR = 4.4, 95% CI 3.4–5.7), 
and the association was even stronger for serum dioxin levels above 64 pg 
WHO98-TEQDF/g lipid (OR = 7.8, 95% CI 5.6–10.9). After adjusting for age 
and BMI in multiple logistic regression models, high dioxin levels of 20–63 pg 
WHO98-TEQDF/g lipid (OR = 2.1, 95% CI 1.5–2.8) and ≥ 64 pg WHO98-
TEQDF/g lipid (OR = 2.7, 95% CI 1.9–4.0) were found to increase the risk for 
diabetes. When the dioxin level was included as quartiles in the model, adjusted 
ORs remained elevated and statistically significant, with a statistically significant 
and steep upward trend (p < 0.001). Additional analyses replaced age with the 
duration of residency in the endemic area in the model, and after adjustment for 
the duration of residency and BMI, a high dioxin level of 20–63 pg WHO98-
TEQDF/g lipid (OR = 2.2, 95% CI 1.6–3.0) and ≥ 64 pg WHO98-TEQDF/g lipid 
(OR = 3.6, 95% CI 2.4–5.4) remained strongly associated with risk of diabetes. 
The duration of residency in the endemic area was also an independent risk factor 
for diabetes, with a positive trend (p = 0.01). The strengths of this study include 
its large population (including a substantial proportion with diabetes, n = 425, 
the largest number of cases in studies newly reviewed in this volume); serum 
measurements of dioxin concentration; adjustments for age, BMI and residency; 
and a clear definition of diabetes and control groups. General limitations for this 
study and all studies that used the cross-sectional data collected from this popula-
tion include an unknown age at first exposure to PCDDs and PCDFs, unknown 
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cumulative exposure dose, the cross-sectional design, and the lack of additional 
data on other potentional confounders, such as waist circumference, dietary 
intake, and socioeconomic status.
Van Larebeke et al. (2015) describes how dioxin-like activity and serum 
HCB affected the risk of diabetes in both men and women (n = 1,583; 775 men 
and 808 women) enrolled by biomonitoring programs organized by the Flemish 
Centre for Environment and Health. Associations were based on self-reported 
health outcomes obtained in questionnaires administered in 2011. Blood and 
urine samples provided measures of internal exposure to organochlorine pollut-
ants, PCB 118, and cadmium; samples had been collected from these subjects 
between September 2004 and June 2005. The researchers also assessed dioxin-
like activity in pg TEQ/g fat. Among the participants, 30 men reported having 
diabetes (6.4%), and 62 men (13.2%) reported having either diabetes or a related 
condition; while 29 (5.8%) women reported having diabetes, and 55 (10.9%) 
women reported having diabetes or a related condition. A significant association 
(p ≤ 0.05) was found between internal exposure to the above mentioned pollutants 
and diabetes or a related condition when both men and women were combined; 
however, when the estimates were adjusted for additional covariates and stratified 
by sex, serum dioxin-like activity showed a significantly positive association with 
diabetes and with diabetes or a related condition for men and women separately. 
Results from this study suggest that exposure to dioxin-like chemicals increases 
the risk of diabetes or a related condition.
Other Identified Studies
Two other studies of diabetes were identified but either lacked exposure 
specificity (Swaminathan and Thangavel, 2015) or examined the association of 
diet in diabetics on serum levels of persistent organic pollutants (Kahleova et al., 
2016), which is not considered relevant to the committee’s charge.
Biologic Plausibility
Data from cell culture and animal models support the potential diabetogenic 
effects of TCDD in humans. TCDD is known to modify the expression of genes 
related to insulin transport and signaling and to inflammation (Ambolet-Camoit et 
al., 2015; M. J. Kim et al., 2012), which play a pivortal role in diabetes progres-
sion. In previous VAO updates, several studies have been reviewed that support 
the postulate that TCDD is mechanistically implicated in an increased risk of 
insulin resistance and in the development of diabetes. C. Wang et al. (2011) found 
that mice that lacked the aryl hydrocarbon receptor (Ahr) had enhanced insulin 
sensitivity and enhanced glucose tolerance, suggesting that Ahr has a physiologic 
function in glucose metabolism. This is supported by studies that found that 
sustained activation of Ahr by dioxin-like chemicals could contribute to diabetes, 
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including a study by Kurita et al. (2009), who found that exposing mice to dioxin 
significantly reduced insulin secretion after a glucose challenge. Recent data also 
demonstrate the importance of Ahr in glucose and fat metabolism, showing that 
the chemical inhibition of Ahr leads to decreased obesity and fatty livers in both 
male and female mice (Moyer et al., 2017). In an in vitro study of differentiated 
adipocytes, TCDD was found to significantly reduce insulin-stimulated glucose 
uptake (Hsu et al., 2010). Furthermore, P. Lu et al. (2015) found that activation 
of the AHR leads to dysregulation of the link between fatty liver and insulin re-
sistance, suggesting a mechanism involving fibroblast growth factor 21. A recent 
study used a transcriptomic approach to identify potential molecular mechanisms 
of TCDD-induced changes in the insulin secretion of pancreatic islets and β cells 
(Lai et al., 2017). Taken together, these data provide potential mechanims for the 
metabolic-modulating effects of AHR and dioxins that are critical for the progre-
assion of metabolic diseases, including diabetes.
Among the studies included in the current literature review, K. S. Kim et 
al. (2014) explored the relationships of diabetes and insulin resistance with 14 
organochlorine insecticides and 22 PCBs in visceral adipose tissue and subcutane-
ous adipose tissue in 50 patients with or without type 2 diabetes who underwent 
surgery for either cancer or benign liver or gallbladder lesions. The researchers 
reported that persistent organic pollutants in visceral or subcutaneous fat were 
significantly associated with both diabetes and insulin resistance. These findings 
are consistent with experimental animal studies that have reported that exposure 
to persistent organic pollutan mixtures through contaminated fish oil induces a 
severe impairment of whole-body insulin action (e.g., Ibrahim et al., 2011). Thus, 
on balance, there is biological plausibility for the COIs being causally implicated 
in the development of insulin resistance and diabetes. No new content has been 
identified since Update 2014.
Synthesis
The considerable amount of new evidence regarding type 2 diabetes reviewed 
and considered by the committee in forming its judgment included studies on 
male Vietnam veterans from the United States and New Zealand and studies of 
occupational cohorts and residential population-based studies of exposure. The 
analysis of AFHS data on testosterone levels and incident diabetes was consid-
ered to be of limited value to the committee’s charge because the results were not 
stratified by exposure status and because serum concentrations of dioxin were not 
included in the analysis (Mazur et al., 2014). Cox et al. (2015) calculated annual 
rates of hospital discharge records for New Zealand Vietnam veterans (presumed 
to be exposed to herbicides based on deployment to Vietnam) compared with 
the general residential population of New Zealand. Although slightly elevated 
among the veterans, the standardized hospitalization ratio for diabetes was not 
statistically significant. However, because diabetes is not usually a condition that 
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requires hospitalization, it is likely that only those with the most severe form 
of the disease were identified, and the prevalence of diabetes is expected to be 
higher. Moreover, this analysis is limited because exposure was not confirmed 
through serum measurements, and hospitalization estimates were adjusted only 
for age and not for other important risk factors, such as BMI or ethnicity.
The four occupational studies that were examined presented mixed results 
concerning an association between exposure to the COIs and diabetes mortality 
or prevalence. Among U.S. workers who were exposed to dioxins through the 
manufacturing of TCP or PCP, no difference in the rate of death from diabetes 
was found between either group of workers and the general U.S. population 
(Collins et al., 2016). Although serum dioxin measurements were collected, 
no results based on those measurements were presented for diabetes; instead 
the authors used employment records to categorize exposure, which may have 
introduced exposure misclassification, and use of the general U.S. population 
as a comparison likely introduced selection bias. Moreover, mortality is a poor 
measure of diabetes prevalence since while diabetes is often a contributing factor, 
it is not the actual cause of death and so may not be listed on the death certifi-
cate. Three international cohorts of workers examined the prevalence of diabetes. 
New Zealand workers who were employed in a phenoxy herbicide production 
plant that produced 2,4,5-T were also potentially exposed to the intermediates 
of TCP and other chlorophenols, and TCDD. 't Mannetje et al. (2018) extended 
the follow-up period of the 245 men and women in this cohort to approximately 
30 years from their last 2,4,5-T production exposure. Comparisons of workers 
by job title (high- versus low-exposure jobs) found that workers with highly 
exposed jobs had an elevated risk of doctor-diagnosed diabetes after control-
ling for age, gender, smoking, BMI, and ethnicity, but when the comparison of 
diabetes prevalence was based on serum TCDD concentration, no difference 
in the risk of diabetes was found for workers in the high- versus low-exposure 
groups, although both of the estimates were imprecise. A cross-sectional study 
of Japanese incinerator plant workers that included serum dioxin measurements 
found that the duration of employment was positively associated with TEQ levels 
(Yamamoto et al., 2015). Diabetes was statistically significantly associated with 
PCDDs, PCDFs, coplanar PCBs, and total dioxins based on adjusted odds ratios 
between the first and fourth quartile, and tests for trend were also significant 
for each of these COIs. Finally, among 235 Italian electric arc furnace workers 
exposed to multiple agents including metals and PCDD/Fs, PAHs, and PCBs, 
as sampled in the foundry dust, the prevalence of diabetes among the workers 
was statistically significantly increased compared with the general population; 
however, this study is quite limited because foundry dust is a complex mixture, 
and the authors were unable to discern the impact of the specific contaminants 
of the foundry dust on the health outcomes of those exposed workers. Estimates 
were adjusted only for age group and were not adjusted for other risk factors or 
activities that could affect the association (similar to Cox et al., 2015). It is likely 
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that many of the occupationally exposed study populations received co-exposures 
to metals and chemicals other than those that the committee was charged with 
specifically reviewing. Co-exposure to metals is a possible confounder that may 
affect the estimates and associations reported in those studies but none of them 
attempted to adjust for this factor.
Several studies that examined environmental exposures to the COIs or related 
chemicals were also reviewed. Four of the studies used U.S. populations. An 
analysis of NHANES data that examined serum concentrations of three chlori-
nated dibenzo-p-dioxins, one chlorinated dibenzofuran, and four dioxin-like PCBs 
and diabetes-related nephropathy found that none of the eight dioxin-like chemi-
cals were associated with pre-diabetes (Everett and Thompson, 2016). Two other 
studies, both of U.S. American Indian populations, were examined for diabetes 
prevalence (Aminov et al., 2016a,b) and incidence (Grice et al. 2017) with expo-
sure to the COIs. Aminov et al. (2016a,b) found an association between pesticide 
 (including HCB, a dioxin-like chemical) and PCB exposures and diabetes among 
a sample of people from the Mohowk Nation; however, analyses of individual 
dioxin-like chemcials or congeners were not presented. In a study of American 
Indian men and women in Arizona, Grice et al. (2017) examined incident type 2 
diabetes with a one-time baseline measurement of serum concentrations of POPs, 
including dioxin-like PCBs and HCB, and found that the adjusted odds of diabetes 
were statistically significantly decreased for HCB exposure and that none of the 
measured dioxin-like PCBs were statistically significantly associated with incident 
diabetes.
Three international studies of environmental exposures to the COIs and 
diabetes were reviewed for the current volume. The largest study of diabetes 
reviewed in this volume was a population-based study of diabetes using resi-
dents living in close proximity to a closed PCP-producing factory in Taiwan that 
had contributed to a high dioxin (PCDD/Fs) contamination of the environment 
between 1965 and 1979 (C. Y. Huang et al., 2015). Blood samples and health 
informa tion were collected on 2,898 residents in 2005–2007; 1,143 participants 
had dioxin levels between 20 and 63 pg WHO98-TEQDF/g, and 284 subjects 
had a dioxin level of 64 pg WHO98-TEQDF/g lipid or higher (considered to be 
the high-exposure groups). Serum dioxin levels of 20–63pg WHO98-TEQDF/g 
were associated with statistically significantly increased odds of diabetes in both 
crude and adjusted models (adjusted for age, BMI, and years of residence in 
the contaminated area), and the association was even stronger for serum dioxin 
levels above 64 pg WHO98-TEQDF/g lipid. When the dioxin level was analyzed 
in terms of quartiles in the model, the adjusted estimates remained elevated and 
statistically significant, with a statistically significant and steep upward trend 
(p < 0.001). In a cross-sectional survey of health outcomes that included a 
blood draw to measure the serum concentrations of PCBs (including dioxin-like 
mono-ortho congeners 105, 118, and 156) and organochlorine pesticides in 2,172 
Canadian Inuits aged 18 years and older, 147 respondents self-reported diabetes 
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(Singh et al., 2017). All contaminant concentrations were higher in respondents 
with diabetes. The concentrations of congeners were divided into quartiles, and 
the adjusted odds ratios for diabetes were found to be statistically significant for 
quartile 4 versus quartile 1 for PCB 105, PCB 118, and PCB 156. In the third 
international environmental study, Van Larebeke et al. (2015) conducted a general 
population study in Beligium and described how dioxin-like activity and serum 
HCB affected the risk of diabetes in both men and women. They assessed dioxin-
like activity in pg TEQ/g fat and found a statistically significant association for 
both sexes between internal exposure to the COIs as well as dioxin-like activity 
in pg TEQ/g fat and diabetes or a related condition.
Several lines of toxicologic evidence support mechanisms by which dioxins 
and dioxin-like chemicals could increase risk for diabetes. First, these chemicals 
modify the expression of genes related to insulin transport and signaling and 
to inflammation (Ambolet-Camoit et al., 2015; Kim et al., 2012). Studies in 
Ahr knockout mice demonstrate increased insulin resistance and glucose toler-
ance (J. Wang et al., 2011), findings that are consistent with an experiment that 
found dioxin-exposed mice to have significantly reduced insulin secretion after 
a glucose challenge (Kurita et al., 2009). More recently, Lai et al. (2017) used 
a transcriptomic approach to identify the potential molecular mechanisms of 
TCDD-induced changes in the insulin secretion of pancreatic islets and β cells.
In the aggregate, the epidemiologic studies provide new evidence supporting 
the previously observed associations between dioxins or dioxin-like PCBs and in-
creased risk for type 2 diabetes. Although some studies had substantial limitations 
or weaknesses, the Taiwanese study was large and demonstrated that even after 
adjustment for the factors associated with diabetes in their study, the odds ratios 
for dioxin-like chemicals equivalents had a strong monotonic trend for higher 
risk. The committee was divided on whether the newly reviewed studies were 
adequate to move the level of evidence of association of the COIs and diabetes 
to sufficient versus leaving the conclusion as limited or suggestive.
Conclusion
Following extensive deliberations regarding the strengths and weaknesses of 
the new evidence and evidence from studies reviewed in previous VAO reports, 
the current committee could not reach a consensus on whether the body of lit-
erature continues to constitute limited or suggestive evidence of an association 
between exposure to the COIs and diabetes or whether it now meets the criteria, 
shown below, for sufficient evidence of an association:
Epidemiologic evidence is sufficient to conclude that there is a positive associa-
tion. That is, a positive association has been observed between exposure to her-
bicides and the outcome in studies in which chance, bias, and confounding could 
be ruled out with reasonable confidence. For example, if several small studies 
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that are free of bias and confounding show an association that is consistent in 
magnitude and direction, then there could be sufficient evidence of an association.
Studies quite consistently show a relationship between exposure to dioxin 
and dioxin-like chemicals, characterized via serum levels, occupation, or subject 
self-report, and measures of diabetes health outcomes. These studies include 
multiple, independent studies of Vietnam veteran populations as well as studies 
of diverse cohorts of men and women with occupational or environmental expo-
sure to the COIs. Much is known about the risk factors for diabetes, such as age, 
obesity, and family history, and these have by and large been controlled for in the 
analyses of most studies reviewed. The studies of Ranch Hand veterans reviewed 
by previous committees and the Taiwan study examined by this committee dem-
onstrate strong dose–response trends and excellent control for confounding. The 
disease is, unfortunately, common enough that it has been feasible for a number 
of investigators to conduct epidemiological investigations in worker or general 
populations with sufficient statistical power to allow for conclusions to be drawn 
from the results. Importantly, there is a separate scientific literature that has 
identified candidate biologic mechanisms that would account for the observed 
health outcomes in humans.
However, the human evidence base also has its weaknesses. Although posi-
tive associations have been observed, some of the relative risks reported are low. 
A number of studies examined cohorts exposed to mixtures of both dioxin and 
dioxin-like chemicals and, importantly, a number of other chemicals that could 
plausibly influence diabetes outcomes. This lack of exposure specificity compli-
cates any attribution of the outcome to the COIs. While most studies adjusted 
for the primary risk factors for diabetes, several investigations relied on self-
reported information that might affect the development of the disease, rendering 
any adjustment for confounders possibly less effective. The studies of diabetes 
mortality are of limited utility because death from diabetes, either as a primary 
or a contributing cause, is underdiagnosed, which could introduce bias. Finally, 
some committee members felt that it is not yet possible to dismiss the notion that 
an as yet unidentified systematic bias, including confounding, may be influencing 
the observed results.
Given these observations, it was not clear to all committee members that a 
category change was appropriate. Thus, the committee was unable to reach con-
sensus as to whether the evidence regarding exposure to the COIs and diabetes 
should be classified as “limited or suggestive” or “sufficient.”
CIRCULATORY DISORDERS
Circulatory diseases are a group of diverse conditions, of which hyperten-
sion, coronary heart disease, and stroke are the most prevalent. CDC reports that 
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the number one cause of death for people 65 years of age and older is diseases of 
the heart. In the United States, 28.4 million adults (11.7% of the population) have 
a physician-diagnosed heart disease. American Indian and Alaska Natives have 
the highest incidence of heart disease, estimated at 13.7%, followed by whites 
with 11.3% and blacks with 9.5% (CDC, n.d.).
In 2016 more than 630,000 people died as a result of diseases of the heart, 
and more than 140,000 people died as a result of cerebrovascular disease and 
stroke (CDC, 2016). In addition to family history, the major risk factors for cir-
culatory diseases include age, male gender, smoking, hyperlipidemia, diabetes, 
and hypertension (World Heart Federation, 2018). Ideally, epidemiologic inves-
tigations of circulatory diseases would consider the conditions in this category 
separately rather than as a group because they all have different patterns of 
occurrence, and many have different etiologies. However, many mortality studies 
follow the ICD-9 rubric and report deaths from circulatory diseases together as 
a single category. Deaths from coronary or ischemic heart disease (IHD), heart 
failure, and, to a lesser extent, stroke predominate. Many of the reports also 
break out subcategories such as cerebrovascular disease and hypertension. The 
American Heart Association reports mortality related to coronary heart disease, 
not to its symptoms, which include angina and myocardial infarction. The relative 
importance of heart failure is determined by the age of the cohort. In younger age 
groups, most of the deaths in this category are expected to be from IHD. In most 
cases, cerebrovascular deaths are deaths from strokes, which can be classified 
as either ischemic or hemorrhagic. In the U.S. population, the great majority of 
strokes are of the ischemic type.
The methods used in morbidity studies of circulatory diseases may involve 
a direct assessment of the circulatory system, including an analysis of symptoms 
or history, a physical examination of the heart and peripheral arteries, ultra-
sound measurements of the heart and arteries, electrocardiography (ECG), chest 
radiography, cardiac computed tomography (CT), and, more recently, cardiac 
magnetic resonance imaging (MRI). Carotid ultrasound, echocardiogram, CT, 
MRI, and nuclear medicine studies can be used to visualize the heart and related 
vasculature directly as well as to assess function. ECG can be used to detect heart 
conditions and abnormalities, such as arrhythmias (abnormal heart rhythms), 
heart enlargement, and ischemia (acute or past myocardial infarctions). Chest 
radiography can be used to assess the consequences of IHD and hypertension, 
such as the enlargement of the heart often seen in heart failure. It is sometimes 
difficult to determine the time of onset of clinical findings, making the temporal 
relationship between exposure and disease occurrence uncertain. Although the 
ideal way to study cardiovascular outcomes would be to prospectively follow-
ing a well-characterized cohort and monitor for the incidence of discrete clinical 
events, researchers often must rely instead on medical records (which may or 
may not have all CVD-related information and outcomes) or death certificates 
(which may list nonspecific causes of death [e.g., respiratory arrest] and may not 
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contain all comorbid or contributing factors of death). New-onset angina or the 
performance of a revascularization procedure in a person who has no history of 
disease is also used as evidence of incident disease.
The committee responsible for Update 2006 began evaluating hypertension 
separately from other circulatory diseases, and the committee responsible for 
Update 2008 began the practice of evaluating IHD separately from other car-
diovascular outcomes. Beginning in Update 2012, stroke and cerebrovascular 
disease were also considered separately from discussions of “other circulatory 
diseases.” The current committee has continued the practice of evaluating the 
literature related to these outcomes as independent subsections.
A number of studies of different populations that received potentially rel-
evant exposures were identified in the literature search, but the studies did not 
characterize exposure with sufficient specificity for their results to meet the com-
mittee’s criteria for inclusion in the evidentiary database (see Chapter 3), and they 
are only briefly mentioned under the heading of “Other Identified Studies.” For 
instance, this rubric would apply to the occupational study conducted by Ruder et 
al. (2014) in which 24,865 eligible workers from capacitor manufacturing, repair, 
and maintenance sites in the United States were exposed to arochlor 1254, 1242, 
and 1016, among others (mixed PCBs), and the authors sought to examine the 
relationship between PCB exposure and different causes of mortality. However, 
the study did not name specific dioxin-like PCBs, and no TEQs or other quanti-
fication of relevant exposures was presented. Likewise, Ljunggren et al. (2014) 
assessed serum concentrations of dioxin-like chemicals in patients diagnosed 
with CVD but did not define how this determination was made, and therefore the 
work is of little utility to the commmittee.
Table 42, which can be found at www.nap.edu/catalog/25137, summarizes 
the results of studies related to circulatory disorders.
Biologic Plausibility
Studies have demonstrated that both the vasculature and the adipose tissue 
are targets of TCDD toxicity, and these studies have provided a mechanistic 
understanding of how TCDD exposure increases the risk of circulatory diseases, 
such as hypertension, IHD, and stroke. Exposing cultured endothelial cells or 
cultured adipocytes to TCDD induces major changes in gene expression and leads 
to substantial increases in oxidative stress and inflammatory markers (Andersson 
et al., 2011; S. G. Han et al., 2012; Ishimura et al., 2009; Kerley-Hamilton et al., 
2012a; M. J. Kim et al., 2012; Kopf and Walker, 2010; Majkova et al., 2009; 
Puga et al., 2004; Qin et al., 2015; Zhou et al., 2017). Studies also indicate that 
the exposure of cultured endothelial cells to TCDD results in the down-regulation 
of genes involved in blood pressure regulation and the up-regulation of genes in-
volved in the myocardial infarction pathways (Qin et al., 2015) and can promote 
endothelial cell apoptosis (Q. Liu et al., 2017). In animal models, developmental 
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exposure to TCDD has been shown to cause structural, molecular and functional 
cardiac abnormalities, and altered heart physiology in mouse embryos and to 
predispose adults to cardiac disease (Carreira et al., 2015). Furthermore, the 
loss of AHR, as happens in Ahr knockout mice, is associated with decreases 
in blood pressure (modeling hypotension), while sustained activation of AHR 
resulting from dioxin exposure leads to increases in blood pressure (Agbor et 
al., 2011). N. Zhang et al. (2010) showed that the genetic loss of AHR from all 
tissues or solely from endothelial cells results in hypotension. In contrast, Kopf 
et al. (2010) demonstrated that the chronic exposure of mice to TCDD induces 
hypertension that is associated with significant increases in vascular oxidative 
stress and decreases in vascular relaxation. Those changes in vascular function 
and blood pressure could be mediated in part by increases in the metabolism of 
arachidonic acid to vasoconstrictive and inflammatory eicosanoids (Bui et al., 
2012; Diani-Moore et al., 2014). Studies have also demonstrated that exposure 
to AHR agonists, including TCDD and benzo[a]pyrene, increases the incidence, 
severity, and progression of atherosclerosis, a primary cause of IHD and stroke 
(Dalton et al., 2001; Kerley-Hamilton et al., 2012a; D. Wu et al., 2011). Further-
more, D. Wu et al. (2011) demonstrated that TCDD mediates those effects in part 
by increasing vascular inflammation, a finding that is suppored by a recent study 
in chick embryos showing that TCDD-cardiotoxicity is eliminated with exposure 
to a COX-2 inhibitor (Fujisawa et al., 2014). Another study in human coronary 
artery smooth muscle cells indicates that the AHR pathway can cooperate with 
the Tcf21 pathway to initiate the expression of pro-inflammatory genes (J. B. Kim 
et al., 2017). In addition to the vasculature, studies also suggest that the heart is 
a target of TCDD. TCDD exposure increases the hypertrophy of rat cardiac cells 
in culture (Zordoky and El-Kadi, 2010) and impairs the differentiation of mouse 
embryonic stem cells into cardiomyocytes (Neri et al., 2011).
In addition to the direct effects of TCDD on the vasculature and heart, there 
is evidence that TCDD influences other CVD risk factors, for example, by pro-
moting obesity (Brulport et al., 2017; Kerley-Hamilton et al., 2012b), accumulat-
ing macrophage lipid, inducing lipid mobilization, and altering lipid metabolism. 
Thus, on the basis of animal models, there appear to be several overlapping and 
potentially contributing pathways that link TCDD exposure and increased CVD 
risk.
Arsenic exposure has also been linked to heart effects in a study examining 
the relationship between the expression of AHR and CYP1A1 in humans exposed 
to arsenic in drinking water. Data from this study indicate that arsenic exposure 
was associated with an increased expression of AHR and CYP1A1 in the blood 
and that increased CYP1A1 was associated with a prolonged corrected QT inter-
val following long-term exposure to arsenic (Cui et al., 2016).
Long-term exposure to oxidative stress is suspected to be etiologic to many 
chronic diseases, including CVDs. A variety of data, some discussed above, 
demonstrates a link between TCDD exposure and oxidative stress (reviewed in 
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Mohsenzadeh et al., 2018). A recent small study by Lerro et al. (2017) indicates 
a link between 2,4-D and biologic markers of oxidative stress in 30 farmers 
who participated in the AHS and who applied pesticides occupationally and in 
10 non-farming controls who did not apply pesticicides; all were non-smoking 
men ages 40–60 years. Multivariate linear mixed-effect models for repeated 
measures were used for each pesticide– oxidative stress marker combination, 
and all estimates were adjusted for age, farmer or control subject, study time 
point, and creatinine to account for pesticide metabolites and oxidative stress 
markers in urine. Other confounders included were BMI, smoking history 
and duration, alcohol use, regular physical activity, multivitamin or vitamin C 
supplementation, infection or symptoms at sample collection, allergy symptoms 
at sample collection, and history of cancer. Farmers had significantly higher 
urinary 2,4-D levels compared with controls, and this was associated with 
elevated levels of 8-OHdG, a marker of oxidative stress (β = 0.066, 95% CI 
0.008–0.124), and 8-isoPGF, a product of lipoprotein peroxidation (β = 0.088, 
95% CI 0.004–0.172). Thus, this study provides one route to plausibility for 
the 2,4-D association with cardiovascular outcomes, although studies will need 
to be specifically conducted in individuals with known clinical endpoints (e.g., 
hypertension) in order to implicate this mechanism directly.
Hypertension
Hypertension, typically defined as blood pressure above 140/90 mmHg, 
affects more than 70 million adult Americans and is a major risk factor for coronary 
heart disease, myocardial infarction, stroke, and heart and renal failure. The major 
quantifiable risk factors for hypertension are well established and include family 
history, age, sex, race, obesity, reduced nephron number, high dietary salt intake, 
tobacco use, excessive alcohol intake, and physical inactivity (CDC, 2014b). The 
strongest conclusions regarding a potential increase in the incidence of hyperten-
sion come from studies that have controlled for these risk factors. CDC estimates 
that in the United States, 64% of men and 69% of women ages 65–74 years have 
hypertension. When stratified by race/ethnicity and sex, the prevalence of diag-
nosed hypertension is highest among African American men and women (43.0% 
and 45.7%, respectively), followed by white men and women (33.9% and 31.3%, 
respectively). For the groups reported, hypertension is lowest among Mexican 
Americans (27.8% for men and 28.9% for women) (CDC, 2018).
Conclusions from VAO and Previous Updates
The committee responsible for Update 2006 first concluded that the avail-
able evidence placed hypertension in the limited or suggestive category, based 
primarily on consistent evidence from several studies of Vietnam veterans that 
used measured serum concentration of dioxin. Additional evidence reviewed 
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in Update 2008, Update 2010, Update 2012, and Update 2014 reaffirmed this 
conclusion.
Several studies of hypertension among Vietnam veterans have been reviewed 
in the VAO series. These have included well-designed studies of incidence, preva-
lence, or mortality in the U.S. ACC (Cypel and Kang, 2010; Kang et al., 2006) 
and the AFHS (AFHS, 1995, 2000, 2005) cohorts that have consistently reported 
increased hypertension with increasing levels of serum dioxin. Other studies of 
U.S. Vietnam veterans that did not use serum dioxin concentrations as markers of 
exposure also reported an increased prevalence of hypertension associated with 
presumed exposure to herbicides.
Among international cohorts of Vietnam veterans, the prevalence of and 
mortality due to hypertension have been assessed among Australians and South 
Koreans. A statistically significant increased prevalence was found among the 
Australian veterans compared with standardized population controls. Two preva-
lence studies of hypertension among the Korean Vietnam veteran cohort did not 
find an increased prevalence of hypertension (Yi, 2013; Yi et al., 2014a), but the 
studies were limited because they do not include veterans who died or relocated 
between their Vietnam service and the start of the investigation. Thus, the validity 
of the calculated exposure–outcome relationship is based on the strong assump-
tion that the observed relationships in those included are similar to those who 
were not included, which is doubtful. In some cases, 40% of the relevant data for 
the population are missing. In addition, the determination of hypertension was 
either by self-report or through health insurance claims. It cannot be certain that 
all participants with hypertension were detected because no standardized blood 
pressure assessment was done.
Mortality studies that report hypertension are rarely informative because 
hypertension is so prevalent in the adult population and many more people die 
with hypertension than from hypertension. For those with hypertension listed 
as the cause or a contributing cause of death, it is uncertain how representative 
those who died from hypertension are of all people who may have developed it. 
Several mortality studies that included hypertension have been reviewed by VAO 
committees, but they have shown inconsistent findings, likely because they suffer 
from the limitations listed above as well as from a lack of adjustment for many 
important confounding factors. A decreased, but not statistically significant, risk 
of mortality from hypertension was found in the study of U.S. women veterans 
as well as when the population was limited to nurses only (Kang et al., 2014a), 
whereas a slight, but again, not statistically significant, increase was reported 
among Korean veterans (Yi et al., 2014b).
The studies of occupational cohorts reviewed by previous VAO update com-
mittees rarely reported hypertension as a discrete outcome; among those that 
did, the results were mixed, with reports of both increased and decreased risk, 
but none of the risk estimates were statistically significant. Several studies did 
not define hypertension, therefore making it difficult to draw conclusions on its 
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association with the COIs. Similar mixed and not statistically significant findings 
were reported for the environmental studies that have been reviewed.
Update of the Epidemiologic Literature
Six new studies of exposure to the COIs and hypertension have been pub-
lished since Update 2014.
Vietnam-Veteran Studies Cypel et al. (2016) analyzed the results of a 2013 
survey of 3,086 (80.3% response rate) ACC veterans that compared outcomes 
in both Vietnam-deployed (n = 1,477) and non-Vietnam-deployed (n = 1,609) 
herbicide sprayers and non-sprayers. Eligibility for the ACC cohort was restricted 
to men who had a minimum of 18 months of active U.S. Army service from July 
4, 1965, to March 28, 1973, and who were alive in October 2011 and whose 
health allowed them to participate. ACC veterans were specifically involved in 
chemical operations in Vietnam and were directly exposed to herbicides and other 
chemicals, including tear gas and napalm (see descrip tion of the ACC veterans 
in Chapter 5). Participants self-reported physician -diagnosed hypertension, but 
the diagnosis was evaluated and confirmed by blood pressure measurements 
taken by trained medical technicians and by medical record reviews for a sub-
set of 468 individuals. Overall agreement between the medical records review 
and self-reported hypertension was 89%. Additionally, individual exposure to 
herbicides was collected by self-report to questions of mixing, handling, and 
spraying herbicides while in the military and was verified by using measured 
serum TCDD levels for a subset of 636 individuals who had participated in an 
earlier health survey of the cohort (1999–2000) and who had had blood drawn 
and serum TCDD (ppt or pg/g lipid) measurements made at that time. A history 
of herbicide spraying was much higher among the Vietnam-deployed (62.0%) 
than non-Vietnam-deployed veterans (28.0%) (p < 0.0001). A greater percentage 
of Vietnam-deployed veterans were current or former smokers (72.3%) than non-
Vietnam-deployed veterans (64.0%) (p < 0.0001). Hypertension was highest in 
Vietnam-deployed sprayers (81.6%), followed by non-Vietnam-deployed sprayers 
(77.4%), Vietnam-deployed non-sprayers (72.2%), and non-Vietnam-deployed 
non-sprayers (64.6%). Overall, self-reported hypertension was found in 78.0% of 
all participants who served in Vietnam and in 68.2% of all participants who did 
not deploy to Vietnam, indicating a possible effect of Vietnam tour of duty over 
and above exposure to herbicides. To demonstrate a dose– response relationship, 
the authors showed that the mean serum TCDD levels were significantly higher 
among Vietnam herbicide sprayers (mean = 3.5 ppt, range: 0.5–30.6) than among 
Vietnam non-sprayers (mean = 2.5 ppt, range: 0.7–17.7) (p < 0.0001), but no 
differences in mean TCDD level were observed between non-Vietnam-deployed 
sprayers (mean = 2.4 ppt, range: 0.7–9.6) and non-sprayers (mean = 2.2 ppt, 
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range: 0.4–12.5) (p = 0.69). Using logistic regression and adjusting for Vietnam 
service status, rank, age at the time of the survey, tobacco use, alcohol use, race, 
and BMI, having sprayed herbicides (OR = 1.74, 95% CI 1.44–2.11) and having 
deployed to Vietnam (OR = 1.26, 95% CI 1.05–1.53) were both strongly as-
sociated with self-reported hypertension. The association was strongest when 
comparing Vietnam-deployed sprayers to non-Vietnam-deployed non-sprayers 
(OR = 2.21, 95% CI 1.76–2.77). Finally, among Vietnam-deployed veterans, a 
significantly elevated association between the odds of hypertension for sprayers 
and non-sprayers remained after an adjustment was made for potential confound-
ers (OR = 1.77, 95% CI 1.35–2.30). Similarly, for those veterans who did not 
deploy to Vietnam, self-reported hypertension was significantly elevated when 
sprayers were compared with non-sprayers (OR = 1.72, 95% CI 1.31–2.26).
This was a well-designed study with a large sample size and conducted 
among the most relevant population (Vietnam veterans with known herbicide 
exposure) which included several levels of exposure (herbicide sprayers and 
non-sprayers and Vietnam-deployed and non-Vietnam-deployed) and an attempt 
to quantify it in the participants. Although serum TCDD concentrations were not 
available for all participants and were collected at least 25 years after Vietnam-
era service, for those with serum TCDD levels available, self-reported herbide 
spray status had high agreement with the measured levels. The highest mean 
serum TCDD level was observed among sprayers deployed to Vietnam, and the 
lowest mean TCDD level was found for non-Vietnam non-sprayers, as would 
be expected, with a significant dose–response association. Likewise, there was 
high agreement (89%) between self-reported hypertension and in-person blood 
pressure measurements and medical records review for a subsample of study 
participants. The analyses controlled for important risk factors for hypertension, 
including age, race (white versus others), BMI, tobacco smoking status, rank, 
Vietnam service status, and alcohol intake, but did not collect information on 
(and therefore did not control for) other risk factors such as diabetes, a family 
history of hypertension, and dietary intake of sodium and fat. A major strength of 
this analysis was using the non-Vietnam-deployed ACC veterans as a comparison 
group because they were similar to members of the study group with respect to 
branch, length and time period of service, military occupation, and duties except 
for deployment in Vietnam, which has the effect of minimizing unmeasured expo-
sures and confounders of concern and bias. Additionally, because all of the men 
who served in ACC units were stationed at Fort McClellan for at least some time, 
and Fort McClellan is in close proximity to Anniston, Alabama, where Monsanto 
operated a plant that produced PCBs, all ACC veterans were likely exposed to 
at least low levels of these and other chemicals. Therefore, comparisons using 
deployed and non-deployed ACC men are likely to be biased toward the null 
due to this baseline of increased exposure, but despite that, the adjusted effect 
estimate when Vietnam-deployed sprayers were compared with non-Vietnam-
deployed non-sprayers was still more than twice as high, precise, and statistically 
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significant. Although the exact types and quantities of the various chemicals these 
ACC veterans were possibly exposed to during the Vietnam War are unknown 
and may include chemicals other than the herbicides (such as insecticides, diesel 
and jet fuels, cleaning solvents, tear gas, napalm, and antimalarial medications), 
there is statistically significant support for an association between herbicide 
exposure and self-reported, physician-diagnosed hypertension.
Occupational Studies Cappelletti et al. (2016) performed a retrospective study 
of 331 male electric arc foundry workers at a single plant in Trentino, Italy, to 
determine if they experienced excess mortality from all causes or were at an 
increased risk for several other disases including complicated (with end organ 
damage) and uncomplicated (no end organ damage) hypertension, diabetes, and 
CVD due to their occupational exposure to foundry dust. An analysis of the dust 
emissions found that the dust contained metals (including iron, aluminum, zinc, 
manganese, lead, chromium, nickel, cadmium, mercury, and arsenic), PAHs, 
PCBs, and PCDD/Fs (reported as TEQs). Because foundry dust is a mixture, it 
is not known which of the agents were associated with a specific outcome or to 
what extent. The men included in the study had worked at the factory for at least 
1 year. For the hypertension analysis, 235 living workers, were compared with the 
standardized general population of Region Trentino-Alto Adige (where the fac-
tory was located) because there were few non-exposed foundry workers and high 
attrition rates. Company and medical records were used to determine vital status. 
Requests for exemption health care fees were used as a surrogate measure to iden-
tify the most prevalent morbid conditions in the general population, which were 
then applied to the cohort to compute relative risks for each of the conditions. The 
workers were followed from March 19, 1979 (or their first day of employment), 
through December 31, 2009 or date of death. Effect estimates (prevalence ratios) 
were calculated using Mantel-Haenszel estimator adjusted for age group (20–64, 
65–74, ≥ 75 years). Compared with the age-adjusted provincial population, sta-
tistically significantly elevated risks of both non-complicated hypertension (n = 
30; RR = 2.44, 95% CI 1.75–3.40) and complicated hypertension (n = 14; RR = 
2.22, 95% CI 1.35–3.65) were found among the electric arc furnace workers. The 
strengths of the study include its long-term follow-up of the workers. This study 
is most limited by the fact that foundry dust is a complex mixture, which made it 
impossible to discern the impacts of the specific contaminants of the foundry dust 
on the health outcomes of the exposed workers. Estimates were adjusted only for 
age group and were not adjusted for other risk factors such as tobacco use, BMI, 
or other jobs or activities that could result in similar exposures. The possible 
exposure to foundry dust by the general population that was used for comparison 
is not discussed, although the foundry appears to be in the local vicinity and 
emissions from it were reported to be present within a 2-kilometer radius of it.
Yamamoto et al. (2015) performed a cross-sectional study to investigate the 
health outcomes that 698 male workers sustained while employed at 36 municipal 
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and private waste incineration plants in Japan; serum dioxin measurements were 
obtained for 678 of the workers. These workers were employed from 2000 
to 2007. First, a questionnaire was completed by participants on lifestyle and 
medical history. Blood samples were taken from each subject to evaluate serum 
dioxin, PCDD, PCDF, and coplanar PCB levels (77, 81, 126, 169, 105, 114, 
118, 123, 156, 157, 167, and 189). Serum concentrations of dioxin isomers were 
expressed as pg/g lipid, converted to TEQ, and expressed as TEQ/g lipid. Both 
clinical and physiological examinations were also performed. Participants were 
then categorized into four groups: workers whose jobs did not involve working 
directly in an incineration facility, workers whose jobs did involve work inside 
the incineration facility (but only handling solidified fly ash and slag or residues 
that were nonflammable), workers whose jobs involved helping with incineration- 
related work inside an incineration facility, and workers whose jobs mainly 
involved the operation and maintenance of an incinerator including a furnace, 
electric dust collector, and wet scrubber inside an incineration facility. Subjects 
were tested for diabetes, hypertension, hyperlipidemia, and liver dysfunction. The 
total serum dioxin concentration level for incinerator workers was 13.7 (median) 
or 17.2 (arithmetic mean) pg TEQ/g lipid, while the (arithmetic mean) average 
total dioxin concentration was 19.4 pg TEQ/g lipid for the general population 
in Japan, indicating no real difference between the two groups. However, in the 
exposed workers, the duration of employment was positively associated with 
TEQ levels (9.8 and 21.7 pg TEQ/g lipid for those employed 9 years and 15.5 
years, respectively). Coplanar PCBs were significantly correlated (p < 0.05) 
with 14 parameters of laboratory and physiological tests. Serum concentrations 
of total dioxins were higher in workers whose jobs involved operation, mainte-
nance, and other incinerator work inside the facilities regardless of the duration 
of their employment as compared with workers without these job duties. Serum 
concentrations of dioxin congeners (PCDDs, PCDFs, coplanar PCBs, and total 
dioxins) were used to divide the participants into quartiles, and odds ratios for 
hypertension were computed for each category of dioxin congener by comparing 
each quartile to the lowest quartile (referent) and adjusting for age, survey year, 
BMI, smoking, and alcohol consumption. Although the adjusted associations 
between quartiles 2 and 3 and the referent were not consistently significantly 
elevated, the comparisons of quartile 4 with the referent group for PCDDs (OR = 
1.66, 95% CI 1.00–2.78, p < 0.05), PCDFs (OR = 1.90, 95% CI 1.12–3.25, p < 0.05), 
coplanar PCBs (OR = 2.31, 95% CI 1.33–4.02, p < 0.01), and total dioxins (OR 
= 1.92, 95% CI 1.12–3.28, p < 0.05) showed elevated, statistically significant 
associations between the serum levels of PCDD/Fs and total dioxins with the 
prevalence of hypertension. The test for trend was also significant (p < 0.05) 
for each of these COIs. Overall, there was no difference in the prevalence of 
hypertension among the workers of all ages and the Japanese population (44.8% 
versus 46.2%, respectively). However, when stratified by age groups and com-
pared with the general Japanese population, the prevalence of hypertension was 
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statistically significantly increased in in workers between the ages of 29 to 
49 years. Nonetheless, there were no statistically significant differences in any of 
the age groups in the total dioxin concentrations between the incinerator workers 
and the general population, suggesting that something other than dioxin may be 
contributing to the increased risk for hypertension among this younger popula-
tion. The strengths of this study include a large sample size, the homogeneity 
of study subjects with respect to ethnicity and workplace, the measurement of 
exposure for individuals, significance for each congener, and the adjustments of 
multiple confounders in the analysis.
Environmental Studies Shiue et al. (2014) used the U.S. population-based 
NHANES study data from 2011–2012 to examine whether different sets of envi-
ronmental chemical concentrations were risk factors of high blood pressure. The 
study used previously collected demographics and blood pressure readings along 
with the concentrations of various environmental chemicals (14 heavy metals and 
20 industrial chemicals, including arsenic compounds and 2,4-D) measured in 
urine. The urine samples were available for only a subsample of the study popu-
lation (20–30%). High blood pressure was defined as a systolic blood pressure ≥ 
140 mmHg or a diastolic blood pressure ≥ 90 mmHg. The analysis used a total 
sample size of 9,756 participants who were 20 years of age or older, of whom 
3,035 (31.1%) had high blood pressure. This sample is quite young, with 63% of 
participants being under age 39 years, a group in whom hypertension would be 
uncommon. The associations of the environmental contaminents with high blood 
pressure were adjusted for urinary creatinine, age, sex, ethnicity, and BMI and 
were weighted for the survey design using logistic regression. After full adjust-
ment, even though a number of heavy metals and chemicals were associated with 
high blood pressure, none of them were the COIs. Of note, however, although 
total arsenic was marginally associated with high blood pressure in the weighted 
model (OR = 1.13, 95% CI 0.99–1.29, p = 0.066), trimethylarsine oxide (OR = 
2.47, 95% CI 1.27–4.81, p = 0.011) and dimethylarsonic acid concentrations (OR 
= 1.42, 95% CI 1.12–1.79, p = 0.006) were associated with high blood pressure. 
Thus, in the general U.S. population, arsenic and its related compounds were 
found to elevate the risk for hypertension, even in this low at-risk NHANES 
sample, and the correlation was likely detected because of the large sample size 
and accurate determinations of exposure concentrations.
Van Larebeke et al. (2015) prospectively studied the associations of exposure 
to organochlorine pollutants, HCB, dioxin-like (PCB 118) and non-dioxin PCBs, 
and cadmium with a variety of self-reported health conditions, including diabetes 
and hypertension, as part of a Flemmish biomonitoring program. In 2004–2005, 
height, weight, urine, and serum were collected from the participants. Dioxin-like 
activity in pg TEQ/g fat was also assessed. Subjects filled out a survey collecting 
demographic data and information on education and tobacco and alcohol use. In 
2011, participants in the program were mailed a second survey to collect updated 
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information on general health, smoking and alcohol consumption behaviors, 
medical conditions, and current medications. There were 973 respondents, 504 
women and 469 men (response rate 65.6%), whose information was used for the 
current analysis. Serum was assayed for HCB, dioxin-like PCB 118, and other 
chemicals. Medical diagnoses were all self-reported and not confirmed. For the 
diagnosis of hypertension, subjects were asked, “Do you suffer or have you suf-
fered from arterial hypertension in the past 10 years?” Although 162 (34.5%) men 
and 172 (34.1%) women reported hypertension, it is likely underreported in this 
population of adults aged 50–65 years when recruited in 2002–2006. Overall, 
there were no differences in the levels of dioxin-like activity (pg/TEQ/g fat) or 
PCB 118 (ng/g fat) between participants and non-participants of the follow-up 
survey, emphasizing the representativeness of the sample. However there was 
a difference for HCB (p = 0.051). In the combined sample, after adjusting for 
BMI, exercise in minutes per week, level of education, and glasses of alcoholic 
beverages per week, dioxin-like activity was positively associated with a risk of 
hypertension (OR = 1.61, p = 0.014), as were HCBs (OR = 1.99, p = 0.0005); 
PCB 118 was not reported. PCBs with dioxin-like activity approached statisti-
cal significance in men only (p = 0.066), while HCBs were significant for both 
men and women in at least one model. In a crude model, the serum concentra-
tion of PCB 118 was not associatied with hypertension. In a model accounting 
for confounders and with additional adjustments made for correlated exposures 
(HCB, p,p′-DDE, cadmium, and non-dioxin PCBs), there was a significant asso-
ciation between serum PCB 118 levels and hypertension in men, but not women. 
The odds ratio for men for the 90th percentile vs. 10th percentile was 3.27 (p 
= 0.0011). In a model with additional adjustments for covariates and correlated 
exposures (HCB, p,p′-DDE, cadmium, and non-dioxin PCBs), the association 
with hypertension was marginally significant for men: the OR for 90th percentile 
versus 10th percentile was 1.95 (p = 0.09). The strengths of the study included its 
prospective design, its large sample size, the representativeness of the older adult 
general population, and the use of objective measures of exposure. However, the 
findings are limited by the absence of validated medical diagnoses. Although 
HCB was associated with hypertension in several models, mono-ortho dioxin-like 
PCB 118 was not associated with hypertension.
P. M. Lind et al. (2014) examined hypertension in participants of the PIVUS 
(Prospective Investigation of the Vasculature in Uppsala Seniors) cohort, who 
were men and women aged 70 years or older and residents of Uppsala, Sweden. 
Of 2,025 eligible subjects, only half (n = 1,016) agreed to participate. Partici-
pants completed a questionnaire to assess their medical history, smoking history, 
and medication use. A clinical exam including blood pressure measurement was 
performed, and fasting blood work was obtained for lipid and glucose analysis. 
Hypertension was defined as having a systolic blood pressure > 140 mmHg, 
a diastolic blood pressure > 90 mmHg, or using antihypertensive medication. 
General exposure to 23 persistent organic pollutants (POPs) was quantified from 
Veterans and Agent Orange: Update 11 (2018)
Copyright National Academy of Sciences. All rights reserved.
METABOLIC AND CARDIOVASCULAR DISORDERS 495
stored serum samples collected at the time of entry into the PIVUS study using 
high-resolution gas chromatography/mass spectrometry. Normalized POPs were 
estimated using individualized lipid levels and TEQs measured for dioxin-like 
PCBs and OCDD combined and separately for the dioxin-like coplanar non-
ortho PCBs (PCB 126 and PCB 169) and the dioxin-like mono-ortho PCBs (105, 
118, 156, 157, and 189). As the participation rate in this cohort was only 50%, 
an evaluation of cardiovascular disorders and medications in 100 consecutive 
non-PIVUS participants was also performed to serve as a control. Although both 
PIVUS participants and non-participants were broadly similar, the prevalence of 
diabetes, congestive heart failure, and stroke was higher among non-participants. 
Overall, 72% of the participants in this study had hypertension. When exposures 
were adjusted for gender, BMI, smoking status, exercise habits, and education 
levels, none of the dioxin-like PCBs were associated with prevalent hyperten-
sion: PCB 105 (OR = 1.23, 95% CI 0.96–1.60; p = 0.11), PCB 118 (OR = 1.26, 
95% CI 0.95–1.67; p = 0.11), PCB 156 (OR = 0.9, 95% CI 0.63–1.3; p = 0.58), 
PCB 157 (OR = 0.9, 95% CI 0.65–1.26; p = 0.55), PCB 189 (OR = 0.87, 95% 
CI 0.69–1.09; p = 0.22), PCB 126 (OR = 1.1, 95% CI 0.94–1.3; p = 0.24), and 
PCB 169 (OR = 0.86, 95% CI 0.61–1.2; p = 0.36). When exposure was classified 
by individual POPs, PCB 105 (OR = 1.5, 95% CI 1.19–1.89) and PCB 118 (OR 
= 1.56, 95% CI 1.2–2.01) were significant when adjusted for gender only. This 
was a large and well-designed and analyzed study of elderly adults that when 
adjusted for gender, BMI, smoking staus, exercise habits, and education showed 
no associations between hypertension and dioxin-like PCBs.
Other Identified Studies One other occupational study was identified that re-
ported deaths from hypertension with underlying heart disease, but it was limited 
by a lack of exposure specificity (Ruder et al., 2014). An environmental study 
was also identified (Akahane et al., 2017) that examined the prevalence of self-
reported long-term health outcomes (including high blood pressure) in people 
exposed to PCBs, dioxins (e.g., PCDD/Fs), and dioxin-like chemicals through the 
ingestion of contaminated rice bran oil (Yusho accident) compared with an age-, 
sex- and residential-area-matched group. Because no TEQs or other quantifica-
tion of relevant exposures was presented, the study was not considered further.
Biologic Plausibility
The biological mechanism for dioxin’s impact on hypertension is being 
investigated in animal models and human cell cultures, and it has shown clear 
effects on gene expression, vascular function, and lipid glucose metabolism. 
The exposure of human endothelial cells to TCDD causes the down-regulation 
of genes involved in blood pressure regulation (Qin et al., 2015), suggesting a 
potential molecular mechanism for TCDD’s impact on hypertension. Recent data 
also indicate that the increase in hypertension following AHR activation is linked 
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to the inactivation of endothelial nitric oxide synthases, which is expressed in en-
dothelial cells and functions to modulate vascular blood pressure (C. C. Chang et 
al., 2017). Data also demonstrate a link to the Ahr pathway using mouse models, 
demonstrating that sustained Ahr activation by dioxins results in increased blood 
pressure, which is associated with significant increases in vascular oxidative 
stress and decreases in vascular relaxation (Kopf et al., 2010). Conversely, hypo-
tension is associated with Ahr loss in knockout models, either knocked out in the 
whole animal or specifically in endothelial cells, (Agbor et al., 2011; N. Zhang et 
al. 2010). Those changes in vascular function and blood pressure could be medi-
ated in part by increases in the metabolism of arachidonic acid to vasoconstrictive 
and inflammatory eicosanoids (Bui et al., 2012; Diani-Moore et al., 2014).
A recent study on genetic polymorphisms of the AHR signaling pathway 
genes in a human cohort recruited from central Russian (Kursk) cardiology and 
neurology clinics also suggests a plausible link between exposure to TCDD 
and dioxin-like chemicals and essential hypertension (Polonikov et al., 2017). 
Seven common polymorphisms in the AHR pathway genes AHR, ARNT, AHRR, 
CYP1A1, CYP1A2, CYP1B1, and NQO1 were genotyped from venous blood 
samples of 1,341 cases and 819 controls. A polymorphism in ARNT was shown to 
be associated with increased essential hypertension, whereas a single nucleotide 
polymorphism in CYP1A2 showed a decreased risk of essential hypertension in 
a recessive genetic model. Additional log-likelihood ratio tests showed epistatic 
interactions on essential hypertension susceptibility for all single nucleotide poly-
morphisms. These results are generally consistent with the suggestion that the 
AHR pathway is involved in hypertension and that TCDD activation of this path-
way can influence hypertension in the human population.
Synthesis
Hypertension, defined as a systoloic/diastolic blood pressure exceeding 
140/90 mmHg, affects approximately 75 million Americans, or one in every 
three adults. This trait remains one of the main contributing risk factors to cardio-
vascular, peripheral vascular, and cerebrovascular disease. Risk factors include 
family history, age, sex, race, obesity, reduced nephron number, high dietary salt 
intake, tobacco use, excessive alcohol intake, and physical inactivity. Owing to 
its frequency, assessing whether there is increased risk with exposure to the COIs 
has been challenging. However, the committee for the current update believes 
that there are enough new data to move the category of association to sufficient 
evidence.
Cypel et al. (2016) offers the most compelling evidence for the change. The 
well-designed study was conducted in the population of interest, U.S. Vietnam 
veterans, had a large sample size, appropriate controls (non-Vietnam-deployed 
sprayers, Vietnam non-sprayers, and non-Vietnam-deployed non-sprayers), and 
validated endpoints (self-reported physician-diagnosed hypertension that was 
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confirmed with measurements and medical record reviews). The study also quan-
tified exposures using serum TCDD measurements that were validated in a subset 
of participants. Finally, the statistical analyses conducted are robust, used state-
of-the art methods, and adjusted for appropriate confounders. This study clearly 
demonstrated that self-reported physician-diagnosed hypertension rates were the 
highest among Vietnam-deployed sprayers (81.6%) compared with non-Vietnam-
deployed sprayers (77.4%), Vietnam-deployed non-sprayers (72.2%), and non-
Vietnam-deployed non-sprayers (64.6%), representing a significant association 
with exposure.
The five additional studies reviewed were occupational (Cappeletti et al., 
2016; Yamamoto et al., 2015) and environmental (Lind et al., 2014; Shiue et al., 
2014; Van Larebeke et al., 2015) exposure investigations. Each of these has one 
or more significant study design deficiencies as compared to Cypel et al. (2016) 
and would not be considered adequate to change the level of association indi-
vidually. However, at least a portion of the effect model results corroborate the 
positive, elevated risk between exposure to the COIs and hypertension using a 
variety of study designs, populations, and measurements of exposure.
Briefly, among the occupational cohorts, Yamamoto et al. (2015) found 
hypertension to be statistically significantly associated with serum concentra-
tions of PCDDs, PCDFs, dioxin-like PCBs, and total dioxins based on adjusted 
odds ratios between the first and fourth quartile of each of those COIs among 
incinerator workers, and tests for trend were also significant for each of these 
COIs. Among 235 Italian electric arc furnace workers exposed to multiple agents, 
including metals and PCDD/Fs, PAHs, and PCBs, as sampled in the foundry dust, 
the prevalence of both complicated and non-complicated hypertension among 
the workers compared with the general regional population showed statistically 
significant increased risks; however, this study is quite limited because foundry 
dust is a complex mixture, and the authors were unable to discern the impact of 
the specific contaminants of the foundry dust on the health outcomes of those 
exposed workers (Cappelletti et al., 2016). Estimates were only adjusted for age 
group, and were not adjusted for other risk factors or activities that could affect 
the association. It is likely that workers of both of these occupationally exposed 
study populations received co-exposures to metals and chemicals other than those 
that the committee was charged with specifically reviewing that may be possible 
confounders that may affect the true estimate of association.
The results of the three environmental exposure studies had mixed findings. 
In their analysis of 2011–2012 NHANES data, Shiue and colleagues (2014) found 
an increased risk of hypertension with urinary levels of a number of heavy metals 
and other chemicals, including trimethylarsine oxide and dimethylarsonic acid, 
after adjusting for several risk factors of hypertension. Among the participants of 
a Flemish biomonitoring program, Van Larebeke et al. (2015) found an elevated 
risk of self-reported (and unconfirmed) hypertension for dioxin-like activity and 
HCB after adjusting for BMI, exercise in minutes per week, level of education, 
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and glasses of alcoholic beverages per week that was significant for men and 
women combined. However, when stratified by sex, the risk of hypertension was 
only marginally significant for men exposed to PCBs with dioxin-like activity, 
while HCBs were significant for both men and women in at least one model. In 
the third environmental exposure study of elderly residents of Upsala, Sweden, 
significant positive associations between hypertension and dioxin-like PCBs were 
found only for PCB 105 and PCB 118 when analyses were adjusted for gender 
only. When models were fully adjusted for the risk factors of hypertension, no 
association between dioxin-like PCBs and hypertension was found (Lind et al., 
2014).
In addition to the new studies, the committee re-examined the studies 
reviewed from the previous VAO reports, specifically those among Vietnam 
veterans (AFHS, 1995, 2000, 2005; CDC, 1988a; Cypel and Kang, 2010; Kang 
et al., 2006, 2014; J. S. Kim et al., 2003; O’Toole et al., 2009; Yi et al., 2014a,b) 
when making its decision of the strength of the evidence of exposure to the COIs 
and hypertension. Furthermore, data from animal and human cell-culture models 
support the hypothesis that TCDD activation of AHR increases the development 
of hypertension, and suggest plausible molecular mechanisms for hypertension.
Conclusion
After an examination of the literature that had been previously reviewed with 
the additional new evidence, the committee determined that there is sufficient 
evidence of an association between at least one of the COIs and hypertension.
Ischemic Heart Disease
IHD refers to a loss of blood flow and lack of oxygen to the heart muscle. 
It is also referred to as cornonary heart disease or myocardial ischemia and 
includes the conditions of stable angina, unstable angina, myocardial infarction, 
and sudden cardiac death. It is often the result of an atherosclerotic narrowing 
of the blood vessels that supply the heart muscle. Risk factors include smoking, 
hypertension, hyperlipidemia, obesity, family history, age, and male sex. It is one 
of the leading causes of death in the United States, at a rate of 97.2 per 100,000 
deaths (Healthypeople.gov, 2018a). IHD was first addressed as a separate oucome 
in Update 2008.
Conclusions from VAO and Previous Updates
The committee responsible for Update 2008 revisited the entire body of 
evidence on TCDD exposure and heart disease and concluded that the evidence 
supported moving IHD to the limited or suggestive category. That conclusion was 
based on evidence of a dose–response relationship in the occupational cohorts, 
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evidence of an increased risk of myocardial infarction in Vietnam veterans, sup-
porting cross-sectional survey data, and a strong biologic rationale. Evidence 
reviewed for Update 2010 and Update 2012 continued to support that classifica-
tion. A number of studies of potential relevance were reviewed for Update 2014, 
including several studies of Vietnam veterans. The studies of New Zealand, Ko-
rean, and female U.S. veterans did not find an increase in IHD mortality (Kang 
et al. 2014a; McBride et al. 2013; Yi et al. 2013a, 2014a,b). However, because 
IHD is not a uniformly fatal disease, mortality rates may not be the most accu-
rate marker of prevalence. Information on IHD gleaned from death certificates 
represents not only disease occurrence but also disease severity—the validity of 
which depends on those dying of the disease being a fair representation of all 
persons developing IHD. For example, in the Korean Veterans Health Study of 
veterans who served in Vietnam, the mortality analysis included 843 deaths from 
IHD, but analyses of disease prevalence in the same population identified more 
than 20,000 persons with this condition.
Studies comparing mortality among veteran populations to that among the 
general population may also be biased by the so called “healthy warrior effect,” 
in which veterans have a health advantage over the general population across a 
range of health outcomes. Furthermore, only the study of Korean veterans quan-
tified possible herbicide exposure, whereas the New Zealand and U.S. veteran 
studies assumed deployment to be synonymous with herbicide exposure. Each 
of the Vietnam veteran cohort studies was limited by not adjusting the estimates 
for various relevant confounding variables. Additional studies of CVD, which 
includes IHD, in well-conducted and nationally representative samples, such as 
NHANES (Lin et al., 2012), found an increase in the risk of CVD death in those 
with higher levels of dioxin TEQs, but other studies of CVD did not demonstrate 
such relationships; thus IHD has remained in the limited or suggestive category.
Update of the Epidemiologic Literature
Results of new studies of IHD and exposures to the COIs are summarized 
below. No case-control studies of exposure to the COIs and IHD have been pub-
lished since Update 2014.
Vietnam-Veteran Studies Cox et al. (2015) used hospital discharge records 
from 1988 to 2009 to identify prevalent health conditions in 2,783 male New 
Zealand veterans who served in Vietnam. Age-specific hospitalization rates 
were calculated using the total number of annual hospitalizations published 
by the Ministry of Health and the average annual resident population. Stan-
dardized hospitalization rates and 99% CIs were calculated for the veteran co-
hort and the general population and reported for CVD overall as well as for 
acute myocardial infarction, coronary atherosclerosis, chest pain, cardiac ar-
rest, dysrhythmia, and congestive heart failure. CVD was broken down into 
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acute myocardial infarction (SHR = 1.16, 99% CI 1.00–1.33), coronary ath-
erosclerosis (SHR = 1.27, 99% CI 1.14–1.39), chest pain (SHR = 1.35, 99% 
CI 1.16–1.53), cardiac arrest (SHR = 1.54, 99% CI 0.22–2.86), dysrhythmia (SHR 
= 1.27, 99% CI 1.06–1.48), and congestive heart failure (SHR = 1.02, 99% CI 
0.78–1.26). Acute myocardial infarction, coronary atherosclerosis, and chest pain 
were further examined by 4-year periods of time. In each case, the time period 
2006–2009 had the highest SHR, which was also statistically significant. The 
authors concluded that there was a small but significant increase in the number 
of hospitalizations for New Zealand Vietnam veterans, with modest increases in 
hospitalization for common conditions such as CVD. Exposure to the COIs was 
not validated through serum measurements, and the study did not control for 
smoking or ethnicity or other potentially important risk factors.
Occupational Studies Collins et al. (2016) offers additional follow-up time to 
a retrospective analysis of a cohort of 2,192 workers exposed to dioxins during 
TCP and PCP production at a chemical manufacturing plant in Michigan. The 
U.S. population was used as the comparator for standardized mortality ratios. 
Work history records were used to determine the length of exposure. Serum 
samples to measure levels of six types of dioxins, which were collected from 
431 TCP and PCP workers. The historical concentrations for each dioxin con-
gener were calculated from the median concentrations from the serum samples 
and the known half-lives associated with each congener. Complete vital status 
follow-up was achieved for the cohort, and there were 1,198 decedents through 
the entire study period (1979–2011). For IHD, there were 371 deaths among all 
workers combined (SMR = 1.10, 95% CI 0.99–1.22). No difference in mortality 
from IHD was found among the TCP workers (n = 256; SMR = 1.07, 95% CI 
0.95–1.21), but there was a slight increase of death from IHD among the PCP 
workers (n = 150; SMR = 1.20, 95% CI 1.01–1.41). When the SMRs for IHD 
were evaluated by exposure levels of each constituent congener, only the middle 
estimates for HpCDD and OCDD were statistically significantly elevated, but 
the trend was not.
't Mannetje et al. (2018) conducted a morbidity survey among a subset of 
workers who were employed at the New Plymouth, New Zealand, phenoxy her-
bicide production plant for at least 1 month between 1969 and 1984. The plant 
produced 2,4,5-T, and workers were potentially exposed to 2,4,5-T, intermedi-
ates of TCP and other chlorophenols, and TCDD. Workers had previously been 
recruited and examined as part of the international cohort of producers of phe-
noxy herbicides led by IARC (Kogevinas et al., 1997); see Chapter 5 for more 
details on the IARC cohort and the New Zealand phenoxy producers. This study 
extended the follow-up period of these workers to approximately 30 years from 
the final 2,4,5-T production exposure. From the original cohort of 1,025 workers, 
631 were living, had a current address in New Zealand, and were below 80 years 
of age on January 1, 2006. For the current 't Mannetje et al. follow-up, 430 or the 
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631 workers were randomly selected and invited to participate in a morbidity sur-
vey, of whom 245 (57%) participated. The survey was administered in 2007–2008 
by face-to-face interviews and collected information on demographic factors and 
health information, including doctor-diagnosed conditions and the year of diag-
nosis. A blood sample was also collected at that time and analyzed for TCDD, 
lipids, thyroid hormones, and other parameters. A neurological examination was 
conducted for 111 of the participants. Associations between exposure and health 
outcomes were assessed using logistic regression models that controlled for age, 
gender, smoking, BMI, and ethnicity using two methods: working in a TCDD-
exposed job (based on occupational records) and serum TCDD concentration 
≥10 pg/g lipid (18%). Mean TCDD concentrations were 19 pg/g lipid in the 60 
men directly involved in phenoxy/TCP production and 6 pg/g lipid in the 141 
men and 43 women who worked in other parts of the plant. Compared with the 
people in the not highly exposed jobs, the people who had ever worked in a highly 
exposed job at the plant did not have any difference in risk of doctor-diagnosed 
heart disease (n = 10; OR = 2.71; 95% CI 0.65–11.4), although the estimate 
was imprecise. When compared by serum TCDD concentration, again there was 
no difference in the risk of heart disease for workers in the high- versus low-
exposure groups (n = 5; OR = 1.64; 95% CI 0.41–6.57), although the estimate 
was again imprecise.
Cappelletti et al. (2016) performed a retrospective study of 331 male electric 
arc foundry workers at a single plant in Trentino, Italy, to determine if they expe-
rienced excess mortality from all causes or were at an increased risk for several 
other disases including CVD, due to an occupational exposure to foundry dust. 
An analysis of the dust emissions found that the dust contained metals (including 
iron, aluminum, zinc, manganese, lead, chromium, nickel, cadmium, mercury, 
and arsenic), PAHs, PCBs, and PCDD/Fs (reported as TEQs). Because foundry 
dust is a mixture, it is not known which of the agents were associated with a 
specific outcome or to what extent. The men included in the study had worked 
at the factory for at least 1 year. Company and medical records were used to 
determine vital status. Requests for exemption health care fees were used as a 
surrogate measure to identify the most prevalent morbid conditions in the general 
population, which were then applied to the cohort to compute relative risks for 
each of the conditions. The workers were followed from March 19, 1979 (or their 
first day of employment), through December 31, 2009, or date of death. Effect 
estimates (prevalence ratios) were calculated using Mantel-Haenszel estimator 
adjusted for age group (20–64, 65–74, ≥ 75 years). Compared with the age-
adjusted provincial population, no difference in death from IHD (n = 4; SMR 
= 1.27, 95% CI 0.35–3.26) was found among the electric arc furnace workers. 
However, a statistically significantly elevated risk of CVD (n = 5; RR = 1.74, 
95% CI 1.07–2.82) was found. This study is most limited by the fact that foundry 
dust is a complex mixture, which makes it impossible to discern the impact of 
the specific contaminants of the foundry dust on the health outcomes of those 
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exposed workers. Estimates were adjusted only for age group and were not ad-
justed for other risk factors such as tobacco use, BMI, or other jobs or activities 
that could have resulted in similar exposures. Exposure to foundry dust by the 
general population that was used for comparison is not discussed, although the 
foundry appears to be in the local vicinity and emissions from it were reported 
to be present within a 2-kilometer radius of it.
Environmental Studies Van Larebeke et al. (2015) carried out a prospective 
study of the associations of exposure to organochlorine pollutants, HCB, dioxin-like 
(PCB 118) and non-dioxin-like PCBs, and cadmium with a variety of self-reported 
health conditions, including diabetes, hypertension, and atheromata (the results for 
diabetes and hypertension were described earlier) as part of a Flemmish biomoni-
toring program. In 2004–2005, height, weight, urine, and serum were collected 
from the participants. Dioxin-like activity in pg TEQ/g fat was also assessed. 
Subjects filled out a survey that collected demographic data and information on 
education, tobacco use, and alcohol consumption. In 2011, participants in the pro-
gram were mailed a second survey to collect updated information general health, 
smoking and alcohol consumption behaviors, medical conditions, and current 
medications. There were 973 respondents, 504 women and 469 men (response 
rate 65.6%), whose information was used for the current analysis. The serum was 
assayed for HCB, dioxin-like PCB 118, and other chemicals. Medical diagnoses 
were all self-reported and not confirmed. For the diagnosis of atheromata, subjects 
were asked, “Did you have a problem with the blood circulation in the brain (cere-
brovascular incident, ischemic episode)?” “Have you ever experienced a heart 
infarction?” and “Do you sometimes suffer from pain in the thorax during physical 
effort?” A positive response to at least one of these questions was considered a 
diagnosis. A total of 71 men (15.1%) and 62 women (12.3%) reported atheromata, 
and 27 men (5.8%) and 10 women (2%) reported myocardial infarction. Overall, 
there were no differences in the levels of dioxin-like activity (pg/TEQ/g fat) or 
PCB 118 (ng/g fat) in participants versus non-participants of the follow-up survey, 
but there was a difference for HCB (p = 0.051). In the combined sample, after 
adjusting for BMI, the level of education, and cholesterol concentration in blood, 
the researchers found that dioxin-like activity was not associated with the risk of 
atheromata (OR = 1.60, p = 0.083); estimates for HCBs and PCB 118 were not pro-
vided. In a model accounting for confounders and making additional adjustments 
for correlated exposures (HCB, p,p’-DDE, cadmium, and non-dioxin PCBs), the 
odds of atheromata in the 90th versus the 10th percentiles were increased in men 
only (OR = 1.83, p = 0.031). No individual analyses were performed for myocar-
dial infarction. The strengths of the study include its prospecitive design, its large 
sample size, the representativeness of the older adult population of Flanders, and 
the use of objective measures of exposure. However, the findings are limited by 
the study’s lack of validated medical diagnoses, and the data were collected based 
on self-report from a survey that was not validated.
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Bergkvist et al. (2015) performed a prospective population-based cohort study 
of 33,446 women who participated in the Swedish Mammography Cohort and who 
were free of CVD, diabetes, and cancer at baseline. The women were followed 
for 12 years to determine the association between dietary PCB exposure and the 
risk of myocardial infarction. Fish fatty acid consumption was also measured to 
determine any protective effects of the consumption of eiconsapentaenoic acid 
and docosahexaenoic acid. The food frequency questionnaire- based dietary PCB 
estimates have been extensively validated against serum PCBs in women from 
this cohort. During the follow-up period, 1,386 myocardial infarctions occurred, 
276 of which were fatal. Cases were ascertained through a computerized link-
age to the National Hospital Discharge and Cause of Death Registers in Sweden 
using personal identification numbers. PCB exposure was grouped into quartiles, 
and women in the highest quartile of dietary PCB exposure were found to be 
more likely to report high cholesterol levels, to use fish oil supplements, to have 
a slightly higher consumption of alcohol and red and processed meat, and to have 
up to a six-times-higher consumption of fish than those in the lowest quartile. 
Multivariate-adjusted analysis was used to determine the asso ciation between risk 
of myocardial infarction and PCB exposure. Models were adjusted for several 
factors, including postsecondary education, a family history of myocardial infarc-
tion before the age of 60 years, ever use of postmenopausal hormones, the use 
of aspirin, the use of fish oil supplements, and a weight loss of ≥ 5 kg within 
1 year, which were treated as dichotomous variables (yes/no). Additional variables 
were also included in Cox proportional hazards regression models: smoking sta-
tus (never, past, or current); waist circumference (< 80, 80–87, ≥ 88 cm); parity 
(0, ≥ 1 children); total physical activity (quartiles, MET-h); alcohol consumption 
(0, > 0–4.9, 5.0–14.9, > 15.0 g/day); energy intake (continuous, kcal/day); consump-
tion of fruit and vegetables (quartiles, servings/week), dairy products (quartiles, 
servings/day), and red and processed meat (quartiles, servings/week); dietary intake 
of saturated fatty acids (quartiles, g/day); and dietary methyl mercury exposure (quartiles, 
μg/day). In additional adjustments, the dietary sum of both eiconsapentaenoic acid 
and docosahexaenoic acid (quartiles, g/day) was also included. Models were not 
adjusted for hypertension or high cholesterol levels because the authors reasoned 
that these intermediate risk factors may be in the causal pathway between PCB 
exposure and CVD. Dietary PCB expo sure was associated with total myocardial 
infarction in the multivariable-adjusted model (RR = 1.21, 95% CI 1.01–1.45; p for 
trend = 0.012), and this estimate increased after adjusting the model for the sum 
intake of eiconsapentaenoic acid and docosahexaenoic acid (RR = 1.58, 95% CI 
1.10–2.24; p for trend = 0.007). There are several limitations to the study. Although 
the survey was validated with a serum PCB analysis in this population, recall bias is 
of concern, as is the fact that this information was collected only at baseline, yet the 
cohort was followed for 12 years. Using a prospective design eliminates concerns 
of temporal ambiguity. Methyl mercury is a potentially confounding factor. Though 
adjustments were made for dietary intake, it is not possible to ascertain the role of 
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mercury in risk of CVD. Most importantly, because exposure to PCBs is grouped, 
it is not possible to know if any of the increased risk is due to dioxin-like PCBs 
and which specifically those might be.
Other Identified Studies One other study that reported deaths from IHD was 
identified, but it was limited by its lack of exposure specificity (Ruder et al., 
2014).
Biologic Plausibility
Experimental studies demonstrate that exposure to AHR agonists, including 
TCDD and benzo[a]pyrene, increase the incidence, severity, and progression of 
atherosclerosis, a primary cause of IHD (Dalton et al., 2001; Kerley-Hamilton et 
al., 2012a; D. Wu et al., 2011). There is also evidence that TCDD influences other 
IHD risk factors by promoting obesity (Brulport et al., 2017; Kerley-Hamilton 
et al., 2012b), accumulating macrophage lipid, inducing lipid mobilization, and 
altering lipid metabolism. Thus, on the basis of animal models there appear to 
be several overlapping and potentially contributing pathways that link TCDD 
exposure and increased IHD risk.
Synthesis
This committee considered six new studies in addition to the multiple stud-
ies reviewed by prior VAO committees when determining its conclusion of the 
level of association. Among New Zealand veterans who had served in Viet-
nam, Cox et al. (2015) calculated hospitalization ratios for CVD and found ele-
vated rates for the outcomes of acute myocardial infarction, chest pain, and 
coronary atherosclerosis among the veterans. The two occupational studies of 
heart disease mortality—one among U.S. workers producing TCP and PCP 
(Collins et al., 2016) and the other among Italian electric arc foundry workers 
exposed to dioxins (Cappelletti et al., 2016)—both found no difference in mortality 
from heart disease compared with their resepective general populations; however 
the use of general populations as a comparator likely introduced selection bias. A 
third occupational study of morbidity among people who had worked in a New Zea-
land plant that produced phenoxy herbicides also found no increased risk of heart 
disease based on high versus low exposure ('t Mannetje et al., 2018). Two studies 
of populations with environmental exposures were also examined. Bergkvist et al. 
(2015) followed a cohort of women for 12 years who were free of CVD at baseline 
and who were exposed to PCBs via dietary exposure. Even though adjustments 
were made for dietary intake, PCBs were grouped together, making it difficult to 
determine the role of individual dioxin-like PCBs in the CVD risk. Regardless, 
these data are not immediately generalizable, given that very few women were 
exposed to the herbicides. The occupational studies are further limited because 
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these populations of workers likely received  co-exposures to metals and chemicals 
other than those that the committee was charged with specifically reviewing that 
may be possible confounders that may affect the true estimate of association. Van 
Larebecke et al. (2015) studied the association of exposure to organochlorine pol-
lutants, HCB, and dioxin-like and non-dioxin-like PCBs with a self-reported history 
of atheromata and myocardial infarction. While there was a significant association 
for men reporting atheromata, this association lost significance when the analysis 
corrected for other risk factors known to cause atheromata. Furthermore, based on 
a review of available experimental data, there appear to be several overlapping and 
potentially contributing pathways that link TCDD exposure and an increased risk 
of IHD.
The above studies were limited by relatively small numbers of cases, a lack 
of consistent case definitions for the various types of CVD (IHD versus angina 
versus chest pain versus atheromata), the use of non-validated surveys for diag-
nosis, and the presence of mixtures of chemicals in addition to the COIs. Most of 
the new studies used mortality or hospitalization data, which, as discussed above, 
may not be the best endpoint for determining an increased risk for a particular 
condition. Given these considerations, the committee reaffirmed the decision of 
previous VAO committees to keep IHD in the limited or suggestive category.
Conclusion
After reviewing the new evidence, the present committee concurred with 
those for previous updates that there is limited or suggestive evidence that IHD 
is associated with exposure to the COIs.
Cerebrovascular Disease and Stroke
Cerebrovascular disease refers to a disorder that affects the circulation in 
the brain. The most common conditons are ischemic stroke, hemorrhagic stroke, 
and transient ischemic attack. This disease is one of the top 10 causes of death in 
the United States and was responsible for 5.2% of deaths overall in 2015 (CDC, 
2017b). Presented by race, in 2015 whites had the greatest number of deaths from 
cerebrovascular disease (~117,000) followed by blacks (~18,000), Asian and 
Pacific Islanders (~5,000), and American Indians/Alaska Natives (~700) (CDC, 
2017b). Mortality rates from cerebrovascular disease and stroke were declining, 
but have remained stagnant in recent years (CDC, 2017d).
Conclusions from VAO and Previous Updates
Among U.S. Vietnam veterans, stroke and cerebrovascular disease have not 
been found to be elevated in the AFHS, ACC, or female veteran cohorts (Cypel 
and Kang, 2010; Kang et al., 2014; Ketchum and Michalek, 2005). Similar to 
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the analysis of deployed and non-deployed U.S. female veteans, analyses of 
Australian Vietnam veterans compared with the general Australian population 
have found a decreased risk of stroke and cerebral hemorrhage. Among Korean 
Vietnam-era veterans, after adjustment for multiple behavioral, demographic, and 
service-related factors, stroke prevelance was statistically significantly elevated 
among the more highly exposed cohort members (Yi et al., 2014a). The associa-
tion was seen for both major stroke types: cerebral infarction (ICD-10 I63) and 
cerebral hemorrhage (ICD-10 I60–I62). In the mortality study in the same cohort, 
after adjusting for only age and rank, no differences were found in mortality from 
cerebrovascular disease (ICD-10 I60–I69) between the groups with high and low 
potential for herbicide exposure or when individual exposure potential was used 
as a continuous variable (Yi et al., 2014b).
Few occupational cohorts have examined stroke and cerebrovascular diseases, 
but those that have, have reported very few cases and very few differences in 
mortality rates. Such studies have included Dutch herbicide production workers 
(Boers et al., 2010), the U.S. National Institute for Occupational Safety and Health 
mortality cohort (Steenland et al., 1999), PCP production workers in Midland, 
Michigan (Collins et al., 2009a), and Italian licensed pesticide users (Gambini et 
al., 1997). One study of AHS applicators and their wives (Waggoner et al., 2011) 
found a statistically significantly decreased risk of cerebrovascular disease.
Only two environmental studies have reported on stroke or cerebrovascular 
disease. Y. S. Lin et al. (2012) reported a positive, but not significant association 
between dioxin-like compounds in the blood and mortality from cerebrovascular 
disease (defined as a stroke) in an analysis of NHANES data. In the 25-year 
follow-up of the Seveso cohort, Consonni et al. (2008) found no difference in 
cerebrovascular disease between people exposed in Zone A and nonexposed 
residents of 11 surrounding municipalities, but slight statistically significant 
increases in cerebrovascular disease were found for people residing in Zones B 
and R compared with the nonexposed residents of 11 surrounding municipalities.
Therefore, based on these studies the evidence to determine an association 
between exposure to the COIs and cerebrovascular disease and stroke remains 
limited or suggestive.
Update of the Epidemiologic Literature
Four new studies of exposure to at least one COI and cerebrovascular disease 
and stroke outcomes have been identified since Update 2014.
Vietnam-Veteran Studies Cox et al. (2015) used hospital discharge records 
from 1988 to 2009 to identify prevalent health conditions in 2,783 male New 
Zealand veterans who served in Vietnam. Age-specific hospitalization rates were 
calculated using the total number of annual hospitalizations published by the 
Ministry of Health and the average annual resident population. Standardized 
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hospitalization rates and 99% CIs were calculated for the veteran cohort and the 
general population and reported for several noncancerous conditions. A total of 
170 cases of acute cerebrovascular disease were found in the veteran population, 
which was statistically significantly elevated compared with the standardized 
hospitalization rate of New Zealand (SHR = 1.31, 99% CI 1.05–1.56). In addi-
tion, a total of 45 cases of aneurysm within the veteran population were identified 
(SHR = 1.47, 99% CI 0.91–2.04). The study was limited by its assumption that 
deployment to Vietnam was synonomous with herbicide exposure, which was not 
validated through serum measurements, and by a lack of adjustment for smoking 
or ethnicity or other potentially important risk factors.
Han et al. (2016) conducted a small hospital-based study of Korean Vietnam 
veterans in Seoul who had presumed Agent Orange exposure (determined by 
deployment to Vietnam) to examine whether exposure resulted in differences 
in the vascular features of acute ischemic stroke. A total of 91 veterans with 
preseumed exposure were compared with 288 male patients from other area 
general hospitals (and presumed to be unexposed to Agent Orange). Both groups 
of patients were compared on lifestyle factors, clinical history, and the clinical 
manifestations of stroke at admission and discharge. Vascularity was examined 
within 7 days of acute ischemic stroke onset, and stroke was confirmed by MRI 
within 1 week after onset. The subtype of the stroke was assessed using the acute 
stroke treatment protocol and the modified Rankin Scale at discharge and at 
3 months after onset. The two groups were comparable for many demographic and 
lifestyle factors except that veterans (exposed) had higher rates of smoking and 
comorbid diabetes and the unexposed males had higher hyperlipidemia and his-
tory of stroke. Stroke subtypes were statistically significantly different (p = 0.014) 
between the two groups, and characterized by small vessel occlusion in exposed 
subjects and large artery atherosclerosis in unexposed subjects. These features 
may have led to a somewhat better short-term prognosis of exposed than unex-
posed members. The exposed veterans had lower scores on the stroke scale at 
admission than the control group (p = 0.003), but there was no significant dif-
ference between the two groups at discharge. This study was small and exposure 
was assumed based on deployment to Vietnam and not otherwise objectively 
measured or validated. Only simple comparison testing was used, but the study 
does indicate that studying stroke as a single category may lose statistical power 
especially when attempting to study the effects of potential exposure to the COIs.
Occupational Studies Collins et al. (2016) offered additional follow-up time 
to a retrospective analysis of a cohort of 2,192 workers exposed to dioxins dur-
ing TCP and PCP production at chemical manufacturing plant in Michigan. The 
U.S. population was used as the comparator for standardized mortality ratios. 
Work history records were used to determine the length of exposure. Serum 
samples were collected from 431 TCP and PCP workers to measure the levels 
of six types of dioxins. The historical concentrations for each dioxin congener 
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were calculated from the median concentrations from the serum samples and 
the known half-lives associated with each congener. Complete vital status fol-
low-up was achieved for the cohort, and there were 1,198 deaths through the 
entire study period (1979–2011). For cerebrovascular disease, there were 68 
deaths among all workers combined and no difference in the mortality rate 
compared with the general population (SMR = 1.03, 95% CI 0.80–1.30). No 
difference in mortality from cerebrovascular disease was found among the 
TCP workers (n = 49; SMR = 1.07, 95% CI 0.79–1.41) or the PCP workers 
(n = 27; SMR = 1.07, 95% CI 0.701–1.55). Although serum dioxin measurements 
were collected, no results based on those measurements were presented for cere-
brovascular disease; instead the authors used employment records to categorize 
exposure, which may have introduced exposure misclassification, and use of the 
general U.S. population as a comparison likely introduced selection bias.
Environmental Studies Van Larebeke et al. (2015) carried out a prospec-
tive study of the associations of exposure to organochlorine pollutants, HCB, 
dioxin-like (PCB 118) and non-dioxin-like PCBs, and cadmium with a variety 
of self-reported health conditions, including atheromata, as part of a Flemmish 
biomonitoring program. Because a diagnosis of atheromata was assessed based 
on three questions, one of which was “Did you have a problem with the blood 
circulation in the brain (cerebrovascular incident, ischemic episode)?” the results 
for atheromata were described in the section on IHD.
Other Identified Studies One other study that reported deaths from cerebro-
vascular disease was identified, but it was limited by a lack of exposure specificity 
(Ruder et al., 2014).
Biologic Plausibility
Although no papers were identified that specifically addressed cerebrovascu-
lar disease and stroke following exposure to the COIs, many of the mechanisms 
that influence stroke and cerebrovascular disease incidence and progression have 
been shown to be targets of TCDD and the AHR pathway, as noted in the intro-
duction of the biologic plausibility section under the circulatory diseases heading. 
These mechanisms include impacts on endothelial cell function and proliferation, 
inflammation, and blood vessel blockage.
Synthesis
Four new studies on cerebrovascular disease or stroke were reviewed for 
the current update. Two studies followed Vietnam veterans. Cox et al. (2015) 
used hospital discharge records from 1988 to 2009 to identify the health condi-
tions that had affected the veterans. Among New Zealand veterans, 170 cases 
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of cerebrovascular disease or stroke were observed, resulting in a significant 
increase in the standardized hospitalization rate for acute cerebrovascular disease 
compared with the general population. Han et al. (2016) published a hospital-
based case-control study of 91 Korean veterans presumed to have been exposed 
to Agent Orange during their deployment to Vietnam who presented for medical 
attention within 7 days of the onset of an acute ischemic stroke. The key finding 
was a statistically different type of stroke between the presumed exposed and 
unexposed groups, with small vessel occlusion more common in the exposed 
subjects and large artery atherosclerosis more common in the unexposed subjects, 
resulting in a somewhat better short-term prognosis for the exposed versus the 
unexposed patients. While this study is small and requires replication as well as 
exposure validation, it raises an important issue about including all stroke sub-
types in future studies of stroke and exposure to the COIs. Among a long-term 
follow-up of U.S. workers exposed to dioxins during TCP and PCP production, 
Collins et al. (2016) found no difference in the mortality rate from cerebrovas-
cular disease between the workers and the standardized general population, but 
the study is limited by likely exposure misclassification and selection bias. In a 
prospective study of environmental exposure to organochlorine pollutants, HCB, 
and dioxin-like and non-dioxin-like PCBs in Belgium, Van Larebeke et al. (2015) 
assessed levels of exposure with a variety of self-reported health conditions, 
including atheromata. A small but statistically significant increase was found 
between the 90th versus the 10th percentile of exposure, but this was found for 
men only. The strengths of the study include its prospecitive design and large 
sample size, the representativeness of the older adult population of Flanders, and 
the use of objective measures of exposure. However, the findings are limited by 
the study’s lack of validated medical diagnoses and by the fact that the data were 
collected based on self-report from a survey that was not validated. No new data 
specifically addressing the biological plausibity of the impact of exposure to the 
COIs on cerebrovascular disease and stroke were identified. Therefore, on the 
basis of the new studies, the committee maintained the previous conclusion of 
limited or suggestive evidence between exposure to the COIs and cerebrovascular 
disease or stroke.
Conclusion
After carefully reviewing the previous evidence as well as the new evidence 
related to exposure to the COIs and cerebrovascular disease and stroke, the 
committee maintains the prior conclusion of limited or suggestive evidence of 
association that cerebrovascular disease and stroke are associated with exposure 
to the COIs.
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Other Cardiovascular Outcomes
The previous sections in this chapter cover hypertension, IHD, and cerebro-
vascular disease and stroke. This section covers additional cardiovascular and 
blood disorders that have been examined in studies that have measured exposure 
to the COIs.
Vietnam-Veteran Studies
Cox et al. (2015) used hospital discharge records from 1988 to 2009 to 
identify health conditions in 2,783 male New Zealand veterans who served in 
Vietnam. Age-specific hospitalization rates were calculated using the total num-
ber of annual hospitalizations published by the Ministry of Health and the aver-
age annual resident population. Standardized hospitalization rates and 99% CIs 
were calculated for the veteran cohort and the general population and reported 
for cardiovascular and other outcomes. Syncope (n = 100; SHR = 1.47, 99% 
CI 1.18–1.76) and phlebitis (n = 51; SHR =1.67, 99% CI 1.07–2.28) were 
both elevated among the veterans compared with the standardized New Zealand 
population. No difference in the hospitalization rate for peripheral atherosclerosis 
(n = 70; SHR = 1.17, 99% CI 0.81–1.53) was found. Asymptomatic peripheral 
arterial vascular disease is more common than symptomatic disease and does not 
often result in death or hospitalization. This study was limited by its assumption 
that deployment to Vietnam was synonomous with herbicide exposure, which was 
not validated through serum measurements, and by the fact that important risk 
factors, such as smoking and ethnicity, were not controlled for in the analysis.
Occupational Studies
Laverda et al. (2015) assessed the association between weight gain (using 
BMI) and pesticide use using data on 8,365 male pesticide applicators from the 
AHS. The goal was to assess the effect of common factors beyond high-calorie 
diet and physical activity on BMI; pesticides were studied because many include 
endocrine disruptors and thus have a biological rationale for why they might affect 
BMI. Details of the AHS study design, exposure measurement, and data collection 
are presented in Chapter 5. Multivariate linear regression was used to estimate the 
unit change in BMI (kg/m2/d) associated with a unit change in exposure to a pes-
ticide class/individual pesticide. To assess validity and the strength and direction 
of the associations, partial Spearman correlation coefficients controlling for all 
covariates were calculated for BMI at follow-up in relation to cumulative exposure 
days to each pesticide class/individual pesticide. Ordinal logistic regression was 
used to evaluate the exposure–response associations between BMI and pesticide 
exposures. Models were adjusted for BMI at age 20 years (from enrollment data), 
age, smoking, energy input, and energy output (from follow-up data). Results 
Veterans and Agent Orange: Update 11 (2018)
Copyright National Academy of Sciences. All rights reserved.
METABOLIC AND CARDIOVASCULAR DISORDERS 511
were also adjusted for the state of residence and used multiple test corrections. In 
this analysis, 1,262 (15.1%) applicators reported exposure to phenoxy herbicides 
(2,4,5-T and 2,4,5-TP), and 1,214 (14.9%) applicators reported exposure to 2,4-D. 
The adjusted parameter estimate for unit change in BMI (kg/m2/d) was statisti-
cally significant for both phenoxy herbicides and 2,4-D in the entire sample (p = 
0.02 for both), but when stratified by state, the two parameter estimates remained 
statistically significant for Iowan applicators only.
Environmental Studies
S. A. Kim et al. (2015) used serum concentrations of persistent organic 
pollutants, including dioxin-like and non-dioxin-like PCBs and organochlorine 
pesticides collected within the 1999–2004 NHANES and adjusted for fat mass 
in order to make associations with overall mortality, mortality from all cancers 
combined, and mortality from CVDs in people 70 years and older. Among the 633 
people for whom there was information on PCBs, 50 had died of cardiovascular 
disease during the follow-up, while 56 had died among the 675 people for whom 
there was information on organochlorine pesticides. Models were adjusted for 
age, sex, race, BMI, cigarette smoking, and physical activity. When fat mass was 
excluded from the analysis of PCB exposure by tertiles, the adjusted hazard ratio 
for death from CVD in the second tertiles compared with the lowest exposure 
(tertile 1) was not different (HR = 1.06, 95% CI 0.47–2.40), but it was elevated 
for the third versus first tertile (HR = 2.37, 95% CI 1.10–5.09), and the trend for 
increasing exposure was statistically significant (p = 0.02). For organochlorine 
pesticides there was no difference in cardiovascular deaths between the sec-
ond and third tertiles and the referent (p trend = 0.17). When individuals were 
stratified by body fat mass (< 25%, 25%–75%, and > 75%) and estimates were 
adjusted for the factors listed above, there were statistically significantly more 
deaths from CVD with exposure to PCBs only for the comparison of the third 
tertile with the first in the intermediate fat mass group (25– < 75%) (HR = 3.42, 
95% CI 1.02–11.4), but this estimated is imprecise. This study was limited by the 
relatively low numbers of deaths, especially when stratified by exposure levels. 
This study measured death, not the incidence of disease, and it is possible that 
the POPs affect development of disease differently than they affect survival once 
the disease has been acquired.
Penell et al. (2014) investigated whether baseline circulating levels of POPs 
can predict future changes in circulating lipid levels. They measured lipid levels 
and the levels of 23 different POPs in 598 individuals in the PIVUS study at ages 
70 and 75 years. No subjects were on lipid-lowering medications. POPs included 
non-dioxin-like PCBs, organochlorine pesticides, one dioxin (OCDD), and one 
brominated flame retardant compound. There were no significant difference re-
lated to the level of dioxin. The authors propose that the increase in low-density 
lipoproteins could strengthen the link between POP exposure and CVD.
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Other Identified Studies
Zong et al. (2015) conducted a methodological study to assess the relation-
ship between POPs and the fat mass percentage in the trunk, leg, and whole body, 
so the study does not have direct relevance to a health outcome. Their rationale 
was that since fat biopsies are used for assessing long-term lipophilic pollutant 
exposure, the anatomical location of the biopsy may affect the estimated body bur-
den of these chemicals. The analysis included 2,358 men and women 20 years of 
age and older who had participated in NHANES 1999–2004 and who had stored 
serum samples. Serum measurements of 49 to 68 POPs were measured using gas 
chromatography/isotope dilution mass spectrometry. X-ray bone densitometry 
was used for dual-energy X-ray absorptiometry scans and fat mass percentage 
measurement. Demographics and information on lifestyle, medical history, and 
the history of lactation and parity for women were collected using questionnaires. 
Ethnicity, educational attainment, smoking and alcohol use, and physical activity 
were used as covariates. β-hexachlorocyclohexane, heptachlorodibenzo-p-dioxin, 
octachlorodibenzo-p-dioxin, and PCB 126 showed stronger positive correlations 
with trunk fat mass percentage than with leg fat mass percentage, suggesting a 
more important or greater role of trunk fat in the action and pharmacokinetics 
of persistent organic pollutants as endocrine disrupters. This study highlights 
one explanation for why studies may provide varying results on a metabolic or 
cardiovascular effect of COI exposure depending on which anatomical site was 
used for measurement.
Biologic Plausibility
Stea et al. (2016) suggest that the inconsistent associations of chronic low-
dose exposure to arsenic on CVD may be due to high inter- individual variabil-
ity in susceptibility to arsenic’s toxicity, a part of which is genetic. To assess 
this relationship, 214 healthy Italian volunteers between the ages of 20 and 
46 years were studied for arsenic and related compounds in first voided urine, 
intima-media thickness, and genotypes for arsenic-metabolizing genes (ASIIIMT 
Met287Thr, GSTT1+/−, and GSTM1+/−). The samples were tested for inorganic 
arsenics (including trivalent and pentavalent), for methylated metabolites (i.e., 
mono-methylarsinic [MMA] and dimethylarsinic acid [DMA]), and for total 
arsenic using high-performance liquid chromatography and mass spectrometry. 
Intima-media thickness was measured on the common carotid artery on both sides 
using carotid ultrasound by a trained cardiologist. All genotypes were obtained 
by PCR and RFLP analysis. The main finding was that in both men and women 
with chronic low dose exposure to arsenic, intima-media thickness increases sig-
nificantly faster with age than in the healthy population. The findings also suggest 
that GSTT1 and hOGG1 gene polymorphisms might play an important role in the 
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individual risk of arsenic-induced carotid atherosclerosis, with the same exposure 
providing differential outcomes.
Synthesis
In addition to outcomes related to hypertension, IHD, and cerebrovascular 
disease, several studies presented other cardiovascular and circulatory outcomes. 
However, most of these findings were of limited use because they examined dif-
ferent outcomes and different measures, and some of the outcomes were more 
methodologic or surrogates in the pathway of disease. For example, Penell et 
al. (2014) examined whether POPs can predict changes in lipid levels because 
higher blood lipid levels are a risk factor for CVD; however, no association was 
found for dioxin-like chemicals. S. A. Kim et al. (2015) conducted an analysis 
using NHANES data to look for an association between the concentrations of 
POPs (both dioxin-like and non-dioxin-like) and organochlorine pesticides and 
mortality from CVD. While there were statistically significant trends in death 
from cardiovascular disease among several subgroups classified by body fat, the 
estimates were imprecise. Stea et al. (2016) examined how exposure to arsenic 
may be a possible contributing factor to the individual risk of arsenic-induced 
carotid atherosclerosis, but a genetic component appears to play a part. The study 
of hospitalization risk among New Zealand Vietnam veterans used deployment 
to Vietnam as an indicator of presumed exposure to herbicides, and in analyses 
that did not control for smoking or other important risk factors of CVDs they 
found elevated rates of syncope and phlebitis but not peripheral atherosclerosis. 
Although there is similarity in the mechanisms by which atherosclerosis de-
velops regardless of where it occurs (e.g., the heart, central nervous system, or 
periphery), asymptomatic peripheral arterial vascular disease is more common 
than symptomatic disease. The peripheral vascular disease literature is limited by 
high rates of asymptomatic disease, the requirement for specific and often costly 
testing to document clinically silent disease, death due to myocardial infarction 
and stroke before diagnosis, and infrequency of death or hospitalization from 
peripheral vascular disease alone.
In an assessment of weight gain (using BMI) and pesticide use from the 
AHS, Laverda et al. (2015) found that the parameter estimate for unit change 
in BMI (kg/m2/d) was statistically significant for both phenoxy herbicides and 
2,4-D in the entire sample. However, based on the myriad studies and outcomes 
examined, no conclusion can be made concerning an association of exposure to 
the COIs and other cardiovascular disorders.
Veterans and Agent Orange: Update 11 (2018)
Copyright National Academy of Sciences. All rights reserved.
514 VETERANS AND AGENT ORANGE: UPDATE 11
Conclusion
After carefully reviewing the previous evidence as well as the new evidence 
related to exposure to the COIs, the committee maintains the prior conclution 
that there is inadequate or insufficient evidence that blood disorders and other 
cardiovascular disorders are associated with exposure to the COIs.
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Other Chronic Health Outcomes
Chapter Overview
Based on new evidence and a review of prior studies, the current committee 
did not find any new associations between exposure to the chemicals of interest 
(COIs; 2,4-dichlorophenoxyacetic acid [2,4-D], 2,4,5-trichlorophenoxyacetic 
acid [2,4,5-T], picloram, dimethylarsinic acid [DMA or cacodylic acid], and 
2,3,7,8-tetrachlorodibenzo-p-dioxin [TCDD]) and other chronic, non-malignant 
outcomes including respiratory disorders, gastrointestinal and digestive diseases, 
adverse effects on thyroid homeostasis, kidney and urinary disorders, chronic 
skin conditions, eye problems, and bone conditions. Current evidence supports 
the results of earlier updates that:
• There is sufficient evidence of an association between the COIs and 
chloracne.
• There is limited or suggestive evidence of an association between expo-
sure to the COIs and hypothyroidism, early onset peripheral neuropathy, 
and porphyria cutanea tarda.
• There is inadequate or insufficient evidence to determine whether there is 
an association between exposure to the COIs and respiratory disorders, 
gastrointestinal and digestive disease (including liver toxicity), kidney and 
urinary disorders, adverse effects on endocrine function (other than hy-
pothyroidism), chronic skin conditions, eye problems, or bone conditions.
This chapter discusses data on the possible association between exposure to 
the COIs and several non-cancer health outcomes: respiratory disorders, gastroin-
testinal and digestive disease (including liver toxicity), adverse effects on thyroid 
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homeostasis, kidney and urinary disorders, chronic skin conditions, eye problems, 
and bone conditions. The committee also considers the results of studies of expo-
sure to polychlorinated biphenyls (PCBs) and other dioxin-like chemicals to be 
informative if they were reported in terms of TCDD toxic equivalents (TEQs) or 
as concentrations of dioxin-like specific congeners. Although all studies report-
ing TEQs based on PCBs were reviewed, TEQs based only on mono-ortho PCBs 
(which are PCBs 105, 114, 118, 123, 156, 157, 167, and 189) are several orders 
of magnitude lower than those of the non-ortho PCBs (77, 81, 126, and 169), 
based on the revised World Health Organization (WHO) toxicity equivalency 
factor (TEF) scheme of 2005 (La Rocca et al., 2008; van den Berg et al., 2006). 
The lower TEQs of the mono-ortho PCBs, however, may be counterbalanced by 
their abundance, which is generally many orders of magnitude higher than that 
of the non-ortho PCBs (Park et al., 2010).
In previous updates, chloracne and porphyria cutanea tarda were consid-
ered with the chronic non-cancer conditions. They are accepted as being asso-
ciated with dioxin exposure, but they are considered acute outcomes and are 
no longer considered specifically in this chapter. For each type of health out-
come, background information is followed by a brief summary of the findings 
described in earlier Veterans and Agent Orange (VAO) reports. In the discus-
sion of the most recent scientific literature, the studies are grouped by expo-
sure type (Vietnam veteran, occupational, or environmental). For articles that 
report on the health outcomes of a previously studied population, the detailed 
design information is summarized in Chapter 5. A synopsis of toxicologic and 
clinical information related to the biologic plausibility of the COIs influenc-
ing the occurrence of a health outcome is presented next and is followed by 
a synthesis of all the material reviewed. Each health-outcome section ends 
with the committee’s conclusions regarding the strength of the evidence that 
supports an association with the COIs. The categories of association and the 
committee’s approach to categorizing the health outcomes are discussed in 
Chapter 3.
NON-CANCEROUS RESPIRATORY DISORDERS
For the purposes of this report, “non-cancerous respiratory disorders” are 
defined as all acute and chronic lung diseases other than cancers; the variety of 
conditions are described by the International Classification of Diseases (ICD), 
9th Revision (ICD-9 460–519) or 10th Revision (ICD-10 J00–J99). Acute non-
cancerous respiratory disorders include pneumonia and other respiratory infec-
tions; they can increase in frequency and severity when the normal defense 
mechanisms of the lower respiratory tract are compromised.
Chronic non-cancerous respiratory disorders generally take two forms: air-
ways diseases and parenchymal diseases. Airway diseases are disorders charac-
terized by an obstruction of the flow of air out of the lungs; common examples 
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are asthma and chronic obstructive pulmonary disease (COPD). COPD includes 
such disorders as emphysema and chronic bronchitis. Parenchymal disease, or 
interstitial disease, generally includes disorders that cause inflammation and 
scarring of the deep lung tissue, including the air sacs and supporting structures. 
Parenchymal disease is less common than airway diseases and is characterized 
by a reduction in lung capacity, although it can also include a component of air-
way obstruction. Some severe chronic lung disorders, such as cystic fibrosis, are 
hereditary. Because Vietnam veterans received health screenings before entering 
military service, few severe hereditary chronic lung disorders are expected in 
that population.
More than 25 million people in the United States are thought to be living 
with asthma. As of 2015, the mortality rate for asthma among children and adults 
in the United States was highest among African Americans with 13.2 deaths per 
100,000 in people less than 35 years old. Non-Hispanic whites had the second 
highest mortality rate, with 4.3 deaths per 100,000 in people less than 35 years 
old. There are nearly 14.8 million people who have physician-diagnosed COPD, 
but 12 million people are estimated to have undiagnosed COPD. The mortality 
rate for COPD was highest among non-Hispanic whites, with 127.8 deaths per 
100,000 people. Native Americans had a death rate of 81.1 per 100,000 in indi-
viduals 45 years and older. African Americans ranked third, with a rate of 78.4 
deaths per 100,000 people 45 years and older. Mortality rates were lowest among 
Asian or Pacific Islanders with 30.3 per 100,000 (healthypeople.gov, 2018b).
The most important risk factor for many non-cancerous respiratory disorders 
is the inhalation of cigarette smoke. Although exposure to cigarette smoke is not 
associated with every disease of the lungs, it is the major cause of many airway 
disorders, especially COPD; it also contributes to some interstitial disease, and it 
compromises host defenses in such a way that people who smoke are generally 
more susceptible to some types of pneumonia. Cigarette smoking also makes 
almost every respiratory disorder more severe and symptomatic than it would 
otherwise be. The incidence rates of habitual cigarette smoking vary with occupa-
tion, socioeconomic status, and generation. For those reasons, cigarette smoking 
can be a major confounding factor in interpreting the literature on risk factors for 
respiratory disease. Vietnam veterans are reported to smoke more heavily than 
non-Vietnam veterans (Kang et al., 2006; McKinney et al., 1997).
The causes of death from respiratory diseases, especially chronic diseases, 
are often misclassified on death certificates (Mieno et al. 2016). Grouping vari-
ous respiratory diseases for analysis, unless they all are associated with a given 
exposure, will lead to an attenuation of the estimates of relative risk and to a 
diminution of statistical power. Moreover, the diagnosis of the primary cause of 
death from respiratory and cardiovascular diseases is often inconsistent. In par-
ticular, when a person had both conditions concurrently and both contributed to 
the death, there may be some uncertainty about which cause should be selected 
as the primary underlying cause. In other instances, errors may arise in selecting 
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one underlying cause in a complex chain of health events (for example, if COPD 
leads to congestive heart failure and then to respiratory failure).
Many study populations are small, so investigators often group deaths from 
all non-cancerous respiratory diseases into one category that combines pneumo-
nia, influenza, and other diseases with COPD and asthma. The committee notes 
that an association between the group of all non-cancerous respiratory diseases 
with any of the COIs would be too nonspecific to be clinically meaningful; at 
most, such a pattern would be an indication that within this broad classification, 
the incidence of some particular disease entity might be affected by an exposure 
to a COI.
Conclusions from VAO and Previous Updates
The committee responsible for the initial VAO report (IOM, 1994) concluded 
that there was inadequate or insufficient information to determine whether there 
is an association between exposure to the COIs and respiratory disorders. Ad-
ditional information available to the committees responsible for Update 1996 
(IOM, 1996), Update 1998 (IOM, 1999), Update 2000 (IOM, 2001), Update 
2002 (IOM, 2003c), and Update 2004 (IOM, 2005) also maintained the original 
conclusion of an inadequate or insufficient level of association.
A number of studies of non-malignant respiratory diseases in Vietnam vet-
erans have since been reviewed. However, the majority of these studies were not 
able to control for major risk factors, such as smoking or tobacco use. Mortality 
from respiratory diseases was not found to be higher than expected in the Centers 
for Disease Control and Prevention’s Vietnam Experience Study (Boehmer et al., 
2004), in the Air Force Health Study (AFHS) (Ketchum and Michalek, 2005), or 
in two Australian studies of Vietnam veterans (ADVA, 2005b,c), but it is possible 
that the use of death certificates may have introduced some misclassification of 
respiratory deaths (Drummond et al., 2010). In contrast, in the Army Chemical 
Corps (ACC) cohort of Vietnam veterans, the prevalence of self-reported non-
cancerous respiratory problems diagnosed by a doctor was significantly increased 
by about 40–60%, although no differences in the prevalence of respiratory prob-
lems were found in the subset of veterans whose serum TCDD was above 2.5 
parts per trillion (Kang et al., 2006). Further study of cause- specific mortality in 
the ACC cohort by Cypel and Kang (2010) found a statistically significant ex-
cess of mortality from COPD when comparing the deployed and non-deployed 
groups. In a later analysis, Cypel and Kang were able to control for self-reported 
herbicide exposure, body mass index (BMI), and smoking status but found no 
statistically significant differences in respiratory diseases between sprayers and 
nonsprayers. Deaths due to COPD were lower in non-deployed ACC veterans 
than in males in the U.S. population; this is noteworthy because the prevalence 
of smoking in the non-deployed ACC veterans was about twice that in men in 
the U.S. population (Kang et al., 2006). Kang et al. (2014a) found lower risks 
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of respiratory system disease deaths and COPD deaths in women veterans who 
were deployed to Vietnam compared with non-deployed women veterans, but 
these associations were not statistically significant.
Comparing New Zealand veterans who served in Vietnam with the standard-
ized general male population of New Zealand, the risk of death from all non-
malignant respiratory diseases (excluding COPD) was statistically significantly 
lower, but for COPD specifically no difference was found (McBride et al., 2013). 
Researchers of the Korean Veterans Health Study applied the Stellman exposure 
model and found no statistically significant difference for deaths from respiratory 
disease (Yi et al., 2014a,b). A comparison of deaths in the low-exposure category 
with the deaths in the high-exposure category found a statistically significant risk 
for non-malignant respiratory diseases that was statistically significantly elevated 
for COPD but not for pneumonia or asthma. A separate analysis of disease preva-
lence in the Korean Veterans Health Study used insurance claim data and found 
no difference in the risk of diseases of the respiratory system overall between the 
high-exposure and the low-exposure groups, but it did report statistically signifi-
cant differences in the risks for COPD, pneumonia not due to influenza, chronic 
bronchitis, bronchiectasis, and asthma (Yi et al., 2014a).
Several studies of occupational cohorts have also been reviewed by the many 
VAO Update committees. Update 2000 (IOM, 2001) drew attention to findings 
in the Seveso cohort that suggested a higher mortality from non-cancerous re-
spiratory disorders in study subjects, particularly males, who were more heavily 
exposed to TCDD. Additional follow-up of mortality in the Seveso cohort found 
some increase in mortality from COPD at the 15- and 20-year points (Bertazzi 
et al., 1998, 2001) as well as at the 25-year follow-up (Consonni et al., 2008).
Occupational and industrial cohorts in the United States, the United Kingdom, 
New Zealand, and Australia did not find increased mortality from non-cancerous 
respiratory diseases overall (Boers et al., 2010; Collins et al., 2009a,c; McBride 
et al., 2009a), though they were unable to control for smoking. An update of the 
National Institute for Occupational Safety and Health (NIOSH) cohort of pen-
tochlorophenol (PCP) workers (Ruder and Yin, 2011) did not find an association 
between exposure to the COIs and deaths from all non-malignant respiratory 
diseases; no association with COPD deaths was found for the subgroup exposed 
to both TCDD and PCP. Updated mortality data on workers in two chlorphenoxy 
herbicide plants in the Netherlands were reanalyzed by Boers et al. (2012) using 
serum measurements, but no association of TCDD exposure with respiratory dis-
eases was observed. An updated mortality study of workers in a pesticide factory 
with TCDD contamination (Manuwald et al., 2012) showed no association of 
non-malignant respiratory disease with exposure.
No associations were observed with respiratory mortality in a small sub-
cohort of New Zealand phenoxy herbicide sprayers ('t Mannetje et al., 2005) or 
with mortality from COPD in private applicators or their spouses in the Agricul-
tural Health Study (AHS) (Blair et al., 2005a). Several other studies using the 
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AHS cohort that examined morbidity from particular self-reported respiratory 
health problems, including wheeze, asthma, “farmer’s lung” or hypersensitivity 
pneumonitis, and chronic bronchitis were examined by update committees, but 
most findings were not statistically significant.
Based on the many studies considered in various cohorts that applied differ-
ent designs, measures of exposure, and definitions of non-malignant respiratory 
outcomes, the conclusion of inadequate or insufficient evidence of an association 
between exposure to the COIs and mortality from all non-cancerous respiratory 
diseases or from COPD specifically, has remained unchanged. There also remains 
inadequate or insufficient evidence of an association between exposure to the 
COIs and the prevalence of respiratory diseases, such as wheeze or asthma, 
COPD, and farmer’s lung.
Update of the Epidemiologic Literature
This section summarizes the results of the relevant studies on respiratory 
disorders and exposures to the COIs. One new study of Vietnam veterans and 
respiratory disorders, one occupational study, and three other relevant studies 
of respiratory disorders and the COIs have been identified since Update 2014. 
Tables 43 and 44, which can be found at www.nap.edu/catalog/25137, summarize 
the results of studies related to non-cancer respiratory disease and COPD and 
pulmonary function, respectively.
Vietnam-Veteran Studies
Since Update 2014, one follow-up study of 2,783 male New Zealand Viet-
nam veterans, who served during 1964 to 1972 was identified and reviewed. Cox 
et al. (2015) used hospital discharge records from 1988 to 2009 to report the 
prevalent health conditions among this population. Age-specific hospitalization 
rates were calculated using the total number of annual hospitalizations published 
by the Ministry of Health and the average annual resident population. Standard-
ized hospitalization rates and 99% confidence intervals (CIs) were calculated 
for both the veteran cohort and the general population, and a standardized hos-
pitalization ratio (SHR) was calculated using the two rates. Results showed a 
statistically significant increase in the hospitalization risk for COPD (n = 300; 
SHR = 1.68, 99% CI 1.43–1.93) and pneumonia (n = 174; SHR = 1.36, 99% 
CI 1.09–1.63). No difference in the ratio was found for asthma, although the 
estimate was decreased (n = 33; SHR = 0.84, 99% CI 0.46–1.21). Overall, the 
results of this study showed a small increase in hospital admissions of Vietnam 
veterans for COPD and pneumonia compared with the standardized population 
of New Zealand. Because smoking is a major risk factor for respiratory condi-
tions, the lack of smoking-adjusted ratios raises concerns about the validity of 
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the estimates. Moreover, exposure to the COIs was not validated and was simply 
assumed based on deployment to Vietnam.
Occupational Studies
Collins et al. (2016) added follow-up time for a retrospective cohort of 2,192 
workers exposed to dioxins during trichlorophenol (TCP) and PCP production 
at chemical manufacturing plant in Michigan. Workers were compared with the 
U.S. population in order to calculate standardized mortality ratios, and work 
history records provided information about the length of the exposure. Serum 
samples used to measure levels of six types of dioxins were collected from 431 
TCP and PCP workers. The historical concentrations for each dioxin congener 
were calculated based on the median concentration in the serum samples and the 
known half-lives associated with each congener. Complete vital status follow-up 
was achieved for the cohort, and there were 1,198 deaths during the entire study 
period (1979–2011). For the 1,198 TCP and PCP workers, there were 110 deaths 
from respiratory system disorders, with an SMR of 0.94 (95% CI 0.77–1.13).
Henneberger et al. (2014) examined the exacerbation of asthma among 
pesticide applicators with asthma who were enrolled in the AHS; details of the 
AHS study design, data collection, and cohort are found in Chapter 5. In this 
analysis, participants were selected for inclusion based on completing both the 
baseline and an additional take-home questionnaire and having reported a doc-
tor diagnosis of asthma and also having reported active asthma based on having 
had at least one episode of wheezing or whistling in the previous 12 months and 
having had breathing problems in the same time period. The final study sample 
included 926 adult pesticide applicators with active asthma. Exacerbation was 
defined as having visited a hospital emergency room or doctor for an episode 
of wheezing or whistling in the previous 12 months. AHS participants were 
asked about their use of individual pesticides, and this analysis focused on the 
36 pesticides used in the 12 months before enrollment (current exposure) by at 
least 10 applicators with at least two exacerbation cases. Logistic regression was 
used to estimate odds ratios for pesticide exposure, controlling for age, state, 
type of pesticide applicator (private or commercial), cigarette smoking status, 
allergy status based on self-reports of doctor-diagnosed hay fever or eczema, and 
adult onset of asthma based on onset at >20 years of age. No association with 
an elevated odds of asthma exacerbation was found for either 2,4-D (OR = 0.8; 
95% CI 0.5–1.3) or dicamba (OR = 1.0; 95% CI 0.6–1.6). Interaction models for 
pesticide exposure and allergic status were not significant for 2,4-D and dicamba. 
The authors interpreted the inverse associations as related to the possibility that 
asthmatic farmers avoided certain activities and exposures. The AHS includes a 
well-characterized cohort with self-reported pesticide exposure data that has been 
shown to be reliable and the asthma and exacerbation outcomes were carefully 
Veterans and Agent Orange: Update 11 (2018)
Copyright National Academy of Sciences. All rights reserved.
522 VETERANS AND AGENT ORANGE: UPDATE 11
defined. However, the data are cross-sectional, and the sequence of exposure and 
events cannot be determined.
't Mannetje et al. (2018) conducted a morbidity survey among a subset of 
workers who were employed at the New Plymouth, New Zealand, phenoxy 
herbicide production plant for at least 1 month between 1969 and 1984. The 
plant produced 2,4,5-T, and workers were potentially exposed to 2,4,5-T, the 
intermediates of TCP and other chlorophenols, and TCDD. Workers had previ-
ously been recruited and examined as part of the international cohort of pro-
ducers of phenoxy herbicides led by the International Agency for Research on 
Cancer (IARC) (Kogevinas et al., 1997); see Chapter 5 for more details on the 
IARC cohort and the New Zealand phenoxy producers. This study extends the 
follow-up period of these workers to approximately 30 years from their last 
2,4,5-T production exposure. From the original cohort of 1,025 workers, 631 
were living, had a current address in New Zealand, and were below 80 years of 
age on January 1, 2006. For the current follow-up, 430 of the 631 workers were 
randomly selected and invited to participate in the morbidity survey, of which 
245 (57%) participated. The survey was administered in 2007–2008 by face-to-
face interview, and information was collected on demographic factors and health 
information, including doctor-diagnosed conditions and the year of diagnosis. 
A blood sample was also collected at that time and analyzed for TCDD, lipids, 
thyroid hormones, and other substances. For 111 participants, a neurological 
examination was conducted. Associations between exposure and health outcomes 
were assessed using logistic regression models that controlled for age, gender, 
smoking, BMI, and ethnicity using two different methods of exposure: having 
worked in a TCDD-exposed job (based on occupational records) and having 
serum TCDD concentration ≥10 pg/g lipid (18%). Mean TCDD concentrations 
were 19 pg/g lipid in the 60 men directly involved in phenoxy/TCP production, 
and 6 pg/g lipid in the 141 men and 43 women who worked in other parts of the 
plant. Compared with the 124 people in the non-highly-exposed jobs, the 121 
people who had ever worked in a highly exposed job were no more likely to 
have doctor-diagnosed asthma (n = 8; OR = 1.13; 95% CI 0.40–3.22) or chronic 
bronchitis (n = 3; OR = 2.39; 95% CI 0.17–34.0). When compared by serum 
TCDD concentration ≥10 pg/g lipid, there were few cases of asthma or chronic 
bronchitis, and no difference in risk was found. Diagnoses of tuberculosis, pleu-
risy, or pneumonia were also examined, but there were too few cases to present 
valid estimates.
Cappelletti et al. (2016) performed a retrospective study of 331 male elec-
tric arc foundry workers at a single plant in Trentino, Italy, to determine if 
they experienced excess mortality from all causes or were at an increased risk 
for several other diseases, including asthma, due to occupational exposures to 
foundry dust. Analysis of the dust emissions found that the dust contained metals 
(including iron, aluminum, zinc, manganese, lead, chromium, nickel, cadmium, 
mercury, and arsenic), polycyclic aromatic hydrocarbons (PAHs), PCBs, and 
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polychlorinated dibenzo-p-dioxin/dibenzofurans (PCDD/Fs) (reported as TEQs). 
Therefore, the authors could not determine which of the agents were associated 
with a specific outcome or to what extent. The men had worked at the factory for 
at least 1 year and, for the asthma analysis, were compared with 32 presumed 
non-exposed workers (clerks, managers, and watchmen) or with the standard-
ized general population of Region Trentino-Alto Adige (where the factory was 
located) because there were few non-exposed foundry workers and high attrition 
rates. Company and medical records were used to determine vital status; the cause 
of death was determined from death certificates or other registries. Requests for 
exemption health care fees were used as a surrogate measure to identify the most 
common morbid conditions in the general population, which were then applied 
to the cohort to compute the relative risks for each of the conditions. The workers 
were followed from March 19, 1979 (or their first day of employment), through 
December 31, 2009, or date of death. The analysis for asthma was limited to 235 
workers, and effect estimates were calculated using Mantel-Haenszel tests. Only 
two cases of asthma were found among the workers, and there was no difference 
in risk compared with the age-adjusted provincial population, although the effect 
estimate was imprecise (RR = 1.08, 95% CI = 0.27–4.31). This study is most 
limited by the fact that foundry dust is a complex mixture, which made it impos-
sible to discern the impact of the specific contaminants of the foundry dust on 
the health outcomes of those exposed workers. Estimates were adjusted for only 
the age group and were not adjusted for other risk factors such as tobacco use, 
BMI, or other jobs or activities that could result in similar exposures. Exposure 
to foundry dust by the general population that was used for comparison was not 
discussed, although the foundry appears to be in the local vicinity, and emissions 
from it were reported to be present within a 2-kilometer radius.
Other Identified Studies
Five other studies of non-malignant respiratory diseases were identified, 
but all lacked sufficient exposure specificity to be included as contributing to 
the evidence base of the potential effect of the COIs. One study of U.S. capaci-
tor manufacturer workers exposed to mixed PCBs that reported on deaths from 
respiratory diseases was identified, but it was limited by its lack of exposure 
specificity (Ruder et al., 2014). An analysis of data from the AGRICAN French 
cohort study examined the prevalence of respiratory diseases in adult men and 
women who were active or retired farm workers or owners, but all exposures 
and outcomes, which included asthma, were self-reported, and exposures to 
specific pesticides were not ascertained (Baldi et al., 2014). Butinof et al. (2015) 
conducted a cross-sectional study of male pesticide applicators who were li-
censed in Argentina and who were directly exposed to pesticides (n = 880). All 
participants completed a self-administered questionnaire that was adapted from 
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the U.S. AHS, which collected information about herbicides, insecticides, and 
fungicides used, but no pesticide-specific exposure assessment was conducted, 
which limited the study’s utility. A study of occupational exposure to pesticides 
in Ethiopian farmers and farm workers and respiratory health effects was con-
ducted by Negatu et al. (2016) but was not considered further since data on 
specific pesticides were not collected. Finally, Akahane et al. (2017) examined 
the prevalence of self-reported long-term health effects (including respiratory 
disorders) in people exposed to PCBs, dioxins (e.g., PCDD/Fs), and dioxin-like 
chemicals through the ingestion of contaminated rice bran oil (Yusho accident) 
compared with an age-, sex- and residential-area-matched group. Because no 
TEQs or other quantification of relevant exposures were presented, the study 
was not considered further.
Biologic Plausibility
Several recent studies explored the pro- and anti-inflammatory activity of 
TCDD exposure and of aryl hydrocarbon receptor (Ahr) in lungs in mice and in 
mouse and human lung cells. These studies addressed such health effects as lung 
response to viral infections, asthma, COPD, and allergen-induced lung inflam-
mation. Cho et al. (2015) found that nuclear coactivator 7 (NCOA7) showed 
differential activity in a cell-culture study of TCDD exposure in normal lung 
epithelial and lung cancer cells with NCOA7 increasing CYP1A1 activity and 
the levels of inflammatory cytokines in the diseased cells but not in normal cells. 
S. M. Lee et al. (2017) found that AHR activation by the endogenous ligand 
kynurenine plays a role in immune regulation in inflammatory responses in a 
mouse model of lung injury.
Q. Liu et al. (2014) exposed juvenile zebrafish to TCDD in diet and reported 
a novel finding of lesions in nasal epithelium. Boule et al. (2015) exposed mice 
to TCDD during development and investigated their response to viral infection 
as adults. Treated mice had increased bronchopulmonary inflammation with an 
enhanced CD4+ T-cell response.
X. M. Li et al. (2016) found that TCDD-Ahr activation prevented inflam-
mation and airway hyper-responsiveness in a non-eosinophilic asthma model 
in mice. The lungs of treated mice showed reduced eosinophil and neutrophil 
infiltration, and Th17 cytokine IL-17 was reduced in serum and bronchio-alveolar 
lavage fluid (with Th2 cytokine IL-4 also reduced). In a study comparing Ahr 
knockout and wild-type mice, T. Xu et al. (2015) found that TCDD treatment 
enhanced mesenchymal stem cell recruitment, thereby suppressing allergen-induced 
lung inflammation.
Sarill et al. (2015) explored the role of AHR and suggested that AHR has 
a role regulating anti-oxidant defenses in lung structural cells. In Ahr knockout 
mouse lung fibroblasts and human lung adenoma cells that were deficient in 
AHR expression and exposed to cigarette smoke extract, they found increased 
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oxidative stress compared to wild-type cells. They also showed that anti-oxidant 
gene induction was significantly less in the Ahr knockout mouse lung fibroblasts. 
In lung fibroblasts from mice with an Ahr mutation (incapable of DNA binding), 
they showed that anti-oxidant sulfiredoxin 1 induction after cigarette smoke-
extract exposure was independent of dioxin-response element binding (i.e., a 
role for AHR independent of exogenous ligand). In sum, the findings of Sarill 
et al. (2015) suggest that low AHR expression may facilitate the development 
or progression of COPD. Zago et al. (2017) studied the role of AHR and Cox-2 
protein suppression and also concluded that low AHR contributes to increased 
inflammation, based on their study in human lung fibroblasts.
Synthesis
Update 2014 included new data that did not add any compelling evidence 
of an association of exposure to the COIs and respiratory disorders. The cur-
rent update still does not display a coherent body of epidemiologic evidence to 
support conclusions concerning whether the risks of other particular respiratory 
problems are associated with exposure to the COIs. Cox et al. (2015) showed an 
increase in hospitalization risk rates for COPD and pneumonia, but not asthma, 
in New Zealand Vietnam veterans. However, smoking was not controlled for in 
the analysis and exposure to the COIs was not verified. In a 30-year follow-up of 
workers who produced 2,4,5-T in New Zealand, highly exposed workers did not 
have an elevated risk of doctor-diagnosed asthma, chronic bronchitis, tuberculo-
sis, pleurisy, or pneumonia compared with lower-exposed workers based on job 
duties or serum TCDD concentration. The study of electric arc foundry workers 
in Italy (Cappelletti et al., 2016) reported no difference in the risk of asthma, but 
this was based on two cases. Moreover, the primary exposure, foundry dust, is a 
complex mixture, and it is not possible to isolate any potential COI exposure. In a 
follow-up of TCP and PCP workers at the Dow Midland, Michigan, plant, Collins 
et al. (2016) did not find elevated mortality for respiratory system disorders. 
 Henneburger et al. (2014) found no association of asthma exacerbation with ex-
posure to the COIs in the AHS. Therefore, the prior assessment cannot be altered 
since the new findings are mixed, and the study designs have limitations.
Conclusion
On the basis of the evidence reviewed here and in previous VAO reports, 
the committee concludes that there is inadequate or insufficient evidence of an 
association between exposure to the COIs and mortality from all non-cancerous 
respiratory diseases or from COPD specifically. There is also inadequate or 
insufficient evidence of an association between exposure to the COIs and the 
prevalence of respiratory disorders.
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GASTROINTESTINAL AND DIGESTIVE DESEASES, 
INCLUDING LIVER TOXICITY
This section discusses a variety of conditions specified by ICD-9 520–579 or 
ICD-10 K00–K95: diseases of the esophagus, stomach, intestines, rectum, liver, 
and pancreas. Details on peptic ulcer and liver disease, the two conditions most 
often discussed in the literature reviewed, are provided below. The symptoms 
and signs of gastrointestinal disease and liver toxicity are highly varied and often 
vague.
The essential functions of the gastrointestinal tract are to absorb nutrients and 
to eliminate waste. Those complex tasks involve numerous chemical and molecu-
lar interactions on the mucosal surface and complex local and distant neural and 
endocrine activity. One common condition of the gastrointestinal tract is motil-
ity disorder, which is present in about 15% of adults. The most convenient way 
to categorize diseases that affect the gastrointestinal system is according to the 
affected anatomic segment. Esophageal disorders predominantly affect swallow-
ing, gastric disorders are related to acid secretion, and conditions that affect the 
small and large intestines are reflected in alterations in nutrition, mucosal integ-
rity, and motility. Some systemic disorders (inflammatory, vascular, infectious, 
and neoplastic conditions) also affect the gastrointestinal system.
Peptic-Ulcer Disease
Peptic-ulcer disease refers to ulcerative disorders of the gastrointestinal tract 
that are caused by the action of acid and pepsin on the stomach or duodenal mucosa. 
Peptic-ulcer disease is characterized as gastric or duodenal ulcer, depending on 
the site of origin. Peptic-ulcer disease occurs when the corrosive action of gastric 
acid and pepsin overcomes the normal mucosal defense mechanisms that protect 
against ulceration. About 10% of the population has clinical evidence of having 
had a duodenal ulcer at some time in their lives; a similar percentage is affected 
by gastric ulcer. The incidence of duodenal ulcer peaks in the fifth decade, and 
the incidence of gastric ulcer about 10 years later.
Evidence increasingly indicates that the bacterium Helicobacter pylori is 
linked to peptic-ulcer disease (both duodenal and gastric). H. pylori colonizes 
the gastric mucosa in 95–100% of patients who have a duodenal ulcer and in 
75–80% of patients who have a gastric ulcer. Healthy people in the United States 
under 30 years old have gastric colonization rates of about 10%. Over the age 
of 60 years, colonization rates exceed 60%. Colonization alone, however, is not 
sufficient for the development of ulcer disease; only 15–20% of subjects who 
have H. pylori colonization will develop ulcers in their lifetime. Other risk fac-
tors include genetic predisposition (such as some blood and human leukocyte 
antigen types), cigarette smoking, and psychologic factors (chronic anxiety and 
stress).
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Liver Disease
Blood tests of liver function are the mainstay of diagnosing liver disease. 
Increases in serum bilirubin and in the serum concentrations of some hepatic 
enzymes—aspartate aminotransferase, alanine aminotransferase, alkaline phos-
phatase, and γ-glutamyltransferase (GGT)—are commonly noted in liver dis-
orders. The relative sensitivity and specificity of those enzymes for diagnosing 
liver disease vary, and a diagnosis can require several tests. The only regularly 
reported abnormality in liver function associated with TCDD exposure in humans 
is an increase in GGT. The estimated serum activity of that enzyme is a sensitive 
indicator of a variety of conditions, including alcohol and drug hepatotoxicity, 
infiltrative lesions of the liver, parenchymal liver disease, and biliary tract 
obstruction. Increases are noted after many chemical and drug exposures that 
are not followed by evidence of liver injury. The confounding effects of alcohol 
use (often associated with increased GGT) make it difficult to interpret changes 
in GGT in exposed people (Calvert et al., 1992). An increase in GGT can be 
considered a normal biologic adaptation to chemical, drug, or hormone exposure.
Cirrhosis is the most commonly reported liver disease in epidemiologic stud-
ies of herbicide or TCDD exposure. Cirrhosis is an irreversible chronic injury 
of the liver with extensive scarring and a resulting loss of function. Clinical 
symptoms and signs include jaundice, edema, abnormalities in blood clotting, and 
metabolic disturbances. Cirrhosis can lead to portal hypertension with associated 
gastroesophageal varices, an enlarged spleen, abdominal swelling attributable 
to ascites, and, ultimately, hepatic encephalopathy that can progress to coma. 
It is generally impossible to distinguish the various causes of cirrhosis through 
the clinical signs and symptoms or pathologic characteristics. The most com-
mon cause of cirrhosis in North America and many parts of western Europe and 
South America is excessive alcohol consumption. Other causes are chronic viral 
infection (hepatitis B or hepatitis C), the poorly understood condition primary 
biliary cirrhosis, chronic right-sided heart failure, and a variety of less common 
metabolic and drug-related conditions.
Conclusions from VAO and Previous Updates
Several studies reviewed by previous VAO committees have reported on 
several non-cancerous digestive system outcomes, and for that reason this section 
and the update of new epidemiologic literature presents all results for digestive 
and hepatobiliary outcomes by publication. Some studies that have been reviewed 
focused on liver enzymes, while others reported on specific liver diseases. An 
evaluation of the effects of herbicide and TCDD exposure on non-cancerous 
gastrointestinal ailments is challenging in that clinical experience suggests that 
medical history and physical examination are undependable diagnostic tools 
for some ailments, so incidence data are sometimes problematic. The strong 
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interdependence among the characteristics of a given person (such as weight and 
the laboratory indexes of hepatic function and health) and TCDD body burden 
complicates the already difficult task of assessing association.
Studies of Vietnam veterans have generally examined different laboratory 
endpoints and clinical conditions, making comparisons and overall conclusions 
difficult. An analysis of the AFHS found that a significantly higher percentage of 
Ranch Hand veterans in the high-dioxin category had excesses of transaminase 
and other nonspecific laboratory measures of liver function than their comparison 
subjects. The data were consistent with an interpretation of a dose–response rela-
tionship, but other explanations were also plausible (AFHS, 2000). Later analyses 
also reported some abnormalities in liver enzymes among the Ranch Hands, 
including decreasing levels of C4 complement as dioxin increased and abnor-
mal triglyceride concentrations that increased as the 1987 dioxin concentration 
increased (AFHS, 2005). However, mortality studies of the Ranch Hand cohort 
have not found an increased mortality related to gastrointestinal or liver disease 
(Ketchum and Michalek, 2005). Among ACC veterans, an increased rate of 
hepatitis was associated with Vietnam service but not with a history of spraying 
herbicide (Kang et al., 2006), and an 80% excess of digestive system or cirrhosis 
deaths was observed in veterans who handled or sprayed herbicides in Vietnam 
compared with their non-Vietnam-veteran peers (Cypel and Kang, 2010).
Studies of digestive and liver disease among other Vietnam veterans cohorts 
have not found associations with presumed herbicide exposure. The Australian 
Vietnam-veterans study (ADVA, 2005b) did not find an increase in liver disease 
in military personnel who served in Vietnam compared with the general popula-
tion of Australia. The relationship between possible herbicide exposure and liver 
and gastric-ulcer disease was described in a sample of Korean Vietnam-era veter-
ans in three publications by Yi et al. (2013, 2014a,b). Based on health insurance 
claims data, the adjusted prevalence of peptic-ulcer disease was found to be 3% 
higher in those with high exposure than in those with low exposure after adjust-
ing for several behavioral, demographic, and service-related factors. For liver 
cirrhosis, there was likewise a small elevation in the prevalence and a significant 
log-linear relationship between an exposure opportunity score and the odds of 
having cirrhosis. In the mortality study in the same cohort of Korean Vietnam 
veterans, there was no association between putative log-transformed exposure 
and mortality from peptic ulcers (Yi et al., 2014b). However, highly exposed vet-
erans were 17% more likely to die from cirrhosis than those with low exposure. 
Deaths from alcoholic liver disease were also statistically significantly elevated 
in the more highly exposed veterans.
Most of the analyses of occupational or environmental cohorts have had 
insufficient numbers of cases to support confident conclusions. Gastric ulcer was 
not associated with serum levels of dioxin-like PCDD/Fs or dioxin-like PCBs or 
with total TEQs after adjusting for possible confounders in a general population 
sample of 2,264 Japanese adults (Nakamoto et al., 2013). An analysis of National 
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Health and Nutrition Examination Survey (NHANES) data on blood levels of 37 
environmental pollutants and alanine aminotransferase levels in 1,345 persons 
aged 12 years and older found that, in general, blood levels of dioxin-like chemi-
cals were not significantly correlated with alanine aminotransferase levels. The 
exception was 1,2,3,4,6,7,8-heptachlorodibenzo-p-dioxin, which was associated 
with only a slight elevation (< 1%) (Yorita Christensen et al., 2013).
A study of the IARC cohort of phenoxy -herbicide and chlorophenol produc-
tion workers and sprayers (Vena et al., 1998), the only study that had a relatively 
large number of observations, found less digestive system disease and cirrhosis 
mortality in exposed workers than in non-exposed controls. The mortality results 
through 2001 for the Seveso, Italy, cohort (Consonni et al., 2008) found no ex-
cess of deaths related to digestive diseases or specifically to cirrhosis. Several 
mortality studies of various occupational cohorts exposed to the COIs have been 
inconsistent but generally found no statistically significant increases in deaths 
from either ulcers or cirrhosis (Boers et al., 2010, 2012; Collins et al., 2010a,b; 
Manuwald et al., 2012; McBride et al., 2009a,b; Ruder and Yiin, 2011).
Thus, the reports have been inconsistent, and interpreting individual studies 
is difficult because of a lack of information on alcohol consumption and other 
risk factors. In the studies that showed the strongest association between potential 
exposure and gastrointestinal disease (specifically cirrhosis), there was strong 
evidence that excess alcohol consumption was the cause of the cirrhosis. The 
committee responsible for VAO concluded that there was inadequate or insuffi-
cient information to determine whether there is an association between exposure 
to the COIs and gastrointestinal and digestive disease, including liver toxicity. 
Additional information available to the committees responsible for subsequent 
updates has not changed that conclusion.
Update of the Epidemiologic Literature
One new study of gastrointestinal diseases among Vietnam veterans and two 
occupational studies of workers in herbicide-producing plants have been identi-
fied since Update 2014.
Vietnam-Veteran Studies
Cox et al. (2015) used hospital discharge records from 1988 to 2009 to 
identify health conditions that affected 2,783 male New Zealand veterans who 
had served in Vietnam during 1964–1972. Age-specific hospitalization rates 
were calculated using the total number of annual hospitalizations published by 
the Ministry of Health and the average annual resident population. Standardized 
hospitalization rates and 99% CIs were calculated for the veteran cohort and 
the general population and reported for 14 conditions related to gastrointesti-
nal and hepatobiliary outcomes. Those conditions were: esophageal disorders, 
Veterans and Agent Orange: Update 11 (2018)
Copyright National Academy of Sciences. All rights reserved.
530 VETERANS AND AGENT ORANGE: UPDATE 11
gastroduodenal ulcer, gastritis, appendicitis, abdominal hernia, intestinal obstruc-
tion, diverticulosis, anal/rectal disorders, biliary disorders, alcoholic liver dis-
ease, other liver disease, pancreatic disease, abdominal pain, and gastrointestinal 
hemorrhage. The risk of hospitalization for gastroduodenal ulcer was elevated 
for veterans (n = 44; SHR = 1.80, 99% CI 1.10–2.50). Few cases of alcoholic 
liver disease were found, but the risk of hospitalization was not different between 
veterans and the general population (n = 11; SHR = 1.07, 99% CI 0.24–1.90). 
The risk of hospitalization from other liver disease (not further defined) was 
higher in veterans (n = 48; SHR = 1.86, 99% CI 1.17–2.55). No other increased 
or decreased risks of gastrointestinal and hepatobiliary outcomes were found. 
Exposure to the COIs was not validated and was assumed based on deployment 
to Vietnam. Moreover, the analysis did not control for smoking or ethnicity or 
other potentially important risk factors.
Occupational Studies
 Collins et al. (2016) included additional follow-up time in a retrospective 
analysis of a cohort of 2,192 workers exposed to dioxins during TCP and PCP 
production at chemical manufacturing plant in Michigan. The U.S. population 
was used as the comparator for estimating standardized mortality ratios. Work 
history records were used to determine the length of the exposure. Serum samples 
for measuring the levels of six types of dioxins were collected for 431 TCP and 
PCP workers. The historical concentrations for each dioxin congener were cal-
culated from the median concentrations from the serum samples and the known 
half-lives associated with each congener. Complete vital status follow-up was 
achieved for the cohort, and there were 1,198 deaths through the entire study 
period (1979–2011). Deaths from ulcer of the stomach and duodenum (K25–K27) 
and cirrhosis of the liver (K70–K74) were also included. No difference in the 
mortality of ulcer of the stomach and duodenum was found for the TCP workers 
(n = 2; SMR = 0.78, 95% CI 0.10–2.82), but an increased risk was found for the 
PCP workers (n = 5; SMR = 3.38, 95% CI 1.10–7.89). However, the interpreta-
tion of this finding is limited because the number of deaths from ulcers was small 
and the resulting risk estimates were imprecise. There were 16 total reported 
deaths from liver cirrhosis, but no difference in mortality was found for the TCP 
workers (n = 8; SMR = 0.44, 95% CI 0.19–87.2) or the PCP workers (n = 8; SMR 
= 0.97, 95% CI 0.42–1.91) compared with the standardized U.S. population. 
The committee notes that there is a possible mistake in the confidence interval 
reported for the TCP risk estimate, but there is no compelling data to indicate that 
cirrhosis of the liver is associated with exposure to dioxin. The committee also 
notes that no new deaths from stomach or duodenum ulcer have been reported 
since the last update of this cohort in 2003 (Collins et al., 2009a,b) at which time 
a statistically significant increase in stomach and duodenal ulcer deaths was found 
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for PCP workers but not TCP workers. Since 2003, two additional deaths from 
liver cirrhosis among TCP workers were reported.
't Mannetje et al. (2018) conducted a morbidity survey among a subset of 
workers who were employed at the New Plymouth, New Zealand, phenoxy her-
bicide production plant for at least 1 month between 1969 and 1984. The plant 
produced 2,4,5-T, and workers were potentially exposed to 2,4,5-T, the inter-
mediates of TCP and other chlorophenols, and TCDD. Workers had previously 
been recruited and examined as part of the international cohort of producers of 
phenoxy herbicides led by IARC (Kogevinas et al., 1997); see Chapter 5 for more 
details on the IARC cohort and the New Zealand phenoxy producers. This study 
extends the follow-up period of these workers to approximately 30 years from 
their last 2,4,5-T production exposure. From the original cohort of 1,025 work-
ers, 631 were living, had a current address in New Zealand, and were below 80 
years of age on January 1, 2006. For the current follow-up, 430 of the 631 work-
ers were randomly selected and invited to participate in the morbidity survey, 
of which 245 (57%) participated. The survey was administered in 2007–2008 
by face-to-face interview, and information was collected on demographic fac-
tors and health information, including doctor-diagnosed conditions and the year 
of diagnosis. A blood sample was also collected at that time and analyzed for 
TCDD, lipids, thyroid hormones, and other substances. For 111 participants, a 
neurological examination was conducted. Associations between exposure and 
health outcomes were assessed using logistic regression models that controlled 
for age, gender, smoking, BMI, and ethnicity using two different methods of 
exposure: having worked in a TCDD-exposed job (based on occupational records) 
and having serum TCDD concentration ≥10 pg/g lipid (18%). Mean TCDD con-
centrations were 19 pg/g lipid in the 60 men directly involved in phenoxy/TCP 
production and 6 pg/g lipid in the 141 men and 43 women who worked in other 
parts of the plant. Compared with the 124 people in the non-highly-exposed jobs, 
the 121 people who had ever worked in a highly exposed job were no more likely 
to have a doctor-diagnosed liver function problem (n = 10; OR = 0.84; 95% CI 
0.30–2.34). When compared by serum TCDD concentration ≥10 pg/g lipid, there 
were few cases of liver function problem, leading to imprecise effect estimates (n 
= 3; OR = 0.54; 95% CI 0.12–2.36).
Other Identified Studies
Ruder et al. (2014) assessed cause-specific mortality including grouped dis-
eases of the digestive system among 24,865 workers exposed to dioxin-like and 
non-dioxin-like PCBs from three U.S. electrical capacitor manufacturing plants who 
were employed 3 months or more from as early as 1939 through 1977. However, a 
lack of exposure specificity precluded further consideration. Akahane et al. (2017) 
examined the prevalence of self-reported long-term health effects in people exposed 
to PCBs, dioxins (e.g., PCDD/Fs), and dioxin-like chemicals through the ingestion 
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of contaminated rice bran oil (Yusho accident) compared with an age-, sex- and 
residential-area-matched group. Because no TEQs or other quantification of the 
relevant exposures was presented, the study was not considered further.
Yamamoto et al. (2015) studied 678 male workers at a waste incineration 
plant in Japan. Blood samples were measured to determine the amounts of TCDD 
and PCBs in the blood, and several markers of hematology and blood chemistry 
profiles were also measured. Although some of these tests may be able to detect 
liver dysfunction, it was not linked to a health outcome, and the study was not 
considered further.
Biologic Plausibility
The liver is the first organ that encounters chemicals absorbed from the 
gastrointestinal tract, and it is responsible for metabolizing them to water-soluble 
chemicals that can be excreted in the urine. Because the liver has many de-
toxifying enzymes that efficiently metabolize many chemicals, liver toxicity is 
usually associated only with high-dose acute exposure or lower-dose chronic 
exposure. The liver can be damaged if the metabolism of a chemical results 
in the production of a reactive intermediate that is more toxic than the parent 
chemical. Changes in the serum concentrations of liver enzymes are biomark-
ers of liver toxicity, and their magnitudes correlate with the degree of liver 
damage. The exposure of laboratory animals to high doses of 2,4-D, 2,4,5-T, 
and TCDD is known to cause liver damage. The mechanisms by which the phe-
noxy herbicides damage the liver are based on the inhibition of mitochondrial 
function by the blocking of oxidative phosphorylation; this leads to a loss of 
generation of adenosine triphosphate, the death of cells, and hepatic necrosis 
and fibrosis. TCDD-induced hepatotoxicity is mediated by the activation of the 
AHR, which leads to changes in gene transcription and associated changes in 
cell function. Changes in gene expression are associated with several physi-
ologic processes, oxidative stress, and apoptosis (Boverhof et al., 2005, 2006). 
TCDD-mediated hepatic steatosis is characterized by the accumulation of tri-
glycerides caused by the combined up-regulation of CD36/fatty acid translocase 
and fatty acid transport proteins, the suppression of fatty acid oxidation, the 
inhibition of the hepatic export of triglycerides, an increase in peripheral fat 
mobilization, and an increase in hepatic oxidative stress (J. H. Lee et al., 2010). 
Recent evidence suggests that hepatic steatosis produced by TCDD might be 
mediated by the mitochondria (He et al., 2013). The exposure of rats to TCDD 
over a 2-year period (NTP, 2004) also produced several changes in the liver, 
including hepatocyte hypertrophy, multinucleated hepatocytes, inflammation, 
pigmentation, diffuse fatty change, necrosis, bile duct hyperplasia, bile duct cyst, 
nodular hyperplasia, portal fibrosis, and cholangiofibrosis. Lamb et al. (2016) 
studied a mouse model of liver injury and found that TCDD exposure increased 
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liver damage and inflammation, suggesting that TCDD-activated AHR enhanced 
hepatic stellate cell activity.
AHR displays species differences; for example, amino acid sequences in the 
C-terminal region of human and mouse AHR are only 58% identical. Compared 
with the mouse Ahr, the human AHR has about a 10-fold lower relative affinity 
for TCDD; the difference has been attributed to the amino acid residue valine 381 
in the ligand-binding domain of the human AHR (Flaveny et al., 2009; Ramadoss 
and Perdew, 2004). The existence of species differences associated with AHR 
activation is supported by the divergence in the transcriptomic and metabolomic 
responses to TCDD in mouse, rat, and human liver (Boutros et al., 2008, 2009; 
Carlson et al., 2009; Forgacs et al., 2012, 2013; Kim et al., 2009; Nault et al., 
2013; Watson et al., 2017). In a recent study, gene-expression changes were com-
pared in adult female primary human and rat hepatocytes that had been exposed 
to TCDD in vitro (Black et al., 2012). Whole-genome microarrays found that 
TCDD produced divergent gene-expression profiles in rat and human hepatocytes, 
both on an ortholog basis (conserved genes in different species) and on a path-
way basis. For commonly affected orthologs or signaling pathways, the human 
hepatocytes were about 15-fold less sensitive than rat hepatocytes. Another mi-
croarray study examining species-specific transcriptomic differences in primary 
hepatocytes from humans, mice, and rats identified 16 orthologous genes that were 
dysregulated by TCDD in all three species (Forgacs et al., 2013). Such findings are 
consistent with epidemiologic studies that have shown humans to be less sensitive 
to TCDD-induced hepatotoxicity. However, it should be noted that in vitro human 
hepatocyte studies may not reflect the in vivo response of human liver to TCDD.
There have been few reports of health-relevant effects of phenoxy herbi-
cides or TCDD on the gastrointestinal tract, even after high exposure. A series of 
recent papers demonstrated the influence of TCDD and the Ahr pathway on the 
development of the gut microbiome in mice (Stedtfeld et al., 2017a,b,c), which is 
thought to influence immune response that may affect gastrointestinal disorders. 
However, the available animal data do not support a plausible link between her-
bicide exposure and gastrointestinal toxicity in Vietnam veterans.
Synthesis
Previous updates indicated that there have been inconsistent findings for the 
COIs and gastrointestinal and liver disease and that interpreting individual studies 
is difficult because of a lack of information on alcohol consumption (especially 
for liver cirrhosis) and other risk factors. The recent studies of Vietnam veterans 
from New Zealand (Cox et al., 2015) and occupational cohorts of phenoxy her-
bicide producers (Collins et al., 2016; 't Mannetje et al., 2018) have not provided 
informative evidence for an association with the COIs. Although a few animal 
studies have shown an influence of TCDD and the Ahr pathway on the devel-
opment of the gut microbiome in mice (Stedtfeld et al., 2017a,b,c), which may 
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modify the immune response in gastrointestinal disorders. The available animal 
data do not support a plausible link between herbicide exposure and gastrointes-
tinal toxicity in Vietnam veterans.
Conclusion
On the basis of the evidence reviewed here and in previous VAO reports, 
the committee concludes that there is inadequate or insufficient evidence to 
determine whether there is an association between exposure to the COIs and 
gastrointestinal and digestive diseases.
KIDNEY AND URINARY DISORDERS
Update 2014 was the first update for which the literature search identified 
studies reporting results concerning a possible association between exposure to 
the COIs and kidney diseases (ICD-9 580–589; ICD-10 N00–N29). The kidneys 
are located in the lower back region; their main function is to filter wastes and 
excess water out of the blood, which results in the production of urine. The 
kidneys are also responsible for helping maintain the body’s chemical balance, 
helping control blood pressure, and synthesizing hormones. When problems arise 
with kidney function, it is often the result of damaged nephrons, which may leave 
the kidneys unable to filter blood and, thus, unable to remove wastes, which can 
then accumulate in the body. Chronic kidney disease is characterized by a gradual 
and usually permanent loss of kidney function that often results in renal failure. 
Diabetes, hypertension, and glomerulonephritis (acute inflammation) can all 
increase the risk of kidney disease.
Conclusions from VAO and Previous Updates
Publications from the Korean Veterans Health Study included findings for 
non-malignant kidney disease. Yi et al. (2013a) examined the prevalence of self-
reported exposure based on six questions and self-reported kidney failure using a 
postal survey of 114,562 Korean veterans who had served in the Vietnam War. The 
incidence of kidney failure was compared by defining high and low categories of 
exposure based on the six exposure questions and also by exposure opportunity 
index (EOI) scores that were calculated. Self-reported kidney failure was statisti-
cally significantly increased when the analysis was based on perceived exposures, 
but it was not significant when the analysis was based on the EOI scores. In a study 
of cause-specific mortality through 2005 for 180,639 Korean veterans who were 
alive in 1992, Yi et al. (2014b) found that after adjustment for age in 1992 and 
rank, no differences in the hazard ratios were observed for acute renal failure or 
for chronic renal failure when the analyses were based on the EOI scores.
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Two environmental studies of non-U.S. populations were also considered. 
In a cross-sectional study of 2,264 Japanese men and women who had not been 
occupationally exposed to dioxins, self-reported kidney disease (not otherwise 
specified) was not associated with serum levels of dioxin-like PCDD/Fs or 
dioxin-like PCBs or with total TEQs after adjusting for possible confounders 
(Nakamoto et al., 2013). The second study sought to determine the factors con-
tributing to a form of kidney disease not related to diabetes, hypertension, or 
any other recognized cause in adults in Sri Lanka (Jayatilake et al., 2013). Urine 
samples were taken from 57 cases and from 39 controls who were from non-
endemic areas, and the samples were analyzed for 11 biomarkers of pesticides, 
including the COIs 2,4-D, 2,4,5-T, and 2,4,5-TCP. Of these, only 2,4-D was 
among the seven biomarkers found at concentrations above the limit of detec-
tion; 3.5% of the cases had 2,4-D concentrations above the reference limit of 
0.3 μg/L. Since the urinary pesticide results were presented for only the cases, 
no inference can be made about the relative risk for this kidney condition in 
association with 2,4-D.
Based on these four studies, the committee for Update 2014 concluded that 
there was inadequate or insufficient evidence of exposure to the COIs and non-
malignant kidney diseases.
Update of the Epidemiologic Literature
One new study of Vietnam veterans and kidney and urinary disorders has 
been identified since Update 2014, as well as supporting occupational, environ-
mental, and case-control studies of kidney and urinary disorders and exposure 
to the COIs.
Vietnam-Veteran Studies
Cox et al. (2015) used hospital discharge records from 1988 to 2009 to 
identify health conditions that affected 2,783 male New Zealand veterans who 
had served in Vietnam during 1964–1972. Age-specific hospitalization rates 
were calculated using the total number of annual hospitalizations published by 
the Ministry of Health and the average annual resident population. Standardized 
hospitalization rates and 99% CIs were calculated for the veteran cohort and the 
general population and the two rates were used to calculate an SHR for several 
conditions including kidney and urinary outcomes. An elevation in chronic renal 
failure risk was identified (SHR = 1.21, 95% CI 1.07–1.36), with an acceleration 
in the risk for later time periods. No significant associations were identified with 
urinary tract infections (OR = 1.06, 95% CI 0.66–1.46), benign prostatic hyper-
trophy (OR = 1.11, 95% CI 0.79–1.42), or urinary stones (OR = 1.06, 95% CI 
0.81–1.31). The exposures were not validated through serum measurements and 
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were assumed based on deployment to Vietnam, and the study did not control for 
smoking status, ethnicity, or other potentially important risk factors.
Occupational Studies
Two studies using data from the AHS were reviewed. Using a prospective 
cohort design with an average of 16 years of follow-up, Lebov et al. (2016) evalu-
ated the association between use of 41 specific pesticides and end-stage renal 
disease in 55,580 male pesticide applicators. Significant associations were found 
with several non-COIs (p for trend < 0.05), but there were no statistically signifi-
cant associations with the phenoxy herbicides (2,4-D p for trend = 0.32; 2,4,5,T 
p for trend = 0.55). An education level greater than high school and obesity at 
enrollment were also associated with end-stage renal disease, as were diabetes, 
high blood pressure, and kidney disease.
Lebov et al. (2015) evaluated the use of 50 pesticides and factors of use and 
exposure, including frequency and duration, duration of residence on a farm, 
specific farm tasks performed, household practices of pesticides, and end-stage 
renal disease in the wives of pesticide applicators (n = 31,142). End-stage renal 
disease was higher in women who were obese, who used nonsteroidal anti-
inflammatory drugs, or who had diabetes and hypertension. There was a protec-
tive effect associated with the personal use of any pesticide (hazard ratio [HR] 
= 0.42, 95% CI 0.28–0.64), but among women who personally mixed or applied 
pesticides, positive associations were observed only for the highest category of 
lifetime exposure days (HR = 4.22, 95% CI 1.26–14.20), although the estimate 
was imprecise. Wives with end-stage renal disease who reported having direct 
exposure to phenoxy herbicides (n = 9; HR = 1.10, 95% CI 0.50–2.39) or 2,4-D 
(n = 9; HR = 1.11, 95% CI 0.51–2.41) were found not to be at an elevated risk 
of the disease. Among wives who reported no direct use of pesticides but whose 
husbands used phenoxy herbicides (n = 47; HR = 0.86, 95% CI 0.49–1.51), 2,4-D 
(n = 45; HR = 0.82, 95% CI 0.47–1.43), 2,4,5-T (n = 12; HR = 0.69, 95% CI 
0.36–1.32), or 2,4,5-TP (n = 5; HR = 0.88, 95% CI 0.36–2.15), the risks of end-
stage renal disease were all decreased.
A third occupational exposure study was identified. 't Mannetje et al. (2018) 
conducted a morbidity survey among a subset of workers who were employed 
at the New Plymouth, New Zealand, phenoxy herbicide production plant for 
at least 1 month between 1969 and 1984. The plant produced 2,4,5-T, and the 
workers were potentially exposed to 2,4,5-T, the intermediates of TCP and other 
chlorophenols, as well as to TCDD. Workers had previously been recruited and 
examined as part of the international cohort of producers of phenoxy herbicides 
led by IARC (Kogevinas et al., 1997); see Chapter 5 for more details on the 
IARC cohort and the New Zealand phenoxy producers. This study extends the 
follow-up period of these workers to approximately 30 years from their last 
2,4,5-T production exposure. From the original cohort of 1,025 workers, 631 
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were living, had a current address in New Zealand, and were below 80 years of 
age on January 1, 2006. For the current follow-up, 430 of the 631 workers were 
randomly selected and invited to participate in the morbidity survey, of whom 
245 (57%) participated. The survey was administered in 2007–2008 by face-to-
face interview, and information was collected on demographic factors and health 
information, including doctor-diagnosed conditions and the year of diagnosis. A 
blood sample was also collected at that time and was analyzed for TCDD, lipids, 
thyroid hormones, and other substances. For 111 participants, a neurological ex-
amination was conducted. Associations between exposure and health outcomes 
were assessed using logistic regression models that controlled for age, gender, 
smoking, BMI, and ethnicity using two different methods of exposure: having 
worked in a TCDD-exposed job (based on occupational records) and having 
serum TCDD concentration ≥10 pg/g lipid (18%). Mean TCDD concentrations 
were 19 pg/g lipid in the 60 men directly involved in phenoxy/TCP production 
and 6 pg/g lipid in the 141 men and 43 women who worked in other parts of 
the plant. Compared with the people in the non-highly exposed jobs, the people 
who had ever worked in a highly exposed job at the plant were no more likely 
to have a doctor-diagnosed kidney function problem (n = 13; OR = 0.82, 95% 
CI 0.34–1.99). When compared by serum TCDD concentration, no difference in 
the risk of kidney function problems was found for workers in the high- versus 
low-exposure groups (n = 5; OR = 1.03, 95% CI 0.32–3.33).
Environmental Studies
Using data from the 1999–2004 cycles of NHANES, Everett and Thompson 
(2016) evaluated the association of blood levels of three chlorinated dibenzo- 
p-dioxins, one chlorinated dibenzofuran, and four dioxin-like PCBs with nephro-
pathy (microalbuminuria or macroalbuminuria) among 1,505 adolescents and 
young adults (12–30 years of age) with normal glycohemoglobin (A1c < 5.7%). 
In logistic regression models 1,2,3,6,7,8-hexachlorodibenzo-p-dioxin (OR = 51.1, 
95% CI 4.1–641.6), PCB 126 (OR = 8.9, 95% CI 2.0–39.7), PCB 169 (OR = 9.4, 
95% CI 1.02–87.6), and PCB 156 (OR = 17.9, 95% CI 2.1–152.6) were associ-
ated with nephropathy (OR = 7.1, 95% CI 1.8–28.1) when one or more of these 
four dioxin-like chemicals was elevated; however, the effect estimates are quite 
imprecise. The effect was driven by females (OR = 17.4, 95% CI 3.4–88.6), 
as among males there were no cases of nephropathy when one or more of 
the four dioxin-like chemicals were elevated. These results were verified by 
TEQs; TEQ8 ≥ 50.12 fg/g was associated with nephropathy among females 
(OR = 11.9, 95% CI 1.6–87.2) but not males. Thus, in a cross-sectional study, 
dioxin-like chemicals were associated with nephropathy among young females, 
but not males, though reverse causality cannot be excluded, and the effect esti-
mates were very imprecise.
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Two analyses using data from the cross-sectional, community-based study 
in the Annan District of Tainan City, Taiwan, where a former PCP factory had 
operated, and had released PCDD/Fs into the surrounding area, were identified 
that examined outcomes related to kidney disease (J. W. Chang et al., 2013; C. Y. 
Huang et al., 2016). As described in Chapter 5, people who were 18 years of age 
and older and who were residents of the exposure area were asked to participate 
in the study. Health examinations were performed on each participating individ-
ual, and serum samples had been previously collected and measured for levels of 
dioxins by the Tainan City Bureau of Health. A self-administered questionnaire, 
which was administered at the same time as the examination, was used to collect 
demographic information and medical history. C. Y. Huang et al. (2016) examined 
chronic kidney disease, defined as having an estimated glomerular filtration rate 
≤ 60 mL/min/1.73m2 or having been diagnosed by a physician. People diagnosed 
with congenital kidney disease, IgA nephropathy, post-infectious kidney dis-
ease, or medicine-induced kidney disease were excluded from the study. Of the 
2,828 participating individuals, 1,427 had high dioxin levels (defined as > 20 pg 
WHO98-TEQDF/g lipid in the serum), and 156 had chronic kidney disease. High 
dioxin levels were associated with an increased prevalence of chronic kidney 
disease compared with low dioxin levels (10.9% versus 1.6%, respectively, p < 
0.001). After adjustment for PCDD/Fs, gender, mercury, metabolic syndrome, 
age, fasting glucose, insulin, and uric acid, a high dioxin level was found to 
be significantly associated with chronic kidney disease (OR = 1.74, 95% CI 
1.02–2.97). The strengths of this study include a large population, adjustments 
for age, fasting glucose, insulin, and uric acid, as well as serum measurements of 
exposure and a clear definition of chronic kidney disease. However, this study is 
limited by having had no follow-up of renal function measurements, the fact that 
the serum PCDD/Fs levels were collected over an extended period of time that 
ended about 3 years before the interview and health examination, unknown age at 
first exposure to PCDD/Fs, unknown duration of exposure, unknown cumulative 
exposure dose, the cross-sectional design, and a lack of additional data collection. 
Data on other potential confounders, such as waist circumference, dietary intake, 
and socioeconomic status, were not available.
Case-Control Studies
Raines et al. (2014) examined agricultural behaviors and health outcomes 
via questionnaire in a Nicaraguan community. Of the 424 total participants, 151 
reported an occupational history of agriculture. The pesticides that were reported 
by participants as commonly used included 2,4-D. Decreased glomerular filtration 
rate was found in 9.8% of the women and 41.9% of the men. Glomerular filtration 
rate was associated with cutting sugarcane during dry season (OR = 5.86, 95% 
CI 2.45–14.01) and sugarcane chewing (OR = 3.24, 95% CI 1.39–7.58). Glo-
merular filtration rate was also associated with non-deliberate pesticide inhalation 
Veterans and Agent Orange: Update 11 (2018)
Copyright National Academy of Sciences. All rights reserved.
OTHER CHRONIC HEALTH OUTCOMES 539
(OR = 3.31, 95% CI 1.32–8.31). This study is limited by its lack of exposure 
validation through serum or other measures.
Other Identified Studies
Two other studies of kidney and urinary disorders were identified, but both 
were limited by a lack of exposure specificity (Orantes et al., 2015; Ruder et al., 
2014). In a study of women in agricultural communities in El Salvador (Orantes 
et al., 2015), the authors examined exposures to various agrochemicals, which 
may have included organophosphate insecticides as well as phenoxy herbicides 
(2,4,-D, hedonal), but the results were not stratified by chemical exposures, and 
thus the study was not considered further.
A third study was also identified, but instead of being limited by exposure 
specificity, it was limited by the fact that the outcomes examined were not 
diagnosed health outcomes but rather indicators of biologic effects. In a separate 
analysis of people residing near the former PCP factory in Taiwan, J. W. Chang et 
al. (2013) evaluated associations between PCDD/Fs and the risk of hyperuricemia 
(too much uric acid in the blood) in a subset of healthy subjects from the com-
munity health study (n = 1,531). Serum levels of 17 2,3,7,8-substituted PCDD/Fs 
were measured, and associations were tested between the serum TEQDF-2005 
(total PCDD/Fs 2005 WHO TEQ) and various factors, including uric acid, glo-
merular filtration rates, and hyperuricemia risk. Hyperuricemia is a measure of 
disturbed metabolism, not a health outcome, and therefore this study was not 
considered relevant to the committee’s task.
Biologic Plausibility
Studies of mice, rats, goldfish, and zebrafish have documented kidney toxic-
ity from TCDD exposure. Studies of 2,4-D in goldfish and TCDD in rats report 
oxidative stress in kidneys (Matviishyn et al., 2014; Palaniswamy et al., 2014). 
Q. Liu et al. (2014) investigated the effects of developmental exposure to TCDD 
in zebrafish and found kidney lesions and the dysregulation of the genes in-
volved in renal necrosis and cell death as well as decreased hematopoietic cells 
in the kidney marrow. Aida-Yasuoka et al. (2014) reported a chance finding that 
C57BL/6J mouse pups are more susceptible to TCDD-induced hydronephrosis 
than BALB/cA mice; in pups exposed to TCDD on postnatal days 1–7, the preva-
lence of hydronephrosis was 64% in the C57BL/6J pups and 0% in BALB/cA 
pups. In both strains of mice, the Ahr receptors are highly responsive to TCDD; 
however, genetic differences were found in expression of renal m-Prostaglandin 
E synthase-1 and early growth response 1 (Egr-1). In a study of mice, Bu et 
al. (2017) found that Ahr activation up-regulates glucose transporter 9 (Glut9), 
which plays a role in maintaining uric acid homeostasis.
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Synthesis
Since Update 2014, seven studies have been reviewed for kidney disease 
and urinary disorder outcomes related to exposure to the COIs. A hospitaliza-
tion study of New Zealand Vietnam veterans found that chronic renal failure 
risk was statistically significantly increased among the veterans compared with 
the standardized general population of New Zealand, but there was no dif-
ference in the prevalence of other kidney or urinary outcomes (Cox et al., 
2015); however, there was no exposure validation, some of the conditions 
(such as urinary tract infections) do not typically require hospitalization, and 
potentially important risk factors were not adjusted for in the analysis. In a 
30-year follow-up study of New Zealand workers in a plant that produced 
2,4,5-T, having a doctor-diagnosed kidney function problem was not different 
for workers in high- versus low-exposure groups, based on reported job and 
duties in the plant or on serum TCDD levels. Two analyses of end-stage renal 
disease in the AHS (Lebov et al., 2015, 2016) found no statistically significant 
associations with the phenoxy herbicides 2,4-D or 2,4,5-T among the male 
pesticide applicators or their wives. In an analysis of NHANES, Everett and 
Thompson (2016) evaluated the association of the blood levels of three chlo-
rinated dibenzo-p-dioxins, one chlorinated dibenzofuran, and four dioxin-like 
PCBs with nephropathy among 1,505 adolescents and young adults and found 
that dioxin-like chemicals were associated with nephropathy among young 
females, but not males, although the effect estimates were very imprecise. An 
environmental exposure study of Taiwanese residents living in close proxim-
ity to a former PCP-producing factory found that those who had high serum 
dioxin levels had a statistically significantly elevated risk of chronic kidney 
disease (Huang et al., 2016). A second analysis of this population was identi-
fied (Chang et al., 2013), but because it examined hyperuricemia, which is 
a measure of disturbed metabolism and not a recognized health outcome, it 
was not considered as part of the evidence base of chronic kidney conditions 
related to exposure to the COIs. A cross-sectional study of agricultural behav-
iors, including the use of 2,4-D, and health outcomes in a Nicaraguan com-
munity (Raines et al., 2014) found a decreased glomerular filtration rate to 
be associated with cutting sugarcane, sugarcane chewing, and non-deliberate 
pesticide inhalation, but no serum or other objective measure of exposure 
were collected. Studies of mice, rats, goldfish, and zebrafish document kidney 
toxicity from TCDD exposure, but such outcomes do not present a consistent 
mechanism for the kidney dysfunction diseases in humans. Epidemiology stud-
ies concerning exposure to the COIs and kidney diseases were not reported 
prior to Update 2014. However, the new epidemiologic findings reviewed do 
not present a coherent pattern of an association between exposure to the COIs 
and kidney or urinary disorders.
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Conclusion
After reviewing the new evidence of exposure to the COIs and non-malig-
nant kidney and urinary outcomes, the committee concludes that there remains 
inadequate or insufficient evidence of an association between exposure to the 
COIs and non-malignant kidney or urinary disorders.
THYROID HOMEOSTASIS AND OTHER ENDOCRINE FUNCTIONS
This section discusses a variety of conditions related to endocrine function, 
excluding diabetes and other pancreatic disorders, which were discussed in Chap-
ter 10: Cardiovascular and Metabolic Outcomes. In particular, clinical disrup-
tions of thyroid function are grouped as ICD-9 240–246 or as ICD-10 E00–E07, 
E20–21, while the remaining endocrine disorders are grouped as ICD-9 252–259 
or as ICD-10 E22–E35. Thyroid homeostasis in humans was first addressed with 
respect to the COIs by the committee for Update 2002.
The thyroid secretes the hormones thyroxine (T4) and triiodothyronine (T3), 
which stimulate and help to regulate metabolism throughout the body. The thy-
roid also secretes calcitonin, a hormone that controls calcium concentration in the 
blood and the storage of calcium in bones. Secretion of T4 and T3 is under the 
control of thyroid-stimulating hormone (TSH), which is secreted by the anterior 
pituitary. Iodine operates in thyroid physiology both as a constituent of thyroid 
hormones and as a regulator of glandular function. Concentrations of those cir-
culating hormones are regulated primarily by a negative-feedback pathway that 
involves three organs: the thyroid, the pituitary, and the hypothalamus. In the 
hypothalamus–pituitary–thyroid feedback scheme, the hypothalamus releases 
thyrotropin-releasing hormone (TRH), which stimulates the pituitary to pro-
duce TSH, which in turn triggers the thyroid to produce T4 and T3. Cells in the 
hypothalamus and pituitary respond to concentrations of circulating T4 and T3. 
When T4 and T3 are low, the pituitary is stimulated to deliver more TSH to the 
thyroid, which increases T4 and T3 output. When circulating T4 and T3 are high, 
it triggers a reduction in the output of TRH and TSH. The negative-feedback loop 
maintains hormone homeostasis.
A disruption of thyroid homeostasis can be stimulatory (hyperthyroidism) 
or suppressive (hypothyroidism). Both conditions are diagnosed on the basis of 
blood concentrations of thyroid hormones, TSH, and other proteins (antithyroid 
antibodies). The prevalence of thyroid dysfunction in adults in the general popu-
lation ranges from 1% to 10%, depending on the group, the testing setting, sex, 
age, the method of assessment, and the presence of conditions that affect thyroid 
function. People who have subclinical (biochemical) conditions may or may not 
show other signs or symptoms of thyroid dysfunction.
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It is important to distinguish between potential effects on adults and effects 
that may occur during development. In adults, the thyroid is able to compensate, 
within reasonable limits, for mild or moderate disruption (such as that caused by 
hyperplasia or goiter). In contrast, the fetus is highly sensitive to alterations in 
thyroid hormones, and alterations in thyroid homeostasis can hamper the devel-
opment of many organ systems, including the nervous and reproductive systems; 
such findings are discussed in Chapter 8, which addresses the potential effects of 
Vietnam veterans’ exposure to herbicides on their offspring. Only observations 
on adults are considered here.
Conclusions from VAO and Previous Updates
Thyroid homeostasis in humans was first addressed with respect to the COIs 
by the committee for Update 2002. After consideration of several new studies and 
because of the consistent observations of exposures to the COIs being related to 
perturbations of thyroid function—and to clinical hypothyroidism in particular—
the committee for Update 2014 considered the body of epidemiologic data, in 
combination with strong biologic plausibility, to represent limited or suggestive 
evidence of an association between exposure to the COIs and hypothyroidism. 
Additional endocrine effects have been observed in conjunction with exposure 
to the COIs in both humans and animals, but the evidence is inadequate or insuf-
ficient to establish an association with herbicide exposure for them.
An extensive assessment of endocrine function in clinical examinations, 
including a series of thyroid-function tests, failed to show systematic differences 
in thyroid function between Ranch Hands and comparison veterans (AFHS, 
1991a). In analyzing individual TCDD readings obtained for subjects in the 
AFHS, however, Pavuk et al. (2003) found statistically significantly increased 
TSH measures from the 1985 and 1987 examinations in the high-exposure cat-
egory and a significant increasing trend across the three TCDD categories during 
the 1982, 1985, 1987, and 1992 examinations. No increased risk of disorders of 
the thyroid was found among a study of Australian Vietnam veterans (O’Toole et 
al., 2009). Among Korean Vietnam veterans, two publications considered thyroid 
outcomes (Yi et al., 2014a,b). The first (Yi et al., 2014a) used claims data to report 
on the prevalence of disorders of the thyroid gland in 111,726 veterans and found 
an increased risk of thyroid conditions overall (ICD-10 E00–E07) with herbicide 
exposure, after adjustment for several factors. The pattern was very similar for 
both non-iodine-deficiency hypothyroidism (ICD-10 E03) and for other non-
toxic goiter (ICD-10 E04). The risk of thyroiditis (ICD-10 E06) overall was not 
found to be significantly associated with herbicide exposure, but the strongest 
endocrine-related results were for autoimmune thyroiditis (ICD-10 E06.3), a 
subcategory of thyroiditis. No difference in the risk of hyperthyroidism (ICD-10 
E05) was found between high- and low-exposure groups. Comparing the high-
exposure group with the low-exposure group based on EOI scores, an elevated 
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risk was observed for pituitary hypofunction (p = 0.011), while the risk of pituitary 
hyperfunction was not different between high- and low-exposure groups. The risk 
of hyperaldosteronism was also not elevated. A mortality analysis of the Korean 
Vietnam veteran cohort of 180,639 male veterans did not find any association 
between herbicide exposure and deaths from endocrine diseases when the cohort 
was analyzed as a group (Yi et al., 2014b).
Few studies of thyroid function have been conducted among occupational 
cohorts exposed to the COIs. Calvert et al. (1999) provided evidence of higher 
adjusted mean free-T4 concentrations in TCDD-exposed workers in the NIOSH 
Cross-Sectional Medical Study, but there was no dose–response relationship 
with serum TCDD. Bloom et al. (2006) found indications of an inverse relation-
ship between the sum of dioxin-like chemicals and the concentration of free T4 
in anglers in New York State, but no association between the sum of dioxin-
like chemicals and TSH or T3. An analysis of the AHS that was restricted to 
male private pesticide applicators examined self-reported physician-diagnosed 
hyperthyroidism, hypothyroidism, and other thyroid conditions and the use of 50 
specific agents, including 2,4-D, 2,4,5-T, and 2-(2,4,5-triphenoxy) proprionic acid 
(2,4,5-TP) (Goldner et al., 2013). After adjusting for age, education, and BMI, the 
odds of hypothyroidism for ever-use versus never-use were significantly elevated 
for 2,4-D, for 2,4,5-T, and for 2,4,5-TP. In comparison with those who had never 
used 2,4-D, an increased risk of hypothyroidism was seen in both those who had 
used 2,4-D for more than the median number of days and those whose days of 
2,4-D use were fewer than the median (p-trend = 0.025). The use of 2,4,5-TP 
was found to be associated with a decreased risk of hyperthyroidism. None of the 
phenoxy herbicides were found to be related to having histories of other thyroid 
diseases. In an Italian study that compared urban and rural workers, Ciarrocca et 
al. (2012) found that the workers’ urinary arsenic levels differed by a factor of 
between 2 and 4, and urinary arsenic was positively correlated with serum TSH 
and thyroglobulin and negatively with free T3 and T4.
The results from several environmental studies have also been reviewed by 
update committees, and no evidence was found of effects on thyroid function 
or disease in women exposed to pesticides (Chevrier et al., 2008) or, among 
women in the AHS, exposed to phenoxy herbicides (Goldner et al., 2010). Us-
ing data from NHANES III (1988–1994), Schreinemachers (2010) did not find 
associations between recent exposure to 2,4-D and T4 or TSH concentrations. An 
analysis of 1999–2002 NHANES data (Turyk et al., 2007) found total T4 to have 
a weak inverse relationship with serum TEQs; the effect was somewhat stronger 
in people over 60 years old and in women.
Among women exposed in the Seveso incident, a significant inverse asso-
ciation was found between serum concentrations of TCDD over a 20-year pe-
riod (1976–1996) with serum total T4, but not with TSH or free T3, which 
were measured in 1996. This association was stronger for women who were 
exposed before menarche than for women exposed after menarche. When thyroid 
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hormones were measured again in 2008 and compared with TCDD levels in 
1976 and 1996, the association was no longer present (Chevrier et al., 2014). 
In a cross-sectional study of 2,264 Japanese men and women who had not 
been occupationally exposed to dioxins, self-reported thyroid disease (not oth-
erwise specified) was not associated with serum levels of dioxin-like PCDD/Fs 
or dioxin-like PCBs or with total TEQs after adjusting for possible confounders 
(Nakamoto et al., 2013). Abdelouahab et al. (2008) described thyroid function in 
adult freshwater-fish consumers in Canada; dioxin-like congeners were associ-
ated with an increase in TSH and a decrease in T4 but below the threshold at 
which clinical symptoms would be present. Clear effects of dioxin-like chemicals 
on thyroid function were not apparent in Inuit adults (Dallaire et al., 2009) or in 
a cross-sectional study of a Chinese community exposed to an electronic-waste 
recycling plant (J. Zhang et al., 2010). Manh et al. (2013) and Kido et al. (2014) 
studied steroid hormone levels in the serum and saliva and dioxin concentrations 
in the breast milk of lactating Vietnamese women living in an “Agent Orange 
hot spot” (n = 51) or in an area with no suspected exposure (n = 58). Levels of 
cortisol and corticosterone in serum and saliva were higher in those women liv-
ing in the hot spot area and were positively correlated with breast-milk dioxin 
concentrations. Trnovec et al. (2013) measured thyroid gland volume and free 
T4 in 320 adults from an organochlorine-contaminated area in Slovakia. Blood 
samples from these subjects produced readings above the limits of detection for 
all 7 dioxins, 8 of 10 furans, and all but 1 of the 12 PCBs on the 2005 WHO list 
of dioxin-like chemicals.
Update of the Epidemiologic Literature
One new epidemiological study of occupational exposures to the COIs and 
thyroid or endocrine effects has been identified for this update. Table 45, which 
can be found at www.nap.edu/catalog/25137, summarizes the results of studies 
related to thyroid homeostasis that have been reviewed in the VAO series.
Occupational Studies
't Mannetje et al. (2018) conducted a morbidity survey among a subset of 
workers who were employed at the New Plymouth, New Zealand, phenoxy her-
bicide production plant for at least 1 month between 1969 and 1984. The plant 
produced 2,4,5-T, and workers were potentially exposed to 2,4,5-T, the inter-
mediates of TCP and other chlorophenols, and TCDD. Workers had previously 
been recruited and examined as part of the international cohort of producers of 
phenoxy herbicides led by IARC (Kogevinas et al., 1997); see Chapter 5 for more 
details on the IARC cohort and the New Zealand phenoxy producers. This study 
extends the follow-up period of these workers to approximately 30 years from 
their last 2,4,5-T production exposure. From the original cohort of 1,025 workers, 
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631 were living, had a current address in New Zealand, and were below 80 years 
of age on January 1, 2006. For the current follow-up, 430 of the 631 workers were 
randomly selected and invited to participate in the morbidity survey, of which 
245 (57%) participated. The survey was administered in 2007–2008 by face-to-
face interview and information was collected on demographic factors and health 
information, including doctor-diagnosed conditions and the year of diagnosis. 
A blood sample was also collected at that time and analyzed for TCDD, lipids, 
thyroid hormones, and other substances. Associations between exposure and 
health outcomes were assessed using logistic regression models that controlled 
for age, gender, smoking, BMI, and ethnicity using two different methods of ex-
posure: having worked in a TCDD-exposed job (based on occupational records) 
and having serum TCDD concentration ≥10 pg/g lipid (18%). Mean TCDD con-
centrations were 19 pg/g lipid in the 60 men directly involved in phenoxy/TCP 
production and 6 pg/g lipid in the 141 men and 43 women who worked in other 
parts of the plant. Compared with the people in the non-highly exposed jobs, the 
people who had ever worked in a highly exposed job at the plant were no more 
likely to have a doctor-diagnosed thyroid disorder (n = 6; OR = 0.95, 95% CI 
0.19–4.67). When compared by serum TCDD concentration, no difference in the 
risk of thyroid disorder was found for workers in the high- versus low-exposure 
groups (n = 5; OR = 4.00, 95% CI 0.76–21.0), but the estimate is very imprecise 
owing to the small number of cases.
Other Identified Studies
Three additional epidemiologic studies were identified that presented out-
comes on endocrine and metabolic effects. A cross-sectional study of endo-
crine effects from the use of pesticides was conducted using a random sample 
of agricultural workers aged 18–69 years old in Brazil (Piccoli et al., 2016). 
Although questionnaires that collected detailed information on exposures were 
administered by trained interviewers to the participants and blood samples 
were collected from all participants to test cholinesterase activity, serum resi-
dues of organochlorine pesticides, and levels of free T4, total T3, and TSH, the 
researchers did not offer results for specific herbicides and organochlorine pesti-
cides, thereby limiting the usefulness of this study to provide evidentiary weight 
regarding a potential association between exposure to the COIs and thyroid 
functioning. The second study was a cross-sectional study that examined whether 
the presence of metabolic syndrome altered serum concentrations of dioxin-like 
and non-dioxin-like PCBs under conditions of weight loss (Dirinck et al., 2016). 
Given the cross-sectional nature of the work, it is of limited usefulness in assess-
ing the association of metabolic syndrome with dioxin-like chemicals.
A study by X. Sun et al. (2014) collected blood samples to determine the 
dioxin concentration and levels of nine steroid hormones from 48 men in an 
herbicide-sprayed hot spot and 36 men from a non-sprayed area. Participants 
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also completed a questionnaire about their health status. The levels of the steroid 
hormones, including testosterone, dehydroepiandrosterone, and estradiol, were 
measured and compared by exposure group. However, the differences in hormone 
levels are not surrogate measures of a health outcome, and, therefore, this study 
was not considered relevant to the committee’s charge.
Biologic Plausibility
The influence of TCDD on thyroid-hormone homeostasis has been mea-
sured in numerous animal studies, and TCDD exposure has been associated with 
changes in serum concentrations of T4, T3, and TSH. In most studies, TCDD 
exposure is associated with a hypothyroid state, including reduced circulating T3 
and T4 and increased TSH, especially after chronic exposure. The reduction in 
circulating T4 concentrations is robust and has recently been proposed as a bio-
marker of the effect of dioxin-like chemicals (J. M. Yang et al., 2010). Female rats 
exposed chronically to TCDD showed follicular-cell hyperplasia and hypertrophy 
of thyroid follicles, which were consistent with an overstimulation of the thyroid 
by TSH (TSH increases as a homeostatic response to low T4 levels) (Yoshizawa 
et al., 2010). TCDD enhances the metabolism of thyroid hormones primarily 
through an AHR-dependent induction of glucuronyl transferase activity (Gessner 
et al., 2012; Y. Kato et al., 2010; Martin et al., 2012; Nishimura et al., 2005). An 
enhanced accumulation of T4 in hepatic tissue of TCDD-treated mice may also 
contribute to the reduction in circulating T4 (Y. Kato et al., 2010).
The possibility that arsenic could act as an endocrine disruptor on  thyroid 
 hormone–mediated processes has been proposed on the basis of cell-culture studies 
and experiments with the ex vivo amphibian tail metamorphosis  assay (Davey et 
al., 2008). In guinea pigs that were fed diets containing 50 ppm arsenic as sodium 
arsenite or arsenic trioxide for 11 weeks, serum (total) T3 and T4 were  reduced 
compared to controls by about 20–25% and 33%,  respectively (Mohanta et al., 
2014). Recent data in zebrafish show that arsenite exposure increases thyroxine 
levels and alters the expression of genes in the hypothalamic–pituitary–thyroid 
axis, including thyroid receptors α and β, TSH, and corticotropin-releasing hor-
mone (H. J. Sun et al., 2015). These data raise the possibility that cacodylic acid 
may also disrupt thyroid homeostasis, but there are no published epidemiologic 
studies that have addressed this.
Synthesis
Numerous animal experiments and several epidemiologic studies have shown 
that TCDD and dioxin-like chemicals exert some influence on thyroid homeosta-
sis, with the findings being most consistently indicative of hypothyroidism (Boas 
et al., 2006, 2012; Chevrier et al., 2014). The underlying molecular mechanisms 
resulting in these effects on thyroid hormone and TSH concentrations in humans, 
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however, are not yet fully characterized. In addition, there are some data to sug-
gest the possibility that arsenic-based herbicides may also affect thyroid function.
Several previous studies of populations environmentally exposed to PCBs 
found some combination of elevated TSH concentrations and depressed T4 and 
T3 levels (Bloom et al., 2006; Hagmar et al., 2001a; Persky et al., 2001; Schell 
et al., 2004), although some (Hagmar et al., 2001b; Sala et al., 2001) found no 
significant effect. For example, Pavuk et al. (2003) reported a trend of higher 
TCDD serum concentrations being associated with increasing concentrations of 
TSH that was not accompanied by changes in circulating T4 or T3 (which would 
be interpreted as subclinical hypothyroidism) in participants in the AFHS. This 
finding in U.S. Vietnam veterans is complemented by the results from the Korean 
Veterans Health Study (Yi et al., 2014a), which found evidence of an increased 
occurrence of clinical hypothyroid disease, possibly associated with autoim-
mune hypothyroidism, in association with higher estimated potential herbicide 
exposure. In addition, the report from the AHS of increased physician-diagnosed 
hypothyroidism in herbicide applicators with phenoxy herbicide exposure (Gold-
ner et al., 2013) supports the notion that this association is real. Results from the 
Korean Veterans Health Study suggest that adrenal and possibly pituitary function 
may also be affected by exposure to dioxin-like chemicals.
For the current update, in vitro and animal data continue to support previous 
findings that the COIs can alter thyroid homeostasis. There is additional new data 
(Sun et al., 2015) that raise the possibility that cacodylic acid might similarly 
disrupt the normal action of the thyroid. There is little additional epidemiologic 
data available regarding the association of the COIs with thyroid disease or other 
endocrine function. A follow-up of phenoxy herbicide producers in New Zealand 
did not find any difference in thyroid disorders between high- and low-exposure 
groups ('t Mannetje et al., 2018).
Conclusion
On the basis of the new evidence and that reviewed in previous VAO reports, 
the committee concludes that there is limited or suggestive evidence of an asso-
ciation between exposure to at least one of the COIs and hypothyroidism. There 
is inadequate or insufficient evidence for disruption of thyroid homeostasis or 
other endocrine disorders.
CHRONIC SKIN DISORDERS
In previous VAO reports, skin disorders such as chloracne were mentioned, 
but they were not consistently included as independent outcomes. However, due to 
the nature of new published epidemiologic literature, the committee has reviewed 
several studies of exposure to the COIs that have included skin conditions, and thus 
the committee has decided to include them as a distinct outcome in this chapter.
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Chloracne is a skin disease that is characteristic of high levels of exposure 
to TCDD and other diaromatic organochlorine chemicals. It is one of the few 
outcomes in humans that are consistently associated with such exposure, and it 
is a well-validated indicator of high-dose exposure to TCDD and related chemi-
cals (Sweeney et al., 1997/1998). Chloracne shares some pathologic processes 
(such as the occlusion of the orifice of the sebaceous follicle) with more common 
forms of acne (such as acne vulgaris), but it can be differentiated by the presence 
of epidermoid inclusion cysts, which are caused by the proliferation and hyper-
keratinization (horn-like cornification) of the epidermis and sebaceous gland 
epithelium. Although chloracne is typically distributed over the eyes, ears, and 
neck, it can also occur on the trunk, genitalia, and buttocks of chemical-industry 
workers exposed to TCDD (Neuberger et al., 1998).
If chloracne occurs, it appears within a few months after the chemical expo-
sure, not after a long latent period; therefore, new cases of chloracne among 
Vietnam veterans would not be the result of exposure during the Vietnam War. 
Although it is resistant to acne treatments, it usually regresses.
The chronic skin conditions considered include skin infections, nuclear buds, 
karyolysis or karyorrhexis, comedones, scar formation, and skin pigmentation.
Conclusions from VAO and Previous Updates
The committee responsible for VAO (IOM, 1994) determined that there 
was sufficient evidence of an association between exposure to at least one COI 
(TCDD) and chloracne. Additional information available to the committees 
respon sible for Update 1996 (IOM, 1996), Update 1998 (IOM, 1999), Update 
2000 (IOM, 2001), Update 2002 (IOM, 2003c), Update 2004 (IOM, 2005), 
and Update 2006 (IOM, 2007) maintained that conclusion. Even in the absence 
of a full understanding of the cellular and molecular mechanisms that lead to 
the disease, several notable reviews (Panteleyev and Bickers, 2006; Sweeney 
and Mocarelli, 2000) have deemed the clinical and epidemiologic evidence of 
dioxin-induced chloracne to be strong. The occupational epidemiologic literature 
has many examples of chloracne in workers after reported industrial exposures 
(Beck et al., 1989; Bond et al., 1987, 1989a,b; Cook et al., 1980; Goldman, 1972; 
May, 1973, 1982; Oliver, 1975; Pazderova-Vejlupkova et al., 1981; Poland et al., 
1971; Suskind and Hertzberg, 1984; Suskind et al., 1953; Zober et al., 1990). 
With relative risk estimates as high as 5.5 in exposed workers compared with 
referent non-exposed workers, Bond et al. (1989a) identified a dose–response 
relationship between probable exposure to TCDD and chloracne. Not everyone 
who is exposed to relatively high doses develops chloracne, and some with lower 
exposure may demonstrate the condition (Beck et al., 1989).
Almost 200 cases of chloracne were recorded among those residing in the 
vicinity of the accidental industrial release of dioxin in Seveso, Italy; most cases 
were in children and in those who lived in the highest-exposure zone, and most 
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had resolved within 7 years (Assennato et al., 1989a,b; Caramaschi et al., 1981; 
Mocarelli et al., 1991).
Exposures of Vietnam veterans were substantially lower than those observed 
in occupational studies and in environmental disasters, such as in Seveso. The 
long period since the putative exposure has imposed methodologic limitations on 
the studies of Vietnam cohorts for chloracne. Nonetheless, the Vietnam Experi-
ence Study (CDC, 1988a) found that chloracne-like lesions were self-reported 
more often by Vietnam veterans than by Vietnam-era veterans (OR = 1.4; 95% 
CI 0.7–2.9). No excess risk was found in Vietnam versus era veterans among 
subjects who had dermatologic examinations (OR = 0.9, 95% CI 0.7–1.2 for 
comedones and acne from lesions; OR = 1.2, 95% CI 0.9–1.7 for hyperpigmen-
tation). Compared with matched, non-exposed controls, Ranch Hand personnel 
reported a significant excess of acne (OR = 1.6, 95% CI 1.1–2.1) (Wolfe et al., 
1990), but no cases of chloracne or post-inflammatory scars were found on physi-
cal examination 20 years after the potential herbicide exposure (AFHS, 1991b).
Update of Epidemiologic Literature
Three new studies of exposure to the COIs and chronic skin conditions have 
been identified since Update 2014. However, each study examined different out-
comes, making comparisons among the studies difficult.
Vietnam-Veteran Studies
Cox et al. (2015) used hospital discharge records from 1988 to 2009 to 
identify health conditions that affected 2,783 male New Zealand veterans who 
had served in Vietnam during 1964–1972. Age-specific hospitalization rates were 
calculated using the total number of annual hospitalizations published by the 
Ministry of Health and the average annual resident population. Standardized 
hospitalization rates and 99% CIs were calculated for the veteran cohort and for 
the general population for several noncancerous conditions, and an SHR was 
calculated using the two rates. This analysis found that hospitalization for skin 
infections (n = 140; SHR = 1.22, 99% CI 1.15–1.21) was greater in Vietnam 
veterans than what would be expected based on same-age New Zealand males. 
However, there was no difference in hospitalizations for other skin diseases (n = 
60; SHR = 1.17, 99% CI 0.87–1.46). This analysis was restricted to the first hos-
pitalization for each cause in order to account for chronic disease. This analysis 
did not include information on or control for lifestyle factors or ethnicity. Expo-
sure was not validated through serum measurements and was assumed based on 
deployment to Vietnam.
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Occupational Studies
't Mannetje et al. (2018) conducted a morbidity survey among a subset of 
workers who were employed at the New Plymouth, New Zealand, phenoxy her-
bicide production plant for at least 1 month between 1969 and 1984. The plant 
produced 2,4,5-T, and workers were potentially exposed to 2,4,5-T, the inter-
mediates of TCP and other chlorophenols, and TCDD. Workers had previously 
been recruited and examined as part of the international cohort of producers of 
phenoxy herbicides led by IARC (Kogevinas et al., 1997); see Chapter 5 for more 
details on the IARC cohort and the New Zealand phenoxy producers. This study 
extends the follow-up period of these workers to approximately 30 years from 
their last 2,4,5-T production exposure. From the original cohort of 1,025 work-
ers, 631 were living, had a current address in New Zealand, and were below 80 
years of age on January 1, 2006. For the current follow-up, 430 of the 631 work-
ers were randomly selected and invited to participate in the morbidity survey, 
of which 245 (57%) participated. The survey was administered in 2007–2008 
by face-to-face interview, and information was collected on demographic fac-
tors and health information, including doctor-diagnosed conditions and the year 
of diagnosis. A blood sample was also collected at that time and analyzed for 
TCDD, lipids, thyroid hormones, and other substances. For 111 participants, a 
neurological examination was conducted. Associations between exposure and 
health outcomes were assessed using logistic regression models that controlled 
for age, gender, smoking, BMI, and ethnicity using two different methods of 
exposure: having worked in a TCDD-exposed job (based on occupational records) 
and having serum TCDD concentration ≥10 pg/g lipid (18%). The mean TCDD 
concentrations were 19 pg/g lipid in the 60 men directly involved in phenoxy/
TCP production and 6 pg/g lipid in the 141 men and 43 women who worked in 
other parts of the plant. Compared with the 124 people in the non-highly exposed 
jobs, the 121 people who had ever worked in a highly exposed job were no more 
likely to have doctor-diagnosed eczema (n = 17; OR = 0.57, 95% CI 0.27–1.21) 
or acne (n = 2; OR = 0.73, 95% CI 0.10–5.47). When compared by serum TCDD 
concentration ≥10 pg/g lipid, no difference in eczema (n = 8; OR = 1.31, 95% CI 
0.47–3.61) or acne (based on 1 case) was found.
Environmental Studies
In 1968, bran rice oil was accidentally contaminated with high concentra-
tions of PCBs, dioxins, and dioxin-like chemicals in Western Japan (the Yusho 
accident). People who were poisoned were recruited into a cohort (i.e., the Yusho 
Group) and received regular medical follow-up. Mitoma et al. (2015) examined 
skin symptoms in the Yusho Group (n = 352) who underwent dermatological 
check-ups in 2012. PCB and dioxin serum concentrations were still elevated in 
the Yusho Group compared to the general Japanese population, and skin diseases 
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were still very common. Furthermore, black comedones and scar formation were 
significantly correlated with blood 2,3,4,7,8-PeCDF level, and black comedones 
(n = 115; 32.7% of all patients), scar formation (n = 111; 31.5% of all patients), 
and skin pigmentation (n = 57; 16.2% of all patients) were significantly positively 
associated with the total serum PCB concentration. These results show that the 
prevalence of skin conditions such as black comedones, scar formation, and skin 
pigmentation are correlated with exposure to PCBs, dioxins, and dioxin-like 
chemicals, and that chloracne was persistent in this population 44 years after the 
acute ingestion of dioxins and dioxin-like chemicals.
Other Identified Studies
Four additional studies that reported skin conditions were identified, but 
each lacked the necessary exposure specificity to be considered further. A second 
study of long-term health effects from the Yusho accident (Akahane et al., 2017) 
examined the prevalence of self-reported conditions including diseases of the skin 
compared with an age-, sex-, and residential area–matched group. Because no 
TEQs or other quantification of relevant exposures was presented, the study was 
not considered further. Butinof et al. (2015) conducted a cross-sectional study of 
male pesticide applicators (n = 880) who were issued applicator licenses by the 
Agriculture, Livestock, and Food Ministry of Argentina between 2007 and 2010. 
All participants completed a self-administered questionnaire that was adapted 
from the U.S. AHS. The average worker was exposed to 11 different chemicals, 
and no pesticide-specific exposure assessment was conducted. Ruder et al. (2014) 
examined skin conditions such as chloracne and hyperpigmentation in a U.S. 
cohort of capacitor manufacturers exposed to dioxin-like and non-dioxin-like 
PCBs, but it was limited by a lack of exposure specificity. C.Y. Yang et al. (2015) 
evaluated 240 Yucheng, Taiwan, subjects aged 9–65 years who were exposed to 
PCB-contaminated rice oil in 1979 and who completed a health-related quality-
of-life questionnaire about 30 years following the exposure. Exposure was not 
verified by serum measurements or other means.
A fifth study (Carbajal-Lopez et al., 2016) involved a cross-sectional study 
that examined biomarkers of DNA damage in buccal cells in male agricultural 
workers in Mexico who were exposed to pesticides that likely included 2,4-D 
and dicamba (n = 111) and compared them with males who had no occupa-
tional history of pesticide exposure (n = 60). Although significantly (p < 0.0001) 
more evidence of DNA damage, as measured by comet tail length, micronuclei, 
binucleated cells, pycnosis, and condensed chromatin, was found among the 
agricultural workers who were exposed to pesticides than among the non-exposed 
workers, these differences are not tied to an observable health outcome, and the 
study was not considered further.
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Biologic Plausibility
Previous updates have reported that chloracne-like skin lesions have been 
observed in several animal species in response to exposure to TCDD but not to 
purified phenoxy herbicides. Data accruing over the past several decades dem-
onstrated that TCDD alters the differentiation of human keratinocytes, and more 
recent studies have illuminated how. TCDD accelerates the events associated with 
early differentiation and also obstructs the completion of differentiation (Bock, 
2017a,b; Fontao et al., 2017; Geusau et al., 2005; Mandavia, 2015). Panteleyev 
and Bickers (2006) proposed that the major mechanism of TCDD induction of 
chloracne is activation of the stem cells in the basal layer of the skin to differenti-
ate and then an inhibition of their ability to commit fully to a differentiated status. 
De Abrew et al. (2014) elucidated the role of matrix metalloproteinase-10 in the 
histopathological changes that typify chloracne. Work by Tauchi et al. (2005) and 
K. J. Smith et al. (2017) implicated additional inflammation-related mechanisms 
by which TCDD exposure may lead to chloracne. The data provide biologically 
plausible mechanisms for the induction of chloracne by TCDD.
Synthesis
No epidemiologic data in the past decade have refuted the conclusion of 
prior VAO committees that the evidence of an association between exposure 
to dioxin and chloracne is sufficient. Because TCDD-associated chloracne 
becomes evident within a few months after exposure, there is no risk of new 
cases long after service in Vietnam. Given the established relationship of an 
association between TCDD and chloracne and the long period that has elapsed 
since service in Vietnam, the present committee concludes that the emergence 
of persistent additional biologic or epidemiologic evidence that would merit 
review and deliberation by later VAO committees is unlikely. The formation 
of chloracne lesions and other skin disorders after the administration of TCDD 
has been observed in some species of laboratory animals. The newly identified 
epidemiologic studies (Cox et al., 2015; Mitoma et al., 2015; 't Mannetje et 
al., 2018) examined different outcomes and had varying exposure specificity, 
thereby limiting the comparisons that could be made. Although some differ-
ences between exposed and unexposed populations were noted, each study 
had several limitations that did not change the evidence of association with 
exposure to the COIs and chronic skin conditions.
Conclusion
On the basis of numerous epidemiologic studies of occupationally and envi-
ronmentally exposed populations and supportive toxicologic information, previ-
ous VAO committees have consistently concluded that there is sufficient evidence 
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of an association between exposure to at least one COI and chloracne. After 
review of new literature, the committee concludes that there is inadequate or 
insufficient evidence of an association between exposure to the COIs and other 
chronic skin conditions.
EYE PROBLEMS
This section discusses eye problems (ICD-9 360–379; ICD-10 H00–H59). 
The loss of vision is increasingly common with advanced age, and about one-sixth 
of people over 70 years old have substantial impairment, with men and women 
being similarly affected (NCHS, 2010). The most prevalent ocular problems in 
the current age range of Vietnam veterans are age-related macular degeneration, 
cataracts, glaucoma, and diabetic retinopathy. Ocular problems involving chemi-
cal agents most often arise from acute, direct contact with caustic or corrosive 
substances that may have permanent consequences. Ocular impairment arising 
from systemic exposure to toxic agents may be mediated by nerve damage. Cata-
racts can be induced by a chronic internal exposure of the lens to such chemicals 
as 2,4-dinitrophenol, corticosteroids, and thallium; glaucoma may be secondary 
to a toxic inflammation or may result from topical or systemic treatment with 
anti-inflammatory corticosteroids (Casarett and Doull, 1995).
Conclusions from VAO and Previous Updates
Update 2010 considered one study of Australian Vietnam veterans that found 
that the veterans had a higher prevalence of all the eye conditions assessed— 
cataracts, presbyopia, color blindness, and other diseases of the eye—than the 
Australian population (O’Toole et al., 2009). However, the committee noted a 
lack of information on exposure to the COIs and a lack of clinical confirmation 
of the eye conditions, and it had serious concerns about the possibility that recall 
bias had played a role in the findings. On the basis of that one study, the commit-
tee for Update 2010 concluded that there was inadequate or insufficient evidence 
to determine whether there is an association between exposure to the COIs and 
eye conditions. No new epidemiologic studies of exposure to the COIs and eye 
problems had been published for review in Update 2012 and Update 2014.
Update of Epidemiologic Literature
Only one new study of eye conditions was identified. Cox et al. (2015) used 
hospital discharge records from 1988 to 2009 to identify prevalent health condi-
tions in 2,783 male New Zealand veterans who had served in Vietnam during 
1964–1972. Age-specific hospitalization rates were calculated using the total 
number of annual hospitalizations published by the Ministry of Health and the 
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average annual resident population. Standardized hospitalization rates and 99% 
CIs were calculated for the veteran cohort and the general population, and an 
SHR was calculated using the two rates for two conditions related to the eyes. 
Neither the risk of hospitalization for cataracts (n = 99; SHR = 1.11, 99% CI 
0.82–1.40) nor retinal disease (n = 31; SHR = 1.35, 99% CI 0.73–1.98) was 
different between the veterans and general New Zealand population. Cataract 
and retinal disease are not generally conditions that require hospitalization, and 
therefore, the estimated prevalence may be higher. Exposure was not validated 
through serum measurements and was assumed based on deployment to Vietnam.
Biologic Plausibility
There have been several recent reports of ocular activity associated with 
Ahr activation or TCDD exposure of rats (Sugamo et al., 2009), mice (Takeuchi 
et al., 2009), and human non-pigmented ciliary epithelial cells (Volotinen et al., 
2009). Hu et al. (2013) reported that mice harboring the null allele at the Ahr 
locus developed macular age-related degeneration-like pathology.
Woeller et al. (2016) investigated whether AHR activation had therapeutic 
potential for thyroid eye disease, which includes myofibroblast accumulation and 
orbital scarring. TGF-β induces myofibroblast formation, and AHR influences 
TGF-β signaling. Using orbital fibroblasts cultured from thyroid eye disease 
patients, Woeller et al. found that exposure to AHR ligands 6-formylindolo(3,2-
b)carbazole2-(1′H-indole-3′-carbonyl)-thiazole-4-carboxylic acid methyl ester 
(FICZ and ITE) prevented TGF-β-induced myofibroblast formation.
Synthesis
Hospital discharge data from New Zealand Vietnam veterans (Cox et al., 
2015) do not suggest any association between exposure to the COIs and retinal 
disease or cataracts. The data generated in vitro or in vivo in animal models 
reveal a quite modest possibility of ocular activity for the COIs; these are lim-
ited data that do not assist the committee in determining an association between 
exposure to the COIs and eye conditions.
Conclusion
Given the lack of additional evidence, the committee concludes that there is 
inadequate or insufficient evidence to determine whether there is an association 
between exposure to the COIs and eye conditions.
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BONE CONDITIONS
This section discusses osteoporosis, or decreased bone density (ICD-9 
733.0–733.1; ICD-10 M80–M81), and other joint and connective tissue disease, 
excluding arthritis, which is discussed in Chapter 6: Immune System Disorders. 
Osteoporosis is a skeletal disorder characterized by a decrease in bone mineral 
density and a loss of the structural and biomechanical properties of the skeleton, 
which leads to an increased risk of fractures. Although there are no practical 
methods for assessing overall bone strength, bone mineral density correlates 
closely with skeletal load-bearing capacity and fracture risk (Lash et al., 2009). 
WHO has defined osteoporosis based on bone mineral density measurements. The 
diagnostic T-score derived by dual energy X-ray absorptiometry is the number of 
standard deviations from the mean bone mineral density for healthy women. In 
women, readings greater than −1.0 are normal, whereas osteopenia is defined by 
a T-score between −1.0 and −2.5, osteoporosis is defined by a T-score between 
−2.5 and −5.0, and severe osteoporosis corresponds to a T-score of −5.0 or lower. 
Diagnostic criteria have not been standardized for osteoporosis in men. Although 
men have much higher baseline bone mineral density than women, they seem to 
have a similar fracture risk for a given bone mineral density (Lash et al., 2009), 
so most authorities apply the same WHO ranges for T-scores calculated relative 
to normal young women.
Sex is an important risk factor for osteoporosis; about 56% of postmeno-
pausal women have decreased bone mineral density, and 6% have osteoporosis 
(CDC, 2002). The effects of aging on bone loss in women are well known, but 
many health care providers and patients are less familiar with the prevalence and 
effects of bone changes in older men (Orwoll et al., 2010). Individual patients 
have genetic and acquired risks of osteoporosis, and the osteoporosis disease 
process can be without symptoms for decades. It is well known that hormones, 
vitamins, and pharmaceuticals can have adverse effects on bone and that drug-
induced osteoporosis occurs primarily in postmenopausal women, but premeno-
pausal women and men are also significantly affected. Glucocorticoids are the 
most common cause of drug-induced osteoporosis (Mazziotti et al., 2010). Other 
risk factors for the loss of bone mineral density include the use of long-acting 
benzodiazepine or anticonvulsant drugs, previous hyperthyroidism, excessive 
caffeine intake, and routinely standing for less than 4 hours per day (Lash et al., 
2009).
Several studies have described a link between organochlorine exposure and 
effects on bone growth, most notably reports of infants exposed in utero to high 
concentration of PCBs and PCDFs who developed irregular calcifications of 
their skulls (Miller, 1985) and reports of accidental organochlorine poisoning 
that resulted in osteoporosis (Cripps et al., 1984; Gocmen et al., 1989). How-
ever, epidemiologic studies of the association between environmental exposures 
to organochlorine compounds and bone disorders have had inconsistent results.
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Conclusions from VAO and Previous Updates
Update 2010 was the first report in the VAO series to review studies of 
the association between exposures to the COIs and a decrease in bone mineral 
density. Few studies have reported results in this category with enough exposure 
specificity to be fully informative. Hodgson et al. (2008) studied the relation-
ship between environmental exposures and bone mineral density in a set of 325 
members of the Osteoporosis Cadmium as a Risk Factor (OSCAR) cohort who 
were at least 60 years old. Forearm bone mineral density was measured, blood 
samples were analyzed for the five dioxin-like mono-ortho PCB congeners (PCB 
105, 118, 156, 157, and 167), and TEQs were calculated. In men, PCB 118 was 
significantly negatively associated with bone mineral density, but there was no 
association between the TEQ for any of the five dioxin-like mono-ortho PCBs 
and bone mineral density. In women, PCB 118 and the TEQs for all five dioxin-
like mono-ortho PCBs were positively associated with bone mineral density. 
When the risk of low bone mineral density was treated as a binary variable in 
an adjusted logistic model, there was a significant association with PCB 118 in 
men, but none of the measured compounds was predictive in women. A study of 
350 women who were exposed to TCDD as a result of the chemical explosion 
in Seveso, Italy, examined the relationship of DEXA-assessed bone mineral den-
sity and TCDD serum levels (Eskenazi et al., 2014). The results suggested that 
TCDD levels were associated with some evidence of better bone structure in the 
48 women for whom exposure occurred after peak bone mass, which is estimated 
to happen 2 years after menarche, but the findings did not support the hypothesis 
that postnatal TCDD exposure adversely affects adult bone health. Two cross-
sectional studies that examined the association of exposure to dioxin-like chemi-
cals and bone quality in residents of Canada’s northern regions, who are known 
to be exposed to these chemicals as a result of their diet of marine mammals and 
predatory fish (Paunescu et al., 2013a,b), found an increase in dioxin-like PCBs 
105 and 108 to be negatively associated with a “stiffness index,” and neither total 
plasma dioxin-like chemicals levels nor any specific dioxin-like PCB level was 
associated with ultrasonography-assessed bone strength in Inuit women.
Update of the Epidemiologic Literature
Only one new study of bone conditions was identified. Cox et al. (2015) 
used hospital discharge records from 1988 to 2009 to identify health conditions 
that had affected 2,783 male New Zealand veterans who had served in Vietnam 
during 1964 to 1972. Age-specific hospitalization rates were calculated using the 
total number of annual hospitalizations published by the Ministry of Health and 
the average annual resident population. Standardized hospitalization rates and 
99% CIs were calculated for the veteran cohort and the general population, 
and an SHR was calculated using the two rates for conditions related to other joint 
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diseases and other connective tissue diseases. An elevated risk of hospitalization 
for other joint diseases (n = 77; SHR = 1.34, 99% CI 1.04–1.64) and other con-
nective tissue disease (n = 169; SHR = 1.25, 99% CI 1.06–1.44), neither of which 
is further defined, was found for veterans when compared with the standardized 
New Zealand population. Since these disease categories were not clearly defined, 
it is difficult to interpret the findings. The study is also limited because the expo-
sures were not validated through serum measurements and were assumed based 
on deployment to Vietnam.
Biologic Plausibility
Animal studies suggest that TCDD may have some influence on bone for-
mation and maintenance. Recent work from Herlin et al. (2013) showed that the 
exposure of adult mice to TCDD resulted in harder bone matrix, thinner cortical 
bone, mechanically weaker bones, and, most notably, increased trabecular bone 
volume fraction in Ahr knockout mice. It is known that TCDD can induce chon-
drocyte apoptosis in culture, which could be an initial event leading to the sort of 
cartilage degradation observed in arthritis (Yang and Lee, 2010). Lee and Yang 
(2012) recently demonstrated that this is mediated by reactive oxygen species. In 
addition, TCDD exposure via the dam’s milk impaired bone mineralization dur-
ing postnatal development in mice because of a reduction in osteoblastic activity 
as a result of TCDD-induced up-regulation in the active form of vitamin D in 
serum (Nishimura et al., 2009). TCDD altered osteogenesis (bone formation) in 
an in vitro osteoblast model and led to alterations in the proteins associated with 
cytoskeleton organization and biogenesis, a decrease in the expression of cal-
cium-binding proteins, and a decrease in osteoblast calcium deposition (Carpi et 
al., 2009). In adult rats, TCDD exposure reduced trabecular bone cross-sectional 
area, but it significantly increased total bone mineral density; it was further noted 
that TCDD decreased the expression of the bone-formation marker procollagen 
type I N-terminal propeptide and increased the expression of the bone-resorption 
marker carboxy-terminal collagen cross-link, suggesting a net loss of bone tissue 
(Lind et al., 2009). It is also known that exposure to polyaromatic hydrocarbons 
(such as those in tobacco smoke) can affect bone health, and some of these altera-
tions have been shown to be mediated, at least in part, by the AHR. That implies 
that TCDD may alter or modify the effects of osteoblast formation and function 
as well as inhibit osteoclast formation and function (Kung et al., 2012; Yan et 
al., 2011). Iqbal et al. (2013) recently addressed this, studying genetically altered 
mice in order to understand the contributions of tobacco carcinogens and TCDD. 
In their work, mice in which the Ahr or CYP1A1, CYP1A2, and CYP1B1 genes 
were deleted displayed reduced resorption and high bone mass. In contrast, Ahr 
activation by administering benzo[a]pyrene to wild-type mice increased osteo-
clastogenesis and bone resorption.
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Synthesis
The small amount of available epidemiologic information on the possible 
adverse effects of exposure to the COIs on bone structure has previously been 
based entirely on dioxin-like mono-ortho PCBs, which contribute a small per-
centage to total TEQs based on all dioxin-like PCBs. The recent data from New 
Zealand Vietnam veterans, while suggesting a slightly statistically elevated risk 
of “other” bone and joint conditions, has poorly described outcomes (with essen-
tially no data on the exact bone conditions considered) and is further limited by 
the use of hospitalization rates for such outcomes, which are difficult to interpret. 
Biological data confirm that TCDD is active in bone metabolism, but the pattern 
of association of exposure to the COIs and subsequent disease is not consistent 
in the current literature.
Conclusion
There is inadequate or insufficient evidence of an association between expo-
sure to the COIs and clinical or overt adverse effects of osteoporosis, loss of bone 
mineral density, or other bone conditions.
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Conclusions and Recommendations
Chapter Overview
This final chapter presents a synopsis of the conclusions drawn by the committee 
regarding statistical associations between diseases and possible exposure to dioxin 
and other chemical compounds in herbicides used in Vietnam. It also presents the 
committee’s recommendations regarding future research on Vietnam veterans’ health.
SYNOPSIS OF COMMITTEE CONCLUSIONS
Under the aegis of Public Law (PL) 102-4, the current committee reviewed 
and evaluated the available scientific evidence regarding the associations between 
diseases and exposure to dioxin and other chemical compounds in herbicides used 
during the Vietnam War.1 In reaching its conclusions, it weighed the strengths and 
limitations of the epidemiologic evidence reviewed in its report and in previous 
Veterans and Agent Orange (VAO) reports. Although the studies published since 
Update 2014 are the subject of a detailed evaluation here, the committee drew 
its conclusions in the context of the entire body of literature. The contribution of 
recent publications to the scientific evidence base is emphasized in this report, 
but the weight of the evidence in its totality was the primary consideration guid-
ing the evaluation of health outcomes. Although the study subjects in much of 
the new literature reviewed here were not the male U.S. Vietnam veterans who 
1 These chemicals—2,4-dichlorophenoxyacetic acid (2,4-D), 2,4,5-trichlorophenoxyacetic acid 
(2,4,5-T), picloram, and cacodylic acid—and 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD or dioxin) 
are collectively referred to as the “chemicals of interest” (COIs) in the report.
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constitute most of the population affected by the VAO reports, the new studies 
from U.S. and other Vietnam veteran populations provided pertinent information.
Epidemiologic methods and analytic capabilities have continued to improve 
over the period in which the previous VAO updates have been conducted. As 
has been the case for recent updates, a considerable number of the new studies 
presented their results in terms of serum TCDD concentrations or total toxic 
equivalents (TEQs), which are particularly useful for the committee’s purpose be-
cause they provide a cumulative measure of exposure to all dioxin-like chemicals.
The committee also notes that considerable experimental data related to the 
biologic plausibility of the health conditions statistically associated with expo-
sure to the components of the herbicides sprayed in Vietnam have emerged since 
the beginning of the VAO report series. These findings help to inform decisions 
about how to categorize the degree of association for individual conditions. On 
the basis of its evaluation of epidemiology studies of Vietnam-veteran popula-
tions and of occupationally and environmentally exposed populations, and aided 
by experimental studies on biologic plausibility, the committee assigned each 
health outcome to one of four categories of relative certainty of association 
with exposure to the herbicides used in Vietnam or to any of their components 
or contaminants.
Principal Changes from Previous Updates
The application of the committee’s evaluation methodology led to three 
principal changes in the conclusions regarding exposure to the chemicals of 
interest (COIs) and adverse health outcomes reported in Update 2014. They are 
explicated in the preceding chapters and summarized below.
First, the current committee concluded that the information now assembled 
constitutes sufficient evidence of an association between exposure to at least one 
of the COIs and hypertension. As detailed in Chapter 10, the decision to change 
the classification from limited or suggestive evidence of an association was 
motivated in large part by the work of Cypel and colleagues (2016). These inves-
tigators conducted a study on the population of interest, U.S. Vietnam veterans 
(specifically, the Army Chemical Corps), that was characterized by a large sample 
size, appropriate controls (non-Vietnam-deployed sprayers, Vietnam-deployed 
non-sprayers, and non-Vietnam-deployed non-sprayers), and validated endpoints 
(self-reported physician-diagnosed hypertension that was confirmed by medical 
record reviews and serum TCDD measurements in a subset of participants). The 
statistical analyses conducted were robust, used state-of-the art methods, and 
adjusted for relevant confounders. The study clearly showed that self-reported 
hypertension rates were the highest among Vietnam-deployed sprayers (81.6%) 
followed by non-Vietnam-deployed sprayers (77.4%), Vietnam-deployed non-
sprayers (72.2%), and non-Vietnam-deployed non-sprayers (64.6%), providing a 
significant association with exposure. Among Vietnam-deployed veterans, there 
was a significantly elevated association between the odds of hypertension for 
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sprayers versus non-sprayers that remained after adjustment for potential con-
founders (odds ratio [OR] = 1.77, 95% confidence interval [CI] 1.35–2.30). 
Similarly, for those veterans who did not deploy to Vietnam, self-reported hyper-
tension was significantly elevated when sprayers were compared with non-spray-
ers (OR = 1.72, 95% CI 1.31–2.26). When considered in light of other new 
research and earlier papers that demonstrated a consistency in the direction and 
magnitude of this effect—notably Kang et al. (2006), Cypel and Kang (2010), 
and multiple publications from the Air Force Health Study (AFHS; AFHS, 1995, 
2000, 2005)—the committee found that this body of literature constituted suf-
ficient evidence of an association.
The committee also concluded (as detailed in Chapter 7) that there was suf-
ficient evidence of an association between exposure to at least one of the COIs 
and a previously unclassified health condition, monoclonal gammopathy of un-
determined significance (MGUS). MGUS is a precursor to multiple myeloma, 
although only an estimated 1% of cases of it progress to multiple myeloma each 
year. It is a clinically silent condition defined by the presence of a monoclonal 
antibody, antibody heavy chain, or antibody light chain in the blood or urine of 
a person lacking symptoms or signs of a more serious plasma cell dyscrasia. The 
foundation of this finding was a well-conducted study by Landgren et al. (2015) 
that examined data and biospecimens from a population of veterans that included 
participants with known exposure to herbicides in Vietnam: the AFHS cohort. 
Landgren and colleagues used previously measured serum levels of TCDD and 
performed a new assay of 958 serum samples to detect MGUS. Known confound-
ers, including age, race, body mass index, smoking and drinking history, and a 
history of radiation therapy or chemotherapy, were considered. The investiga-
tors found that the prevalence of MGUS in veterans involved in herbicide spray 
operations (7.1%) was higher than in comparison veterans (3.1%) (adjusted OR 
= 2.37, 95% CI 1.27–4.44; p = 0.007). The direct relevance of the exposure and 
exposed population, combined with the high quality of the study and underlying 
database, were persuasive in convincing the committee that there was sufficient 
evidence of an association.
Finally, the committee—after extensive deliberations regarding the strengths 
and weaknesses of the new evidence and evidence from studies reviewed in 
previous VAO reports—could not come to a consensus on whether the available 
scientific information regarding exposure to the COIs and type 2 diabetes should 
continue to be categorized as limited or suggestive or whether it meets the criteria 
for sufficient evidence of an association (see Chapter 10). Newly and previously 
reviewed studies consistently show a relationship between well-characterized 
exposure to dioxin and dioxin-like chemicals and measures of diabetes health 
outcomes in diverse cohorts, including Vietnam veteran populations. However, 
the lack of exposure specificity and the potential for uncontrolled confounding 
that characterized many of these studies complicates any attribution of the out-
come to the COIs. It was therefore not clear to the committee as a whole whether 
a category change was appropriate.
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Health Outcomes Identified by the Department 
of Veterans Affairs for Specific Focus
The Department of Veterans Affairs (VA) also asked the committee to spe-
cifically focus on three health outcomes: possible generational health effects that 
may be the result of herbicide exposure among male Vietnam veterans, myelo-
proliferative neoplasms, and glioblastoma multiforme. 
Chapter 8 summarizes the available literature on the effects of exposure to 
the COIs on the reproductive health of Vietnam veterans and on the health of 
their descendants. This is a burgeoning area of research, and there were sev-
eral new studies for the committee to consider. Few of them address Vietnam 
veterans specifically, however, and almost all of those that were conducted on 
other populations have weaknesses—prominently, different exposures than those 
experienced by veterans and also poor exposure characterization—that limit 
their usefulness in assessing risks for veterans. Some find associations between 
exposures and various outcomes, but there are no circumstances for which there 
is a consistent and compelling body of evidence that would lead the committee 
to conclude that there might be limited or suggestive or sufficient evidence of an 
association between an exposure to a COI and a particular outcome. Transgenera-
tional effects—those that might occur in veterans’ grandchildren and subsequent 
generations in which gestational exposure did not take place—are of great interest 
to veterans, but no epidemiological literature exists to evaluate whether exposure 
to the COIs might lead to such outcomes.
As further delineated below, the committee strongly believes that more work 
in this area is warranted. It concurs with the Update 2014 committee that it is 
critical that such research include animal studies in order to elucidate whether 
and which mechanisms for intergenerational and transgenerational effects might 
exist. It is, in principle, possible to do studies on the health of children and grand-
children of veterans, but it must be understood up front that such complex studies 
will need to be carefully planned and conducted if they are to yield meaningful 
results. Voluntary participation surveys and registries relying on self-reported 
information will not be helpful. The 2018 National Academies of Sciences, 
Engineering, and Medicine report Gulf War and Health, Volume 11: Generational 
Health Effects of Serving in the Gulf War (NASEM, 2018) addresses how studies 
of health outcomes in the progeny of veterans might be conducted.
Myeloproliferative neoplasms (MPNs) and myelodysplastic syndromes, 
addressed in Chapter 7, are diseases of the blood cells and bone marrow. VA asked 
that MPNs be explicitly examined as part of the consideration of the literature 
concerning leukemias and related diseases. However, after conducting a targeted 
search of scientific and medical databases (delineated in Box 3-1), the committee 
was unable to identify any papers that addressed the outcome with the exception of 
Yi and Ohrr (2014) (reviewed in Update 2014), which assessed cancer incidence 
among Korean veterans who had served in Vietnam between 1964 and 1973. 
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Those authors reported non-significant and imprecise increased risks of myelo-
proliferative disease and myelodisplastic syndrome in internal comparisons of 
high- and low-exposure groups, based on  so-called exposure opportunity scores.2 
The organization MPN Advocacy and Education International presented anecdotal 
information on MPNs in Vietnam veterans for the committee’s consideration, but 
this was not usable for drawing conclusions.
The committee observes that, in general, those studies that looked at expo-
sure to the COIs and hematological outcomes have generated much more com-
pelling results—including results on abnormalities of lymphoid development and 
immune function such as non-Hodgkin lymphoma, chronic lymphocytic leuke-
mia, multiple myeloma, and MGUS—than have those that examined whether 
myeloid neoplasms or MPNs have some relation with the COIs.
Given the absence of new studies, the paucity of epidemiologic studies in 
general, and the lack of information on the biologic plausibility of a connection 
between exposures to the COIs and abnormalities of hematopoietic cells associ-
ated with nonmalignant bone marrow –derived diseases, the committee concluded 
that there was inadequate or insufficient evidence of an association between 
exposure to the COIs and MPNs. Because the outcome has not been subject to 
previous research attention and is of interest to veterans, the committee recom-
mends that investigators examine existing databases on myeloid diseases to 
determine whether there are data available that would allow for an evalu-
ation of MPNs in Vietnam veterans and others who have been exposed to 
dioxin and the other COIs.
The scientific literature regarding exposure to the COIs and brain and other 
nervous system cancers, including glioblastoma multiforme (often abbreviated as 
glioblastoma), has been examined since the first VAO report. The body of evi-
dence that has been developed, which is summarized in Chapter 7, has not found 
statistically significant associations between exposure and any relevant outcome 
in studies performed on Vietnam-veteran, occupational, or environmental cohorts. 
These studies have by and large been underpowered because of the relative rarity of 
these cancers. Given the limited epidemiologic data available on glioblastoma, the 
committee heard invited presentations from two experts on the disease. While their 
presentations to the committee were helpful and impressive, demonstrating that the 
biological understanding of glioblastoma in particular is rapidly advancing, they 
reinforced the absence of clear data suggesting that the COIs are associated with 
the occurrence of brain cancers. Information on glioblastomas in Vietnam veterans 
submitted for the committee’s consideration by the Sierra Valley Cancer Registry 
Services, Inc., was, in part, anecdotal and without documented levels of exposure 
and was therefore of limited usefulness for the purpose of drawing conclusions. 
2 In brief, an exposure opportunity score is a means of quantifying exposure that accounts for the 
quantity of herbicide sprayed and the distance in time and space from the spraying (S. D. Stellman 
and J. M. Stellman, 2004).
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Furthermore, the committee did not identify any animal studies that have reported 
an association between exposure to the COIs and any brain cancer. While some 
studies have put forward mechanisms that might explain why dioxin exposure would 
be associated with glioblastoma, the information reviewed by the committee along 
with the presentations it received from experts in the field were not sufficient to alter 
the conclusion of previous reports that the evidence is inadequate or insufficient to 
determine whether there is an association between exposure to the COIs and brain or 
other nervous system cancers. The committee believes it is appropriate for VA to be 
mindful of the concerns raised about the possible association between Vietnam ser-
vice and glioblastoma, but it observes that the outcome is so rare and the information 
concerning herbicide exposures so imprecise that it is doubtful that any logistically 
and economically feasible epidemiologic study of veterans—no matter how well 
designed or executed—would produce meaningful results. The committee therefore 
recommends that epidemiologic studies of glioblastoma in Vietnam veterans 
should not be pursued and that VA should instead focus on fostering advance-
ments in other areas that may be used to inform improved treatment options.
Other Health Outcomes
Table 12-1 summarizes the conclusions regarding exposure to the COIs and 
health outcomes, with changes to the categorizations determined by the commit-
tee for Update 2014 noted in boldface. As mandated by PL 102-4, the distinctions 
among categories are based on statistical association and not on strict causality. 
The committee was directed to review the scientific data, not to recommend VA 
policy, and, therefore, the conclusions presented in Table 12-1 are not intended to 
imply or suggest policy decisions. Instead, the conclusions are based on observed 
associations between exposure and health outcomes in human populations. These 
categorizations do not address the likelihood that the health problems of any one 
individual are associated with or caused by the chemicals in question.
OTHER COMMITTEE RECOMMENDATIONS
As part of their charge, all VAO committees have been asked to offer recom-
mendations concerning the need for additional scientific studies and research to 
resolve areas of continuing scientific uncertainty concerning the health effects of 
exposure to the COIs. The previous update of the VAO series (the tenth update; 
Update 2014) was originally understood to be the last of the reports mandated 
by the Agent Orange Act (PL 102-4, renewed in PL 107-103, and subsequently 
extended). The committee responsible for that report thus considered it appropriate 
to compile the recommendations made by prior VAO committees and to consider, 
in light of the lessons learned in this process, what would be the most important 
activities to undertake in the future. They produced two tables as part of this effort:
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TABLE 12-1 Summary of the Eleventh Biennial Update Findings on  
Vietnam-Veteran, Occupational, and Environmental Studies Regarding 
Scientifically Relevant Associations Between Exposure to Herbicides and 
Specific Health Outcomesа
Sufficient Evidence of an Association
Epidemiologic evidence is sufficient to conclude that there is a positive association. That is, 
a positive association has been observed between exposure to herbicides and the outcome in 
studies in which chance, bias, and confounding could be ruled out with reasonable confidence.b 
For example, if several small studies that are free of bias and confounding show an association 
that is consistent in magnitude and direction, there could be sufficient evidence of an association. 
There is sufficient evidence of an association between exposure to the chemicals of interest and the 
following health outcomes:
 Soft-tissue sarcoma (including heart)
* Non-Hodgkin lymphoma
*  Chronic lymphocytic leukemia (including hairy cell leukemia and other chronic B-cell 
  leukemias)
* Hodgkin lymphoma
 Chloracne
 Hypertension (category change from Limited or Suggestive in Update 2014)
  Monoclonal gammopathy of undetermined significance (MGUS) (newly considered 
  condition)
The committee did not reach consensus on whether the evidence regarding type 2 diabetes 
(mellitus) was more properly classified as Sufficient or Limited or Suggestive.
Limited or Suggestive Evidence of an Association
Epidemiologic evidence suggests an association between exposure to herbicides and the 
outcome, but a firm conclusion is limited because chance, bias, and confounding could not be 
ruled out with confidence.b For example, a well-conducted study with strong findings in accord 
with less compelling results from studies of populations with similar exposures could constitute 
such evidence. There is limited or suggestive evidence of an association between exposure to the 
chemicals of interest and the following health outcomes:
 Laryngeal cancer
 Cancer of the lung, bronchus, or trachea
 Prostate cancer
 Cancer of the urinary bladder
* Multiple myeloma
* AL amyloidosis
 Early-onset peripheral neuropathy
 Parkinson disease (including Parkinsonism and Parkinson-like syndromes)
 Porphyria cutanea tarda
 Ischemic heart disease
 Stroke
 Hypothyroidism
The committee did not reach consensus on whether the evidence regarding type 2 diabetes 
(mellitus) was more properly classified as Sufficient or Limited or Suggestive.
continued
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TABLE 12-1 Continued
Inadequate or Insufficient Evidence to Determine an Association
The available epidemiologic studies are of insufficient quality, consistency, or statistical power to 
permit a conclusion regarding the presence or absence of an association. For example, studies fail 
to control for confounding, have inadequate exposure assessment, or fail to address latency. There 
is inadequate or insufficient evidence to determine association between exposure to the chemicals 
of interest and the following health outcomes that were explicitly reviewed:
Cancers of the oral cavity (including lips and tongue), pharynx (including tonsils), or nasal 
cavity (including ears and sinuses)
Cancers of the pleura, mediastinum, and other unspecified sites in the respiratory system 
and intrathoracic organs
Esophageal cancer
Stomach cancer
Colorectal cancer (including small intestine and anus)
Hepatobiliary cancers (liver, gallbladder, and bile ducts)
Pancreatic cancer
Bone and joint cancers
Melanoma
Non-melanoma skin cancer (basal-cell and squamous-cell)
Breast cancer
Cancers of reproductive organs (cervix, uterus, ovary, testes, and penis; excluding prostate)
Renal cancer (kidney and renal pelvis)
Cancers of brain and nervous system (including eye)
Endocrine cancers (thyroid, thymus, and other endocrine organs)
Leukemia (other than chronic lymphocytic leukemia, including hairy-cell leukemia and 
other chronic B-cell leukemias)
   Other myeloid diseases (including myeloproliferative neoplasms)
Cancers at other and unspecified sites
Infertility
Spontaneous abortion (other than after paternal exposure to TCDD, which appears not to be 
associated)
Neonatal or infant death and stillbirth in offspring of exposed people
Low birth weight in offspring of exposed people
Birth defects in offspring of exposed people, including spina bifida
Childhood cancer (including acute myeloid leukemia) or other adverse health outcomes in 
offspring of exposed people
Neurobehavioral disorders (cognitive and neuropsychiatric)
Neurodegenerative diseases, excluding Parkinson disease
Chronic peripheral nervous system disorders
Hearing loss
Respiratory disorders (wheeze or asthma, chronic obstructive pulmonary disease, and 
farmer’s lung)
Gastrointestinal, metabolic, and digestive disorders (changes in hepatic enzymes, liver 
disorders including cirrhosis, lipid abnormalities, and ulcers)
Immune system disorders (immune suppression, allergy, and autoimmunity)
Circulatory disorders (other than hypertension, ischemic heart disease, and stroke)
Endometriosis
continued
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• a compendium of the recommendations of prior committees condensed 
and sorted into topic areas, with comments on what response these rec-
ommendations received from VA, the Department of Defense, and other 
parties (Update 2014, Table 14-2, pp. 910–917), and
• a summary of the future activities the committee considered most impor-
tant for monitoring and evaluating the health issues of Vietnam veterans 
and other veterans who might experience service-related health problems 
long after discharge (Update 2014, Table 14-3, pp. 918–919).
Generally speaking, the recommendations of previous VAO committees 
fell into four primary areas: better management of veterans’ health information; 
additional epidemiologic studies; the improvement of exposure estimation; and 
TABLE 12-1 Continued
Disruption of thyroid homeostasis (other than hypothyroidism)
Eye problems
Bone conditions
   Kidney and urinary disorders (including chronic kidney disorder, differences in kidney  
   function, nephropathy, and end stage renal disorder)
   Chronic skin disorders (including skin infections and changes in skin pigmentation)
The committee used a classification that spans the full array of cancers. However, reviews for 
non-malignant conditions were conducted only if they were found to have been the subjects of 
epidemiologic investigation or at the request of the Department of Veterans Affairs. By default, any 
health outcome on which no epidemiologic information has been found falls into this category.
Limited or Suggestive Evidence of No Association
Several adequate studies, which cover the full range of human exposure, are consistent in 
not showing a positive association between any magnitude of exposure to a component of the 
herbicides of interest and the outcome. A conclusion of “no association” is inevitably limited to the 
conditions, exposures, and length of observation covered by the available studies. In addition, the 
possibility of a very small increase in risk at the exposure studied can never be excluded. There is 
limited or suggestive evidence of no association between exposure to the herbicide components of 
interest and the following health outcome:
Spontaneous abortion after paternal exposure to TCDD
 aHerbicides indicates the following chemicals of interest: 2,4-dichlorophenoxyacetic acid (2,4-D), 
2,4,5-trichlorophenoxyacetic acid (2,4,5-T) and its contaminant 2,3,7,8-tetrachlorodibenzo-p-dioxin 
(TCDD or dioxin), cacodylic acid, and picloram. The evidence regarding association was drawn 
from veteran, occupational, and environmental cohort studies in which people were exposed to the 
herbicides used in Vietnam, to their components, or to their contaminants.
 bEvidence of an association is strengthened by experimental data supporting biologic plausibility, 
but its absence would not detract from the epidemiologic evidence.
 *The committee notes the consistency of these findings with the biologic understanding of the 
clonal derivation of lymphohematopoietic cancers that is the basis of the World Health Organiza-
tion classification system (Campo et al., 2011; see table here: www.ncbi.nlm.nih.gov/pmc/articles/
PMC3109529/table/T1, accessed May 17, 2018).
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priority areas for toxicologic research. Suggested future activities included ini-
tiatives in these areas plus other initiatives related to the collection and analysis 
of additional information on Vietnam veterans’ service, exposures, and health. 
Complete details may be found in Chapter 14 of the Update 2014 report.
While there have been a few laudable exceptions—notably, the initiation 
of additional epidemiologic studies on Vietnam veterans, the development of a 
herbicide exposure assessment model for use in studies of Vietnam veterans, and 
the fostering of additional research on the data and biospecimens collected in the 
course of the AFHS3—there has been no known follow-up to the vast majority of 
recommendations that have been offered. The current committee did not choose 
to revisit this issue in general, concluding that the Update 2014 committee had 
effectively covered it.
It does observe, though, that the very first VAO (1994) indicated that “care-
fully conducted epidemiologic studies—with adequate sample size to detect ele-
vated associations—of the reproductive history of individuals with occupational 
or environmental exposure to herbicides and dioxin are . . . needed” (p. 731). 
Several subsequent volumes (Updates 2006, 2008, 2010, 2012, and 2014; sum-
marized in Table 12-2) have echoed and expanded on this. The current com-
mittee is in agreement with these sentiments and therefore recommends further 
specific study of the health of offspring of male Vietnam veterans.
The Update 2014 committee also offered suggestions for research activities 
that should follow the end of the VAO report series. Several of these, summa-
rized in Table 12-3, addressed reproductive outcomes. As that committee noted, 
although progress has been made in understanding the health effects of exposure 
to the COIs and the mechanisms underlying these effects, significant gaps in our 
knowledge remain. Many additional opportunities for progress via continuing 
and new toxicologic, mechanistic, and epidemiologic research exist. Such work 
should include efforts to gain new knowledge through the integration of existing 
Department of Defense and VA databases. While such research opportunities 
were mentioned in previous VAO updates, the Update 2014 committee restated 
them to emphasize its conviction that more progress should be made in the fields 
noted. This committee concurs in this assessment and endorses the recommenda-
tions offered in Table 12-3, noting that research in the rapidly advancing field 
of epigenetics appears to hold particular promise. Furthermore, the committee 
observes that VA’s Vietnam Era Health Retrospective Observational Study (VE-
HEROeS)—a study of the health and well-being of U.S. Vietnam and Vietnam-
era veterans—was under way at the time this report was completed and that it, 
along with other ongoing Vietnam veteran research efforts, holds the promise of 
adding to the body of knowledge.
3 The Institute of Medicine publications Disposition of the Air Force Health Study (IOM, 2006) 
and The Air Force Health Study Assets Research Program (IOM, 2015) provide details of this work.
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FINAL OBSERVATIONS
In the course of carrying out its Statement of Task, the committee has offered 
myriad criticisms of the conduct of studies of Vietnam veterans’ health, pointing 
out specific weaknesses and shortcomings in particular papers along with wide-
spread (although not universal) issues such as poor exposure characterization, 
failure to fully control for confounding influences on outcomes, and sample sizes 
that are inadequate for drawing statistically meaningful results. The committee 
wishes to make clear, though, that the difficulty in conducting research on Viet-
nam veteran health issues should not act as a barrier to carrying out such work. 
There are many questions regarding veterans’ health that cannot be adequately 
answered by examining superficially analogous exposures and outcomes in other 
populations. It is only through research on veterans themselves that the totality of 
the military service experience can be properly accounted for.
TABLE 12-3 Suggested Activities to Follow the Completion of the Veterans 
and Agent Orange Report Series Mandated by the Agent Orange Act Related to 
Effects on Veterans’ Descendants (excerpted from Update 2014, Table 14-3)
OVERSIGHT OF LONG-TERM HEALTH STATUS OF DEPLOYED SERVICE MEMBERS
 Very careful review of evidence concerning whether paternal exposure to any toxicant has 
definitively been demonstrated to result in abnormalities in even the first generation of offspring.
 Careful assessment of the risks to offspring that may arise from maternal exposure is also 
merited, given the greatly increased number of women now serving in the military.
EPIDEMIOLOGIC STUDIES
 Air Force Health Study (AFHS)
 Comprehensive longitudinal analysis of the AFHS data collected in the six intensive medical-
cycle examinations (including birth defects in veterans’ offspring), making use of the available 
exposure data.
 Use AFHS samples for study of epigenetic changes and definition of biomarkers of exposure 
and effect.*
 Other Epidemiology Goals
 Pursue development of protocols that could feasibly and efficiently investigate paternal 
transmission of adverse effects to offspring at birth or manifesting with maturation that have 
sufficient power for convincing findings. The logistics of attempting to detect adverse effects in 
the grandchildren of Vietnam veterans would be considerably more challenging.
TOXICOLOGIC RESEARCH
 Foster investigation of epigenetic changes in both somatic tissues and germ cells and during 
gestation.
 Without sophisticated and specific markers of environmentally induced epigenetic activity, 
epidemiologic investigations will not be able to distinguish the mechanisms inducing any 
observed adverse health effects in exposed people or their offspring.
 Fully investigate whether paternally transmitted adverse effects occur in animal models.
 *A pilot study by Boekelheide and colleagues—described in IOM (2005)—proposed to use a 
“new epigenome-wide molecular approach to detect dioxin exposure-related alterations in DNA 
methylation in biospecimens from the Air Force Health Study” (p. 112). Proof-of-concept work was 
conducted, but the project was not carried forward due to lack of funding.
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Appendix A
Public Meeting Agendas
FIRST PUBLIC MEETING
March 2, 2017
Keck Center of the National Academies
500 Fifth Street, NW
Washington, DC 20001
Open Session
1:00–1:10 p.m. Welcome and introductions; conduct of the open session
 Irva Hertz-Picciotto, Ph.D. – Committee Chair
1:10–2:00 p.m. Charge to the committee and discussion
 Peter R. Rumm, M.D., M.P.H. – Director, Pre-9/11 Era 
Environmental Health Program, Department of Veterans 
Affairs (VA), with Dr. R. Loren Erickson, Chief Consultant, 
Post-Deployment Health Services
2:00–2:45 p.m. Overview of VA’s Vietnam Era Health Retrospective 
Observational Study (VE-HEROeS)
 Victoria Davey, Ph.D., M.P.H., R.N. – Principal Investigator, 
VA
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2:45–3:30 p.m. VA Health Care Utilization for Vietnam Veterans
 Aaron I. Schneiderman, Ph.D., M.P.H., R.N. – Director, 
Epidemiology Program Post-Deployment Health Services, 
VA
3:30–4:30 p.m. Public comments
 Thomas Berger, Ph.D., Vietnam Veterans of America
 Ann Brazeau, MPN Advocacy and Education International
 Carla L. Dean, Bladder Cancer Foundation of Florida
 Cindy Fabbri
 MSgt LeRoy G. Foster
  Raajit K. Rampal, M.D., Ph.D., Memorial Sloan Kettering 
Cancer Center
 Rick Weidman, Vietnam Veterans of America
4:30 p.m. Open session adjourns
SECOND PUBLIC MEETING
September 7, 2017
Courtyard Marriott Bloomington by Mall of America
7800 Bloomington Avenue S.
Lake Hiawatha Room
Bloomington, MN 55425
Open Session
1:00–1:10 p.m. Welcome | Notes on the conduct of the open session | 
Introduction of participants
 Irva Hertz-Picciotto, Ph.D. – Committee Chair
1:10–2:30 p.m. Presentations and comments by participants and questions 
from the committee
 Ronald R. Bach, Ph.D.
 Robert Behrens
 Richard Bergling
 Linda O. Bergum, M.D.
 Jeremy Eberley and parents
 Maynard Kaderlick
 Lee McClary
 Mokie Porter
2:30 p.m. Wrap-up and thanks to participants
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THIRD PUBLIC MEETING
November 30, 2017
Keck Center of the National Academies
500 Fifth Street, NW
Washington, DC 20001
Open Session
10:15–10:30 a.m. Welcome | Notes on the conduct of the open session | 
Introduction of participants
 Irva Hertz-Picciotto, Ph.D. – Committee Chair
10:30–11:15 a.m. Exposures and Heritable Effects
 Thaddeus (Thad) Schug, Ph.D. – Health Scientist 
Administrator, Population Health Branch, National Institute 
of Environmental Health Sciences and the National 
Toxicology Program
11:15 a.m.– Russian Children’s Study: Dioxins and Semen Quality
12:00 p.m. Russ Hauser, Sc.D. – Frederick Lee Hisaw Professor 
of Reproductive Physiology. Chair, Department of 
Environmental Health, Harvard T.H. Chan School of Public 
Health
12:45–1:30 p.m. Multiple Myeloma and its Precursor Disease (MGUS)
 C. Ola Landgren, M.D., Ph.D. – Professor of Medicine 
and Chief Attending Physician of the Myeloma Service, 
Memorial Sloan Kettering Cancer Center
1:30–2:15 p.m. Epidemiology of Glioma
 Quinn T. Ostrom, Ph.D., M.P.H. – Research Coordinator, 
Case Comprehensive Cancer Center, Case Western Reserve 
University School of Medicine; Research Manager and 
Primary Analyst, Central Brain Tumor Registry of the 
United States
2:15–3:00 p.m. Glioblastoma – State of the Science
 Paul S. Mischel, M.D. – Member and Head, Laboratory of 
Molecular Pathology, Ludwig Institute for Cancer Research 
San Diego and Professor, Department of Pathology, 
University of California, San Diego
Veterans and Agent Orange: Update 11 (2018)
Copyright National Academy of Sciences. All rights reserved.
708 VETERANS AND AGENT ORANGE: UPDATE 11
3:00–3:30 p.m. U.S. Department of Veterans Affairs: Vietnam Veterans and 
Brain Cancer
 Ralph L. Erickson, M.D., Dr.P.H., Chief Consultant, Post-
Deployment Health Services
 Peter D. Rumm, M.D., M.P.H., Director, Pre-9/11 Era 
Environmental Health Program
3:30–4:00 p.m. Public comments (spoken comments may not exceed 3 
minutes per person; written submissions of any length are 
welcome)
 Kathy-Lynn Carroll Josenhans
 Robert M. (Bob) Hunter, Ph.D.
 Pegi Scarlett
 Laurel Smith Holt
4:00 p.m. Open session adjourns
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Appendix B
Committee and Staff Biographies
COMMITTEE BIOGRAPHIES
Irva Hertz-Picciotto, Ph.D., M.P.H., M.A. (Chair), is a professor in the Depart-
ment of Public Health Sciences in the School of Medicine and also at the Medical 
Investigations of Neurodevelopmental Disorders (MIND) Institute, University of 
California, Davis (UC Davis), and she is the chief of the Division of Environ-
mental and Occupational Health. She is also the deputy director of the Center for 
Children’s Environmental Health at UC Davis and the director of the Northern 
California Center for the National Children’s Study. She has published widely on 
environmental exposures, including metals, pesticides, polychlorinated biphenyls, 
and air pollution and on their effects on pregnancy, the neonate, and early child 
development as well as on methods in epidemiologic research. She has also led 
several cohort studies of toxic chemicals and both pregnancy outcomes and early 
child development in Chile, eastern Europe, and Mexico. Recently she co-founded 
Project TENDR (Targeting Environment and Neuro-Developmental Risks), a col-
laborative effort of scientists, clinicians, policy makers, and advocates that aims 
to decrease the incidence of neurodevelopmental disorders by reducing the neu-
rotoxicant exposures that contribute to them. Dr. Hertz-Picciotto has served on 
scientific advisory panels for the Environmental Protection Agency, the National 
Institutes of Health’s (NIH’s) National Toxicology Program, the National Institute 
for Occupational Safety and Health, the NIH Interagency Coordinating Com-
mittee on Autism Research, and the California Governor’s Proposition 65 com-
mittee. She has served or currently sits on the editorial boards for the American 
Journal of Epidemiology, Environmental Health Perspectives, Epidemiology, and 
Autism Research. She served as the president of the Society for Epidemiologic 
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Research and of the International Society for Environmental Epidemiology, 
and in 2011 she received the Goldsmith Lifetime Achievement Award from 
the International Society for Environmental Epidemiology. Dr. Hertz-Picciotto 
has previously chaired three National Academies’ committees: one on breast 
cancer and the environment and two previous updates of Committees to Review 
the Health Effects in Vietnam Veterans of Exposure to Herbicides. She received 
a Ph.D. and an M.P.H. in epidemiology and an M.A. in biostatistics from UC 
Berkeley. Before joining the faculty at UC Davis, Dr. Hertz-Picciotto was a 
professor in the Department of Epidemiology at the School of Public Health at 
University of North Carolina at Chapel Hill. She is a National Associate of the 
National Academies.
Nancy Berliner, M.D., is the chief of the Division of Hematology at Brigham and 
Women’s Hospital and a professor at Harvard Medical School. Her research focus 
is gene regulatory pathways of normal white blood cell development and how 
they are disrupted in leukemia and pre-leukemic syndromes as well as the patho-
genesis of the anemia of aging and benign and malignant hematologic disorders. 
Most recently, her laboratory has studied the role of cellular stress responses in 
the disruption of hematopoietic cell differentiation in myelodysplasia. A second 
focus of her laboratory is the role of inflammatory cytokines in the anemia of 
the elderly and in modulating the natural history of myelodysplasia. Dr. Berliner 
is a member of the National Academy of Medicine (NAM; elected 2010). She 
received her M.D. from the Yale University School of Medicine.
Wendy B. Bernstein, M.D., is a staff physician in the Department of Hematol-
ogy Oncology at Walter Reed National Military Medical Center and an associate 
professor of medicine at the Uniformed Services University of the Health Sci-
ences (USUHS). Prior assignments included chairing the central scientific review 
committee at Walter Reed and serving as a staff clinician at the National Cancer 
Institute’s Medical Oncology Branch. Her clinical interests include malignan-
cies in immune-compromised hosts, and her research activities involve immune 
reconstitution in HIV-infected persons using CAR-T cells. Dr. Bernstein is a 28-
year veteran of the Army Medical Corps, having retired with the rank of colonel. 
She received her M.D. from USUHS and is board certified in internal medicine, 
oncology, and hematology.
Michael J. Carvan III, Ph.D., M.S., is a Shaw Professor at the School of Fresh-
water Sciences and School of Public Health, both of the University of Wiscon-
sin–Milwaukee. He earned his M.S. in biologic oceanography at the University of 
Miami’s Rosenstiel School of Marine and Atmospheric Science in Coral Gables 
and his Ph.D. in veterinary anatomy and public health with a focus in toxicology 
from Texas A&M University’s College of Veterinary Medicine in College Station. 
After obtaining his doctorate, Dr. Carvan held National Institute of Environmental 
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Health Sciences molecular toxicology fellowships at the University of Cincinnati 
Medical Center. His research uses zebrafish as a genetic system for identifying 
genes that influence the susceptibility of response to xenobiotics. He has served 
on the National Academies of Sciences, Engineering, and Medicine’s Board on 
Life Sciences and as a committee member on the ninth and tenth updates of 
Committees to Review the Health Effects in Vietnam Veterans of Exposure to 
Herbicides.
Aravinda Chakravarti, Ph.D., is a professor of medicine and neuroscience at 
the New York University School of Medicine and the director of the Center for 
Human Genetics and Genomics. He has been a key participant and architect of 
the Human Genome, HapMap, and 1000 Genomes projects. His research focus 
is the genome-scale analysis of humans and the computational analysis of gene 
variation and function to understand the molecular genetic basis of complex 
human phenotypes, particularly disease. Dr. Chakravarti’s discovery of genes 
and pathways contributing to Hirschsprung disease has served as a model for 
the genetic dissection of other multifactorial human disorders, such as autism 
spectrum disorders, hypertension, and sudden cardiac death. He was president of 
the American Society of Human Genetics in 2008 and received its William Allan 
Award in 2013. He is one of the founding editors-in-chief of Genome Research 
and the Annual Reviews of Genomics and Human Genetics, and has served and 
serves on the boards of numerous international journals, academic societies, the 
National Institutes of Health, and biotechnology companies. He is a member of 
the National Academy of Sciences (elected 2015) and the National Academy of 
Medicine (NAM) (elected 2007). Dr. Chakravarti is also an honorary fellow of the 
Indian Academy of Sciences. Currently he serves on the NAM Council nominat-
ing committee. He received his Ph.D. in human genetics from the University of 
Texas–Houston Health Science Center.
Dana C. Dolinoy, Ph.D., is the NSF International Chair of Environmental Health 
Sciences and a professor of environmental health sciences and nutritional sci-
ences at the University of Michigan School of Public Health, and she leads the 
Environmental Epigenetics and Nutrition Laboratory, which investigates how 
nutritional and environmental factors interact with epigenetic gene regulation 
to shape health and disease. She serves on the editorial boards of the Journal of 
Nutritional Biochemistry and Epigenetics and is an associate editor for Environ-
mental Health Perspectives, Environmental Epigenetics, and Toxicological Sci-
ences. She is an active member of the Society of Toxicology, the Environmental 
Mutagen and Genomics Society, and the American Society for Nutrition, and 
she served as the chair of the 2015 Gordon Research Conference in Molecular 
and Cellular Mechanisms of Toxicity. In 2011 Dr. Dolinoy received the Nor-
man Kretchmer Memorial Award from the American Society for Nutrition and 
the Classic Paper of the Year Award from Environmental Health Perspectives 
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for Dolinoy et al. “Maternal genistein alters coat color and protects Avy mouse 
offspring from obesity by modifying the fetal epigenome.” In 2012 she was the 
recipient of the Association of Schools of Public Health/Pfizer Research Award 
for the article, “An expression microarray approach for the identification of 
metastable epialleles in the mouse genome.” This work was cited as a model 
approach that may allow for directly assessing the role of early nutritional and 
environmental exposures in human adult disease. Dr. Dolinoy recently received 
the 2015 National Institutes of Health Director’s Transformative Research Award 
to develop novel epigenome editing tools to reduce disease risk, and in 2016 
served as the chair of the Society of Toxicology’s Contemporary Concepts in 
Toxicology meeting, ToxicoEpigenetics: The Interface of Epigenetics and Risk 
Assessment. Dr. Dolinoy holds an M.Sc. in environmental sciences and engineer-
ing from the Harvard T.H. Chan School of Public Health and a Ph.D. in genetics 
and genomics and integrated toxicology from Duke University.
Mary A. Fox, Ph.D., is an assistant professor in the Department of Health Policy 
and Management and the co-director of the Risk Sciences and Public Policy 
Institute at the Johns Hopkins Bloomberg School of Public Health. She teaches 
courses in quantitative risk assessment methods and risk policy and management 
for the Risk Sciences and Public Policy Institute’s Certificate Program. Dr. Fox’s 
research is focused on human health risk assessment as a part of environmental 
policy making, particularly approaches to cumulative and chemical mixtures 
risk assessment. Dr. Fox has served on three National Academies’ committees: 
Gulf War and Health, Volume 10: Update of Health Effects of Serving in the 
Gulf War, Long-Term Health Consequences of Exposure to Burn Pits in Iraq and 
Afghanistan, and Health Risks of Phthalates. Dr. Fox began her public health 
career conducting community health studies around hazardous waste sites as a 
research scientist in the New York State Department of Health. Dr. Fox received 
her M.P.H. from the University of Rochester School of Medicine and Dentistry 
and a Ph.D. from the Johns Hopkins Bloomberg School of Public Health.
Karl T. Kelsey, M.D., M.O.H., is a professor of epidemiology, pathology, and 
laboratory medicine at Brown University. Dr. Kelsey received his M.D. from 
the University of Minnesota and a master’s degree in occupational health from 
Harvard University. Until 2007 he was on the faculty of the Harvard T.H. Chan 
School of Public Health and Harvard Medical School. He is interested in the 
application of laboratory-based biomarkers in chronic-disease epidemiology 
and tumor biology and in characterizing individual susceptibility to cancer. He 
is an author of more than 200 publications and has served on the National 
Academies’ Committees on Toxicity Testing and Assessment of Environmental 
Agents, on Copper in Drinking Water, on the Evaluation of the Department of 
Veterans Affairs Uniform Case Assessment Protocol to Review the Health Con-
sequences of Service During the Persian Gulf War, on Curriculum Development 
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in Environmental Medicine, on the Health Effects of Mustard Gas and Lewisite, 
and, most recently, on the past three Committees to Review the Health Effects in 
Vietnam Veterans of Exposure to Herbicides.
Molly L. Kile, Sc.D. is an associate professor in the College of Public Health 
and Human Sciences at Oregon State University and the director of its Environ-
mental Exposure and Biomarker Lab, and she coordinates the program in envi-
ronmental and occupational health. She has affiliations with the university’s 
Center for Global Health and is a visiting scholar in the Department of Environ-
mental Health at the Harvard T.H. Chan School of Public Health. She also leads 
the Community Engagement Core of Oregon State University’s Superfund 
Basic Research Program, which works in collaboration with Native American 
tribes in the Pacific Northwest to investigate their environmental health con-
cerns and is funded by the National Institute of Environmental Health Sciences 
on a research project examining the potential for developmental exposures to 
influence immune functioning in children. Dr. Kile’s primary research interest 
is in environmental and molecular epidemiology. Her research has focused on 
the application of biological markers for studying exposures and the interac-
tion between host factors (genetic polymorphisms, nutritional status, microbi-
ome, and epigenetic markers) and environmental exposures. She serves as an 
editor for the Journal of Environmental and Public Health. Dr. Kile received 
her Ph.D. from the Harvard T.H. Chan School of Public Health in environ-
mental health and continued her postdoctoral training at Harvard in molecular 
epidemiology.
Andrew F. Olshan, Ph.D., is the Barbara Sorenson Hulka Distinguished Pro-
fessor in the Department of Epidemiology of the University of North Carolina 
(UNC) Gillings School of Global Public Health. He is also the associate director 
of population sciences at the UNC Lineberger Comprehensive Cancer Center. 
His research interests are the etiology of cancer and reproductive, perinatal, 
and pediatric outcomes. Recent work has focused on the role of environmental 
exposures, genetic factors, and adverse health effects in children and adults. He 
directs the National Institutes of Health–funded studies of head and neck cancer, 
breast cancer, and childhood cancer. He is director of the Centers for Disease 
Control and Prevention–funded North Carolina Center for Birth Defects Research 
and Prevention. He has served on several National Academies’ committees, most 
recently as co-chair of the Committee to Review the Draft IRIS Assessment on 
Formaldehyde. He has also served as a member on four prior committees to 
review health effects in Vietnam veterans exposed to Agent Orange and other 
herbicides. Dr. Olshan received both his M.S. and Ph.D. in epidemiology from 
the University of Washington and was a postdoctoral fellow in medical genetics 
at the University of British Columbia.
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Beate R. Ritz, M.D., Ph.D., M.P.H, is a professor in and the former chair of the 
Epidemiology Department at the School of Public Health at the University of 
California, Los Angeles (UCLA), where she has been a faculty member since 1995. 
Dr. Ritz holds co-appointments in both the environmental health department at the 
UCLA School of Public Health and in neurology at the UCLA School of Medicine. 
She received both her M.D. and Ph.D. in medical sociology from the University of 
Hamburg, Germany, in 1987. Dr. Ritz was a research fellow and served her resi-
dency at the Psychiatric University Hospital in Hamburg. She went on to receive 
her doctoral training and a Ph.D. in epidemiology in 1995 from UCLA. Dr. Ritz’s 
research has focused on environmental toxins and the health effects they may have 
on birth outcomes, neurodegenerative and neurodevelopmental disorders, cancers, 
and chronic diseases. For the past two decades, she has conducted research on the 
effects of air pollution on adverse birth outcomes and neurodevelopmental disor-
ders in children who live in Southern California. She also studied the long-term 
effects of pesticides exposure on Parkinson disease and cancer and is working 
on establishing a Parkinson disease registry in California. Dr. Ritz previously 
served on National Academies’ committees including two committees responsible 
for Gulf War and Health series reports, on the Committee on the Review of the 
Scientific Literature on Amyotrophic Lateral Sclerosis in Veterans, and, most 
recently, Using 21st Century Science to Improve Risk-Related Evaluations.
Lori A. White, Ph.D., M.S., is an associate professor in the Department of 
Biochemistry and Microbiology of the School of Environmental and Biological 
Sciences of Rutgers, the State University of New Jersey. She received a master’s 
degree in zoology from the University of Maine, earned a Ph.D. in biochemistry 
from the Dartmouth Medical School, and did postdoctoral work at the University 
of Wisconsin. She has been active in Gordon Research Conference programs and 
was the chairperson for the Mechanisms of Toxicology summer session in 2008. 
Her past research focused on the elucidation of dioxin’s carcinogenic activity, 
specifically how TCDD activates the aryl hydrocarbon receptor pathway resulting 
in altered gene expression in different biologically relevant targets. In addition 
to this project, her laboratory currently uses the zebrafish model to study the 
neurotoxicological and behavioral effects following exposure to environmental 
contaminants during development. She served on the ninth and tenth biennial 
updates of the Committees to Review the Health Effects in Vietnam Veterans of 
Exposure to Herbicides.
STAFF BIOGRAPHIES
David A. Butler, Ph.D., is a scholar in and the director of the Office of Mili-
tary and Veterans Health in the Health and Medicine Division of the National 
Academies of Sciences, Engineering, and Medicine. He earned his B.S. and M.S. 
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degrees in engineering from the University of Rochester and his doctoral degree 
in public policy analysis from Carnegie Mellon University. Before joining the 
National Academies, Dr. Butler served as an analyst for the U.S. Congress 
Office of Technology Assessment, was a research associate in the Department 
of Environmental Health of the Harvard T.H. Chan School of Public Health, and 
conducted research at Harvard’s  John F. Kennedy School of Government. He 
has directed several National Academies studies on military and veterans health, 
environmental health, and risk assessment topics, including ones that produced 
Research on the Health Effects of Low-Level Ionizing Radiation: Opportunities 
for the Armed Forces Radiobiology Research Institute; Future Uses of the DoD 
Joint Pathology Center Biorepository; Provision of Mental Health Counseling 
Services Under TRICARE; PTSD Compensation and Military Service; Veterans 
and Agent Orange: Update 1998 and Update 2000; Disposition of the Air Force 
Health Study; and the report series Characterizing the Exposure of Veterans to 
Agent Orange and Other Herbicides Used in Vietnam. Dr. Butler was also a co-
editor of Systems Engineering to Improve Traumatic Brain Injury Care in the 
Military Health System.
Anne N. Styka, M.P.H., is a senionr program officer in the Health and Medi-
cine Division of the National Academies. Over her tenure she has worked on 
more than 10 studies on a broad range of topics related to the health of military 
and veteran populations. Studies have included mental health treatment offered 
in the Department of Defense and the Department of Veterans Affairs (VA); 
designing and evaluating epidemiological research studies using VA data for 
health outcomes related to deployment-related exposures, including burn pits and 
chemicals; and directing a research program of fostering new research studies 
using data and biospecimens collected as part of the 20-year Air Force Health 
Study. Before coming to the National Academies, Ms. Styka spent several years 
working as an epidemiologist for the New Mexico Department of Health and the 
Albuquerque Area Southwest Tribal Epidemiology Center, and she spent several 
months in Zambia as the epidemiologist on a study of silicosis and other nonma-
lignant respiratory diseases among copper miners. She has several peer-reviewed 
publications and has contributed to numerous state and national reports. She 
received her B.S. in cell and tissue bioengineering from the University of Illinois 
at Chicago and has an M.P.H. in epidemiology from the University of Michigan. 
Ms. Styka was the 2017 recipient of the Division of Earth and Life Sciences 
Mt. Everest Award, the 2015 recipient of the Institute of Medicine and National 
Academy of Medicine Multitasker Award, and a member of the 2011 National 
Academies’ Distinguished Group Award.
T. Cheri Banks, M.P.H., is a research associate in the Health and Medicine Divi-
sion of the National Academies. Originally from Atlanta, Georgia, Ms. Banks 
spent time working at Emory University in the Office for Clinical Research and the 
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Office of Grants and Contracts Accounting, where she managed all grants-related 
issues, wrote for the Emory research newsletter, and conducted proposal train-
ing courses. Ms. Banks also spent time working with the Georgia Department of 
Health (GDPH) in Atlanta on the DPH13-1305 cooperative agreement funded by 
the Centers for Disease Control and Prevention. In her role with GDPH, Ms. Banks 
analyzed wellness policies for schools in various counties within Georgia and 
made recommendations for each county to improve their policy. She received her 
B.A. in psychology from Oglethorpe University and has an M.P.H. in prevention 
science from the Rollins School of Public Health–Emory University in Atlanta.
Elizabeth Barksdale Boyle, M.P.H., CIH, has more than 15 years of experience 
in environmental health and epidemiology. She is a program officer within the 
Division on Earth and Life Studies of the National Academies. Formerly, she was 
an environmental health scientist at Westat, where she supported the Environmen-
tal Protection Agency, the National Institute of Child Health and Development, 
and the National Cancer Institute by completing other environmental epidemi-
ology–related projects. Prior to her tenure at Westat, Ms. Boyle was a student 
epidemiologist at the Minnesota Department of Health and an industrial hygien-
ist at a consulting firm in Cincinnati. She serves as the chair of the nominations 
committee for the International Society of Exposure Science. She is also a fellow 
of the Bloomberg American Health Initiative at the Johns Hopkins Bloomberg 
School of Public Health, where she is pursuing a doctorate of public health in 
environmental health. 
Pamela Ramey-McCray, is an administrative assistant in the Health and Medi-
cine Division. She has worked to support numerous studies on military and 
veterans health, malaria research, and U.S. veteran twins since coming to the 
National Academies in 1993. Ms. Ramey-McCray is a recipient of the Institute 
of Medicine’s 2009 Veteran Award. She earned her bachelor’s degree in human 
relations at Trinity Washington University in Washington, DC. Before coming to 
the National Academies, Ms. Ramey-McCray worked for the American Psycho-
logical Society and the Consumer Product Safety Commission.
